Citrus Sinensis ID: 027225
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 226 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | yes | no | 0.982 | 0.270 | 0.900 | 1e-116 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.946 | 0.229 | 0.678 | 5e-83 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.898 | 0.157 | 0.480 | 1e-50 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.907 | 0.273 | 0.469 | 7e-50 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.889 | 0.219 | 0.475 | 3e-48 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.907 | 0.297 | 0.440 | 8e-47 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.920 | 0.323 | 0.448 | 8e-47 | |
| Q54U31 | 744 | Dual specificity protein | no | no | 0.920 | 0.279 | 0.436 | 4e-43 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.920 | 0.411 | 0.450 | 5e-43 | |
| Q86HG9 | 1024 | Probable serine/threonine | no | no | 0.876 | 0.193 | 0.451 | 1e-42 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 418 bits (1075), Expect = e-116, Method: Compositional matrix adjust.
Identities = 200/222 (90%), Positives = 210/222 (94%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 600 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 659
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLH RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA+TFLSSKSAAGTPEWMA
Sbjct: 660 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 719
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP
Sbjct: 720 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 779
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
VA+IIE CW NEPWKRPSF+TIM+LLRPLIKS P P+ +D+
Sbjct: 780 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 821
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (786), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 148/218 (67%), Positives = 175/218 (80%), Gaps = 4/218 (1%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+RLRHPN+V F+GAVT+PPNLSIVTE+L RGSLYR+LH+P + +DERRR+ MA DVA
Sbjct: 718 MRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--KSHIDERRRIKMALDVA 775
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
GMN LH P IVHRDLK+PNLLVD + VKV DFGLSRLK NTFLSSKS AGTPEWMA
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+EPSNEK D+YSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ ++P
Sbjct: 836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPV 895
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPL--IKSPTPQ 216
V II CW +P RPSF+ + E+L+PL + PTPQ
Sbjct: 896 VGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPTPQ 933
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (506), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 100/208 (48%), Positives = 139/208 (66%), Gaps = 5/208 (2%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
+LRHPNIVLFMGA T+P + IVTEYLSRGSL +L + +D RL + +D A+G
Sbjct: 902 KLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIE--MDWGLRLQLGFDCARG 959
Query: 63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 122
M YLH RNP I+HRDLK+ NLLVD + VKV DFGL+ +K++TF +K+ GT W+APE
Sbjct: 960 MTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPE 1017
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVA 182
VL +E EK+D+YS+ ++LWEL T P+ N QVV ++ +G+RL +P P A
Sbjct: 1018 VLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYA 1076
Query: 183 SIIEACWANEPWKRPSFSTIMELLRPLI 210
+++ CW +P RPSF I+ ++ +I
Sbjct: 1077 ALMNRCWETDPTHRPSFPEILPIMEGMI 1104
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 100/213 (46%), Positives = 137/213 (64%), Gaps = 8/213 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +LRHPNI F+G PP + IV EY+ GSLYR+LH P + LD R +MA D+A
Sbjct: 541 MSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSIS--LDWPRMKSMALDIA 598
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSA---AGTP 116
KGMNYLH +P ++HRDLKS NLLVD+ Y VK+ DFGLS R K + L K+A GTP
Sbjct: 599 KGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKH--LDKKTAMTPVGTP 656
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APEVLR++P EK+D++SF ++LWE+ T + P+ + Q+V +VG R +P
Sbjct: 657 CWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQ 716
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209
V+ +I CW+ +P +RPSF I++ L +
Sbjct: 717 VSAPFTRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (485), Expect = 3e-48, Method: Composition-based stats.
Identities = 98/206 (47%), Positives = 134/206 (65%), Gaps = 5/206 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ RLRHPNIVL M A T PPNL +TEYL GSLY LH ++ + ++L A +A
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKL--AIQIA 769
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GMNYLH ++HRD+KS NLL+D+ VK+CDFGLS+LK+ + +KS G+P WM+
Sbjct: 770 QGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSI-GSPIWMS 826
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+L E EK D+Y+FG+ILWEL T + P+ L+ Q+ AV K R IP
Sbjct: 827 PELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQ 886
Query: 181 VASIIEACWANEPWKRPSFSTIMELL 206
++ +I+ACW +P KRPSF+ I+ LL
Sbjct: 887 LSHLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 8e-47, Method: Composition-based stats.
Identities = 92/209 (44%), Positives = 130/209 (62%), Gaps = 4/209 (1%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK LRHPN++ F+G+ P++ I TEY+ RGSLY +LH ++ +R M D A
Sbjct: 440 MKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKR--MMIDAA 497
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KG+ YLH P I+HRDLKS NLLVD+ + VKV DFGLS ++ ++ +A GTP W +
Sbjct: 498 KGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTS 555
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR + EK+D+YSFG+ILWE AT Q P+ + P QV+ AVG +G R P+ P
Sbjct: 556 PEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPK 615
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPL 209
+++ C P +RP+ +E+L +
Sbjct: 616 YIQLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 95/212 (44%), Positives = 131/212 (61%), Gaps = 4/212 (1%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK LRHPN++ F+G+ PP++ I TEY+ RGSLY +LH ++ L + M D A
Sbjct: 423 MKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQ--LQWSLLIKMMIDAA 480
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KG+ YLH P I+HRDLKS NLLVD+ + VKV DFGLS ++ ++ +A GTP W +
Sbjct: 481 KGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTS 538
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR + EK+D+YSFG+ILWE AT Q P+ + P QV+ AVG +G R +P+N P
Sbjct: 539 PEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPK 598
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
++ C P RP+ +E L + S
Sbjct: 599 YIQLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 92/211 (43%), Positives = 127/211 (60%), Gaps = 3/211 (1%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M ++ HPN+VLF+GA TQ + IVTE L + L +LLH ++ RR+ MA D A
Sbjct: 326 MSKIFHPNVVLFLGACTQSGKMQIVTE-LCQTDLEKLLHNDRTKKEFSLFRRMQMAKDAA 384
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
GMN+LH IVH DLK+ NLLVD VKV DFG S++K K+A GTP WMA
Sbjct: 385 LGMNWLHGITR-IVHNDLKTANLLVDINLRVKVTDFGFSQIKEGEEFQDKAAKGTPLWMA 443
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV-VAAVGFKGKRLEIPRNVNP 179
PEV+ P NEK+D+YSFG+ILWE+ T + P+ + + A+ + +R IP + P
Sbjct: 444 PEVMMGNPYNEKADVYSFGIILWEILTKEAPYSHHKDYDIFFNAICNEKERPPIPADTLP 503
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ +I+ CW + P RPSFS I+ L ++
Sbjct: 504 SLRHLIQTCWDHNPQNRPSFSEILFRLNEIL 534
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 5e-43, Method: Compositional matrix adjust.
Identities = 96/213 (45%), Positives = 128/213 (60%), Gaps = 5/213 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M ++ HPNI LFMGA T P IVTE + +G+L LLH ++ L R+ MA D A
Sbjct: 73 MSKIYHPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQ--LPLYLRMRMARDAA 130
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEW 118
G+N+LH NP VHRD+KS NLLVD+ VK+CDFGLS LK + SA GTP +
Sbjct: 131 LGINWLHESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLY 190
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV-AAVGFKGKRLEIPRNV 177
MAPEV+ + NE SD+YSFG++LWE+ T ++P+ + + AV K +R IP +
Sbjct: 191 MAPEVMMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDC 250
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ +IE CW EP RPSF I+ L +I
Sbjct: 251 LDSLRRLIEKCWDKEPISRPSFKEIISALDHVI 283
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum GN=DDB_G0271682 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 1e-42, Method: Composition-based stats.
Identities = 94/208 (45%), Positives = 125/208 (60%), Gaps = 10/208 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K LRHPN+VLFMG NL+I+TEYL+RGSL +L E L ++ M DVA
Sbjct: 409 LKCLRHPNVVLFMGTCLLNGNLAIITEYLNRGSLRDVLTTMNKSE-LSLSVKVKMLIDVA 467
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWM 119
+GMNYLH +PPI+HRDLKS NLLVD + VKV DFGLSR + SS K+ GT W+
Sbjct: 468 QGMNYLHTYSPPIIHRDLKSLNLLVDNNFNVKVSDFGLSRFISGGIGSSAKTFCGTLSWI 527
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
APEV K D+YSFG++LWE+ T +QP GN++ + E+P N
Sbjct: 528 APEVFNGSGYTTKVDVYSFGIVLWEILTHKQPSGNISATSL--------GHPELPSNCPQ 579
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLR 207
+ +I+ C P +RP+FS I+ L+
Sbjct: 580 SFSDLIKECCNRNPDQRPNFSQILLKLK 607
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 226 | ||||||
| 359481975 | 850 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.265 | 0.915 | 1e-119 | |
| 255575367 | 871 | map3k delta-1 protein kinase, putative [ | 1.0 | 0.259 | 0.898 | 1e-119 | |
| 297740063 | 745 | unnamed protein product [Vitis vinifera] | 1.0 | 0.303 | 0.915 | 1e-119 | |
| 384979221 | 845 | CTR1 [Fragaria x ananassa] | 0.991 | 0.265 | 0.911 | 1e-118 | |
| 13936371 | 847 | CTR1-like protein kinase [Rosa hybrid cu | 0.991 | 0.264 | 0.915 | 1e-118 | |
| 114229339 | 809 | ethylene control element [Malus x domest | 1.0 | 0.279 | 0.902 | 1e-118 | |
| 223413882 | 245 | CTR1-like protein kinase CTR1 [Eriobotry | 1.0 | 0.922 | 0.902 | 1e-118 | |
| 114229343 | 843 | ethylene control element variant [Malus | 1.0 | 0.268 | 0.902 | 1e-118 | |
| 114229341 | 843 | ethylene control element variant [Malus | 1.0 | 0.268 | 0.902 | 1e-118 | |
| 270268951 | 851 | serine/threonine protein kinase 1 [Gossy | 1.0 | 0.265 | 0.898 | 1e-117 |
| >gi|359481975|ref|XP_002277360.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1112), Expect = e-119, Method: Compositional matrix adjust.
Identities = 207/226 (91%), Positives = 213/226 (94%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG REMLDERRRL+MAYDVA
Sbjct: 625 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGAREMLDERRRLSMAYDVA 684
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR KANTFLSSKSAAGTPEWMA
Sbjct: 685 KGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEWMA 744
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDE SNEKSDIYSFG+ILWELATLQQPW NLNPAQVVAAVGFKGKRLEIPR++NP
Sbjct: 745 PEVLRDEASNEKSDIYSFGIILWELATLQQPWSNLNPAQVVAAVGFKGKRLEIPRDLNPQ 804
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VASIIEACWANEPWKRPSF IME L+PLIK PTPQP D PLLT
Sbjct: 805 VASIIEACWANEPWKRPSFFNIMESLKPLIKPPTPQPVRADRPLLT 850
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575367|ref|XP_002528586.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223531982|gb|EEF33794.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1110), Expect = e-119, Method: Compositional matrix adjust.
Identities = 203/226 (89%), Positives = 215/226 (95%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 646 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREALDERRRLSMAYDVA 705
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 706 KGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 765
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVI+WELATLQQPWGNLNPAQVVAAVGFKG+RLEIPR++NP
Sbjct: 766 PEVLRDEPSNEKSDVYSFGVIMWELATLQQPWGNLNPAQVVAAVGFKGRRLEIPRDLNPQ 825
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VA+IIEACWANEPWKRPSF+TIM+ LR LIK+P PQ D+PLLT
Sbjct: 826 VATIIEACWANEPWKRPSFATIMDSLRLLIKAPIPQTGHADVPLLT 871
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740063|emb|CBI30245.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1109), Expect = e-119, Method: Compositional matrix adjust.
Identities = 207/226 (91%), Positives = 213/226 (94%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG REMLDERRRL+MAYDVA
Sbjct: 520 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGAREMLDERRRLSMAYDVA 579
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR KANTFLSSKSAAGTPEWMA
Sbjct: 580 KGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEWMA 639
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDE SNEKSDIYSFG+ILWELATLQQPW NLNPAQVVAAVGFKGKRLEIPR++NP
Sbjct: 640 PEVLRDEASNEKSDIYSFGIILWELATLQQPWSNLNPAQVVAAVGFKGKRLEIPRDLNPQ 699
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VASIIEACWANEPWKRPSF IME L+PLIK PTPQP D PLLT
Sbjct: 700 VASIIEACWANEPWKRPSFFNIMESLKPLIKPPTPQPVRADRPLLT 745
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|384979221|gb|AFI38955.1| CTR1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1105), Expect = e-118, Method: Compositional matrix adjust.
Identities = 206/226 (91%), Positives = 218/226 (96%), Gaps = 2/226 (0%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHKPG +LDERRRLNMA+DVA
Sbjct: 622 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKPG--PVLDERRRLNMAHDVA 679
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 680 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 739
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPR++NP
Sbjct: 740 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPQ 799
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VASIIEACWANEPWKRPSF++IME L+PLIK+PTPQPS D+P+LT
Sbjct: 800 VASIIEACWANEPWKRPSFASIMESLKPLIKAPTPQPSHADLPILT 845
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13936371|gb|AAK40361.1| CTR1-like protein kinase [Rosa hybrid cultivar] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1105), Expect = e-118, Method: Compositional matrix adjust.
Identities = 207/226 (91%), Positives = 217/226 (96%), Gaps = 2/226 (0%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHKPG +LDERRRL MA+DVA
Sbjct: 624 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKPG--PILDERRRLYMAHDVA 681
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 682 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 741
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPR++NP
Sbjct: 742 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPQ 801
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VASIIEACWANEPWKRPSF++IME LRPLIK+PTPQPS DMP+LT
Sbjct: 802 VASIIEACWANEPWKRPSFASIMESLRPLIKAPTPQPSHADMPILT 847
|
Source: Rosa hybrid cultivar Species: Rosa hybrid cultivar Genus: Rosa Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229339|gb|ABI58288.1| ethylene control element [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1104), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/226 (90%), Positives = 215/226 (95%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 584 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVA 643
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 644 KGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 703
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGFK KRLEIPR++NP+
Sbjct: 704 PEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPN 763
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPS DMPLLT
Sbjct: 764 VAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRADMPLLT 809
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|223413882|gb|ACM89300.1| CTR1-like protein kinase CTR1 [Eriobotrya japonica] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/226 (90%), Positives = 216/226 (95%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 20 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVA 79
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 80 KGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 139
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVILWELAT+QQPWGNLNPAQVVAAVGFK KRLEIPR++NP+
Sbjct: 140 PEVLRDEPSNEKSDVYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPN 199
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPSP DMPLLT
Sbjct: 200 VAAIIEACWANEPWKRPSFASIMDSLTPLIKAPLTQPSPADMPLLT 245
|
Source: Eriobotrya japonica Species: Eriobotrya japonica Genus: Eriobotrya Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229343|gb|ABI58290.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1100), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/226 (90%), Positives = 215/226 (95%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 618 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVA 677
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 678 KGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 737
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGFK KRLEIPR++NP+
Sbjct: 738 PEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPN 797
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPS DMPLLT
Sbjct: 798 VAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRADMPLLT 843
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229341|gb|ABI58289.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1100), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/226 (90%), Positives = 215/226 (95%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 618 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVA 677
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 678 KGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 737
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGFK KRLEIPR++NP+
Sbjct: 738 PEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPN 797
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPS DMPLLT
Sbjct: 798 VAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRADMPLLT 843
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|270268951|gb|ACZ66010.1| serine/threonine protein kinase 1 [Gossypium hirsutum] gi|357372870|gb|AET74054.1| constitutive triple response 1 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 203/226 (89%), Positives = 213/226 (94%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL+RLLHKPGVRE+LDERRRL+MAYDVA
Sbjct: 626 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLFRLLHKPGVREVLDERRRLSMAYDVA 685
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLHR NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 686 KGMNYLHRHNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 745
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGF+GKRL+IPR++NP
Sbjct: 746 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFRGKRLDIPRDLNPQ 805
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
VA+IIE CWANEPWKRPSFS IME L+ LIK TPQ DMPLL
Sbjct: 806 VAAIIEDCWANEPWKRPSFSNIMERLKSLIKPSTPQQGHPDMPLLA 851
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 226 | ||||||
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.982 | 0.270 | 0.900 | 1e-107 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.991 | 0.225 | 0.668 | 1.4e-78 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.991 | 0.217 | 0.660 | 3.8e-78 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.946 | 0.229 | 0.678 | 5.5e-77 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.915 | 0.235 | 0.693 | 9e-77 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.933 | 0.286 | 0.605 | 1.7e-68 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.915 | 0.267 | 0.622 | 4.4e-68 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.942 | 0.278 | 0.592 | 5.1e-67 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.827 | 0.278 | 0.650 | 1.4e-64 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.818 | 0.222 | 0.571 | 5.1e-62 |
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
Identities = 200/222 (90%), Positives = 210/222 (94%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 600 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 659
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLH RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA+TFLSSKSAAGTPEWMA
Sbjct: 660 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 719
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP
Sbjct: 720 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 779
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
VA+IIE CW NEPWKRPSF+TIM+LLRPLIKS P P+ +D+
Sbjct: 780 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 821
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 1.4e-78, P = 1.4e-78
Identities = 151/226 (66%), Positives = 177/226 (78%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+RLRHPNIVLFMGAVT+PPNLSIVTE+L RGSLYRL+H+P LDER+RL MA D A
Sbjct: 764 MRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPN--NQLDERKRLRMALDAA 821
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GMNYLH NP IVHRDLKSPNLLVDK + VKVCDFGLSR+K +T+LSSKS AGT EWMA
Sbjct: 822 RGMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMA 881
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+EP++EK D+YS+GVILWEL TLQQPWG +NP QVV AVGF+ +RL+IP V+P
Sbjct: 882 PEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPG 941
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226
+A II CW +P RPSF IM+ L+ L K P+ L T
Sbjct: 942 IADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAAVPSSSALTT 987
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 786 (281.7 bits), Expect = 3.8e-78, P = 3.8e-78
Identities = 152/230 (66%), Positives = 180/230 (78%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRHPNIVLFMGAVT+PPNLSIVTE+L RGSLYRL+H+P LDERRRL MA D A
Sbjct: 797 MKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPN--NQLDERRRLRMALDAA 854
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GMNYLH NP IVHRDLKSPNLLVDK + VKVCDFGLSR+K +T+LSSKS AGT EWMA
Sbjct: 855 RGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMA 914
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+EP++EK D+YS+GVILWEL TLQQPWG +NP QVV AVGF+ +RL+IP V+P
Sbjct: 915 PEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPA 974
Query: 181 VASIIEACWANEPWKRPSFSTIM----ELLRPLIKSPTPQPSPTDMPLLT 226
+A +I CW + RPSF+ IM L +P+ S P+P P+ L T
Sbjct: 975 IADLISKCWQTDSKLRPSFAEIMASLKRLQKPVTGSNIPRPVPSSSSLPT 1024
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
Identities = 148/218 (67%), Positives = 175/218 (80%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+RLRHPN+V F+GAVT+PPNLSIVTE+L RGSLYR+LH+P + +DERRR+ MA DVA
Sbjct: 718 MRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--KSHIDERRRIKMALDVA 775
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
GMN LH P IVHRDLK+PNLLVD + VKV DFGLSRLK NTFLSSKS AGTPEWMA
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+EPSNEK D+YSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ ++P
Sbjct: 836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPV 895
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPL--IKSPTPQ 216
V II CW +P RPSF+ + E+L+PL + PTPQ
Sbjct: 896 VGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPTPQ 933
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
Identities = 145/209 (69%), Positives = 171/209 (81%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M RLRHPN+VLFMGAVT+PPN SI+TE+L RGSLYRLLH+P LDE+RR+ MA DVA
Sbjct: 658 MLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPN--HQLDEKRRMRMALDVA 715
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLH +P +VHRDLKSPNLLVDK + VKVCDFGLSR+K +T+LSSKS AGTPEWMA
Sbjct: 716 KGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMA 775
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+EP+NEK D+YSFGVILWELAT + PW LNP QVV AVGF+ +RLEIP +++
Sbjct: 776 PEVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLT 835
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPL 209
VA II CW EP RPSF+ +M+ L+ L
Sbjct: 836 VAQIIRECWQTEPHLRPSFTQLMQSLKRL 864
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 695 (249.7 bits), Expect = 1.7e-68, P = 1.7e-68
Identities = 129/213 (60%), Positives = 159/213 (74%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRHPN++LFMGAV +I+ EY+ RGSL+++LH + LD++RRL MA DVA
Sbjct: 517 MKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHN--TNQPLDKKRRLRMALDVA 574
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GMNYLHRRNPPIVHRDLKS NLLVDK + VKV DFGLS+ K TFLS+KS GTP+WMA
Sbjct: 575 RGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMA 634
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR EPSNEK D++SFGVILWEL T PW LN QVV VGF +RL++P +NP
Sbjct: 635 PEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPR 694
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
+ASII+ CW +P KRPSF ++ + L + P
Sbjct: 695 IASIIQDCWQTDPAKRPSFEELISQMMSLFRKP 727
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 4.4e-68, P = 4.4e-68
Identities = 130/209 (62%), Positives = 166/209 (79%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPN++LFMGAVT P L IV+E+L RGSL+RLL K + LD RRR++MA D+A
Sbjct: 543 MKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSK--LDWRRRIHMALDIA 600
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GMNYLH +PPI+HRDLKS NLLVDK +TVKV DFGLSR+K T+L+SKS GTP+WMA
Sbjct: 601 RGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMA 660
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+E ++EKSDIYSFGV+LWELAT + PW LN QV+ AVGF +RLEIP++++P
Sbjct: 661 PEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPR 720
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPL 209
S++E+CW ++ RP+F +M+ LR L
Sbjct: 721 WISLMESCWHSDTKLRPTFQELMDKLRDL 749
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 5.1e-67, P = 5.1e-67
Identities = 128/216 (59%), Positives = 168/216 (77%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPN++LFMGAV P L IVTE+L RGSL+RLL + + LD RRR++MA D+A
Sbjct: 536 MKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRN--KSKLDLRRRIHMASDIA 593
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GMNYLH +PPI+HRDLKS NLLVD+ +TVKV DFGLSR+K T+L++ + GTP+WMA
Sbjct: 594 RGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTT-NGRGTPQWMA 652
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+E ++EKSD+YSFGV+LWEL T + PW NLN QV+ AVGF +RLE+P++V+P
Sbjct: 653 PEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQ 712
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+++E+CW +EP RPSF +M+ LR L + T Q
Sbjct: 713 WIALMESCWHSEPQCRPSFQELMDKLRELQRKYTIQ 748
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
Identities = 123/189 (65%), Positives = 153/189 (80%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPN++LFMGAVT P L IV+E++ RGSL+RLL + LD RRR+NMA D+A
Sbjct: 483 MKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRS--MSKLDWRRRINMALDIA 540
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GMNYLH +PPI+HRDLKS NLLVD+ +TVKV DFGLSR+K T+L+SKS GTP+WMA
Sbjct: 541 RGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMA 600
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR+E ++EKSDIYSFGV+LWELAT + PW NLN QV+ AVGF +RLEIP++ +P
Sbjct: 601 PEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIPKDTDPD 660
Query: 181 VASIIEACW 189
S+IE+CW
Sbjct: 661 WISLIESCW 669
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 5.1e-62, Sum P(2) = 5.1e-62
Identities = 108/189 (57%), Positives = 136/189 (71%)
Query: 28 YLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK 87
Y S SL +LL+ V ML L + A+GMNYLH PPI+HRDLKS NLLVDK
Sbjct: 630 YYSLDSLIQLLYL--VYNML--HIFLTYFFAQARGMNYLHHCTPPIIHRDLKSSNLLVDK 685
Query: 88 KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
+TVKV DFGLSR+K T+L++K+ GTP+WMAPEVLR+E ++EKSD+YSFGVILWEL T
Sbjct: 686 NWTVKVADFGLSRIKHETYLTTKTGRGTPQWMAPEVLRNEAADEKSDVYSFGVILWELVT 745
Query: 148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ PW +LN QV+ AVGF +RLE+P+NV+P S++E+CW +EP RPSF IME LR
Sbjct: 746 EKIPWESLNAMQVIGAVGFMNQRLEVPKNVDPQWISLMESCWHSEPQDRPSFQEIMEKLR 805
Query: 208 PLIKSPTPQ 216
L + T Q
Sbjct: 806 ELQRKYTIQ 814
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q05609 | CTR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9009 | 0.9823 | 0.2704 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00021674001 | SubName- Full=Chromosome chr8 scaffold_23, whole genome shotgun sequence; (777 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 226 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-72 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-72 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-71 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-68 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-53 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-45 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-44 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-43 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-42 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-42 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-42 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-40 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-39 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-38 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-38 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-38 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-38 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-37 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-37 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-37 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-35 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-35 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-34 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-34 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-34 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-33 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-33 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-33 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-33 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-32 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-32 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-32 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-31 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-31 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-31 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-31 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-30 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-30 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-30 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-30 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-30 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-29 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-29 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-29 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-29 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-29 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-29 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-29 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-28 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-28 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-28 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-28 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-28 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-27 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-27 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-27 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-27 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-26 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-26 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-26 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-26 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-25 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-24 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-23 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-23 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-23 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-21 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-21 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-19 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 1e-72
Identities = 80/210 (38%), Positives = 116/210 (55%), Gaps = 11/210 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++L HPN+V +G T+ L IV EY+ G L L K R L L+ A +A
Sbjct: 55 MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN--RPKLSLSDLLSFALQIA 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+GM YL +N +HRDL + N LV + VK+ DFGLSR + G
Sbjct: 113 RGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIR 168
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
WMAPE L++ KSD++SFGV+LWE+ TL +QP+ ++ +V+ + G RL P N
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPN 227
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELL 206
P + ++ CWA +P RP+FS ++E+L
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 2e-72
Identities = 82/210 (39%), Positives = 119/210 (56%), Gaps = 10/210 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++L HPNIV +G T+ L IV EY+ G L L K +E L L+ A +A
Sbjct: 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIA 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+GM YL +N +HRDL + N LV + VK+ DFGLSR + G
Sbjct: 114 RGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYKVKGGKLPIR 169
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
WMAPE L++ KSD++SFGV+LWE+ TL ++P+ ++ A+V+ + KG RL P N
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPN 228
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELL 206
P + ++ CWA +P RP+FS ++E+L
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 1e-71
Identities = 87/209 (41%), Positives = 119/209 (56%), Gaps = 8/209 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+L HPNIV +G TQ L IVTEY+ G L L K G + L + L MA +A
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIA 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTP-EW 118
KGM YL +N VHRDL + N LV + VK+ DFGLSR + + P +W
Sbjct: 113 KGMEYLESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
MAPE L+D KSD++SFGV+LWE+ TL +QP+ ++ +V+ + G RL P N
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENC 229
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELL 206
+ ++ CWA +P RP+FS ++E L
Sbjct: 230 PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-68
Identities = 78/217 (35%), Positives = 113/217 (52%), Gaps = 14/217 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL------YRLLHKPGVREMLDERRRLN 54
MK+L HPN+V +G T+ L +V EY+ G L R + + L + L+
Sbjct: 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
A +AKGM YL + VHRDL + N LV + VK+ DFGLSR + + G
Sbjct: 110 FAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-DYYRKKTG 166
Query: 115 TPE---WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
WMAPE L+D KSD++SFGV+LWE+ TL P+ L+ +V+ + KG R
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYR 225
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
L P + ++ +CW +P RP+FS ++E L
Sbjct: 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-60
Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 8/206 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+L+HPNIV L +V EY G L+ LL K G L E +
Sbjct: 51 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEARFYLRQIL 107
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH + IVHRDLK N+L+D+ VK+ DFGL+R + GTPE+MA
Sbjct: 108 SALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMA 164
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVN 178
PEVL + + DI+S GVIL+EL T + P+ + + K K P +++
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224
Query: 179 PHVASIIEACWANEPWKRPSFSTIME 204
P +I +P KR + ++
Sbjct: 225 PEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-57
Identities = 73/208 (35%), Positives = 99/208 (47%), Gaps = 39/208 (18%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+L HPNIV G +L +V EY GSL LL + + L E L + +
Sbjct: 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQIL 102
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+G+ YLH I+HRDLK N+L+D VK+ DFGLS+L + K+ GTP +M
Sbjct: 103 EGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160
Query: 120 APEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APEVL + +EKSDI+S GVIL+EL L+
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYELPELKD---------------------------- 192
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
+I +P KRPS I+E L
Sbjct: 193 -----LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-55
Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++RL HPNIV + A +L +V EY G L+ L + G L E +A +
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQIL 108
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ YLH I+HRDLK N+L+D+ VK+ DFGL++ + S + GTP +MA
Sbjct: 109 RGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPA---QVVAAVGFKGKRLEIPR- 175
PEVL K D++S GVIL+EL T + P+ N Q++ + G LE
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI--LGPPLEFDEP 224
Query: 176 ---NVNPHVASIIEACWANEPWKRPSFSTIME 204
+ + +I+ C +P KRP+ I++
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-53
Identities = 79/214 (36%), Positives = 111/214 (51%), Gaps = 17/214 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDER--RRLNMA 56
+ L+HPNIV + G+ L+I EY+S GSL LL K G L E R+
Sbjct: 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK---LPEPVIRKY--T 107
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAG 114
+ +G+ YLH IVHRD+K N+LVD VK+ DFG ++ + + S G
Sbjct: 108 RQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEI 173
TP WMAPEV+R E +DI+S G + E+AT + PW L NP + +G G+ EI
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI 225
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
P +++ + C +P KRP T ELL+
Sbjct: 226 PEHLSEEAKDFLRKCLRRDPKKRP---TADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 3e-47
Identities = 83/208 (39%), Positives = 120/208 (57%), Gaps = 10/208 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M LRHPN+V +G V Q L IVTEY+++GSL L G R ++ ++L A DV
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVC 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+GM YL +N VHRDL + N+LV + KV DFGL++ + S K P +W
Sbjct: 113 EGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWT 166
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG R+E P
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCP 225
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
P V +++ CW +P KRP+F + E L
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-45
Identities = 65/211 (30%), Positives = 117/211 (55%), Gaps = 6/211 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
+K+L HPNI+ + + + L IV EY G L + + K + E + L+ +
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ YLH R I+HRD+K N+ + VK+ DFG+S++ ++T +K+ GTP ++
Sbjct: 113 CLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
+PE+ +++P N KSDI+S G +L+EL TL+ P+ N ++ + KG+ IP +
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSS 229
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ +++ + +P +RPS + I++ P I
Sbjct: 230 ELRNLVSSLLQKDPEERPSIAQILQS--PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-44
Identities = 69/208 (33%), Positives = 113/208 (54%), Gaps = 6/208 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRH +V ++ + IVTEY+S+GSL L ++ L + ++MA +A
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIA 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+GM YL RN +HRDL + N+LV + K+ DFGL+RL + +++ A P +W
Sbjct: 114 EGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE KSD++SFG++L E+ T + P+ + +V+ V +G R+ P N
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCP 230
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
+ ++ CW +P +RP+F + L
Sbjct: 231 EELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-43
Identities = 71/208 (34%), Positives = 109/208 (52%), Gaps = 7/208 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L HPN+V G T+ + IVTEY++ G L L + + L L+M DV
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVC 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+ M YL +HRDL + N LV + VKV DFGL+R + +S P +W
Sbjct: 111 EAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
PEV + KSD++SFGV++WE+ + + P+ + ++VV +V G RL P+
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAP 227
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
V +I+ +CW +P RP+F ++ L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-42
Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M L H N++ G V P L +VTE GSL L K + L + A +A
Sbjct: 50 MHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIA 107
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT--FLSSKSAAGTPE 117
GM YL + +HRDL + N+L+ VK+ DFGL R L N ++ +
Sbjct: 108 NGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE LR + SD++ FGV LWE+ T ++PW L+ +Q++ + +G+RLE P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELL 206
+ +++ CWA+ P RP+F+ + E L
Sbjct: 226 CPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-42
Identities = 77/212 (36%), Positives = 120/212 (56%), Gaps = 6/212 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK ++HPN+V +G T+ P I+TE+++ G+L L + R+ ++ L MA ++
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWM 119
M YL ++N +HRDL + N LV + + VKV DFGLSRL +T+ + A +W
Sbjct: 115 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE L + KSD+++FGV+LWE+AT P+ ++ +QV + KG R+E P
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCP 231
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
P V ++ ACW P RPSF+ I + +
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-42
Identities = 73/208 (35%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ +L+HPNIV ++G + NL I E + GSL +LL K G E +
Sbjct: 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQIL 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ YLH RN VHRD+K N+LVD VK+ DFG+++ + F +KS G+P WMA
Sbjct: 113 LGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMA 169
Query: 121 PEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
PEV+ + +DI+S G + E+AT + PW L V +G + IP +++
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLR 207
I C +P RP T ELL
Sbjct: 230 EAKDFILKCLQRDPSLRP---TAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-42
Identities = 75/213 (35%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY--- 57
+K+ +HPNIV + G+ + L IV E+ S GSL LL L E +AY
Sbjct: 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--LTES---QIAYVCK 105
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
++ KG+ YLH I+HRD+K+ N+L+ VK+ DFGLS ++T + + GTP
Sbjct: 106 ELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPY 162
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV---VAAVGFKGKRLEIP 174
WMAPEV+ +P + K+DI+S G+ ELA + P+ L P + +A G G L P
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG--LRNP 220
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ ++ C P KRP T +LL+
Sbjct: 221 EKWSDEFKDFLKKCLQKNPEKRP---TAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-41
Identities = 75/220 (34%), Positives = 114/220 (51%), Gaps = 17/220 (7%)
Query: 1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSL--YRLLHKP-----GVREMLDERR 51
MK ++V +G V+ QP +V E +++G L Y +P ++
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPT--LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
+ MA ++A GM YL + VHRDL + N +V + TVK+ DFG++R T K
Sbjct: 121 FIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 112 AAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
G P WMAPE L+D KSD++SFGV+LWE+ATL +QP+ L+ +V+ V G
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208
L++P N + ++ CW P RP+F I+ L+
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-40
Identities = 65/199 (32%), Positives = 107/199 (53%), Gaps = 8/199 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+HPNIV ++G++ +L I+ EY GSL +++ K G E Y V
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVL 109
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
+G+ YLH + ++HRD+K+ N+L K VK+ DFG++ +L + S GTP WM
Sbjct: 110 QGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWM 166
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
APEV+ ++ SDI+S G + EL T P+ +LNP + + + +P ++P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISP 225
Query: 180 HVASIIEACWANEPWKRPS 198
+ + C+ +P RP+
Sbjct: 226 ELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-40
Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 7/205 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L H +V G T+ + IVTEY+S G L L + G R + L M DV
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVC 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
+GM YL + +HRDL + N LVD + VKV DFGLSR + + + SS + W
Sbjct: 111 EGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
PEVL + KSD+++FGV++WE+ +L + P+ N ++ V V +G RL P +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLAS 227
Query: 179 PHVASIIEACWANEPWKRPSFSTIM 203
V +I+ +CW + +RP+F ++
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-39
Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 8/209 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+ HPNIV +G Q + IV E + GSL L K R L ++ L M+ D A
Sbjct: 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAA 103
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-TP-EW 118
GM YL +N +HRDL + N LV + +K+ DFG+SR + + P +W
Sbjct: 104 AGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE L +SD++S+G++LWE +L P+ ++ Q + G R+ P+
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLC 220
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELL 206
+ ++ CWA +P RPSFS I L
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-39
Identities = 71/207 (34%), Positives = 107/207 (51%), Gaps = 5/207 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+KRLRH +++ + + I+TE + +GSL L P + +L ++MA VA
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVA 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GM YL +N +HRDL + N+LV + KV DFGL+RL S +W A
Sbjct: 115 EGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA 172
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
PE + KSD++SFG++L+E+ T Q P+ +N +V + G R+ P
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQ 231
Query: 180 HVASIIEACWANEPWKRPSFSTIMELL 206
+ I+ CWA EP RPSF + E L
Sbjct: 232 EIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-38
Identities = 71/227 (31%), Positives = 117/227 (51%), Gaps = 27/227 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
++ L H NIV + G +P +L ++ EYL GSL L R+ ++ +R L +
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQ 117
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
+ KGM+YL + +HRDL + N+LV+ + VK+ DFGL+++ + + K +P
Sbjct: 118 ICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK------- 167
W APE LR + SD++SFGV L+EL T P + +P A+ + +G
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP--SQSPPAEFLRMIGIAQGQMIVT 233
Query: 168 --------GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
G+RL P + V +++ CW EP RPSF+ ++ ++
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-38
Identities = 72/211 (34%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L HP IV +G V + L +V E G L + L K R + +A+ VA
Sbjct: 50 MAQLDHPCIVRLIG-VCKGEPLMLVMELAPLGPLLKYLKK---RREIPVSDLKELAHQVA 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKA-NTFLSSKSAAGTP-E 117
GM YL ++ VHRDL + N+L+ ++ K+ DFG+SR L A + + + +A P +
Sbjct: 106 MGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + KSD++S+GV LWE + +P+G + A+V+A + G+RL P
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEE 222
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ SI+ +CW P RP+FS + R
Sbjct: 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-38
Identities = 74/211 (35%), Positives = 114/211 (54%), Gaps = 13/211 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGV--REMLDERRRLNMAY 57
M +L HP +V G TQ L IVTE++ G L L + G ++ML L+M
Sbjct: 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQ 107
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP- 116
DV +GM YL R + +HRDL + N LV VKV DFG++R + +S S A P
Sbjct: 108 DVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPR 175
+W PEV + KSD++SFGV++WE+ T + P+ + +VV + +G RL P+
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPK 224
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELL 206
+ V ++ +CW +P RP+F+ ++ +
Sbjct: 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 6e-38
Identities = 76/209 (36%), Positives = 115/209 (55%), Gaps = 9/209 (4%)
Query: 1 MKRLRHPNIVLFMGA-VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
M +LRH N+V +G V + L IVTEY+++GSL L G R +L L + DV
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 111
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ M YL N VHRDL + N+LV + KV DFGL++ ++T + K +W
Sbjct: 112 CEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWT 166
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG +++ P
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 225
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLR 207
P V +++ CW + RPSF + E L
Sbjct: 226 PVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-38
Identities = 71/218 (32%), Positives = 110/218 (50%), Gaps = 26/218 (11%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
H NIV +GA T + ++TEY G L L + L L+ +Y VAKGM +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAF 156
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---------LKANTFLSSKSAAGTP 116
L +N +HRDL + N+L+ VK+CDFGL+R +K N L K
Sbjct: 157 LASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK------ 208
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----GKRLE 172
WMAPE + + +SD++S+G++LWE+ +L N P V + +K G R+
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFSLG---SNPYPGMPVDSKFYKLIKEGYRMA 264
Query: 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
P + + I++ CW +P KRP+F I++L+ +
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 7e-38
Identities = 71/217 (32%), Positives = 115/217 (52%), Gaps = 11/217 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAY 57
++ L+HPNIV + + N L IV EY G L +L+ K R+ ++E +
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 58 DVAKGMNYLHRRNPP---IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ + H R+ P ++HRDLK N+ +D VK+ DFGL+++ + +K+ G
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
TP +M+PE L +EKSDI+S G +++EL L P+ N Q+ + + +GK IP
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIP 231
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLI 210
+ + +I++ +P KRPS ELL+ PLI
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-38
Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 8/213 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HPNI+ G VT+ + I+TEY+ GSL + L + + + M +A
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIA 116
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-TP-EW 118
GM YL N VHRDL + N+LV+ KV DFGLSR ++ + + G P W
Sbjct: 117 SGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE + SD++SFG+++WE+ + ++P+ +++ V+ AV G RL P +
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDC 233
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ ++ CW + +RP+FS I+ L +I
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-37
Identities = 74/209 (35%), Positives = 112/209 (53%), Gaps = 8/209 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+ HPNIV +G TQ + IV E + G L G R L + + M + A
Sbjct: 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAA 104
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTP-EW 118
GM YL ++ +HRDL + N LV +K +K+ DFG+SR + + + S+ P +W
Sbjct: 105 AGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE L + +SD++SFG++LWE +L P+ NL+ Q A+ +G RL P
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELC 221
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELL 206
V ++E CW +P +RPSFST+ + L
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-37
Identities = 75/207 (36%), Positives = 116/207 (56%), Gaps = 9/207 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L H N+V +G + L IV E +S+G+L L G R ++ + L + DVA
Sbjct: 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVA 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+GM YL + +VHRDL + N+LV + KV DFGL+R+ + +SK +W A
Sbjct: 111 EGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTA 165
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
PE L+ + + KSD++S+GV+LWE+ + + P+ ++ +V V KG R+E P
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPA 224
Query: 180 HVASIIEACWANEPWKRPSFSTIMELL 206
V ++ +CW EP KRPSF + E L
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-37
Identities = 70/204 (34%), Positives = 106/204 (51%), Gaps = 6/204 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRHP ++ T + IVTE + GSL L R L + ++MA VA
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVA 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
GM YL +N +HRDL + N+LV + KV DFGL+R+ ++ A P +W
Sbjct: 114 SGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE + KSD++SFG++L E+ T + P+ + A+V+ V +G R+ P
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCP 230
Query: 179 PHVASIIEACWANEPWKRPSFSTI 202
+ I+ CW +P RP+F T+
Sbjct: 231 KELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-37
Identities = 76/231 (32%), Positives = 122/231 (52%), Gaps = 23/231 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY--- 57
MK +HPNIV + + L +V EY+ GSL ++ + VR ++E + +AY
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--MNEPQ---IAYVCR 123
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG----LSRLKANTFLSSKSAA 113
+V +G+ YLH +N ++HRD+KS N+L+ K +VK+ DFG L++ K+ S
Sbjct: 124 EVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVV 177
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLE 172
GTP WMAPEV++ + K DI+S G++ E+A + P+ P + + + KG L+
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK 237
Query: 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
P +P + C +P KRPS ELL+ P +K P+ +
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAE---ELLQHPFLKKACPKEEFAPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-37
Identities = 77/218 (35%), Positives = 112/218 (51%), Gaps = 15/218 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE----MLDERRRLNMA 56
M HPNIV +G I+ E + G L L V +L + L++
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSR-LKANTFLSSK 110
DVAKG YL + + +HRDL + N LV +K VK+ DFGL+R + + + +
Sbjct: 113 LDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
P WMAPE L D +SD++SFGV++WE+ TL QQP+ LN +V+ V G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AG 229
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
RL+ P N + ++ CWA +P +RP+F I E+L
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 9e-37
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS---LYRLLHKPGVREMLDERRRLNMAY 57
+K+ P IV + G+ + +L IV EY GS + ++ +K L E + Y
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILY 106
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
KG+ YLH +HRD+K+ N+L++++ K+ DFG+S +T + GTP
Sbjct: 107 QTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRN 176
WMAPEV+++ N K+DI+S G+ E+A + P+ +++P + + + K L P
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224
Query: 177 VNPHVASIIEACWANEPWKRPS 198
+P ++ C +P +RPS
Sbjct: 225 WSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-36
Identities = 78/228 (34%), Positives = 110/228 (48%), Gaps = 28/228 (12%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN------ 54
+ RL PNI +G T P L ++ EY+ G L + L K N
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK---HVAETSGLACNSKSLSF 129
Query: 55 -----MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLS 108
MA +A GM YL N VHRDL + N LV K YT+K+ DFG+SR L ++ +
Sbjct: 130 STLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 109 SKSAAGTP-EWMAPE-VLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVV--A 162
+ A P WMA E VL + + KSD+++FGV LWE+ TL +QP+ +L QV+ A
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENA 246
Query: 163 AVGFKGKRLEI----PRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
F+ +I P N + ++ CW + RP+F I L
Sbjct: 247 GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-35
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L H NIV ++G T LSI EY+ GS+ L G +E+ V
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVL 118
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
+G+ YLH + I+HRDLK+ NLLVD K+ DFG+S+ + + + + S G+ W
Sbjct: 119 EGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 119 MAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
MAPEV+ + K DI+S G ++ E+ ++PW + + +G K IP +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236
Query: 177 VNPHVASI----IEACWANEPWKRPSFSTIMELLR 207
V+ +++ + + AC+ P RP T ELL+
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRP---TARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-35
Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 20/223 (8%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKP-----------GVREM 46
MK + +H NI+ +G TQ L +V EY + G+L L +P E
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 105
L ++ ++ AY VA+GM +L + +HRDL + N+LV + + +K+ DFGL+R +
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 106 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAA 163
+ + P +WMAPE L D +SD++SFGV+LWE+ TL P+ + ++
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
+ +G R+E P+N + ++ CW P +RP+F ++E L
Sbjct: 247 LK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-35
Identities = 74/225 (32%), Positives = 111/225 (49%), Gaps = 19/225 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKP-----------GVREML 47
M L+HPNIV +G T+ ++ EYL+ G L+ L + P V+ L
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTF 106
D L++A +A GM YL + VHRDL + N LV + TVK+ DFGLSR + +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
+S + P WM PE + +SDI+SFGV+LWE+ + QP+ + +V+ +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209
+ L P + V +++ CW P +RP F I LR
Sbjct: 240 R-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-35
Identities = 73/209 (34%), Positives = 116/209 (55%), Gaps = 16/209 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L HPNI+ + + L IV EY G+L + K +LDE L+ +
Sbjct: 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQIL 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAA----GT 115
++++H + I+HRDLK+ N+L+DK V K+ DFG+S++ LSSKS A GT
Sbjct: 112 LALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGT 164
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIP 174
P +++PE+ +P N+KSDI++ G +L+ELA+L++ + N PA V+ + G I
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTFAPIS 222
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIM 203
+P + +I + +P KRP S IM
Sbjct: 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-34
Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV ++G+ +L+I EY+ GS+ LL+ G +E N +
Sbjct: 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQIL 116
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK-----SAAG 114
KG+NYLH R I+HRD+K N+LVD K +K+ DFG+S+ L+AN+ + S G
Sbjct: 117 KGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
+ WMAPEV++ K+DI+S G ++ E+ T + P+ + Q + +G EIP
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPEIP 233
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIM 203
N++ +E + + KRP+ + ++
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-34
Identities = 70/209 (33%), Positives = 120/209 (57%), Gaps = 9/209 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
MK+L+HP +V VTQ P + I+TEY+ GSL L P G++ L + ++MA +
Sbjct: 55 MKQLQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQI 111
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
A+GM ++ R+N +HRDL++ N+LV + K+ DFGL+RL + +++ A P +W
Sbjct: 112 AEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE + KSD++SFG++L E+ T + P+ + +V+ + +G R+ P N
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNC 228
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELL 206
+ ++ CW +P +RP+F + +L
Sbjct: 229 PEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-34
Identities = 77/234 (32%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
R P I + G+ + L I+ EY GS LL KPG LDE + +V G+
Sbjct: 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGK---LDETYIAFILREVLLGL 111
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAGTPE 117
YLH +HRD+K+ N+L+ ++ VK+ DFG+S K NTF GTP
Sbjct: 112 EYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGTPF 163
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
WMAPEV++ +EK+DI+S G+ ELA + P +L+P +V+ IP+N
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNN 214
Query: 178 NP----HVAS-----IIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTD 221
P + S + C +P +RPS ELL+ IK T
Sbjct: 215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHKFIKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-34
Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 7/208 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L HP +V G T+ + +V E++ G L L R + L M DV
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVC 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+GM YL N ++HRDL + N LV + VKV DFG++R + +S + P +W
Sbjct: 111 EGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWEL-ATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+PEV + KSD++SFGV++WE+ + + P+ N + ++VV + G RL PR +
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLAS 227
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
V +++ CW P RPSFS ++ L
Sbjct: 228 QSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-34
Identities = 68/216 (31%), Positives = 115/216 (53%), Gaps = 18/216 (8%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKP-----GVREMLDERRRLNMAY 57
L H NI+ + + V Y++ G+L L + + L ++ ++MA
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
+A GM+YLH+R ++H+D+ + N ++D++ VK+ D LSR + F G E
Sbjct: 125 QIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNE 179
Query: 118 -----WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRL 171
WMA E L ++ + SD++SFGV+LWEL TL Q P+ ++P ++ A + G RL
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYRL 238
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
P N + +++ CWA +P +RPSFS +++ L
Sbjct: 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-33
Identities = 75/208 (36%), Positives = 115/208 (55%), Gaps = 7/208 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRH +V V++ P + IVTEY+S+GSL L K G L ++MA VA
Sbjct: 55 MKKLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVA 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
GM Y+ R N +HRDL+S N+LV K+ DFGL+RL + +++ A P +W
Sbjct: 113 AGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE KSD++SFG++L EL T + P+ +N +V+ V +G R+ P++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 229
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
+ ++ CW +P +RP+F + L
Sbjct: 230 ISLHELMLQCWKKDPEERPTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-33
Identities = 55/207 (26%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVAK 61
L+HPNI+ + L I EY + G+LY +++ + G ++ +E L + +
Sbjct: 55 LLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVS 112
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
++Y+H+ I+HRD+K+ N+ + K +K+ DFG+S++ + + +++ GTP +M+P
Sbjct: 113 AVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSP 170
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
E+ + N KSDI++ G +L+EL TL++ + NP +V + +G + + +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSEL 229
Query: 182 ASIIEACWANEPWKRPSFSTIMELLRP 208
S++ + +P KRP+ +++
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-33
Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H IV + G + LSI EY+ GS+ L G L E +
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQIL 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKA----NTFLSSKSAAGT 115
+G+ YLH IVHRD+K N+L D VK+ DFG S RL+ T + KS GT
Sbjct: 115 EGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGT 170
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
P WM+PEV+ E K+D++S G + E+ T + PW + + + ++P
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+V+P + + + KRPS ELLR
Sbjct: 231 HVSPDARNFLRRTFVENAKKRPS---AEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-33
Identities = 73/212 (34%), Positives = 106/212 (50%), Gaps = 16/212 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY--- 57
+K RHPNIV + G+ + L IV EY GSL + R L E L +AY
Sbjct: 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSE---LQIAYVCR 108
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
+ KG+ YLH +HRD+K N+L+ + VK+ DFG+S T KS GTP
Sbjct: 109 ETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY 166
Query: 118 WMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKGKRL 171
WMAPEV R + K DI++ G+ ELA LQ P +L+P + + + F +L
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL 226
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203
+ +P I+ C +P KRP+ + ++
Sbjct: 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-33
Identities = 74/213 (34%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERR 51
HPNI+ +GA L I EY G+L L K V E L ++
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
L A DVA GM YL + +HRDL + N+LV + K+ DFGLSR K+
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT 176
Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFKGK 169
P WMA E L KSD++SFGV+LWE+ +L P+ + A++ + +G
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235
Query: 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 202
R+E PRN + V ++ CW + P++RP F+ I
Sbjct: 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 6e-33
Identities = 75/237 (31%), Positives = 122/237 (51%), Gaps = 28/237 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-----------KPGVREML-- 47
+K++ HP+++ GA +Q L ++ EY GSL L G R
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 48 --DERRRLNM------AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
+ R L M A+ +++GM YL +VHRDL + N+LV + +K+ DFGLS
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
R + ++++ +WMA E L D +SD++SFGV+LWE+ TL P+ +
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM-ELLRPLIKS 212
P ++ + G R+E P N + + +++ CW EP KRP+F+ I EL + ++KS
Sbjct: 235 PERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-33
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 8/208 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++ HP+IV +G +T+ P + IV E G L L + LD + +Y ++
Sbjct: 61 MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLS 117
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+ YL + VHRD+ + N+LV VK+ DFGLSR + S P +WM
Sbjct: 118 TALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE + SD++ FGV +WE+ L +P+ + V+ + G+RL +P N
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 234
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
P + S++ CWA +P KRP F+ + L
Sbjct: 235 PTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-32
Identities = 73/213 (34%), Positives = 110/213 (51%), Gaps = 20/213 (9%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERRR 52
HPNI+ +GA L + EY G+L L K V E L ++
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
L+ A DVA+GM+YL ++ +HRDL + N+LV + Y K+ DFGLSR K+
Sbjct: 127 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 182
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKR 170
P WMA E L SD++S+GV+LWE+ +L P+ + A++ + +G R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 241
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203
LE P N + V ++ CW +P++RPSF+ I+
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-32
Identities = 71/221 (32%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM---------LDE 49
+ +H NIV F G T+ +V EY+ G L + L H P + L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 50 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLS 108
+ L +A +A GM YL ++ VHRDL + N LV VK+ DFG+SR + +
Sbjct: 122 SQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 109 SKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGF 166
P WM PE + +SD++SFGV+LWE+ T +QPW L+ +V+ +
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT- 238
Query: 167 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+G+ L+ PR V I+ CW +P +R + I E L+
Sbjct: 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-32
Identities = 64/209 (30%), Positives = 120/209 (57%), Gaps = 8/209 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
MK L+H +V VT+ + I+TEY+++GSL L G + +L + ++ + +
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQI 112
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
A+GM Y+ R+N +HRDL++ N+LV + K+ DFGL+R+ + +++ A P +W
Sbjct: 113 AEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE + KSD++SFG++L+E+ T + P+ ++ + V++A+ +G R+ N
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENC 229
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELL 206
+ I++ CW + +RP+F + +L
Sbjct: 230 PDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 10/212 (4%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL--YRLLHKPGVREM----LDERRRLNMA 56
+L H N+V +G + ++ EY G L + K ++ L ++++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
+A GM++L N VHRDL + N LV + VKV LS+ N+ A P
Sbjct: 124 TQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
W+APE ++++ + KSD++SFGV++WE+ T + P+ L+ +V+ + L +P
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
+ ++ CWA P RPSFS ++ L
Sbjct: 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-32
Identities = 73/212 (34%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERRR 52
HPNI+ +GA L + EY G+L L K V E L ++
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
L+ A DVA+GM+YL ++ +HRDL + N+LV + Y K+ DFGLSR K+
Sbjct: 115 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKR 170
P WMA E L SD++S+GV+LWE+ +L P+ + A++ + +G R
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 229
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTI 202
LE P N + V ++ CW +P++RPSF+ I
Sbjct: 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-32
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 9/217 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HP++V +G + + ++T+ + G L + ++ + + LN +A
Sbjct: 63 MASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIA 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-TP-EW 118
KGM+YL + +VHRDL + N+LV VK+ DFGL++L + G P +W
Sbjct: 120 KGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
MA E + KSD++S+GV +WEL T +P+ + ++ + KG+RL P
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPIC 236
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214
V ++ CW + RP+F ++ + + P
Sbjct: 237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-32
Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL---LHKPGVREMLDERRRLNMAYDVAK 61
+HPNIV A L I+ E+ G+L + L + L E + + + +
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-----LTEPQIRYVCRQMLE 114
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
+N+LH ++HRDLK+ N+L+ VK+ DFG+S +T + GTP WMAP
Sbjct: 115 ALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172
Query: 122 EVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
EV+ +D P + K+DI+S G+ L ELA ++ P LNP +V+ K + E P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL----LKILKSEPPTL 228
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
P W++ SF+ L L+K P +P+ ++
Sbjct: 229 DQPSK-------WSS------SFNDF--LKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-32
Identities = 72/216 (33%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HPN+V + + L +V YLS GSL ++ R LDE + +V
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA----NTFLSSKSAAGTP 116
KG+ YLH +HRD+K+ N+L+ + +VK+ DFG+S A T K+ GTP
Sbjct: 113 KGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 117 EWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIP 174
WMAPEV+ + + K+DI+SFG+ ELAT P+ P +V+ LE
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG 230
Query: 175 RNVNPHVAS---IIEACWANEPWKRPSFSTIMELLR 207
+ + S +I C +P KRP+ ELL+
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAE---ELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 74/223 (33%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
MK ++V +G V++ +V E ++ G L L P ++EM+
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
MA ++A GM YL+ + VHRDL + N +V +TVK+ DFG++R T
Sbjct: 123 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 108 SSKSAAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
K G WMAPE L+D SD++SFGV+LWE+ +L +QP+ L+ QV+ V
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
G L+ P N V ++ CW P RP+F I+ LL+
Sbjct: 235 -MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-31
Identities = 70/211 (33%), Positives = 108/211 (51%), Gaps = 13/211 (6%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
P +V GA + +SIV EY+ GSL LL K + E +A + KG++Y
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDY 114
Query: 66 LHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
LH R+ I+HRD+K NLL++ K VK+ DFG+S++ NT + GT +M+PE +
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
+ E + +DI+S G+ L E A + P+ G + +++ A+ +P
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 182 ASIIEACWANEPWKRPSFSTIMELLR-PLIK 211
I AC +P KRP + ELL+ P IK
Sbjct: 233 RDFISACLQKDPKKRP---SAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-31
Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 7/208 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+ HPNIV +G TQ + IV E + G L K ++ L ++ + A D A
Sbjct: 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAA 103
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
GM YL +N +HRDL + N LV + +K+ DFG+SR + + SS P +W
Sbjct: 104 AGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT 161
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE L + +SD++S+G++LWE +L P+ + Q V KG R+ P+
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCP 220
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
V +++ CW +P RP FS + + L
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-31
Identities = 74/226 (32%), Positives = 111/226 (49%), Gaps = 21/226 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR-------- 52
M RL++PNI+ +G L ++TEY+ G L + L + +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 53 -LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
L MA +A GM YL N VHRDL + N LV YT+K+ DFG+SR L + + +
Sbjct: 131 LLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVVAAVG-- 165
A P WMA E + SD+++FGV LWE+ TL +QP+ L+ QV+ G
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248
Query: 166 FKGKRLEIPRNVNP----HVASIIEACWANEPWKRPSFSTIMELLR 207
F+ + +I + P V ++ CW+ + RP+F+ I LR
Sbjct: 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-31
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 1 MKRLRHPNIV-LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYD 58
+ R+ HP IV L T+ L +V EY G L+ L K E R R A +
Sbjct: 47 LSRINHPFIVKLHYAFQTEE-KLYLVLEYAPGGELFSHLSK---EGRFSEERARFYAA-E 101
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+ + YLH I++RDLK N+L+D +K+ DFGL++ ++ + + GTPE+
Sbjct: 102 IVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+APEVL + + D +S GV+L+E+ T + P+ + ++ + L P ++
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLS 217
Query: 179 PHVASIIEACWANEPWKR 196
P +I +P KR
Sbjct: 218 PEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-31
Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M RL HP+I+ +GA + + ++ E+++ GS+ LL K G E +N +
Sbjct: 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLS-RLKAN---TFLSSKSAAGT 115
+G++YLH I+HRD+K NLL+D +++ DFG + RL A GT
Sbjct: 114 RGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKGKRLE 172
+MAPEVLR E D++S G ++ E+AT + PW N ++ +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
Query: 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
IP +++P + + C +P RP ELL+
Sbjct: 232 IPEHLSPGLRDVTLRCLELQPEDRPP---SRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-31
Identities = 66/222 (29%), Positives = 114/222 (51%), Gaps = 15/222 (6%)
Query: 1 MKRLRHPNIVLFMG------AVTQPPNLSIVTEYLSRGSLYRLL---HKPGVREMLDERR 51
MK HPN++ +G ++ + P ++ ++ G L+ L G+ E L +
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
L D+A GM YL RN +HRDL + N ++ + TV V DFGLS+ + + +
Sbjct: 115 LLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
A P +W+A E L D KSD+++FGV +WE+AT Q P+ + ++ + G
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHG 231
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
RL+ P + + ++ +CW +P RP+F+ + E+L ++
Sbjct: 232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-31
Identities = 74/215 (34%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERR---------- 51
L+H +IV F G T+ L +V EY+ G L R L H P + +L
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAK-ILAGGEDVAPGQLTLG 122
Query: 52 -RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
L +A +A GM YL + VHRDL + N LV + VK+ DFG+SR + + +
Sbjct: 123 QMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
P WM PE + +SDI+SFGV+LWE+ T +QPW L+ + + + +
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 168 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 202
G+ LE PR P V +I++ CW EP +R I
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-31
Identities = 71/208 (34%), Positives = 115/208 (55%), Gaps = 7/208 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRH +V V++ P + IVTE++ +GSL L K G + L + ++MA +A
Sbjct: 55 MKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIA 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
GM Y+ R N +HRDL++ N+LV K+ DFGL+RL + +++ A P +W
Sbjct: 113 DGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE KSD++SFG++L EL T + P+ + +V+ V +G R+ P+
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCP 229
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
+ +++ CW +P +RP+F I L
Sbjct: 230 ESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-31
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 4/205 (1%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ +L I+ + + L+IV EY G L++LL R + E + +
Sbjct: 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL-PEDQVWRFFIQIL 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ +LH + I+HRD+KS NL +D VK+ D G+++L ++ + + GTP +++
Sbjct: 112 LGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+ D+P NEKSD+++ GV+L+E T + P+ N ++ + +G + + +
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQ 228
Query: 181 VASIIEACWANEPWKRPSFSTIMEL 205
+A +I+ C + +RP ++
Sbjct: 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-30
Identities = 74/208 (35%), Positives = 115/208 (55%), Gaps = 7/208 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRH +V V++ P + IVTEY+S+GSL L K + + L + ++MA +A
Sbjct: 55 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + +++ A P +W
Sbjct: 113 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE KSD++SFG++L EL T + P+ + +V+ V +G R+ P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 229
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELL 206
+ ++ CW EP +RP+F + L
Sbjct: 230 ESLHDLMCQCWRKEPEERPTFEYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-30
Identities = 68/212 (32%), Positives = 119/212 (56%), Gaps = 9/212 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+ +++HPNIV F + + L IV EY G L R+ + GV + E + L+ +
Sbjct: 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV--LFSEDQILSWFVQI 110
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEW 118
+ G+ ++H R I+HRD+KS N+ + K V K+ DFG++R ++ + + GTP +
Sbjct: 111 SLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
++PE+ ++ P N K+DI+S G +L+EL TL+ P+ N Q+V + +G I N +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFS 227
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ S+I + P RPS ++I++ RP +
Sbjct: 228 RDLRSLISQLFKVSPRDRPSITSILK--RPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 74/216 (34%), Positives = 115/216 (53%), Gaps = 19/216 (8%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGV----------REMLDERR 51
+H NI+ +GA TQ L ++ EY S+G+L L PG+ E L +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
++ AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R N K+
Sbjct: 136 LVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
G +WMAPE L D +SD++SFGV+LWE+ TL P+ + P + + + +G
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEG 252
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
R++ P N + I+ CW P +RP+F ++E
Sbjct: 253 HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-30
Identities = 60/211 (28%), Positives = 117/211 (55%), Gaps = 8/211 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
+ ++HPNIV + + + NL IV +Y G LY+ ++ GV + E + L+ +
Sbjct: 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV--LFPEDQILDWFVQI 110
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ ++H R I+HRD+KS N+ + K T+K+ DFG++R+ +T +++ GTP ++
Sbjct: 111 CLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
+PE+ + P N KSDI++ G +L+E+ TL+ + N +V + +G + + +
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSY 227
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ +++ + P RPS ++I+E + I
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILE--KNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-30
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
MK HPN++ +G +V Y+ G L + H P V++++
Sbjct: 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI------GF 103
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKANTFLSSKSA 112
VAKGM YL + VHRDL + N ++D+ +TVKV DFGL+R K + + +
Sbjct: 104 GLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
A P +WMA E L+ + KSD++SFGV+LWEL T P+ +++ + + +G+R
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRR 220
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTI 202
L P + ++ +CW +P RP+FS +
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-30
Identities = 76/220 (34%), Positives = 111/220 (50%), Gaps = 24/220 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K L+H NIV + G NL +V EYL GSL L K RE LD R+ L A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQ 116
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
+ KGM YL + VHRDL + N+LV+ + VK+ DFGL+++ + + + +P
Sbjct: 117 ICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 117 E-WMAPEVLRDEPSNEKSDIYSFGVILWELAT-----------LQQPWGNLNPAQVV--- 161
W APE L + + SD++SFGV+L+EL T + GN Q++
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234
Query: 162 -AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 200
+ RL P + +I++ CW N+P +RPSFS
Sbjct: 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-30
Identities = 72/236 (30%), Positives = 122/236 (51%), Gaps = 19/236 (8%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGV----------REMLDERR 51
+H NI+ +G TQ L ++ EY ++G+L L PG E L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
++ AY VA+GM YL R +HRDL + N+LV + +K+ DFGL+R + K+
Sbjct: 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
+ G +WMAPE L D +SD++SFG+++WE+ TL P+ + P + + + +G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREG 252
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 224
R++ P N + ++ CW P +RP+F ++E L ++ + + + MP
Sbjct: 253 HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPF 308
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-30
Identities = 78/231 (33%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRR------ 52
+ L+H +IV F G L +V EY+ G L + L H P ++D + R
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 53 -----LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTF 106
L++A +A GM YL ++ VHRDL + N LV VK+ DFG+SR + + +
Sbjct: 121 GLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
P WM PE + +SD++SFGVILWE+ T +QPW L+ +V+ +
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215
+G+ LE PR V I+ CW EP +R + I ++L L K+ TP
Sbjct: 239 T-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA-TP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-30
Identities = 73/218 (33%), Positives = 116/218 (53%), Gaps = 19/218 (8%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH---KPGVR----------EMLDERR 51
+H NI+ +GA TQ L ++ EY S+G+L L PG+ E L +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
++ AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R + K+
Sbjct: 142 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
G +WMAPE L D +SD++SFGV+LWE+ TL P+ + P + + + +G
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 258
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
R++ P N + ++ CW P +RP+F ++E L
Sbjct: 259 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-29
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 15/212 (7%)
Query: 1 MKRLRH---PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
+ +LR PNI + G+ + P L I+ EY GS+ R L K G + E+ +
Sbjct: 53 LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGP---IAEKYISVIIR 108
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
+V + Y+H+ ++HRD+K+ N+LV VK+CDFG++ L + GTP
Sbjct: 109 EVLVALKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY 166
Query: 118 WMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRLEIPR 175
WMAPEV+ + + K+DI+S G+ ++E+AT P+ +++ + + + K RLE
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DN 225
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ + + AC EP +R S ELL+
Sbjct: 226 GYSKLLREFVAACLDEEPKERLSAE---ELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 72/218 (33%), Positives = 113/218 (51%), Gaps = 19/218 (8%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVREMLDERR---------- 51
+H NI+ +GA TQ L ++ EY S+G+L L PG+ D R
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
++ Y VA+GM YL + +HRDL + N+LV + +K+ DFGL+R N K+
Sbjct: 139 LVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
G +WMAPE L D +SD++SFGV++WE+ TL P+ + P + + + +G
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 255
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
R++ P N + ++ CW P RP+F ++E L
Sbjct: 256 HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-29
Identities = 56/160 (35%), Positives = 91/160 (56%), Gaps = 5/160 (3%)
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
++ VA+GM +L R +HRDL + N+L+ + VK+CDFGL+R K ++ A
Sbjct: 179 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
+WMAPE + D+ +SD++SFGV+LWE+ +L P+ + + +G R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296
Query: 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
P P + SI+ CW N P RP+FS ++E+L L++
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 72/223 (32%), Positives = 113/223 (50%), Gaps = 25/223 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
MK ++V +G V+Q ++ E ++RG L L P +++M+
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
MA ++A GM YL+ VHRDL + N +V + +TVK+ DFG++R T
Sbjct: 123 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 108 SSKSAAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
K G WM+PE L+D SD++SFGV+LWE+ATL +QP+ ++ QV+ V
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+G L+ P N + ++ CW P RPSF I+ ++
Sbjct: 235 -MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 27/218 (12%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
+K+L HPN++ ++ + + L+IV E G L R++ H + ++ ER +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-----G 114
+ ++H + I+HRD+K N+ + VK+ D GL R F SSK+ A G
Sbjct: 116 CSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVG 168
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFKGKR 170
TP +M+PE + + N KSDI+S G +L+E+A LQ P+ NL ++ K ++
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEK 222
Query: 171 LEIPRNVNPHVA----SIIEACWANEPWKRPSFSTIME 204
+ P H + ++ C +P KRP S +++
Sbjct: 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 72/224 (32%), Positives = 111/224 (49%), Gaps = 20/224 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--------------HKPGVREM 46
M L HPNIV +G VTQ + ++ EYL++G L+ L V+
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 105
LD L++A +A GM YL VH+DL + N+L+ ++ VK+ D GLSR + +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 106 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAA 163
+ + + P WM PE + + SDI+SFGV+LWE+ + QP+ + +V+
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
V K + L + P + S++ CW P +RP F I LR
Sbjct: 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-29
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 15/214 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV ++G +SI E++ GS+ +L++ G L E +
Sbjct: 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQIL 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS------KSAAG 114
G+ YLH +VHRD+K N+++ +K+ DFG +R A L KS G
Sbjct: 113 DGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRLEI 173
TP WMAPEV+ + KSDI+S G ++E+AT + P +++ + +G +G +
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL 230
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
P + + + +C + +RPS ++LLR
Sbjct: 231 PDSFSAAAIDFVTSCLTRDQHERPS---ALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-29
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ L+HPN+V + G + I EY S G+L LL + LDE + Y +
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI---LDE--HVIRVYTLQ 107
Query: 61 --KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT---FLSSKSAAG 114
+G+ YLH IVHRD+K N+ +D +K+ DFG + +LK NT +S AG
Sbjct: 108 LLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 115 TPEWMAPEVLRDEPSNEK---SDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKR 170
TP +MAPEV+ +DI+S G ++ E+AT ++PW L N Q++ VG G +
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK 224
Query: 171 LEIPRN--VNPHVASIIEACWANEPWKRPSFSTIMELL 206
IP + ++P ++ C ++P KRP T ELL
Sbjct: 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-29
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ + + P +V + NL +V EYL G L LL G LDE ++
Sbjct: 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS---LDEDVARIYIAEIV 103
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
+ YLH I+HRDLK N+L+D +K+ DFGLS++ + K
Sbjct: 104 LALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 172
GTP+++APEV+ + ++ D +S G IL+E P+ P ++ + ++E
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIE 219
Query: 173 IPR--NVNPHVASIIEACWANEPWKRPSFSTIMEL 205
P V+ +I +P KR +I E+
Sbjct: 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-29
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
+ + HPNI+ + A L IV EY G L + + K R+++ E+ + +
Sbjct: 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+G+ LH + I+HRDLKS N+L+ VK+ D G+S++ K+ GTP +M
Sbjct: 113 LRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYM 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
APEV + P + KSDI+S G +L+E+AT P+ Q + +GK IP +
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQ 227
Query: 180 HVASIIEACWANEPWKRPSFSTIM 203
+ + I + +P RP+ I+
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-29
Identities = 61/204 (29%), Positives = 113/204 (55%), Gaps = 5/204 (2%)
Query: 1 MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+ +L+HPNIV + + + L IV + G LY L K ++L E + + +
Sbjct: 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQI 111
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
A + YLH ++ I+HRDLK+ N+ + + +KV D G++R+ N + + GTP +M
Sbjct: 112 AMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
+PE+ ++P N KSD+++ G ++E+ATL+ + + +V + +GK +P++ +P
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSP 228
Query: 180 HVASIIEACWANEPWKRPSFSTIM 203
+ +I + P KRPS +I+
Sbjct: 229 ELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-29
Identities = 74/224 (33%), Positives = 114/224 (50%), Gaps = 20/224 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRL----- 53
M RL+ PNI+ + L ++TEY+ G L + L H+P + +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 54 -NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 111
MA +A GM YL N VHRDL + N LV K YT+K+ DFG+SR L + + +
Sbjct: 133 IFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVVAAVG--F 166
A P WM+ E + SD+++FGV LWE+ TL +QP+ L+ QV+ G F
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF 250
Query: 167 K--GKRLEIPR-NVNPH-VASIIEACWANEPWKRPSFSTIMELL 206
+ G+++ +P+ + P + ++ +CW +RPSF I L
Sbjct: 251 RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 59/155 (38%), Positives = 88/155 (56%), Gaps = 5/155 (3%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
+ P IV F GA ++SI EY+ GSL ++L V+ + ER +A V K
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLK 111
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
G+ YLH I+HRD+K N+LV+ + +K+CDFG+S N+ +K+ GT +MAP
Sbjct: 112 GLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAP 168
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
E ++ + KSDI+S G+ L ELAT + P+ N
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 67/209 (32%), Positives = 120/209 (57%), Gaps = 9/209 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
MK L+H +V VT+ P + I+TE++++GSL L G ++ L + ++ + +
Sbjct: 55 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQI 111
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
A+GM ++ +RN +HRDL++ N+LV K+ DFGL+R+ + +++ A P +W
Sbjct: 112 AEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE + KSD++SFG++L E+ T + P+ ++ +V+ A+ +G R+ P N
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC 228
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELL 206
+ +I+ CW N P +RP+F I +L
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 11/215 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
M + H NI+ G VT+ I+TEY+ G+L + L G + + M +
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGI 116
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--- 116
A GM YL N VHRDL + N+LV+ KV DFGLSR+ + + + +G
Sbjct: 117 AAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPR 175
W APE + SD++SFG+++WE+ + ++P+ +++ +V+ A+ G RL P
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPM 233
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ V ++ CW + +RP F I+ LL L+
Sbjct: 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-28
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 7/212 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ + H NIV G +T+ + IVTEY+S G+L L K L + + M +A
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLA 117
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG-LSRLKANTFLSSKSAAGTPEWM 119
GM YL VH+ L + +LV+ K+ F L K+ ++ S W
Sbjct: 118 SGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE ++ + SD++SFG+++WE+ + ++P+ +++ V+ AV G RL PRN
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCP 234
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ ++ CW E +RP FS I +L ++
Sbjct: 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-28
Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 16/225 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM--------LDER 50
+ L+H +IV F G + L +V EY+ G L + L H P M L +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 51 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
+ L++A +A GM YL ++ VHRDL + N LV + VK+ DFG+SR + + +
Sbjct: 121 QMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
P WM PE + +SD++S GV+LWE+ T +QPW L+ +V+ + +
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-Q 237
Query: 168 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
G+ L+ PR V ++ CW EP R + I LL+ L K+
Sbjct: 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-28
Identities = 67/214 (31%), Positives = 111/214 (51%), Gaps = 9/214 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HPNI+ G VT+ + IVTEY+ GSL L K + + + + M +A
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL--VGMLRGIA 116
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
GM YL + VHRDL + N+LV+ KV DFGLSR+ + ++ + G
Sbjct: 117 SGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + SD++S+G+++WE+ + ++P+ ++ V+ A+ +G RL P +
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMD 233
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+ ++ CW + +RP F I+ +L LI
Sbjct: 234 CPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-27
Identities = 57/159 (35%), Positives = 93/159 (58%), Gaps = 5/159 (3%)
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
++ VA+GM +L R +HRDL + N+L+ + VK+CDFGL+R K ++ SA
Sbjct: 180 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
+WMAPE + D+ +SD++SFGV+LWE+ +L P+ + + G R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
P N P + I+ ACW +P +RP+FS ++E+L L++
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-27
Identities = 63/211 (29%), Positives = 118/211 (55%), Gaps = 10/211 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L +P IV +G V + L +V E S G L + L G ++ + + + + V+
Sbjct: 49 MHQLDNPYIVRMIG-VCEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVS 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTP-E 117
GM YL +N VHRDL + N+L+ ++ K+ DFGLS+ +++ ++SA P +
Sbjct: 106 MGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + +SD++S+G+ +WE + Q+P+ + +V++ + +GKRL+ P
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAE 222
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLR 207
P + ++++ CW + RP+F+ + E +R
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 64/211 (30%), Positives = 113/211 (53%), Gaps = 11/211 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++L +P IV +G + + + +V E G L + L K + + E+ + + V+
Sbjct: 50 MQQLDNPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQK---NKHVTEKNITELVHQVS 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN-TFLSSKSAAGTP-E 117
GM YL N VHRDL + N+L+ ++ K+ DFGLS+ L A+ + +K+ P +
Sbjct: 106 MGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + KSD++SFGV++WE + Q+P+ + +V + G+R+E P+
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQR 222
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLR 207
P + +++ CW +RP F+ + LR
Sbjct: 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (266), Expect = 2e-27
Identities = 68/248 (27%), Positives = 111/248 (44%), Gaps = 26/248 (10%)
Query: 1 MKRLRHP-NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+ L HP NIV +L +V EY+ GSL LL K G + L E L + +
Sbjct: 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLKANTFLSS------KSA 112
+ YLH + I+HRD+K N+L+D+ VK+ DFGL++L + +S ++
Sbjct: 111 LSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 113 AGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVG 165
GTP +MAPEVL ++ SDI+S G+ L+EL T P+ + +Q + +
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
Query: 166 FKGKRL-------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218
P ++ + +++ A +P R S+ +L L+ + S
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL--SSSSDLSHDLLAHLKLKES 286
Query: 219 PTDMPLLT 226
L
Sbjct: 287 DLSDLLKP 294
|
Length = 384 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-27
Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
M + H NIV +G + I+ E ++ G L L +P M D L
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD---LL 119
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR--LKANTFLS 108
A DVAKG YL + +HRD+ + N L+ K K+ DFG++R +A+ +
Sbjct: 120 FCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
A +WM PE D K+D++SFGV+LWE+ +L P+ +V+ V
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TG 236
Query: 168 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
G RL+ P+ V I+ CW + P RP+F+TI+E +
Sbjct: 237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-27
Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 31/232 (13%)
Query: 1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSL---YRLLHKPGVREMLDERRRLNM 55
K + P IV + GA ++ I EY GSL Y+ + K G R + E+ +
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR--IGEKVLGKI 110
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
A V KG++YLH R I+HRD+K N+L+ +K VK+CDFG+S N+ + + GT
Sbjct: 111 AESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGT 166
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-----GNLNPAQVVAAVGFKGKR 170
+MAPE ++ +P + SD++S G+ L E+A + P+ L P ++++ +
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI------ 220
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
VN + + W F ++ + L K PT +P+P DM
Sbjct: 221 ------VNMPNPELKDEPGNGIKWSEE-FKDFIK--QCLEKDPTRRPTPWDM 263
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-27
Identities = 72/235 (30%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR-------- 52
+ RL+ PNI+ +G L ++TEY+ G L + L + D+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSS---HHLDDKEENGNDAVPPA 129
Query: 53 -----------LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR- 100
L++A +A GM YL N VHRDL + N LV + T+K+ DFG+SR
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 101 LKANTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNP 157
L A + + A P WMA E + SD+++FGV LWE+ L +QP+G L
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247
Query: 158 AQVVAAVG--FKGKRLEI----PRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
QV+ G F+ + ++ P + ++ CW+ + +RPSFS I L
Sbjct: 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-27
Identities = 58/166 (34%), Positives = 93/166 (56%), Gaps = 11/166 (6%)
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 110
L+ Y VA+GM +L +N VHRDL + N+L+ + VK+CDFGL+R + + ++S
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--- 167
S +WMAPE + D SD++S+G++LWE+ +L G P +V + +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG---GTPYPGMIVDSTFYNKIK 354
Query: 168 -GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
G R+ P + V I+ CW +EP KRPSF + +++ L+ S
Sbjct: 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 74/233 (31%), Positives = 109/233 (46%), Gaps = 47/233 (20%)
Query: 6 HPNIVLFMGAVTQ--PPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN---MA 56
HPNI F GA + PP L +V E GS+ L V+ + + +RL +A
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL-----VKGLRKKGKRLKEEWIA 116
Query: 57 Y---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
Y + +G+ YLH ++HRD+K N+L+ K VK+ DFG+S +T +
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 114 GTPEWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 168
GTP WMAPEV+ D + +SD++S G+ ELA + P +++P + + FK
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK- 229
Query: 169 KRLEIPRNVNPHVAS----------IIEACWANEPWKRPSFSTIMELLR-PLI 210
IPRN P + S I C +RP + ELL P I
Sbjct: 230 ----IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP---FMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+HPNIV + + L +V EY L + L K L ++ Y +
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLL 108
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+G+ Y H I+HRDLK N+L+++ +K+ DFGL+R T E
Sbjct: 109 RGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVT 161
Query: 118 -WM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
W APE+L + DI+S G I E+ T
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 15/218 (6%)
Query: 1 MKRLRHPNIVLFMG------AVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE---MLDERR 51
MK HPN++ +G A + P ++ ++ G L+ L + E L +
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
+ D+A GM YL +N +HRDL + N ++++ TV V DFGLS+ + + +
Sbjct: 115 LVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
A+ P +W+A E L D SD+++FGV +WE+ T Q P+ + +++ + KG
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKG 231
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
RL+ P + V ++ CW+ EP RPSF + + L
Sbjct: 232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 57/167 (34%), Positives = 96/167 (57%), Gaps = 13/167 (7%)
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 105
LD L+ +Y VAKGM++L +N +HRDL + N+L+ K+CDFGL+R ++ ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268
Query: 106 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
K A P +WMAPE + + +SD++S+G++LWE+ +L P+ P V +
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVDS 324
Query: 164 VGFK----GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
+K G R+ P + I+++CW +P KRP+F I++L+
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-26
Identities = 69/209 (33%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P I + G+ + L I+ EYL GS LL KPG L+E + ++ KG++YL
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGP---LEETYIATILREILKGLDYL 117
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
H +HRD+K+ N+L+ ++ VK+ DFG++ +T + + GTP WMAPEV++
Sbjct: 118 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV----- 181
+ K+DI+S G+ ELA + P +L+P +V+ IP+N P +
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYS 226
Query: 182 ---ASIIEACWANEPWKRPSFSTIMELLR 207
+EAC +P RP T ELL+
Sbjct: 227 KPFKEFVEACLNKDPRFRP---TAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 5/160 (3%)
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
++ VAKGM +L R +HRDL + N+L+ + VK+CDFGL+R K ++ A
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
+WMAPE + D +SD++SFGV+LWE+ +L P+ + + +G R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
P P + + CW EP +RP+FS ++E L L+++
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-26
Identities = 72/231 (31%), Positives = 111/231 (48%), Gaps = 29/231 (12%)
Query: 1 MKRLRHPNIVLFMG--AVTQPPNLSIVTEYLSRGSLYRLLHK------------------ 40
M HPNIV +G AV +P + ++ EY++ G L L
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 41 -PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
L +L +A VA GM YL R VHRDL + N LV + VK+ DFGLS
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
R A+ + +S++ A WM PE + +SD++++GV+LWE+ + QP+ +
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+V+ V G L P N + +++ CW+ P RPSF++I +L+
Sbjct: 238 HEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-26
Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P + + G+ + L I+ EYL GS LL +PG LDE + + ++ KG++YL
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREILKGLDYL 117
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
H +HRD+K+ N+L+ + VK+ DFG++ +T + + GTP WMAPEV++
Sbjct: 118 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIE 186
+ K+DI+S G+ ELA + P L+P +V+ + K + N + + +E
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVE 234
Query: 187 ACWANEPWKRPSFSTIMELLR 207
AC EP RP T ELL+
Sbjct: 235 ACLNKEPSFRP---TAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-26
Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 4/203 (1%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ +++HPNIV F + +L IV EY G L + + K ++ E L +
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMC 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ ++H + ++HRD+KS N+ + + VK+ DFG +RL + + + GTP ++
Sbjct: 111 LGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+ + P N KSDI+S G IL+EL TL+ P+ + ++ V +G +P + +
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKPLPSHYSYE 227
Query: 181 VASIIEACWANEPWKRPSFSTIM 203
+ S+I+ + P RPS +TI+
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-26
Identities = 70/238 (29%), Positives = 107/238 (44%), Gaps = 47/238 (19%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYD 58
M R P IV F GA N+ + E++ GSL R+ K P E+L + +A
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK-----IAVA 111
Query: 59 VAKGMNYL---HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----RLKANTFLSSKS 111
V +G+ YL HR I+HRD+K N+LV+ + +K+CDFG+S A+TF+
Sbjct: 112 VVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---- 163
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
GT +M+PE ++ KSD++S G+ + ELA + P+ N
Sbjct: 164 --GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-------- 213
Query: 172 EIPRNVNPHVASIIE--ACWANEPWKR-PS--FSTIMELL--RPLIKSPTPQPSPTDM 222
I++ EP R PS F + L+K PT +P+P +
Sbjct: 214 --------DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+ RL HP I+ NL V EY G L + + K G LDE+ A ++
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEI 111
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----------KANTFLSS 109
+ YLH + I+HRDLK N+L+DK +K+ DFG +++ K +
Sbjct: 112 LLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 110 KSAA----------GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159
GT E+++PE+L ++P+ + SD+++ G I++++ T + P+ N
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ P N P +IE +P R + + L+
Sbjct: 230 TFQKI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 70/224 (31%), Positives = 113/224 (50%), Gaps = 25/224 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
++ L H NIV + G T+ I + E+L GSL L P + ++ +++L A
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQ 117
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT-FLSSKSAAGTP 116
+ KGM+YL R VHRDL + N+LV+ ++ VK+ DFGL++ ++ + + + K +P
Sbjct: 118 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 117 E-WMAPEVLRDEPSNEKSDIYSFGVILWELAT---------------LQQPWGNLNPAQV 160
W APE L SD++SFGV L+EL T + G + ++
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
V + +GKRL P N V ++ CW +P KR +F ++E
Sbjct: 236 VRVLE-EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-25
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P + + G+ + L I+ EYL GS LL DE + M ++ KG++YL
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYL 117
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
H +HRD+K+ N+L+ ++ VK+ DFG++ +T + + GTP WMAPEV++
Sbjct: 118 HSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVA---- 182
+ K+DI+S G+ ELA + P +++P +V+ IP+N P +
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFS 226
Query: 183 ----SIIEACWANEPWKRPSFSTIMELLR 207
I+AC +P RP T ELL+
Sbjct: 227 KPFKEFIDACLNKDPSFRP---TAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-25
Identities = 68/228 (29%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
+K L H NIV + G ++ L ++ EY+ GSL L HK + ++L A
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFA 113
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
+ +GM YLH ++ +HRDL + N+L+D VK+ DFGL++ + + + +
Sbjct: 114 QQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 115 TPE-WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN--------LNPAQ----VV 161
+P W A E L++ + SD++SFGV L+EL T + + P Q VV
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231
Query: 162 AAVGF--KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ +G RL P+N V +++ CW E RP+F +++ +L+
Sbjct: 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-25
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNM-AYDV 59
L+H NIV ++G+ ++ I E + GSL LL K G + D + + +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQI 117
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPE 117
+G+ YLH IVHRD+K N+LV+ Y+ VK+ DFG S+ A +++ GT +
Sbjct: 118 LEGLKYLHDNQ--IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 118 WMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIP 174
+MAPEV+ P +DI+S G + E+AT + P+ L P + VG EIP
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIME 204
+++ + I C+ +P KR S +++
Sbjct: 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-25
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 13/217 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
M + HPNI+ G VT+ + I+TE++ G+L L G ++ + + M +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGI 115
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKSAAG 114
A GM YL N VHRDL + N+LV+ KV DFGLSR + T+ SS
Sbjct: 116 AAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 173
W APE + SD++S+G+++WE+ + ++P+ +++ V+ A+ + RL
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPP 232
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
P + + ++ CW + RP F I+ L +I
Sbjct: 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 7e-25
Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLY------RLLHKPGVREMLD 48
MK HPN++ +G Q P+ ++ ++ G L+ RL P + L
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP---QYLP 110
Query: 49 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTF 106
+ + D+A GM YL ++ +HRDL + N ++++ V V DFGLS+ + +
Sbjct: 111 TQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 165
+ A +W+A E L D KSD++SFGV +WE+AT Q P+ + +++ +
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228
Query: 166 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
+G RL+ P + + S++ +CW P RPSF T+ L
Sbjct: 229 -QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-24
Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 1 MKRLRHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
++R+ NI+ + V P LS++ EY +RG L +L K + L + +L+MA
Sbjct: 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMA 128
Query: 57 YDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
D KG+ L++ N P +++L S + LV + Y +K+ GL ++ ++ K+
Sbjct: 129 IDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNV-NF 183
Query: 116 PEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
+ + ++L D K DIYS GV+LWE+ T + P+ NL ++ + K L++
Sbjct: 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
P + + I+EAC +++ KRP+ I+ L
Sbjct: 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-24
Identities = 69/212 (32%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K L H IV + G + P LSI E++ GS+ L G L E
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQ 114
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 115
+ +G++YLH IVHRD+K N+L D VK+ DFG S+ LS KS GT
Sbjct: 115 ILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
P WM+PEV+ E K+DI+S G + E+ T + PW + + + +P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP 232
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+V+ H ++ + E RPS ELLR
Sbjct: 233 HVSDHCRDFLKRIFV-EAKLRPSAD---ELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-24
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYL---SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
++LRHPNIV + + L IV + + G + L + R E R N+
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTEERIWNIFVQ 121
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTPE 117
+ + YLH+ IVHRDL N+++ + V + DFGL++ K + L S GT
Sbjct: 122 MVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTIL 178
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
+ PE++++EP EK+D+++FG IL+++ TLQ P+ + N + + + +P +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-VEAVYEPLPEGM 237
Query: 178 -NPHVASIIEACWANEPWKRP 197
+ V +I +C + RP
Sbjct: 238 YSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-24
Identities = 53/161 (32%), Positives = 90/161 (55%), Gaps = 5/161 (3%)
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 110
+ +Y VA GM +L +N VHRDL + N+L+ + VK+CDFGL+R ++ + ++S
Sbjct: 242 VGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG 299
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
S +WMAPE + + SD++SFG++LWE+ TL P+ L + +G
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359
Query: 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
R+ P + + + I++ CW + RP FS ++ L+ L+
Sbjct: 360 RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-24
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 9/158 (5%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P + + L +V EYL+ G L+ G L E +V G+ L
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDL 113
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
H+R I+HRD+K NLL+D+ +K+ DFGLSR L +K GTP+++APE +
Sbjct: 114 HQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILG 167
Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
++ SD +S G +++E P+ P V +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-24
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK +H NIV + G+ + L I E+ GSL + H G L E + ++ +
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETL 116
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ YLH + +HRD+K N+L+ VK+ DFG+S T KS GTP WMA
Sbjct: 117 QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174
Query: 121 PEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ---VVAAVGFKGKRLEIP 174
PEV R N+ DI++ G+ ELA LQ P +L+P + ++ F+ +L+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ ++ P KRP+ +++
Sbjct: 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-23
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 5/205 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDV 59
+ +L HP IV F + + I+TEY L +L + L E + +
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
G++Y+H+R I+HRDLK+ N+ + K +K+ DFG+SRL + + + GTP +M
Sbjct: 116 LLGVHYMHQRR--ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYM 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
+PE L+ + + KSDI+S G IL+E+ L + N VV + +G +P +
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSR 231
Query: 180 HVASIIEACWANEPWKRPSFSTIME 204
+ SI+++ +P RPS + I+
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 1e-23
Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 9/225 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK L++PNIV F+ + L +V EYL+ GSL ++ +DE + + +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECL 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ + +LH ++HRD+KS N+L+ +VK+ DFG + GTP WMA
Sbjct: 126 QALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
PEV+ + K DI+S G++ E+ + P+ N NP + + + G L+ P ++P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 224
+ C + KR S +++ P +K P S T + L
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKPLSSLTPLIL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-23
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 9/217 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + +P++ +G + + ++T+ + G L + + ++ + + LN +A
Sbjct: 63 MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
KGMNYL R +VHRDL + N+LV VK+ DFGL++ L A+ P +W
Sbjct: 120 KGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
MA E + +SD++S+GV +WEL T +P+ + PA ++++ KG+RL P
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 236
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214
V I+ CW + RP F ++ + + P
Sbjct: 237 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-23
Identities = 58/178 (32%), Positives = 96/178 (53%), Gaps = 27/178 (15%)
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------ 100
LD L + VA+GM++L +N +HRD+ + N+L+ K+CDFGL+R
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 101 ---LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
+K N L K WMAPE + D +SD++S+G++LWE+ +L + P+
Sbjct: 267 NYVVKGNARLPVK-------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY---- 315
Query: 157 PAQVVAAVGFK----GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
P +V + +K G ++ P P + SI++ CW EP +RP+FS I +L++ +
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-23
Identities = 69/226 (30%), Positives = 105/226 (46%), Gaps = 34/226 (15%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGS-------LYRLLHKPGV----REMLDERRRLN 54
HP IV +GA L I+ E+ G+ L R L +P + R+ML+
Sbjct: 68 HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE------ 121
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ YLH I+HRDLK+ N+L+ +K+ DFG+S T S G
Sbjct: 122 -------ALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIG 172
Query: 115 TPEWMAPEV-----LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKG 168
TP WMAPEV ++D P + K+DI+S G+ L E+A ++ P LNP +V+ + +
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 232
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214
L P + ++ P RPS + ++E P + S T
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE--HPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-23
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K +H NIV + G+ L I EY GSL + H G L E + + +
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETL 116
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ YLH + +HRD+K N+L+ VK+ DFG++ T KS GTP WMA
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 121 PEVLRDEPS---NEKSDIYSFGVILWELATLQQPWGNLNPAQ---VVAAVGFKGKRLEIP 174
PEV E + N+ DI++ G+ ELA LQ P +L+P + +++ F+ +L+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234
Query: 175 RNVNPHVASIIEACWANEPWKRPS 198
+ + ++ P KRP+
Sbjct: 235 TKWSSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-23
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 9/216 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HP++V +G V P + +VT+ + G L +H+ ++ + + LN +A
Sbjct: 63 MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIA 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
KGM YL R +VHRDL + N+LV VK+ DFGL+RL + G +W
Sbjct: 120 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
MA E + +SD++S+GV +WEL T +P+ + P + + + KG+RL P
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPIC 236
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
V ++ CW + RP F + + + P
Sbjct: 237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-23
Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 11/224 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ +HPNIV + L +V E+L G+L ++ ++E + + V
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVL 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
K +++LH + ++HRD+KS ++L+ VK+ DFG + KS GTP WMA
Sbjct: 126 KALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKGKRLEIPRNVNP 179
PEV+ P + DI+S G+++ E+ + P+ N P Q + + +L+ V+P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP 243
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
+ S ++ +P +R +T ELL P + P S +
Sbjct: 244 RLRSFLDRMLVRDPAQR---ATAAELLNHPFLAKAGPPSSIVPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-23
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M L H IV +G + +L +VT+ GSL L H R+ LD +R LN +A
Sbjct: 63 MGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGT 115
KGM YL +VHR+L + N+L+ V++ DFG++ L K + S T
Sbjct: 120 KGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKT 173
Query: 116 P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 173
P +WMA E + +SD++S+GV +WE+ + +P+ + P +V + KG+RL
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQ 232
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
P+ V ++ CW + RP+F + + + P
Sbjct: 233 PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-23
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYDVAK 61
L HPN++ +G + +V E+ G L L V +M + MA +VA
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL--SRLKANTFLSSKSAAGTPEWM 119
G+ +LH+ + +H DL N + +VK+ D+GL + + +++ A W+
Sbjct: 112 GLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 120 APEVLRDEPSN-------EKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRL 171
APE++ + +KS+I+S GV +WEL T QP+ +L+ QV+ V + + +
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDI 228
Query: 172 EIPR-NVNPHVA----SIIEACWANEPWKRPSFSTIMELL 206
++P+ ++ + +++ CW +P RP+ + ELL
Sbjct: 229 KLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-23
Identities = 55/212 (25%), Positives = 108/212 (50%), Gaps = 9/212 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
+K+L HPN++ + + + L+IV E G L R++ H + ++ E+ +
Sbjct: 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ ++H R ++HRD+K N+ + VK+ D GL R ++ ++ S GTP +M
Sbjct: 116 CSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
+PE + + N KSDI+S G +L+E+A LQ P+ + ++ K ++ + P +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQCDYPPLPSD 231
Query: 180 HVAS----IIEACWANEPWKRPSFSTIMELLR 207
H + ++ C +P KRP + + ++ +
Sbjct: 232 HYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-23
Identities = 47/145 (32%), Positives = 93/145 (64%), Gaps = 5/145 (3%)
Query: 63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMA 120
++++H ++ ++HRD+KS N+L+ VK+ DFG S++ A T ++ GTP ++A
Sbjct: 156 VHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+ R +P ++K+D++S GV+L+EL TL++P+ N +V+ G+ +P +++P
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-LAGRYDPLPPSISPE 272
Query: 181 VASIIEACWANEPWKRPSFSTIMEL 205
+ I+ A +++P +RPS S ++ +
Sbjct: 273 MQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 8e-23
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 36/199 (18%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ +RHP +V G+ NL +V EY+ G L+ L K R VA
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---------SGRFPE--PVA 103
Query: 61 K--------GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKS 111
+ + YLH + IV+RDLK NLL+D +K+ DFG + R+K T+ +
Sbjct: 104 RFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----T 157
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFK 167
GTPE++APE++ + + D ++ G++++E+ P+ + NP Q ++
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG---- 213
Query: 168 GKRLEIPRNVNPHVASIIE 186
++ P +P +I
Sbjct: 214 --KVRFPSFFSPDAKDLIR 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 8e-23
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-------------HKPGVREMLDE 49
RL+HPNIV +G VT+ LS++ Y S L+ L V+ L+
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 50 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--------- 100
+++ +A GM +L + +VH+DL + N+LV K VK+ D GL R
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 101 LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQ 159
L N+ L + WM+PE + + SDI+S+GV+LWE+ + QP+ +
Sbjct: 182 LMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234
Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
V+ + + + L P + V +++ CW P +RP F I LR
Sbjct: 235 VIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-22
Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 10/183 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K LRH IV + G + P LSI EY+ GS+ L G L E
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQ 114
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 115
+ +G++YLH IVHRD+K N+L D VK+ DFG S+ +S KS GT
Sbjct: 115 ILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
P WM+PEV+ E K+D++S + E+ T + PW + + + + +P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 176 NVN 178
V+
Sbjct: 233 GVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-22
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ RHP + A L V EY + G L+ H R +ER R A ++
Sbjct: 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH R+ +V+RD+K NL++DK +K+ DFGL + + + K+ GTPE++A
Sbjct: 106 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVL D D + GV+++E+ + P+ N + ++ + + R PR ++P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 221
Query: 181 VASIIEACWANEPWKR 196
S++ +P +R
Sbjct: 222 AKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-22
Identities = 53/210 (25%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
+K+L HPN++ ++ + + L+IV E G L +++ + + ++ ER +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ ++H R ++HRD+K N+ + VK+ D GL R ++ ++ S GTP +M
Sbjct: 116 CSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
+PE + + N KSDI+S G +L+E+A LQ P+ + ++ K ++ + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPTE 231
Query: 180 HVAS----IIEACWANEPWKRPSFSTIMEL 205
H + ++ C +P +RP + ++
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-22
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K L+H IV + G + L+I EY+ GS+ L G L E
Sbjct: 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQ 114
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 115
+ +GM+YLH IVHRD+K N+L D VK+ DFG S+ +S +S GT
Sbjct: 115 ILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
P WM+PEV+ E K+D++S G + E+ T + PW + + + ++P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+++ H + C E RPS ELLR
Sbjct: 233 HISEHARDFL-GCIFVEARHRPSAE---ELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
HPN+V + ++ E++ GSL + DE+ ++A + G+ Y
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAY 183
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
LHRR+ IVHRD+K NLL++ VK+ DFG+SR+ A T S+ GT +M+PE +
Sbjct: 184 LHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241
Query: 126 DEPSNEK-----SDIYSFGVILWELATLQQPWG---NLNPAQVVAAVGFKGKRLEIPRNV 177
+ ++ DI+S GV + E + P+G + A ++ A+ + E P
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATA 300
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSP 219
+ I C EP KR S M+LL+ P I P
Sbjct: 301 SREFRHFISCCLQREPAKRWS---AMQLLQHPFILRAQPGQGQ 340
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-22
Identities = 58/172 (33%), Positives = 88/172 (51%), Gaps = 23/172 (13%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGS-------LYRLLHKPGVREMLDERRRLNMAYD 58
HPNIV + A NL I+ E+ + G+ L R L +P +R + +
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ--------- 111
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+ +NYLH I+HRDLK+ N+L +K+ DFG+S T S GTP W
Sbjct: 112 TLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 119 MAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
MAPEV+ +D P + K+D++S G+ L E+A ++ P LNP +V+ +
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-22
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
+HP + L V EY++ G L + + G DE R A ++ G+
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQ 110
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAGTPEW 118
+LH R I++RDLK N+L+D + +K+ DFG+ + +TF GTP++
Sbjct: 111 FLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDY 162
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+APE+L +P D ++ GV+L+E+ Q P+ + ++ ++ + PR ++
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLS 220
Query: 179 PHVASIIEACWANEPWKR 196
SI+++ P KR
Sbjct: 221 KEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-22
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L HPNI+ + +L +V E++ LY+L+ + L E + Y +
Sbjct: 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIK--DRQRGLPESLIKSYLYQLL 108
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+G+ + H I+HRDLK NLL++ + +K+ DFGL+R S T
Sbjct: 109 QGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVT 161
Query: 118 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 149
W APE+L D+ + DI+S G I EL + +
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-21
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 9/221 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ +HPNIV ++ + L +V EYL+ GSL ++ +DE + + +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ + +LH ++HRD+KS N+L+ +VK+ DFG + GTP WMA
Sbjct: 126 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
PEV+ + K DI+S G++ E+ + P+ N NP + + + G L+ P ++
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPT 220
+ C + KR S +++ P +K P S T
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 1 MKRLRH-----------PNIVLFMGAVTQPPNLSIVTEY--LSRGSLYRLLHKPGVREML 47
KRL P IV F GA+ + + I E +S Y+ +++ + ++
Sbjct: 46 QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVI 104
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
E +A K +NYL + I+HRD+K N+L+D+ +K+CDFG+S ++
Sbjct: 105 PEEILGKIAVATVKALNYL-KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163
Query: 108 SSKSAAGTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-----AQ 159
++ A P +MAPE + + + +SD++S G+ L+E+AT + P+ N Q
Sbjct: 164 KTRDAGCRP-YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ 222
Query: 160 VVAAVGFKGK--RL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
VV KG L R +P + I C + KRP + ++E
Sbjct: 223 VV-----KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-21
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
RHP +V ++ V EY + G L +H ++ E R + A V G
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLG 113
Query: 63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMA 120
+ YLH IV+RDLK NLL+D + VK+ DFGL K +++ GTPE++A
Sbjct: 114 LQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLA 169
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
PEVL + D + GV+++E+ + P
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-21
Identities = 70/247 (28%), Positives = 112/247 (45%), Gaps = 58/247 (23%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
+L V EYL+ G L + G DE R A ++ G+ +LH++ I++RDLK
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKL 124
Query: 81 PNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 134
N+L+DK +K+ DFG+ + KA+TF GTP+++APE+L+ + NE D
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTF------CGTPDYIAPEILKGQKYNESVD 178
Query: 135 IYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI---PRNVNPHVASIIEACWAN 191
+SFGV+L+E+ Q P+ + ++ F + PR ++ + +
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRPHFPRWISKEAKDCLSKLFER 233
Query: 192 EPWKR----------PSFSTI-MELL---------RPLIKSPT-------------PQPS 218
+P KR P F I E L +P +KSP+ + S
Sbjct: 234 DPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLS 293
Query: 219 PTDMPLL 225
P D LL
Sbjct: 294 PVDKKLL 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 4e-21
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K RHP + + L V EY++ G L+ H R ++R R A ++
Sbjct: 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIV 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
++YLH + IV+RDLK NL++DK +K+ DFGL + + K+ GTPE++A
Sbjct: 106 SALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVL D D + GV+++E+ + P+ N + ++ + + ++ PR ++
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSAD 221
Query: 181 VASIIEACWANEPWKR 196
S++ +P KR
Sbjct: 222 AKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-20
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ RHP + + L V EY + G L+ L + V ++R R A ++
Sbjct: 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIV 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH + +V+RDLK NL++DK +K+ DFGL + + + K+ GTPE++A
Sbjct: 106 SALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVL D D + GV+++E+ + P+ N + ++ + + + PR ++P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPE 221
Query: 181 VASIIEACWANEPWKR 196
S++ +P +R
Sbjct: 222 AKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-20
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ HP IV + ++ EY G L+ +L G + DE V
Sbjct: 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIACVV 103
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL-----SRLKANTFLSSKSAAGT 115
YLH R I++RDLK NLL+D VK+ DFG S K TF GT
Sbjct: 104 LAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GT 155
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKGKRLE 172
PE++APE++ ++ + D +S G++L+EL T + P+G + + + GK LE
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-LE 214
Query: 173 IPRNVNPHVASIIEACWANEPWKR 196
P ++ +I+ P +R
Sbjct: 215 FPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-20
Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 6/196 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ RHP + + L V EY + G L+ H R ++R R A ++
Sbjct: 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIV 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
++YLH +V+RDLK NL++DK +K+ DFGL + + K+ GTPE++A
Sbjct: 106 SALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVL D D + GV+++E+ + P+ N + ++ + + R PR ++P
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPE 222
Query: 181 VASIIEACWANEPWKR 196
S++ +P +R
Sbjct: 223 AKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-20
Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDV 59
++ L HP +V + N+ +V + L G L Y L K + +E+ + + ++
Sbjct: 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWIC-EI 109
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEW 118
+ YLH + I+HRD+K N+L+D++ V + DF ++ + +T +S S GTP +
Sbjct: 110 VLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGY 165
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
MAPEVL + + D +S GV +E ++P+
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
+ +VT+ + G L L + ++ + + LN +AKGM+YL +VHRDL +
Sbjct: 83 VQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAAR 138
Query: 82 NLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139
N+LV VK+ DFGL+RL T + +WMA E + +SD++S+G
Sbjct: 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 140 VILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 198
V +WEL T +P+ + PA+ + + KG+RL P V I+ CW + RP
Sbjct: 199 VTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPR 257
Query: 199 FSTIMELLRPLIKSPT 214
F +++ + + P+
Sbjct: 258 FRELVDEFSRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-20
Identities = 51/145 (35%), Positives = 79/145 (54%), Gaps = 5/145 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+HP +V + L V +Y++ G L+ H R L+ R R A +VA
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVA 106
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH N I++RDLK N+L+D + V + DFGL + ++ + GTPE++A
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLA 164
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
PEVLR EP + D + G +L+E+
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-20
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P IV F GA +SI E++ GSL ++L K G + E ++ V +G+ YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYL 115
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTPEWMAPE 122
R I+HRD+K N+LV+ + +K+CDFG+S AN+F+ GT +M+PE
Sbjct: 116 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE 168
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVA 182
L+ +SDI+S G+ L E+A + P + ++ A R V+ A
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM---------FGRPVSEGEA 219
Query: 183 SIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215
+ P P I ELL ++ P P
Sbjct: 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP 252
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-20
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 38/214 (17%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYD 58
+++LRHPN + + G + +V EY GS +L HK ++E E + +
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEVHKKPLQE--VEIAAI--CHG 123
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTP 116
+G+ YLH +HRD+K+ N+L+ + TVK+ DFG + L AN+F+ GTP
Sbjct: 124 ALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTP 175
Query: 117 EWMAPEVL--RDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
WMAPEV+ DE + K D++S G+ ELA + P N+N + I
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHI 226
Query: 174 PRNVNPHVASI---------IEACWANEPWKRPS 198
+N +P ++S +++C P RPS
Sbjct: 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-20
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 9/223 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ ++PNIV ++ + L +V EYL+ GSL ++ +DE + + +
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ +++LH ++HRD+KS N+L+ +VK+ DFG + GTP WMA
Sbjct: 126 QALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
PEV+ + K DI+S G++ E+ + P+ N NP + + + G L+ P ++
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA 243
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
+ C + +R S +++ P +K P S T +
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-20
Identities = 69/229 (30%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 6 HPNIVLFMGAVTQPPNLS-----IVTEYLSRGSLYRL---LHKPGVREMLDERRRLNMAY 57
HPN+V F G + L +V E + GS+ L L G R LDE + Y
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILY 135
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
G+ +LH N I+HRD+K N+L+ + VK+ DFG+S +T L ++ GTP
Sbjct: 136 GALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193
Query: 118 WMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 172
WMAPEV+ D + + D++S G+ EL P +++P + + +
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---------FK 244
Query: 173 IPRNVNPHV----------ASIIEACWANEPWKRPSFSTIMELLRPLIK 211
IPRN P + I C + RPS + ++E P IK
Sbjct: 245 IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE--HPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-19
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P IV F GA + + EY+ GSL +L E + E + Y V KG+ +L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
+ I+HRD+K N+LV+ VK+CDFG+S L A+ +K+ G +MAPE ++
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIK 174
Query: 126 DEPSNE------KSDIYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKGKRL 171
N+ +SD++S G+ + E+A + P+ P AQ+ A V G
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIV--DGDPP 228
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+P + + C P +RP+++ ++E P +
Sbjct: 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 56/198 (28%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
HP +V L V EY++ G L + H R++ +E R A +++ +NY
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNY 111
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
LH R I++RDLK N+L+D + +K+ D+G+ + ++ + GTP ++APE+LR
Sbjct: 112 LHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
E D ++ GV+++E+ + P+ + NP Q F+ K++ IPR+++
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229
Query: 179 PHVASIIEACWANEPWKR 196
AS++++ +P +R
Sbjct: 230 VKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-19
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P IV G ++ I E +S L +LL + ++ + E M + K ++YL
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYL 130
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RL---KANTFLSSKSAAGTPEWMAPE 122
+ ++HRD+K N+L+D VK+CDFG+S RL KA T +AG +MAPE
Sbjct: 131 -KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-----RSAGCAAYMAPE 184
Query: 123 VLRDEPSNEK----SDIYSFGVILWELATLQQPWGNLNPA-QVVAAV-GFKGKRLEIPRN 176
+ N K +D++S G+ L ELAT Q P+ N +V+ + + L
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIME 204
+P S ++ C + KRP + +++
Sbjct: 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
+ +V + A L + EY+ G LL+ GV L E R MA +
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFE-AV 114
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
+ LH +HRDLK N L+D +K+ DFGLS + S G+P++MAPEV
Sbjct: 115 DALHELG--YIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEV 169
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS 183
LR + + D +S G +L+E P+ P + + + + L+ P +P
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP---- 225
Query: 184 IIEACWANEPW 194
++E W
Sbjct: 226 --RFNLSDEAW 234
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 3e-19
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
++LRHPNIV VT SI V EY+ L LL P V+ + + +
Sbjct: 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--MKQL 109
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE-- 117
+G+ YLH I+HRD+K N+L++ +K+ DFGL+R + SA T
Sbjct: 110 LEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVI 163
Query: 118 --WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
W PE+L + D++S G IL EL
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-19
Identities = 50/148 (33%), Positives = 74/148 (50%), Gaps = 4/148 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+HPNIV + Q L ++ E+LS L + L + +D + Y +
Sbjct: 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ + H R ++HRDLK NLL+D K +K+ DFGL+R T + A
Sbjct: 112 QGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169
Query: 121 PEVLRDEPS-NEKSDIYSFGVILWELAT 147
PEVL P + DI+S G I E+AT
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-19
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 7/220 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ ++PNIV ++ + L +V EYL+ GSL ++ +DE + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 126
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ + +LH ++HRD+KS N+L+ +VK+ DFG + GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
PEV+ + K DI+S G++ E+ + P+ N NP + + + G L+ P ++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219
+ C + KR S +++ I P +P
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-19
Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
P V F GA+ + ++ I E + S Y+ ++ G+ + E +A + K +
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLT--IPEDILGKIAVSIVKALE 117
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
YLH ++HRD+K N+L+++ VK+CDFG+S ++ ++ AG +MAPE +
Sbjct: 118 YLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERI 175
Query: 125 RDEPS----NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIPRN-VN 178
E + + KSD++S G+ + ELAT + P+ + P Q + V + ++P +
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSPQLPAEKFS 234
Query: 179 PHVASIIEACWANEPWKRPSFSTIME 204
P + C +RP++ +++
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-19
Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K ++HP +V + L V +Y++ G L+ L + R + R R A ++A
Sbjct: 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARF-YAAEIA 106
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH N I++RDLK N+L+D + V + DFGL + ++ + GTPE++A
Sbjct: 107 SALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLA 164
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLR +P + D + G +L+E+ P+ + + A++ + K L + N++
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKPLRLKPNISVS 222
Query: 181 VASIIEACWANEPWKR 196
++E + KR
Sbjct: 223 ARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-18
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML--DERRRLNMAYDV 59
+ L+H N++ +G T+ +V E+ G L L E++ D MA ++
Sbjct: 50 RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPE 117
A G+ +LH+ N +H DL N L+ TVK+ D+GLS K + +++
Sbjct: 110 ALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 118 WMAPEVLRDEPSN-------EKSDIYSFGVILWELATL-QQPWGNLNPAQVVA-AVGFKG 168
W+APE++ + N ++S+++S GV +WEL L QP+ +L+ QV+ V +
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 169 KRLEIPRNVNPHVA---SIIEACWANEPWKRPSFSTIMELL 206
+L PR P +++ CW +P +RPS + LL
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWL-QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 1e-18
Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 52/232 (22%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
HPNIV + L V EY+ G+LY+L+ + E ++ Y + +G+
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGK-PFSESVIRSIIYQILQGLA 113
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA------GTPEW 118
++H+ HRDLK NLLV VK+ DFGL+R +S T +
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWY 164
Query: 119 MAPEV-LRDEPSNEKSDIYSFGVILWELATL------------------------QQPWG 153
APE+ LR + DI++ G I+ EL TL +Q W
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW- 223
Query: 154 NLNPAQVVAAVGFK-----GKRLE--IPRNVNPHVASIIEACWANEPWKRPS 198
++ + +GF+ L IP N +P +I+ +P KRP+
Sbjct: 224 -PEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-18
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P I+ F GA +SI TE++ GSL V + E +A V KG+ YL
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYL 111
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
I+HRD+K N+LV+ + VK+CDFG+S N+ +K+ GT +MAPE +
Sbjct: 112 WSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISG 167
Query: 127 EPSNEKSDIYSFGVILWELATLQQPW-------GNLNPAQVVAAVGFKGKRLEIPRNVNP 179
E SD++S G+ ELA + P+ G+L P Q++ + + + +
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227
Query: 180 HVASIIEACWANEPWKRPSFSTIME 204
I C +P +RP+ +M+
Sbjct: 228 KFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-18
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 2 KRLRHPNIVLFMGAVTQ--PPNLS----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
K H NI + GA + PP + +V E+ GS+ L+ K L E +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYI 116
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
++ +G+++LH+ ++HRD+K N+L+ + VK+ DFG+S T + GT
Sbjct: 117 CREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 116 PEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR 170
P WMAPEV+ D + KSD++S G+ E+A P +++P + +
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------- 225
Query: 171 LEIPRNVNPHVA---------SIIEACWANEPWKRPSFSTIME 204
IPRN P + S IE+C +RP+ +M+
Sbjct: 226 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-18
Identities = 56/172 (32%), Positives = 94/172 (54%), Gaps = 8/172 (4%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P IV + +L +VT+Y+S G L+ L K G ++R + +A ++ + +L
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS--EDRAKFYIA-ELVLALEHL 112
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
H+ + IV+RDLK N+L+D + +CDFGLS+ ++ + GT E++APEVL D
Sbjct: 113 HKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 127 EPSNEKS-DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
E K D +S GV+++E+ P+ + Q+ + F GK + P+NV
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-GK-VRFPKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-18
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 8/214 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K ++HP +V + L V +Y++ G L+ L + R L+ R R A ++A
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARF-YAAEIA 106
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH N IV+RDLK N+L+D + + + DFGL + ++ + GTPE++A
Sbjct: 107 SALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLA 164
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVL +P + D + G +L+E+ P+ + N A++ + K L++ N+
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNS 222
Query: 181 VASIIEACWANEPWKRPSFST-IMELLRPLIKSP 213
++E + KR ME+ + SP
Sbjct: 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-18
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 6 HPNIVLFMGA-----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN------ 54
HPN+V F G V L +V E + GS+ L V+ L R+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL-----VKGFLKRGERMEEPIIAY 128
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ ++ G+ +LH +HRD+K N+L+ + VK+ DFG+S +T L ++ G
Sbjct: 129 ILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186
Query: 115 TPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
TP WMAPEV+ D + + D++S G+ EL P +L+P + +
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-------- 238
Query: 170 RLEIPRNVNPHVAS----------IIEACWANEPWKRPSFSTIME 204
+IPRN P + I C + KRP+ S +++
Sbjct: 239 -FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-18
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ L HP IV M + + + E++ G L+ L K G DVA
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-----------RFPNDVA 120
Query: 61 K--------GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKS 111
K YLH ++ I++RDLK NLL+D K VKV DFG + ++ TF +
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----T 174
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
GTPE++APEV++ + + D ++ GV+L+E P+ + P ++ + G RL
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-LAG-RL 232
Query: 172 EIPRNVNPHVASIIEACWANEPWKR 196
+ P + +++ + KR
Sbjct: 233 KFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-18
Identities = 54/187 (28%), Positives = 99/187 (52%), Gaps = 12/187 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K + HP I+ L ++ EY+ G L+ L G L A ++
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIV 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
+ YLH + IV+RDLK N+L+DK+ +K+ DFG ++ L+ T+ + GTPE++
Sbjct: 112 CALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYL 165
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
APEV++ + N+ D ++ G++++E+ P+ + NP + + GK LE PR+++
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-LAGK-LEFPRHLDL 223
Query: 180 HVASIIE 186
+ +I+
Sbjct: 224 YAKDLIK 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-18
Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML--DERRRLNMAYDVAKGM 63
HP IV A L ++ ++L G L+ L K E++ +E + +A ++A +
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLA-ELALAL 111
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
++LH I++RDLK N+L+D++ +K+ DFGLS+ + + S GT E+MAPEV
Sbjct: 112 DHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS 183
+ + +D +SFGV+++E+ T P+ + + + + K K L +P+ ++P S
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-LKAK-LGMPQFLSPEAQS 227
Query: 184 IIEACWANEPWKR--------------PSFSTI--MELLRPLIKSP 213
++ A + P R P FSTI +L R IK P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 9e-18
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ H N+V + L +V E+L G+L ++ ++E + + V
Sbjct: 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVL 128
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ ++YLH N ++HRD+KS ++L+ +K+ DFG + KS GTP WMA
Sbjct: 129 RALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNP 179
PEV+ P + DI+S G+++ E+ + P+ N P Q + + R++ V+
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSS 246
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTP 215
+ ++ EP +R +T ELL+ P +K P
Sbjct: 247 VLRGFLDLMLVREPSQR---ATAQELLQHPFLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-17
Identities = 45/175 (25%), Positives = 96/175 (54%), Gaps = 7/175 (4%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
L V EY++ G L + + G E + + A +++ G+ +LHRR I++RDLK
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLD 130
Query: 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
N+++D + +K+ DFG+ + +++++ GTP+++APE++ +P + D +++GV+
Sbjct: 131 NVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190
Query: 142 LWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 196
L+E+ Q P+ + ++ ++ + P++++ SI + P KR
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEY-LSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+++LRHPN + + G + +V EY L S +HK ++E+ + +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGA 124
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG A+ + GTP WM
Sbjct: 125 LQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXFVGTPYWM 178
Query: 120 APEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
APEV+ DE + K D++S G+ ELA + P N+N + + +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIME 204
+ + + +++C P RP+ +++
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-17
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 2 KRLRHPNIVLFMGAVTQ--PP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
K H NI + GA + PP L +V E+ GS+ L+ K L E +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYI 126
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
++ +G+ +LH ++HRD+K N+L+ + VK+ DFG+S T + GT
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184
Query: 116 PEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR 170
P WMAPEV+ D + +SDI+S G+ E+A P +++P + +
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--------- 235
Query: 171 LEIPRNVNPHVAS---------IIEACWANEPWKRPSFSTIME 204
IPRN P + S IE C RPS +++
Sbjct: 236 FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-17
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
HP + NL V EYL+ G L + H + D R A ++ G+ +
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHK-FDLPRATFYAAEIICGLQF 111
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------LKANTFLSSKSAAGTPEWM 119
LH + IV+RDLK N+L+D +K+ DFG+ + K TF GTP+++
Sbjct: 112 LHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF------CGTPDYI 163
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE---IPRN 176
APE+L + N D +SFGV+L+E+ Q P+ + ++ F+ R++ PR
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNPCYPRW 218
Query: 177 VNPHVASIIEACWANEPWKR 196
+ I+ + EP +R
Sbjct: 219 LTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-17
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ +H N+V + L ++ E+L G+L ++ + R L+E + + V
Sbjct: 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TR--LNEEQIATVCESVL 127
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ + YLH + ++HRD+KS ++L+ VK+ DFG + KS GTP WMA
Sbjct: 128 QALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP---RN- 176
PEV+ P + DI+S G+++ E+ + P+ + +P Q + K R P +N
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKNA 240
Query: 177 --VNPHVASIIEACWANEPWKRPSFSTIME 204
++P + +E EP +R + +++
Sbjct: 241 HKISPVLRDFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-17
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
++R++HPN + + G + +V EY S L + KP L E + +
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHG 133
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + + AN+F+ GTP
Sbjct: 134 ALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTP 185
Query: 117 EWMAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
WMAPEV+ DE + K D++S G+ ELA + P N+N + I
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHI 236
Query: 174 PRNVNPHVAS---------IIEACWANEPWKRPSFSTIMELLRPLIKSP 213
+N +P + S +++C P RP+ +++ + L + P
Sbjct: 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 7e-17
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 33/165 (20%)
Query: 1 MKRLRHPNIV-LFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRL 53
++ LRH NI+ L + +PP+ IVTE + L++++ P + + D+ +
Sbjct: 53 LRHLRHENIIGLL--DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP--QPLTDDHIQY 107
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
+ Y + +G+ YLH N ++HRDLK N+LV+ +K+CDFGL+R
Sbjct: 108 FL-YQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE------- 157
Query: 114 GTPEWM----------APEVLRDEPSNEKS-DIYSFGVILWELAT 147
++ APE+L K+ DI+S G I EL T
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-17
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 41/223 (18%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+++L+HPN + + G + +V EY S L + KP L E + +
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHG 129
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTP 116
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + AN+F+ GTP
Sbjct: 130 ALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTP 181
Query: 117 EWMAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
WMAPEV+ DE + K D++S G+ ELA + P N+N + I
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHI 232
Query: 174 PRNVNPHVAS---------IIEACWANEPWKRPSFSTIMELLR 207
+N +P + S ++ C P +RP ELLR
Sbjct: 233 AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERP---ASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 50/161 (31%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK--------GMNYLHRRNPP 72
+L +V EY+ G L LL + V E + A+ ++ +H+
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRKDV---FPE--------ETARFYIAELVLALDSVHKLG-- 121
Query: 73 IVHRDLKSPNLLVDKKYTVKVCDFGLS-----------------------------RLKA 103
+HRD+K N+L+D +K+ DFGL R
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144
+ + S GTP+++APEVLR P + D +S GVIL+E
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-16
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 7/210 (3%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P IV F GA +SI E++ GSL ++L K G + E+ ++ V KG+ YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 119
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
R I+HRD+K N+LV+ + +K+CDFG+S ++ + S GT +M+PE L+
Sbjct: 120 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 176
Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIE 186
+ +SDI+S G+ L E+A + P + ++ G + +P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236
Query: 187 ACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ P RP + I ELL ++ P P+
Sbjct: 237 PLSSYGPDSRPPMA-IFELLDYIVNEPPPK 265
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-16
Identities = 49/180 (27%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
L +V EY++ G L + H R++ +E R A ++ +N+LH R I++RDLK
Sbjct: 71 LFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHERG--IIYRDLKLD 125
Query: 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
N+L+D +K+ D+G+ + ++ + GTP ++APE+LR E D ++ GV+
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL 185
Query: 142 LWELATLQQPWGNL--NPAQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKR 196
++E+ + P+ + NP F+ K + IPR ++ + +++ +P +R
Sbjct: 186 MFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-16
Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 37/219 (16%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
+L V E+L+ G L + G D R A ++ G+ +LH + I++RDLK
Sbjct: 70 HLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKL 124
Query: 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDIYSF 138
N+++D+ +K+ DFG+ K N F ++++ GTP+++APE+L+ D +SF
Sbjct: 125 DNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182
Query: 139 GVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI---PRNVNPHVASIIEACWANEPWK 195
GV+L+E+ Q P+ + ++ F+ R++ PR + I+E + +P +
Sbjct: 183 GVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 196 R----------PSFSTI-------MEL---LRPLIKSPT 214
R P F TI EL +P +KSP+
Sbjct: 238 RLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPS 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-16
Identities = 46/145 (31%), Positives = 79/145 (54%), Gaps = 5/145 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K ++HP +V + L V ++++ G L+ L + R + R R A ++A
Sbjct: 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAA-EIA 106
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH N IV+RDLK N+L+D + V + DFGL + ++ + GTPE++A
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLA 164
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
PEV+R +P + D + G +L+E+
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-16
Identities = 45/175 (25%), Positives = 94/175 (53%), Gaps = 7/175 (4%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
L V EY++ G L + + G E + A ++A G+ +LH + I++RDLK
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLD 130
Query: 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
N+++D + +K+ DFG+ + +++K+ GTP+++APE++ +P + D ++FGV+
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190
Query: 142 LWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 196
L+E+ Q P+ + ++ ++ + P++++ +I + P KR
Sbjct: 191 LYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-16
Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 19/155 (12%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
+++LRH NIV A + L +V EY+ R L L P G+ D R + +
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPP--DAVRSY--IWQL 109
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA------ 113
+ + Y H N I+HRD+K N+LV + +K+CDFG +R L ++ A+
Sbjct: 110 LQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162
Query: 114 GTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
T + APE+L + + K D+++ G I+ EL
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-16
Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK L+H NIV + L +V EY+ L + + GVR LD + Y +
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKANTFLSSKSAAGTPE 117
KG+ + H ++HRDLK NLL++K+ +K+ DFGL+R + NTF + T
Sbjct: 111 KGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLW 165
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
+ AP+VL + S DI+S G I+ E+ T
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-16
Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ +H N+V + L +V E+L G+L ++ ++E + + V
Sbjct: 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 126
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
K ++ LH + ++HRD+KS ++L+ VK+ DFG + KS GTP WMA
Sbjct: 127 KALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNP 179
PE++ P + DI+S G+++ E+ + P+ N P + + + +L+ V+P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSP 244
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTP 215
+ ++ +P +R +T ELL+ P + P
Sbjct: 245 SLKGFLDRLLVRDPAQR---ATAAELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-16
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
E R + G+ +LH+R I++RDLK N+L+D V++ D GL+ +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 166
+K AGTP +MAPE+L+ E + D ++ GV L+E+ + P+ A G
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF---------RARGE 202
Query: 167 KGKRLEIPRNV-----------NPHVASIIEACWANEPWKRPSF 199
K + E+ + + +P S EA A +P KR F
Sbjct: 203 KVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-16
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
HP +V L V E++S G L + H R++ +E R A +++ +N+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNF 111
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
LH R I++RDLK N+L+D + +K+ D+G+ + ++ + GTP ++APE+LR
Sbjct: 112 LHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
E D ++ GV+++E+ + P+ + NP Q F+ K++ IPR+++
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229
Query: 179 PHVASIIEACWANEPWKR 196
+S+++ +P +R
Sbjct: 230 VKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-16
Identities = 45/175 (25%), Positives = 93/175 (53%), Gaps = 7/175 (4%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
L V EY++ G L + + G E + A ++A G+ +LH + I++RDLK
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLD 130
Query: 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
N+++D + +K+ DFG+ + ++++ GTP+++APE++ +P + D ++FGV+
Sbjct: 131 NVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190
Query: 142 LWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 196
L+E+ Q P+ + ++ ++ + P++++ SI + P KR
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-16
Identities = 52/156 (33%), Positives = 69/156 (44%), Gaps = 16/156 (10%)
Query: 3 RLRHPNIV-LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
RL HPNIV L P L V EY+ +L +L G + R + D
Sbjct: 34 RLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLD--- 90
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRL-------KANTFLSSKS 111
+ H + IVHRDLK N++V + KV DFG+ L T +
Sbjct: 91 ALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
GTP + APE LR EP SD+Y++G+I E T
Sbjct: 149 VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-15
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 6/148 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+LRH N+V + + L +V E++ L L P LDE R + +
Sbjct: 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQIL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ + H N I+HRD+K N+LV + VK+CDFG +R A T + A
Sbjct: 111 RGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 121 PEVLRDEPSNEKS-DIYSFGVILWELAT 147
PE+L + ++ DI++ G ++ E+ T
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-15
Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
IV A +L +V ++ G L ++ G E R + A + G+ +L
Sbjct: 53 RFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHL 111
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
H+R IV+RDLK N+L+D V++ D GL+ LK K AGTP +MAPEVL+
Sbjct: 112 HQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQ 167
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW 152
E + D ++ G L+E+ + P+
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-15
Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 10/152 (6%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
R P +V A L ++ +Y++ G L+ L++ RE E R+ +A ++ +
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ---REHFTESEVRVYIA-EIVLAL 118
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAPE 122
++LH+ I++RD+K N+L+D + V + DFGLS+ A + S GT E+MAPE
Sbjct: 119 DHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 123 VLRDEPS--NEKSDIYSFGVILWELATLQQPW 152
V+R ++ D +S GV+ +EL T P+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-15
Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-----HKPGVREMLDERRRLNMAYD 58
L+HPNI+ +G + +V EY G L L H+ + +L +R MA +
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR----MACE 107
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL--SRLKANTFLSSKSAAGTP 116
+A G+ ++H+ N +H DL N + TVKV D+G+ SR K + +
Sbjct: 108 IAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165
Query: 117 EWMAPEV-------LRDEPSNEKSDIYSFGVILWEL-ATLQQPWGNLNPAQVVAAVGFKG 168
W+APE+ L + S++++ GV LWEL QP+ +L+ +V+ V K
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IKD 224
Query: 169 KRLEIPRNVNPHVA--------SIIEACWANEPWKRPSFSTIMELL 206
+++++ + P + +++ CW + P KR + + LL
Sbjct: 225 QQVKLFK---PQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-15
Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRL------NMAYDVA 60
P IV F GA +SI E++ GSL ++L E +R+ ++ V
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSL---------DQVLKEAKRIPEEILGKVSIAVL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ YL R I+HRD+K N+LV+ + +K+CDFG+S ++ + S GT +M+
Sbjct: 114 RGLAYL-REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMS 170
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG---FKGKRLEIPRNV 177
PE L+ + +SDI+S G+ L ELA + P + ++ A G G+ E P ++
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE-PHSI 229
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+P + RP+ + I ELL ++ P P+
Sbjct: 230 SPRPRPPGRPVSGHGMDSRPAMA-IFELLDYIVNEPPPK 267
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-15
Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ ++ P IV + P L +V +++ G L+ L + G D R ++
Sbjct: 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELL 103
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ LH+ N +++RDLK N+L+D + + +CDFGL +L + + GTPE++A
Sbjct: 104 CALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+L + D ++ GV+L+E+ T P+ + N ++ + + L P +
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDRD 219
Query: 181 VASIIEACWANEPWKR 196
++ + +P +R
Sbjct: 220 AKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 54/192 (28%), Positives = 104/192 (54%), Gaps = 10/192 (5%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREML--DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79
L ++ EY S G L + + K ++E L E + Y + ++ +H R ++HRDLK
Sbjct: 140 LLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLK 196
Query: 80 SPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYS 137
S N+ + +K+ DFG S+ +++ + S GTP ++APE+ + ++K+D++S
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256
Query: 138 FGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 197
GVIL+EL TL +P+ + +++ V + GK P V+ + ++++ + P RP
Sbjct: 257 LGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSKNPALRP 315
Query: 198 SFSTIM--ELLR 207
+ ++ E L+
Sbjct: 316 TTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML-DERRRLNMAYDV 59
++ L+HPNI+ + N+++V E++ L +++ + D + + M
Sbjct: 56 LQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL-- 112
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPE 117
+G+ YLH I+HRDLK NLL+ +K+ DFGL+R N ++ + T
Sbjct: 113 -RGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRW 167
Query: 118 WMAPEVLRDEPSNEKS---DIYSFGVILWEL 145
+ APE+L + D++S G I EL
Sbjct: 168 YRAPELLFG--ARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-14
Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
+HP + L V EY++ G L + + DE R A +V +
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALM 110
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
+LHR +++RDLK N+L+D + K+ DFG+ + +++ + GTP+++APE+L
Sbjct: 111 FLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPW 152
++ D ++ GV+++E+ Q P+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 56/250 (22%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKP-GVREMLDERRRLNMAY 57
++L+HPNI+ ++ + L +V+ ++ GS LL H P G+ E+ +A+
Sbjct: 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAF 105
Query: 58 ---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-------LKANTFL 107
DV ++Y+H + +HR +K+ ++L+ V + S +
Sbjct: 106 ILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 108 SSKSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPW------------- 152
KS+ W++PEVL+ NEKSDIYS G+ ELA P+
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV 223
Query: 153 -----------------GNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEP 193
+++ ++ ++ P R + H +E C +P
Sbjct: 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDP 283
Query: 194 WKRPSFSTIM 203
RPS S ++
Sbjct: 284 ESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 27/159 (16%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L HPNIV + V L +V E+L + P LD + Y +
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLL 109
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+G+ Y H ++HRDLK NLL+D++ +K+ DFGL+R A G P
Sbjct: 110 QGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR-----------AFGVPVRTY 156
Query: 118 -------WM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
W APE+L DI+S G I E+
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-14
Identities = 48/143 (33%), Positives = 77/143 (53%), Gaps = 19/143 (13%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY----DVAKGMNYLHRRNPPIVHR 76
NL +V EY G L LL++ + DE +MA ++ ++ +H+ VHR
Sbjct: 75 NLYLVMEYQPGGDLLSLLNR--YEDQFDE----DMAQFYLAELVLAIHSVHQMG--YVHR 126
Query: 77 DLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-- 133
D+K N+L+D+ +K+ DFG + RL AN ++SK GTP+++APEVL + K
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 134 ----DIYSFGVILWELATLQQPW 152
D +S GVI +E+ + P+
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+L+HPN+V + + L +V EY L L P + E + +
Sbjct: 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ +N+ H+ N +HRD+K N+L+ K+ +K+CDFG +R+ T + A
Sbjct: 111 QAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168
Query: 121 PEVL-RDEPSNEKSDIYSFGVILWELATLQQPW----------------GNLNP--AQVV 161
PE+L D D+++ G + EL T Q W G+L P Q+
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228
Query: 162 AAVG-FKGKRLEIP----------RNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ FKG + P N++ S ++ C +P +R S ++E
Sbjct: 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-14
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 29/162 (17%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
++RL HPNI+ + + L++V E L +LY L+ G + L E+R + Y
Sbjct: 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMDMNLYELIK--GRKRPLPEKRVKSYMY 107
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP- 116
+ K ++++HR I HRD+K N+L+ K +K+ DFG S + P
Sbjct: 108 QLLKSLDHMHRNG--IFHRDIKPENILI-KDDILKLADFG----------SCRGIYSKPP 154
Query: 117 -------EWM-APE-VLRDEPSNEKSDIYSFGVILWELATLQ 149
W APE +L D K DI++ G + +E+ +L
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 45/177 (25%)
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSA---- 112
+ + Y+H + ++HRDLK N+L+ V + D+G + K L
Sbjct: 122 ICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 113 ------------AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
GTP++MAPE L P++E +DIY+ GVIL+++ TL P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK----- 234
Query: 161 VAAVGFKGK------RLEIPRNVNPH------VASIIEACWANEPWKRPSFSTIMEL 205
KG+ + P V P+ ++ I A +P +R +S++ EL
Sbjct: 235 ------KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER--YSSVQEL 283
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-14
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ + HP+++ + +V + LY L K L + L + +
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP--LPIDQALIIEKQIL 167
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEW 118
+G+ YLH + I+HRD+K+ N+ ++ V + D G ++ FL AGT E
Sbjct: 168 EGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVET 222
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWEL 145
APEVL + N K+DI+S G++L+E+
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 14/148 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYD 58
+K LRH NI+ P ++ VTE L L+RLL +P L+++ Y
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP-----LEKQFIQYFLYQ 116
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+ +G+ Y+H + +VHRDLK N+L+++ +K+CDFGL+R++ S T +
Sbjct: 117 ILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---TRYY 171
Query: 119 MAPEV-LRDEPSNEKSDIYSFGVILWEL 145
APE+ L + + + DI+S G I E+
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
MK + H NI+ + T +L +V E L +L +++ LD R
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQM-----DLDHERMSY 122
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + G+ +LH + I+HRDLK N++V T+K+ DFGL+R +F+ +
Sbjct: 123 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 179
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + APEV+ E DI+S G I+ E+
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDE---RRRLNMAY 57
++ +HP +V + +V EY+ L +L L E + + M
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRD--EERPLPEAQVKSYMRM-- 107
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTP 116
+ KG+ Y+H I+HRDLK NLL+ +K+ DFGL+RL + T
Sbjct: 108 -LLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 117 EWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
+ APE+L + D+++ G I EL
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-13
Identities = 50/182 (27%), Positives = 97/182 (53%), Gaps = 7/182 (3%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
++HP IV + A L ++ EYLS G L+ L + G+ +++ ++ +++ +
Sbjct: 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLS-EISLAL 113
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
+LH++ I++RDLK N+L+D + VK+ DFGL + + + + GT E+MAPE+
Sbjct: 114 EHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS 183
L + D +S G +++++ T P+ N + + + KGK L +P + P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKGK-LNLPPYLTPEARD 229
Query: 184 II 185
++
Sbjct: 230 LL 231
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHK---PGVREMLDERRR 52
++ HPNIV + P L++V E++ + L L K PG L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG----LPPETI 109
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
++ + +G+++LH IVHRDLK N+LV VK+ DFGL+R+ + ++ S
Sbjct: 110 KDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSV 166
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 149
T + APEVL D++S G I EL +
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 39/108 (36%), Positives = 61/108 (56%), Gaps = 13/108 (12%)
Query: 1 MKRLRHPNIV-LFMGAVTQPPNLS-------IVTEYLSRGSLYRLLHKPGVREMLDERRR 52
+K+L+HPN+V L AV +P +VT Y+ L LL P V+ L E +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVK--LTESQI 117
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100
+ +G+NYLH + I+HRD+K+ N+L+D + +K+ DFGL+R
Sbjct: 118 KCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-13
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L H ++V G + N+ +V EY+ G L LH+ + + +L++A +A
Sbjct: 55 MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLA 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYT--VKVCDFGLSRLKANTFLSSKSAA 113
++YL + +VH ++ N+LV ++ Y +K+ D G+ T LS +
Sbjct: 112 SALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERV 165
Query: 114 GTPEWMAPEVLRDEPSNEKS--DIYSFGVILWELATLQQPWGN--LNPAQVVAAVGFKGK 169
W+APE +R+ ++ D +SFG L E+ + G L+ F
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS----NGEEPLSTLSSSEKERFYQD 221
Query: 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203
+ +P +A++I CW +P KRPSF I+
Sbjct: 222 QHRLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-13
Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 5/147 (3%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
HP + P L V E+++ G L + H R DE R A ++ + +
Sbjct: 55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRR-FDEARARFYAAEITSALMF 111
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
LH + I++RDLK N+L+D + K+ DFG+ + ++ + GTP+++APE+L+
Sbjct: 112 LHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW 152
+ D ++ GV+L+E+ P+
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-13
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 61/256 (23%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
RHPNI+ T L +++ +++ GS LL K E + E N+ + +G+
Sbjct: 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL-KTYFPEGMSEALIGNILFGALRGL 114
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPE---- 117
NYLH+ +HR++K+ ++L+ V + GLS L + +K P+
Sbjct: 115 NYLHQNG--YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 118 ---WMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQ------------- 159
W++PE+LR + N KSDIYS G+ ELAT + P+ ++ Q
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230
Query: 160 ---------------------------VVAAVG---FKGKRLEIP--RNVNPHVASIIEA 187
VVAA +RL P + +P +++E
Sbjct: 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290
Query: 188 CWANEPWKRPSFSTIM 203
C +P KRPS S+++
Sbjct: 291 CLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 9e-13
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 22/157 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
++R +H NI+ + + +PP+ IV E + LY+L+ + L
Sbjct: 57 LRRFKHENIIGIL-DIIRPPSFESFNDVYIVQELMET-DLYKLIKT----QHLSNDHIQY 110
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-----FLSS 109
Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R+ FL+
Sbjct: 111 FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
A T + APE++ + K+ DI+S G IL E+
Sbjct: 169 YVA--TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 22/155 (14%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
+P +V + +L +V EY+ G LL G + + R+ A V + Y
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV--DMARMYFAETVL-ALEY 116
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----------------KANTFLSS 109
LH N IVHRDLK NLL+ +K+ DFGLS++ FL
Sbjct: 117 LH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL-D 173
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144
K GTPE++APEV+ + + D ++ G+IL+E
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 44/155 (28%), Positives = 82/155 (52%), Gaps = 20/155 (12%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDE-RRRLNM---- 55
+K L+H NIV + +L++V EYL + +++ LD+ +NM
Sbjct: 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD----------LKQYLDDCGNSINMHNVK 107
Query: 56 --AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
+ + +G+NY HRR ++HRDLK NLL++++ +K+ DFGL+R K+ + +
Sbjct: 108 LFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165
Query: 114 GTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
T + P++L + + D++ G I +E++T
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + L++V EYL L + + M + + + + +
Sbjct: 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM---FQLL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G++Y H+R I+HRDLK NLL+++K +K+ DFGL+R K+ + + T +
Sbjct: 114 RGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171
Query: 121 PEVLRDEPSNEKS---DIYSFGVILWELAT 147
P+VL S E S D++ G IL+E+AT
Sbjct: 172 PDVLLG--STEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P +V A L ++ +Y++ G L+ L + RE E+ + ++ + +L
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHL 121
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAPEVLR 125
H+ I++RD+K N+L+D V + DFGLS+ + + S GT E+MAP+++R
Sbjct: 122 HKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 126 --DEPSNEKSDIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
D ++ D +S GV+++EL T P+ G N ++ K P+ ++
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL 238
Query: 181 VASIIEACWANEPWKR 196
II+ +P KR
Sbjct: 239 AKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-12
Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L H ++VL G +V EY+ GSL L K + +++ +L +A +A
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLA 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLV----DKKYT----VKVCDFGLSRLKANTFLSSKSA 112
+++L + + H ++ + N+L+ D+K +K+ D G+S T L +
Sbjct: 111 WALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEIL 164
Query: 113 AGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKR 170
W+ PE + + + + +D +SFG LWE+ + +P L+ + + F R
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDR 221
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203
++P +A++I C EP RPSF I+
Sbjct: 222 HQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L+HPNIV +G ++ EY+ +L +L R + ERRR +A +A
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRR-KIAIGIA 790
Query: 61 KGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
K + +LH R +P +V +L +++D K + L L S+A ++
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YV 845
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE------- 172
APE + EKSDIY FG+IL EL T + +PA A G G +E
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGK------SPAD--AEFGVHGSIVEWARYCYS 897
Query: 173 -----------IPRNVNPHVASIIEA------CWANEPWKRPSFSTIMELLRPLIKS 212
I +V+ + I+E C A +P RP + +++ L +S
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-12
Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 12/151 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
+K L+H NIV V +L++V EYL + L + + G + M + + L Y +
Sbjct: 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL---YQI 113
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+G+ Y HRR ++HRDLK NLL++++ +K+ DFGL+R K+ + + T +
Sbjct: 114 LRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYR 171
Query: 120 APEVLRDEPSNEKS---DIYSFGVILWELAT 147
P+VL S+E S D++ G I +E+A+
Sbjct: 172 PPDVLLG--SSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 4e-12
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
+PN + +VT ++ +Y+ G L+ LL K L E + + + +N
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALND 124
Query: 66 LHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAA-GTPEWMAPEV 123
LH+ N I+H D+K N+L D K + +CD+GL ++ + S GT ++ +PE
Sbjct: 125 LHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSPEK 177
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQP 151
++ + D ++ GV+ +EL T + P
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-12
Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ L+ NIV A + L +V EY+ + L L P + E+ R + Y +
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVR-SYIYQLI 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
K +++ H+ + IVHRD+K NLL+ +K+CDFG +R L + + T +
Sbjct: 111 KAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQ 149
+PE+L P + D++S G IL EL+ Q
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 5e-12
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 21/98 (21%)
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
Y + K + Y+H N ++HRDLK N+L++ VK+ DFGL+R + + P
Sbjct: 114 YQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENP 167
Query: 117 --------EWM-APEVLRDEPSNEKSDIYSFGVILWEL 145
W APE+L S Y+ GV +W +
Sbjct: 168 VLTDYVATRWYRAPEILL------GSTRYTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-12
Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+ LRHPNIV V ++ +V EY + L LL + E + +
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQ 116
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+ +G+ YLH I+HRDLK NLL+ K +K+ DFGL+R T +
Sbjct: 117 LLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWEL 145
APE+L + + D+++ G IL EL
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-12
Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 15/152 (9%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P +V A L ++ +Y+S G ++ L++ R+ E + ++ + +L
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHL 121
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK-----SAAGTPEWMAP 121
H+ IV+RD+K N+L+D + V + DFGLS+ FLS + S GT E+MAP
Sbjct: 122 HKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYMAP 175
Query: 122 EVLRDEPSNEKS-DIYSFGVILWELATLQQPW 152
E++R + + K+ D +S G++++EL T P+
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-11
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVRE--MLDERRRLNMAYDVA 60
+H N VL + QPP++ E Y+ + LHK V + + ++ Y +
Sbjct: 56 FKHDN-VLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQIL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG---TPE 117
+G+ YLH I+HRD+K NLLV+ +K+CDFGL+R++ SK T
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVE--EPDESKHMTQEVVTQY 169
Query: 118 WMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
+ APE+L DI+S G I EL
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + L++V EYL + G M + R L + +
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFL---FQLL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ Y H+R ++HRDLK NLL+ ++ +K+ DFGL+R K+ + + T +
Sbjct: 114 RGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRP 171
Query: 121 PEVLRDEPSNEKS---DIYSFGVILWELAT 147
P+VL S E S D++ G I +E+AT
Sbjct: 172 PDVLLG--STEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+K + H NI+ + T +L +V E L +L +++H LD R
Sbjct: 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSY 127
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + G+ +LH + I+HRDLK N++V T+K+ DFGL+R F+ +
Sbjct: 128 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV- 184
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + APEV+ E DI+S G I+ EL
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P IV A P LS + + ++ G L+ L + GV E A ++ G+ ++
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEAEMRFYAAEIILGLEHM 113
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMAPEVL 124
H R +V+RDLK N+L+D+ V++ D GL A F K A GT +MAPEVL
Sbjct: 114 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 167
Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW 152
+ + + S D +S G +L++L P+
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-11
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P IV A P L + + ++ G L+ L + GV E+ A ++ G+ ++
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHM 113
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEWMAPEVL 124
H R +V+RDLK N+L+D+ V++ D GL A F K ++ GT +MAPEVL
Sbjct: 114 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 167
Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW 152
+ + + S D +S G +L++L P+
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-11
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR------LN 54
++ + HP+I+ G T Y L +K + L +R L
Sbjct: 137 LRAINHPSIIQLKGTFT----------YNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----RLKANTFLSSK 110
+ V + + YLH I+HRD+K+ N+ ++ V + DFG + + AN +
Sbjct: 187 IERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG-- 242
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 149
AGT APE+L +P DI+S G++L+E+AT
Sbjct: 243 -WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
+E R L A ++ G+ LHR N V+RDLK N+L+D +++ D GL+ +K
Sbjct: 99 FEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEG 155
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
S + GT +MAPEVL ++ D + G +++E+ Q P+
Sbjct: 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 13/92 (14%)
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAAGTP 116
G+ +LH I+HRDLK+ NLL++ + +K+CDFGL+R LK T L T
Sbjct: 118 GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TL 170
Query: 117 EWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
+ APE+L + D++S G I EL T
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-11
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M IV A L +V EY+ G L L+ + E + R A +V
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWARFYTA-EVV 152
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
++ +H + +HRD+K N+L+DK +K+ DFG ++ AN + +A GTP+++
Sbjct: 153 LALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 120 APEVLRDEPSN----EKSDIYSFGVILWEL 145
+PEVL+ + + + D +S GV L+E+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-11
Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 11/151 (7%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
P +V A L +V EY+ G L L+ V E + +V ++ +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF----YTAEVVLALDAI 158
Query: 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
H ++HRD+K N+L+DK +K+ DFG ++ + +A GTP++++PEVL+
Sbjct: 159 HSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 126 DEPSN----EKSDIYSFGVILWELATLQQPW 152
+ + + D +S GV L+E+ P+
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-11
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS---KSA 112
Y + G+ Y+H N ++HRDLK NLLV+ +K+CDFGL+R N ++
Sbjct: 112 YQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 113 AGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
T + APE++ S K+ D++S G IL EL
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-11
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 39/171 (22%)
Query: 1 MKRLRHPNIVLFMGAV---TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
M ++H NI MG V + +++V + ++ L ++++D + RL +
Sbjct: 74 MNEIKHENI---MGLVDVYVEGDFINLVMDIMA----SDL------KKVVDRKIRLTESQ 120
Query: 58 ------DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
+ G+N LH+ +HRDL N+ ++ K K+ DFGL+R S
Sbjct: 121 VKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 112 AAG---------TPE-----WMAPEVLR-DEPSNEKSDIYSFGVILWELAT 147
+ T + + APE+L E + D++S G I EL T
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-11
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
MK + H NI+ + T +L IV E L +L ++ ++ LD R
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQV-----IQMELDHERMSY 130
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + G+ +LH + I+HRDLK N++V T+K+ DFGL+R +F+ +
Sbjct: 131 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 187
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + APEV+ E DI+S G I+ E+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-11
Identities = 33/106 (31%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
+E R + A ++ G+ LH+ IV+RDLK N+L+D +++ D GL+ +
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEG 155
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
+ K GT +MAPEV+++E D ++ G +L+E+ Q P+
Sbjct: 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 20/148 (13%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN-----MAYD 58
+ HP V G+ L +V E++ G + L + +R N A
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR--------NKRFPNDVGCFYAAQ 139
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPE 117
+ YL N IV+RDLK NLL+DK +K+ DFG +++ T+ + GTPE
Sbjct: 140 IVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPE 193
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWEL 145
++APE+L + + +D ++ G+ ++E+
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-10
Identities = 42/155 (27%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++++ P IV A +L +V ++ G L ++ G R L+ R ++ + +
Sbjct: 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQIT 105
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
G+ +LH + IV+RD+K N+L+D + ++ D GL+ LK ++ + AGT +M
Sbjct: 106 CGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYM 161
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
APE+L++EP + D ++ G ++E+ + P+ +
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 40/179 (22%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
NL ++ E+L G + LL K ++ L E + ++ +H+ +HRD+K
Sbjct: 75 NLYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKP 129
Query: 81 PNLLVDKKYTVKVCDFGL------------------------------SRLKANTFLSSK 110
NLL+D K VK+ DFGL S+ KA T+ ++
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189
Query: 111 -----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
S GTP+++APEV N+ D +S GVI++E+ P+ + P + V
Sbjct: 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-10
Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 48/182 (26%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
NL V +Y+ G + LL + G+ E ++ R +A ++ + +H+ +HRD+K
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRLGIFE--EDLARFYIA-ELTCAIESVHKMG--FIHRDIKP 129
Query: 81 PNLLVDKKYTVKVCDFGLS----------------------------------------- 99
N+L+D+ +K+ DFGL
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLE 189
Query: 100 --RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157
R + + + S GTP ++APEVL + D +S GVIL+E+ Q P+ P
Sbjct: 190 RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249
Query: 158 AQ 159
A+
Sbjct: 250 AE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 40/179 (22%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
NL ++ E+L G + LL K ++ L E + ++ +H+ +HRD+K
Sbjct: 75 NLYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKP 129
Query: 81 PNLLVDKKYTVKVCDFGL------------------------------SRLKANTFLSSK 110
NLL+D K VK+ DFGL S+ KA T+ ++
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189
Query: 111 -----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
S GTP+++APEV N+ D +S GVI++E+ P+ + P + V
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 6/146 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIVL + L+ V EY+ ++ PG + RL M + +
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFM-FQLL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ Y+H ++ I+HRDLK NLL+ +K+ DFGL+R K+ + S T +
Sbjct: 114 RGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171
Query: 121 PEVLRDEPSNEKS-DIYSFGVILWEL 145
P+VL + DI+ G I E+
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 43/133 (32%), Positives = 62/133 (46%), Gaps = 5/133 (3%)
Query: 20 PNLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78
P+L +V EYL + + G L + + Y + KG+ + H+ ++HRDL
Sbjct: 79 PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDL 136
Query: 79 KSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-DIY 136
K NLLVDK K +K+ D GL R + S T + APEVL DI+
Sbjct: 137 KPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIW 196
Query: 137 SFGVILWELATLQ 149
S G I E++ Q
Sbjct: 197 SVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTF 106
DE R + A ++ G+ LHR IV+RDLK N+L+D +++ D GL+ +
Sbjct: 100 DEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
+ + GT +MAPEV+++E D + G +++E+ + P+
Sbjct: 158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY----DVAKGMNYLHRRNPPIVHR 76
NL +V +Y G L LL K ++R +MA ++ ++ +H+ VHR
Sbjct: 75 NLYLVMDYYVGGDLLTLLSK------FEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHR 126
Query: 77 DLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-- 133
D+K N+L+DK +++ DFG RL A+ + S A GTP++++PE+L+ +
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186
Query: 134 ---DIYSFGVILWELATLQQPW 152
D +S GV ++E+ + P+
Sbjct: 187 PECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 45/164 (27%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGMNYLHRRNPPIVHRDLK 79
L ++ EYL G + LL K ++ E R +A + ++ +H+ +HRD+K
Sbjct: 75 YLYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIA-ETILAIDSIHKLG--YIHRDIK 128
Query: 80 SPNLLVDKKYTVKVCDFGL---------------------------------SRLKANTF 106
NLL+D K +K+ DFGL S+ KA T+
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188
Query: 107 LSSK-----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
++ S GTP+++APEV N++ D +S GVI++E+
Sbjct: 189 KRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 3/145 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK + H NI+ + T +L + L ++ LD R + Y +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ +LH + I+HRDLK N++V T+K+ DFGL+R +F+ + T + A
Sbjct: 130 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 186
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
PEV+ E DI+S G I+ E+
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
+ P IV ++ N+ +V EYL G + LLH G DE + +VA ++
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALD 118
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
YLHR I+HRDLK N+L+ + +K+ DFGLS++ N L+ TP P
Sbjct: 119 YLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R + T
Sbjct: 115 YQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172
Query: 117 EWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
+ APE+L + + D++S G I EL
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+K ++H N++ + T +L + YL + L K E L E R + Y +
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
KG+ Y+H I+HRDLK NL V++ +K+ DFGL+R + ++ ++ T +
Sbjct: 128 LKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVV--TRWYR 182
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
APEV+ + + DI+S G I+ E+ T
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+K + H N++ + T +L +VT + L ++ +++ D+ +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIV---KCQKLSDDHIQF- 122
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + +G+ Y+H I+HRDLK N+ V++ +K+ DFGL+R + ++ A
Sbjct: 123 LVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTGYVA-- 177
Query: 115 TPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
T + APE++ + N+ DI+S G I+ EL T
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
L +V EY+ G L L+ V E + R A +V ++ +H +HRD+K
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVVLALDAIHSMG--FIHRDVKPD 171
Query: 82 NLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSN----EKSDIY 136
N+L+DK +K+ DFG ++ + +A GTP++++PEVL+ + + + D +
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 137 SFGVILWELATLQQPW 152
S GV L+E+ P+
Sbjct: 232 SVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-10
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV- 59
M ++ H ++ G + +V E++ G L L K E+ R+ +A+ +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--------EKGRVPVAWKIT 121
Query: 60 -----AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-------VKVCDFGLSRLKANTFL 107
A ++YL +N +VH ++ + N+L+ + +K+ D G+S T L
Sbjct: 122 VAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TAL 175
Query: 108 SSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVG 165
S + W+APE + S + +D +SFG L E+ + P P++
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KER 232
Query: 166 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
F K+ +P +A++I C EP +RPSF TI+ L
Sbjct: 233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-10
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 6/152 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + L++V EY + L + +D + + +
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFD--SCNGDIDPEIVKSFMFQLL 109
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KG+ + H N ++HRDLK NLL++K +K+ DFGL+R + T +
Sbjct: 110 KGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 167
Query: 121 PEVLRDEPSNEKS-DIYSFGVILWELATLQQP 151
P+VL S D++S G I ELA +P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
DE+R + A ++ G+ L R IV+RDLK N+L+D + +++ D GL+ ++
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEG 155
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
+ + GT +MAPEV+ +E D + G +++E+ Q P+
Sbjct: 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-09
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 1 MKRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHK---PGV-REMLDERR 51
++ HPN+V T + L++V E++ + L L K PGV E + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD-- 114
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
M + + +G+++LH +VHRDLK N+LV +K+ DFGL+R+ + + S
Sbjct: 115 ---MMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-S 168
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + APEVL D++S G I E+
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 2e-09
Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 36/187 (19%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREM---LDERRRLNM 55
M+ L+H NIV ++ N L I+ E+ G L R + K +M ++E +++
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK--CYKMFGKIEEHAIVDI 123
Query: 56 AYDVAKGMNYLHR-RNPP----IVHRDLKSPNLLV-----------------DKKYTVKV 93
+ + Y H ++ P ++HRDLK N+ + + + K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 94 CDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQ 149
DFGLS+ N + S S GTP + +PE+L E ++KSD+++ G I++EL + +
Sbjct: 184 GDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 150 QPWGNLN 156
P+ N
Sbjct: 241 TPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 1 MKRLRHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
++ +H NI+ + ++ +V + L L+ ++H + + +E R +
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH--SDQPLTEEHIRYFL- 113
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN------TFLSSK 110
Y + +G+ Y+H N ++HRDLK NLLV++ +++ DFG++R ++ F++
Sbjct: 114 YQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 111 SAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
A T + APE+L P D++S G I E+
Sbjct: 172 VA--TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-09
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIVL + L++V EY+ + PG + E +L + + +
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPG--GLHPENVKLFL-FQLL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G++Y+H+R I+HRDLK NLL+ +K+ DFGL+R K+ + + T +
Sbjct: 114 RGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 121 PEVLRDEPSNEKS---DIYSFGVILWEL 145
P+VL S E S D++ G I E+
Sbjct: 172 PDVLLG--STEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-09
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERR----RLNMAYDVAKGMNYLHRRNPPIVHR 76
NL +V +Y G L LL K R D R + +A D ++Y VHR
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--------VHR 126
Query: 77 DLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNE---- 131
D+K N+L+D +++ DFG +L + + S A GTP++++PE+L+ +
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYG 186
Query: 132 -KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
+ D +S GV ++E+ + P+ + + + +R + P V
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 32/167 (19%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-----------RLLHKPGVREMLDE 49
++ L+H N+V + +GS Y LL V+ L E
Sbjct: 65 LQLLKHENVVNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 50 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS 109
++ + + G+ Y+HR I+HRD+K+ N+L+ K +K+ DFGL+R F S
Sbjct: 121 IKK--VMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLS 172
Query: 110 KSAAG--------TPEWMAPEV-LRDEPSNEKSDIYSFGVILWELAT 147
K++ T + PE+ L + D++ G I+ E+ T
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-09
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 25/163 (15%)
Query: 1 MKRLRHPNIVLFMGAVT--QPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDER 50
+++L H NIV VT Q +V EY+ L LL V E
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVH--FSED 116
Query: 51 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 110
+ + +G+NY H++N +HRD+K N+L++ K +K+ DFGL+RL + S +
Sbjct: 117 HIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL----YNSEE 170
Query: 111 SAAGTPE----WMAPE--VLRDEPSNEKSDIYSFGVILWELAT 147
S T + W P +L +E D++S G IL EL T
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-09
Identities = 65/261 (24%), Positives = 98/261 (37%), Gaps = 68/261 (26%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY---D 58
K HPNIV + L +VT +++ GS L+ +D L +AY
Sbjct: 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMSELAIAYILQG 109
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL----------SRLKANTFLS 108
V K ++Y+H VHR +K+ ++L+ KV GL RL+
Sbjct: 110 VLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165
Query: 109 SKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGN------------ 154
S P W++PEVL+ + + KSDIYS G+ ELA P+ +
Sbjct: 166 KYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 224
Query: 155 ------------------LNPAQVVAAVGF-KGKRLEIPRNVN-------------PHVA 182
+ P++ A G + + PR N PH
Sbjct: 225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFH 284
Query: 183 SIIEACWANEPWKRPSFSTIM 203
+E C P RPS ST++
Sbjct: 285 HFVEQCLQRNPDARPSASTLL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L HPNIV + + L +V E+L + L + + + + + + + +
Sbjct: 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK-SYLFQLL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ + H ++HRDLK NLL++ + +K+ DFGL+R + T + A
Sbjct: 111 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
PE+L + + DI+S G I E+ T
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRR 52
+K ++H N++ + T +L + +Y + H G +++ D+ +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 123
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
+ Y + +G+ Y+H + I+HRDLK NL V++ +K+ DFGL+R +
Sbjct: 124 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGY 177
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
T + APE++ + N+ DI+S G I+ EL T
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 34/173 (19%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDVAK 61
L HP + + L +V +Y G L+RLL + PG + L E A +V
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLL 114
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---------------- 105
+ YLH IV+RDLK N+L+ + + + DF LS+
Sbjct: 115 ALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 106 -------FLS------SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
S S S GT E++APEV+ + D ++ G++L+E+
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+K ++H N++ + T + + YL + L K + +++ + + Y +
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-LVYQM 126
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
G+ Y+H I+HRDLK NL V++ +K+ DFGL+R A+ ++ T +
Sbjct: 127 LCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV--TRWYR 181
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
APEV+ + N+ DI+S G I+ E+ T
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+++ H +IVL G + +V E++ G L +H+ ++L + +A +A
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLA 115
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYT--VKVCDFGLSRLKANTFLSSKSAA 113
++YL ++ +VH ++ + N+L+ D + +K+ D G+ T LS +
Sbjct: 116 SALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVLSRQECV 169
Query: 114 GTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVGFKGKRL 171
W+APE + D + + +D +SFG LWE+ + P L + F +
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP---LKDKTLAEKERFYEGQC 226
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203
+ +A ++ C +P +RP F IM
Sbjct: 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-08
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 7/153 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K ++H NIV V L +V EYL + P + + R Y +
Sbjct: 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK--NPRLIKTYLYQIL 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+G+ Y H ++HRDLK NLL+D++ +K+ DFGL+R + T +
Sbjct: 113 RGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 120 APEVLRDEPS-NEKSDIYSFGVILWELATLQQP 151
APE+L + DI+S G I E+ Q+P
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 7e-08
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 4 LRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYDV 59
L+H N+V + + + S+ + +Y + L++++ H+ R + ++ + +
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKAN---TFLSSKSA 112
G++YLH ++HRDLK N+LV ++ VK+ D GL+RL
Sbjct: 118 LNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 113 AGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQ 149
T + APE+L K+ DI++ G I EL TL+
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 43/163 (26%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
L +V +Y G L LL K R + ++ R +A ++ ++ +H+ + VHRD+K
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIA-EMVLAIHSIHQLH--YVHRDIKPD 131
Query: 82 NLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-----NEKSD 134
N+L+D +++ DFG S LK N + S A GTP++++PE+L+ + D
Sbjct: 132 NVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190
Query: 135 IYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
+S GV ++E+ + P+ + + + +R + P ++
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-07
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 13/153 (8%)
Query: 1 MKRLR---HPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR 52
+KRL HPNIV M + +++V E++ + L P + +
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD 112
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
L + +G+++LH IVHRDLK N+LV VK+ DFGL+R+ + ++
Sbjct: 113 LMRQF--LRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPV 167
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + APEVL D++S G I E+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 40/147 (27%), Positives = 77/147 (52%), Gaps = 7/147 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+K ++H N++ + T ++ E YL + L+ + L + + Y +
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+G+ Y+H + I+HRDLK N+ V++ +++ DFGL+R +A+ ++ A T +
Sbjct: 128 LRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEMTGYVA--TRWYR 182
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWEL 145
APE++ + N+ DI+S G I+ EL
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-07
Identities = 30/84 (35%), Positives = 51/84 (60%), Gaps = 4/84 (4%)
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSA-AGTPEWMAPE 122
YLH R I+HRD+K+ N+ +D+ + DFG + +L A+ +GT E +PE
Sbjct: 200 YLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE 257
Query: 123 VLRDEPSNEKSDIYSFGVILWELA 146
+L +P K+DI+S G++L+E++
Sbjct: 258 LLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-07
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKS 111
Y + + + Y+H N + HRDLK N+L + +K+CDFGL+R+ N F +
Sbjct: 110 YQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 112 AAGTPEWMAPEVLRDEPSNEKS--DIYSFGVILWELAT 147
A T + APE+ S DI+S G I E+ T
Sbjct: 168 A--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-07
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 28/167 (16%)
Query: 1 MKRLRHPNIV-----LFMGAVTQPPNLSIVTEY--------LSRGSLYRLLHKPGVREML 47
++RL H NIV L ++ +TE L +L + +
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLS 112
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTF 106
+E RL M Y + +G+ Y+H N ++HRDLK N+ ++ + V K+ DFGL+R+ +
Sbjct: 113 EEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARI-VDPH 168
Query: 107 LSSK---SAAGTPEWM-APEVLRDEPSN--EKSDIYSFGVILWELAT 147
S K S +W +P +L P+N + D+++ G I E+ T
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 54/214 (25%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
NL V +Y+ G + LL + G+ ++ R +A ++ + +H+ +HRD+K
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMGIFP--EDLARFYIA-ELTCAVESVHKMG--FIHRDIKP 129
Query: 81 PNLLVDKKYTVKVCDFGL---------------------------------------SRL 101
N+L+D+ +K+ DFGL RL
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRL 189
Query: 102 KANTFLSSK--------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 153
K +++ S GTP ++APEVL + D +S GVIL+E+ Q P+
Sbjct: 190 KPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 249
Query: 154 NLNPAQVVAAVGFKGKRLEIP--RNVNPHVASII 185
P + V L IP ++P + +I
Sbjct: 250 AQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 61/265 (23%), Positives = 94/265 (35%), Gaps = 64/265 (24%)
Query: 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
NL V +Y+ G + LL + V E ++ + +H+ +HRD+K
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVHKMG--FIHRDIKP 129
Query: 81 PNLLVDKKYTVKVCDFGL---------------------------------------SRL 101
N+L+D +K+ DFGL RL
Sbjct: 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRL 189
Query: 102 KANTFLSSK--------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 153
K ++K S GTP ++APEVL + + D +S GVIL+E+ Q P+
Sbjct: 190 KTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFL 249
Query: 154 NLNPAQVVAAVGFKGKRLEIPRNV--NPHVASIIE--ACWANE--------PWKRPSFST 201
P + V L IP V +P +I C A E K F +
Sbjct: 250 APTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309
Query: 202 IMELLRPLIKSPTPQPSPTDMPLLT 226
++ + P P P+ T
Sbjct: 310 EVDFSSDIRTQPAPYVPKISHPMDT 334
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-06
Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 4/86 (4%)
Query: 63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMA 120
++Y+H I+HRD+K+ N+LV+ + + DFG + ++ + AGT + A
Sbjct: 273 IDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
PEVL +P DI+S G++++E A
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 31/118 (26%), Positives = 51/118 (43%), Gaps = 47/118 (39%)
Query: 74 VHRDLKSPNLLVDKKYTVKVCDFGLS-------------RL---KANTF----------- 106
+HRD+K N+L+D+ +K+ DFGLS +L K+N
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 107 -----LSSK---------------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144
+SSK S GTP+++APE+ + ++ D +S G I++E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 15/97 (15%)
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFG-----LSRLKANTFLSS 109
+Y + + + Y+H + I HRDLK NLL+D +T+K+CDFG L+ ++ +++ S
Sbjct: 176 SYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233
Query: 110 KSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
+ + APE++ + D++S G I+ E+
Sbjct: 234 RF------YRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 105 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146
F + + + P +MAPEV++ + EK+DIYS G+ L+E
Sbjct: 57 AFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.001
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF--L 107
++ Y + G++YLH ++HRDLK N+LV ++ VK+ D G +RL + L
Sbjct: 112 SLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 108 SSKSAAGTPEWM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
+ W APE+L K+ DI++ G I EL T
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF--L 107
++ Y + G++YLH ++HRDLK N+LV ++ VK+ D G +RL + L
Sbjct: 112 SLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 108 SSKSAAGTPEWM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
+ W APE+L K+ DI++ G I EL T
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----REMLDERRRLNMA 56
+ RL H NI+ + N ++T+ LY ++ R +L + R +
Sbjct: 217 LGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAI--M 273
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA---- 112
+ + Y+H + ++HRD+K N+ ++ + + DFG A F + A
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFG----TAMPFEKEREAFDYG 327
Query: 113 -AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
GT +PE+L + E +DI+S G+IL ++ +
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.004
Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 16/191 (8%)
Query: 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDVAKGMNY 65
PN+V + ++ +V ++ G L+ + K + E +R A ++ ++
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR----WAAEMVVALDA 100
Query: 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
LHR IV RDL N+L+D + +++ F + S A + APEV
Sbjct: 101 LHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---SCDGEAVENMYCAPEVGG 155
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASII 185
E D +S G IL+EL T + +P+ + L IP V+ S++
Sbjct: 156 ISEETEACDWWSLGAILFELLT-GKTLVECHPSGINTHT-----TLNIPEWVSEEARSLL 209
Query: 186 EACWANEPWKR 196
+ P +R
Sbjct: 210 QQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 226 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.66 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.65 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.49 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.42 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.32 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.27 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.26 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.92 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.6 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.53 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.93 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.39 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.34 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.27 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.13 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.79 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.63 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.63 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.36 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.19 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.95 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.85 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.72 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.6 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.59 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.45 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.07 | |
| PLN02236 | 344 | choline kinase | 94.78 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.42 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.28 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.17 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.12 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.07 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.01 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 93.95 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.63 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.57 | |
| PF10140 | 359 | YukC: WXG100 protein secretion system (Wss), prote | 93.5 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.41 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.3 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 91.16 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=316.82 Aligned_cols=200 Identities=30% Similarity=0.531 Sum_probs=188.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++|+|||||+++++|++.++.|+|.|.|..++|..++++ ++.+++.+++.++.||+.||.|||+++ |+|||||..
T Consensus 73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLG 147 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLG 147 (592)
T ss_pred HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchh
Confidence 689999999999999999999999999999999999997 445999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
|+|++++.++|++|||+|+......+.....+|++.|+|||++...+++..+||||+||+||-|+.|++||...+..++.
T Consensus 148 NlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 148 NLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred heeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence 99999999999999999999888777788899999999999999999999999999999999999999999999999999
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..++ ......|..++.+.++||.++|+.||.+|||+++|++ ++++
T Consensus 228 ~~Ik--~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff 272 (592)
T KOG0575|consen 228 NKIK--LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFF 272 (592)
T ss_pred HHHH--hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhh
Confidence 9885 4455567799999999999999999999999999999 8888
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=293.14 Aligned_cols=205 Identities=34% Similarity=0.585 Sum_probs=183.2
Q ss_pred CCCCCCcCcceeeeEEecCCc-eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di 78 (226)
|++++|||||++++.|..++. .+++|||+++|||.+++...+ ++++.....++.++++||.|||. ++ |+||||
T Consensus 131 l~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDI 205 (364)
T KOG0581|consen 131 LRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDI 205 (364)
T ss_pred HhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccC
Confidence 457799999999999999985 999999999999999998754 49999999999999999999996 88 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL--- 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~--- 155 (226)
||+|++++..|.+||+|||.+....+. ......|+..|||||.+.+..++.++||||||+.++|+.+|+.||...
T Consensus 206 KPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~ 283 (364)
T KOG0581|consen 206 KPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP 283 (364)
T ss_pred CHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence 999999999999999999999877766 456788999999999999999999999999999999999999999764
Q ss_pred --CHHHHHHHHhhCCccCCCCCC-CCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 156 --NPAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+..+....+- ....+.+|.. +|+++++|+..||+.||.+|||++++++ +.+++....
T Consensus 284 ~~~~~~Ll~~Iv-~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~~~ 343 (364)
T KOG0581|consen 284 YLDIFELLCAIV-DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKFED 343 (364)
T ss_pred CCCHHHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhccc
Confidence 5566666664 4566677776 9999999999999999999999999998 777776544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=283.23 Aligned_cols=207 Identities=27% Similarity=0.479 Sum_probs=182.0
Q ss_pred CCCCCCcCcceeee-EEecCCc-eEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhc--CCCCeEE
Q 027225 1 MKRLRHPNIVLFMG-AVTQPPN-LSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHR--RNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~i~h 75 (226)
|++|+|||||++++ .|.+++. .++|||+|.+|+|...++.. ..++.+++..+|+++.|++.||.++|+ ....+.|
T Consensus 72 LkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH 151 (375)
T KOG0591|consen 72 LKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH 151 (375)
T ss_pred HHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence 68999999999998 5555544 99999999999999999853 225679999999999999999999999 2223999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|||||.|||++.+|.+||+|||+++.............|+|.||+||.+.+.+++.++||||+||++|+|+.-+.||.+.
T Consensus 152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 152 RDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred ccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 99999999999999999999999998888777788899999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhhCCccCCCC-CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIP-RNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
+..+....+.. ...+++| ..+|..++.+|..|+..||+.||+...++..++.
T Consensus 232 n~~~L~~KI~q-gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 232 NLLSLCKKIEQ-GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cHHHHHHHHHc-CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 88888888863 4555566 7789999999999999999999996666665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=289.58 Aligned_cols=213 Identities=52% Similarity=0.863 Sum_probs=191.8
Q ss_pred CCCCCCcCcceeeeEEecCC-ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++|||||++++++.+.. ..++||||+++|+|..++.+. ....++...+..++.+|+.|+.|||++++ |+|+|||
T Consensus 93 l~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK 170 (362)
T KOG0192|consen 93 LSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLK 170 (362)
T ss_pred HHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccC
Confidence 45799999999999999987 799999999999999999874 23459999999999999999999999986 8999999
Q ss_pred CCcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCccccc--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 80 SPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 80 p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|+||+++.++ .+||+|||+++.............|+..|||||++. ...++.|+||||+|+++|+|+||..||.+..
T Consensus 171 ~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 171 SDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred hhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 9999999997 999999999987665433344467889999999999 5689999999999999999999999999999
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
..+..........++.++...++.+..++.+||..||.+||++.+++..|+.+.+....
T Consensus 251 ~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 251 PVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 88888878778888898999999999999999999999999999999999988775543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=291.19 Aligned_cols=206 Identities=26% Similarity=0.397 Sum_probs=175.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|||||++.++|+..+..|+|+||++||.|.+.+-.++ .+.+....-++.||+.|+.|||++| |+||||||
T Consensus 230 LkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKP 304 (475)
T KOG0615|consen 230 LKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKP 304 (475)
T ss_pred HHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC--cccccCCc
Confidence 578999999999999999999999999999999999998844 4888888999999999999999999 99999999
Q ss_pred CcEEEcCC---CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC---CCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||++..+ -.+|++|||+++..+ ........+|++.|.|||++.+.+. ..+.|+||+||++|-+++|.+||.+
T Consensus 305 eNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 305 ENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred ceEEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 99999766 578999999998776 3345678899999999999987653 3478999999999999999999976
Q ss_pred CCHHH-HHHHHhhCC--ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 155 LNPAQ-VVAAVGFKG--KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 155 ~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
..... ..+.+.... ..+..+..++.+..++|++||..||+.|||+.|+++ ++|++..+
T Consensus 384 ~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--hpW~~~~~ 444 (475)
T KOG0615|consen 384 EYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN--HPWFKDAP 444 (475)
T ss_pred ccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--Chhhhccc
Confidence 54433 333332221 223445688999999999999999999999999999 77777554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=280.05 Aligned_cols=198 Identities=27% Similarity=0.477 Sum_probs=179.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||+||+++-.|++.+++|+|+||+.||.|...+++.+ .+++..++.++.+|+.||.|||+.| |+|||+||
T Consensus 79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKP 153 (357)
T KOG0598|consen 79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKP 153 (357)
T ss_pred HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCH
Confidence 457899999999999999999999999999999999999865 3999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+|||+|..|.++|+|||+++............+|++.|+|||++.+.+++..+|+||||+++|+|++|..||...+..+.
T Consensus 154 ENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 154 ENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred HHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 99999999999999999998776666667778999999999999999999999999999999999999999999998888
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~~l~ 204 (226)
...+. .......+..++.+.+++++++|+.+|++|. ++.+|.+
T Consensus 234 ~~~I~-~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 234 YDKIL-KGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHh-cCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 88885 3334555666999999999999999999995 4555543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=296.17 Aligned_cols=207 Identities=31% Similarity=0.594 Sum_probs=188.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+..+|+|||++++.|...+.+|+||||++||+|.+.+.... +++.++..++.++++||+|||.+| |+|+|||.
T Consensus 324 m~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKS 397 (550)
T KOG0578|consen 324 MRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG--IIHRDIKS 397 (550)
T ss_pred HHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc--eeeecccc
Confidence 467899999999999998899999999999999999998654 999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.+|++||+|||+|..............|+++|||||+.....|..+.||||||++++||+.|.+||-..++...
T Consensus 398 DnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA 477 (550)
T KOG0578|consen 398 DNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 477 (550)
T ss_pred ceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH
Confidence 99999999999999999999887776667788999999999999999999999999999999999999999988888777
Q ss_pred HHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
...+...+ .....+..+|+++++|+.+||+.|+.+|+++.|+|+ +.+++...+
T Consensus 478 lyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl~~a~p 531 (550)
T KOG0578|consen 478 LYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE--HPFLKMAKP 531 (550)
T ss_pred HHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc--ChhhhhcCC
Confidence 77665333 345667899999999999999999999999999999 888755444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=287.55 Aligned_cols=203 Identities=32% Similarity=0.562 Sum_probs=183.4
Q ss_pred CCCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++++ ||||+++++++.....+|+||||+.||.|.+++.+.+ ++.+..++.++.|+++|++|+|++| |+|||||
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK 147 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLK 147 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCC
Confidence 35677 9999999999999999999999999999999999844 4999999999999999999999999 9999999
Q ss_pred CCcEEEcCC-CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 80 SPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SN-EKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 80 p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~-~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|+|++++.+ +++||+|||++.............+|++.|+|||++.+.. ++ .++||||+|+++|.|++|+.||.+.+
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 999999999 9999999999987743345577889999999999999977 64 78999999999999999999999988
Q ss_pred HHHHHHHHhhCCccCCCCCCC-CHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNV-NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.......+ ......+|..+ +++++.++.+||..||.+|+|+.++++ +.+++.
T Consensus 228 ~~~l~~ki--~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~~ 280 (370)
T KOG0583|consen 228 VPNLYRKI--RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE--HPWFQK 280 (370)
T ss_pred HHHHHHHH--hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhcc
Confidence 87777775 56667778888 999999999999999999999999995 777776
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=280.60 Aligned_cols=206 Identities=26% Similarity=0.525 Sum_probs=182.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++|||||.++|++..++..|+|||||+||+|.+++++++ .+++..++.++.||+.|+++||+++ |+||||||
T Consensus 63 Lkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKP 137 (429)
T KOG0595|consen 63 LKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN--IIHRDLKP 137 (429)
T ss_pred HHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCc
Confidence 578999999999999999999999999999999999999865 3999999999999999999999999 99999999
Q ss_pred CcEEEcCC------CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKK------YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||+++.+ -.+|+.|||+++..... ......+|++.|||||++....|+.|+|+||+|+++|++++|..||..
T Consensus 138 QNiLLs~~~~~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 138 QNILLSTTARNDTSPVLKIADFGFARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred ceEEeccCCCCCCCceEEecccchhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999764 46899999999876643 445678899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhhCCccCC-CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 155 LNPAQVVAAVGFKGKRLE-IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.+..+....++......+ ++...+..+.+++...++.++.+|.+..+... +.++...+
T Consensus 217 ~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~--~~~l~~~p 275 (429)
T KOG0595|consen 217 ETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD--HPFLAANP 275 (429)
T ss_pred cCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh--hhhcccCc
Confidence 999999887775555443 45677888899999999999999988887776 66666544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=291.92 Aligned_cols=213 Identities=30% Similarity=0.537 Sum_probs=191.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++||||+++||+|+++.++|+|.||++||-|++++-++| .+++.+++++++||+.|+.|+|..+ |+|+|+||
T Consensus 66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKp 140 (786)
T KOG0588|consen 66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKP 140 (786)
T ss_pred HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCc
Confidence 466899999999999999999999999999999999999865 3999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+|++++..+++|+.|||+|...... .-.+..+|.+.|.+||++.|..| ..++||||-|+|+|.|++|+.||++.+...
T Consensus 141 ENlLLd~~~nIKIADFGMAsLe~~g-klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~ 219 (786)
T KOG0588|consen 141 ENLLLDVKNNIKIADFGMASLEVPG-KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV 219 (786)
T ss_pred hhhhhhcccCEeeeccceeecccCC-ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH
Confidence 9999999999999999998764432 34567789999999999999987 578999999999999999999999999888
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCCCC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~ 223 (226)
+...++ .+....|..+++++++||.+||..||.+|.|.++|++ +.++..-...+.++.+|
T Consensus 220 LLlKV~--~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g~~~~~~~~~~~ 279 (786)
T KOG0588|consen 220 LLLKVQ--RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK--HPFLSGYTSLPSSKSLR 279 (786)
T ss_pred HHHHHH--cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh--CchhhcCCCCChhhhcC
Confidence 887774 5556678999999999999999999999999999999 88888877777764444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=278.40 Aligned_cols=209 Identities=33% Similarity=0.596 Sum_probs=177.4
Q ss_pred CCCCCCcCcceeeeEEecCC--ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++|||||++++...... .++++|||+.+|||.+++.+.+. .+++..+..+..|+++||.|||++| ++|+||
T Consensus 68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~Di 143 (313)
T KOG0198|consen 68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDI 143 (313)
T ss_pred HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCc
Confidence 46789999999999754443 69999999999999999998763 4999999999999999999999999 999999
Q ss_pred CCCcEEEcC-CCcEEEccCCCcccccc---cccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 79 KSPNLLVDK-KYTVKVCDFGLSRLKAN---TFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 79 ~p~nil~~~-~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||+||+++. ++.+||.|||.+..... .........+++.|+|||++... ....++|||||||++.+|+||+.||.
T Consensus 144 K~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 144 KPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 999999999 79999999998876553 22234457789999999999953 33459999999999999999999998
Q ss_pred C-CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 154 N-LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 154 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
. ....+....+......+.+|..++.+.++++.+|+..+|++|||+.++++ +.+++...+
T Consensus 224 ~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~--hpf~~~~~~ 284 (313)
T KOG0198|consen 224 EFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE--HPFLKQNSI 284 (313)
T ss_pred hhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh--Chhhhcccc
Confidence 7 55555556665555566889999999999999999999999999999999 666655443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=279.96 Aligned_cols=211 Identities=36% Similarity=0.657 Sum_probs=189.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++|+|+|||+++++|..++.+||||||+..|+|.++++... +..+...+...++.||++|.+||++++ ++||||-.
T Consensus 255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAA 331 (468)
T KOG0197|consen 255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAA 331 (468)
T ss_pred HHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhh
Confidence 578999999999999999889999999999999999999733 456999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
.|||+++++.+|++|||+++...+... ......-...|.|||.+....++.++||||+|++|+|++| |+.|+...+..
T Consensus 332 RNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 332 RNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred hheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 999999999999999999995443322 2222333457999999999999999999999999999998 78899999999
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+....+. .+.++..|..+|+++.+++..||..+|++|||++.+...++++.....+
T Consensus 412 ev~~~le-~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 412 EVLELLE-RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred HHHHHHh-ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 9999886 7888899999999999999999999999999999999999999876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=281.29 Aligned_cols=196 Identities=30% Similarity=0.507 Sum_probs=177.0
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
.+| .||.|++++-.|.++..+|+|+||+++|.|.+++.+.+. +++..++.++.+|+.||+|||++| |+||||||
T Consensus 128 ~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G--IIHRDlKP 202 (604)
T KOG0592|consen 128 TQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG--IIHRDLKP 202 (604)
T ss_pred HHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC--ceeccCCh
Confidence 345 899999999999999999999999999999999999764 999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-----------c--CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-----------S--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-----------~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
+|||++++++++|+|||.+......... . ..+.|+-.|.+||++.+...+..+|+|+|||++|.|+.
T Consensus 203 ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla 282 (604)
T KOG0592|consen 203 ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA 282 (604)
T ss_pred hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc
Confidence 9999999999999999998754322111 1 34778899999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
|.+||...+.--+.+.+. .-...++..+++...+||+++|..||.+|+|+++|.+
T Consensus 283 G~PPFra~NeyliFqkI~--~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 283 GQPPFRAANEYLIFQKIQ--ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCCccccHHHHHHHHH--HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 999999998887777773 4555778999999999999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=260.91 Aligned_cols=186 Identities=28% Similarity=0.532 Sum_probs=173.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++||+++++++.|.+.++.|+||||++||.|.+++++.+ ++++..++.++.|++.||+|||+.+ |++||+||
T Consensus 98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~--iiYRDLKP 172 (355)
T KOG0616|consen 98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKP 172 (355)
T ss_pred HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCCh
Confidence 567899999999999999999999999999999999999855 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++|++|.+|++|||+++..... ....+|++.|+|||++...++..++|.|+||+++|||+.|.+||...++.++
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 9999999999999999999765443 5577899999999999999999999999999999999999999999998777
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 196 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 196 (226)
.+.+ ......+|..+++++++|+.++|+.|-.+|
T Consensus 250 Y~KI--~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKI--LEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHH--HhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 7766 677788999999999999999999999999
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=276.07 Aligned_cols=201 Identities=31% Similarity=0.538 Sum_probs=186.6
Q ss_pred CCCCCCcCcceeeeEEecCCc-eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++|||||.+.+.|.+++. .+|||+||+||++.+.+.++. +..++++.+..|+.|++.|+.|||++. |+|||||
T Consensus 57 is~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK 133 (426)
T KOG0589|consen 57 LSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLK 133 (426)
T ss_pred HHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccch
Confidence 468999999999999999888 999999999999999998765 556999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+.|||+++++.++|+|||+++.............|++.|+.||.+.+..+..|+|+|||||++|+|++-+++|...+...
T Consensus 134 ~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~ 213 (426)
T KOG0589|consen 134 CANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE 213 (426)
T ss_pred hhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence 99999999999999999999988777656777889999999999999999999999999999999999999999999988
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
....+.. ....+.+..++.+++.+|+.||..+|..||++.+++..
T Consensus 214 Li~ki~~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 214 LILKINR-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHhh-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 8888853 33677889999999999999999999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=264.31 Aligned_cols=202 Identities=29% Similarity=0.487 Sum_probs=174.5
Q ss_pred CCCCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h 75 (226)
|++++||||+++++++.+ ....++|+||+++|+|.+++...+ .+++.....++.+++.|+.+||+ .+ ++|
T Consensus 72 l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~--~~H 146 (283)
T PHA02988 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN--KPY 146 (283)
T ss_pred HHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC--CCC
Confidence 468899999999999876 346899999999999999998743 48899999999999999999998 48 889
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
+||+|+||++++++.+|++|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 147 rdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 147 KNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred CcCChhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999988654332 123345678999999976 568999999999999999999999999
Q ss_pred CCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..+..+....+.........+...++++.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 888777766665455566667678999999999999999999999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=272.57 Aligned_cols=197 Identities=28% Similarity=0.489 Sum_probs=172.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..|+||||+.+++|.+++...+ .+++..+..++.||+.||+|||+.| ++||||||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp 123 (323)
T cd05571 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKL 123 (323)
T ss_pred HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCH
Confidence 357899999999999999999999999999999999997643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++..............+++.|+|||++.+..++.++|+||+||++++|++|..||...+....
T Consensus 124 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 203 (323)
T cd05571 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (323)
T ss_pred HHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH
Confidence 99999999999999999886533332233345678899999999988899999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
...+. .....++..+++++.++|.+||..||++|| ++.++++
T Consensus 204 ~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 204 FELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 65553 334566788999999999999999999999 8999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=269.16 Aligned_cols=209 Identities=33% Similarity=0.619 Sum_probs=170.3
Q ss_pred CCC-CCcCcceeeeEEecC-CceEEEEeecccCCHHHHhcCCCC------------------------------------
Q 027225 2 KRL-RHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGV------------------------------------ 43 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~------------------------------------ 43 (226)
+++ +||||+++++++... +..++||||+++|+|.+++.....
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (338)
T cd05102 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV 144 (338)
T ss_pred HHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence 345 899999999988764 458999999999999999875321
Q ss_pred -----------------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 44 -----------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 44 -----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~ 222 (338)
T cd05102 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR 222 (338)
T ss_pred cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeeccccc
Confidence 124788899999999999999999999 9999999999999999999999999986
Q ss_pred cccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCC
Q 027225 101 LKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177 (226)
Q Consensus 101 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (226)
...... .......++..|+|||++.+..++.++|+||+|+++|+|++ |..||......+..............+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (338)
T cd05102 223 DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENA 302 (338)
T ss_pred ccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCC
Confidence 543211 11122334567999999988889999999999999999997 999998765433333332334445566788
Q ss_pred CHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 178 ~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
++++.+++.+||+.||.+|||+.++++.|++++.+
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=261.47 Aligned_cols=207 Identities=26% Similarity=0.367 Sum_probs=180.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++||.++.+|..|+.++..|++||||.||+|..+++++. .+.++++.++.++.+++.||+|||..| |++|||||
T Consensus 131 L~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKP 207 (459)
T KOG0610|consen 131 LSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKP 207 (459)
T ss_pred HHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCc
Confidence 567999999999999999999999999999999999999876 678999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccc---------------------------------c-c--------------------
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKAN---------------------------------T-F-------------------- 106 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~---------------------------------~-~-------------------- 106 (226)
+||++.++|.+.|+||+++..... . .
T Consensus 208 ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep 287 (459)
T KOG0610|consen 208 ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEP 287 (459)
T ss_pred ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCC
Confidence 999999999999999998742110 0 0
Q ss_pred --cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHH
Q 027225 107 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI 184 (226)
Q Consensus 107 --~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 184 (226)
.......|+-.|+|||++.+.+.+.++|+|+||+++|||+.|..||.+.+..+....+-...........++..++||
T Consensus 288 ~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 288 TGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDL 367 (459)
T ss_pred CCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHH
Confidence 011124577899999999999999999999999999999999999999999998888865555555556889999999
Q ss_pred HHHHcccCCCCCCC----HHHHHHHHHHhhcC
Q 027225 185 IEACWANEPWKRPS----FSTIMELLRPLIKS 212 (226)
Q Consensus 185 i~~~l~~~p~~Rps----~~~~l~~l~~~~~~ 212 (226)
|+++|..||.+|.. +.||-+ +.++++
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~--HpFF~g 397 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKR--HPFFEG 397 (459)
T ss_pred HHHHhccChhhhhccccchHHhhc--CccccC
Confidence 99999999999998 888876 455443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=267.49 Aligned_cols=217 Identities=25% Similarity=0.398 Sum_probs=185.1
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++|+||||+++.+...+. +.+|+|+||++. +|.-++...+.+ |++.++..++.||+.||+|+|++| +.||||
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vk--ft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDI 244 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVK--FTEPQIKCYMKQLLEGLEYCHSRG--VLHRDI 244 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcc--cChHHHHHHHHHHHHHHHHHhhcC--eeeccc
Confidence 6899999999999999876 679999999987 999998876544 999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|.+|||+|++|.+||.|||+++...... ........+.+|+|||.+.|.. |+.+.|+||.|||+.||++|++.+.+.+
T Consensus 245 K~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 245 KGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred cccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 9999999999999999999998654432 2345566788999999998765 8999999999999999999999999988
Q ss_pred HHHHHHHHhhCCccC--------CCC-------------------CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 157 PAQVVAAVGFKGKRL--------EIP-------------------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~--------~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
..+....+-...+.+ .+| ..++.+..+|+..+|..||.+|.|+.++++ .++
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--sey 402 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEY 402 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--Ccc
Confidence 777665553322211 111 246788999999999999999999999999 899
Q ss_pred hcCCCCCCCCCCCCC
Q 027225 210 IKSPTPQPSPTDMPL 224 (226)
Q Consensus 210 ~~~~~~~~~~~~~~~ 224 (226)
++..+....|..+|.
T Consensus 403 F~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 403 FTTEPLPCDPSSLPK 417 (560)
T ss_pred cccCCCCCCcccCCC
Confidence 988888888888875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=258.02 Aligned_cols=199 Identities=23% Similarity=0.397 Sum_probs=168.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|||+|.++++|......++|+|||+. ++.+-+.+...+ .+.+.+..+++|++.|+.|+|+++ ++||||||
T Consensus 55 LKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKP 129 (396)
T KOG0593|consen 55 LKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKP 129 (396)
T ss_pred HHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC--eecccCCh
Confidence 5899999999999999999999999999987 555555543322 899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.+|.+||+|||+++....+.........+.+|+|||.+.+ -+|....|||++||++.||++|.+.|.+....+
T Consensus 130 ENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 130 ENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred hheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 9999999999999999999988777677777788899999999988 568899999999999999999999998876655
Q ss_pred HHHHHhhCCccC-----------------CCC------------CCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKRL-----------------EIP------------RNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~~-----------------~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+...-+.+ .+| ..++..+.+++++||..||.+|++-++++.
T Consensus 210 QLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 210 QLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 544443221111 011 245678999999999999999999999984
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=263.28 Aligned_cols=208 Identities=30% Similarity=0.489 Sum_probs=172.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++||||++++..|..+..+|+||.|+.+||+.+++...- ...+++..+..+++++++||.|||++| .+|||||+
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKA 154 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG--HIHRDVKA 154 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC--ceeccccc
Confidence 467899999999999999999999999999999999998643 223999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc----CCCCCCCCccCccccc--CCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS----KSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
.||+++.+|.++|+|||.+....+..... ....++++|+|||++. ..+|+.|+||||||+...|+.+|..||..
T Consensus 155 gnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 155 GNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred ccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 99999999999999999875433332222 4558899999999954 34589999999999999999999999998
Q ss_pred CCHHHHHHHHhhCCcc-CC-------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 155 LNPAQVVAAVGFKGKR-LE-------IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+.+..-..-..... +. -...++++++++|..||..||.+|||+.++++ ..+++..
T Consensus 235 ~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk--h~FFk~~ 299 (516)
T KOG0582|consen 235 YPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK--HAFFKKA 299 (516)
T ss_pred CChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc--cHHHhhc
Confidence 8877755443222221 10 11346789999999999999999999999998 6666554
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=267.28 Aligned_cols=197 Identities=28% Similarity=0.501 Sum_probs=171.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..|+||||+.+++|..++.+.+ .+++..++.++.||+.||.|||++| ++|+||||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp 123 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKL 123 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCH
Confidence 357899999999999999999999999999999999887643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+||++|+|++|..||...+....
T Consensus 124 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~ 203 (323)
T cd05595 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203 (323)
T ss_pred HHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999876533222223345678899999999988889999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
...+. .....++..+++++.++|.+||+.||.+|+ ++.++++
T Consensus 204 ~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 204 FELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 55543 334456778999999999999999999998 8998887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=267.02 Aligned_cols=197 Identities=25% Similarity=0.447 Sum_probs=170.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+||+.+++|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||||
T Consensus 47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp 121 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHKFN--VIYRDLKP 121 (312)
T ss_pred HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCH
Confidence 357899999999999999999999999999999999997643 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++..............+++.|+|||++.+..++.++|+||+|+++++|++|..||...+..+.
T Consensus 122 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~ 201 (312)
T cd05585 122 ENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201 (312)
T ss_pred HHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH
Confidence 99999999999999999987543322223345678899999999998899999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC---HHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS---FSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~ 204 (226)
...+. .....++..+++++.++|.+||+.||.+||+ +.++++
T Consensus 202 ~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 202 YRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 65553 3455677889999999999999999999975 566665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=266.67 Aligned_cols=197 Identities=28% Similarity=0.494 Sum_probs=171.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++||||+++++|.+++...+ .+++.++..++.||+.||+|||++| ++|+||||
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp 123 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKL 123 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCH
Confidence 357899999999999999999999999999999999987643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.
T Consensus 124 ~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~ 203 (328)
T cd05593 124 ENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (328)
T ss_pred HHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH
Confidence 99999999999999999876533222223345678899999999988889999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
...+ ......++..+++++.++|.+||+.||.+|+ ++.++++
T Consensus 204 ~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 204 FELI--LMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHh--ccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 5554 2344566788999999999999999999997 8999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=264.40 Aligned_cols=199 Identities=26% Similarity=0.485 Sum_probs=173.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+.+++|.+++.+.+ .+++..+..++.|++.||+|||++| ++||||+|
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 129 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKP 129 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCH
Confidence 467899999999999999999999999999999999998644 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 130 ~NIli~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~ 206 (291)
T cd05612 130 ENILLDKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206 (291)
T ss_pred HHeEECCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999988654332 2234578899999999988889999999999999999999999998877666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhc
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIK 211 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~ 211 (226)
...+. .....++..++..+.++|++||+.||.+|++ ++++++ +.+++
T Consensus 207 ~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~--h~~~~ 258 (291)
T cd05612 207 YEKIL--AGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN--HRWFK 258 (291)
T ss_pred HHHHH--hCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc--Ccccc
Confidence 65553 3345667788999999999999999999995 999987 55554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=264.96 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=173.5
Q ss_pred CCCCC-CcCcceeeeEEecCC-ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLR-HPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|+++. ||||+++.+++.+.+ .+|+||||++. +|.+++..+ +..+++..++.|+.||++||+|+|++| ++|||+
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDl 136 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDL 136 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccC
Confidence 56787 999999999998887 89999999965 999999876 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
||+||++.....+||.|||+|+....... ......+.+|+|||++... .|+.+.|+|++||+++|+.+-++.|.+.+.
T Consensus 137 KPENiLi~~~~~iKiaDFGLARev~SkpP-YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 137 KPENILISGNDVIKIADFGLAREVRSKPP-YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred ChhheEecccceeEecccccccccccCCC-cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 99999999888999999999987665533 3355678899999998654 588999999999999999999999988777
Q ss_pred HHHHHHHhhCCccCC----------------------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 158 AQVVAAVGFKGKRLE----------------------------IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.+.+..+-...+.+. +-...+.++.++|.+|+..||.+|||+.++++ ..+
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~--~pf 293 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ--HPF 293 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc--Ccc
Confidence 665554432222111 11247889999999999999999999999998 666
Q ss_pred hcCCCCC
Q 027225 210 IKSPTPQ 216 (226)
Q Consensus 210 ~~~~~~~ 216 (226)
+....+.
T Consensus 294 fq~~~~~ 300 (538)
T KOG0661|consen 294 FQVGRAS 300 (538)
T ss_pred ccccccc
Confidence 5554443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=244.17 Aligned_cols=216 Identities=23% Similarity=0.337 Sum_probs=182.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++|+||+.++|+|.+.++..+|+||++. +|...++... ..++...+..++.++++||+|||++. |.||||||
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKP 129 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKP 129 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCc
Confidence 5678999999999999999999999999976 9999998753 35999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
.|++++.+|.+|+.|||+++..+...........+.+|+|||.+.|.. |+...|+||+||++.||+.+.+.|.+.++-+
T Consensus 130 nNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 130 NNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred cceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 999999999999999999998887766555557788999999988764 8889999999999999999999887766555
Q ss_pred HHHHHhhCCccCC--------------------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 160 VVAAVGFKGKRLE--------------------------IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 160 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
....+-...+.+. +-...+.+..+|+.+||..||.+|+++.|+++ .+.+++.
T Consensus 210 QL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~~ 287 (318)
T KOG0659|consen 210 QLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKSL 287 (318)
T ss_pred HHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhcC
Confidence 4443322222111 11235678899999999999999999999999 8999987
Q ss_pred CCCCCCCCCC
Q 027225 214 TPQPSPTDMP 223 (226)
Q Consensus 214 ~~~~~~~~~~ 223 (226)
|++..|..+|
T Consensus 288 P~pt~~~~lp 297 (318)
T KOG0659|consen 288 PLPTPPSKLP 297 (318)
T ss_pred CCCCChhhCc
Confidence 7776666655
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=263.79 Aligned_cols=195 Identities=28% Similarity=0.456 Sum_probs=169.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..|+||||+.+++|..++... .+++..+..++.|++.||.|||+.| ++|+||||+
T Consensus 57 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~ 130 (324)
T cd05589 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLD 130 (324)
T ss_pred cccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHH
Confidence 5678999999999999999999999999999999888653 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 131 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 131 NLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred HeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998764333222233456788999999999888999999999999999999999999988877666
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
..+. ......+..+++++.++|.+||+.||.+|| ++.++++
T Consensus 211 ~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 211 DSIV--NDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHH--hCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 6553 233456778899999999999999999999 5777776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=265.45 Aligned_cols=197 Identities=25% Similarity=0.445 Sum_probs=171.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..|+||||+.+++|.+++.+.+ .+.+..+..++.|++.||.|||++| ++|+||||
T Consensus 54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp 128 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKP 128 (323)
T ss_pred HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 467899999999999999999999999999999999997644 3888999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 129 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~ 208 (323)
T cd05584 129 ENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT 208 (323)
T ss_pred HHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999999876433322223345678899999999988889999999999999999999999988777665
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
...+. ......+..+++++.++|.+||+.+|.+|| +++++++
T Consensus 209 ~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 IDKIL--KGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHH--cCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 55543 344566778899999999999999999999 8888887
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=266.66 Aligned_cols=194 Identities=26% Similarity=0.467 Sum_probs=170.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+.+++|.+++.+.+ .+++..+..++.|++.||+|||++| ++|+||||
T Consensus 72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp 146 (329)
T PTZ00263 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKP 146 (329)
T ss_pred HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCH
Confidence 357899999999999999999999999999999999998744 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+...... .....+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.
T Consensus 147 ~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 147 ENLLLDNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred HHEEECCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999998754332 2234578899999999998889999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~ 204 (226)
...+. ......+..++..+.++|.+||+.||.+|++ ++++++
T Consensus 224 ~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 224 YEKIL--AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHh--cCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 55553 3455667789999999999999999999987 688876
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=255.25 Aligned_cols=211 Identities=35% Similarity=0.580 Sum_probs=178.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++++||||+++++++...+..++|+||+++++|.+++..++. ...+++..++.++.||+.||++||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999999999999999975431 234889999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
++| ++|+||+|+||+++.++.++|+|||.+....... .......+...|+|||.+.+..++.++|+||+|+++++|
T Consensus 141 ~~~--i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 218 (291)
T cd05094 141 SQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218 (291)
T ss_pred hCC--eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHH
Confidence 999 9999999999999999999999999886543321 112233446689999999988889999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
++ |..||...+..+...... .......+...+..+.+++.+||+.+|++|||+.++++.|+++.+..+
T Consensus 219 ~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 219 FTYGKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HhCCCCCCCCCCHHHHHHHHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 98 999998877766655543 333344556778999999999999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=271.29 Aligned_cols=203 Identities=38% Similarity=0.726 Sum_probs=182.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++|+||||+.+.++|.....+|||||||..|.|...++... .++......|..+|+.|..|||.+. |+|||||.
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKS 240 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKS 240 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCC
Confidence 688999999999999999999999999999999999998744 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
-||+++.+..+||+|||-++...+. ...-.+.|+..|||||++.+...++|.||||+|+|+|+|+||..||.+.+...+
T Consensus 241 PNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 241 PNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred CceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 9999999999999999988765554 223457789999999999999999999999999999999999999998877766
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+.-.....-.+..|...++.++-|++.||+.+|..||++.+++..|+-+
T Consensus 320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 6655545556677899999999999999999999999999999988643
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=265.92 Aligned_cols=196 Identities=28% Similarity=0.497 Sum_probs=170.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p 80 (226)
++++||||+++++++.+++..|+||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||+ .| ++|+||||
T Consensus 50 ~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp 124 (325)
T cd05594 50 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKL 124 (325)
T ss_pred HhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCC
Confidence 56799999999999999999999999999999999987643 48999999999999999999997 79 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++..............++..|+|||++.+..++.++|+||+|+++|+|++|..||...+..+.
T Consensus 125 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~ 204 (325)
T cd05594 125 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204 (325)
T ss_pred CeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH
Confidence 99999999999999999876433222223344578899999999988899999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
...+. .....++..+++++.+++.+||+.||.+|+ ++.++++
T Consensus 205 ~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 205 FELIL--MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 65553 344556778999999999999999999996 8999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=250.90 Aligned_cols=205 Identities=35% Similarity=0.607 Sum_probs=176.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+||+++++|.+++.+.. ...+++..+..++.|++.||.+||++| ++|+||+|
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~ 132 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAA 132 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCc
Confidence 467899999999999999999999999999999999998643 345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............+...|++||.+.+..++.++|+||||++++++++ |..||...+..+
T Consensus 133 ~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 133 RNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred ceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999999988765433222223334567999999988888999999999999999998 899998877766
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
....+. .......+...+.++.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 213 VYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 666554 3344455678899999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=251.29 Aligned_cols=204 Identities=30% Similarity=0.541 Sum_probs=172.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.| ++|+||+|
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp 135 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAA 135 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccH
Confidence 457899999999999999999999999999999999987643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||+|++++++++ |..||...+..
T Consensus 136 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~ 215 (266)
T cd05064 136 HKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215 (266)
T ss_pred hhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 9999999999999999976543222111 112233467999999988889999999999999999775 99999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+....+. .......+..++..+.+++.+||+.+|.+||+++++.+.|+++
T Consensus 216 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 DVIKAVE-DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 6665554 3334456778899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=254.06 Aligned_cols=206 Identities=34% Similarity=0.574 Sum_probs=174.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
|++++||||+++++++.+.+..++++||+.+++|.+++..... ...+++..++.++.|++.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3568999999999999999999999999999999999875321 135888999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
+.| ++|+||+|+||++++++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|
T Consensus 142 ~~~--i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el 219 (283)
T cd05048 142 SHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219 (283)
T ss_pred hCC--eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHH
Confidence 999 9999999999999999999999999886543221 112233446789999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
++ |..||.+.+..+....+. .......+..++.++.+++.+||+.||.+||++.++++.|+++
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 220 FSYGLQPYYGFSNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 98 999998877777666554 3334455678999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=254.04 Aligned_cols=210 Identities=34% Similarity=0.583 Sum_probs=177.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC----------CCcCCHHHHHHHHHHHHHHHHHHhcCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----------REMLDERRRLNMAYDVAKGMNYLHRRN 70 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~~ 70 (226)
|++++||||+++++++...+..++|+||+.+++|.+++...+. ...+++..++.++.|++.||++||++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999999999999999999999999875331 224899999999999999999999999
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT- 147 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 147 (226)
++|+||+|+||++++++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 141 --i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~ 218 (288)
T cd05093 141 --FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218 (288)
T ss_pred --eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999886543221 11222334567999999998888999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
|..||......+....+. .......+...+.++.+++.+||+.||.+|||+.++.+.|+.+.+..
T Consensus 219 g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 219 GKQPWYQLSNNEVIECIT-QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred CCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 899998877766655554 23334456678899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=264.84 Aligned_cols=200 Identities=23% Similarity=0.411 Sum_probs=173.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+.+|+|.+++.+.+ .+++..+..++.|++.||.|||+.| ++||||||
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp 159 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKP 159 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCH
Confidence 356899999999999999999999999999999999998744 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+...... .....+++.|+|||++.+..++.++|+||+||++|+|++|..||...+....
T Consensus 160 ~NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 236 (340)
T PTZ00426 160 ENLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236 (340)
T ss_pred HHEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999998654322 2334578899999999988889999999999999999999999998877666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
...+. ......+..+++.+.++|++||+.+|.+|+ +++++++ +.++++
T Consensus 237 ~~~i~--~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~--hp~f~~ 289 (340)
T PTZ00426 237 YQKIL--EGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE--HPWFGN 289 (340)
T ss_pred HHHHh--cCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc--CCCcCC
Confidence 55553 334456778899999999999999999995 8999987 455543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=272.41 Aligned_cols=201 Identities=26% Similarity=0.451 Sum_probs=172.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++..++..|+||||+++|+|.+++.+. .....+++..+..++.|++.||.|||++| ++|||||
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlk 196 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLK 196 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcC
Confidence 46789999999999999999999999999999999887642 22345899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
|+||+++.++.++|+|||++........ ......+++.|+|||++.+..++.++|+||+||++++|++|..||...+.
T Consensus 197 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999876443211 22344578899999999988899999999999999999999999988877
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+....+.. ......+..++.++.++|.+||..+|++||++.+++.
T Consensus 277 ~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 REIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHh-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 766665543 2333456778999999999999999999999999874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=250.38 Aligned_cols=206 Identities=37% Similarity=0.662 Sum_probs=174.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++|+||+.+++|.+++.... ...+++..++.++.|++.||++||++| ++|+||+|
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp 132 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAA 132 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCc
Confidence 357899999999999999999999999999999999987543 234889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||++++++.++|+|||.+......... ......+..|+|||.+.+..++.++|+||||+++++|++ |..||...+..
T Consensus 133 ~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 133 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred ceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999988654432111 112223457999999988888999999999999999998 89999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
+...... .......+..++.++.+++.+||+.+|.+||++.++++.|+.++
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 213 QVYELLE-KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 6655553 23344567788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=263.76 Aligned_cols=216 Identities=26% Similarity=0.445 Sum_probs=190.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++|||||++|++......+|+|.|.-++|+|.+|+-++..+ +.++.+.+++.||+.||.|+|+.. ++||||||
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKP 146 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKP 146 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCc
Confidence 35579999999999999999999999999999999999876433 999999999999999999999999 99999999
Q ss_pred CcEEE-cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLV-DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||.+ -+-|-+||+|||++..... .......+|...|-|||++.+..|+ ++.||||||+++|.+++|+.||...+..
T Consensus 147 ENVVFFEKlGlVKLTDFGFSNkf~P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 147 ENVVFFEKLGLVKLTDFGFSNKFQP-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred ceeEEeeecCceEeeeccccccCCC-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 99865 5778999999999865443 3445677889999999999988774 5789999999999999999999998888
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCCCCCCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 226 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 226 (226)
+..-.+ .......|..++.++++||.+||..||++|.+.++|.. ..|++...+..+.. +|+++
T Consensus 226 ETLTmI--mDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wlq~~D~~~sT~-iPLvs 288 (864)
T KOG4717|consen 226 ETLTMI--MDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS--TSWLQAGDRGLSTA-IPLVS 288 (864)
T ss_pred hhhhhh--hcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc--cccccCCCCCcccc-Cceee
Confidence 887776 56677889999999999999999999999999999999 88998888777764 88763
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=261.59 Aligned_cols=199 Identities=25% Similarity=0.438 Sum_probs=170.9
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.+||||+++++++...+..|+||||+++++|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||||+||
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NI 127 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNV 127 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHe
Confidence 379999999999999999999999999999999987643 3899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+....
T Consensus 128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (320)
T cd05590 128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207 (320)
T ss_pred EECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 99999999999999876533222223345678899999999988889999999999999999999999998887776665
Q ss_pred HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH------HHHHHHHHHhhc
Q 027225 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF------STIMELLRPLIK 211 (226)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~~l~~l~~~~~ 211 (226)
+. ......+..++.++.+++.+||+.||.+|+++ +++++ +.++.
T Consensus 208 i~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~--h~~f~ 257 (320)
T cd05590 208 IL--NDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR--HPFFK 257 (320)
T ss_pred Hh--cCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc--CCCcC
Confidence 53 33445667789999999999999999999998 66665 44443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=262.73 Aligned_cols=192 Identities=28% Similarity=0.461 Sum_probs=166.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++.+.+..++||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||++| ++||||||+
T Consensus 51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~ 125 (323)
T cd05575 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPE 125 (323)
T ss_pred hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHH
Confidence 56899999999999999999999999999999999987643 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 126 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 205 (323)
T cd05575 126 NILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205 (323)
T ss_pred HeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 99999999999999998865333323333456788999999999888999999999999999999999999988776665
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
..+. ......+..++.++.++|.+||+.||.+||++.
T Consensus 206 ~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 206 DNIL--NKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHH--cCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 5553 233455667899999999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=247.63 Aligned_cols=198 Identities=25% Similarity=0.409 Sum_probs=173.5
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
-||+|+++.|+++.+...++|+|.++.|.|.+++...- .+++...+.++.|++.|++|||.++ |+|+|+||+||+
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENIL 155 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENIL 155 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhhee
Confidence 69999999999999999999999999999999998744 3999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD------EPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
++++.+++|+|||+++..... +.....+|+++|+|||.+.. .+++...|.|+.|++||-++.|+.||-.....
T Consensus 156 lddn~~i~isDFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm 234 (411)
T KOG0599|consen 156 LDDNMNIKISDFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM 234 (411)
T ss_pred eccccceEEeccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH
Confidence 999999999999999886654 34567789999999999863 35678899999999999999999999876666
Q ss_pred HHHHHHhhCCc--cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 159 QVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 159 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
-....+..... ..+-+.+++.+.++||.+||+.||.+|.|++|+++ +.++
T Consensus 235 lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La--Hpff 286 (411)
T KOG0599|consen 235 LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA--HPFF 286 (411)
T ss_pred HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc--ChHH
Confidence 66666654433 33445688999999999999999999999999998 4444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=267.42 Aligned_cols=208 Identities=32% Similarity=0.554 Sum_probs=185.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|.+++++||.++|+.+..+..+|++||||.||++.+.+.... .+.+..+..++.+++.|+.|||.++ .+|+|||+
T Consensus 65 Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKa 139 (467)
T KOG0201|consen 65 LSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKA 139 (467)
T ss_pred HHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc--eecccccc
Confidence 467899999999999999999999999999999999998754 3588899999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
.||++..+|.++|.|||.+............+.|++.|||||++....|+.++|+||||++.++|++|.+|+....+...
T Consensus 140 anil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv 219 (467)
T KOG0201|consen 140 ANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV 219 (467)
T ss_pred cceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence 99999999999999999998887776666889999999999999988999999999999999999999999988877544
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
...+. +...+.+...+++.+++|+..||+.||+.||++.++++ +++++...+.
T Consensus 220 lflIp-k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk~a~k~ 272 (467)
T KOG0201|consen 220 LFLIP-KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK--HKFIKRAKKT 272 (467)
T ss_pred EEecc-CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh--hHHHHhcCCc
Confidence 44443 34445566689999999999999999999999999999 8888775543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=268.53 Aligned_cols=201 Identities=32% Similarity=0.594 Sum_probs=181.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+.+++.|+...+.|+|+||+.| +|..++...+ .++++.+..++.++++||.|||+++ |.|+|+||
T Consensus 55 ~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kP 128 (808)
T KOG0597|consen 55 LRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKP 128 (808)
T ss_pred HHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCc
Confidence 3679999999999999999999999999987 9999998744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
.||+++++|.+|++|||+++.............|++.|||||...+..++..+|.|||||++|++.+|++||-.....+.
T Consensus 129 qniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L 208 (808)
T KOG0597|consen 129 QNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL 208 (808)
T ss_pred ceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH
Confidence 99999999999999999998877665556677899999999999999999999999999999999999999988777777
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
...+. ......|...+.++..++..+|..||.+|.+..+++. +.+.+
T Consensus 209 v~~I~--~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~--HpF~k 255 (808)
T KOG0597|consen 209 VKSIL--KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG--HPFWK 255 (808)
T ss_pred HHHHh--cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc--ChHHh
Confidence 77774 4455567799999999999999999999999999997 44443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=259.96 Aligned_cols=202 Identities=28% Similarity=0.409 Sum_probs=168.6
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++|||||+++++..+. +++|+|+|||..|.+.+.-.. ...+++.+++.++..++.||+|||.+| |+||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDI 236 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDI 236 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcC--eecccc
Confidence 5789999999999999764 679999999998776654433 222999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccc-----cccccccCCCCCCCCccCcccccCCC----CCCchhHHHHHHHHHHHHhCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLK-----ANTFLSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~-----~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l~~g~ 149 (226)
||+|++++.+|.+||+|||.+... .+.........|++.|+|||...+.. .+.+.||||+|+++|.++.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 999999999999999999988754 22222334578999999999987732 367899999999999999999
Q ss_pred CCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 150 QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
.||.+....+....+....-..+........+++||.+||..||++|.++.+|.....
T Consensus 317 ~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 317 LPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred CCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 9999988888888875433333333457899999999999999999999999988443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=261.44 Aligned_cols=202 Identities=25% Similarity=0.406 Sum_probs=173.8
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
..++|+||+++-.|.+.+++|+||||++||++-.++.+.+ .+++..++.++.+++.||+.+|+.| ++||||||+|
T Consensus 197 ~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdN 271 (550)
T KOG0605|consen 197 EVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDN 271 (550)
T ss_pred hcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhh
Confidence 3578999999999999999999999999999999999855 4999999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCccccccc---------------------cccc--------------------------CCCCCC
Q 027225 83 LLVDKKYTVKVCDFGLSRLKANT---------------------FLSS--------------------------KSAAGT 115 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~~~~---------------------~~~~--------------------------~~~~~~ 115 (226)
+++|..|++||+|||++...... .... ....|+
T Consensus 272 lLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGT 351 (550)
T KOG0605|consen 272 LLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGT 351 (550)
T ss_pred eeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCC
Confidence 99999999999999998421110 0000 013488
Q ss_pred CCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCC--CCCHHHHHHHHHHcccCC
Q 027225 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEP 193 (226)
Q Consensus 116 ~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p 193 (226)
|.|+|||++.+.++...+|+||||||||||+.|.+||...++.++...+......+..|. ..+++.++||.+|+. ||
T Consensus 352 PDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 352 PDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred ccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 999999999999999999999999999999999999999999999988877666666664 567999999999999 99
Q ss_pred CCCCC---HHHHHHHHHHhhcC
Q 027225 194 WKRPS---FSTIMELLRPLIKS 212 (226)
Q Consensus 194 ~~Rps---~~~~l~~l~~~~~~ 212 (226)
.+|.- ++||.+ +.++++
T Consensus 431 ~~RLG~~G~~EIK~--HPfF~~ 450 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKK--HPFFKG 450 (550)
T ss_pred HHhcCcccHHHHhc--CCcccc
Confidence 99964 777766 455443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=263.06 Aligned_cols=195 Identities=28% Similarity=0.445 Sum_probs=168.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||++| ++||||||+
T Consensus 51 ~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~ 125 (325)
T cd05602 51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPE 125 (325)
T ss_pred HhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence 56899999999999999999999999999999999997643 3888999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............+++.|+|||++.+..++.++|+||+||++|+|++|..||...+..+..
T Consensus 126 Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (325)
T cd05602 126 NILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205 (325)
T ss_pred HeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999998865433323334456788999999999988999999999999999999999999888777665
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
..+. ......+..++.++.++|.+||+.+|.+|+++.+.+
T Consensus 206 ~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 206 DNIL--NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHH--hCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 5553 233445667899999999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=263.40 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=171.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||+.| ++||||+|+
T Consensus 56 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~ 130 (333)
T cd05600 56 TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPE 130 (333)
T ss_pred HhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence 56789999999999999999999999999999999997643 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..... ......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+..
T Consensus 131 Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 207 (333)
T cd05600 131 NFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207 (333)
T ss_pred HEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence 99999999999999998865433 233456788999999999888999999999999999999999999988877665
Q ss_pred HHHhhCCccCCCC------CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 162 AAVGFKGKRLEIP------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 162 ~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..+.........+ ..++.++.++|.+||..+|.+||+++++++ ..+++.
T Consensus 208 ~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~--h~~~~~ 262 (333)
T cd05600 208 ENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN--HPFFKE 262 (333)
T ss_pred HHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh--CcccCC
Confidence 5554322222222 256899999999999999999999999998 444443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=258.84 Aligned_cols=195 Identities=29% Similarity=0.508 Sum_probs=169.0
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
..+||||+++++++..++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.| ++||||||+|
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~N 126 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDN 126 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHH
Confidence 3589999999999999999999999999999999987643 3899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 027225 83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 162 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 162 (226)
|+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+||++++|++|..||...+..+...
T Consensus 127 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~ 206 (316)
T cd05592 127 VLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206 (316)
T ss_pred eEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999998654332233334567889999999998889999999999999999999999999888777666
Q ss_pred HHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH-HHHH
Q 027225 163 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIME 204 (226)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~ 204 (226)
.+. ......+..++.++.+++.+||+.+|.+||++. ++++
T Consensus 207 ~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 207 SIL--NDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHH--cCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 553 344556778899999999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=259.56 Aligned_cols=195 Identities=25% Similarity=0.428 Sum_probs=167.9
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
..+||||+++++++.+++..|+||||+.+++|.+++...+ .+++..+..++.|++.||+|||++| ++||||||+|
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~N 126 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDN 126 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHH
Confidence 3589999999999999999999999999999999987643 4899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 027225 83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 162 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 162 (226)
|+++.++.++|+|||.+..............++..|+|||++.+..++.++|+||+|+++++|++|..||...+..+...
T Consensus 127 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~ 206 (316)
T cd05620 127 VMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206 (316)
T ss_pred eEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999987643222222334557889999999998889999999999999999999999998887777666
Q ss_pred HHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH-HHHH
Q 027225 163 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIME 204 (226)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~ 204 (226)
.+. ......+..++.++.++|.+||..||.+|+++. ++++
T Consensus 207 ~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 207 SIR--VDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHH--hCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 553 334455677899999999999999999999984 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=255.30 Aligned_cols=197 Identities=27% Similarity=0.493 Sum_probs=176.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.|+||||+.++++|+..+...+||||..+|.|.+|+.+++. +++.+++.++.||++|+.|+|+++ ++|+|||.
T Consensus 107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKL 181 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR--VVHRDLKL 181 (668)
T ss_pred HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc--ceecccch
Confidence 4679999999999999999999999999999999999998654 999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||++|.++++|+.|||++....+. .....++|.+-|.+||+.++..| ....|.||||+++|-++.|..||++.+...
T Consensus 182 ENILLD~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~ 260 (668)
T KOG0611|consen 182 ENILLDQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR 260 (668)
T ss_pred hheeecCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence 9999999999999999998776654 34567889999999999999987 567999999999999999999999999888
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
....+.....+ ...-+....-||++||-.||++|.|+++|....
T Consensus 261 lvrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 261 LVRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 88877644333 234556778899999999999999999999854
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=264.12 Aligned_cols=194 Identities=28% Similarity=0.453 Sum_probs=168.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+|+||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 126 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKP 126 (318)
T ss_pred HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCH
Confidence 467899999999999999999999999999999999997643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+.
T Consensus 127 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 206 (318)
T cd05582 127 ENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206 (318)
T ss_pred HHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH
Confidence 99999999999999999886544332233345678899999999988889999999999999999999999988877666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 201 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 201 (226)
...+. ......+..+++++.++|.+||+.||.+||++.+
T Consensus 207 ~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 MTMIL--KAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 65553 3344567788999999999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=258.05 Aligned_cols=194 Identities=27% Similarity=0.444 Sum_probs=167.7
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
++||||+++++++.+++..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+.| ++|+||||+||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Ni 127 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNI 127 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHE
Confidence 589999999999999999999999999999999997643 3889999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
+++.++.++|+|||++..............++..|+|||++.+..++.++|+||+||++|+|++|..||...+..+....
T Consensus 128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 128 LLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred EECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999886432222222344578899999999988899999999999999999999999998887776666
Q ss_pred HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH-HHHH
Q 027225 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIME 204 (226)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~ 204 (226)
+... ....+..++.++.+++.+||+.||.+||++. ++++
T Consensus 208 i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 208 IRMD--NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHhC--CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 5432 3345667899999999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=263.27 Aligned_cols=207 Identities=32% Similarity=0.560 Sum_probs=169.4
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC--------------------------------------
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------------------------------- 42 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------------------------------- 42 (226)
+++ +|+||+++++++...+..++||||+.+|+|.+++....
T Consensus 96 ~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (374)
T cd05106 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS 175 (374)
T ss_pred HhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence 456 89999999999999999999999999999999885421
Q ss_pred -----------------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEE
Q 027225 43 -----------------------------VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKV 93 (226)
Q Consensus 43 -----------------------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l 93 (226)
....+++..++.++.|++.||.|||++| ++||||||+||++++++.++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL 253 (374)
T cd05106 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKI 253 (374)
T ss_pred cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEE
Confidence 0124788899999999999999999999 999999999999999999999
Q ss_pred ccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCcc
Q 027225 94 CDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKR 170 (226)
Q Consensus 94 ~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 170 (226)
+|||+++....... ......++..|+|||++.+..++.++|+||+|+++++|++ |..||..................
T Consensus 254 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~ 333 (374)
T cd05106 254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333 (374)
T ss_pred eeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence 99999865432211 1112233457999999988889999999999999999997 99999776544333333223334
Q ss_pred CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 171 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
...+...++++.+++.+||+.||.+|||+.++++.|++++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 4455667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=259.99 Aligned_cols=194 Identities=25% Similarity=0.424 Sum_probs=169.2
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.+||||+++++++.+++..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++| ++||||||+||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Ni 127 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNI 127 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHe
Confidence 489999999999999999999999999999999987643 3899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
+++.++.++|+|||.+..............++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+..+....
T Consensus 128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 207 (321)
T cd05591 128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES 207 (321)
T ss_pred EECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999999886543332333345678899999999988899999999999999999999999998887776665
Q ss_pred HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-------CHHHHHH
Q 027225 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-------SFSTIME 204 (226)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~~~~l~ 204 (226)
+. ......+..++.++.+++.+||+.||.+|+ +++++++
T Consensus 208 i~--~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 208 IL--HDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HH--cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 53 233455667899999999999999999999 8888886
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=238.55 Aligned_cols=204 Identities=27% Similarity=0.433 Sum_probs=176.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.|+||||+++.+.+.+++..|+|+|+++|+.|..-+-.+ ..+++..+-..+.||+.+|.|+|.+| |+|||+||.
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~ 139 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPE 139 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChh
Confidence 3589999999999999999999999999999996544432 34899999999999999999999999 999999999
Q ss_pred cEEEc---CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
|+++- +..-+||+|||++....+. .....+.|++.|+|||++....++..+|+|+-|+++|-++.|+.||.+.+..
T Consensus 140 nllLASK~~~A~vKL~~FGvAi~l~~g-~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~ 218 (355)
T KOG0033|consen 140 NLLLASKAKGAAVKLADFGLAIEVNDG-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 218 (355)
T ss_pred heeeeeccCCCceeecccceEEEeCCc-cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence 99993 3446899999999876633 3345678999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.+.+.+....... +.+.+++++.++|+++||..||.+|.|+.|.++ ++++.+-
T Consensus 219 rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~--HpWi~~r 273 (355)
T KOG0033|consen 219 RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK--HPWICNR 273 (355)
T ss_pred HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC--Cchhcch
Confidence 8888776554433 345789999999999999999999999999997 5555543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=258.32 Aligned_cols=193 Identities=27% Similarity=0.487 Sum_probs=168.6
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+.+..|+||||+.+++|.+++.+.+ .+++..+..++.|++.||.|||+.| ++|+||+|+||+
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil 128 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVL 128 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeE
Confidence 79999999999999999999999999999999987643 3899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+||++++|++|..||...+..+....+
T Consensus 129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i 208 (318)
T cd05570 129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208 (318)
T ss_pred ECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 99999999999998864322222233345788999999999988999999999999999999999999887776666555
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH-----HHHHH
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----STIME 204 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~ 204 (226)
. ......+..++.++.++|.+||..||.+||++ .++++
T Consensus 209 ~--~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 209 L--EDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred H--cCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3 33445677889999999999999999999999 88876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=253.70 Aligned_cols=201 Identities=38% Similarity=0.698 Sum_probs=167.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+|+|.+++.... ...+++..+..++.|++.||+|||+++ ++|++|+++
T Consensus 56 ~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~ 132 (259)
T PF07714_consen 56 RKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPS 132 (259)
T ss_dssp HTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc--ccccccccc
Confidence 56799999999999998888999999999999999998762 234899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccc--cccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
||+++.++.+||+|||++..... .............|+|||.+.+..++.++||||||++++++++ |..||...+..
T Consensus 133 nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~ 212 (259)
T PF07714_consen 133 NILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE 212 (259)
T ss_dssp GEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999998876521 1122233345568999999988889999999999999999999 68999988887
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+....+ ........+..++..+.+++.+||..+|.+|||+.++++.|
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 213 EIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccc-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 777766 45566677888999999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=253.15 Aligned_cols=206 Identities=23% Similarity=0.356 Sum_probs=169.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++.+++..++|+||+.+|+|.+++.... ...+++..+..++.|++.||+|||+.| ++|+||||
T Consensus 54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp 130 (285)
T cd05631 54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKP 130 (285)
T ss_pred HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCH
Confidence 357899999999999999999999999999999998876533 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++++.++|+|||++....... ......++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+....
T Consensus 131 ~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 131 ENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred HHEEECCCCCEEEeeCCCcEEcCCCC-eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 99999999999999999987543221 12344678899999999988899999999999999999999999976543221
Q ss_pred HH--HHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhcC
Q 027225 161 VA--AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~~ 212 (226)
.. ...........+..++.++.+++++||+.||.+||+ ++++++ ++++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~--h~~~~~ 266 (285)
T cd05631 210 REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ--HPIFKN 266 (285)
T ss_pred HHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc--CHhhcC
Confidence 11 111123344566789999999999999999999997 788887 444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=266.54 Aligned_cols=192 Identities=29% Similarity=0.494 Sum_probs=175.5
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||.+++++.+|..+++.|.||||+.||++..+.+. +.+++..++.++..++.||.|||++| |+|||||.+||+
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiL 500 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLL 500 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheE
Confidence 799999999999999999999999999995544443 34999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
+|.+|.+||.|||+++............+|++.|+|||++.+..|+.+.|+|+||++||+|+.|+.||.+.+.+++...+
T Consensus 501 LD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 501 LDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI 580 (694)
T ss_pred EcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999988776666778899999999999999999999999999999999999999999999999999988
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH-----HHHHH
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----STIME 204 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~ 204 (226)
......+|..++.+...+++++|..+|++|.-+ ++|.+
T Consensus 581 --~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 581 --VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred --hcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 556677888999999999999999999999655 55554
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=276.07 Aligned_cols=213 Identities=28% Similarity=0.469 Sum_probs=173.5
Q ss_pred CCCCC-CcCcceeeeE-EecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLR-HPNIVLFMGA-VTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~-h~~i~~~~~~-~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
||+|+ |+|||.|+|. .... -.++++||||.||+|.++++.+... .+++.++++|+.++++|+++||...++
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pP 166 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPP 166 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCc
Confidence 46676 9999999993 3211 2388999999999999999975533 399999999999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccccccccc---------ccCCCCCCCCccCccccc---CCCCCCchhHHHHHH
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---------SSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGV 140 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~ 140 (226)
++|||||.+|||++.+|.+||||||.++....... ......-++.|++||++. +...++|+|||+|||
T Consensus 167 iIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 167 IIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGC 246 (738)
T ss_pred cchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHH
Confidence 99999999999999999999999999864332221 112344678999999874 677899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 141 ILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 141 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
++|.|+....||+......+.. .....+....++..+.+||+.||+.||.+||++.+++..+-.+....++.+.
T Consensus 247 lLYkLCy~t~PFe~sg~laIln----g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~ 320 (738)
T KOG1989|consen 247 LLYKLCYFTTPFEESGKLAILN----GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD 320 (738)
T ss_pred HHHHHHHhCCCcCcCcceeEEe----ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence 9999999999998764433322 2222333357999999999999999999999999999999988877666544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=255.71 Aligned_cols=205 Identities=28% Similarity=0.463 Sum_probs=168.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~ 79 (226)
|++++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. + ++|+|||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlk 131 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVK 131 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCC
Confidence 467899999999999999999999999999999999997643 389999999999999999999985 7 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+
T Consensus 132 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 132 PSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred hhhEEEcCCCcEEEccCcccccccccc--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999886543321 233457889999999998889999999999999999999999997766544
Q ss_pred HHHHHhhC---------------------------------------------CccCC-CCCCCCHHHHHHHHHHcccCC
Q 027225 160 VVAAVGFK---------------------------------------------GKRLE-IPRNVNPHVASIIEACWANEP 193 (226)
Q Consensus 160 ~~~~~~~~---------------------------------------------~~~~~-~~~~~~~~~~~li~~~l~~~p 193 (226)
........ ..... ....+++++++||.+||+.||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCc
Confidence 43222100 00011 112468899999999999999
Q ss_pred CCCCCHHHHHHHHHHhhcCCC
Q 027225 194 WKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 194 ~~Rps~~~~l~~l~~~~~~~~ 214 (226)
++|||++++++ +.+++...
T Consensus 290 ~~Rpt~~ell~--h~~~~~~~ 308 (331)
T cd06649 290 AERADLKMLMN--HTFIKRSE 308 (331)
T ss_pred ccCCCHHHHhc--ChHHhhcc
Confidence 99999999998 56665543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=242.15 Aligned_cols=209 Identities=21% Similarity=0.399 Sum_probs=164.8
Q ss_pred CCCCCcCcceeeeEEecCCc-----eEEEEeecccCCHHHHhcCCCCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGVR-EMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||++++++...+.. .|++++|+..|||++.+++.... ..+++.++.+++.++++||.+||+..++++|
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 57899999999998855433 99999999999999999875443 3799999999999999999999999888999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCccccccccccc---------CCCCCCCCccCcccccC---CCCCCchhHHHHHHHHH
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---------KSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILW 143 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---------~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~ 143 (226)
+||||.||++++++.++++|||+++...-.-... .....+..|+|||.+.- ...++++|||||||++|
T Consensus 153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 9999999999999999999999987533221111 12345778999999864 44689999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhhCCccCCC--CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 144 ELATLQQPWGNLNPAQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 144 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
.|+.|..||+..-................+ ...+|..+.++|++|++.||.+||++.+++..++.+.
T Consensus 233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 999999999642211100000001111122 2348999999999999999999999999999988764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=245.19 Aligned_cols=202 Identities=35% Similarity=0.615 Sum_probs=168.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++...+..++|+||+.+++|.+++.+.+ ..+++..++.++.|++.||.|||+.| ++|+||+|
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p 122 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAA 122 (252)
T ss_pred HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccch
Confidence 467899999999999999999999999999999999987543 24889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc--cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+......... .........|+|||.+.+..++.++|+||||++++++++ |..||...+.
T Consensus 123 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 123 RNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred heEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 9999999999999999987643322111 111122346999999988888999999999999999997 8889977666
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
........ .......+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 203 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 203 QQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 55544443 23344566778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=246.54 Aligned_cols=205 Identities=33% Similarity=0.613 Sum_probs=173.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++|+||+.+++|.+++.... ..+++..+..++.|++.||++||+++ ++|+||+|
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p 134 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAA 134 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCc
Confidence 467899999999999999999999999999999999997643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+....... ...........|+|||.+.+..++.++|+||+|++++++++ |..||.....
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 135 RNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred ceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 99999999999999999987654211 11112233467999999988889999999999999999998 9999987776
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
.+....+. .......+..++..+.+++.+|++.+|.+||++.++++.|++++
T Consensus 215 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 215 QDVIKAVE-DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 66655553 23344456678999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=244.76 Aligned_cols=218 Identities=22% Similarity=0.293 Sum_probs=184.3
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|.+++|||||.+-++..- -+..|+|||||+. +|.+++.+.+ ..+...++.-++.|++.|++|||.+. |+||||
T Consensus 129 Ll~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDL 203 (419)
T KOG0663|consen 129 LLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDL 203 (419)
T ss_pred HHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce--eEeccc
Confidence 457899999999998753 3569999999987 9999998754 35999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
|++|++++..|.+|++|||+++..+.+........-+.+|+|||.+.+.. ++.+.|+||+|||+.+++++.+.|.+...
T Consensus 204 K~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 204 KTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred chhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 99999999999999999999999888866666777789999999998765 89999999999999999999999987665
Q ss_pred HHHHHHHhhCCccCC-----------------------------CCC-CCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 158 AQVVAAVGFKGKRLE-----------------------------IPR-NVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~-----------------------------~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
.+....+-..-+.++ ++. .++..-++|++.+|..||.+|.|+++.++ .
T Consensus 284 ~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h 361 (419)
T KOG0663|consen 284 IDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--H 361 (419)
T ss_pred HHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--c
Confidence 444433321211110 011 15578899999999999999999999999 9
Q ss_pred HhhcCCCCCCCCCCCCCC
Q 027225 208 PLIKSPTPQPSPTDMPLL 225 (226)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~ 225 (226)
.++++.|.+-.|..+|.+
T Consensus 362 ~~F~e~P~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 362 EYFRETPLPIDPSMFPTW 379 (419)
T ss_pred cccccCCCCCChhhcCCC
Confidence 999999988888888864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=253.26 Aligned_cols=199 Identities=25% Similarity=0.375 Sum_probs=162.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++|+||+.+ +|.+++...+ ..+++..+..++.|++.||+|||++| ++||||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp 131 (288)
T cd07871 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKP 131 (288)
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCH
Confidence 3578999999999999999999999999975 8999887543 23789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+..+
T Consensus 132 ~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~ 211 (288)
T cd07871 132 QNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211 (288)
T ss_pred HHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999988654333222334456788999999865 457899999999999999999999998776655
Q ss_pred HHHHHhhCCcc----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKR----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+...... ......++.+..++|++||+.||.+|||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 44332111000 0011346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=246.85 Aligned_cols=205 Identities=30% Similarity=0.570 Sum_probs=172.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++.+.+..++++||+.+++|.+++.+.. ...+++..+..++.|++.||+|||+.+ ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p 131 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRA 131 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccch
Confidence 357899999999999999999999999999999999987543 334889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..
T Consensus 132 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 132 ANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred hhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 9999999999999999998764432211 112233457999999988888899999999999999998 99999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+....+.. ....+....++.++.+++.+|+..+|++||+++++.+.|+++
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 212 DVMSALQR-GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 66655542 233344567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=249.25 Aligned_cols=209 Identities=32% Similarity=0.587 Sum_probs=175.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC---------------------CCCcCCHHHHHHHHHHH
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG---------------------VREMLDERRRLNMAYDV 59 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------------~~~~~~~~~~~~~~~~l 59 (226)
|++++||||+++++.+.+++..++++||+.+++|.+++.... ....+++..++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 367899999999999999999999999999999999976421 11347889999999999
Q ss_pred HHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHH
Q 027225 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYS 137 (226)
Q Consensus 60 ~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 137 (226)
+.||.+||+.| ++|+||+|+||++++++.++|+|||.+........ .......+..|+|||.+.+..++.++|+||
T Consensus 137 ~~~l~~LH~~~--ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 214 (290)
T cd05045 137 SRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWS 214 (290)
T ss_pred HHHHHHHHHCC--eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHH
Confidence 99999999999 99999999999999999999999999865332211 112223456799999998888899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 138 FGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 138 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
||+++++|++ |..||....+.+...... .......+..++.++.+++.+||+.+|.+||++.++++.|++++..
T Consensus 215 lG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 215 FGVLLWEIVTLGGNPYPGIAPERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 9999999998 999998888777666554 2334455677899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=246.94 Aligned_cols=200 Identities=28% Similarity=0.501 Sum_probs=171.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++|+||+++++|.+++.... ...+++..++.++.+++.||.|||+.| ++|+||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~ 129 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKS 129 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCc
Confidence 367899999999999999999999999999999999997642 345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............+...|+|||+..+..++.++|+||||+++++|++|..||...+..+.
T Consensus 130 ~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08529 130 LNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209 (256)
T ss_pred ceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999887554432223334567789999999988889999999999999999999999988776655
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+. .......+..++.++.+++.+||+.+|++||++.++++
T Consensus 210 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 210 ILKII-RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHHH-cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 55443 33344455678999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=253.90 Aligned_cols=209 Identities=22% Similarity=0.338 Sum_probs=164.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.++...++|+||+. ++|.+++.... ..++++.+..++.|++.||+|||+.| ++|+||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp 131 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKP 131 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 367899999999999999999999999996 58888776532 23889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-H
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNP-A 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~ 158 (226)
+||+++.++.++|+|||.+..............++..|+|||++.+. .++.++|+||+||++++|++|..||.+... .
T Consensus 132 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 132 QNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred HHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 99999999999999999886543332233345567889999998754 478899999999999999999999976533 2
Q ss_pred HHHHHHhhCCcc-------------------CC--C---------CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 159 QVVAAVGFKGKR-------------------LE--I---------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 159 ~~~~~~~~~~~~-------------------~~--~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
+....+...... .. . ...++.++.+++.+||+.||++|||++++++ ++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--h~ 289 (303)
T cd07869 212 DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS--HE 289 (303)
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc--Cc
Confidence 222111100000 00 0 0124578899999999999999999999999 88
Q ss_pred hhcCCCCC
Q 027225 209 LIKSPTPQ 216 (226)
Q Consensus 209 ~~~~~~~~ 216 (226)
+++..++.
T Consensus 290 ~f~~~~~~ 297 (303)
T cd07869 290 YFSDLPPR 297 (303)
T ss_pred ccccCChh
Confidence 88876553
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=246.20 Aligned_cols=204 Identities=37% Similarity=0.628 Sum_probs=176.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------REMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
+++++|+||+++++++......++|+||+++++|.+++..... ...+++..++.++.|++.||++||++| ++
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~ 127 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FV 127 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cc
Confidence 3567899999999999999999999999999999999987411 245999999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP 151 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p 151 (226)
|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|++++++++ |..|
T Consensus 128 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 207 (262)
T cd00192 128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207 (262)
T ss_pred cCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999987654432 22334455678999999988888999999999999999999 5999
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
|...+..+....... ......+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 208 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 208 YPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 988877776666653 4455667788999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=245.46 Aligned_cols=203 Identities=30% Similarity=0.533 Sum_probs=171.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++. .+..++|+||+.+++|.+++...+ .+++..+..++.|++.||.+||++| ++|+||+|
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp 123 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAA 123 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--Eeecccch
Confidence 35689999999999886 456899999999999999997643 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc---cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++|+|||.+......... .....+...|+|||.+.....+.++|+||||++++++++ |..||...+
T Consensus 124 ~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 124 RNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred hhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999988654332211 112222468999999988778899999999999999998 999998877
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..+....+. .......+..+++++.++|.+||+.||.+||++.+|.+.|+++.
T Consensus 204 ~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 204 GNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred HHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 777666665 33445667789999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=246.81 Aligned_cols=199 Identities=32% Similarity=0.560 Sum_probs=171.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+|++++++|.+++...+ .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p 132 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKG 132 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 357899999999999999999999999999999999987643 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc---CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+.......... ....+...|+|||.+.+...+.++|+||+|++++++++|+.||...+.
T Consensus 133 ~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 133 ANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred HHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 99999999999999999886433221111 223456789999999988889999999999999999999999987766
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
................+..++..+.++|.+||..+|.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 213 MAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 65555554455556677889999999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=260.03 Aligned_cols=193 Identities=27% Similarity=0.423 Sum_probs=166.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++..++..|+||||+.+++|..++.+.+ .+++..+..++.||+.||.|||+.| ++||||||+
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~ 125 (325)
T cd05604 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPE 125 (325)
T ss_pred HhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHH
Confidence 46899999999999999999999999999999999887643 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+||++++|++|..||...+..+..
T Consensus 126 NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~ 205 (325)
T cd05604 126 NILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205 (325)
T ss_pred HeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH
Confidence 99999999999999998865333223333456788999999999988999999999999999999999999888777666
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 201 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 201 (226)
..+.. .....+...+.++.+++.+||..+|.+||++.+
T Consensus 206 ~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 206 DNILH--KPLVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHc--CCccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 55532 333445678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=258.07 Aligned_cols=192 Identities=29% Similarity=0.452 Sum_probs=166.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..|+||||+++++|...+.+.. .+++..+..++.||+.||.|||+.| ++||||||+
T Consensus 51 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~ 125 (321)
T cd05603 51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPE 125 (321)
T ss_pred HhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHH
Confidence 56899999999999999999999999999999998887633 4889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+..
T Consensus 126 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (321)
T cd05603 126 NILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205 (321)
T ss_pred HeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 99999999999999998865333222333456788999999999888899999999999999999999999888776665
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
..+. ......+...+.++.++|.+||+.+|.+|+++.
T Consensus 206 ~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 206 DNIL--HKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHh--cCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 5553 334566778899999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=259.66 Aligned_cols=206 Identities=32% Similarity=0.561 Sum_probs=167.0
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------------------------------
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------------------------------------- 43 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------------------------------- 43 (226)
+++ +||||+++++++.+.+..++||||+++|+|.+++.....
T Consensus 93 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (375)
T cd05104 93 SYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK 172 (375)
T ss_pred HHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence 345 899999999999999999999999999999999864321
Q ss_pred -----------------------------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCC
Q 027225 44 -----------------------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK 88 (226)
Q Consensus 44 -----------------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~ 88 (226)
...+++..+..++.|++.||.|||+.| ++|+||||+||+++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~ 250 (375)
T cd05104 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG 250 (375)
T ss_pred CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC
Confidence 124788899999999999999999999 9999999999999999
Q ss_pred CcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 027225 89 YTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVG 165 (226)
Q Consensus 89 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 165 (226)
+.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++++|++ |..||.............
T Consensus 251 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~ 330 (375)
T cd05104 251 RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330 (375)
T ss_pred CcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence 9999999999865433211 1112233457999999998889999999999999999998 888987655433322222
Q ss_pred hCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 166 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
........+...+.++.+++.+||+.||++|||+.++++.|++.
T Consensus 331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 23333344566789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=248.18 Aligned_cols=204 Identities=34% Similarity=0.577 Sum_probs=172.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-----------CCcCCHHHHHHHHHHHHHHHHHHhcC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----------REMLDERRRLNMAYDVAKGMNYLHRR 69 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~ 69 (226)
|++++||||+++++++......++|+||+++++|.+++...+. ...+++..+..++.|++.|+.+||++
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 3578999999999999999999999999999999999975431 23478899999999999999999999
Q ss_pred CCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 70 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
| ++|+||+|+||+++.++.++|+|||.+....... ........+..|+|||.+.+..++.++|+||||+++++|++
T Consensus 142 ~--i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~ 219 (280)
T cd05049 142 H--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219 (280)
T ss_pred C--eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHh
Confidence 9 9999999999999999999999999886432211 11222334567999999998889999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 148 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
|..||...+..+....+. .......+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 220 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 220 YGKQPWYGLSNEEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 999998877776666554 33334456678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=250.48 Aligned_cols=208 Identities=25% Similarity=0.381 Sum_probs=169.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++.+++..+...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.| ++|+||+
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 124 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLK 124 (280)
T ss_pred HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCC
Confidence 35789999999999999999999999999999999887532 22345899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||++++++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......
T Consensus 125 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 204 (280)
T cd05608 125 PENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 204 (280)
T ss_pred HHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 99999999999999999988654433222334467789999999998889999999999999999999999997543211
Q ss_pred --HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 160 --VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 160 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
..............+..++.++.+++.+||+.||.+|| +++++++ +++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~--h~~~~~ 262 (280)
T cd05608 205 ENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HPLFRD 262 (280)
T ss_pred hHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc--Chhhhc
Confidence 11111112333455677899999999999999999999 7788887 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=244.41 Aligned_cols=204 Identities=28% Similarity=0.542 Sum_probs=170.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++. .+..++|+||+++++|.+++.... ..+++..+..++.|++.||.+||++| ++|+||+|
T Consensus 49 l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp 123 (257)
T cd05115 49 MHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAA 123 (257)
T ss_pred HHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccch
Confidence 46789999999999886 457899999999999999987532 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc---cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||++++++++ |..||....
T Consensus 124 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 124 RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred heEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 9999999999999999988643322111 111122457999999988888999999999999999996 999998877
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..+....+. .......+...++++.+++.+||..+|++||++.++.+.|+.++
T Consensus 204 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 204 GPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 766655553 33445667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=250.27 Aligned_cols=211 Identities=34% Similarity=0.602 Sum_probs=174.9
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++ +||||+++++++.+.+..++++||+++++|.+++.... ....+++..++.++.|++.||++||
T Consensus 57 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 136 (297)
T cd05089 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS 136 (297)
T ss_pred HhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 355 79999999999999999999999999999999986532 1134889999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
++| ++|+||||+||+++.++.++|+|||++........ .........|+|||.+.+..++.++|+||||+++++|++
T Consensus 137 ~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t 213 (297)
T cd05089 137 EKQ--FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213 (297)
T ss_pred HCC--cccCcCCcceEEECCCCeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 999 99999999999999999999999998753222111 111222346999999988888999999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 148 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
|..||...+..+...... .......+..++.++.+++.+||+.+|.+|||++++++.|+.++......
T Consensus 214 ~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 214 LGGTPYCGMTCAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred CCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 999998887776665553 22334456678999999999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=246.22 Aligned_cols=205 Identities=34% Similarity=0.647 Sum_probs=170.6
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++ +||||+++++++...+..++++||+++++|.+++.... ....+++..+..++.|++.||+|||
T Consensus 50 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH 129 (270)
T cd05047 50 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 129 (270)
T ss_pred HhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456 79999999999999999999999999999999987532 1234789999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
+.| ++|+||+|+||++++++.++++|||++...... ........+..|+|||.+.+..++.++|+||||+++++|++
T Consensus 130 ~~~--i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~ 206 (270)
T cd05047 130 QKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206 (270)
T ss_pred HCC--EeecccccceEEEcCCCeEEECCCCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHc
Confidence 999 999999999999999999999999987532211 11112223456999999988888999999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 148 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
|..||...+..+....+. .......+...+.++.+++.+|+..+|.+|||+.++++.|++++
T Consensus 207 ~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 207 LGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCccccCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 999998777666555543 22334456678899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=257.99 Aligned_cols=193 Identities=25% Similarity=0.469 Sum_probs=162.6
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+.+..|+||||+++++|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||||+||+
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil 128 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVL 128 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeE
Confidence 79999999999999999999999999999999887643 4999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-------- 156 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------- 156 (226)
++.++.++|+|||++..............++..|+|||++.+..++.++|+||+|+++|+|++|..||....
T Consensus 129 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05588 129 LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208 (329)
T ss_pred ECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc
Confidence 999999999999988643222223334567889999999999889999999999999999999999995321
Q ss_pred -HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC------HHHHHH
Q 027225 157 -PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS------FSTIME 204 (226)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~~l~ 204 (226)
.......+ .......+..++.++.++|.+||+.||.+|++ ++++++
T Consensus 209 ~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 209 TEDYLFQVI--LEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred chHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11122222 33445667889999999999999999999987 677775
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=245.41 Aligned_cols=208 Identities=29% Similarity=0.520 Sum_probs=173.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.. ...++++||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 63 l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp 137 (279)
T cd05111 63 MGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAA 137 (279)
T ss_pred HhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCc
Confidence 357899999999998864 45789999999999999997643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+....... .......+...|++||.+.+..++.++|+||+|+++|++++ |..||.+...
T Consensus 138 ~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 138 RNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred ceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999886532211 11222334567999999988889999999999999999998 9999988776
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.+...... .......+...+..+.+++.+|+..+|.+|||+.++++.|..+.+..+
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 218 HEVPDLLE-KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred HHHHHHHH-CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 66555543 334445556678899999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=251.18 Aligned_cols=205 Identities=33% Similarity=0.540 Sum_probs=165.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC----------------CCcCCHHHHHHHHHHHHHHHH
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----------------REMLDERRRLNMAYDVAKGMN 64 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~~l~ 64 (226)
|++++||||+++++++.+.+..++|+||+.+++|.+++..... ...+++..++.++.|++.||.
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999865321 124678889999999999999
Q ss_pred HHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHH
Q 027225 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 142 (226)
Q Consensus 65 ~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 142 (226)
|||+.| ++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++
T Consensus 153 ~lH~~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 230 (304)
T cd05096 153 YLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230 (304)
T ss_pred HHHHCC--ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence 999999 9999999999999999999999999886533221 112233345689999999888899999999999999
Q ss_pred HHHHh--CCCCCCCCCHHHHHHHHhhC------CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 143 WELAT--LQQPWGNLNPAQVVAAVGFK------GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 143 ~~l~~--g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
++|++ +..||...+..+........ ......+..++..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99987 56688776665544333211 1112234567899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=246.99 Aligned_cols=200 Identities=31% Similarity=0.530 Sum_probs=172.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++.+.+++..++++||+++++|.+++.... ...+++..+..++.|++.||.+||++| ++|+||+|
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p 128 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKS 128 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCc
Confidence 357899999999999999999999999999999999886533 334889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++++.++++|||.+..............++..|+|||++.+...+.++|+||+|+++++|++|..||...+....
T Consensus 129 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 129 KNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred ceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 99999999999999999886554433333344567789999999888889999999999999999999999988776665
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..... .......+..++..+.+++.+||+.||.+||++.+++.
T Consensus 209 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 209 ILKVC-QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHh-cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 55543 33344566778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=262.76 Aligned_cols=203 Identities=27% Similarity=0.452 Sum_probs=172.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||+.+++|.+++.+. ..+++..+..++.|++.||+|||+.| ++||||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~ 130 (350)
T cd05573 56 ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPD 130 (350)
T ss_pred HhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 5678999999999999999999999999999999999875 34899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-----------------------------cccCCCCCCCCccCcccccCCCCCCc
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-----------------------------LSSKSAAGTPEWMAPEVLRDEPSNEK 132 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~ 132 (226)
||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.+
T Consensus 131 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 210 (350)
T cd05573 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE 210 (350)
T ss_pred HeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc
Confidence 9999999999999999987544332 12234457889999999999889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCCCCCC-HHHHHHHHHHh
Q 027225 133 SDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWKRPS-FSTIMELLRPL 209 (226)
Q Consensus 133 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps-~~~~l~~l~~~ 209 (226)
+|+|||||++|+|++|+.||...+..+....+.........+ ..+++++.++|.+|+. +|.+|++ ++++++ +.+
T Consensus 211 ~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~--hp~ 287 (350)
T cd05573 211 CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS--HPF 287 (350)
T ss_pred eeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc--CCC
Confidence 999999999999999999998888766665554322333333 3469999999999997 9999999 999998 445
Q ss_pred hcC
Q 027225 210 IKS 212 (226)
Q Consensus 210 ~~~ 212 (226)
++.
T Consensus 288 ~~~ 290 (350)
T cd05573 288 FKG 290 (350)
T ss_pred cCC
Confidence 443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=244.50 Aligned_cols=201 Identities=35% Similarity=0.615 Sum_probs=169.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+.+++|.+++..... .+++..++.++.|++.||+|||+.| ++|+||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p 128 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAA 128 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCc
Confidence 4678999999999999999999999999999999999976432 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+........ ......++..|++||.+.+..++.++|+||||+++++|++ |..||...+..
T Consensus 129 ~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 129 RNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred ceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 999999999999999998764432211 1112233457999999988888999999999999999998 99999887766
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+....+. .......+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 209 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 209 ETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 6555553 3333445667789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=244.09 Aligned_cols=201 Identities=35% Similarity=0.603 Sum_probs=169.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p 128 (256)
T cd05114 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAA 128 (256)
T ss_pred HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCc
Confidence 467899999999999999999999999999999999987532 23889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||++++++.++++|||.+......... .....+...|+|||.+.+..++.++|+||+|++++++++ |+.||...+..
T Consensus 129 ~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 129 RNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred ceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999987654322111 112233457999999988888999999999999999999 89999888777
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+....+.. ......+...+.++.+++.+||+.+|.+||++.++++.|
T Consensus 209 ~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 209 EVVEMISR-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 66666543 333445667889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=250.05 Aligned_cols=207 Identities=32% Similarity=0.611 Sum_probs=173.8
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-------------CCCCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-------------GVREMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++ +|+||+++++++..++..++++||+.+++|.+++... .....+++..+..++.|++.||.|||
T Consensus 70 ~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred HhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 355 7999999999999999999999999999999998642 12345899999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
+.| ++|+||+|+||++++++.++|+|||.+....... .......+...|+|||.+.+..++.++|+||+|+++|++
T Consensus 150 ~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (293)
T cd05053 150 SKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227 (293)
T ss_pred HCC--ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHH
Confidence 999 9999999999999999999999999887543321 111222334579999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
++ |..||......+...... .......+...+.++.+++.+||..+|++|||+.++++.|+.+++
T Consensus 228 ~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~ 293 (293)
T cd05053 228 FTLGGSPYPGIPVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293 (293)
T ss_pred hcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence 97 899998877766665554 333445566788999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=244.13 Aligned_cols=205 Identities=34% Similarity=0.563 Sum_probs=173.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++...+..++|+||+.+++|.+++.... ...+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p 131 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAA 131 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCc
Confidence 357899999999999999999999999999999999997644 335899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+......... .........|+|||...+..++.++|+||||++++++++ |+.||...+..
T Consensus 132 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 132 RNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred ceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999988765432111 111222347999999988888999999999999999999 99999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+....+. .......+...+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 212 EVLQQVD-QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHH-cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 6665553 2333445667899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=247.67 Aligned_cols=203 Identities=33% Similarity=0.570 Sum_probs=169.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------REMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
++++||||+++++++.++...++|+||+.+++|.+++.+... ...+++..+..++.|++.||.|||+.| ++
T Consensus 64 ~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~v 141 (277)
T cd05062 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FV 141 (277)
T ss_pred HhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 568999999999999999999999999999999999865321 123678889999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP 151 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p 151 (226)
|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||++++++++ |..|
T Consensus 142 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p 221 (277)
T cd05062 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221 (277)
T ss_pred cCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999998764332211 1122233567999999988888999999999999999998 6889
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
|...+..+...... .......+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 222 YQGMSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 98877766555443 33334556778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=260.22 Aligned_cols=203 Identities=24% Similarity=0.385 Sum_probs=170.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++||||+++++++.+++..|+|+||+++|+|.+++.+.. +++..+..++.|++.||+|||+.| ++||||||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp 170 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMG--FIHRDVKP 170 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence 356899999999999999999999999999999999987543 889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCC----CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE----PSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~----~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.++|+|||.+........ ......+++.|+|||++.+. .++.++|+|||||++|+|++|..||...
T Consensus 171 ~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 999999999999999999865433211 22345678899999998653 3678999999999999999999999988
Q ss_pred CHHHHHHHHhhCCccCCCCC--CCCHHHHHHHHHHcccCCCC--CCCHHHHHHHHHHhhc
Q 027225 156 NPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWK--RPSFSTIMELLRPLIK 211 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~ 211 (226)
+.......+.........+. .++.++.++|.+||+.+|.+ |++++++++ +.+++
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~--h~~~~ 308 (370)
T cd05596 251 SLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS--HPFFK 308 (370)
T ss_pred CHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc--CcccC
Confidence 77666665543333344443 57999999999999999988 999999988 45544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=256.86 Aligned_cols=204 Identities=30% Similarity=0.517 Sum_probs=165.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++.+++..++|+||+.+++|.+.. ...+..+..++.||+.||.|||++| ++|+||||
T Consensus 126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 196 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKP 196 (353)
T ss_pred HHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCH
Confidence 35789999999999999999999999999999986532 2567788899999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.++|+|||++..............++..|+|||.+.. ...+.++|||||||++|+|++|+.||...
T Consensus 197 ~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 197 SNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred HHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998765443333344567889999998753 22346899999999999999999999743
Q ss_pred CHHH---HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 156 NPAQ---VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 156 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
...+ ....+. .......+..++.++.++|.+||+.||.+|||+.++++ +.++......
T Consensus 277 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~~~~~ 337 (353)
T PLN00034 277 RQGDWASLMCAIC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILRAQPG 337 (353)
T ss_pred CCccHHHHHHHHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--CcccccCCcc
Confidence 3222 111111 23334456678999999999999999999999999999 7777776443
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=249.12 Aligned_cols=210 Identities=30% Similarity=0.523 Sum_probs=176.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+.+++|.+++... .+++.++..++.+++.|+++||+.| ++|+||+|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p 143 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKS 143 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 35789999999999999999999999999999999998753 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|++++|..||...+....
T Consensus 144 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred HHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999876543322222334567789999999888889999999999999999999999988776554
Q ss_pred HHHHhh-CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 161 VAAVGF-KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 161 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
...+.. .......+..+++.+.++|.+||..+|.+||++.++++ .++++...+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~~~~~~~~ 280 (296)
T cd06655 224 LYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKPLSS 280 (296)
T ss_pred HHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhhcccccc
Confidence 433322 22233456678999999999999999999999999998 888876554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=243.64 Aligned_cols=203 Identities=33% Similarity=0.579 Sum_probs=173.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+ ...++|+||+++++|.+++.+... ..+++..++.++.|++.||++||+.| ++|+||+|
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p 125 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAA 125 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCc
Confidence 468899999999999988 889999999999999999976542 45899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++|+|||.+........ ......+...|+|||.+.+..++.++|+||+|+++++|++ |..||...+
T Consensus 126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 126 RNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999998875433211 1122345568999999988889999999999999999998 999998877
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
..+....+.........+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 206 GSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 777666655444455556678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=247.63 Aligned_cols=204 Identities=33% Similarity=0.574 Sum_probs=173.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------REMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
|++++||||+++++++......++|+||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ +
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i 140 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--F 140 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 3568999999999999999999999999999999999875321 224788899999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ 150 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~ 150 (226)
+|+||+|+||+++.++.++|+|||.++...... .......++..|+|||.+.+...+.++|+||||++++++++ |..
T Consensus 141 ~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 220 (277)
T cd05032 141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQ 220 (277)
T ss_pred cccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCC
Confidence 999999999999999999999999886543221 11223334568999999988888999999999999999998 899
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
||...+..+...... .......+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 221 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 221 PYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 998877777666665 44555667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=246.80 Aligned_cols=206 Identities=34% Similarity=0.584 Sum_probs=171.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--------------CCcCCHHHHHHHHHHHHHHHHHH
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------------REMLDERRRLNMAYDVAKGMNYL 66 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~l 66 (226)
|++++||||+++++++..++..|+|+||+.+++|.+++..... ...+++.++..++.|++.||.||
T Consensus 61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999853211 22478889999999999999999
Q ss_pred hcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHH
Q 027225 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144 (226)
Q Consensus 67 H~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 144 (226)
|++| ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++++
T Consensus 141 H~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 218 (283)
T cd05090 141 SSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE 218 (283)
T ss_pred HhcC--eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHH
Confidence 9999 9999999999999999999999999886543221 11222334567999999988888999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 145 LAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 145 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
|++ |..||...........+. .......+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 219 l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 219 IFSFGLQPYYGFSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 998 888998776655555554 3334456678899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=246.34 Aligned_cols=204 Identities=36% Similarity=0.599 Sum_probs=171.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC------------CCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------------REMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
|++++|+||+++++++.+.+..++++||+.+++|.+++...+. ...+++..++.++.|++.|++|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999999999999999876431 1347899999999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
.| ++|+||+|+||++++++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|+
T Consensus 141 ~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 218 (280)
T cd05092 141 LH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218 (280)
T ss_pred CC--eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 99 9999999999999999999999999886432211 1112223356799999999888999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
+ |..||......+...... .......+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 219 TYGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCCCCCCccCCHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 8 899998777666555553 33344556778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=242.98 Aligned_cols=202 Identities=36% Similarity=0.662 Sum_probs=170.1
Q ss_pred CCCCCCcCcceeeeEEe-cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++++|+|++++++++. +++..++|+||+++++|.+++...+ ...+++..+..++.|++.||++||++| ++|+||+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk 129 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLA 129 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--Eeccccc
Confidence 46789999999999764 5567999999999999999987644 334889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
|+||++++++.++|+|||.+....... ........|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..
T Consensus 130 p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~ 206 (256)
T cd05082 130 ARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred hheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543321 12233457999999988888999999999999999997 99999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+....+.. ......+..+++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 207 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 207 DVVPRVEK-GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 66655542 333455677899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=248.44 Aligned_cols=205 Identities=32% Similarity=0.588 Sum_probs=169.6
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++ +||||+++++++...+..++|+||+.+++|.+++.... ...+++.++..++.+++.||.|||+.+ ++|+||+|
T Consensus 93 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp 169 (302)
T cd05055 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 169 (302)
T ss_pred HhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhcc
Confidence 466 79999999999999999999999999999999997533 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||+|++++++++ |..||.....
T Consensus 170 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 170 RNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred ceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 999999999999999998865432211 1122334567999999988888999999999999999998 9999977665
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.+..............+...+.++.+++.+||+.+|.+|||+.++++.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 250 DSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred hHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 4433333222333344556789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=243.20 Aligned_cols=201 Identities=35% Similarity=0.623 Sum_probs=170.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+++++|.+++..... .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p 128 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAA 128 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 3578999999999999999999999999999999999976432 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc-CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+....+..... ........|+|||.+.+..++.++|+||+|++++++++ |..||...+..
T Consensus 129 ~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 129 RNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred hhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 99999999999999999886543321111 11222347999999988888999999999999999998 79999877776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+....+. .......+..++.++.+++.+||..+|.+|||+.++++.|
T Consensus 209 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 209 EVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 6665554 3334455677899999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=246.04 Aligned_cols=207 Identities=24% Similarity=0.452 Sum_probs=170.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+.+..++|+||+++++|.+++..... ...+++..+..++.|++.||.|||++| ++|+||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~ 133 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIK 133 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCC
Confidence 4678999999999999999999999999999999998864221 234889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--H
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--P 157 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~ 157 (226)
|+||+++.++.++|+|||.+..............+...|+|||.+.+...+.++|+||+|++++++++|..||.... .
T Consensus 134 ~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 213 (267)
T cd08228 134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred HHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH
Confidence 99999999999999999987654433222233456778999999988888899999999999999999999986543 2
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.+....+............++..+.+++.+||..+|.+||++.++++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 214 FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 3333333322222222346788999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=242.56 Aligned_cols=203 Identities=33% Similarity=0.544 Sum_probs=171.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++. .+..++|+||+.+++|.+++.+.. .+++..+..++.|++.||.+||..+ ++|+||+|
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p 123 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAA 123 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCccc
Confidence 35789999999999876 456899999999999999998744 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc---CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+
T Consensus 124 ~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 124 RNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred ceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999887543322111 11112347999999988889999999999999999998 999998887
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..+....+. .......+..++..+.++|.+||+.+|.+||++.++++.|+.+.
T Consensus 204 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 204 GAEVIAMLE-SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 766665554 33344567788999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=249.80 Aligned_cols=208 Identities=32% Similarity=0.591 Sum_probs=174.0
Q ss_pred CC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
++ +||||+++++++..++..|+|+||+.+++|.+++..+.. ...+++.+++.++.|++.||+|||+
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 45 799999999999999999999999999999999976431 1248889999999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc--cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
+| ++|+||+|+||+++.++.++|+|||.+......... .........|+|||.+.+..++.++|+||+|+++|+|+
T Consensus 159 ~g--i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 236 (307)
T cd05098 159 KK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236 (307)
T ss_pred CC--cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHH
Confidence 99 999999999999999999999999988654322111 11122345799999998888899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+ |..||...+..+...... .......+...+.++.+++.+||..+|.+|||+.++++.|++++...
T Consensus 237 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 237 TLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred cCCCCCCCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 8 888998777666555553 33344566778999999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=249.92 Aligned_cols=209 Identities=31% Similarity=0.606 Sum_probs=174.5
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++ +||||+++++++.+++..++++||+.+++|.+++.... ....+++.++..++.|++.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 151 (314)
T cd05099 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151 (314)
T ss_pred HhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 345 69999999999999999999999999999999997532 1235889999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
++| ++|+||+|+||+++.++.++|+|||.+........ ......+...|+|||.+.+..++.++|+||||+++|++
T Consensus 152 ~~g--i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 152 SRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred HCC--eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHH
Confidence 999 99999999999999999999999999865432211 11122233579999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
++ |..||...+..+....+. .......+..++.++.+++.+||+.+|++|||+.++++.|+++....
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 230 FTLGGSPYPGIPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 99 888998877766666554 33344556778899999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=254.11 Aligned_cols=195 Identities=25% Similarity=0.454 Sum_probs=166.4
Q ss_pred CCCC-cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
.++| ++|+++++++.+.+..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||++| ++|+||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~ 130 (324)
T cd05587 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLD 130 (324)
T ss_pred hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence 4445 568899999999999999999999999999997643 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............++..|+|||++.+..++.++|+||+|+++++|++|+.||...+..+..
T Consensus 131 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~ 210 (324)
T cd05587 131 NVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210 (324)
T ss_pred HeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998764322222233445788999999999888899999999999999999999999988877766
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH-----HHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----STIME 204 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~ 204 (226)
..+. ......+..+++++.+++.+||..||.+|++. +++++
T Consensus 211 ~~i~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 211 QSIM--EHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHHH--cCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 6653 34455677899999999999999999999986 56655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=250.45 Aligned_cols=209 Identities=34% Similarity=0.641 Sum_probs=172.7
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++ +||||+++++++.+++..++|+||+++++|.+++.+.+. ...+++..+..++.|++.||+|||
T Consensus 62 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 141 (303)
T cd05088 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 141 (303)
T ss_pred HHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH
Confidence 456 899999999999999999999999999999999975321 235889999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
++| ++||||+|+||+++.++.++|+|||++...... ...........|+|||.+.+..++.++|+||+|++++++++
T Consensus 142 ~~g--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 142 QKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred hCC--ccccccchheEEecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence 999 999999999999999999999999987532211 11112223457999999988888899999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 148 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
|..||...+..+...... .......+...+.++.+++.+||+.+|.+||++.+++..|..++....
T Consensus 219 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 219 LGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCCCCcccCChHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 999998777666555443 222334456688999999999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=242.01 Aligned_cols=202 Identities=40% Similarity=0.706 Sum_probs=172.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++.+++..++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p 130 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAA 130 (256)
T ss_pred HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhccc
Confidence 357899999999999999999999999999999999997644 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+........ .......|+|||.+.+..++.++|+||+|++++++++ |..||...+..+
T Consensus 131 ~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 131 RNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred ceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998876532211 2233457999999988888899999999999999997 999998887776
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
....... ......+..+++.+.++|.+||..+|.+|||+.+++++|+.+
T Consensus 208 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 VVPHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHhc-CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 6655542 334455677899999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=253.48 Aligned_cols=193 Identities=25% Similarity=0.475 Sum_probs=167.5
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+|++|+++++++.+.+..++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++| ++||||||+||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nil 133 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVM 133 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeE
Confidence 68999999999999999999999999999999987643 3899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.++.++|+|||++..............+++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+....+
T Consensus 134 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 134 LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred ECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998865332222333456788999999999888999999999999999999999999988877766665
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH-----HHHHH
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----STIME 204 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~ 204 (226)
. ......+..++.++.+++.+||+.+|.+|++. .++++
T Consensus 214 ~--~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 214 M--EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred H--hCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 4 33445677899999999999999999999985 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=252.35 Aligned_cols=205 Identities=28% Similarity=0.471 Sum_probs=167.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~ 79 (226)
|++++||||+++++++.+++..++||||+.+++|.+++.+.+ .+++..+..++.+++.||.|||+ .+ ++|+|||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlk 131 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVK 131 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCC
Confidence 357899999999999999999999999999999999997643 38899999999999999999997 58 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||+||+++++++|+.||......+
T Consensus 132 p~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 132 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred hhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 99999999999999999988654332 1223456789999999998888999999999999999999999997655433
Q ss_pred HHHHHh-------------------------------------------hCCccCCC-CCCCCHHHHHHHHHHcccCCCC
Q 027225 160 VVAAVG-------------------------------------------FKGKRLEI-PRNVNPHVASIIEACWANEPWK 195 (226)
Q Consensus 160 ~~~~~~-------------------------------------------~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~ 195 (226)
...... ........ ...++.++.+++.+||+.||.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCccc
Confidence 322110 00001111 1236789999999999999999
Q ss_pred CCCHHHHHHHHHHhhcCCC
Q 027225 196 RPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 196 Rps~~~~l~~l~~~~~~~~ 214 (226)
|||+.++++ +.+++...
T Consensus 290 Rpt~~ell~--h~~~~~~~ 306 (333)
T cd06650 290 RADLKQLMV--HAFIKRSE 306 (333)
T ss_pred CcCHHHHhh--CHHHhcCc
Confidence 999999998 77776653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=244.98 Aligned_cols=204 Identities=32% Similarity=0.527 Sum_probs=170.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
+++++|+||+++++++.+.+..++|+||+.+++|.+++.+.+. ...+++..+..++.|++.||+|||+.+ ++|+
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~ 140 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHR 140 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--Eeec
Confidence 3578999999999999999999999999999999999876432 124899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCC---cEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCC
Q 027225 77 DLKSPNLLVDKKY---TVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ 150 (226)
Q Consensus 77 di~p~nil~~~~~---~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~ 150 (226)
||+|+||+++.++ .++|+|||.+........ ..........|+|||.+.+..++.++|+|||||++++|++ |..
T Consensus 141 dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~ 220 (277)
T cd05036 141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM 220 (277)
T ss_pred ccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999998654 589999998875432211 1112222457999999988889999999999999999997 999
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
||...+..+....+. .......+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 221 pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 221 PYPGRTNQEVMEFVT-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 998877766655543 33445567788999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=256.55 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=166.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++.+.++...|+||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||++| ++||||||+
T Consensus 56 ~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~ 130 (363)
T cd05628 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPD 130 (363)
T ss_pred HhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHH
Confidence 56799999999999999999999999999999999998743 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-----------------------------------ccCCCCCCCCccCcccccC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-----------------------------------SSKSAAGTPEWMAPEVLRD 126 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~PE~~~~ 126 (226)
||+++.++.++|+|||++........ ......|++.|+|||++.+
T Consensus 131 NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 210 (363)
T cd05628 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ 210 (363)
T ss_pred HeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC
Confidence 99999999999999998764321100 0112457889999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCC---CCCCHHH
Q 027225 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPW---KRPSFST 201 (226)
Q Consensus 127 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~---~Rps~~~ 201 (226)
..++.++|+||+||++|+|++|..||...+..+....+........++ ..+++++.++|.+|+. +|. .||++++
T Consensus 211 ~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~e 289 (363)
T cd05628 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 889999999999999999999999999888777666664333333333 3478999999999775 444 4689999
Q ss_pred HHHHHHHhhc
Q 027225 202 IMELLRPLIK 211 (226)
Q Consensus 202 ~l~~l~~~~~ 211 (226)
+++ +.+++
T Consensus 290 i~~--hp~f~ 297 (363)
T cd05628 290 IKT--NPFFE 297 (363)
T ss_pred HhC--CCCCC
Confidence 998 44443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=242.60 Aligned_cols=205 Identities=32% Similarity=0.573 Sum_probs=172.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++.+++.+.+..++|+||+.+++|.+++.... ..+++..+..++.|++.|+.+||+.| ++|+||+|
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp 135 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAA 135 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccch
Confidence 467899999999999999999999999999999999997542 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc---CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++++|||.+.......... ........|+|||.+.+..++.++|+||+|+++|++++ |..||...+
T Consensus 136 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 136 RNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred hhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 99999999999999999886543221111 11122346999999988888999999999999999997 999998777
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..+....+.. ......+...+.++.+++.+|++.+|.+||++.++++.|++++
T Consensus 216 ~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 216 NHEVMKAIND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 6666665542 3344445668899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=254.57 Aligned_cols=194 Identities=26% Similarity=0.474 Sum_probs=162.7
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.+||||+++++++..++..++||||+.+++|..++.+.+ .+++..+..++.|++.||+|||++| ++||||||+||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Ni 127 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNV 127 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHE
Confidence 489999999999999999999999999999999887643 4899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN------- 156 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------- 156 (226)
+++.++.++|+|||++..............++..|+|||++.+..++.++|+||+|+++|+|++|..||....
T Consensus 128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05618 128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207 (329)
T ss_pred EECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence 9999999999999988653322223334567889999999998888999999999999999999999995211
Q ss_pred --HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC------HHHHHH
Q 027225 157 --PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS------FSTIME 204 (226)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~~l~ 204 (226)
.......+ ......++..++..+.++|.+||+.||.+||+ +.++++
T Consensus 208 ~~~~~~~~~i--~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 208 NTEDYLFQVI--LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred ccHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 11122222 33445677889999999999999999999998 467765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=240.04 Aligned_cols=202 Identities=33% Similarity=0.597 Sum_probs=170.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++...+..++|+||+.+++|.+++.... ..+++..+..++.+++.+|.++|++| ++|+||+|
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p 121 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAA 121 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCh
Confidence 356899999999999999999999999999999999987543 23789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc-CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+.......... ........|+|||.+.+..++.++|+||+|++++++++ |..||...+..
T Consensus 122 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred heEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999886533321111 12223457999999988888999999999999999998 89999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
.....+. .......+..++..+.+++.+|++.+|.+||++.++++.|.
T Consensus 202 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 202 QAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 6655554 33344556778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=232.01 Aligned_cols=196 Identities=26% Similarity=0.490 Sum_probs=177.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.|+||||++++++|.++...|+++||..+|++...++.+. .+.+++...+.++.|++.||.|+|..+ ++||||||+
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpe 153 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPE 153 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHH
Confidence 46899999999999999999999999999999999998543 455999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
|++++..|.+|+.|||-+.... .......+++..|.+||...+...+...|+|++|++.|+++.|..||...+..+..
T Consensus 154 nlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY 231 (281)
T KOG0580|consen 154 NLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY 231 (281)
T ss_pred HhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH
Confidence 9999999999999999876544 23345678899999999999999999999999999999999999999998877777
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+ ......+|..++.+..++|.+|+..+|.+|.+..++++
T Consensus 232 krI--~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 232 KRI--RKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHH--HHccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 666 45566778999999999999999999999999999998
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=256.60 Aligned_cols=208 Identities=35% Similarity=0.572 Sum_probs=170.2
Q ss_pred CCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------------------------------
Q 027225 2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------------------------------------- 43 (226)
Q Consensus 2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------------------------------- 43 (226)
+++. ||||+++++++.+.+..|+||||+.+|+|.+++.....
T Consensus 95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 4564 99999999999999999999999999999998764210
Q ss_pred --------------------------------------------------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 44 --------------------------------------------------------REMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 44 --------------------------------------------------------~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
...+++..+..++.|++.||.|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 124778888999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
+.+ ++|+||+|+||++++++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++++|
T Consensus 255 ~~~--ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 255 SKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred hCC--eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHH
Confidence 999 99999999999999999999999999865432211 12223345679999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
++ |..||.....................+..++.++.+++.+||+.+|++|||+.++.+.|++++.
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 97 8899876554333322222334455567789999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=246.93 Aligned_cols=209 Identities=32% Similarity=0.589 Sum_probs=175.6
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+.+ +||||+++++++...+..++|+||+.+++|.+++.+... ...+++..+..++.|++.||.|||
T Consensus 75 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 154 (304)
T cd05101 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA 154 (304)
T ss_pred HhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence 346 799999999999999999999999999999999976321 234788889999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc--cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
++| ++|+||+|+||+++.++.++|+|||.+......... .....+...|+|||.+.+..++.++|+||||++++++
T Consensus 155 ~~g--ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 232 (304)
T cd05101 155 SQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred HCC--eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999 999999999999999999999999998754332111 1222334679999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
++ |..||...+..+....+. .......+...+.++.+++.+||..+|.+|||+.++++.|++++...
T Consensus 233 ~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 233 FTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 98 788888877777766664 33344456678999999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=245.34 Aligned_cols=205 Identities=31% Similarity=0.532 Sum_probs=171.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
++++||||+++++++.+.+..++++||+.+++|.+++.... ....+++..+..++.|++.||.|+|+
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred hcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999985321 12347888899999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
+| ++|+||||+||++++++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+|+++++|+
T Consensus 143 ~g--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 143 HH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred cC--ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 99 9999999999999999999999999876543221 1122333456899999998888899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+ |..||......+....+. .......+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 221 ~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 221 SYGLQPYCGYSNQDVIEMIR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 8 888998877776666554 3334456778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=240.74 Aligned_cols=206 Identities=31% Similarity=0.567 Sum_probs=167.6
Q ss_pred CCCCCCcCcceeeeEEe-cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++.++||||+++++++. .++..++|+||+.+++|.+++.+... ..++..+..++.|++.||.|||+.+ ++|+||+
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk 125 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLA 125 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccC
Confidence 46789999999999775 45668999999999999999976432 2677888899999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccc----cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGN 154 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~ 154 (226)
|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++| ..||..
T Consensus 126 ~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 126 ARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred cceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999886543211 111122335579999999888889999999999999999995 566776
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
.+..+...... .......+...++.+.+++.+||..+|++||++.++++.|++++.
T Consensus 206 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 206 VDSFDITVYLL-QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 66655554442 333444456678999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=248.62 Aligned_cols=199 Identities=23% Similarity=0.335 Sum_probs=160.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++..++..++|+||+.++++..+.... ..+++..++.++.|++.||.|||+.| ++|+||+|
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp 128 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKP 128 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 36789999999999999999999999999987776655432 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+....... .......++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+..+
T Consensus 129 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred HHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999987643221 11223456788999999988888999999999999999999999998765443
Q ss_pred HHHHHhhCCc-----------------cC-------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGK-----------------RL-------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~-----------------~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+..... .. .....++.++.+++++||+.||++|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 209 QLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 3222111000 00 011236788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=247.35 Aligned_cols=198 Identities=24% Similarity=0.357 Sum_probs=160.6
Q ss_pred CCCCCcCcceeeeEEe-----cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++. .....++|+|++. ++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~ 134 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHR 134 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeC
Confidence 4568999999999885 3456999999996 59999987643 234899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 135 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 135 DLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred CCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99999999999999999999998654332 22334456789999999988888999999999999999999999998776
Q ss_pred HHHHHHHHhhCCccC-------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PAQVVAAVGFKGKRL-------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+....+....... .....++..+.+++.+||+.||++|||+.++++
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 655443332110000 011357788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=248.79 Aligned_cols=205 Identities=27% Similarity=0.479 Sum_probs=170.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++.+..+...++|+||+.+++|.+++.+. .+++.++..++.|++.||.|||+.| ++|+||+|
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp 144 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKS 144 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 35679999999999999999999999999999999998653 3789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............+++.|+|||.+.+...+.++|+||+|+++++|++|..||...+....
T Consensus 145 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~ 224 (296)
T cd06654 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (296)
T ss_pred HHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh
Confidence 99999999999999999876543322222334567789999999888888999999999999999999999987665443
Q ss_pred HHHHhh-CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 161 VAAVGF-KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 161 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
...... .......+..++..+.+++.+||..+|.+||++.++++ .+++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~--~~~~~~~ 276 (296)
T cd06654 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIA 276 (296)
T ss_pred HHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh--Chhhhcc
Confidence 322221 11222345678899999999999999999999999998 5555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=242.40 Aligned_cols=205 Identities=32% Similarity=0.597 Sum_probs=171.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++|+||+++++|.+++.... ..+++.++..++.|++.||.+||+.| ++|+||+|
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp 134 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAA 134 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--Eeehhhch
Confidence 357899999999999999999999999999999999997643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc---cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++|+|||.+......... ......+..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 135 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred hcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 9999999999999999988654332111 111222457999999998888999999999999999886 999998777
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..+....+.. ......+..+++.+.+++.+|++.+|.+||++.++++.|++++
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 215 NQDVIKAIEE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred HHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 6665555442 2334445678899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=246.84 Aligned_cols=208 Identities=22% Similarity=0.321 Sum_probs=165.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.++...++||||+.+++|.+++...+ ...+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp 123 (277)
T cd05607 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKP 123 (277)
T ss_pred HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCCh
Confidence 357899999999999999999999999999999998886543 234889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP--- 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--- 157 (226)
+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....
T Consensus 124 ~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~ 202 (277)
T cd05607 124 ENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202 (277)
T ss_pred HhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 99999999999999999876543321 12234567899999999888899999999999999999999999975432
Q ss_pred -HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH--HHhhcCC
Q 027225 158 -AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL--RPLIKSP 213 (226)
Q Consensus 158 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l--~~~~~~~ 213 (226)
.+...... ..........++.++.+++.+||+.||.+||++.++++.+ +++++..
T Consensus 203 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 203 KEELKRRTL-EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHHHHHhh-ccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 12222111 1111112346899999999999999999999996654322 3555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=264.36 Aligned_cols=216 Identities=32% Similarity=0.554 Sum_probs=190.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-----------CCcCCHHHHHHHHHHHHHHHHHHhcC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----------REMLDERRRLNMAYDVAKGMNYLHRR 69 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~ 69 (226)
|..++|||||+++|+|.+++-.|+|+||+..|+|.+++..++. ...++..+...++.||+.|..||-++
T Consensus 543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~ 622 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH 622 (774)
T ss_pred HHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999999999999999999999999975321 22388899999999999999999999
Q ss_pred CCCeEEeCCCCCcEEEcCCCcEEEccCCCccccc--ccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 70 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
. ++||||-..|++++++..+|++|||+++... ++........-...|||||.+....++.++||||+|+++||+++
T Consensus 623 ~--FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 623 H--FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFS 700 (774)
T ss_pred c--ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhc
Confidence 9 9999999999999999999999999998643 33333334444678999999999999999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCC
Q 027225 148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219 (226)
Q Consensus 148 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~ 219 (226)
|..||.+...+++++.++... .++.|...+.++++|+..||+.+|.+||++.||-..|+++..+++.-.+.
T Consensus 701 yG~QPy~glSn~EVIe~i~~g~-lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~~ 772 (774)
T KOG1026|consen 701 YGKQPYYGLSNQEVIECIRAGQ-LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSSL 772 (774)
T ss_pred cccCcccccchHHHHHHHHcCC-cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccccc
Confidence 788999999999999998444 48999999999999999999999999999999999999999887765543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=252.96 Aligned_cols=207 Identities=25% Similarity=0.405 Sum_probs=162.3
Q ss_pred CCCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|++++||||+++++++... ...|+|+||+. ++|.+++.+.. .+++..+..++.|++.||.|||+.| ++|
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH 126 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN--VFH 126 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence 3578999999999988543 34899999995 68999887643 3899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccC--CCCCCchhHHHHHHHHHHHHhCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+||||+||+++.++.++|+|||.+....... .......++..|+|||++.+ ..++.++|+||+||++++|++|+.
T Consensus 127 ~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred CCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999986533221 11233467889999999875 567889999999999999999999
Q ss_pred CCCCCCHHHHHHHHhhC-------------------------C-ccC---CCCCCCCHHHHHHHHHHcccCCCCCCCHHH
Q 027225 151 PWGNLNPAQVVAAVGFK-------------------------G-KRL---EIPRNVNPHVASIIEACWANEPWKRPSFST 201 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~-------------------------~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 201 (226)
||...+.......+... . ... .....+++++.+++.+||+.||++|||+++
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e 286 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286 (338)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence 99766543322111000 0 000 011246788999999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 027225 202 IMELLRPLIKSPTP 215 (226)
Q Consensus 202 ~l~~l~~~~~~~~~ 215 (226)
+++ +++++....
T Consensus 287 ~l~--hp~f~~~~~ 298 (338)
T cd07859 287 ALA--DPYFKGLAK 298 (338)
T ss_pred Hhc--CchhhhcCc
Confidence 998 777766444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=244.36 Aligned_cols=207 Identities=25% Similarity=0.461 Sum_probs=169.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++||||+++++++.+++..++++||+.+++|.+++.... ....+++..++.++.|++.||.|||++| ++|+||+|
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p 134 (267)
T cd08229 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKP 134 (267)
T ss_pred HHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 56899999999999999999999999999999999887422 2345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-- 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-- 158 (226)
+||+++.++.++++|||.+..............++..|+|||.+.+...+.++|+||+|+++++|++|..||......
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred HHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 999999999999999998765443322223345677899999998888899999999999999999999999654432
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
+....+.........+..++.++.+++.+||..+|.+|||+.+|++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 2222222111122223457899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=245.11 Aligned_cols=208 Identities=29% Similarity=0.491 Sum_probs=171.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++..++..++|+||+.+++|..++.+.. ..+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 57 ~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~ 132 (282)
T cd06643 57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAG 132 (282)
T ss_pred HHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcc
Confidence 56899999999999999999999999999999998876422 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+++.++.++++|||.+..............++..|+|||.+. +..++.++|+||+|+++++|++|..||...+
T Consensus 133 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 133 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 99999999999999998865443322233445678899999974 3346789999999999999999999998877
Q ss_pred HHHHHHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 157 PAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
..+........ ......+..++.++.++|.+||+.+|.+||++.++++ +.+++....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~~ 270 (282)
T cd06643 213 PMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ--HPFVTVNSN 270 (282)
T ss_pred HHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CCCEeccCC
Confidence 65544443222 2233445678899999999999999999999999998 777665443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=257.00 Aligned_cols=203 Identities=25% Similarity=0.384 Sum_probs=168.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.| ++||||+|+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~ 131 (330)
T cd05601 56 SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPE 131 (330)
T ss_pred HhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchH
Confidence 46789999999999999999999999999999999998752 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCccccc------CCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR------DEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
||+++.++.++|+|||.+........ ......++..|+|||++. ...++.++|+||+|+++|+|++|..||..
T Consensus 132 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 132 NVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred heEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 99999999999999999865433211 222345788999999986 34567899999999999999999999988
Q ss_pred CCHHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 155 LNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
.+..+....+.........+ ..++.++.++|.+||+ +|.+|||++++++ ++++.
T Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~--h~~~~ 267 (330)
T cd05601 212 GTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC--HPFFS 267 (330)
T ss_pred CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC--CCCcC
Confidence 77766555543333222333 3578999999999997 9999999999997 44444
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=257.50 Aligned_cols=198 Identities=26% Similarity=0.417 Sum_probs=166.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.| ++||||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp 129 (364)
T cd05599 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKP 129 (364)
T ss_pred HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCH
Confidence 356789999999999999999999999999999999997643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--------------------------------------ccCCCCCCCCccCcc
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--------------------------------------SSKSAAGTPEWMAPE 122 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~PE 122 (226)
+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus 130 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred HHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 999999999999999998754221100 001234788999999
Q ss_pred cccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCC--CCCHHHHHHHHHHcccCCCCCCC--
Q 027225 123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWKRPS-- 198 (226)
Q Consensus 123 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps-- 198 (226)
++.+..++.++|+||+||++|+|++|..||...+..+....+.........+. .+++++.++|.+|+. +|.+|++
T Consensus 210 ~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~ 288 (364)
T cd05599 210 VFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNN 288 (364)
T ss_pred HHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCC
Confidence 99988899999999999999999999999998887766555543333333333 578999999999996 9999997
Q ss_pred -HHHHHH
Q 027225 199 -FSTIME 204 (226)
Q Consensus 199 -~~~~l~ 204 (226)
+.++++
T Consensus 289 ~~~~ll~ 295 (364)
T cd05599 289 GVNEIKS 295 (364)
T ss_pred CHHHHhc
Confidence 999887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=258.21 Aligned_cols=204 Identities=34% Similarity=0.580 Sum_probs=178.7
Q ss_pred CCCCCCcCcceeeeEEecCCc--eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|+.|+||||++++++|.+..+ ..+|+|.+..|+|..|+.+.+. .+...+..|+.||+.||.|||++.++|+||||
T Consensus 95 LKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDL 171 (632)
T KOG0584|consen 95 LKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDL 171 (632)
T ss_pred HccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCcccccc
Confidence 678999999999999987655 8899999999999999998653 89999999999999999999999999999999
Q ss_pred CCCcEEEc-CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CC
Q 027225 79 KSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN-LN 156 (226)
Q Consensus 79 ~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~ 156 (226)
|-+|||++ ..|.+||+|+|+|+....... ..-.|+|.|||||++. ..|.+..||||||++|.+|+|+..||.. .+
T Consensus 172 KCDNIFinG~~G~VKIGDLGLAtl~r~s~a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 172 KCDNIFVNGNLGEVKIGDLGLATLLRKSHA--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred ccceEEEcCCcCceeecchhHHHHhhcccc--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 99999996 568999999999987665432 3468999999999988 5589999999999999999999999966 56
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+.++........+...+..--++++++||.+||.. ..+|+|+.|+++ +.++...
T Consensus 249 ~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~d 302 (632)
T KOG0584|consen 249 PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDED 302 (632)
T ss_pred HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhccc
Confidence 77777777655555556666689999999999998 999999999999 8887764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=266.12 Aligned_cols=215 Identities=31% Similarity=0.521 Sum_probs=185.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcC-CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++|.|||+++|.+.+++++-+.||-++||||.++++. +|.- .=++..+..+..||++||.|||.+. |+|||||.
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPl-KDNEstm~fYtkQILeGLkYLHen~--IVHRDIKG 703 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPL-KDNESTMNFYTKQILEGLKYLHENK--IVHRDIKG 703 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCC-ccchhHHHHHHHHHHHHhhhhhhcc--eeeccccC
Confidence 468999999999999999999999999999999999985 4421 1277888889999999999999999 99999999
Q ss_pred CcEEEc-CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCCCCC-C
Q 027225 81 PNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNL-N 156 (226)
Q Consensus 81 ~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~ 156 (226)
+||+++ ..|.+|++|||-++.......-.+.+.|+..|||||++..+ +|..++|||||||.+.+|.||++||-.. .
T Consensus 704 DNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 704 DNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred CcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 999995 68899999999998877776667788999999999999754 5889999999999999999999999654 4
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 221 (226)
+.............+++|..++.+.+.+|.+|+.++|.+||++.+++. ..++...+..+.|.-
T Consensus 784 pqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~--DpFlq~~~kk~r~~l 846 (1226)
T KOG4279|consen 784 PQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ--DPFLQHNNKKPRPKL 846 (1226)
T ss_pred hhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc--CcccccCCCCCCCCC
Confidence 444555555566778889999999999999999999999999999998 788776655554443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=257.18 Aligned_cols=203 Identities=25% Similarity=0.414 Sum_probs=169.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++.+++..|+||||+++|+|.+++.... +++..+..++.||+.||+|||++| ++||||||+
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~ 171 (370)
T cd05621 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPD 171 (370)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence 56799999999999999999999999999999999997543 889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||++++++.++|+|||++....... .......+++.|+|||++.+.. ++.++|+||+||++|+|++|..||...+
T Consensus 172 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 172 NMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred HEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 9999999999999999987643321 1223456888999999987543 6789999999999999999999998887
Q ss_pred HHHHHHHHhhCCccCCCCC--CCCHHHHHHHHHHcccCCCC--CCCHHHHHHHHHHhhcC
Q 027225 157 PAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWK--RPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~~ 212 (226)
..+....+.........+. .++..+.+++.+||..++.+ |+++.++++ +.+++.
T Consensus 252 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--hp~~~~ 309 (370)
T cd05621 252 LVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--HPFFKN 309 (370)
T ss_pred HHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc--CcccCC
Confidence 7666665544333344443 56999999999999855543 899999999 666654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=248.44 Aligned_cols=210 Identities=26% Similarity=0.487 Sum_probs=174.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++.+...+..++|+||+++++|.+++... .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp 146 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKS 146 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCH
Confidence 35689999999999999999999999999999999988643 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|++++++++|..||...+..+.
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred HHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999886543332223334567789999999888889999999999999999999999987766554
Q ss_pred HHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 161 VAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
...+... .........++..+.+++.+||..+|.+|||++++++ +.+++..++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~~~~ 283 (292)
T cd06658 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPSC 283 (292)
T ss_pred HHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCCccc
Confidence 4433221 1222233457889999999999999999999999999 778876555553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=239.75 Aligned_cols=203 Identities=33% Similarity=0.600 Sum_probs=169.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|||++++++++.. +..+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~ 130 (260)
T cd05069 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRA 130 (260)
T ss_pred HHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCc
Confidence 357899999999998854 56899999999999999997643 334889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||++++++.++|+|||.+....... .......++..|+|||...+...+.++|+||||++++++++ |..||.+....
T Consensus 131 ~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 131 ANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred ceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999886543221 11112234567999999988888999999999999999999 89999887766
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
+....+. .......+...+..+.+++.+||..+|.+||+++++++.|++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 EVLEQVE-RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHH-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6555543 233345566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=258.19 Aligned_cols=204 Identities=22% Similarity=0.349 Sum_probs=167.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..|+||||+.+|+|.+++...+ .+++..++.++.|++.||+|||+.| ++||||||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp 129 (377)
T cd05629 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKP 129 (377)
T ss_pred HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence 356899999999999999999999999999999999997643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc--------------c---------------------------------ccCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF--------------L---------------------------------SSKSAA 113 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~--------------~---------------------------------~~~~~~ 113 (226)
+||+++.++.++|+|||+++...... . ......
T Consensus 130 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred HHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 99999999999999999885321100 0 000135
Q ss_pred CCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCC--CCCHHHHHHHHHHccc
Q 027225 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWAN 191 (226)
Q Consensus 114 ~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 191 (226)
+++.|+|||++.+..++.++|+||+||++|+|++|..||...+..+....+.........+. .++.++.++|.+||.
T Consensus 210 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred CCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-
Confidence 78899999999988899999999999999999999999988777665554433333333343 578999999999997
Q ss_pred CCCCC---CCHHHHHHHHHHhhcC
Q 027225 192 EPWKR---PSFSTIMELLRPLIKS 212 (226)
Q Consensus 192 ~p~~R---ps~~~~l~~l~~~~~~ 212 (226)
+|.+| +++.++++ +.++++
T Consensus 289 ~~~~r~~r~~~~~~l~--hp~~~~ 310 (377)
T cd05629 289 NAENRLGRGGAHEIKS--HPFFRG 310 (377)
T ss_pred CHhhcCCCCCHHHHhc--CCCcCC
Confidence 67765 59999988 555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=240.23 Aligned_cols=205 Identities=34% Similarity=0.583 Sum_probs=170.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+ ...++|+||+.+++|.+++.+.. ...+++..+..++.|++.||++||+.+ ++|+||+|+
T Consensus 56 ~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ 131 (262)
T cd05071 56 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA 131 (262)
T ss_pred HhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcc
Confidence 56899999999998754 55899999999999999997532 234789999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||++++++.++|+|||.+........ ......++..|++||...+..++.++|+||||++++++++ |..||......+
T Consensus 132 Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~ 211 (262)
T cd05071 132 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 211 (262)
T ss_pred cEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH
Confidence 99999999999999998865433221 1112234557999999988888999999999999999999 788998777666
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
....+. .......+..++..+.+++.+|++.+|.+||++.++++.|+++++
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~~ 262 (262)
T cd05071 212 VLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262 (262)
T ss_pred HHHHHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhcC
Confidence 555443 223334456789999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=244.46 Aligned_cols=204 Identities=31% Similarity=0.528 Sum_probs=164.1
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++... ...++|+||+.+++|.+++.... +++.+++.++.|++.||.+||+.| ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dl 133 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQH--YIHRDL 133 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCC--eecccc
Confidence 4678999999999988654 45899999999999999997643 899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccc---cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+......... .....+...|+|||.+.+...+.++|+||||+++++|++|..||...
T Consensus 134 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 134 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred ChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998754432111 11223445699999998888899999999999999999999998643
Q ss_pred CHHH--HH------------HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 156 NPAQ--VV------------AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 156 ~~~~--~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
.... .. ............+...+.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 214 PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 3210 00 0000111223345678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=247.13 Aligned_cols=208 Identities=28% Similarity=0.540 Sum_probs=173.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++... ..++|+||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.| ++|+||||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp 137 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAA 137 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccch
Confidence 3678999999999999765 5789999999999999998643 23888999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc--cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||++++++.++|+|||.+......... ......+..|++||.+.+..++.++|+||+|+++|++++ |..||.+...
T Consensus 138 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 138 RNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred hheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999998764432111 112223457999999998889999999999999999997 9999988776
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.+...... .......+...+.++.+++.+||..+|.+||++.+++..+.++.+...
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 218 SEISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred HHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 66554443 344445566788999999999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=240.87 Aligned_cols=204 Identities=32% Similarity=0.637 Sum_probs=170.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++. .+..++++||+.+++|.+++.... ...+++.++..++.|++.||++||+.| ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p 130 (260)
T cd05067 55 MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRA 130 (260)
T ss_pred HHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccH
Confidence 36789999999999875 456999999999999999987543 335899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc-ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||++++++.++|+|||.+...... ........+...|+|||.+.+..++.++|+||+|++++++++ |..||...+..
T Consensus 131 ~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 131 ANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred HhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 9999999999999999988654421 111122334567999999988888999999999999999998 99999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+...... .......+...+.++.+++.+||..+|++||+++++++.|+.+
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 211 EVIQNLE-RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 6655553 2334455677889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=240.49 Aligned_cols=201 Identities=27% Similarity=0.535 Sum_probs=172.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++.+++..++++||+++++|.+++.+.. ...+++..+..++.|++.+|.+||+.| ++|+||+|
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p 129 (256)
T cd08221 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKT 129 (256)
T ss_pred HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCh
Confidence 467899999999999999999999999999999999998653 345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++++.++++|||.+..............++..|.|||...+...+.++|+||+|+++++|++|..||...+..+.
T Consensus 130 ~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08221 130 LNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209 (256)
T ss_pred HhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99999999999999999887654433223345567899999999888888999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
...+.. ......+..++.++.+++.+||..+|.+||++.++++.
T Consensus 210 ~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 210 VVKIVQ-GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHc-CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 655542 33334456788999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=243.90 Aligned_cols=209 Identities=33% Similarity=0.568 Sum_probs=172.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------REMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
+++++||||+++++++.+.+..++||||+.+|+|.+++.+.+. ...++...+..++.|++.||.|||+++ +
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i 140 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--F 140 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--C
Confidence 3568999999999999999999999999999999999975321 234677888999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ 150 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~ 150 (226)
+|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|++++++++ |..
T Consensus 141 ~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~ 220 (288)
T cd05061 141 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 220 (288)
T ss_pred cCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999886433221 11122233567999999988888999999999999999998 788
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
||...+..+....+. .......+...++.+.+++.+||+.+|.+|||+.++++.|++.+..
T Consensus 221 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 221 PYQGLSNEQVLKFVM-DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred CCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 998877766555443 3334455667789999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=241.13 Aligned_cols=200 Identities=30% Similarity=0.566 Sum_probs=168.1
Q ss_pred CCCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++++|+|++++++.+.. +...++++||+++++|.+++.... ...+++.++..++.+++.||++||+.| ++|+||+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~ 129 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLK 129 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCC
Confidence 357899999999998864 445899999999999999987632 334899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.++.++|+|||.+..............++..|+|||...+..++.++|+||+|++++++++|..||...+...
T Consensus 130 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 209 (257)
T cd08223 130 TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209 (257)
T ss_pred chhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999999988655433233334456788999999998888899999999999999999999998777655
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...... .......+..+++++.+++.+|++.+|.+|||+.++++
T Consensus 210 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 210 LVYRII-EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHH-hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 544432 23333456778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=241.05 Aligned_cols=207 Identities=31% Similarity=0.567 Sum_probs=169.4
Q ss_pred CCCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCC---CCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
|++++||||+++++++... ...++++||+.+++|.+++.... ....+++..+..++.|++.||.|||++|
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~- 132 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS- 132 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3578999999999987432 24789999999999998874211 1234889999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-C
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L 148 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 148 (226)
++|+||||+||+++.++.++|+|||.+........ ..........|++||...+..++.++|+||+|++++++++ |
T Consensus 133 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 133 -FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred -eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999875433211 1122334567999999998889999999999999999999 7
Q ss_pred CCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..||......+....+. .......+..++..+.++|.+||+.+|.+|||+.++++.|++++
T Consensus 212 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 212 QTPYPGVENSEIYDYLR-QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 88998777766665554 33344556678899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=249.33 Aligned_cols=211 Identities=34% Similarity=0.547 Sum_probs=165.9
Q ss_pred CCCCCCcCcceeeeEEecCCc-eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di 78 (226)
|.+++|||+++++|||.+.+. .++|+||+..|||.+.+...... .++|..+.+|+.++++||+|||.. .++|+||||
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi 203 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI 203 (361)
T ss_pred HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence 468899999999999999984 99999999999999999875533 689999999999999999999995 346999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCC-CCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA-AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN- 156 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~- 156 (226)
|++||++|.+.+.|++|||++............. .++.+|++||.......+.++||||+|+++.++++|+.+.....
T Consensus 204 KssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~ 283 (361)
T KOG1187|consen 204 KSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP 283 (361)
T ss_pred CHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence 9999999999999999999996544311111111 77889999999998889999999999999999999998776432
Q ss_pred --HHHHHHH---HhhCCc-----cCCCC-CCCC--H---HHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 157 --PAQVVAA---VGFKGK-----RLEIP-RNVN--P---HVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 --~~~~~~~---~~~~~~-----~~~~~-~~~~--~---~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....... ...... .+.+. ..++ . .+..+..+|++.+|.+||++.+|+++|+.+...
T Consensus 284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 1111111 111111 11112 2333 2 266788999999999999999999999776655
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=256.69 Aligned_cols=205 Identities=26% Similarity=0.379 Sum_probs=167.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..|+||||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+.| |+||||||
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp 129 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKP 129 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcH
Confidence 357899999999999999999999999999999999998744 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-----------------------------------------------cccCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-----------------------------------------------LSSKSAA 113 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-----------------------------------------------~~~~~~~ 113 (226)
+||+++.++.++|+|||++....... .......
T Consensus 130 ~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (381)
T cd05626 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209 (381)
T ss_pred HHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccccccc
Confidence 99999999999999999864321000 0001235
Q ss_pred CCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHc--
Q 027225 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACW-- 189 (226)
Q Consensus 114 ~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l-- 189 (226)
++..|+|||.+.+..++.++|+||+||++|+|++|..||...+..+....+.........+ ..+++++.++|.+|+
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred CCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccC
Confidence 7889999999998889999999999999999999999998877666554443323333333 357999999999965
Q ss_pred ccCCCCCCCHHHHHHHHHHhhcC
Q 027225 190 ANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 190 ~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..++..|+++.++++ +.++++
T Consensus 290 ~~~~~~R~~~~~~l~--hp~f~~ 310 (381)
T cd05626 290 AEERLGRNGADDIKA--HPFFSE 310 (381)
T ss_pred cccccCCCCHHHHhc--CcccCC
Confidence 455556999999998 566544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=241.52 Aligned_cols=204 Identities=36% Similarity=0.613 Sum_probs=170.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|++++||||+++++++...+..++|+||+++++|.+++.+.. ....+++..+..++.|++.||.|||+.+ ++|+
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~ 130 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHR 130 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 467899999999999999999999999999999999987532 1234788999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCC-----cEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-C
Q 027225 77 DLKSPNLLVDKKY-----TVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L 148 (226)
Q Consensus 77 di~p~nil~~~~~-----~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 148 (226)
||+|+||+++.++ .++++|||++....... ........+..|+|||.+.+...+.++|+||||+++++|++ |
T Consensus 131 dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g 210 (269)
T cd05044 131 DLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG 210 (269)
T ss_pred CCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcC
Confidence 9999999999877 89999999886433221 11122234567999999998889999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
..||...+..+....+. .......+...+..+.++|.+||+.+|.+||++.++++.|+
T Consensus 211 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 211 QQPYPALNNQEVLQHVT-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCCCcccCHHHHHHHHh-cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99998777666555543 23344556778899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=243.71 Aligned_cols=203 Identities=31% Similarity=0.531 Sum_probs=173.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++.+++.++...++|+||+.+++|.+++... .+++..+..++.|++.|+.+||+.+ ++|+||+|+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ 127 (274)
T cd06609 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAA 127 (274)
T ss_pred HHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHH
Confidence 5678999999999999999999999999999999999864 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||++++++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|++++++++|..||...+..+..
T Consensus 128 ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~ 207 (274)
T cd06609 128 NILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL 207 (274)
T ss_pred HEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH
Confidence 99999999999999999876654433334455677899999999888999999999999999999999999877766555
Q ss_pred HHHhhCCccCCCCCC-CCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 162 AAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+... .....+.. ++.++.+++.+||..+|.+|||++++++ ..++...
T Consensus 208 ~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~~~ 257 (274)
T cd06609 208 FLIPKN-NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIKKA 257 (274)
T ss_pred HHhhhc-CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh--ChhhcCC
Confidence 444322 22233333 8899999999999999999999999988 6666553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=241.05 Aligned_cols=207 Identities=27% Similarity=0.508 Sum_probs=169.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++++|+||+++++++.+.+..++|+||+++++|.+++.+.. ....+++..+..++.+++.||.+||+.| ++|+||+
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~ 133 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIK 133 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcC
Confidence 357899999999999999999999999999999999986532 1334899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--H
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--P 157 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~ 157 (226)
|+||+++.++.++|+|||.+..............++..|.|||.+.+..++.++|+||+|++++++++|..||.... .
T Consensus 134 p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08224 134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred hhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH
Confidence 99999999999999999987654433222233456778999999988888999999999999999999999985443 2
Q ss_pred HHHHHHHhhCCccCCCCC-CCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 158 AQVVAAVGFKGKRLEIPR-NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
.+...... .......+. .++..+.++|.+||..+|.+|||+.++++.|+++-
T Consensus 214 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 214 YSLCKKIE-KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHhhhh-cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 23333322 122223333 68889999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=241.15 Aligned_cols=207 Identities=30% Similarity=0.574 Sum_probs=171.5
Q ss_pred CCCCCCcCcceeeeEEecCCc------eEEEEeecccCCHHHHhcCCC---CCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
|++++||||+++++++..... .++++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~- 133 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN- 133 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 356899999999998866544 899999999999999885421 1235899999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc--cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-C
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L 148 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 148 (226)
++|+||+|+||++++++.++|+|||.+......... .........|++||.+.+..++.++|+||+|+++++|++ |
T Consensus 134 -i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 134 -FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred -eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCC
Confidence 999999999999999999999999988654322111 111223457999999988888999999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..||.+.+..+...... .......+..++.++.+++.+||+.||.+|||+.++++.|++++
T Consensus 213 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 213 QTPYPGVENHEIYDYLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCCCCCCCHHHHHHHHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 89998877766665554 34455567789999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=238.59 Aligned_cols=208 Identities=26% Similarity=0.394 Sum_probs=171.9
Q ss_pred CCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 5 RHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 5 ~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
.|||||.++|+++. ...+.+|||+++||.|.+.++.++ ...+++.++..++.||..|+.|||+.+ |+||||||
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKp 189 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKP 189 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCCh
Confidence 69999999999964 355889999999999999999877 567999999999999999999999999 99999999
Q ss_pred CcEEEcCC---CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 027225 81 PNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN- 156 (226)
Q Consensus 81 ~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~- 156 (226)
+|++++.+ -.+||+|||+++..... ......+.++.|.|||++....++...|+||+|++||-|++|.+||-+..
T Consensus 190 ENLLyt~t~~na~lKLtDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 190 ENLLYTTTSPNAPLKLTDFGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred hheeeecCCCCcceEecccccccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 99999653 46899999999765542 34557788999999999999999999999999999999999999994332
Q ss_pred ---HHHHHHHHhhCCc--cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 157 ---PAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 157 ---~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
.......+..... ..+.+..+|...+++|+.+|..+|++|.|++++++ +.++...+..|.
T Consensus 269 ~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 269 LAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWINQYEAVPQ 333 (400)
T ss_pred ccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--CchhcccccCCC
Confidence 2223333322221 12234578999999999999999999999999999 888777655443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=239.80 Aligned_cols=205 Identities=33% Similarity=0.588 Sum_probs=172.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++......++|+||+++++|.+++.... ...+++..+..++.+++.|+.+||++| ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p 131 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAA 131 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcch
Confidence 467899999999999999889999999999999999997643 235899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+....... ...........|+|||.+.+...+.++|+||+|++++++++ |+.||...+..
T Consensus 132 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 132 RNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred heEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543211 11112223457999999998888999999999999999998 99999877766
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.....+. .......+...+.++.+++.+|++.+|.+||+++++.+.|+.+
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 212 EVLEQVE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 6655553 2334455667789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=247.17 Aligned_cols=207 Identities=24% Similarity=0.387 Sum_probs=166.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++..++..++|+||+.+ +|.+++...+ ..+++..+..++.|++.||.|||++| ++||||+|
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp 132 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKP 132 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 3578999999999999999999999999975 8888876543 24889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+..+
T Consensus 133 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 133 QNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred HHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999999988654333222333456788999998865 457889999999999999999999998766544
Q ss_pred HHHHHhhCCc----------------------c------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 VVAAVGFKGK----------------------R------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ~~~~~~~~~~----------------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
....+..... . ......++.++.++|.+||+.||.+|||+.++++ +.+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~ 290 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK--HAYFR 290 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--Chhhh
Confidence 3322211000 0 0111357889999999999999999999999999 77777
Q ss_pred CCC
Q 027225 212 SPT 214 (226)
Q Consensus 212 ~~~ 214 (226)
...
T Consensus 291 ~~~ 293 (309)
T cd07872 291 SLG 293 (309)
T ss_pred hcc
Confidence 644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=240.38 Aligned_cols=206 Identities=31% Similarity=0.579 Sum_probs=172.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+ +..++|+||+++++|.+++.+... .+++..+..++.+++.||.+||+.| ++|+||+|
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p 135 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR--FVHRDIAA 135 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCh
Confidence 357899999999999876 457899999999999999976432 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||++......... .........|+|||.+.+..++.++|+||||++++++++ |..||...+..
T Consensus 136 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~ 215 (270)
T cd05056 136 RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215 (270)
T ss_pred heEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 9999999999999999988654332111 112223457999999988888999999999999999986 99999887766
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+. .......+...+.++.+++.+|+..+|.+|||+.++++.|+.+..+
T Consensus 216 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 216 DVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 6555443 3344456778899999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=252.90 Aligned_cols=196 Identities=26% Similarity=0.389 Sum_probs=162.2
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++ +||||+++++++..++..++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+.| ++||||||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp 133 (332)
T cd05614 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKL 133 (332)
T ss_pred HhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCH
Confidence 345 58999999999999999999999999999999987643 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC--
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLN-- 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~-- 156 (226)
+||+++.++.++|+|||+++...... .......++..|+|||.+.+.. ++.++|+||||+++++|++|..||....
T Consensus 134 ~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred HHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 99999999999999999886533221 1222346788999999988653 6889999999999999999999996432
Q ss_pred --HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 157 --PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
.......+ .......+..+++.+.+++.+||+.||++|| +++++++
T Consensus 214 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 214 NTQSEVSRRI--LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 22222222 2334456778999999999999999999999 7778886
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=248.42 Aligned_cols=209 Identities=33% Similarity=0.600 Sum_probs=168.6
Q ss_pred CCC-CCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCCCC------------------------------------
Q 027225 2 KRL-RHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGV------------------------------------ 43 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~------------------------------------ 43 (226)
+++ +|+||+++++++.. +...++++||+.+++|.+++.....
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (337)
T cd05054 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS 144 (337)
T ss_pred HhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence 345 79999999998864 4568899999999999999864211
Q ss_pred ----------------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 44 ----------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 44 ----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
...+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~ 222 (337)
T cd05054 145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARD 222 (337)
T ss_pred cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchh
Confidence 125789999999999999999999999 99999999999999999999999999875
Q ss_pred ccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCC
Q 027225 102 KANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178 (226)
Q Consensus 102 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (226)
..... .......++..|+|||.+.+..++.++|+||+||+++++++ |..||......+..............+...+
T Consensus 223 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (337)
T cd05054 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT 302 (337)
T ss_pred cccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 43221 11222334567999999998889999999999999999997 9999976544333222222333444566788
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 179 ~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+++.+++.+||+.+|.+||++.++++.|++++..
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=256.50 Aligned_cols=211 Identities=35% Similarity=0.599 Sum_probs=189.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++||+...+.-+++|||+|.||+|.+++++.+. .++..+...++.+.+.||+|||+++ ++||||-.
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAA 290 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAA 290 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhH
Confidence 4689999999999999999999999999999999999998653 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
.|++++.++.+|++|||+++.............-...|+|||.+....++.++||||+|+++||+++ |..||.+.+..+
T Consensus 291 RNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~ 370 (474)
T KOG0194|consen 291 RNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE 370 (474)
T ss_pred HHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence 9999999999999999998766532222212234568999999999999999999999999999998 788999999999
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+...+...+.+...+...+.++..++.+|+..+|++||++.++.+.++.+.....+
T Consensus 371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999778888888999999999999999999999999999999999998777554
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=241.35 Aligned_cols=198 Identities=33% Similarity=0.596 Sum_probs=168.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+++++|.+++...+ .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p 134 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKG 134 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCH
Confidence 357899999999999999999999999999999999998744 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||++++++.++|+|||.+....... .......+...|+|||.+.+..++.++|+||+|++++++++|..||..
T Consensus 135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 135 ANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred HHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999876543211 111123456789999999888888999999999999999999999987
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+......... .......+..++..+.++|.+||+.+|.+||++.++++
T Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 215 CTQLQAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccHHHHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 66554443332 23344566788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=239.03 Aligned_cols=203 Identities=35% Similarity=0.605 Sum_probs=169.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++.+ ...++++||+.+++|.+++.... ...+++..+..++.+++.||.|||+.| ++|+||+|
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p 130 (260)
T cd05070 55 MKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRS 130 (260)
T ss_pred HHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCcc
Confidence 467899999999998854 56899999999999999987543 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||++++++.++|+|||.+........ ......+...|+|||...+..++.++|+||||++++++++ |..||...+..
T Consensus 131 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 131 ANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred ceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998865432211 1112223457999999988888999999999999999999 88899887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
+....+. .......+...+..+.+++.+|+..+|.+|||+.++.+.|++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 EVLEQVE-RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6665553 333445567789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=253.81 Aligned_cols=198 Identities=28% Similarity=0.466 Sum_probs=166.3
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+.+..|+||||+.+++|.+++.+.+ .+++..+..++.||+.||+|||++| ++|+||||+||+
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nil 128 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENIL 128 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeE
Confidence 79999999999999999999999999999999987643 4899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
++.++.++|+|||++..............++..|+|||++.+. .++.++|+||+|+++|+|++|..||...+..+....
T Consensus 129 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~ 208 (330)
T cd05586 129 LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208 (330)
T ss_pred ECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence 9999999999999886533322233345678899999998754 478899999999999999999999988877776665
Q ss_pred HhhCCccCCCC-CCCCHHHHHHHHHHcccCCCCCC----CHHHHHHHHHHhhc
Q 027225 164 VGFKGKRLEIP-RNVNPHVASIIEACWANEPWKRP----SFSTIMELLRPLIK 211 (226)
Q Consensus 164 ~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp----s~~~~l~~l~~~~~ 211 (226)
+.... ..++ ..+++++.++|.+||+.||.+|| ++.++++ +.++.
T Consensus 209 i~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~--h~~~~ 257 (330)
T cd05586 209 IAFGK--VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE--HPFFA 257 (330)
T ss_pred HHcCC--CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc--Ccccc
Confidence 54332 2233 35789999999999999999998 5777766 44443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=240.19 Aligned_cols=206 Identities=28% Similarity=0.516 Sum_probs=172.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++... ..++++|++++|+|.+++.... +.+++..+..++.|++.||.|||+.| ++|+||+|+
T Consensus 64 ~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~ 138 (279)
T cd05109 64 AGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAAR 138 (279)
T ss_pred HhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccc
Confidence 467899999999998754 5789999999999999997642 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccc--cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
||++++++.++|+|||++......... .........|++||...+..++.++|+||||+++|++++ |..||......
T Consensus 139 Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred eEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999988754322111 112233467999999988889999999999999999998 89999877766
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.....+. .......+...+.++.+++.+||..||.+||++.++++.|+++.+..
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 219 EIPDLLE-KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHH-CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 6555544 33344556778999999999999999999999999999999887665
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=255.81 Aligned_cols=204 Identities=26% Similarity=0.401 Sum_probs=167.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++.+.+++..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+.| |+||||||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp 129 (382)
T cd05625 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKP 129 (382)
T ss_pred HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 357899999999999999999999999999999999997643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-----------------------------------------------cccCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-----------------------------------------------LSSKSAA 113 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-----------------------------------------------~~~~~~~ 113 (226)
+||+++.++.++|+|||++....... .......
T Consensus 130 ~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (382)
T cd05625 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV 209 (382)
T ss_pred HHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 99999999999999999864211000 0001235
Q ss_pred CCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHccc
Q 027225 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAN 191 (226)
Q Consensus 114 ~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~ 191 (226)
+++.|+|||++.+..++.++|+||+||++|+|++|..||...+..+....+.........+ ..++++..++|.+|+ .
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 210 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-R 288 (382)
T ss_pred cCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-c
Confidence 7789999999998889999999999999999999999998877766555544333333333 467999999999987 5
Q ss_pred CCCCCCC---HHHHHHHHHHhhcC
Q 027225 192 EPWKRPS---FSTIMELLRPLIKS 212 (226)
Q Consensus 192 ~p~~Rps---~~~~l~~l~~~~~~ 212 (226)
+|.+|++ +.++++ +++++.
T Consensus 289 ~p~~R~~~~~~~ei~~--hp~f~~ 310 (382)
T cd05625 289 GPEDRLGKNGADEIKA--HPFFKT 310 (382)
T ss_pred CHhHcCCCCCHHHHhc--CCCcCC
Confidence 9999987 888876 444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=248.60 Aligned_cols=188 Identities=24% Similarity=0.494 Sum_probs=163.3
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+|++|+++++++.+.+..|+||||+++++|.+++...+ .+++.++..++.|++.||.|||++| ++|+||||+||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nil 133 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVM 133 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeE
Confidence 56888899999999999999999999999999997643 3899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.++.++|+|||++..............++..|+|||++.+..++.++|+||+|+++++|++|..||...+..+....+
T Consensus 134 l~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred ECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998865333222233455788999999999888899999999999999999999999988777666655
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF 199 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 199 (226)
. ......+..++.++.+++.+||+.+|.+|++.
T Consensus 214 ~--~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 214 M--EHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred H--hCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 3 33445677889999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=239.62 Aligned_cols=204 Identities=30% Similarity=0.572 Sum_probs=170.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+.+++|.+++.... +.+++.+++.++.|++.||.+||++| ++|+||+|
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p 134 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAA 134 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCh
Confidence 357899999999999999999999999999999999987643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc---ccCCC--CCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSA--AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~--~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~ 154 (226)
+||+++.++.++|+|||.+........ ..... .....|++||.+.+..++.++|+||+|++++++++ |..||..
T Consensus 135 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 135 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred heEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 999999999999999998764332111 01111 11346999999988888999999999999999886 9999988
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.+..+....+. .......+..++..+.+++.+||+.+|.+||+++++++.|+.+
T Consensus 215 ~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 215 MSNQDVINAIE-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 77666655553 3334445567889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=242.87 Aligned_cols=206 Identities=31% Similarity=0.521 Sum_probs=168.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++..++..++||||+.+++|..++.+.. ..+++..+..++.|++.+|.+||+.| ++|+||+|
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp 138 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKA 138 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCc
Confidence 357899999999999999999999999999999988876532 23899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.++|+|||.+..............++..|+|||.+. ...++.++|+||+|+++|+|++|..||...
T Consensus 139 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 999999999999999998765433322233445677899999985 334677899999999999999999999876
Q ss_pred CHHHHHHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 156 NPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 156 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+..+........ ......+..++.++.++|.+||+.+|.+||+++++++ .+++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 274 (292)
T cd06644 219 NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE--HPFVSS 274 (292)
T ss_pred cHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc--Cccccc
Confidence 655444333211 1222345678899999999999999999999999998 666654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=250.25 Aligned_cols=193 Identities=25% Similarity=0.451 Sum_probs=162.1
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+.+..|+||||+++++|..++...+ .+++..+..++.||+.||+|||++| ++|+||||+||+
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nil 128 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVL 128 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence 69999999999999999999999999999999887643 3999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------CHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL------NPA 158 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~------~~~ 158 (226)
++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||... +..
T Consensus 129 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~ 208 (327)
T cd05617 129 LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE 208 (327)
T ss_pred EeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH
Confidence 99999999999998864332222233456788999999999888999999999999999999999999532 111
Q ss_pred -HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH------HHHHH
Q 027225 159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF------STIME 204 (226)
Q Consensus 159 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~~l~ 204 (226)
.....+ .......+..++..+.+++.+||+.||.+|+++ +++++
T Consensus 209 ~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 209 DYLFQVI--LEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred HHHHHHH--HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 222222 334455778899999999999999999999984 57665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=257.30 Aligned_cols=204 Identities=25% Similarity=0.361 Sum_probs=168.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++.+.+++..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp 129 (376)
T cd05598 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKP 129 (376)
T ss_pred HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCH
Confidence 357899999999999999999999999999999999998744 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc-------------------------------------------ccccCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT-------------------------------------------FLSSKSAAGTPE 117 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~-------------------------------------------~~~~~~~~~~~~ 117 (226)
+||+++.++.++|+|||++...... ........+++.
T Consensus 130 ~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred HHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 9999999999999999986421100 000112357889
Q ss_pred ccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCC--CCCCCHHHHHHHHHHcccCCCC
Q 027225 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWK 195 (226)
Q Consensus 118 ~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~ 195 (226)
|+|||++.+..++.++|+||+||++|+|++|..||...+..+....+......... ...+++++.++|.+|+ .+|.+
T Consensus 210 y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~ 288 (376)
T cd05598 210 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAED 288 (376)
T ss_pred ccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhh
Confidence 99999999988999999999999999999999999888776655544332222222 3468899999999987 59999
Q ss_pred CC---CHHHHHHHHHHhhcC
Q 027225 196 RP---SFSTIMELLRPLIKS 212 (226)
Q Consensus 196 Rp---s~~~~l~~l~~~~~~ 212 (226)
|+ ++.++++ +.+++.
T Consensus 289 R~~~~t~~ell~--h~~~~~ 306 (376)
T cd05598 289 RLGKNGADEIKA--HPFFKG 306 (376)
T ss_pred cCCCCCHHHHhC--CCCcCC
Confidence 99 8999998 555543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=237.51 Aligned_cols=202 Identities=33% Similarity=0.591 Sum_probs=169.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++.+....++|+||+.+++|.+++.... ..+++..+..++.+++.+|.+||+++ ++|+||+|
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p 121 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAA 121 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCc
Confidence 367899999999999999999999999999999999986532 24789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc--CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+.......... ........|+|||.+.+..++.++|+||||++++++++ |..||.....
T Consensus 122 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 122 RNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred ceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 99999999999999999886544221111 11222456999999988888999999999999999998 7889987776
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
......+.. ......+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 202 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 202 QQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 665555532 2344556778899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=253.55 Aligned_cols=198 Identities=23% Similarity=0.375 Sum_probs=165.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++.+++..|+||||+++|+|.+++.... +++..+..++.||+.||+|||++| ++||||||+
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~ 171 (371)
T cd05622 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPD 171 (371)
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHH
Confidence 46799999999999999999999999999999999997643 889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+++.++.++|+|||++....... .......+++.|+|||++.+.. ++.++|+||+||++|+|++|..||...+
T Consensus 172 NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred HEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 9999999999999999987543321 1223456788999999987543 6789999999999999999999999888
Q ss_pred HHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 027225 157 PAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWK--RPSFSTIMEL 205 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~ 205 (226)
.......+........++ ..++.++.++|.+||..++.+ |++++++++.
T Consensus 252 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 252 LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 776666654333333333 468999999999999844433 7899999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=246.89 Aligned_cols=211 Identities=27% Similarity=0.487 Sum_probs=174.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++..++..++|+||+++++|.+++.+.. +++.++..++.|++.+|.+||+.| ++|+||+|
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p 143 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKS 143 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 356899999999999999999999999999999999987533 789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++++|||.+..............++..|++||...+..++.++|+||+|++++++++|..||...+....
T Consensus 144 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~ 223 (297)
T cd06656 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (297)
T ss_pred HHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence 99999999999999999876543322222334567789999999888889999999999999999999999977655333
Q ss_pred HHHHhh-CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCC
Q 027225 161 VAAVGF-KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219 (226)
Q Consensus 161 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~ 219 (226)
...... .......+..++..+.+++.+||..+|.+||++.++++ .+++....+.+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~~~~~ 281 (297)
T cd06656 224 LYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSSL 281 (297)
T ss_pred eeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhccccccccc
Confidence 222211 11222345668899999999999999999999999999 7888766655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=246.52 Aligned_cols=210 Identities=33% Similarity=0.598 Sum_probs=175.3
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++ +||||+++++++.+++..++++||+.+++|.+++.+.. ....+++..+..++.|++.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 151 (334)
T cd05100 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA 151 (334)
T ss_pred HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 456 79999999999999999999999999999999987532 1234788899999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc--cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
++| ++|+||+|+||+++.++.++|+|||.++........ .....+...|+|||++.+..++.++|+||||+++++|
T Consensus 152 ~~g--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 229 (334)
T cd05100 152 SQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229 (334)
T ss_pred HCC--eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHH
Confidence 999 999999999999999999999999988654332111 1122233579999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
++ |..||...+..+....+. .......+...+.++.+++.+||..+|.+|||+.++++.|+++++...
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 230 FTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 98 888998877777666554 233344566788999999999999999999999999999999986554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=240.28 Aligned_cols=200 Identities=29% Similarity=0.560 Sum_probs=171.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+.+++|.+++.... ...+++.++..++.|++.|+.+||+.| ++|+||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~ 129 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKS 129 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCH
Confidence 467899999999999999999999999999999999987533 223789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++++|||.+..............++..|+|||...+...+.++|+||+|++++++++|..||...+..+.
T Consensus 130 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08218 130 QNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209 (256)
T ss_pred HHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence 99999999999999999886544432222334467789999999888888999999999999999999999988777666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+. .......+..++.++.++|.+||+.+|.+||++.++++
T Consensus 210 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 210 VLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHh-cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 55553 33444556788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=239.26 Aligned_cols=208 Identities=28% Similarity=0.533 Sum_probs=175.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.. ...++|+||+.+++|.+++.+... .+++..+..++.|++.||+|||+.| ++|+||+|
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p 137 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAA 137 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCc
Confidence 357899999999999987 789999999999999999976432 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc--CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+.......... ........|++||.+....++.++|+||+|++++++++ |..||.....
T Consensus 138 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 138 RNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred ceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 99999999999999999887543221111 11122357999999988888999999999999999998 9999988877
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.+....+. .......+...+..+.+++.+||..+|.+||++.++++.|.++.+..+
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 218 VEIPDLLE-KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 77666554 334445566788999999999999999999999999999999977643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=240.29 Aligned_cols=209 Identities=30% Similarity=0.536 Sum_probs=172.8
Q ss_pred CCCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCCCCC-----CcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVR-----EMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||+++++++.+ +...++++||+.+++|.+++...... ..+++..+..++.|++.||+|||+.+ ++
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~ 139 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VI 139 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--Ee
Confidence 357899999999998765 56799999999999999998754322 45899999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP 151 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p 151 (226)
|+||+|+||++++++.++++|||.++....... ......+...|+|||.+.+..++.++|+||+|++++++++ |..|
T Consensus 140 H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 219 (280)
T cd05043 140 HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219 (280)
T ss_pred ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCC
Confidence 999999999999999999999999865322111 1112234557999999988888999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
|...+..+...... .......+..+++++.+++.+||..+|++|||+.++++.|+.+.+.
T Consensus 220 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 220 YVEIDPFEMAAYLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 98877766655443 2333344556789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=243.05 Aligned_cols=197 Identities=30% Similarity=0.538 Sum_probs=167.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++..++..++|+||+++++|.+++... .+++..+..++.|++.|+.|||++| ++|+||+|
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p 129 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER--KIHRDIKA 129 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCCh
Confidence 35789999999999999999999999999999999998653 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++++.++++|||.+..............+...|+|||.+.+..++.++|+||+|++++++++|..|+........
T Consensus 130 ~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 209 (277)
T cd06642 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV 209 (277)
T ss_pred heEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence 99999999999999999886544332222233467789999999988889999999999999999999999977665554
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+. ...........+.++.++|.+||+.+|.+||++.++++
T Consensus 210 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 210 LFLIP-KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred Hhhhh-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 44332 22233445568899999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=252.56 Aligned_cols=206 Identities=23% Similarity=0.339 Sum_probs=162.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..+...++|+|++. ++|.+++.... .+++..++.++.|++.||.|||++| |+||||||
T Consensus 137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP 210 (391)
T PHA03212 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR--IIHRDIKA 210 (391)
T ss_pred HHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCh
Confidence 467899999999999999999999999995 68888887643 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--- 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--- 156 (226)
+||+++.++.++|+|||++....... .......+++.|+|||++.+..++.++|+||+||++|+|++|..|+...+
T Consensus 211 ~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 211 ENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred HhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 99999999999999999986433221 12234467889999999998889999999999999999999988763221
Q ss_pred ----H-HHHHHHHhhC-----------------------CccCCCC---------CCCCHHHHHHHHHHcccCCCCCCCH
Q 027225 157 ----P-AQVVAAVGFK-----------------------GKRLEIP---------RNVNPHVASIIEACWANEPWKRPSF 199 (226)
Q Consensus 157 ----~-~~~~~~~~~~-----------------------~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~ 199 (226)
. ......+... ......+ ..++.++.++|.+||+.||.+|||+
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence 0 0110000000 0000000 1346789999999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 027225 200 STIMELLRPLIKSPT 214 (226)
Q Consensus 200 ~~~l~~l~~~~~~~~ 214 (226)
+++++ .+++...+
T Consensus 371 ~elL~--hp~f~~~~ 383 (391)
T PHA03212 371 EALLD--FAAFQDIP 383 (391)
T ss_pred HHHhc--ChhhccCC
Confidence 99999 88887743
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=244.77 Aligned_cols=200 Identities=23% Similarity=0.337 Sum_probs=166.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp 130 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKP 130 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCH
Confidence 357899999999999999999999999999999998886543 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..||.+.+....
T Consensus 131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 131 ENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred HHEEECCCCCEEEeeCCCceecCCCC-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence 99999999999999999886543221 12234567899999999888889999999999999999999999987654332
Q ss_pred HHHH--hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAV--GFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
.... .........+..++..+.+++.+||..||.+|| +++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 2111 112333445667899999999999999999999 8889977
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=241.69 Aligned_cols=205 Identities=33% Similarity=0.572 Sum_probs=169.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------------CCcCCHHHHHHHHHHHHH
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------------REMLDERRRLNMAYDVAK 61 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------------~~~~~~~~~~~~~~~l~~ 61 (226)
+++++||||+++++++.+++..++|+||+.+++|.+++..... ...+++..++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 3568999999999999999999999999999999999864211 123778889999999999
Q ss_pred HHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHH
Q 027225 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139 (226)
Q Consensus 62 ~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 139 (226)
||.+||+++ ++|+||+|+||+++.++.++|+|||.+....... ...........|+|||.+.+..++.++|+||||
T Consensus 142 aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 219 (288)
T cd05050 142 GMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYG 219 (288)
T ss_pred HHHHHHhCC--eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHH
Confidence 999999999 9999999999999999999999999876432211 111122334569999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 140 VILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 140 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
+++++|++ |..||...+..+....+. .......+...+.++.+++.+||+.+|.+|||+.|+++.|++
T Consensus 220 ~il~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 220 VVLWEIFSYGMQPYYGMAHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 99999997 888998777766665554 333344566788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=240.32 Aligned_cols=200 Identities=34% Similarity=0.549 Sum_probs=166.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++++||+.+++|.+++.... ..+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p 129 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKG 129 (262)
T ss_pred HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCh
Confidence 467899999999999999999999999999999999987641 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||++++++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|..||...+.
T Consensus 130 ~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 130 ANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred hhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999886544332223334567789999998776 788899999999999999999999987766
Q ss_pred HHHHHHHhhCCc---cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGK---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+.......... .......++.++.+++.+||..+|.+|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 210 MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 554443332211 11223456789999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=243.09 Aligned_cols=201 Identities=31% Similarity=0.496 Sum_probs=162.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++|+||+++++|.+++.+.+ .+++..+..++.|++.|+.|||+.| ++|+||+|
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p 134 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKG 134 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCH
Confidence 357899999999999999999999999999999999987643 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+..............++..|+|||.+. ...++.++|+||+|+++++|++|..||...+.
T Consensus 135 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 135 ANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred HHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 999999999999999999875543322223345677899999874 33467899999999999999999999865544
Q ss_pred HHHHHHHhhCC---ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 158 AQVVAAVGFKG---KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
.+......... ........++.++.+++.+||+.+|.+|||++++++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 215 MRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred hhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 33222211111 11122245789999999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=242.20 Aligned_cols=206 Identities=27% Similarity=0.511 Sum_probs=173.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++...+..++|+||+.+++|.+++... .+++..+..++.|++.|+.+||++| ++|+||+|+
T Consensus 71 ~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~ 144 (285)
T cd06648 71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSD 144 (285)
T ss_pred HHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChh
Confidence 5679999999999999999999999999999999998762 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|+|||...+..++.++|+||+|++++++++|..||...+..+..
T Consensus 145 Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~ 224 (285)
T cd06648 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224 (285)
T ss_pred hEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 99999999999999998764433222223345677899999998888899999999999999999999999877766655
Q ss_pred HHHhhCCc-cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 162 AAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 162 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
..+..... ....+..++..+.+++.+||+.+|++||++.++++ .++++...+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~~ 277 (285)
T cd06648 225 KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGP 277 (285)
T ss_pred HHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc--CcccccCCC
Confidence 55443221 12223347899999999999999999999999998 788877554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=245.68 Aligned_cols=208 Identities=25% Similarity=0.398 Sum_probs=170.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++.+.+.+..|+|+||+.+++|.+++.+.. ...+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 131 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKP 131 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCh
Confidence 357889999999999999999999999999999999987543 345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-----------------------------ccCCCCCCCCccCcccccCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-----------------------------SSKSAAGTPEWMAPEVLRDEPSNE 131 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~PE~~~~~~~~~ 131 (226)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.
T Consensus 132 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 211 (316)
T cd05574 132 ENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS 211 (316)
T ss_pred HHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc
Confidence 999999999999999998754321110 111234567899999999888899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC----HHHHHHHHH
Q 027225 132 KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS----FSTIMELLR 207 (226)
Q Consensus 132 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~l~ 207 (226)
++|+||||+++|++++|..||...+.......+.............+.++.+++.+||..+|++||+ ++++++ .
T Consensus 212 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~--~ 289 (316)
T cd05574 212 AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ--H 289 (316)
T ss_pred hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc--C
Confidence 9999999999999999999998777665554443222222223347899999999999999999999 888888 5
Q ss_pred HhhcCC
Q 027225 208 PLIKSP 213 (226)
Q Consensus 208 ~~~~~~ 213 (226)
++++..
T Consensus 290 ~~~~~~ 295 (316)
T cd05574 290 PFFRGV 295 (316)
T ss_pred chhhcC
Confidence 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=240.76 Aligned_cols=198 Identities=30% Similarity=0.479 Sum_probs=162.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++...+..++|+||+++++|.+++...+ .+++.++..++.|++.||.|||+.| ++|+||+|+
T Consensus 61 ~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~ 135 (267)
T cd06645 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGA 135 (267)
T ss_pred HhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence 56799999999999999999999999999999999987644 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++.++.++|+|||.+..............++..|+|||.+. ...++.++|+||+|+++++|++|..||......
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 136 NILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred HEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 99999999999999998865543333334456778999999874 344788999999999999999999998665543
Q ss_pred HHHHHHhhCCccC---CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFKGKRL---EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
............. .....++..+.++|.+||+.+|++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 3322221111111 112357789999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=242.37 Aligned_cols=207 Identities=30% Similarity=0.539 Sum_probs=171.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++..++..++|+||+++++|.+++.+.+ ..+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p 131 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKA 131 (280)
T ss_pred HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCh
Confidence 367899999999999999999999999999999999987643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.++|+|||.+..............++..|++||.+. +..++.++|+||+|+++|+|++|..||...
T Consensus 132 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred hhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 999999999999999998765443333333445677899999875 334677899999999999999999999887
Q ss_pred CHHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 NPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+..+......... .....+..++.++.+++.+||+.+|.+||++.++++ .++++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~ 268 (280)
T cd06611 212 NPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK--HPFVSDQ 268 (280)
T ss_pred CHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc--Chhhccc
Confidence 7655544443221 223345678899999999999999999999999998 6776654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=241.70 Aligned_cols=201 Identities=27% Similarity=0.360 Sum_probs=161.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+. ++|.+++........+++..++.++.|++.||.|||+.| ++|+||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p 129 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKP 129 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCH
Confidence 357899999999999999999999999997 589888876443456899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|++++++++|+.||...+...
T Consensus 130 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~ 209 (285)
T cd07861 130 QNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID 209 (285)
T ss_pred HHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999999886543332222233456789999988654 46889999999999999999999997655433
Q ss_pred HHHHHhhCC---------------------------ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKG---------------------------KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
......... ........+++++.++|.+||+.||.+|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 210 QLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 221110000 000112357899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=241.23 Aligned_cols=198 Identities=29% Similarity=0.539 Sum_probs=168.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++.||||+++++++.+++..++|+||+.+++|.+++... .+++.++..++.|++.||.+||+.+ ++|+||+|
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p 129 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKA 129 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCCh
Confidence 35789999999999999999999999999999999998753 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++++|||.+..............++..|+|||.+.+...+.++|+||+|+++++|++|..||...+....
T Consensus 130 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 209 (277)
T cd06640 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV 209 (277)
T ss_pred hhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH
Confidence 99999999999999999886544332222334566789999999888889999999999999999999999987766555
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
...+. .......+..++..+.+++.+||+.+|.+||++.++++.
T Consensus 210 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 210 LFLIP-KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhh-cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 44432 233344556678999999999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=253.92 Aligned_cols=203 Identities=25% Similarity=0.380 Sum_probs=167.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++.+.+++..|+||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.| ++||||||+
T Consensus 56 ~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~ 130 (360)
T cd05627 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPD 130 (360)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHH
Confidence 56899999999999999999999999999999999997643 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-----------------------------------cccCCCCCCCCccCcccccC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-----------------------------------LSSKSAAGTPEWMAPEVLRD 126 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~PE~~~~ 126 (226)
||+++.++.++|+|||++....... .......+++.|+|||++.+
T Consensus 131 NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 210 (360)
T cd05627 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ 210 (360)
T ss_pred HEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC
Confidence 9999999999999999875432110 00112357889999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCC--CCCHHHHHHHHHHcccCCCCCCC---HHH
Q 027225 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWKRPS---FST 201 (226)
Q Consensus 127 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~ 201 (226)
..++.++|+||+||++|+|++|..||...+..+....+........++. .++.++.++|.+|+ .+|.+|++ +.+
T Consensus 211 ~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 289 (360)
T cd05627 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEE 289 (360)
T ss_pred CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHH
Confidence 8899999999999999999999999998887776665543333333333 47899999999987 49999985 677
Q ss_pred HHHHHHHhhcC
Q 027225 202 IMELLRPLIKS 212 (226)
Q Consensus 202 ~l~~l~~~~~~ 212 (226)
+++ +.++++
T Consensus 290 i~~--hp~f~~ 298 (360)
T cd05627 290 IKS--HPFFEG 298 (360)
T ss_pred Hhc--CCCCCC
Confidence 776 555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=238.26 Aligned_cols=200 Identities=30% Similarity=0.569 Sum_probs=168.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.++...|+++|++.+++|.+++...+ ..+++..+..++.|++.|+.+||+.+ ++|+||+|
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~ 127 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKA 127 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCc
Confidence 357799999999999999999999999999999999987533 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+....
T Consensus 128 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~ 207 (256)
T cd06612 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207 (256)
T ss_pred ceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh
Confidence 99999999999999999887654433223334467789999999888889999999999999999999999987665544
Q ss_pred HHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....... ......+..++.++.++|.+||+.+|.+|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 208 IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 4333211 1222334567889999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=247.11 Aligned_cols=208 Identities=29% Similarity=0.442 Sum_probs=182.0
Q ss_pred CCCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++ ||||+.+.+.|++....++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| ++|+|+|
T Consensus 89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlK 162 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLK 162 (382)
T ss_pred HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCC
Confidence 45677 999999999999999999999999999999999876 2999999999999999999999999 9999999
Q ss_pred CCcEEEcC----CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 80 SPNLLVDK----KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 80 p~nil~~~----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|+|+++.. ++.++++|||++..... ........|++.|+|||++....++..+|+||+|+++|.|++|..||...
T Consensus 163 pEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 163 PENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred HHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 99999953 34799999999987766 44566788999999999999999999999999999999999999999988
Q ss_pred CHHHHHHHHhhCCc--cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 156 NPAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 156 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
+..+....+..... ....+..++....++|++|+..||.+|+|+.++++ +.|+++....+
T Consensus 242 ~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--HpWi~~~~~~~ 303 (382)
T KOG0032|consen 242 TEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--HPWIKSIGEAT 303 (382)
T ss_pred ChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc--CccccCCcccc
Confidence 87776665544433 33445678999999999999999999999999999 68877753333
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=247.73 Aligned_cols=206 Identities=26% Similarity=0.389 Sum_probs=160.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++..++..++|+||+++++|.+++..+. .+.+++..+..++.|++.||.|||++| ++|+||||+
T Consensus 54 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~ 130 (327)
T cd08227 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKAS 130 (327)
T ss_pred HhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChh
Confidence 56899999999999999999999999999999999997543 234899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-------ccCCCCCCCCccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||+++.++.+++.||+.......... ......++..|+|||.+.+ ..++.++|+||+||+++++++|..||
T Consensus 131 Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 210 (327)
T cd08227 131 HILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210 (327)
T ss_pred hEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999975433221110 0112234567999999875 35789999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCcc--------------------------------------------CCCCCCCCHHHHHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKR--------------------------------------------LEIPRNVNPHVASIIEAC 188 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~li~~~ 188 (226)
.................. ......+++++.+++.+|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 290 (327)
T cd08227 211 KDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQC 290 (327)
T ss_pred CCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHH
Confidence 765443322221100000 001124577899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhcC
Q 027225 189 WANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 189 l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
|+.||.+|||+.++++ ..+++.
T Consensus 291 l~~dP~~Rpt~~ell~--~p~f~~ 312 (327)
T cd08227 291 LQRNPDARPSASTLLN--HSFFKQ 312 (327)
T ss_pred HhhCchhcCCHHHHhc--Chhhhh
Confidence 9999999999999998 555544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=239.57 Aligned_cols=205 Identities=29% Similarity=0.535 Sum_probs=170.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCC------CcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR------EMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++|+||+++++++.+.+..++|+||+++++|.+++...... ..+++..+..++.|++.||.|||+.| ++
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~ 139 (275)
T cd05046 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FV 139 (275)
T ss_pred HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cc
Confidence 46789999999999999999999999999999999999764421 15899999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCccccccc-ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPW 152 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~ 152 (226)
|+||+|+||+++.++.++++|||++...... ........++..|++||.+.+...+.++|+||||++++++++ |..||
T Consensus 140 H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 140 HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred cCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999987533221 111122233456999999888778899999999999999998 78899
Q ss_pred CCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
.....................+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 8776666666554444444456678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=239.25 Aligned_cols=204 Identities=27% Similarity=0.465 Sum_probs=173.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.++...++|+||+++++|.+++.+.. .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~ 121 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKP 121 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCH
Confidence 357899999999999999999999999999999999998743 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--PA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~ 158 (226)
+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|..||...+ ..
T Consensus 122 ~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 200 (262)
T cd05572 122 ENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200 (262)
T ss_pred HHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH
Confidence 99999999999999999887654332 2223456778999999988888999999999999999999999997766 44
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~~ 212 (226)
+....+.........+...+.++.+++.+||+.+|.+||+ ++++++ ..++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~--~~~~~~ 257 (262)
T cd05572 201 EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK--HKWFNG 257 (262)
T ss_pred HHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc--ChhhhC
Confidence 4444443334556667777999999999999999999999 888888 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=239.45 Aligned_cols=199 Identities=28% Similarity=0.480 Sum_probs=163.3
Q ss_pred CC-CCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 3 RL-RHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++ +||||+++++++... ...++|+||+.+++|.+++.... ...+++..+..++.|++.|+.|||+++ ++|
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh 134 (272)
T cd06637 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIH 134 (272)
T ss_pred HhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 44 799999999998653 45899999999999999988633 334889999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+||+|+||++++++.++|+|||++..............++..|+|||++. +..++.++|+||+|+++++|++|..
T Consensus 135 ~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 135 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred CCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999875443323333455677899999986 3346789999999999999999999
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
||........................++.++.+++.+||..+|.+|||+.++++
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 215 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 997766555444443333333344567899999999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=235.09 Aligned_cols=199 Identities=37% Similarity=0.682 Sum_probs=167.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.++ ..++|+||+.+++|.+++.... ...+++..+..++.|++.||.+||+.| ++||||+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p 128 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAA 128 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCc
Confidence 3578999999999998765 4799999999999999997644 334889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+....... ........|+|||.+.+..++.++|+||||+++++|++ |..||...+..+
T Consensus 129 ~nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 129 RNILVSEDGVAKVSDFGLARVGSMGV---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ceEEEcCCCcEEECCCccceeccccC---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 99999999999999999886543221 12223457999999988888999999999999999997 999998877766
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
....+. .......+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 206 VKECVE-KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 655553 23344456678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=238.17 Aligned_cols=199 Identities=30% Similarity=0.523 Sum_probs=167.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++.+.+..++++||+.+++|.+++.+.+ .+++..+..++.|++.||++||+.+ ++|+||+|
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p 130 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKG 130 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCH
Confidence 357899999999999999999999999999999999997643 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc------ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||+++.++.++|+|||.+...... ........++..|+|||.+.+..++.++|+||+|++++++++|..||..
T Consensus 131 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 131 NNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred HhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 9999999999999999987653211 1111233467789999999988889999999999999999999999987
Q ss_pred CCHHHHHHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 155 LNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 155 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+.......+... ......+..++.++.++|.+||..+|.+||++.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 211 MDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 6654443333222 2334566778999999999999999999999999987
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=240.19 Aligned_cols=205 Identities=33% Similarity=0.530 Sum_probs=165.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--------CCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++|+||+++++++..++..++|+||+.+++|.+++.+... ...+++.++..++.|++.||++||+.|
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-- 150 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-- 150 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3578999999999999999999999999999999999876321 124778899999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh--C
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT--L 148 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~--g 148 (226)
++|+||+|+||+++.++.++|+|||.+....... ...........|++||...+..++.++|+||+|+++|+|++ |
T Consensus 151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence 9999999999999999999999999886543221 11112223467999998888788999999999999999998 6
Q ss_pred CCCCCCCCHHHHHHHHhh------CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 149 QQPWGNLNPAQVVAAVGF------KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
..||...+..+....... .......+..+++.+.+++.+||+.||.+||++.++.+.|+
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 788877665554432211 11122334567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=241.46 Aligned_cols=194 Identities=28% Similarity=0.495 Sum_probs=168.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++|+||+++++|.+++...+ .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p 129 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKP 129 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCH
Confidence 457899999999999999999999999999999999998743 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++...... .....+++.|++||.+.+...+.++|+||||+++++|++|..||...+..+.
T Consensus 130 ~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 206 (290)
T cd05580 130 ENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206 (290)
T ss_pred HHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999988765433 2334567789999999888888999999999999999999999988776555
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
...+. ......+..++..+.++|.+||..+|.+|+ +++++++
T Consensus 207 ~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 207 YEKIL--EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHh--cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 44442 344566778899999999999999999998 7888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=241.30 Aligned_cols=205 Identities=36% Similarity=0.572 Sum_probs=167.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--------CCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++||||+++++++..++..++++|++.+++|.+++.+... ...+++..++.++.|++.||.|||+.|
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-- 150 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-- 150 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 3678999999999999999999999999999999999876431 124899999999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh--C
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT--L 148 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~--g 148 (226)
++|+||+|+||++++++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|++++ +
T Consensus 151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230 (296)
T ss_pred ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence 9999999999999999999999999886533221 11223334568999999988788999999999999999998 6
Q ss_pred CCCCCCCCHHHHHHHHhhC------CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 149 QQPWGNLNPAQVVAAVGFK------GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
..||...+..+........ ......+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 231 EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 7788776665554443322 1112234557789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=235.53 Aligned_cols=201 Identities=34% Similarity=0.628 Sum_probs=168.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++......++|+||+.+++|.+++.... ..++++.+..++.+++.++++||+.+ ++|+||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p 128 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAA 128 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccc
Confidence 467899999999999999999999999999999999987543 23789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+......... ......+..|+|||.+.+..++.++|+||+|++++++++ |..||......
T Consensus 129 ~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05112 129 RNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208 (256)
T ss_pred ceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999987654332111 112223457999999988888999999999999999998 89999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+....... ......+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 209 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 209 EVVETINA-GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHhC-CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 66665542 223334556789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=248.39 Aligned_cols=208 Identities=33% Similarity=0.555 Sum_probs=170.2
Q ss_pred CCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------------------------------
Q 027225 2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------------------------------------- 43 (226)
Q Consensus 2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------------------------------- 43 (226)
.++. ||||+++++++..++..++|+||+.+|+|.+++.+.+.
T Consensus 95 ~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (401)
T cd05107 95 SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES 174 (401)
T ss_pred HhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence 4565 99999999999999999999999999999999864321
Q ss_pred ----------------------------------------------------------CCcCCHHHHHHHHHHHHHHHHH
Q 027225 44 ----------------------------------------------------------REMLDERRRLNMAYDVAKGMNY 65 (226)
Q Consensus 44 ----------------------------------------------------------~~~~~~~~~~~~~~~l~~~l~~ 65 (226)
...+++..+..++.|++.||.|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 254 (401)
T cd05107 175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF 254 (401)
T ss_pred CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 1236777888999999999999
Q ss_pred HhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHH
Q 027225 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILW 143 (226)
Q Consensus 66 lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 143 (226)
||+.+ ++|+||+|+||++++++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|++++
T Consensus 255 LH~~~--ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (401)
T cd05107 255 LASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332 (401)
T ss_pred HhcCC--cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHH
Confidence 99999 9999999999999999999999999986532211 1112234456799999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 144 ELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 144 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+|++ |..||......+..............+..++.++.+++.+||..+|.+||++.+|++.|+.++.
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~~ 401 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLLT 401 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhC
Confidence 9998 8889977555444333322334455667789999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=235.36 Aligned_cols=201 Identities=39% Similarity=0.681 Sum_probs=170.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++++++.+.+..++++|++.+++|.+++..... ..+++..+..++.|++.||++||+.| ++|+||+|+
T Consensus 56 ~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~ 132 (258)
T smart00219 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAAR 132 (258)
T ss_pred HhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccc
Confidence 567999999999999999999999999999999999976431 22899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccC-CCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSK-SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+........... ...++..|++||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 133 NCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred eEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876543311111 2234578999999988888999999999999999998 788998877776
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
....... ......+..++.++.+++.+|++.+|.+|||+.++++.|
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 VLEYLKK-GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHhc-CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 6666543 334455667899999999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=235.12 Aligned_cols=203 Identities=31% Similarity=0.590 Sum_probs=169.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++.+ ...++++||+++++|.+++.... ...+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p 130 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRA 130 (260)
T ss_pred HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCc
Confidence 357899999999999987 77999999999999999997643 334788899999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+........ ......+...|+|||.+.+..++.++|+||||++++++++ |..||...+..
T Consensus 131 ~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 131 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred ceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998865432211 1112233457999999988888999999999999999998 89999887766
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
+....+. .......+...+.++.+++.+|+..+|.+||++.++.+.|+.
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 211 EVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHh-CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6655543 233334556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=236.13 Aligned_cols=195 Identities=23% Similarity=0.440 Sum_probs=158.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..+...++|+||+++++|..++.+.. ..+++..+..++.|++.||+|||+.| ++|+||+|
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp 133 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCT 133 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCc
Confidence 356899999999999999999999999999999999887543 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCc-------EEEccCCCcccccccccccCCCCCCCCccCccccc-CCCCCCchhHHHHHHHHHHHH-hCCCC
Q 027225 81 PNLLVDKKYT-------VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELA-TLQQP 151 (226)
Q Consensus 81 ~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~-~g~~p 151 (226)
+||+++.++. ++++|||.+...... ....++..|+|||.+. +..++.++|+||+|+++|+|+ +|..|
T Consensus 134 ~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (262)
T cd05077 134 KNILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209 (262)
T ss_pred ccEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999987664 899999987543321 2234566799999886 455788999999999999997 58888
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+......+..... ..........+.++.+++.+||+.||.+||++.++++.+
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 210 LKDKTLAEKERFY---EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCcchhHHHHHH---hcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 8766554443322 122223344568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=239.55 Aligned_cols=206 Identities=33% Similarity=0.544 Sum_probs=165.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC---------CCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------REMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
|++++|+||+++++++...+..++||||+.+++|.+++..... ...+++..+..++.|++.||.|||+.|
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 4678999999999999999999999999999999999865321 123688899999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh--
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-- 147 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-- 147 (226)
++|+||+|+||+++.++.++|+|||.+....... .......+...|+|||...+..++.++|+||||+++++|++
T Consensus 150 -i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 150 -FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred -eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999886533221 11122233567999999988889999999999999999988
Q ss_pred CCCCCCCCCHHHHHHHHhh------CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 148 LQQPWGNLNPAQVVAAVGF------KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
+..||...+..+....... .......+...+..+.+++.+|++.+|.+|||+.++++.|++
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 5678877665554433221 111123345678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=236.85 Aligned_cols=202 Identities=28% Similarity=0.489 Sum_probs=160.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+.++||||+++++.+.+....++|+||+.+|+|.+++..... ....++..+..++.|++.||+|||++| ++|+|||
T Consensus 50 ~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlk 127 (269)
T cd05042 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLA 127 (269)
T ss_pred HhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--Eeccccc
Confidence 567999999999999999999999999999999999976432 233567888899999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccC-------CCCCCchhHHHHHHHHHHHHh-CC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELAT-LQ 149 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~-g~ 149 (226)
|+||+++.++.++|+|||.+....... ........+..|+|||++.. ...+.++|+||+|+++++|++ |.
T Consensus 128 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~ 207 (269)
T cd05042 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD 207 (269)
T ss_pred HhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999875432211 11122334567999998743 345789999999999999999 78
Q ss_pred CCCCCCCHHHHHHHHhhCC----ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 150 QPWGNLNPAQVVAAVGFKG----KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
.||......+......... .....+..++..+.+++..|+ .||.+|||+++|++.|
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 208 QPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 8888776655444332221 122334568899999999999 5999999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=255.74 Aligned_cols=201 Identities=27% Similarity=0.476 Sum_probs=168.8
Q ss_pred CCCCCcCcceeeeEEecCC--------ceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
..++|+||+++.+.+...+ ..++|+||+.+|+|.+++..+. ....+++..+..++.|++.||.|||+.|
T Consensus 86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-- 163 (496)
T PTZ00283 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-- 163 (496)
T ss_pred hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5678999999988775432 2689999999999999987532 2345899999999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
++||||||+||+++.++.++|+|||+++..... ........+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 164 IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~ 243 (496)
T PTZ00283 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243 (496)
T ss_pred EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999998654322 112234567889999999999889999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
||...+..+...... .......+..+++++.+++.+||+.+|.+||++.++++.
T Consensus 244 Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 244 PFDGENMEEVMHKTL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 999887776665553 333445677899999999999999999999999999863
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=242.33 Aligned_cols=206 Identities=24% Similarity=0.379 Sum_probs=165.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++|+||+. ++|.+++.+.+ ..+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp 132 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKP 132 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCH
Confidence 357899999999999999999999999997 58988887643 23889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|+.||...+..+
T Consensus 133 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 133 QNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred HHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999886543332222334457789999998654 46789999999999999999999998776654
Q ss_pred HHHHHhhCCc-----------------cC-----------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 VVAAVGFKGK-----------------RL-----------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ~~~~~~~~~~-----------------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
....+..... .. .....+++.+.++|.+||+.||.+|||+.++++ .++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~--h~~f~ 290 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK--HPYFH 290 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc--Ccccc
Confidence 4332211100 00 012357889999999999999999999999998 55554
Q ss_pred CC
Q 027225 212 SP 213 (226)
Q Consensus 212 ~~ 213 (226)
..
T Consensus 291 ~~ 292 (301)
T cd07873 291 CL 292 (301)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=238.63 Aligned_cols=205 Identities=32% Similarity=0.548 Sum_probs=164.0
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++.+++.+. ...++|+||+++++|.+++.+.. ..+++..+..++.|++.||.+||++| ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dl 135 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDL 135 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 4678999999999999775 56899999999999999987543 23899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+........ ......+...|+|||.+.+..++.++|+||||++++++++++.|....
T Consensus 136 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~ 215 (284)
T cd05079 136 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSP 215 (284)
T ss_pred chheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccc
Confidence 99999999999999999998865432211 112334456799999998888899999999999999999987654221
Q ss_pred ---------------CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 156 ---------------NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 156 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
......... ........+..++..+.+++.+||+.+|.+|||+.++++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 216 MTLFLKMIGPTHGQMTVTRLVRVL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred cchhhhhcccccccccHHHHHHHH-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 011111111 122334456678999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=240.59 Aligned_cols=216 Identities=22% Similarity=0.323 Sum_probs=172.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++.+++..++|+||+ +++|.+++.+.. ..+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p 130 (298)
T cd07841 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKP 130 (298)
T ss_pred HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCh
Confidence 35789999999999999999999999999 889999997643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+...............+..|+|||.+.+ ..++.++|+||+|++++++++|..+|...+..+
T Consensus 131 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~ 210 (298)
T cd07841 131 NNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210 (298)
T ss_pred hhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH
Confidence 9999999999999999998765443222233345668999998865 346889999999999999999988876655433
Q ss_pred HHHHHhhCCcc--------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 160 VVAAVGFKGKR--------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 160 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
....+...... .......+.++.++|.+||+.+|++|||+.++++ ..++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~ 288 (298)
T cd07841 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSND 288 (298)
T ss_pred HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCC
Confidence 32222110000 0011345788999999999999999999999999 8888886
Q ss_pred CCCCCCCCCC
Q 027225 214 TPQPSPTDMP 223 (226)
Q Consensus 214 ~~~~~~~~~~ 223 (226)
+-...+.+.|
T Consensus 289 ~~~~~~~~~~ 298 (298)
T cd07841 289 PAPTPPSQLP 298 (298)
T ss_pred CCCCCCCCCC
Confidence 6666555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=236.14 Aligned_cols=195 Identities=26% Similarity=0.428 Sum_probs=161.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++||||+.+|+|.+++...+. .+++..+..++.|++.||+|||+.| ++|+||+|
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp 128 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCA 128 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence 3578999999999999998999999999999999999976542 4889999999999999999999999 99999999
Q ss_pred CcEEEcCCCc--------EEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCC-C
Q 027225 81 PNLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQ-Q 150 (226)
Q Consensus 81 ~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~-~ 150 (226)
+||+++.++. ++++|||.+..... .....++..|+|||.+.+. .++.++|+||+|+++|++++|. .
T Consensus 129 ~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~ 204 (258)
T cd05078 129 KNVLLIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204 (258)
T ss_pred ceEEEecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999987664 68999998754332 1223456789999999864 4688999999999999999984 5
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
|+...+........ ......+...+.++.+++.+||+.+|.+|||++++++.|
T Consensus 205 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 205 PLSALDSQKKLQFY---EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ChhhccHHHHHHHH---HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 66655554433322 234456667788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=241.76 Aligned_cols=203 Identities=29% Similarity=0.500 Sum_probs=166.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~ 79 (226)
|++++||||+++++++.+++..++|+||+++++|.+++.+.+ .+++..+..++.|++.||.|||+ .+ ++|+||+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~ 127 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK--IMHRDVK 127 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCC
Confidence 357899999999999999999999999999999999998643 48999999999999999999997 68 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||+|++++++++|..||...+...
T Consensus 128 p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 205 (308)
T cd06615 128 PSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205 (308)
T ss_pred hHHEEEecCCcEEEccCCCcccccccc--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 999999999999999999876443221 223456778999999988888899999999999999999999987655444
Q ss_pred HHHHHhhCCc-----------------------------------cCCCC-CCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 160 VVAAVGFKGK-----------------------------------RLEIP-RNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 160 ~~~~~~~~~~-----------------------------------~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
.......... ....+ ..++.++.+++.+||..+|++|||+.+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3322221110 00111 23678899999999999999999999999
Q ss_pred HHHHHhhcC
Q 027225 204 ELLRPLIKS 212 (226)
Q Consensus 204 ~~l~~~~~~ 212 (226)
+ ..++..
T Consensus 286 ~--~~~~~~ 292 (308)
T cd06615 286 K--HPFIKR 292 (308)
T ss_pred c--Chhhhh
Confidence 9 666654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=236.25 Aligned_cols=195 Identities=25% Similarity=0.427 Sum_probs=159.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.++...++||||+++++|..++.+.. +.+++..+..++.|++.||+|||+.| ++|+||+|
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp 145 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCA 145 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCc
Confidence 367899999999999999999999999999999999986532 24889999999999999999999999 99999999
Q ss_pred CcEEEcCCC-------cEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHH-hCCCC
Q 027225 81 PNLLVDKKY-------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELA-TLQQP 151 (226)
Q Consensus 81 ~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~-~g~~p 151 (226)
+||++++.+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++++++ +|..|
T Consensus 146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 146 KNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred ccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999997643 4899999986543221 12345667999998865 45789999999999999985 68999
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
|......+...... .....+...++.+.++|.+||+.+|.+|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 222 LKERTPSEKERFYE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ccccChHHHHHHHH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 98766655443332 22234455678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=241.93 Aligned_cols=198 Identities=35% Similarity=0.558 Sum_probs=163.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.++...++|+|++.+++|.+++.. ...+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~ 127 (260)
T PF00069_consen 53 RRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPE 127 (260)
T ss_dssp HHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGG
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc--ccccccccc
Confidence 456899999999999999999999999999999999984 334899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.++|+|||.+..............++..|.|||.+. +...+.++|+||+|+++++|++|..||...+....
T Consensus 128 NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~ 207 (260)
T PF00069_consen 128 NILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ 207 (260)
T ss_dssp GEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 99999999999999999875433333344566788999999998 77789999999999999999999999988733222
Q ss_pred HH---HHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VA---AVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~---~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.. .......... .....+.++.+++.+||+.||++|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 208 LEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 2211111111 11223489999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=235.29 Aligned_cols=198 Identities=35% Similarity=0.590 Sum_probs=169.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++.+++..++++||+++++|.+++.+.+ .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~ 130 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKG 130 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 357899999999999999999999999999999999998643 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+....... ......++..|++||.+.... ++.++|+||+|++++++++|..||......+
T Consensus 131 ~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~ 209 (258)
T cd06632 131 ANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA 209 (258)
T ss_pred HHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH
Confidence 99999999999999999876543322 123345677899999987766 8899999999999999999999998776555
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..............+..+++.+.+++.+||+.+|.+||++.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 210 AVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 554444334455567788999999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=239.04 Aligned_cols=210 Identities=32% Similarity=0.575 Sum_probs=173.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++...+..++|+||+++++|.+++.... ..+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p 144 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKS 144 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCh
Confidence 357899999999999999999999999999999999998754 24999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............++..|++||.+.+..++.++|+||+|++++++++|..||...+....
T Consensus 145 ~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~ 224 (286)
T cd06614 145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224 (286)
T ss_pred hhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999876443332222233456789999999888889999999999999999999999987766554
Q ss_pred HHHHhhCCc-cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
...+..... ....+..++.++.++|.+||+.+|.+|||+.++++ ..+++.....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~~~ 279 (286)
T cd06614 225 LFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLKKACPK 279 (286)
T ss_pred HHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhhccCch
Confidence 444332221 22223348899999999999999999999999998 7777765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=278.14 Aligned_cols=198 Identities=31% Similarity=0.502 Sum_probs=175.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
..++|||+++++++=.+.+..+|.||||++|+|.+.++..+ ..++.....+..|++.|++|||++| |+||||||.
T Consensus 1289 E~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~a 1363 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPA 1363 (1509)
T ss_pred HhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCcc
Confidence 46899999999999999999999999999999999998744 2677777889999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc----cccCCCCCCCCccCcccccCC---CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
||+++.+|.+|++|||.+....... .......|++.|||||++.+. +...++||||||||+.||+||+.||..
T Consensus 1364 NI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1364 NILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred ceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 9999999999999999987654432 223456789999999999754 456789999999999999999999998
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+..-.+-+.--.+..+.+|..++++-+++|..||..||++|+++.|+++
T Consensus 1444 ~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1444 LDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 88777766666677788899999999999999999999999999999887
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=238.39 Aligned_cols=206 Identities=25% Similarity=0.377 Sum_probs=162.3
Q ss_pred CCCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|+.++|||||+++-+|... -...+|+||++. +|.+.++... .+..++.-.+.-+++||++||.|||+.| |+
T Consensus 71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--Ic 147 (364)
T KOG0658|consen 71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--IC 147 (364)
T ss_pred HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cc
Confidence 4678999999999888533 246789999965 9999988421 1233778888889999999999999999 99
Q ss_pred EeCCCCCcEEEcCC-CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCC
Q 027225 75 HRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 75 h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||||||+|+++|.+ |.+||+|||+|+....... +.....+..|+|||.+.+.. ++.+.|+||.||++.||+.|+..|
T Consensus 148 HRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF 226 (364)
T KOG0658|consen 148 HRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF 226 (364)
T ss_pred cCCCChheEEEcCCCCeEEeccCCcceeeccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence 99999999999865 8999999999987654433 35556677899999998765 889999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCccCC---------------------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKRLE---------------------------IPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+.+..+....+-...+.++ .....+++..+|+.++|+.+|.+|.++.+++.
T Consensus 227 pG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~- 305 (364)
T KOG0658|consen 227 PGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA- 305 (364)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc-
Confidence 87665444332221111110 22457899999999999999999999999996
Q ss_pred HHHhhcC
Q 027225 206 LRPLIKS 212 (226)
Q Consensus 206 l~~~~~~ 212 (226)
++++..
T Consensus 306 -h~fFde 311 (364)
T KOG0658|consen 306 -HPFFDE 311 (364)
T ss_pred -chhhHH
Confidence 444433
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=239.07 Aligned_cols=206 Identities=30% Similarity=0.561 Sum_probs=171.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++... ..++++||+++|+|.+++..... .+++..+..++.|++.||.|||++| ++|+||+|+
T Consensus 64 ~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~ 138 (303)
T cd05110 64 ASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAAR 138 (303)
T ss_pred HhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccc
Confidence 578999999999998754 47899999999999999876432 3889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
||+++.++.++|+|||.+........ ......++..|++||.+.+..++.++|+||||++++++++ |..||.+....
T Consensus 139 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~ 218 (303)
T cd05110 139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218 (303)
T ss_pred eeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998875432211 1222334567999999988888999999999999999997 89999877665
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+...... .......+...+..+.+++.+|+..+|.+||++.++++.|+++.+..
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 219 EIPDLLE-KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 5555443 33344455667899999999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=240.73 Aligned_cols=204 Identities=26% Similarity=0.492 Sum_probs=170.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++..++..++|+||+++++|.+++... .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p 145 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKS 145 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 35689999999999999999999999999999999988653 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+..+.
T Consensus 146 ~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 225 (297)
T cd06659 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 225 (297)
T ss_pred HHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999876543332223344567889999999888889999999999999999999999987766555
Q ss_pred HHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
...+.... ........++..+.++|.+||+.+|.+||++.++++ ..++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~~~ 276 (297)
T cd06659 226 MKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLLQ 276 (297)
T ss_pred HHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh--Chhhcc
Confidence 44443221 122234567889999999999999999999999999 455544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=246.10 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=156.6
Q ss_pred CCCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
+++++||||+++++++...+ ..|+|+||+.+ +|.+.+.. .+++..+..++.|++.||.|||++| ++
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--iv 145 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--II 145 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 35789999999999986543 47999999975 66666543 2788999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
||||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 146 HrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred cCCCCHHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999988653322 112334567889999999998899999999999999999999999987
Q ss_pred CCHHHHHHHHhhC--------------------CccC--------------------CCCCCCCHHHHHHHHHHcccCCC
Q 027225 155 LNPAQVVAAVGFK--------------------GKRL--------------------EIPRNVNPHVASIIEACWANEPW 194 (226)
Q Consensus 155 ~~~~~~~~~~~~~--------------------~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~ 194 (226)
.+........... .... ......+++++++|.+||..||+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 304 (359)
T cd07876 225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304 (359)
T ss_pred CCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence 6543322111000 0000 01123467899999999999999
Q ss_pred CCCCHHHHHHHHHHhhc
Q 027225 195 KRPSFSTIMELLRPLIK 211 (226)
Q Consensus 195 ~Rps~~~~l~~l~~~~~ 211 (226)
+|||+.|+++ +.+++
T Consensus 305 ~R~t~~e~l~--hp~~~ 319 (359)
T cd07876 305 KRISVDEALR--HPYIT 319 (359)
T ss_pred cCCCHHHHhc--Cchhh
Confidence 9999999998 55543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=234.78 Aligned_cols=202 Identities=27% Similarity=0.467 Sum_probs=168.5
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCC
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS 80 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p 80 (226)
+++||||+++++++.+++..++|+||+.+++|.+++... .....+++..++.++.|++.+|.+||+ .+ ++|+||+|
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~ 142 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTP 142 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCH
Confidence 478999999999999999999999999999999987531 113358999999999999999999996 78 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+....... ......++..|++||...+..++.++|+||+|++++++++|..||...+....
T Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~ 221 (269)
T cd08528 143 NNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221 (269)
T ss_pred HHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence 99999999999999999886544332 22344567789999999988889999999999999999999999987766555
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
................+++++.+++.+||+.||.+||++.++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 54443222222223367899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=233.18 Aligned_cols=209 Identities=25% Similarity=0.356 Sum_probs=169.9
Q ss_pred CCCCCCcC-cceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPN-IVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVR-EMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++|+| |+.++|++...+ ..++|+||++. +|..++...... ...+...+..++.||+.||+|||+++
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-- 140 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-- 140 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 46789999 999999998776 79999999965 999999875422 34777899999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCC
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
|+||||||+||+++++|.+||+|||+++...-+.........+.+|+|||++.+. .++...|+||+||++++|++++..
T Consensus 141 IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 141 ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred eecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999998766555555566778899999999887 588999999999999999999999
Q ss_pred CCCCCHHHHHHHHhhCCccCC----------------C-----C-------CCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKRLE----------------I-----P-------RNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~----------------~-----~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
|.+....+....+-..-+.+. + + ...++...+++.+||+.+|.+|.|++.++
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 987766554443322211110 0 0 12335889999999999999999999999
Q ss_pred HHHHHhhcCCC
Q 027225 204 ELLRPLIKSPT 214 (226)
Q Consensus 204 ~~l~~~~~~~~ 214 (226)
. +..+...+
T Consensus 301 ~--h~yf~~~~ 309 (323)
T KOG0594|consen 301 T--HPYFSELP 309 (323)
T ss_pred c--Chhhcccc
Confidence 8 55555443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=233.86 Aligned_cols=203 Identities=26% Similarity=0.445 Sum_probs=160.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+.++||||+++++.+.+....++|+||+++++|.+++.+... ....+...+..++.|++.||+|||+.+ ++|+||+|
T Consensus 50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp 127 (268)
T cd05086 50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLAL 127 (268)
T ss_pred hccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCcc
Confidence 568999999999999999999999999999999999976432 234677788899999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccc--cccccCCCCCCCCccCcccccC-------CCCCCchhHHHHHHHHHHHHh-CCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELAT-LQQ 150 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~-g~~ 150 (226)
+||+++.++.++|+|||.+..... .........++..|+|||++.. ...+.++|+||+|+++++|++ |..
T Consensus 128 ~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 207 (268)
T cd05086 128 RNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQ 207 (268)
T ss_pred ceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCC
Confidence 999999999999999998753211 1112233455678999998753 234678999999999999997 466
Q ss_pred CCCCCCHHHHHHHHhhCC----ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFKG----KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
||...+..+......... .....+..+++.+.+++..|+ .+|.+||+++++++.|.
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 208 PYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 887766655444332121 223344568899999999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=233.99 Aligned_cols=199 Identities=33% Similarity=0.563 Sum_probs=168.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++.+..++..++|+||+++++|.+++.... ...+++..+..++.+++.++.+||++| ++|+||+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~ 129 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKT 129 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 467899999999999999999999999999999999997643 334899999999999999999999999 99999999
Q ss_pred CcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++ .++|+|||.+....... ......+...|+|||.+.+...+.++|+||+|++++++++|..||...+...
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 208 (256)
T cd08220 130 QNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208 (256)
T ss_pred HHEEEcCCCCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH
Confidence 999998654 57999999887554332 1223456678999999988888899999999999999999999998877666
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+. .......+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 209 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 209 LVLKIM-SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHH-hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 555443 23334556778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=235.77 Aligned_cols=203 Identities=31% Similarity=0.553 Sum_probs=171.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+.+++|.+++... .+++..+..++.+++.++.+||+.| ++|+||+|
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p 129 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKA 129 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCH
Confidence 35789999999999999999999999999999999998753 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++++|||.+..............++..|+|||.+.+...+.++|+||+|++++++++|..||...+....
T Consensus 130 ~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 209 (277)
T cd06641 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV 209 (277)
T ss_pred HhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH
Confidence 99999999999999999876543322222234566789999999888888999999999999999999999987766555
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
...+. .......+..++.++.+++.+||+.+|.+||++.++++ .+++..
T Consensus 210 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~--~~~~~~ 258 (277)
T cd06641 210 LFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFIVR 258 (277)
T ss_pred HHHHh-cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhh
Confidence 54442 23344456678999999999999999999999999999 555544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=247.43 Aligned_cols=204 Identities=24% Similarity=0.406 Sum_probs=163.2
Q ss_pred CCCCCCcCcceeeeEEecCC-----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|++++||||+++++++...+ ..|+|+||+. ++|.+++...+ .+++..+..++.|++.||.|||+.| ++|
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivH 126 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG--ILH 126 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeC
Confidence 35789999999999998776 7899999996 58888876533 4899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+.. ++.++|+||+||++++|++|+.||.
T Consensus 127 ~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred CCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999886543221 1122334577899999988743 6889999999999999999999998
Q ss_pred CCCHHHHHHHHhhCC-----------------------cc-------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 154 NLNPAQVVAAVGFKG-----------------------KR-------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~-----------------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
..+..+....+.... .. .......++++.++|.+||+.||.+|||+.+++
T Consensus 207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 776554433321110 00 012345688999999999999999999999999
Q ss_pred HHHHHhhcC
Q 027225 204 ELLRPLIKS 212 (226)
Q Consensus 204 ~~l~~~~~~ 212 (226)
+ +.++++
T Consensus 287 ~--hp~~~~ 293 (372)
T cd07853 287 A--HPYLDE 293 (372)
T ss_pred c--CHhhCC
Confidence 8 566554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=244.43 Aligned_cols=205 Identities=22% Similarity=0.338 Sum_probs=165.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++++++.++++.|+|+||+.+++|.+++.+.. ..+++..+..++.|++.||.|||++| ++||||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~ 131 (331)
T cd05597 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPD 131 (331)
T ss_pred HhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHH
Confidence 45789999999999999999999999999999999997532 23899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++.++|+|||.+........ ......+++.|+|||++.. ..++.++|+||+||++|+|++|+.||...
T Consensus 132 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 132 NVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred HEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 99999999999999998765433221 1223457889999999863 34678999999999999999999999887
Q ss_pred CHHHHHHHHhhCCccCCCC---CCCCHHHHHHHHHHcccCCCC--CCCHHHHHHHHHHhhcC
Q 027225 156 NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWK--RPSFSTIMELLRPLIKS 212 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~~ 212 (226)
+..+....+.........+ ..++.+++++|.+||..++++ |++++++++ ++++..
T Consensus 212 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~--hp~~~~ 271 (331)
T cd05597 212 SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD--HPFFEG 271 (331)
T ss_pred CHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--CCCCCC
Confidence 7666655554333222222 357899999999998654443 789999998 555543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=236.41 Aligned_cols=198 Identities=28% Similarity=0.406 Sum_probs=164.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++...+..|+|+||+++++|.+++.+.+ ...+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p 123 (277)
T cd05577 47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKP 123 (277)
T ss_pred HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCH
Confidence 467899999999999999999999999999999999987644 235899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP--- 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--- 157 (226)
+||++++++.++|+|||.+...... .......+...|++||.+.+..++.++|+||+|++++++++|..||...+.
T Consensus 124 ~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 202 (277)
T cd05577 124 ENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202 (277)
T ss_pred HHEEECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc
Confidence 9999999999999999987654321 122234456789999999888788999999999999999999999976543
Q ss_pred -HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 158 -AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 158 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
.+.... ........+..+++.+.++|.+||+.+|.+|| ++.++++
T Consensus 203 ~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 203 KEELKRR--TLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHhc--cccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 222211 12334455667899999999999999999999 7777876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=238.94 Aligned_cols=197 Identities=27% Similarity=0.467 Sum_probs=160.1
Q ss_pred CCcCcceeeeEEec------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 5 RHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 5 ~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+|+||+++++++.. ....+++|||+.+++|.+++.... ...+++..+..++.|++.|+.|||+.| ++|+||
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl 147 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK--VIHRDI 147 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCC
Confidence 69999999999853 456899999999999999997643 234788899999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
+|+||++++++.++|+|||.+..............++..|+|||.+. ...++.++|+||+|+++++|++|..||.
T Consensus 148 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 148 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred CHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 99999999999999999998765433222233445677899999875 3446788999999999999999999997
Q ss_pred CCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+...................++.++.++|.+||+.||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 228 DMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 766544443332222222234568899999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=235.04 Aligned_cols=201 Identities=31% Similarity=0.534 Sum_probs=170.0
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHh-----cCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLH-----RRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH-----~~~~~ 72 (226)
+++++||||+++++++.. +...++++||+++++|.+++.+.. ....+++..++.++.|++.||.+|| +.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-- 130 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-- 130 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--
Confidence 367899999999998754 455899999999999999987531 1345899999999999999999999 888
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
++|+||+|+||+++.++.++|+|||.+..............+...|+|||.+.+...+.++|+||+|++++++++|..||
T Consensus 131 i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 210 (265)
T cd08217 131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210 (265)
T ss_pred ceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999998876554433233445678899999998888899999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+..+....+. .......+..++..+.+++.+|++.+|.+||+++++++
T Consensus 211 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 211 TARNQLQLASKIK-EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cCcCHHHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 8877666555554 33344567788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=238.93 Aligned_cols=218 Identities=25% Similarity=0.316 Sum_probs=174.8
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++++|+||+++++++.+. +..++|+||+.+ +|.+++.... ..+++.++..++.|++.||++||+.| ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl 134 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDL 134 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence 3578999999999999765 468999999965 8888887532 34899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+|+||+++.++.++|+|||.+...............+..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.
T Consensus 135 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 135 KVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred CHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999988765433222223334667999999865 4478899999999999999999999987776
Q ss_pred HHHHHHHhhCCcc-----------------CCC-----------CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 158 AQVVAAVGFKGKR-----------------LEI-----------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 158 ~~~~~~~~~~~~~-----------------~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.+....+...... ... ....++++.++|.+||+.||++|||++++++ +++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~ 292 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSY 292 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--Chh
Confidence 6554433221100 000 1225788999999999999999999999999 899
Q ss_pred hcCCCCCCCCCCCCCC
Q 027225 210 IKSPTPQPSPTDMPLL 225 (226)
Q Consensus 210 ~~~~~~~~~~~~~~~~ 225 (226)
++..+..-.|..+|.+
T Consensus 293 f~~~~~~~~~~~~~~~ 308 (309)
T cd07845 293 FKEKPLPCEPEMMPTF 308 (309)
T ss_pred hccCCCCCCCCcCCCC
Confidence 9888777778777765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=235.68 Aligned_cols=198 Identities=31% Similarity=0.560 Sum_probs=165.0
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++.+. ...++++||+.+++|.+++.+.+ .+++..+..++.|++.||++||+.+ ++|+||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l 132 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM--IVHRDI 132 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCC
Confidence 3578999999999998753 56889999999999999997643 3889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|++++++++|+.||...
T Consensus 133 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 133 KGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred CHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 9999999999999999999876433211 1112234567899999998888899999999999999999999999877
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+..+..............+..+++.+.+++ +|+..+|.+||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 213 EAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred chHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 665555555444445566777889999999 577789999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=235.51 Aligned_cols=202 Identities=31% Similarity=0.478 Sum_probs=162.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++..++..++|+||+.+++|.+++.........++..+..++.|++.||+|||+.| ++|+||+|
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p 136 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKG 136 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCH
Confidence 3578999999999999999999999999999999999976421211378888999999999999999999 99999999
Q ss_pred CcEEEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++. ++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|++++++++|..||...+.
T Consensus 137 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred HHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999976 67899999998765433222223345677899999986543 67899999999999999999999976443
Q ss_pred HHH-HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQV-VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
... .............+..+++++.+++.+||+.+|.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 217 PQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 222 22222223344567778999999999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=233.40 Aligned_cols=194 Identities=26% Similarity=0.478 Sum_probs=159.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.. ...++|+||+.+++|.+++...+. .++...+..++.|++.||.|||++| ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp 129 (259)
T cd05037 55 MSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCG 129 (259)
T ss_pred HHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCcc
Confidence 467899999999999988 778999999999999999986442 4889999999999999999999999 99999999
Q ss_pred CcEEEcCCC-------cEEEccCCCcccccccccccCCCCCCCCccCcccccCC--CCCCchhHHHHHHHHHHHHh-CCC
Q 027225 81 PNLLVDKKY-------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELAT-LQQ 150 (226)
Q Consensus 81 ~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~-g~~ 150 (226)
+||+++.++ .++|+|||.+..... .....+...|+|||.+.+. .++.++|+||+|++++++++ |..
T Consensus 130 ~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~ 205 (259)
T cd05037 130 KNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205 (259)
T ss_pred ceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCC
Confidence 999999887 799999998865433 2233445679999998876 68899999999999999999 577
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
||...+..+...... .....+......+.+++.+||..+|.+|||+.++++.|
T Consensus 206 p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 206 PLSTLSSSEKERFYQ---DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CcccCCchhHHHHHh---cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 887765443333322 11222333348999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=234.08 Aligned_cols=202 Identities=28% Similarity=0.427 Sum_probs=166.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++.+|+||+++++++..++..|+|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||+|+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~ 126 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPE 126 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence 35689999999999999999999999999999999997643 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..... .....++..|++||.+.+..++.++|+||+|++++++++|..||...+..+..
T Consensus 127 nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 202 (260)
T cd05611 127 NLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202 (260)
T ss_pred HeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999998764332 22344667899999998887889999999999999999999999887776655
Q ss_pred HHHhhCCc--cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH-HHhhcC
Q 027225 162 AAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL-RPLIKS 212 (226)
Q Consensus 162 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l-~~~~~~ 212 (226)
........ .......+++++.+++.+||+.+|.+||++.++.+.+ +++++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 203 DNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 54432222 1223346789999999999999999999775444433 355543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=234.74 Aligned_cols=202 Identities=34% Similarity=0.567 Sum_probs=170.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p 80 (226)
++++|+||+++++++...+..++|+||+++++|.+++... ..+++..+..++.|++.|+.+||+ .| ++|+||+|
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~ 128 (264)
T cd06623 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKP 128 (264)
T ss_pred HhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCH
Confidence 4678999999999999999999999999999999999864 348999999999999999999999 99 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---H
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN---P 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~ 157 (226)
+||+++.++.++|+|||.+..............+...|+|||.+.+..++.++|+||||++++++++|..||...+ .
T Consensus 129 ~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~ 208 (264)
T cd06623 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208 (264)
T ss_pred HHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH
Confidence 9999999999999999988765433332223456778999999988888999999999999999999999997763 3
Q ss_pred HHHHHHHhhCCccCCCCCC-CCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 158 AQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
.+....+. .......+.. ++..+.++|.+||..+|++||++.++++ .++++
T Consensus 209 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--~~~~~ 260 (264)
T cd06623 209 FELMQAIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ--HPFIK 260 (264)
T ss_pred HHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CHHHH
Confidence 33343333 3333444555 8999999999999999999999999998 55554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=237.62 Aligned_cols=198 Identities=25% Similarity=0.322 Sum_probs=158.2
Q ss_pred CCCCCcCcceeeeEEec-----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++.. ....++|+|++.+ +|.+++.... ...+++..+..++.|++.||.|||+.| ++|+
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~ 132 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHR 132 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence 35689999999998864 2458999999975 8988887543 234899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+|+||+++.++.++|+|||.+....... ......++..|+|||++.+..++.++|+||+||++++|++|..||....
T Consensus 133 dikp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 133 DLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred CCCHHHEEECCCCCEEECccCccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 999999999999999999999886543221 1223456778999999988889999999999999999999999997765
Q ss_pred HHHHHHHHhhCCc---------c----------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PAQVVAAVGFKGK---------R----------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~~~~~~~~~~~~---------~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+....+..... . ......++..+.++|.+||+.||.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 212 EADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 5443322211000 0 0112356788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=238.63 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=166.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++.+.+++..++|+||+.+++|.+++...+ ...+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp 130 (285)
T cd05630 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKP 130 (285)
T ss_pred HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCH
Confidence 357899999999999999999999999999999999886543 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ- 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~- 159 (226)
+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||.......
T Consensus 131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~ 209 (285)
T cd05630 131 ENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209 (285)
T ss_pred HHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch
Confidence 99999999999999999876533221 1223456789999999998889999999999999999999999997643211
Q ss_pred --HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhc
Q 027225 160 --VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIK 211 (226)
Q Consensus 160 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~ 211 (226)
..... ........+..+++++.+++.+||+.||.+||| ++++++ +++++
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~--h~~~~ 265 (285)
T cd05630 210 REEVERL-VKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE--HPLFK 265 (285)
T ss_pred HHHHHhh-hhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc--Chhhh
Confidence 11111 111223456678999999999999999999999 889998 44444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=241.83 Aligned_cols=209 Identities=32% Similarity=0.576 Sum_probs=166.7
Q ss_pred CCC-CCcCcceeeeEEecC-CceEEEEeecccCCHHHHhcCCCC------------------------------------
Q 027225 2 KRL-RHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGV------------------------------------ 43 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~------------------------------------ 43 (226)
+++ +||||+++++++... ...++|+||+++|+|.+++.....
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred HhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 455 689999999988654 468999999999999999864210
Q ss_pred ----------------------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEcc
Q 027225 44 ----------------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCD 95 (226)
Q Consensus 44 ----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~d 95 (226)
...+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~d 222 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICD 222 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEe
Confidence 124678888999999999999999999 99999999999999999999999
Q ss_pred CCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCC
Q 027225 96 FGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLE 172 (226)
Q Consensus 96 f~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 172 (226)
||.+........ ......++..|+|||.+.+..++.++|+||+|++++++++ |..||......+.............
T Consensus 223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 302 (343)
T cd05103 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302 (343)
T ss_pred cccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC
Confidence 998865322211 1112233457999999988888999999999999999996 8899976543332222222334445
Q ss_pred CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 173 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+...++++.+++..||+.+|.+|||+.++++.|+.+++.
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 5666788999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=236.53 Aligned_cols=201 Identities=29% Similarity=0.502 Sum_probs=161.5
Q ss_pred CCC-CCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 2 KRL-RHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
+++ +|+||+++++++.+.. ..++|+||+.+++|.+++.... ....+++..+..++.|++.||.|||+.| +
T Consensus 57 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i 134 (275)
T cd06608 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--V 134 (275)
T ss_pred HHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--c
Confidence 345 7999999999997654 4899999999999999987522 1345899999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g 148 (226)
+|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.. ..++.++|+||+|++++++++|
T Consensus 135 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g 214 (275)
T cd06608 135 IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214 (275)
T ss_pred ccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence 99999999999999999999999988654433333334556778999998753 2357789999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 149 QQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..||...........+.... .....+..++.++.++|.+||..||.+|||+.++++
T Consensus 215 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99997665544443332221 122223457889999999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=236.79 Aligned_cols=202 Identities=34% Similarity=0.587 Sum_probs=166.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p 80 (226)
++++||||+++++++..++..++++||+.+++|.+++.... ..+++..+..++.|++.|+.+||+ .| ++|+||+|
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~ 129 (265)
T cd06605 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKP 129 (265)
T ss_pred HHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCH
Confidence 56789999999999999999999999999999999998642 348999999999999999999999 99 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN---- 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---- 156 (226)
+||+++.++.++|+|||.+......... ...++..|+|||...+..++.++|+||+|++++++++|..||...+
T Consensus 130 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 207 (265)
T cd06605 130 SNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207 (265)
T ss_pred HHEEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc
Confidence 9999999999999999987654332221 2556778999999988889999999999999999999999996542
Q ss_pred -HHHHHHHHhhCCccCCCCCC-CCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 157 -PAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..+...... .......+.. ++.++.++|.+||..+|++|||+.++++ +++++.
T Consensus 208 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--~~~~~~ 262 (265)
T cd06605 208 GIFELLQYIV-NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE--HPFIKK 262 (265)
T ss_pred cHHHHHHHHh-cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh--Cchhhc
Confidence 222222221 2223333444 8899999999999999999999999998 566543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=234.42 Aligned_cols=204 Identities=25% Similarity=0.386 Sum_probs=166.3
Q ss_pred CCCCCCcCcceeeeEEec-----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|+.++|+||+.+++++.- -+..|+|+|+++ -+|...++.+. .++.+.+..++.|++.||.|+|+.+ ++|
T Consensus 75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn--ViH 148 (359)
T KOG0660|consen 75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN--VIH 148 (359)
T ss_pred HHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc--ccc
Confidence 466899999999999864 245999999995 49999998754 3999999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||+||+|++++.+..+|++|||+++..... .........+.+|.|||++.. ..++.+.|+||+||++.+|++|+..|
T Consensus 149 RDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 149 RDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred cccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 999999999999999999999999876432 122334566889999999865 45889999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCccCC-----------------------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKRLE-----------------------------IPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
.+.+..+....+....+.+. .-...++...+|+.+||..||.+|+|++|++
T Consensus 229 pG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 229 PGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred CCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 87766555444332222111 1136789999999999999999999999999
Q ss_pred HHHHHhhcC
Q 027225 204 ELLRPLIKS 212 (226)
Q Consensus 204 ~~l~~~~~~ 212 (226)
+ +..+..
T Consensus 309 ~--hPYl~~ 315 (359)
T KOG0660|consen 309 A--HPYLAP 315 (359)
T ss_pred c--Chhhhh
Confidence 8 665544
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=237.28 Aligned_cols=208 Identities=28% Similarity=0.496 Sum_probs=168.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~ 79 (226)
|++++||||+++++++..++..++|+||+++++|.+++........+++..+..++.+++.||.|||+ .| ++|+||+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~ 130 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVK 130 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCC
Confidence 35689999999999999999999999999999999998764323358999999999999999999996 58 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC------CCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
|+||+++.++.++|+|||.+...... ......+...|+|||.+.+.. ++.++|+||+|++++++++|..||.
T Consensus 131 p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 131 PTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred HHHEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999987654322 122334567899999985543 4789999999999999999999997
Q ss_pred CCCHHHHHHHHh--hCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 154 NLNPAQVVAAVG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 154 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
............ ........+..++.++.++|.+||+.+|.+||++.++++ ..++....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~ 269 (286)
T cd06622 209 PETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYK 269 (286)
T ss_pred CcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--Chhhhhcc
Confidence 655444332221 123344566679999999999999999999999999998 56655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=261.18 Aligned_cols=212 Identities=25% Similarity=0.383 Sum_probs=169.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
++++||||+++++++.+++..++||||++|++|.+++.+... ....+...+..++.|++.||+|||+.| +
T Consensus 57 s~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--I 134 (932)
T PRK13184 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--V 134 (932)
T ss_pred HhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 578999999999999999999999999999999998864210 123566778899999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCccccccc------------------ccccCCCCCCCCccCcccccCCCCCCchhH
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDI 135 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv 135 (226)
+||||||+||+++.++.++++|||.+...... ........+++.|+|||.+.+..++.++|+
T Consensus 135 IHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI 214 (932)
T PRK13184 135 LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214 (932)
T ss_pred cccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH
Confidence 99999999999999999999999998654110 011122457889999999999889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCc-cCCCCCCCCHHHHHHHHHHcccCCCCC-CCHHHHHHHHHHhhcCC
Q 027225 136 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKR-PSFSTIMELLRPLIKSP 213 (226)
Q Consensus 136 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R-ps~~~~l~~l~~~~~~~ 213 (226)
||+||++++|++|..||...+............. .......+++.+.+++.+|+..||++| ++++++++.|++++...
T Consensus 215 WSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 215 YALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 9999999999999999987554443332211111 111234688999999999999999999 57888889999888765
Q ss_pred CC
Q 027225 214 TP 215 (226)
Q Consensus 214 ~~ 215 (226)
+.
T Consensus 295 p~ 296 (932)
T PRK13184 295 PE 296 (932)
T ss_pred cc
Confidence 43
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=238.70 Aligned_cols=208 Identities=28% Similarity=0.505 Sum_probs=170.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++...+..|+|+||+++++|.+++.+.. +++..+..++.|++.||.+||++| ++|+||+|
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p 143 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKS 143 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCH
Confidence 357899999999999999999999999999999999997643 789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............++..|++||.+.+..++.++|+||+|++++++++|..||...+..+.
T Consensus 144 ~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~ 223 (293)
T cd06647 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (293)
T ss_pred HHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 99999999999999999876443332222334566789999999888788999999999999999999999987665443
Q ss_pred HHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 161 VAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
....... ......+..++..+.++|.+||..+|.+||++.+++. +++++...+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~~~~~ 278 (293)
T cd06647 224 LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKPL 278 (293)
T ss_pred eeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhcCccc
Confidence 3222211 1122234457889999999999999999999999998 6777655433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=236.09 Aligned_cols=200 Identities=23% Similarity=0.327 Sum_probs=166.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++.+++..++..++|+||+.+++|.+++...+ ...+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp 130 (285)
T cd05632 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKP 130 (285)
T ss_pred HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCH
Confidence 357899999999999999999999999999999998886543 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..||........
T Consensus 131 ~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 131 ENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred HHEEECCCCCEEEecCCcceecCCCC-cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999876533221 12234567899999999888889999999999999999999999987655433
Q ss_pred HHHHh--hCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHH
Q 027225 161 VAAVG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIME 204 (226)
Q Consensus 161 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~ 204 (226)
..... ........+..++.++.+++.+||+.||.+||+ +.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 210 REEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 22221 122233456678899999999999999999999 778777
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=236.30 Aligned_cols=199 Identities=25% Similarity=0.415 Sum_probs=161.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++...+..++|+||+++++|..+..... .+++..+..++.|++.+|.|||+.| ++|+||+|
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p 128 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKP 128 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCh
Confidence 357899999999999999999999999999988888776533 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||++++++.++|+|||.+..............+...|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+..+
T Consensus 129 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~ 208 (286)
T cd07847 129 ENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208 (286)
T ss_pred hhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999999988765443222223345678999999876 446889999999999999999999998766544
Q ss_pred HHHHHhhCCc-------------------cCC----------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGK-------------------RLE----------IPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~-------------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+..... ... ....++..+.+++.+||+.+|++||++.+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 209 QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 3322211000 000 01346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=233.11 Aligned_cols=204 Identities=27% Similarity=0.439 Sum_probs=160.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++++||||+++++++.+....++|+||+++++|.+++..... ....++..+..++.|++.|++|||+.+ ++|+||
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl 126 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDL 126 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--Eecccc
Confidence 3578999999999999999999999999999999999875321 224667788889999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCC-------CCCCchhHHHHHHHHHHHHh-C
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDE-------PSNEKSDIYSFGVILWELAT-L 148 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~-------~~~~~~Dv~slG~~l~~l~~-g 148 (226)
||+||+++.++.++|+|||.+....... .......++..|+|||++.+. .++.++|+||+|++++++++ |
T Consensus 127 kp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g 206 (269)
T cd05087 127 ALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG 206 (269)
T ss_pred CcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCC
Confidence 9999999999999999999886433221 112223456679999998642 34779999999999999996 9
Q ss_pred CCCCCCCCHHHHHHHHhhCC----ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 149 QQPWGNLNPAQVVAAVGFKG----KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
..||...+..+......... .........+..+.+++.+|+ .+|.+|||+++|.+.|+
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 207 SQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 99998776655433221111 112223356788999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=235.48 Aligned_cols=204 Identities=35% Similarity=0.573 Sum_probs=160.8
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++.. ....++|+||+++++|.+++.+.. ..+++..+..++.|++.||.|||++| ++|+||
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dl 134 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDL 134 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccC
Confidence 457899999999998753 346899999999999999997532 23899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccc---cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+......... .........|+|||...+..++.++|+||+|+++++|++|..++...
T Consensus 135 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 135 ATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred CHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 999999999999999999988754332111 11122234599999998888899999999999999999987765432
Q ss_pred CHHH----------------HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 156 NPAQ----------------VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 156 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.... ..... ........+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 215 PAEFMRMMGNDKQGQMIVYHLIELL-KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chhhhhhcccccccccchHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2111 01111 11223344567889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=250.76 Aligned_cols=207 Identities=22% Similarity=0.319 Sum_probs=158.8
Q ss_pred CCCCCCcCcceeeeEEecC--------CceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
|++++||||+++++++... ...++||||+.+ +|.+++... .....+++..++.++.|++.||.|||+.|
T Consensus 113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~- 190 (440)
T PTZ00036 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF- 190 (440)
T ss_pred HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999999887432 246799999975 777766531 11335899999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCC
Q 027225 72 PIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 149 (226)
|+||||||+||+++.++ .+||+|||++....... ......+++.|+|||++.+. .++.++|+||+||++|+|++|.
T Consensus 191 -IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 191 -ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred -EecCCcCHHHEEEcCCCCceeeeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999998665 69999999987543321 12234567889999998764 5889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhhCCc---------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHH
Q 027225 150 QPWGNLNPAQVVAAVGFKGK---------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 202 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 202 (226)
.||.+.+..+....+..... ...++...+.++.+||.+||+.||.+|||+.++
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~ 348 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 99987665443322211100 011234577899999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 027225 203 MELLRPLIKSP 213 (226)
Q Consensus 203 l~~l~~~~~~~ 213 (226)
++ ++++...
T Consensus 349 l~--hp~f~~~ 357 (440)
T PTZ00036 349 LA--DPFFDDL 357 (440)
T ss_pred hC--ChhHHhh
Confidence 97 5665543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=234.09 Aligned_cols=201 Identities=28% Similarity=0.531 Sum_probs=166.7
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.|||++++++++.++...++|+||+.+++|.+++... .+++..+..++.|++.+|.+||+.| ++|+||+|+||+
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~ 133 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANIL 133 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEE
Confidence 5999999999999999999999999999999998753 3899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|..||...+.......
T Consensus 134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (277)
T cd06917 134 VTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213 (277)
T ss_pred EcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence 9999999999999886554433223334567789999988653 468899999999999999999999987766554433
Q ss_pred HhhCCccCCCCC-CCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 164 VGFKGKRLEIPR-NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 164 ~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.... .....+. .++.++.+++.+||+.||.+||++.++++ .++++...
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~~~ 262 (277)
T cd06917 214 IPKS-KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKAHS 262 (277)
T ss_pred cccC-CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhccc
Confidence 3211 2222333 37899999999999999999999999998 67776544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=233.73 Aligned_cols=200 Identities=31% Similarity=0.584 Sum_probs=169.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++.+.+.+..++|+||+.+++|.+++.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~ 129 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKS 129 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCH
Confidence 357899999999999999999999999999999999987643 234799999999999999999999999 99999999
Q ss_pred CcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||++++++ .++++|||.+..............++..|+|||...+..++.++|+||+|++++++++|..||...+..+
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred HHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 999998876 4699999988765443333333456778999999988888999999999999999999999998776655
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...... ...........+.++.+++.+|+..+|.+|||+.++++
T Consensus 210 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 210 LVLKIC-QGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHh-cccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 554433 33333455678899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=233.30 Aligned_cols=195 Identities=24% Similarity=0.474 Sum_probs=163.4
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++.+..++..++|+||+++++|.+++.... .++++++..++.|++.||.+||+.| ++|+||+|+||+
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil 141 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVL 141 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEE
Confidence 69999999999999999999999999999999998753 4899999999999999999999999 999999999999
Q ss_pred EcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--H
Q 027225 85 VDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV--V 161 (226)
Q Consensus 85 ~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~ 161 (226)
++.++ .++++|||.+...... ....++..|+|||.+.+..++.++|+||+|++++++++|..||........ .
T Consensus 142 ~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T PHA03390 142 YDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217 (267)
T ss_pred EeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence 99988 9999999987654332 223467789999999988889999999999999999999999975443221 1
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-HHHHHHHHHHhh
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-FSTIMELLRPLI 210 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~l~~l~~~~ 210 (226)
............+...++.+.++|.+||+.+|.+||+ ++++++ ++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~--h~~~ 265 (267)
T PHA03390 218 SLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK--HPFL 265 (267)
T ss_pred HHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc--CCcc
Confidence 1111123333455678999999999999999999995 699987 5554
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=241.27 Aligned_cols=200 Identities=22% Similarity=0.333 Sum_probs=164.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++++++.+++..++||||+.+|+|.+++.+.. ..+++..+..++.|++.||.+||+.| ++||||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~ 131 (332)
T cd05623 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPD 131 (332)
T ss_pred hhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence 46799999999999999999999999999999999997632 23899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 132 Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 132 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred HEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 9999999999999999876432221 12223467889999999862 34688999999999999999999999888
Q ss_pred CHHHHHHHHhhCCccCCCC---CCCCHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWK--RPSFSTIMEL 205 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~ 205 (226)
+..+....+.........+ ..+++++.+++.+|+..++.+ |++++++++.
T Consensus 212 ~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 212 SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 7777666654333333333 467999999999999665444 6899999883
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=234.95 Aligned_cols=200 Identities=30% Similarity=0.479 Sum_probs=161.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++...+..++|+||+++++|..+. .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 123 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKP 123 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCH
Confidence 35789999999999999999999999999999997652 2788889999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-- 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-- 158 (226)
+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||......
T Consensus 124 ~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 201 (279)
T cd06619 124 SNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201 (279)
T ss_pred HHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc
Confidence 9999999999999999988654332 123345677899999999888999999999999999999999998643211
Q ss_pred -----HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 -----QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+.................+++++.+++.+||+.+|.+||+++++++ ..++...
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~--~~~~~~~ 259 (279)
T cd06619 202 SLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD--HPFIVQY 259 (279)
T ss_pred ccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc--Ccccccc
Confidence 1111111111111123457889999999999999999999999998 5565543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=249.72 Aligned_cols=207 Identities=30% Similarity=0.565 Sum_probs=182.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|..++||+|+++++.|..++.+|++.|||.||....++-.-+ ..+++.++..++.|++.||.|||+++ |+|||||.
T Consensus 83 La~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKA 158 (1187)
T KOG0579|consen 83 LAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKA 158 (1187)
T ss_pred hhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccc
Confidence 467899999999999999999999999999999988876533 24999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
.||+++-+|.++|.|||.+............+.|+++|||||+.. ..+|+.++||||||+.+.+|..+.+|-...
T Consensus 159 GNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 159 GNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred cceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 999999999999999999987777766777889999999999875 456889999999999999999999999988
Q ss_pred CHHHHHHHHhh-CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 NPAQVVAAVGF-KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
++-.+...+.. ..+.+--|..++.++.+++++||..||..||++.++++ +.|+.+.
T Consensus 239 npMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~--Hpfv~~~ 295 (1187)
T KOG0579|consen 239 NPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK--HPFVQNA 295 (1187)
T ss_pred chHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh--CcccccC
Confidence 88777666543 23344457889999999999999999999999999998 6666643
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=233.29 Aligned_cols=198 Identities=32% Similarity=0.529 Sum_probs=164.0
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++++||||+++++++.+. ...++++||+++++|.+++.+.+ .+++..+..++.|++.||.+||+.+ ++|+||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl 132 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM--IVHRDI 132 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCC
Confidence 3578999999999998764 45889999999999999987643 3789999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+...+.++|+||||++++++++|..||...
T Consensus 133 ~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 133 KGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred CHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 9999999999999999999876433211 1122234667899999998888899999999999999999999999876
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+.................+..++..+.++|.+|+ .+|.+||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 213 EAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred chHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 6555544443333344556678889999999999 49999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=237.52 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=164.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++.+..++..++|+||++|++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p 129 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKP 129 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCch
Confidence 356899999999999999999999999999999999997643 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc---------------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF---------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|++++++
T Consensus 130 ~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el 209 (305)
T cd05609 130 DNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEF 209 (305)
T ss_pred HHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999875311100 001112356689999999888889999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 146 ATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 146 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
++|..||.+.+..+......... ........++.++.++|.+||+.+|.+||+..++.+.|+
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 210 LVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 99999998877766655543322 122223367899999999999999999999655555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=249.25 Aligned_cols=207 Identities=22% Similarity=0.310 Sum_probs=165.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..|+++|++. ++|.+++... ..+++..+..++.||+.||.|||+.| ++||||||
T Consensus 140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp 213 (392)
T PHA03207 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKT 213 (392)
T ss_pred HHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCH
Confidence 467899999999999999999999999995 5888888543 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||+||++|+|++|+.||...+..
T Consensus 214 ~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 214 ENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred HHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 999999999999999999865443221 122346788999999999888999999999999999999999998654321
Q ss_pred ----HHHHHHhh-----------------------CC-cc--CCC-----CCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 159 ----QVVAAVGF-----------------------KG-KR--LEI-----PRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 159 ----~~~~~~~~-----------------------~~-~~--~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
.....+.. .. .+ ... ...++.++.++|.+||..||.+|||+.+++
T Consensus 294 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l 373 (392)
T PHA03207 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373 (392)
T ss_pred CcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence 11111000 00 00 001 124567899999999999999999999999
Q ss_pred HHHHHhhcCCCC
Q 027225 204 ELLRPLIKSPTP 215 (226)
Q Consensus 204 ~~l~~~~~~~~~ 215 (226)
. ..++...+.
T Consensus 374 ~--~p~f~~~~~ 383 (392)
T PHA03207 374 S--LPLFTKEPI 383 (392)
T ss_pred h--Cchhhccch
Confidence 9 778776443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=236.22 Aligned_cols=206 Identities=25% Similarity=0.481 Sum_probs=171.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++++++..++..++|+||+++++|.+++... .+++..+..++.|++.++++||+.| ++|+||+|+
T Consensus 72 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~ 145 (292)
T cd06657 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSD 145 (292)
T ss_pred HhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence 5689999999999999999999999999999999988653 2789999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|++||.+.+..++.++|+||+|++++++++|..||...+..+..
T Consensus 146 Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~ 225 (292)
T cd06657 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225 (292)
T ss_pred HEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998765433222223345677899999998877889999999999999999999999877665544
Q ss_pred HHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 162 AAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
...... .........++..+.+++.+||+.+|.+||++.++++ ++++....+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~ 278 (292)
T cd06657 226 KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 278 (292)
T ss_pred HHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCC
Confidence 443221 1222233567899999999999999999999999999 777776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=239.20 Aligned_cols=209 Identities=27% Similarity=0.503 Sum_probs=184.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++|++.|++|++|+.+-....+|+|||||..||..++++.+ ++.+++.++..++..-+.||+|||... -+|||||.
T Consensus 82 MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKA 157 (502)
T KOG0574|consen 82 MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKA 157 (502)
T ss_pred HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhccc
Confidence 46899999999999888888899999999999999999864 456999999999999999999999998 88999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
.||+++.+|..||.|||.+.+..+.........|++.|+|||++..-+|..++|+||||+...+|..|++||.+.-+-..
T Consensus 158 GNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA 237 (502)
T KOG0574|consen 158 GNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA 237 (502)
T ss_pred ccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce
Confidence 99999999999999999999988887777788899999999999999999999999999999999999999988766554
Q ss_pred HHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+..+.... .....|..++.++.+++++||-.+|++|.|+.++++ +.++++.+.
T Consensus 238 IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~--H~FiknA~g 291 (502)
T KOG0574|consen 238 IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE--HTFIKNAPG 291 (502)
T ss_pred eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh--hhhhcCCCc
Confidence 44443222 233456789999999999999999999999999998 777776554
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=242.70 Aligned_cols=201 Identities=23% Similarity=0.375 Sum_probs=160.0
Q ss_pred CCCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||+++++++... ...|+++|++ +++|.+++... .+++..+..++.|++.||.|||++| ++
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--iv 140 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG--II 140 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 4678999999999988543 3478999988 77999888643 3899999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
|+||||+||+++.++.++|+|||++...... .....++..|+|||++.+ ..++.++|+||+|+++++|++|..||.
T Consensus 141 Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 141 HRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred cccCChhhEEECCCCCEEEcCCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999998754432 223456788999999876 457889999999999999999999997
Q ss_pred CCCHHHHHHHHhhCCcc---------------------C--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGKR---------------------L--------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+..+....+...... . ......++.+.++|.+||..||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 76544333222110000 0 011245677899999999999999999999998
Q ss_pred HHHHhhcCC
Q 027225 205 LLRPLIKSP 213 (226)
Q Consensus 205 ~l~~~~~~~ 213 (226)
+.++...
T Consensus 298 --hp~~~~~ 304 (343)
T cd07878 298 --HPYFSQY 304 (343)
T ss_pred --Ccchhcc
Confidence 6666543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=235.20 Aligned_cols=203 Identities=30% Similarity=0.496 Sum_probs=168.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++.+..++..|+++|++.+++|.+++.+.+ .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 48 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~ 122 (265)
T cd05579 48 SQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPD 122 (265)
T ss_pred HhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHH
Confidence 56789999999999999999999999999999999998744 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc--------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL--------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||+++.++.++|+|||++........ ......+...|++||...+...+.++|+||+|++++++++|..||.
T Consensus 123 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred HeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999998765332211 1223345678999999988888899999999999999999999998
Q ss_pred CCCHHHHHHHHhhCCccCCCCCC--CCHHHHHHHHHHcccCCCCCCCHHHHHHHH-HHhhc
Q 027225 154 NLNPAQVVAAVGFKGKRLEIPRN--VNPHVASIIEACWANEPWKRPSFSTIMELL-RPLIK 211 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~~l~~l-~~~~~ 211 (226)
..+..+....... .....+.. ++..+.+++.+||+.+|.+|||+.++.+.| .++++
T Consensus 203 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 203 GETPEEIFQNILN--GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred CCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 8887776665543 22233333 489999999999999999999994444443 44444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=260.38 Aligned_cols=215 Identities=35% Similarity=0.568 Sum_probs=186.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|+.++||||+++++++.+....++++||+.||+|..++++.. ....++..+.+.++.++++|..||++++ ++||
T Consensus 749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHR 826 (1025)
T KOG1095|consen 749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHR 826 (1025)
T ss_pred HhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCc
Confidence 578999999999999999999999999999999999998741 1234899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccccC--CCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWG 153 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~ 153 (226)
||-..|+|++....+|+.|||+++...+...... .......|||||.+....++.++||||||+++||+++ |..||.
T Consensus 827 DLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 827 DLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred chhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999985433322221 2233458999999999999999999999999999998 788999
Q ss_pred CCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
+.+..++.......+ ++..|..++..+.+++..||+.+|++||++..+++.+..+.....+...
T Consensus 907 ~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 907 SRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred CcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 999999888665444 8899999999999999999999999999999999999888776555443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=232.81 Aligned_cols=201 Identities=32% Similarity=0.517 Sum_probs=166.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++.+..++..++|+|++.+++|.+++.+......+++..+..++.|++.|+.+||+.| ++|+||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p 130 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKA 130 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 3578999999999999999999999999999999999976432345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc----cCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||++++++.++|+|||.+......... .....++..|++||.+... ..+.++|+||+|+++++|++|..||...
T Consensus 131 ~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 131 GNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred HhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 9999999999999999988654433221 1223466789999998776 6889999999999999999999999877
Q ss_pred CHHHHHHHHhhCCccCCCC-----CCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIP-----RNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+..+........ .....+ ..++..+.+++.+||..||.+|||+.++++
T Consensus 211 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 211 PPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 665544433222 111111 357899999999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=232.13 Aligned_cols=199 Identities=32% Similarity=0.578 Sum_probs=163.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++...+..++|+||+.+++|.+++...+ .+++..+..++.+++.|+.+||+.| ++|+||+|
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~ 127 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKP 127 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 357899999999999999999999999999999999998743 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc----CCCCCCCCccCcccccCCC---CCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS----KSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
+||+++.++.++|+|||.+.......... ....++..|++||.+.+.. .+.++|+||+|++++++++|..||.
T Consensus 128 ~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~ 207 (264)
T cd06626 128 ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207 (264)
T ss_pred HHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999886544332211 1245567899999998765 7889999999999999999999997
Q ss_pred CCCHHHHHHHHhhCCccCCCCC--CCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+.................+. .++..+.++|.+||+.+|.+|||+.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 208 ELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 6543332222222233333444 34899999999999999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=234.71 Aligned_cols=204 Identities=32% Similarity=0.577 Sum_probs=165.7
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++++||||+++++++.. +...++|+||+.+++|.+++..... .+++..+..++.|++.||++||+.| ++|+||
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl 135 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR--YIHRDL 135 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence 357899999999999987 5679999999999999999976432 4899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+........ ..........|++||...+..++.++|+||+|+++++|++|..|+...
T Consensus 136 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 136 AARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 99999999999999999998876542211 111223345699999998888899999999999999999999887543
Q ss_pred CHHH---------------HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 156 NPAQ---------------VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 156 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.... ...... .......+...+.++.+++.+||+.+|.+|||+.+++++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cchhccccccccccccHHHHHHHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2211 112221 2233344566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=231.72 Aligned_cols=199 Identities=33% Similarity=0.570 Sum_probs=163.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++...+..++|+||+.+++|.+++.+.+ .+++..+..++.|++.||.+||+.+ ++|+||+|
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~ 136 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKA 136 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCCh
Confidence 457899999999999999999999999999999999998753 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
+||+++.++.++++|||.+........ ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||...+
T Consensus 137 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 137 DNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred hhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 999999999999999998865432211 122334567899999987654 7889999999999999999999997665
Q ss_pred HHHHHHHHhhCCccCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PAQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+..............+ ..++.++.+++.+||..+|.+|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 544433332222222222 356899999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=242.74 Aligned_cols=199 Identities=27% Similarity=0.367 Sum_probs=157.8
Q ss_pred CCCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
++.++||||+++++++... ...|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++| ++
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--iv 148 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--II 148 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--ee
Confidence 3568999999999988543 357999999965 77777753 2788899999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
||||||+||+++.++.++|+|||.+....... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 149 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred cCCCCHHHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999987543321 12334567899999999998899999999999999999999999987
Q ss_pred CCHHHHHHHHhhCCc--------------------cC--------------------CCCCCCCHHHHHHHHHHcccCCC
Q 027225 155 LNPAQVVAAVGFKGK--------------------RL--------------------EIPRNVNPHVASIIEACWANEPW 194 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~--------------------~~--------------------~~~~~~~~~~~~li~~~l~~~p~ 194 (226)
.+..+....+..... .. ......+.+++++|.+||+.||.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 307 (364)
T cd07875 228 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307 (364)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence 665444332211000 00 00112356789999999999999
Q ss_pred CCCCHHHHHHHHHHhh
Q 027225 195 KRPSFSTIMELLRPLI 210 (226)
Q Consensus 195 ~Rps~~~~l~~l~~~~ 210 (226)
+|||+.++++ +.++
T Consensus 308 ~R~t~~e~L~--hp~~ 321 (364)
T cd07875 308 KRISVDEALQ--HPYI 321 (364)
T ss_pred cCCCHHHHhc--Cccc
Confidence 9999999998 4444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=236.55 Aligned_cols=199 Identities=24% Similarity=0.350 Sum_probs=156.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~ 127 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKP 127 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCH
Confidence 3568999999999999999999999999975 8888776432 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCC-CCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPW-GNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~-~~~~~~ 158 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|+++++|++|..|+ ...+..
T Consensus 128 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 128 QNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred HHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 999999999999999998875443322223345567899999987654 688999999999999999998885 333333
Q ss_pred HHHHHHhhCC---------------c---c---------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFKG---------------K---R---------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~~---------------~---~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+....+.... . . ......++.++.++|.+||+.||.+|||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 2222111000 0 0 0112346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=235.47 Aligned_cols=201 Identities=28% Similarity=0.450 Sum_probs=159.7
Q ss_pred CC-CCcCcceeeeEEe-----cCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 3 RL-RHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++ +||||+++++++. .++..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|
T Consensus 70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H 147 (286)
T cd06638 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIH 147 (286)
T ss_pred HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 45 6999999999874 345699999999999999987632 12345889999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+||+|+||+++.++.++|+|||.+..............++..|+|||.+.. ..++.++|+||+|+++++|++|..
T Consensus 148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred cCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 999999999999999999999988654432222233456788999998753 346789999999999999999999
Q ss_pred CCCCCCHHHHHHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
||...+........... ......+..++..+.+++.+||+.+|.+|||+.++++.
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 228 PLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 99776554333222111 11222345578899999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=240.57 Aligned_cols=199 Identities=21% Similarity=0.322 Sum_probs=163.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++++++.+++..|+||||+.||+|.+++.+.. ..+++..+..++.|++.||+|||++| ++|+||||+
T Consensus 56 ~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~ 131 (331)
T cd05624 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPD 131 (331)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchH
Confidence 45789999999999999999999999999999999997632 23899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++|+||+|+++|+|++|+.||...
T Consensus 132 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 132 NVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred HEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 99999999999999998865433221 1223457889999999875 34678999999999999999999999887
Q ss_pred CHHHHHHHHhhCCccCCCC---CCCCHHHHHHHHHHcccCCCC--CCCHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWK--RPSFSTIME 204 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~--Rps~~~~l~ 204 (226)
+..+....+.........+ ..++.++.+++.+|+..++.+ |++++++++
T Consensus 212 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 212 SLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 7766665554333333333 346899999999999866544 468888886
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=245.60 Aligned_cols=192 Identities=23% Similarity=0.355 Sum_probs=165.6
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
-+||||+++.+.+.++.+.|+|||.+.|+-+.+.+..... +. .++..|+.+|+.|+.|||.+| ++|||+||+||
T Consensus 373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NI 446 (612)
T KOG0603|consen 373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNI 446 (612)
T ss_pred cCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhhe
Confidence 3799999999999999999999999999988888776431 33 788889999999999999999 99999999999
Q ss_pred EE-cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Q 027225 84 LV-DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVV 161 (226)
Q Consensus 84 l~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~ 161 (226)
++ +..++++|+|||.++..... ....+-+..|.|||+.....+++++|+||||+++|+|++|+.||...... ++.
T Consensus 447 L~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~ 523 (612)
T KOG0603|consen 447 LLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH 523 (612)
T ss_pred eecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH
Confidence 99 68899999999998765544 34455677899999999888999999999999999999999999765544 333
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
..+ ...++...+|.+.++|+.+||+.||.+|+++.++.. +.|+
T Consensus 524 ~~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 524 TRI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred Hhh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 333 333444889999999999999999999999999999 7777
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=233.11 Aligned_cols=199 Identities=30% Similarity=0.557 Sum_probs=164.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++.+.+..++|+||+.+++|.+++.+.+ .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~ 131 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKG 131 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 356899999999999999999999999999999999997643 4889999999999999999999999 99999999
Q ss_pred CcEEEcCCC-cEEEccCCCccccccccc----ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKY-TVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~-~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++ .++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|++++++++|..||...
T Consensus 132 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred HHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999998775 599999998865443211 112234567899999998888899999999999999999999999654
Q ss_pred CHH---HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 156 NPA---QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 156 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+.. ...............+..+++++.+++.+||..+|.+||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 212 KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 432 2222222223344566678899999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=245.73 Aligned_cols=204 Identities=23% Similarity=0.345 Sum_probs=159.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++..++..++|+|++. ++|.+++.... ..+++..+..++.|++.||.|||++| |+|+||||
T Consensus 214 L~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP 288 (461)
T PHA03211 214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKT 288 (461)
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCH
Confidence 467899999999999999999999999995 68888886532 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL--- 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~--- 155 (226)
+||+++.++.++|+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++|..++...
T Consensus 289 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~ 368 (461)
T PHA03211 289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRG 368 (461)
T ss_pred HHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcc
Confidence 999999999999999999865432211 122345788999999999988999999999999999999987654211
Q ss_pred -----CHHHHHHHHhhCCcc-CCC-------------------------------CCCCCHHHHHHHHHHcccCCCCCCC
Q 027225 156 -----NPAQVVAAVGFKGKR-LEI-------------------------------PRNVNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 156 -----~~~~~~~~~~~~~~~-~~~-------------------------------~~~~~~~~~~li~~~l~~~p~~Rps 198 (226)
...++...+...... ..+ ...++.++.+||.+||+.||.+|||
T Consensus 369 ~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs 448 (461)
T PHA03211 369 DERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS 448 (461)
T ss_pred cccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC
Confidence 122222222211100 000 0134568999999999999999999
Q ss_pred HHHHHHHHHHhhc
Q 027225 199 FSTIMELLRPLIK 211 (226)
Q Consensus 199 ~~~~l~~l~~~~~ 211 (226)
+.|+++ ..+++
T Consensus 449 a~elL~--hp~f~ 459 (461)
T PHA03211 449 AAELLR--LPLFQ 459 (461)
T ss_pred HHHHhh--CcccC
Confidence 999998 55554
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=237.49 Aligned_cols=216 Identities=22% Similarity=0.301 Sum_probs=174.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++|+||+. ++|.+++.... .++++.+..++.|++.||++||+.| ++|+||+|
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~ 147 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSP 147 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 357899999999999999999999999996 59999987633 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--------------ccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--------------FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWEL 145 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--------------~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l 145 (226)
+||+++.++.++|+|||.+...... ........++..|+|||.+.+.. ++.++|+||+|+++++|
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999988654311 11111223466799999987643 68899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhhCCccC--------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCH
Q 027225 146 ATLQQPWGNLNPAQVVAAVGFKGKRL--------------------------EIPRNVNPHVASIIEACWANEPWKRPSF 199 (226)
Q Consensus 146 ~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~ 199 (226)
++|..||...+..+....+....... ......+.++.++|.+||+.+|.+|||+
T Consensus 228 ~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 307 (335)
T PTZ00024 228 LTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307 (335)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence 99999998877655443322110000 0113457889999999999999999999
Q ss_pred HHHHHHHHHhhcCCCCCCCCCCCCC
Q 027225 200 STIMELLRPLIKSPTPQPSPTDMPL 224 (226)
Q Consensus 200 ~~~l~~l~~~~~~~~~~~~~~~~~~ 224 (226)
++++. .++++..+.+..+.+.|+
T Consensus 308 ~~~l~--~~~~~~~~~~~~~~~~~~ 330 (335)
T PTZ00024 308 KEALK--HEYFKSDPLPCDPSQLPF 330 (335)
T ss_pred HHHhc--CcccCCCCCCCCcccCCh
Confidence 99999 899999888888777764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=246.80 Aligned_cols=213 Identities=35% Similarity=0.623 Sum_probs=178.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
||+-+|.||+-+.|+|..... .||+-+|+|-+|..++..... .+.....+.|+.|+++|..|||.++ |+|+|||.
T Consensus 442 lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKS 516 (678)
T KOG0193|consen 442 LKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKS 516 (678)
T ss_pred HhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccc
Confidence 467899999999999998876 999999999999999986543 3999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccc--cccccCCCCCCCCccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
.|||+.+++.|+|+|||++..... .........+...|+|||++.. ..++..+||||+|+++|||++|..||...
T Consensus 517 nNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 517 NNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred cceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence 999999999999999999864332 2233445667889999999864 35789999999999999999999999966
Q ss_pred CHHHHHHHHhhC---CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 156 NPAQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 156 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
+.++++..+... ......-...++++++|+..||..++++||.+.+|+..|+.++...++...
T Consensus 597 ~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 597 NRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred ChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 666665544333 222333456778999999999999999999999999999999886544433
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=234.06 Aligned_cols=200 Identities=30% Similarity=0.470 Sum_probs=160.6
Q ss_pred CC-CCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 3 RL-RHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++ +||||+++++++... +..++|+||+++++|.+++.... ....+++..++.++.|++.||++||+.| ++|
T Consensus 74 ~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH 151 (291)
T cd06639 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIH 151 (291)
T ss_pred HhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 44 799999999998643 35899999999999999886421 1335899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-----CCCCchhHHHHHHHHHHHHhCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+||+|+||+++.++.++|+|||.+..............++..|+|||.+... .++.++|+||+|+++++|++|+.
T Consensus 152 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 152 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred cCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 9999999999999999999999876544322222334567789999987643 25789999999999999999999
Q ss_pred CCCCCCHHHHHHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 151 PWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
||...+..+....+... ......+..++.++.++|.+||+.+|.+||++.++++
T Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 232 PLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99877665444433211 1222334567789999999999999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=233.51 Aligned_cols=200 Identities=22% Similarity=0.320 Sum_probs=159.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+. ++|.+++.... ...+++..+..++.|++.||+|||+.| ++|+||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p 128 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKP 128 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 367899999999999999999999999996 58988886543 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||||++++++++|..||...+...
T Consensus 129 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 129 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred HHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999999999998765433222222334567899999887644 5788999999999999999999997665433
Q ss_pred HHHHHhhCCcc---------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKR---------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
........... ......++.++.++|.+||+.||.+|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 22221100000 0112357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=232.64 Aligned_cols=193 Identities=25% Similarity=0.417 Sum_probs=160.9
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.+||||+.+++++..++..++||||+.+++|.+++..++ .+++..+..++.|++.||.|||+.| ++|+||+|+||
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Ni 128 (279)
T cd05633 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANI 128 (279)
T ss_pred CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHE
Confidence 479999999999999999999999999999999987643 4999999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HH
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPA--QV 160 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~ 160 (226)
+++.++.++|+|||.+....... .....++..|+|||.+.+ ..++.++|+||+|++++++++|..||...... ..
T Consensus 129 l~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 206 (279)
T cd05633 129 LLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (279)
T ss_pred EECCCCCEEEccCCcceeccccC--ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence 99999999999999886543321 223456789999999864 55788999999999999999999999654321 11
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
.... ........+..++.++.++|.+||..||.+|+ +++++++
T Consensus 207 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 207 IDRM-TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred HHHH-hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1111 12233456677899999999999999999999 6999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=227.20 Aligned_cols=198 Identities=33% Similarity=0.582 Sum_probs=166.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++..++..++++||+++++|.+++.... ..+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p 126 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKA 126 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCH
Confidence 357889999999999999999999999999999999998753 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+........ .....+...|++||.+.+...+.++|+||+|++++++++|..||...+....
T Consensus 127 ~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 205 (253)
T cd05122 127 ANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA 205 (253)
T ss_pred HHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 999999999999999998866544321 2344567789999999888888999999999999999999999988755444
Q ss_pred HHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...... ......+ ..++..+.++|.+||+.||.+|||+.++++
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 206 LFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 444332 2222222 334899999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=231.59 Aligned_cols=200 Identities=26% Similarity=0.421 Sum_probs=166.1
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
...||||+++++++.+++..++|+||+.|++|.+++.+.+ .+++..+..++.|++.|++|||+.+ ++|+||+|+|
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~n 127 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPAN 127 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHH
Confidence 3579999999999999999999999999999999987643 4999999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC---HH
Q 027225 83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLN---PA 158 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~ 158 (226)
|+++.++.++|+|||.+...... ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||.... ..
T Consensus 128 ili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~ 205 (278)
T cd05606 128 ILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205 (278)
T ss_pred EEECCCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH
Confidence 99999999999999987654322 12234577899999998754 57889999999999999999999997653 22
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~~ 213 (226)
...... .......+..++.++.+++.+||..+|.+|| ++.++++ ..+++..
T Consensus 206 ~~~~~~--~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--~~~~~~~ 261 (278)
T cd05606 206 EIDRMT--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--HPFFRSL 261 (278)
T ss_pred HHHHHh--hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh--CccccCC
Confidence 222211 2334556677899999999999999999999 9999997 5555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=233.57 Aligned_cols=196 Identities=24% Similarity=0.380 Sum_probs=166.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.++...++|+||+.+++|.+++.... .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~ 128 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKP 128 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence 367899999999999999999999999999999999998652 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP--- 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--- 157 (226)
+||++++++.++|+|||.+....... ......++..|+|||.+.+...+.++|+||+|++++++++|..||...+.
T Consensus 129 ~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 207 (258)
T cd05578 129 DNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR 207 (258)
T ss_pred HHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH
Confidence 99999999999999999876544321 22334566789999999888889999999999999999999999987663
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH--HHHHH
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF--STIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~~l~ 204 (226)
....... .......+..++..+.++|.+||+.+|.+||+. +++++
T Consensus 208 ~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 208 DQIRAKQ--ETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHh--ccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 3333222 224556677889999999999999999999999 66554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=227.54 Aligned_cols=197 Identities=32% Similarity=0.618 Sum_probs=170.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|||++++++++.+.+..++++|++++++|.+++.+.+ .+++..+..++.|++.+|.+||+.| ++|+||+|+
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ 128 (254)
T cd06627 54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAA 128 (254)
T ss_pred HhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHH
Confidence 57899999999999999999999999999999999998753 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|++||...+...+.++|+|++|++++++++|..||...+.....
T Consensus 129 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~ 208 (254)
T cd06627 129 NILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208 (254)
T ss_pred HEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 99999999999999998876554433333455677899999998877889999999999999999999999876654444
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.... .......+..++..+.+++.+||..+|++|||+.+++.
T Consensus 209 ~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 209 FRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3332 34445567788999999999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=241.42 Aligned_cols=204 Identities=23% Similarity=0.366 Sum_probs=157.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+|++. ++|.+++.... ..+++..+..++.|++.||.|||+.| ++||||||
T Consensus 111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 185 (357)
T PHA03209 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKT 185 (357)
T ss_pred HHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 467899999999999999999999999995 58888876532 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHH-
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPA- 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~-~~~~~~- 158 (226)
+||+++.++.++|+|||.+...... .......++..|+|||++.+..++.++|+||+||++|+|+++..++ ......
T Consensus 186 ~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~ 264 (357)
T PHA03209 186 ENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264 (357)
T ss_pred HHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcH
Confidence 9999999999999999988643222 1122345678999999999888999999999999999999865544 321110
Q ss_pred ---------HHHHHHhhCCc-cCCC------------------------------CCCCCHHHHHHHHHHcccCCCCCCC
Q 027225 159 ---------QVVAAVGFKGK-RLEI------------------------------PRNVNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 159 ---------~~~~~~~~~~~-~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rps 198 (226)
.....+..... ...+ ...++.++.++|.+||+.||.+|||
T Consensus 265 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt 344 (357)
T PHA03209 265 EEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS 344 (357)
T ss_pred HHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC
Confidence 01111100000 0000 1145667788999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 027225 199 FSTIMELLRPLIKS 212 (226)
Q Consensus 199 ~~~~l~~l~~~~~~ 212 (226)
+.|+++ ..+++.
T Consensus 345 a~e~l~--hp~f~~ 356 (357)
T PHA03209 345 AEEILN--YPMFAQ 356 (357)
T ss_pred HHHHhc--Cchhcc
Confidence 999998 666553
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=241.13 Aligned_cols=198 Identities=26% Similarity=0.375 Sum_probs=156.3
Q ss_pred CCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++... ...|+|+||+.+ +|.+.+.. .+++..+..++.|++.||.|||++| ++|
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivH 142 (355)
T cd07874 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIH 142 (355)
T ss_pred HHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 567999999999988643 347999999975 67776643 2788999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...
T Consensus 143 rDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CCCChHHEEECCCCCEEEeeCcccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999987544321 123345678999999999888999999999999999999999999876
Q ss_pred CHHHHHHHHhhCC--------------------c--------------------cCCCCCCCCHHHHHHHHHHcccCCCC
Q 027225 156 NPAQVVAAVGFKG--------------------K--------------------RLEIPRNVNPHVASIIEACWANEPWK 195 (226)
Q Consensus 156 ~~~~~~~~~~~~~--------------------~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~ 195 (226)
+..+......... . ....+...+.++.++|.+||..||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence 5433221110000 0 00011234578899999999999999
Q ss_pred CCCHHHHHHHHHHhh
Q 027225 196 RPSFSTIMELLRPLI 210 (226)
Q Consensus 196 Rps~~~~l~~l~~~~ 210 (226)
|||+.++++ +.++
T Consensus 302 Rps~~ell~--hp~~ 314 (355)
T cd07874 302 RISVDEALQ--HPYI 314 (355)
T ss_pred cCCHHHHhc--Ccch
Confidence 999999998 4444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=230.90 Aligned_cols=197 Identities=30% Similarity=0.503 Sum_probs=179.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+..+||.+..+.-.|+.++.+|.||||.+||.|...+.+.. .+++...+.+-..|+.||.|||+++ |++||+|.
T Consensus 222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKL 296 (516)
T KOG0690|consen 222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKL 296 (516)
T ss_pred HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC--eeeeechh
Confidence 467899999999889999999999999999999999998744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+|.++|++|.+|++|||+++............+|++.|+|||++....+..+.|+|.+|++||+|++|+.||-..+....
T Consensus 297 ENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL 376 (516)
T KOG0690|consen 297 ENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL 376 (516)
T ss_pred hhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence 99999999999999999998776666777889999999999999999999999999999999999999999998888887
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
...+. -....+|..++++.+.|+..+|..||++|. ++.||.+
T Consensus 377 FeLIl--~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 377 FELIL--MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHHHH--hhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 77773 456678999999999999999999999994 4556655
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=228.02 Aligned_cols=199 Identities=37% Similarity=0.647 Sum_probs=169.9
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++++||||+++++.+.+. +..++|+|++.+++|.+++.+.. .+++..+..++.|++.+|++||+.| ++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl 127 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDI 127 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Confidence 3578999999999999988 88999999999999999998754 4999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
+|+||+++.++.++|+|||.+........ ......++..|.+||...+...+.++|+||+|++++++++|..||...+
T Consensus 128 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred CHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998876554422 1334556778999999988888999999999999999999999998765
Q ss_pred -HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 -PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.................+...+..+.++|.+|++.+|.+||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 208 NPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred chHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 333333332223445567778999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=228.03 Aligned_cols=200 Identities=32% Similarity=0.574 Sum_probs=173.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++|||++++.+.+......++|+|++++++|.+++.+.. ....+++..+..++.+++.||.+||+.| ++|+||+|
T Consensus 54 ~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~ 131 (258)
T cd08215 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKP 131 (258)
T ss_pred HhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCCh
Confidence 56789999999999999999999999999999999997642 1245999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............+++.|+|||...+...+.++|+||+|++++++++|..||...+..+.
T Consensus 132 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 211 (258)
T cd08215 132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL 211 (258)
T ss_pred HHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH
Confidence 99999999999999999887655443333445667789999999888889999999999999999999999988776666
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..... .......+..++..+.+++.+||..+|.+|||+.++++
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 212 ALKIL-KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 55553 33345566788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=227.58 Aligned_cols=206 Identities=29% Similarity=0.530 Sum_probs=166.3
Q ss_pred CCCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCC---CCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
|++++||||+++++++...+ ..++++||+.+++|.+++.... ....++...+..++.|++.||+|||+.|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~- 133 (273)
T cd05074 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN- 133 (273)
T ss_pred HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 46789999999999886532 2478899999999988874321 1124788999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-C
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L 148 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 148 (226)
++|+||+|+||+++.++.++++|||.+........ ......+...|++||...+..++.++|+||+|++++++++ |
T Consensus 134 -i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 134 -FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred -EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCC
Confidence 99999999999999999999999998875432211 1122334467999999988888999999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
..||...+..+....+. .......+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 213 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 213 QTPYAGVENSEIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88998777665555443 3333444567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=231.74 Aligned_cols=196 Identities=29% Similarity=0.518 Sum_probs=162.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p 80 (226)
++++||||+++++++...+..++|+||+++++|.+++.+.+ .+++..+..++.+++.+|.|||+ .+ ++|+||+|
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p 132 (284)
T cd06620 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKP 132 (284)
T ss_pred HHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCH
Confidence 56899999999999999999999999999999999987643 48999999999999999999997 68 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-- 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-- 158 (226)
+||++++++.++|+|||++....... .....++..|+|||.+.+...+.++|+||+|++++++++|..||......
T Consensus 133 ~nil~~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 210 (284)
T cd06620 133 SNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210 (284)
T ss_pred HHEEECCCCcEEEccCCcccchhhhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence 99999999999999999875432221 22345678899999998888899999999999999999999999765432
Q ss_pred ---------HHHHHHhhCCccCCCCC-CCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 159 ---------QVVAAVGFKGKRLEIPR-NVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 159 ---------~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
+....+. .......+. .++.++.+++.+|++.||.+|||+.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 211 GQDDPMGILDLLQQIV-QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhhhhhHHHHHHHHHh-hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111111 111222222 378899999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=245.64 Aligned_cols=210 Identities=19% Similarity=0.279 Sum_probs=161.5
Q ss_pred CCcCcceeeeEEecC-CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCCCc
Q 027225 5 RHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPN 82 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p~n 82 (226)
.|.+++++++++..+ +++|+|+|++ +++|.+++.+.+ .+++..+..++.||+.||.|||+ .| |+||||||+|
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~N 262 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPEN 262 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHH
Confidence 456799999998765 5689999988 678988887643 48999999999999999999998 59 9999999999
Q ss_pred EEEcCCC----------------cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 83 LLVDKKY----------------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 83 il~~~~~----------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
|+++.++ .+||+|||.+..... ......++..|+|||++.+..++.++|||||||++|+|+
T Consensus 263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred EEEecCCcccccccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 9998765 499999998754222 223456788999999999998999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhhCCccC-------------------------C--------------C-CCCCCHHHHHHHH
Q 027225 147 TLQQPWGNLNPAQVVAAVGFKGKRL-------------------------E--------------I-PRNVNPHVASIIE 186 (226)
Q Consensus 147 ~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~--------------~-~~~~~~~~~~li~ 186 (226)
+|+.||...+..+....+....... . . ....++.+.+||.
T Consensus 340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 419 (467)
T PTZ00284 340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY 419 (467)
T ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence 9999998766544333221110000 0 0 0012456789999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHhhcCCCC-----CCCCCCCCCC
Q 027225 187 ACWANEPWKRPSFSTIMELLRPLIKSPTP-----QPSPTDMPLL 225 (226)
Q Consensus 187 ~~l~~~p~~Rps~~~~l~~l~~~~~~~~~-----~~~~~~~~~~ 225 (226)
+||+.||++|||++|+++ +.++....+ +..+.+.++|
T Consensus 420 ~mL~~dP~~R~ta~e~L~--Hp~~~~~~~~~~~~~~~~~~~~~~ 461 (467)
T PTZ00284 420 GLLHYDRQKRLNARQMTT--HPYVLKYYPECRQHPNYPDNRSML 461 (467)
T ss_pred HhCCcChhhCCCHHHHhc--CccccccCCccccCCCCCCccccC
Confidence 999999999999999999 777766433 3445566554
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=231.53 Aligned_cols=199 Identities=25% Similarity=0.356 Sum_probs=160.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+ +++|.+++.... ..+++.+++.++.|++.||++||+.| ++|+||+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p 127 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKP 127 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCH
Confidence 35788999999999999999999999999 999999987543 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+.. .+.++|+||+|++++++++|..+|...+..
T Consensus 128 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 128 ANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred HHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 999999999999999998865443221 122345677899999986543 588999999999999999998888766554
Q ss_pred HHHHHHhhCCccC----------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+....+....... ......+.++.++|.+||+.+|.+||+++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 4332221110000 011345789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=257.90 Aligned_cols=207 Identities=25% Similarity=0.431 Sum_probs=160.5
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCC-----CC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRN-----PP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----~~ 72 (226)
|++++||||++++++|.+ ...+|+||||+.+++|.+++.... ....+++..++.++.||+.||.|||+.+ ..
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 357899999999998854 356999999999999999987532 1235999999999999999999999832 12
Q ss_pred eEEeCCCCCcEEEcC-----------------CCcEEEccCCCcccccccccccCCCCCCCCccCcccccC--CCCCCch
Q 027225 73 IVHRDLKSPNLLVDK-----------------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSNEKS 133 (226)
Q Consensus 73 i~h~di~p~nil~~~-----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~ 133 (226)
|+|+||||+|||++. .+.++|+|||++....... ......+++.|+|||++.+ ..++.++
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KS 224 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKS 224 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchh
Confidence 999999999999964 2348999999986543321 1234467889999999864 3478899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 134 DIYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 134 Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
|||||||++|+|++|..||...+... ....+. .... ......+.++.+||..||..+|.+||++.+++. .+++..
T Consensus 225 DVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk-~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~--h~~ik~ 300 (1021)
T PTZ00266 225 DMWALGCIIYELCSGKTPFHKANNFSQLISELK-RGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG--YQIIKN 300 (1021)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh-cCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc--cHHHhh
Confidence 99999999999999999997654433 333222 2221 222457899999999999999999999999996 445543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=232.06 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=160.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+||+++++++..++..++|+||+.++.+..+..+.. .+++..+..++.|++.|+.+||+.| ++|+||+|
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~ 128 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKP 128 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 357899999999999999999999999999877766665432 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||++++++.++|+|||.+........ ......+...|+|||.+.+. .++.++|+||+|++++++++|..||......
T Consensus 129 ~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 208 (288)
T cd07833 129 ENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208 (288)
T ss_pred HHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999998876544322 22234556789999999887 7889999999999999999999999766544
Q ss_pred HHHHHHhhCCc------------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFKGK------------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+.......... ....+..++.++.++|++||..+|++||+++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 209 DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 33222211000 00122345889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=233.11 Aligned_cols=201 Identities=28% Similarity=0.473 Sum_probs=163.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++.+++.+++..++|+||+. |++.+++.... +.+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p 143 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKA 143 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCc
Confidence 356899999999999999999999999996 57877775432 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||++++++.++|+|||.+...... ....++..|+|||.+. ...++.++|+||+|++++++++|..||...+.
T Consensus 144 ~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 144 GNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred ccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 9999999999999999987644322 2334567899999874 34578899999999999999999999987776
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
......+.........+..++.++.++|.+||+.+|.+||++.+++. ..++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 272 (307)
T cd06607 220 MSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK--HRFVLR 272 (307)
T ss_pred HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc--Chhhcc
Confidence 55544443222222223457889999999999999999999999998 344443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=236.13 Aligned_cols=208 Identities=26% Similarity=0.400 Sum_probs=163.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++++||+.+++|.+++.+.. ...+++..+..++.|++.||.|||+++ ++|+||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~ 129 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKA 129 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCc
Confidence 357899999999999999999999999999999999998643 234889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
+||+++.++.++++||+.+........ ......++..|+|||.+.+. .++.++|+||+|+++++|++|..|
T Consensus 130 ~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~p 209 (314)
T cd08216 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209 (314)
T ss_pred ceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 999999999999999998764332111 11223345679999998753 478899999999999999999999
Q ss_pred CCCCCHHHHHHHHhhCCc--------------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCH
Q 027225 152 WGNLNPAQVVAAVGFKGK--------------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSF 199 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 199 (226)
|................. .......++.++.+++.+||+.||.+|||+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 289 (314)
T cd08216 210 FKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289 (314)
T ss_pred CCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH
Confidence 987654433221110000 000112345678999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 027225 200 STIMELLRPLIKSP 213 (226)
Q Consensus 200 ~~~l~~l~~~~~~~ 213 (226)
+++++ ..+++..
T Consensus 290 ~~ll~--~p~~~~~ 301 (314)
T cd08216 290 SQLLN--HSFFKQC 301 (314)
T ss_pred HHHhc--CchHhhh
Confidence 99998 6666543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=235.07 Aligned_cols=201 Identities=22% Similarity=0.345 Sum_probs=150.6
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCC------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG------VREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++||||+++++++.. +...|+++||+. ++|.+++.... ....+++..+..++.|++.||.|||+.|
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-- 128 (317)
T cd07868 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 128 (317)
T ss_pred HHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 457899999999999854 456899999985 48888875321 1224889999999999999999999999
Q ss_pred eEEeCCCCCcEEE----cCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHH
Q 027225 73 IVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWE 144 (226)
Q Consensus 73 i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 144 (226)
++|+||||+||++ +.++.++|+|||++........ ......++..|+|||++.+. .++.++|+||+||++++
T Consensus 129 ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 208 (317)
T cd07868 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 208 (317)
T ss_pred EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHH
Confidence 9999999999999 4567899999999875433211 12234567889999998764 47889999999999999
Q ss_pred HHhCCCCCCCCCH----------HHHHHHHhhCCcc-------------------------C----------CCCCCCCH
Q 027225 145 LATLQQPWGNLNP----------AQVVAAVGFKGKR-------------------------L----------EIPRNVNP 179 (226)
Q Consensus 145 l~~g~~p~~~~~~----------~~~~~~~~~~~~~-------------------------~----------~~~~~~~~ 179 (226)
|++|..||..... ............. . ......+.
T Consensus 209 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07868 209 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 288 (317)
T ss_pred HHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCCh
Confidence 9999999964321 1111100000000 0 00112356
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 180 HVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 180 ~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
++.++|.+||+.||.+|||++|+++
T Consensus 289 ~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 289 KAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhc
Confidence 7899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=243.36 Aligned_cols=197 Identities=26% Similarity=0.328 Sum_probs=162.8
Q ss_pred cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEc
Q 027225 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD 86 (226)
Q Consensus 7 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~ 86 (226)
=|+|+++|+|...++.|+|+|.+. .+|.+++..+...+ ++...++.++.||+.||.+||+.| |+|+||||+|||+.
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~ 323 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLK 323 (586)
T ss_pred eeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeec
Confidence 589999999999999999999995 59999999876543 999999999999999999999999 99999999999996
Q ss_pred CCC--cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 87 KKY--TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 87 ~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
+.+ .+|++|||+++....... .......|+|||++.|..++.+.|+||||||++||++|.+.|.+.+..+....+
T Consensus 324 ~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 324 DPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred cCCcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 543 799999999987655422 334456899999999999999999999999999999999889887776655433
Q ss_pred hhCCccCC--------------------------------------------------CC-----------CCCCHHHHH
Q 027225 165 GFKGKRLE--------------------------------------------------IP-----------RNVNPHVAS 183 (226)
Q Consensus 165 ~~~~~~~~--------------------------------------------------~~-----------~~~~~~~~~ 183 (226)
....+.++ .| ..-...+.+
T Consensus 401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 31111000 01 012357899
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 184 IIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 184 li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
++++||..||.+|+|+.++++ +.+++.
T Consensus 481 flk~~L~~dP~~R~tp~qal~--Hpfl~~ 507 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALN--HPFLTG 507 (586)
T ss_pred HHHHHhccCchhcCCHHHHhc--Cccccc
Confidence 999999999999999999999 888874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=227.18 Aligned_cols=196 Identities=30% Similarity=0.475 Sum_probs=169.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++.+..++..++|+|++.+++|.+++.... .+++..+..++.|++.||.++|+.+ ++|+||+|+
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ 122 (250)
T cd05123 48 SRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPE 122 (250)
T ss_pred HHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcc
Confidence 57889999999999999999999999999999999998743 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|++||...+...+.++|+||||++++++++|..||...+..+..
T Consensus 123 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 202 (250)
T cd05123 123 NILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202 (250)
T ss_pred eEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999998876544322333445677899999998888889999999999999999999999887765555
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH---HHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF---STIME 204 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~~l~ 204 (226)
.... ......+...+..+.+++.+||..||.+||++ +++++
T Consensus 203 ~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 203 EKIL--KDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHh--cCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 5443 25566778889999999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=231.32 Aligned_cols=198 Identities=25% Similarity=0.336 Sum_probs=160.3
Q ss_pred CCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++++||||+++++++... +..|+|+||+.+ +|.+++..... .+++..+..++.|++.||+|||+.| ++|+||+
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~ 133 (293)
T cd07843 59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLK 133 (293)
T ss_pred HhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCC
Confidence 568999999999999877 889999999975 99998876432 4899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
|+||+++.++.++|+|||.+..............++..|+|||.+.+.. .+.++|+||+|+++++|++|..||......
T Consensus 134 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 134 TSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred HHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999999999998876554422233344567899999987654 588999999999999999999999876654
Q ss_pred HHHHHHhhCCc-----------------------------cCCCCCC-CCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFKGK-----------------------------RLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~~~-----------------------------~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+....+..... ...++.. +++.+.++|.+||+.+|++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 43332211000 0112222 5888999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=228.26 Aligned_cols=199 Identities=32% Similarity=0.538 Sum_probs=170.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++++|+||+++.+++.+....++|+||+++++|.+++.+... ...+++..+..++.+++.||.+||+.| ++|+||+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~ 130 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLK 130 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCC
Confidence 3578999999999999999999999999999999999875221 245899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.++.++|+|||.+...... ......++..|++||.+.+..++.++|+||+|++++++++|+.||...+..+
T Consensus 131 ~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 131 SANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred cceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999988665443 2223456778999999988888899999999999999999999998887766
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...... .......+..++.++.+++.+||+.+|.+||++.++++
T Consensus 209 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 209 LRYKVQ-RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHh-cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 555443 33334455678899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=230.27 Aligned_cols=199 Identities=26% Similarity=0.401 Sum_probs=155.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+.+ +|.+++.+... .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p 131 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKP 131 (291)
T ss_pred HhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCH
Confidence 4678999999999999999999999999975 99998876432 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLN-PA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~ 158 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.... ..
T Consensus 132 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 211 (291)
T cd07844 132 QNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211 (291)
T ss_pred HHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 9999999999999999987643322222222334678999999875 447889999999999999999999997654 22
Q ss_pred HHHHHHhhC-Cc------------------cC---------CCCCCCC--HHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFK-GK------------------RL---------EIPRNVN--PHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~-~~------------------~~---------~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+....+... .. .. .....++ .++.+++.+||+.+|.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 221111000 00 00 0001234 78899999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=231.38 Aligned_cols=201 Identities=27% Similarity=0.457 Sum_probs=164.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|||++++++++.+++..++|+||+.| +|.+.+.... ..+++.++..++.+++.|+.+||+.| ++|+||+|
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p 153 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKA 153 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCc
Confidence 3578999999999999999999999999975 7877775432 23899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+..... .....++..|+|||.+. +...+.++|+||+|+++++|++|..||...+.
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 154 GNILLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred ccEEECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 999999999999999998754332 22335667899999974 34578899999999999999999999987766
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
......+............+++.+.+++.+||+.+|.+||++.++++....+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 55554443333333334568899999999999999999999999998554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=230.53 Aligned_cols=208 Identities=24% Similarity=0.319 Sum_probs=162.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||++ ++|.+++.... ...+++..+..++.|++.||++||++| ++|+||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p 130 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKP 130 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCc
Confidence 367899999999999999999999999996 48888876543 223688889999999999999999999 99999999
Q ss_pred CcEEEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++. ++.++++|||.+..............++..|+|||.+.+. .++.++|+||+|++++++++|..||...+..
T Consensus 131 ~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 131 QNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred ceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999985 5579999999886543322222333456789999988654 4688999999999999999999999876554
Q ss_pred HHHHHHhhCCcc-------------------C--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKR-------------------L--------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~-------------------~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+........... . .....++.++.+++.+|++.+|++||++.++++ .++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--~~~~~ 288 (294)
T PLN00009 211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--HEYFK 288 (294)
T ss_pred HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--CchHh
Confidence 433322100000 0 012357889999999999999999999999998 66666
Q ss_pred CCC
Q 027225 212 SPT 214 (226)
Q Consensus 212 ~~~ 214 (226)
...
T Consensus 289 ~~~ 291 (294)
T PLN00009 289 DLG 291 (294)
T ss_pred HHh
Confidence 543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=230.16 Aligned_cols=201 Identities=26% Similarity=0.385 Sum_probs=161.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+.+ +|.+++...+....+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p 128 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKP 128 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCH
Confidence 3578999999999999999999999999975 89888876554456899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||++++++.++|+|||.+..............++..|++||.+.+. .++.++|+||+|++++++++|..||...+..+
T Consensus 129 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 208 (284)
T cd07836 129 QNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208 (284)
T ss_pred HHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999999886543322222233456789999988654 46889999999999999999999998766554
Q ss_pred HHHHHhhCCc----------------cC-----------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGK----------------RL-----------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~----------------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+..... .. ......+..+.+++.+|++.||.+||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3332211100 00 011245788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=230.54 Aligned_cols=203 Identities=27% Similarity=0.470 Sum_probs=165.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|||++++++++.+....|+|+||+. +++.+++.... ..+++.++..++.|++.||.|||+.| ++|+||+|
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p 149 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKA 149 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCh
Confidence 357899999999999999999999999996 57888776532 23889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+..... .....++..|+|||.+. ...++.++|+||+|+++++|++|..||...+.
T Consensus 150 ~nili~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 150 GNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred hhEEECCCCCEEEeecCCCcccCC----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999998754322 22345677899999974 34578899999999999999999999987766
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
...................++..+.+++.+||+.+|.+||++.+++. ..+++..+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~--~~~~~~~~ 280 (313)
T cd06633 226 MSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR--HDFVRRDR 280 (313)
T ss_pred HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CcccCCCc
Confidence 55544443333332334467889999999999999999999999998 56665533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=225.15 Aligned_cols=198 Identities=31% Similarity=0.543 Sum_probs=166.1
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++++||||+++++++.+. +.+++++||+.+++|.+++...+ .+++..+..++.|++.||.+||+.| ++|+||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl 132 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM--IVHRDI 132 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCC
Confidence 3578999999999998764 45889999999999999987643 3889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+...+.++|+||+|++++++++|..||...
T Consensus 133 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 133 KGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred CHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999887543211 1112234677899999998888899999999999999999999999877
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+..............+..+++++.+++.+|++ ++..||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 213 EAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 66665555544444556788899999999999998 5799999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=227.85 Aligned_cols=199 Identities=31% Similarity=0.515 Sum_probs=167.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++||||+++++++.+....++|+||+.+++|.+++... .....+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~ 134 (260)
T cd08222 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKA 134 (260)
T ss_pred HhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCh
Confidence 5689999999999999999999999999999999988642 12345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||++++ +.++|+|||.+..............++..|+|||...+..++.++|+||+|++++++++|..||...+..+.
T Consensus 135 ~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~ 213 (260)
T cd08222 135 KNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV 213 (260)
T ss_pred hheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 9999976 579999999886554333333344567789999999888788899999999999999999999987666554
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..... .......+..++.++.++|.+||..+|.+||++.++++
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 214 VLRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 44443 33444556788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=228.47 Aligned_cols=206 Identities=31% Similarity=0.513 Sum_probs=162.7
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
|++++||||+++++++.+. +..++|+||+++++|.+++.... ....++...+..++.|++.||.|||+.| ++|+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~d 130 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRD 130 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCC
Confidence 4678999999999988653 46899999999999998875321 1334889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-- 155 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-- 155 (226)
|+|+||+++.++.++|+|||.+........ ....++..|++||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 131 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (287)
T cd06621 131 IKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208 (287)
T ss_pred CCHHHEEEecCCeEEEeecccccccccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence 999999999999999999998765433211 2334567899999998888899999999999999999999999755
Q ss_pred ---CHHHHHHHHhhCCccCCCC------CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 ---NPAQVVAAVGFKGKRLEIP------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
...+....... ......+ ..+++.+.+++.+||..+|.+|||+.++++ .++++..
T Consensus 209 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~--~~~~~~~ 272 (287)
T cd06621 209 PPLGPIELLSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE--HPWIKAQ 272 (287)
T ss_pred CCCChHHHHHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh--Ccccccc
Confidence 22233332221 1111111 235688999999999999999999999999 6666443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=231.72 Aligned_cols=199 Identities=26% Similarity=0.383 Sum_probs=159.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++..++..++|+||+++++|.++..... .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p 128 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKP 128 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCH
Confidence 356899999999999999999999999999988888776532 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||++++++.++|+|||.+..............+...|+|||...+. .++.++|+||+|++++++++|..||...+..+
T Consensus 129 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~ 208 (286)
T cd07846 129 ENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208 (286)
T ss_pred HHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 99999999999999999876543332222334456789999998753 36788999999999999999999987655433
Q ss_pred HHHHHhhCCcc--------------------C---------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKR--------------------L---------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~--------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+...... . .....++..+.+++.+||..+|.+||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 22211100000 0 012356889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=245.45 Aligned_cols=201 Identities=27% Similarity=0.461 Sum_probs=172.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|||++.|-++|..+...|+|||||-| |-.|++.-+. +++.+.++..++.+.+.||+|||+.+ .+|||||.
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKA 154 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKA 154 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccc
Confidence 5689999999999999999999999999954 9999988643 35999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
.||++++.|.+||.|||++..... ...+.|+++|||||++. .+.|+.++||||||++..++...++|+.+.+.
T Consensus 155 GNILLse~g~VKLaDFGSAsi~~P----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 155 GNILLSEPGLVKLADFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred cceEecCCCeeeeccccchhhcCc----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 999999999999999998765433 35678999999999985 45689999999999999999999999888877
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
-....-+.......--...++..++.|+..||+.-|.+|||.++++. +.+...
T Consensus 231 MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~--H~fv~R 283 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK--HRFVLR 283 (948)
T ss_pred HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh--cchhcc
Confidence 66666554333332235679999999999999999999999999998 555443
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=229.10 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=159.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++++||+. ++|.+++.... ...+++..+..++.|++.||.+||+.+ ++|+||+|
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p 127 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKP 127 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCH
Confidence 356899999999999999999999999995 59999987644 134899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|..||...+...
T Consensus 128 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 207 (283)
T cd07835 128 QNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207 (283)
T ss_pred HHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999886543222222223446789999987664 46889999999999999999999997665433
Q ss_pred HHHHHhhCC---------------------------ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKG---------------------------KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+.... ........++.++.++|.+||+.+|.+|||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 208 QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 222111000 000113457789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=241.10 Aligned_cols=205 Identities=31% Similarity=0.584 Sum_probs=180.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||++++|+|.+. -.|+|||.++-|-|..|++.++. .++.....-++.||..||+|||+.. ++||||-.
T Consensus 445 MrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAa 519 (974)
T KOG4257|consen 445 MRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAA 519 (974)
T ss_pred HHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhh
Confidence 5789999999999999875 49999999999999999997654 3888888899999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
.||++.....+||+|||+++-..+.... .....-..-|+|||.++-+.++.++|||.||++||+++. |..||.+....
T Consensus 520 RNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 520 RNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred hheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 9999999999999999999875544222 223334568999999999999999999999999999886 88999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+++-.+. .+.+++.|..+++.+..+..+||..+|.+||++.++...|.+++.
T Consensus 600 DVI~~iE-nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 600 DVIGHIE-NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ceEEEec-CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 6665553 677889999999999999999999999999999999999988776
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=229.31 Aligned_cols=205 Identities=26% Similarity=0.489 Sum_probs=161.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~ 79 (226)
+..+||||+++++++..++..++++||++ ++|.+++... .....+++..+..++.|++.||.|||++ + ++|+||+
T Consensus 55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlk 131 (283)
T cd06617 55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVK 131 (283)
T ss_pred HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCC
Confidence 45689999999999999999999999996 5888887642 2234689999999999999999999997 9 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD----EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|+||+++.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...
T Consensus 132 p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 132 PSNVLINRNGQVKLCDFGISGYLVDSVA-KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred HHHEEECCCCCEEEeecccccccccccc-cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999875433211 122345678999998865 34578999999999999999999999753
Q ss_pred CH-HHHHHHHhhCCccCCCC-CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 NP-AQVVAAVGFKGKRLEIP-RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.. .+...... .......+ ..++.++.++|.+||..+|.+||++.++++ ..++...
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~ 267 (283)
T cd06617 211 KTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFELH 267 (283)
T ss_pred ccCHHHHHHHH-hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhhc
Confidence 22 22222221 22222222 457899999999999999999999999998 5665554
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=233.10 Aligned_cols=205 Identities=26% Similarity=0.414 Sum_probs=158.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||++++++|..++..++|+||+.+++|.+++.+.. ...+++..+..++.|++.||+|||+.| ++|+||||+
T Consensus 54 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~ 130 (328)
T cd08226 54 HFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKAS 130 (328)
T ss_pred HhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 45799999999999999999999999999999999988643 234889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||+++.++.++++||+.......... ......+...|++||++.+. .++.++|+||+|++++++++|..||
T Consensus 131 Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 210 (328)
T cd08226 131 HILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210 (328)
T ss_pred HEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999975432111100 01112234569999998763 3678999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCc---------------------------------------------cCCCCCCCCHHHHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGK---------------------------------------------RLEIPRNVNPHVASIIEA 187 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~ 187 (226)
......+.......... ....+..++..+.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 290 (328)
T cd08226 211 QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290 (328)
T ss_pred CCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHH
Confidence 87654433322111100 001123456789999999
Q ss_pred HcccCCCCCCCHHHHHHHHHHhhc
Q 027225 188 CWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 188 ~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
||+.||++|||+.++++ +++++
T Consensus 291 ~l~~dP~~Rpta~e~l~--~~~~~ 312 (328)
T cd08226 291 CLQQDPEKRPSASSLLS--HAFFK 312 (328)
T ss_pred HccCCcccCCCHHHHhh--CHHHH
Confidence 99999999999999997 44444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=241.99 Aligned_cols=197 Identities=30% Similarity=0.507 Sum_probs=176.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++||||++++.+.+....+|+||||+.+|.+.+++.+++. ..+..+..++.|+++|++|||+++ ++|+|||.
T Consensus 109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~ 183 (596)
T KOG0586|consen 109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKA 183 (596)
T ss_pred HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc--eeccccch
Confidence 4678999999999999999999999999999999999998664 677899999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+|++++.+.++||+|||++.... ........++.+.|.|||++.+..+ ...+|+||+|+++|.++.|..||.+.+..+
T Consensus 184 eNilL~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 184 ENILLDENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred hhcccccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 99999999999999999998766 3445667889999999999999875 678999999999999999999999888776
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
..... ......++..++.++.++|+++|-.+|.+|++.+++++.
T Consensus 263 Lr~rv--l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 LRPRV--LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccchh--eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 66555 344556677789999999999999999999999999973
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=229.14 Aligned_cols=196 Identities=29% Similarity=0.513 Sum_probs=167.1
Q ss_pred CCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++ ||||+++++++.+++..++|+|++.+++|.+++.+.+ .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 56 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~ 130 (280)
T cd05581 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKP 130 (280)
T ss_pred HhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCH
Confidence 4566 9999999999999999999999999999999998754 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--------------------ccCCCCCCCCccCcccccCCCCCCchhHHHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGV 140 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 140 (226)
+||+++.++.++++|||.+........ ......++..|++||...+...+.++|+||+|+
T Consensus 131 ~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~ 210 (280)
T cd05581 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGC 210 (280)
T ss_pred HHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHH
Confidence 999999999999999998765433221 112234567899999998888899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH----HHHHH
Q 027225 141 ILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF----STIME 204 (226)
Q Consensus 141 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~~l~ 204 (226)
+++++++|..||...+......... ......+..+++.+.+++.+||+.+|.+||++ +++++
T Consensus 211 ~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 211 IIYQMLTGKPPFRGSNEYLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 9999999999998877555444442 34455677889999999999999999999999 77775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=238.95 Aligned_cols=197 Identities=24% Similarity=0.442 Sum_probs=183.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
.+++.|.|+++|..|.++++.|++||-|-||.||..+++++. ++....+.++.-+++|++|||++| |++|||||+
T Consensus 475 ~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPE 549 (732)
T KOG0614|consen 475 MECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPE 549 (732)
T ss_pred HhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC--ceeccCChh
Confidence 356789999999999999999999999999999999998664 999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
|.+++.+|-+||.|||+++..+.. .....++|++.|.|||++.+.+.+.++|.|+||++++++++|.+||.+.++-...
T Consensus 550 NllLd~~Gy~KLVDFGFAKki~~g-~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY 628 (732)
T KOG0614|consen 550 NLLLDNRGYLKLVDFGFAKKIGSG-RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY 628 (732)
T ss_pred heeeccCCceEEeehhhHHHhccC-CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 999999999999999999887664 3456789999999999999999999999999999999999999999999999999
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIME 204 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~ 204 (226)
+.+........+|..+++...++|+++...+|.+|.. +.+|.+
T Consensus 629 n~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 629 NLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred HHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 9998888888999999999999999999999999976 667776
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=232.16 Aligned_cols=201 Identities=22% Similarity=0.360 Sum_probs=150.2
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCC------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKP------GVREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++||||+++++++.. +...++|+||+.+ +|.+++... .....+++..+..++.|++.||.|||+.|
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-- 128 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-- 128 (317)
T ss_pred HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 457899999999998853 4668999999865 887776421 11224889999999999999999999999
Q ss_pred eEEeCCCCCcEEE----cCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHH
Q 027225 73 IVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWE 144 (226)
Q Consensus 73 i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 144 (226)
++|+||||+||++ +.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 129 ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 208 (317)
T cd07867 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 208 (317)
T ss_pred EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHH
Confidence 9999999999999 4567899999999875443221 12234567789999998764 47889999999999999
Q ss_pred HHhCCCCCCCCCHH----------HHHHHHhhCC--------------c---------c------------CCCCCCCCH
Q 027225 145 LATLQQPWGNLNPA----------QVVAAVGFKG--------------K---------R------------LEIPRNVNP 179 (226)
Q Consensus 145 l~~g~~p~~~~~~~----------~~~~~~~~~~--------------~---------~------------~~~~~~~~~ 179 (226)
|++|..||...... .......... . . .......+.
T Consensus 209 l~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07867 209 LLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS 288 (317)
T ss_pred HHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCCh
Confidence 99999998643211 0000000000 0 0 000112456
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 180 HVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 180 ~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+.+++.+||+.||.+|||+.|+++
T Consensus 289 ~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 289 KVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHHHHhccCcccccCHHHHhc
Confidence 7899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=224.88 Aligned_cols=196 Identities=24% Similarity=0.361 Sum_probs=155.8
Q ss_pred CCC-CCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 2 KRL-RHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++ +|+||+++++++.+. +..++|+||+.+ +|.+++.... ..+++..++.++.|++.||++||+.| ++|+||
T Consensus 52 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl 126 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDI 126 (282)
T ss_pred hhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccc
Confidence 345 599999999999887 889999999975 8887776532 24899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+|+||+++. +.++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||+|+++++|++|..||...+.
T Consensus 127 ~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 127 KPENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred CHHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 999999999 9999999998875443222 122345778999997654 4468899999999999999999999987765
Q ss_pred HHHHHHHhhCCc----------------cCC-----------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGK----------------RLE-----------IPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~----------------~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+.......... ... ....++.++.++|.+||+.+|.+||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 443332211000 000 11356799999999999999999999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=228.71 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=161.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++++++..++..++|+||+.+ +|.+++.... ..+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p 126 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKP 126 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCH
Confidence 3567899999999999999999999999975 8888887643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||++++++.++|+|||.+..............++..|+|||.+.+. ..+.++|+||+|++++++++|+.||...+..+
T Consensus 127 ~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~ 206 (283)
T cd05118 127 ENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID 206 (283)
T ss_pred HHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999886554432222233456789999998776 67899999999999999999999997766544
Q ss_pred HHHHHhhCCcc----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKR----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+...... ......++.++.++|.+||+.||.+||++.+++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 207 QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 43322111000 0112346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=227.98 Aligned_cols=196 Identities=28% Similarity=0.475 Sum_probs=160.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++|+|++++.+++......++|+||+. +++.+++.... ..+++..+..++.|++.|+.+||+.+ ++|+||+|
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p 143 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKA 143 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCH
Confidence 357899999999999999999999999996 58887775432 23889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+...... ....++..|+|||.+. ....+.++|+||+|++++++++|..||...+.
T Consensus 144 ~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 144 GNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred HhEEECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 9999999999999999987643321 2334567899999974 34467899999999999999999999877665
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+.................++..+.++|.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 444433332222222345688999999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=222.84 Aligned_cols=182 Identities=23% Similarity=0.266 Sum_probs=152.6
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
..||||+++++++.+++..++|+||+.+++|.+++.+.. .+++..+..++.|++.||.+||+.| ++|+||+|+||
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Ni 116 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL---NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNI 116 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHE
Confidence 468999999999999999999999999999999987643 3899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
+++.++.++++|||.+...... ......+..|+|||...+..++.++|+||+|++++++++|..|+...... .
T Consensus 117 l~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~--- 189 (237)
T cd05576 117 LLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I--- 189 (237)
T ss_pred EEcCCCCEEEecccchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c---
Confidence 9999999999999976544332 12233456799999998887889999999999999999999876542211 0
Q ss_pred HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH
Q 027225 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF 199 (226)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 199 (226)
........+..+++.+.++|.+||+.||.+|+++
T Consensus 190 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 190 --NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred --ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 0112234566789999999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=226.36 Aligned_cols=199 Identities=24% Similarity=0.303 Sum_probs=154.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|+||+++.+++..++..|+|+||+. +++.+++.... ..+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp 131 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKP 131 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCh
Confidence 357899999999999999999999999996 57777665432 23788889999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA- 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~- 158 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|++++++++|..||...+..
T Consensus 132 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~ 211 (291)
T cd07870 132 QNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211 (291)
T ss_pred HHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence 99999999999999999886543332223334457789999998754 4678999999999999999999999765432
Q ss_pred HHHHHHhhCCc-------------------c--CC-------CC--CCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFKGK-------------------R--LE-------IP--RNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~~~-------------------~--~~-------~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+.........+ . .. .. ...+.++.+++.+|+..||.+|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 212 EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 21111100000 0 00 00 123578999999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=218.66 Aligned_cols=202 Identities=28% Similarity=0.479 Sum_probs=162.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p 80 (226)
+..++|+||+++++|..+...++-||.+.. .+..++.+-. +.+++..+-++...+++||.||.. +| |+|||+||
T Consensus 146 ~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKP 220 (391)
T KOG0983|consen 146 KSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKP 220 (391)
T ss_pred hccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCc
Confidence 345689999999999999889999998854 6666666532 348888888999999999999976 67 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||++|..|++||+|||.+....++.... ...|.+.|||||.+.- ..|+.++||||||+.++++.||+.||.+.+.
T Consensus 221 SNILlDe~GniKlCDFGIsGrlvdSkAht-rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 221 SNILLDERGNIKLCDFGISGRLVDSKAHT-RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred cceEEccCCCEEeecccccceeecccccc-cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 99999999999999999998777765443 4567789999999863 3578999999999999999999999987443
Q ss_pred -HH-HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 158 -AQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 158 -~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
-+ ...........+.....+|+.+.+++..||+.|+.+||.+.++++ +.+..
T Consensus 300 dFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~ 353 (391)
T KOG0983|consen 300 DFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIK 353 (391)
T ss_pred cHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc--Cccee
Confidence 23 333333223333334458999999999999999999999999997 44443
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=227.14 Aligned_cols=200 Identities=26% Similarity=0.311 Sum_probs=156.3
Q ss_pred CCC-CCcCcceeeeEEecCCc-----eEEEEeecccCCHHHHhcCCCC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 2 KRL-RHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
+++ +||||+++++++...+. .|+|+||+.+ +|.+++..... ...+++..+..++.|++.||.|||++| +
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i 131 (295)
T cd07837 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--V 131 (295)
T ss_pred HHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 345 46999999999987665 8999999986 88888764321 245899999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCC
Q 027225 74 VHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 74 ~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
+|+||+|+||+++. ++.++|+|||.+..............+++.|+|||.+.+ ..++.++|+||+|+++++|++|..|
T Consensus 132 ~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 99999999999998 889999999988654332222223345678999998865 4468899999999999999999999
Q ss_pred CCCCCHHHHHHHHhhCCcc--------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKR--------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
|...+..+....+...... ......++.++.++|.+||..||.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 9776554433222110000 0011347889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=241.86 Aligned_cols=207 Identities=19% Similarity=0.277 Sum_probs=156.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++.+.+..|+|++++. ++|.+++..... ........+..++.||+.||.|||++| |+|+||
T Consensus 217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDL 293 (501)
T PHA03210 217 LGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDI 293 (501)
T ss_pred HHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence 357899999999999999999999999995 477777654221 223456778889999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLN 156 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~ 156 (226)
||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||+||++|+|++|.. |+....
T Consensus 294 KP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~ 373 (501)
T PHA03210 294 KLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373 (501)
T ss_pred CHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence 99999999999999999999876543322 2223467889999999999889999999999999999999875 443322
Q ss_pred --H-HHHHHHHhhCC-cc-----------------------CC-----CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 --P-AQVVAAVGFKG-KR-----------------------LE-----IPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 --~-~~~~~~~~~~~-~~-----------------------~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
. .+....+.... .. .. ....++..+.++|.+||+.||.+|||+.|+++
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1 11111111000 00 00 01135667888999999999999999999997
Q ss_pred HHHHhhcC
Q 027225 205 LLRPLIKS 212 (226)
Q Consensus 205 ~l~~~~~~ 212 (226)
..++..
T Consensus 454 --hp~f~~ 459 (501)
T PHA03210 454 --LPLFSA 459 (501)
T ss_pred --Chhhhc
Confidence 555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=245.20 Aligned_cols=210 Identities=31% Similarity=0.594 Sum_probs=186.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|-|++||||+++.++....+-..||+||+++|+|.++++.+.. .++..+...++..|+.|..||-..| ++||||-.
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAA 759 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAA 759 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhh
Confidence 4589999999999999999999999999999999999997653 3999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccC-CC--CCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSK-SA--AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~--~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
.||+++.+..+|++|||+++...+...... .. .-...|.|||.+..+.++.++||||+|++|||.++ |..||-+..
T Consensus 760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 999999999999999999987654432221 11 22458999999999999999999999999998765 899999999
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
..+++..+. .+.+++.|...+..+.+|+..||+.|-.+||.+.+|+..|++++++...
T Consensus 840 NQdVIkaIe-~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 840 NQDVIKAIE-QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred hHHHHHHHH-hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 989888886 6778888999999999999999999999999999999999999887543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=231.78 Aligned_cols=205 Identities=26% Similarity=0.408 Sum_probs=165.7
Q ss_pred CCCCCCcCcceeeeEEecCC-----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
+++++||||+++.+++...+ ..|+|+||+. ++|.+++.+.. .+++..+..++.+++.||.+||+.| ++|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g--i~H 126 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN--VIH 126 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 35778999999999998775 7899999997 48999887643 4999999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||+|+++++|++|..|
T Consensus 127 ~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred CCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999887654432 122334457789999999887 788999999999999999999999
Q ss_pred CCCCCHHHHHHHHhhCCccC-----------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKRL-----------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTI 202 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 202 (226)
|...+..+....+....... .....++.++.++|.+||+.+|.+||+++++
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 286 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 98776554433322111100 0123468899999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 027225 203 MELLRPLIKSP 213 (226)
Q Consensus 203 l~~l~~~~~~~ 213 (226)
++ ..++...
T Consensus 287 l~--~~~~~~~ 295 (330)
T cd07834 287 LA--HPYLAQL 295 (330)
T ss_pred Hh--CccHHhh
Confidence 98 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=230.25 Aligned_cols=200 Identities=26% Similarity=0.380 Sum_probs=157.6
Q ss_pred CCCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
+++++||||+++++++... ...|+|+||+.+ +|.+.+... ++...+..++.|++.||++||+.| ++
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g--i~ 140 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG--II 140 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 3578999999999988643 357999999964 888887642 888999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus 141 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred eCCCCHHHEEECCCCCEEEccCccceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999876443211 2233456789999999988899999999999999999999999976
Q ss_pred CCHHHHHHHHhhCCc--------------------cC---------------------CCCCCCCHHHHHHHHHHcccCC
Q 027225 155 LNPAQVVAAVGFKGK--------------------RL---------------------EIPRNVNPHVASIIEACWANEP 193 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~--------------------~~---------------------~~~~~~~~~~~~li~~~l~~~p 193 (226)
.+.......+..... .. ..+...+..+.++|.+||+.||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 299 (353)
T cd07850 220 TDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299 (353)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCCh
Confidence 654332222110000 00 0012346678999999999999
Q ss_pred CCCCCHHHHHHHHHHhhc
Q 027225 194 WKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 194 ~~Rps~~~~l~~l~~~~~ 211 (226)
.+|||+.++++ ..+++
T Consensus 300 ~~R~t~~eiL~--~~~~~ 315 (353)
T cd07850 300 EKRISVDDALQ--HPYIN 315 (353)
T ss_pred hhCcCHHHHhc--ChhHh
Confidence 99999999997 55443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=231.26 Aligned_cols=199 Identities=23% Similarity=0.387 Sum_probs=158.1
Q ss_pred CCCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|+.++|+||+++++++... ...|+|+||+. ++|.+++...+ .+++..+..++.|++.||.+||+.+ ++|
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--i~H 131 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN--VLH 131 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--Eec
Confidence 3567999999999988644 34899999995 68999887643 3999999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||..
T Consensus 132 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 132 RDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred CCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999988765433222333456778999998765 4578999999999999999999999976
Q ss_pred CCHHHHHHHHhhC------------------------Ccc-----CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 155 LNPAQVVAAVGFK------------------------GKR-----LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 155 ~~~~~~~~~~~~~------------------------~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+.......+... ... ......+++++.++|.+||+.+|.+|||++++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 212 KDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 5543322211100 000 01124578999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=225.92 Aligned_cols=202 Identities=30% Similarity=0.524 Sum_probs=157.0
Q ss_pred CC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhc---CCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeC
Q 027225 3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH---KPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRD 77 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~d 77 (226)
++ .||||+++++++..++..++++|++.. ++.++.. ... ...+++..+..++.+++.||+|||+. + ++|+|
T Consensus 58 ~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~d 133 (288)
T cd06616 58 RSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEELK--IIHRD 133 (288)
T ss_pred HhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccC
Confidence 44 499999999999999999999999864 6655432 111 23589999999999999999999974 8 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC---CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
|+|+||+++.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|++++++++|..||..
T Consensus 134 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred CCHHHEEEccCCcEEEeecchhHHhccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 999999999999999999998865433211 1233456789999998766 578899999999999999999999976
Q ss_pred CCHH-HHHHHHhhCCccCC----CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 155 LNPA-QVVAAVGFKGKRLE----IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 155 ~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.... +...... ...... .+..++.++.+++.+||+.+|.+|||++++++ .++++.
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--~~~~~~ 272 (288)
T cd06616 213 WNSVFDQLTQVV-KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--HPFIKD 272 (288)
T ss_pred cchHHHHHhhhc-CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhc
Confidence 5421 1111111 111111 12357899999999999999999999999998 666654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=230.13 Aligned_cols=208 Identities=21% Similarity=0.364 Sum_probs=162.1
Q ss_pred CCCCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|++++||||+++++++.. ....++|+||+. ++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 131 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN--VIHR 131 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence 467899999999998863 346899999995 58999987643 3899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.|
T Consensus 132 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~p 211 (334)
T cd07855 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211 (334)
T ss_pred CCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCc
Confidence 9999999999999999999998865433211 1123356778999999865 3478899999999999999999999
Q ss_pred CCCCCHHHHHHHHhhC------------------------CccCC-----CCCCCCHHHHHHHHHHcccCCCCCCCHHHH
Q 027225 152 WGNLNPAQVVAAVGFK------------------------GKRLE-----IPRNVNPHVASIIEACWANEPWKRPSFSTI 202 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~------------------------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 202 (226)
|...+.......+... ..... .....+.++.++|.+||+.+|.+||++.++
T Consensus 212 f~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 291 (334)
T cd07855 212 FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291 (334)
T ss_pred cCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9766543322211110 00111 113468999999999999999999999999
Q ss_pred HHHHHHhhcCCCCC
Q 027225 203 MELLRPLIKSPTPQ 216 (226)
Q Consensus 203 l~~l~~~~~~~~~~ 216 (226)
++ ..++...+..
T Consensus 292 l~--~~~~~~~~~~ 303 (334)
T cd07855 292 LQ--HPFLAQYHDP 303 (334)
T ss_pred Hh--ChhhhhccCC
Confidence 98 6776544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=226.62 Aligned_cols=201 Identities=22% Similarity=0.354 Sum_probs=154.8
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
+++++||||+++++++.+. +..++|+||+.+ +|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~ 132 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHR 132 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeC
Confidence 3578999999999999888 789999999975 77777653221 235899999999999999999999999 9999
Q ss_pred CCCCCcEEEcC----CCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhC
Q 027225 77 DLKSPNLLVDK----KYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 77 di~p~nil~~~----~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 148 (226)
||+|+||+++. ++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus 133 dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 212 (316)
T cd07842 133 DLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212 (316)
T ss_pred CCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence 99999999999 89999999998875433221 12233456789999988764 478899999999999999999
Q ss_pred CCCCCCCCHHH----------HHHHHhh-----------------------CCccCCCC-----------CCCCHHHHHH
Q 027225 149 QQPWGNLNPAQ----------VVAAVGF-----------------------KGKRLEIP-----------RNVNPHVASI 184 (226)
Q Consensus 149 ~~p~~~~~~~~----------~~~~~~~-----------------------~~~~~~~~-----------~~~~~~~~~l 184 (226)
..||...+... ....... .......+ ...+..+.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 99997544321 0000000 00000111 1567889999
Q ss_pred HHHHcccCCCCCCCHHHHHH
Q 027225 185 IEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 185 i~~~l~~~p~~Rps~~~~l~ 204 (226)
+.+||+.||++|||+.++++
T Consensus 293 i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 293 LRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhcCCcccCcCHHHHhc
Confidence 99999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=223.22 Aligned_cols=198 Identities=17% Similarity=0.289 Sum_probs=154.0
Q ss_pred CCCCCcCcceeeeEEecCC----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 2 KRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
+.++|+||+++++++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+|||+.+ ++|||
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrD 151 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGD 151 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence 4578999999999776543 3477888774 47777776532 2678889999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcccccccc-------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
|||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999986543211 11122457889999999999989999999999999999999999
Q ss_pred CCCCCCH-HHHHHH-----Hh-hCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 151 PWGNLNP-AQVVAA-----VG-FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 151 p~~~~~~-~~~~~~-----~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
||..... ...... .. ...... .....++++.+++..|++.+|.+||++.++++.+
T Consensus 232 P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 232 PWKGFGHNGNLIHAAKCDFIKRLHEGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCccccchHHHHHhHHHHHHHhhhhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9976632 221111 11 111111 2345689999999999999999999999999865
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=228.41 Aligned_cols=198 Identities=24% Similarity=0.447 Sum_probs=154.3
Q ss_pred CCCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|++++||||+++++++... ...++|+||+.+ +|.+++... .+++..+..++.|++.||.+||+.| ++|
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~--ivH 129 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN--VLH 129 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 3578999999999987644 348999999965 888887653 3899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.|
T Consensus 130 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~ 209 (336)
T cd07849 130 RDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209 (336)
T ss_pred cCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998865433211 1122356778999998754 4578899999999999999999999
Q ss_pred CCCCCHHHHHHHHhh------------------------CCccC-----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHH
Q 027225 152 WGNLNPAQVVAAVGF------------------------KGKRL-----EIPRNVNPHVASIIEACWANEPWKRPSFSTI 202 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~------------------------~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 202 (226)
|...+.......... ..... ......++++.+++.+||+.+|.+|||+.++
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 976554322111100 00000 0113467889999999999999999999999
Q ss_pred HHH
Q 027225 203 MEL 205 (226)
Q Consensus 203 l~~ 205 (226)
++.
T Consensus 290 l~h 292 (336)
T cd07849 290 LAH 292 (336)
T ss_pred hcC
Confidence 994
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=222.45 Aligned_cols=198 Identities=26% Similarity=0.338 Sum_probs=159.0
Q ss_pred CCCCCcCcceeeeEEecCCc-----eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++...+. .++++|++.+ +|.+++.+.. ...+++..+..++.|++.||.+||+.+ ++|+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~ 131 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR--IVHR 131 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence 45679999999999988776 9999999975 8998887643 224899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+|+||++++++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 132 ~l~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 132 DLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred cCChhhEEEccCCCEEEeccCcceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 9999999999999999999998866433211 122335678999999988888999999999999999999999998776
Q ss_pred HHHHHHHHhhCCcc-------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PAQVVAAVGFKGKR-------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+....+...... ......++..+.++|.+||+.||.+||++.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 55544333211000 0001235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=226.35 Aligned_cols=204 Identities=27% Similarity=0.399 Sum_probs=173.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+++..+.||.+--.|+..+.+|+|+..++||+|.-.+.+.+ .+.++++.++.++.+|+.||++||+.+ |++||+||
T Consensus 239 L~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKP 315 (591)
T KOG0986|consen 239 LEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKP 315 (591)
T ss_pred HHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCCh
Confidence 456788999999888999999999999999999999998877 356999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP--- 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--- 157 (226)
+||++|+.|+++|+|+|+++....... -....|+.+|||||++.+..|+...|+|+|||++|+|+.|+.||.....
T Consensus 316 eNILLDd~GhvRISDLGLAvei~~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk 394 (591)
T KOG0986|consen 316 ENILLDDHGHVRISDLGLAVEIPEGKP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK 394 (591)
T ss_pred hheeeccCCCeEeeccceEEecCCCCc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence 999999999999999999987665533 2344899999999999999999999999999999999999999965332
Q ss_pred -HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhcC
Q 027225 158 -AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKS 212 (226)
Q Consensus 158 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~~ 212 (226)
+++...+ ......++..+|++.+++...+|+.||.+|.. +.++.+ +.+++.
T Consensus 395 ~eEvdrr~--~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~--HpfFk~ 451 (591)
T KOG0986|consen 395 REEVDRRT--LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE--HPFFKD 451 (591)
T ss_pred HHHHHHHH--hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh--Cccccc
Confidence 2333333 45566778999999999999999999999964 446655 444444
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=223.51 Aligned_cols=199 Identities=24% Similarity=0.335 Sum_probs=154.3
Q ss_pred CCCCCCcCcceeeeEEecCC--------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
+++++||||+++++++...+ ..++|+||+.+ +|.+++.... ..+++.++..++.|++.||+|||++|
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-- 139 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK-- 139 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 36789999999999986543 35999999965 8888876543 24899999999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc----cCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHh
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~ 147 (226)
++|+||+|+||+++.++.++|+|||.+......... .....+...|+|||.+.+.. .+.++|+||+|+++++|++
T Consensus 140 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t 219 (310)
T cd07865 140 ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219 (310)
T ss_pred eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999988654332111 12234566799999886643 6789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhCCcc-----------------CCC-------------CCCCCHHHHHHHHHHcccCCCCCC
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKR-----------------LEI-------------PRNVNPHVASIIEACWANEPWKRP 197 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp 197 (226)
|..||...+.......+...... ... +...+..+.++|.+||..||.+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~ 299 (310)
T cd07865 220 RSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299 (310)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc
Confidence 99999876654433322211100 000 112356788999999999999999
Q ss_pred CHHHHHH
Q 027225 198 SFSTIME 204 (226)
Q Consensus 198 s~~~~l~ 204 (226)
|+.++++
T Consensus 300 t~~e~l~ 306 (310)
T cd07865 300 DADTALN 306 (310)
T ss_pred CHHHHhc
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=247.74 Aligned_cols=199 Identities=26% Similarity=0.388 Sum_probs=175.3
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEE
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~ 85 (226)
.+=|+.+.-.|.+++++|+||||++||+|-.++.+.. .+++..++.++..|+.||..+|+.| ++||||||+||++
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLL 208 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEe
Confidence 3456777778899999999999999999999999865 4999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEccCCCccccc-ccccccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 86 DKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 86 ~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|..|++||.|||.|-... +....+....|+|.|++||++.. +.|+..+|+||+|+++|+|+.|..||-.....+
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 999999999999887655 55566788999999999999852 447889999999999999999999998888888
Q ss_pred HHHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCCCCCC---HHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWKRPS---FSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~l~~~~~~ 212 (226)
....|........+| ..+|.+.++||.+.+ -+|..|.. ++++.+ +.|+.+
T Consensus 289 TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~--HpFF~g 343 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN--HPFFEG 343 (1317)
T ss_pred HHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh--CccccC
Confidence 888887777777777 678999999999998 57788888 888887 555544
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=223.24 Aligned_cols=200 Identities=25% Similarity=0.371 Sum_probs=162.0
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++ +||||+++++.+..+...++|+||+.+++|.+++.... .+++..+..++.|++.+|.+||+.| ++|+||+|
T Consensus 59 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p 133 (288)
T cd05583 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKL 133 (288)
T ss_pred HhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence 456 59999999999999999999999999999999987633 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLN- 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~- 156 (226)
+||+++.++.++|+|||.+........ ......+...|++||...+.. .+.++|+||+|+++++|++|..||...+
T Consensus 134 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 213 (288)
T cd05583 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213 (288)
T ss_pred HHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc
Confidence 999999999999999998765332211 112234677899999987654 6789999999999999999999996432
Q ss_pred ---HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 157 ---PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
..+..... .......+..++.++.+++.+||+.+|++|||+.++.+.|+.
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 214 QNSQSEISRRI--LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cchHHHHHHHH--HccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 12222222 223345567789999999999999999999998877766653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=229.31 Aligned_cols=203 Identities=23% Similarity=0.386 Sum_probs=161.7
Q ss_pred CCCCCCcCcceeeeEEecCCc------eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
+++++||||+++.+++...+. .++|+||+ +++|.+++... .+++..+..++.|++.||.+||+.| ++
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g--i~ 140 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG--II 140 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 357899999999998866554 89999998 66999998753 3899999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
|+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|++++++++|+.||.
T Consensus 141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 141 HRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred cCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999988654332 223345678999998865 357889999999999999999999998
Q ss_pred CCCHHHHHHHHhhCCcc-----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+..+....+...... .......+..+.++|.+||+.+|.+|||+.++++
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 76655443332111100 0111246889999999999999999999999998
Q ss_pred HHHHhhcCCCC
Q 027225 205 LLRPLIKSPTP 215 (226)
Q Consensus 205 ~l~~~~~~~~~ 215 (226)
.+++.....
T Consensus 298 --h~~~~~~~~ 306 (343)
T cd07851 298 --HPYLAEYHD 306 (343)
T ss_pred --CCCccccCC
Confidence 666654433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=222.99 Aligned_cols=198 Identities=25% Similarity=0.350 Sum_probs=160.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++++++.+.+..++|+|++. ++|.+++.+.. ..+++..+..++.+++.||.+||+.| ++|+||+|+
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ 127 (282)
T cd07829 53 KELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQ 127 (282)
T ss_pred HhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChh
Confidence 56789999999999999999999999997 59999998753 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||++++++.++|+|||.+..................|+|||.+.+. .++.++|+||+|++++++++|..||...+..+.
T Consensus 128 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 128 NILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred eEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 9999999999999999886554332222233445679999998766 678899999999999999999999977665443
Q ss_pred HHHHhhCCc-------------------cC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGK-------------------RL--------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~-------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+..... .. ......+..+.++|.+||..+|++||++++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 322211000 00 011235789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=225.32 Aligned_cols=197 Identities=23% Similarity=0.365 Sum_probs=154.8
Q ss_pred CCC-CCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 2 KRL-RHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++ +||||+++++++... ...++|+||+. ++|.+++... .+++..+..++.|++.||.+||+.| ++|+||
T Consensus 61 ~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl 133 (337)
T cd07852 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDL 133 (337)
T ss_pred HHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCC
Confidence 467 999999999998654 35899999997 4999988764 3888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccc-----ccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL-----SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+ ...+.++|+||+|+++++|++|+.||
T Consensus 134 ~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf 213 (337)
T cd07852 134 KPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213 (337)
T ss_pred CHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999998865432211 1122345778999998765 44678999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCc-----------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGK-----------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
......+....+..... .......++.++.++|.+||+.+|.+|||+.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il 293 (337)
T cd07852 214 PGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293 (337)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh
Confidence 76554332221111100 0011234788999999999999999999999999
Q ss_pred HH
Q 027225 204 EL 205 (226)
Q Consensus 204 ~~ 205 (226)
+.
T Consensus 294 ~~ 295 (337)
T cd07852 294 EH 295 (337)
T ss_pred hC
Confidence 83
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=222.13 Aligned_cols=198 Identities=25% Similarity=0.332 Sum_probs=155.9
Q ss_pred CCCCCcCcceeeeEEecCC----------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPP----------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
++++||||+++++++.+.. ..++|+||+++ ++.+++.... ..+++..+..++.|++.||+|||+.|
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~- 136 (302)
T cd07864 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN- 136 (302)
T ss_pred HhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5789999999999987654 79999999976 7777776542 24899999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCC
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 149 (226)
++|+||+|+||++++++.++|+|||.+........ ..........|+|||.+.+. ..+.++|+||+|++++++++|+
T Consensus 137 -i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred -eecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999998865433221 11222345679999988653 4688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhhCCccC----------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHH
Q 027225 150 QPWGNLNPAQVVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWANEPWKRPSFST 201 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 201 (226)
.||...+..+....+....... .....++..+.+++.+||+.+|.+||++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9997765544333222111000 012246889999999999999999999999
Q ss_pred HHH
Q 027225 202 IME 204 (226)
Q Consensus 202 ~l~ 204 (226)
+++
T Consensus 296 il~ 298 (302)
T cd07864 296 ALN 298 (302)
T ss_pred Hhc
Confidence 986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=217.82 Aligned_cols=216 Identities=24% Similarity=0.408 Sum_probs=167.7
Q ss_pred CCCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCC--CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKP--GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
++.++||||+.+..+|.. +...++++||.+. +|+.++.-+ ...+.++...+..+++||+.|++|||++= +.|||
T Consensus 81 ~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRD 157 (438)
T KOG0666|consen 81 LRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRD 157 (438)
T ss_pred HHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeecc
Confidence 367899999999999977 7889999999977 999988742 22457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC----CcEEEccCCCccccccccccc---CCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCC
Q 027225 78 LKSPNLLVDKK----YTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 78 i~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~ 149 (226)
|||.||++..+ |++|+.|+|+++...++.... ..-.-+.+|+|||.+.+.. ++.+.|+|++||++.||++..
T Consensus 158 LKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~ 237 (438)
T KOG0666|consen 158 LKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLE 237 (438)
T ss_pred CCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccC
Confidence 99999999877 899999999999876653322 2334577999999998875 788999999999999999988
Q ss_pred CCCCCCC-------HH---HHHHHHhhCCcc-C-------CC--------------------------CCCCCHHHHHHH
Q 027225 150 QPWGNLN-------PA---QVVAAVGFKGKR-L-------EI--------------------------PRNVNPHVASII 185 (226)
Q Consensus 150 ~p~~~~~-------~~---~~~~~~~~~~~~-~-------~~--------------------------~~~~~~~~~~li 185 (226)
+.|.+.. +- +........+.. . .. ...-++...+|+
T Consensus 238 PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL 317 (438)
T KOG0666|consen 238 PLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLL 317 (438)
T ss_pred ccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHH
Confidence 8774321 11 111111111000 0 00 012345688999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCC
Q 027225 186 EACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221 (226)
Q Consensus 186 ~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 221 (226)
.+||+.||.+|.|+++.++ +..+++.+.+|.|++
T Consensus 318 ~klL~yDP~kRIta~qAle--h~yF~~d~lpp~pt~ 351 (438)
T KOG0666|consen 318 QKLLTYDPIKRITAEQALE--HPYFTEDPLPPLPTS 351 (438)
T ss_pred HHHhccCchhhccHHHHhc--ccccccCCCCCCccc
Confidence 9999999999999999999 888888876655543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=225.59 Aligned_cols=201 Identities=24% Similarity=0.381 Sum_probs=159.9
Q ss_pred CCCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||+++++++..+. .+++|+|++ +++|.+++... .+++..+..++.|++.||.+||+.| ++
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g--i~ 140 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG--II 140 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 46789999999999987653 368999998 77999888653 3899999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
|+||+|+||+++.++.++|+|||.+...... .....++..|++||.+.+ ...+.++|+||+|++++++++|..||.
T Consensus 141 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 141 HRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred cCCCCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999988654332 223345678999999876 347889999999999999999999998
Q ss_pred CCCHHHHHHHHhhCCcc-----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+.......+...... ......+++.+.++|.+|+..||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 76543332221110000 0112457888999999999999999999999997
Q ss_pred HHHHhhcCC
Q 027225 205 LLRPLIKSP 213 (226)
Q Consensus 205 ~l~~~~~~~ 213 (226)
+++++..
T Consensus 298 --~~~~~~~ 304 (343)
T cd07880 298 --HPYFEEF 304 (343)
T ss_pred --CccHhhh
Confidence 6666554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=221.36 Aligned_cols=201 Identities=28% Similarity=0.484 Sum_probs=158.1
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCCCc
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPN 82 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p~n 82 (226)
..||||+++++++.+....++++||+. +++.+++.... ..+++..+..++.|++.|++|||+ .| ++|+||+|+|
T Consensus 71 ~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~n 145 (296)
T cd06618 71 HDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSN 145 (296)
T ss_pred cCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHH
Confidence 369999999999999999999999985 47877776532 248999999999999999999997 58 9999999999
Q ss_pred EEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
|++++++.++|+|||.+........ .....++..|+|||.+.+.. ++.++|+||+|+++++|++|..||......
T Consensus 146 ill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 224 (296)
T cd06618 146 ILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224 (296)
T ss_pred EEEcCCCCEEECccccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH
Confidence 9999999999999998865443222 12334567899999987553 678999999999999999999999764332
Q ss_pred -HHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 -QVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 -~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+......... ........++.++.+++.+||..+|.+||+++++++ ..++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 278 (296)
T cd06618 225 FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIRR 278 (296)
T ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhhc
Confidence 2222221111 122222347899999999999999999999999998 455443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=230.76 Aligned_cols=209 Identities=36% Similarity=0.653 Sum_probs=184.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++|||+|+++++|..+.-+|||+||+..|+|.+|+++.. +..++......++.||.+|.+||..++ ++||||-.
T Consensus 317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAA 393 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAA 393 (1157)
T ss_pred HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhh
Confidence 467899999999999999999999999999999999999865 445777888899999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc-ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
.|.+++++..+|+.|||+++.+... ....-...-..-|.|||.+.-..++.++|||+||+++|++.| |-.||.+.+..
T Consensus 394 RNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 394 RNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred hhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 9999999999999999999886543 222222223457999999998889999999999999999998 77799999888
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
++..... +..+..-|..+++.+.+|++.||+.+|.+||++.|+-+.++.++.+.
T Consensus 474 qVY~LLE-kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 474 QVYGLLE-KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHh-ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 8777664 77888899999999999999999999999999999999999888664
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=219.22 Aligned_cols=198 Identities=25% Similarity=0.357 Sum_probs=158.3
Q ss_pred CCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++++|||++++++++.+. +..++|+||+.+ +|.+++.... ..+++..++.++.|++.||++||+.| ++|+||+
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~ 127 (287)
T cd07840 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIK 127 (287)
T ss_pred HhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCc
Confidence 567899999999999888 889999999975 8998887642 24899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
|+||++++++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|++++++++|..||...+.
T Consensus 128 p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 128 GSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred HHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999998875544321 11223446689999987653 468899999999999999999999987665
Q ss_pred HHHHHHHhhCCccC-----------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGKRL-----------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
......+....... .....++..+.+++.+||+.+|.+||+++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 44333221110000 001113889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=226.44 Aligned_cols=200 Identities=25% Similarity=0.384 Sum_probs=156.1
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.|.+|++++||-..++.+|+||||-+ .+|..+++..... ...-.++.+..|++.|+.++|++| |+|.||||.|++
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFL 492 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFL 492 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEE
Confidence 57899999999999999999999774 5999999876532 333388889999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCC-----------CCCchhHHHHHHHHHHHHhCCCC
Q 027225 85 VDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEP-----------SNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
+-+. ++||+|||.+...... ........|+..||+||.+.... .+.++|||||||++|+|+.|+.|
T Consensus 493 lVkG-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP 571 (677)
T KOG0596|consen 493 LVKG-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP 571 (677)
T ss_pred EEee-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc
Confidence 9875 9999999998754332 33445668899999999986322 35789999999999999999999
Q ss_pred CCCCCH-HHHHHHHhhCCccCCCCCCCC-HHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 152 WGNLNP-AQVVAAVGFKGKRLEIPRNVN-PHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 152 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
|..... -.-...+..-.-..+++..-+ .++.++++.||..||++||++.++++ ..++..
T Consensus 572 f~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq--hpFl~~ 632 (677)
T KOG0596|consen 572 FGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ--HPFLQI 632 (677)
T ss_pred hHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc--Cccccc
Confidence 986442 222222221112223333222 34999999999999999999999998 666654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=226.12 Aligned_cols=204 Identities=23% Similarity=0.383 Sum_probs=157.2
Q ss_pred CCCCCCcCcceeeeEEecC--------------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHH
Q 027225 1 MKRLRHPNIVLFMGAVTQP--------------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 66 (226)
|++++||||+++++++... ...++|+||+. ++|.+++... .+++..+..++.|++.||.||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~L 130 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYI 130 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHH
Confidence 3578999999999877544 35799999997 5898888643 388999999999999999999
Q ss_pred hcCCCCeEEeCCCCCcEEEcC-CCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccC-CCCCCchhHHHHHHH
Q 027225 67 HRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVI 141 (226)
Q Consensus 67 H~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~ 141 (226)
|+.| ++|+||+|+||+++. ++.++++|||.+........ ......++..|+|||.+.+ ..++.++|+|||||+
T Consensus 131 H~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvi 208 (342)
T cd07854 131 HSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 208 (342)
T ss_pred HhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHH
Confidence 9999 999999999999974 55789999998865332211 1122345678999998754 457789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhhCC-----------------------ccC-----CCCCCCCHHHHHHHHHHcccCC
Q 027225 142 LWELATLQQPWGNLNPAQVVAAVGFKG-----------------------KRL-----EIPRNVNPHVASIIEACWANEP 193 (226)
Q Consensus 142 l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------~~~-----~~~~~~~~~~~~li~~~l~~~p 193 (226)
+++|++|+.||...+..+......... ... .....++.++.+++.+||+.||
T Consensus 209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 288 (342)
T cd07854 209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288 (342)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc
Confidence 999999999997665544332221100 000 1123578899999999999999
Q ss_pred CCCCCHHHHHHHHHHhhcCC
Q 027225 194 WKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 194 ~~Rps~~~~l~~l~~~~~~~ 213 (226)
.+|||+.++++ .++++..
T Consensus 289 ~~R~t~~ell~--h~~~~~~ 306 (342)
T cd07854 289 MDRLTAEEALM--HPYMSCY 306 (342)
T ss_pred hhccCHHHHhC--CCccccc
Confidence 99999999998 7777643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=218.57 Aligned_cols=198 Identities=28% Similarity=0.427 Sum_probs=157.9
Q ss_pred CCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++ ||||+++++++.+++..++|+||+ +++|.+++.... ...+++..+..++.|++.+|.+||++| ++|+||+|
T Consensus 52 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~ 127 (283)
T cd07830 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKP 127 (283)
T ss_pred HhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCh
Confidence 4567 999999999999999999999999 779998887643 235899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+........ .....++..|+|||.+. +..++.++|+||+|++++++++|..||......+
T Consensus 128 ~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~ 206 (283)
T cd07830 128 ENLLVSGPEVVKIADFGLAREIRSRPP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206 (283)
T ss_pred hhEEEcCCCCEEEeecccceeccCCCC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence 999999999999999998865443221 22334567899999875 3457889999999999999999999997665443
Q ss_pred HHHHHhhCCcc----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 160 VVAAVGFKGKR----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 160 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
....+...... .......+..+.++|.+||+.+|.+|||+++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 33222110000 0001123688999999999999999999999987
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=218.42 Aligned_cols=196 Identities=24% Similarity=0.391 Sum_probs=159.0
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++ +|+||+++++++..+...++|+||+.+++|.+++.... .+++..+..++.|++.||.+||+.| ++|+||+|
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p 133 (290)
T cd05613 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKL 133 (290)
T ss_pred HhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence 455 58999999999999999999999999999999987643 3889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+....... .......++..|++||.+.+. ..+.++|+||+|++++++++|..||.....
T Consensus 134 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred HHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 99999999999999999876543221 112234467789999998753 357889999999999999999999964322
Q ss_pred ----HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHH
Q 027225 158 ----AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIME 204 (226)
Q Consensus 158 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~ 204 (226)
.+..... .......+..+++.+.+++.+||+.+|.+|| +++++++
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 214 KNSQAEISRRI--LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cccHHHHHHHh--hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 2222222 2233445677899999999999999999997 7788876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=220.53 Aligned_cols=187 Identities=26% Similarity=0.491 Sum_probs=171.2
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+-|.++++..+|+.-+.+|.||||++||+|--.+++.+. +.+..+..++.+|+.||-+||++| |++||||.+||+
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvm 482 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVM 482 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceE
Confidence 457888888899888999999999999999998888653 889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.+|.+||.|||++....-........+|++.|+|||++...++..++|+||+|+++|+|+.|+.||.+.+..+....+
T Consensus 483 Ld~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI 562 (683)
T KOG0696|consen 483 LDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI 562 (683)
T ss_pred eccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999987665556677889999999999999999999999999999999999999999999999988888
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 198 (226)
......+|..+|.+..++++..|...|.+|..
T Consensus 563 --~ehnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 --MEHNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --HHccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 45667789999999999999999999999953
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=224.40 Aligned_cols=201 Identities=24% Similarity=0.375 Sum_probs=156.1
Q ss_pred CCCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
+++++||||+++++++.... .+++|+||+.. +|.++... .++++.+..++.|++.||.+||+.| ++
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--i~ 139 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAG--II 139 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 35789999999999987543 46999999864 77776532 3889999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.
T Consensus 140 H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 140 HRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred cCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987653321 122345678999999876 457889999999999999999999998
Q ss_pred CCCHHHHHHHHhhCCc---------------------cC--------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGK---------------------RL--------EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~---------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+.......+....+ .. ......+..+.++|.+||+.||.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 217 GKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 7664443322211000 00 011246788999999999999999999999997
Q ss_pred HHHHhhcCCC
Q 027225 205 LLRPLIKSPT 214 (226)
Q Consensus 205 ~l~~~~~~~~ 214 (226)
++++....
T Consensus 297 --h~~f~~~~ 304 (342)
T cd07879 297 --HPYFDSFR 304 (342)
T ss_pred --Ccchhhcc
Confidence 45544443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=220.50 Aligned_cols=200 Identities=27% Similarity=0.451 Sum_probs=157.1
Q ss_pred CCCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++++||||+++.+++.. ....++|+||+ +++|.+++.... +++..+..++.|++.||.+||+.| ++|+||+
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~ 135 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAG--VVHRDLK 135 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence 357899999999999865 56799999998 568998886532 788889999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
|+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|++++++++|..||...+..
T Consensus 136 p~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 136 PSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred HHHEeECCCCCEEeCccccccccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999987643321 122345678999998765 55789999999999999999999999766543
Q ss_pred HHHHHHhh------------------------CCccCC-----CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGF------------------------KGKRLE-----IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~------------------------~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.....+.. ...... ....++.++.++|.+||+.+|++||++.+++. .++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~--~~~ 290 (328)
T cd07856 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA--HPY 290 (328)
T ss_pred HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CCc
Confidence 22111100 000000 11346789999999999999999999999988 656
Q ss_pred hcC
Q 027225 210 IKS 212 (226)
Q Consensus 210 ~~~ 212 (226)
+..
T Consensus 291 ~~~ 293 (328)
T cd07856 291 LAP 293 (328)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=221.71 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=157.2
Q ss_pred CCCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
+++++||||+++++++... ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+.| ++
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--iv 142 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--II 142 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 3578999999999988643 3478888877 77999888653 2899999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
|+||+|+||++++++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|++++++++|..||.
T Consensus 143 H~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 143 HRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred ecCCChHHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999988654332 223355678999999866 457889999999999999999999997
Q ss_pred CCCHHHHHHHHhhCCc------------------------cC-----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGK------------------------RL-----EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~------------------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+.......+..... .. ......++++.++|.+||+.||.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 220 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 6554333222111000 00 011246789999999999999999999999998
Q ss_pred HHHHhhcC
Q 027225 205 LLRPLIKS 212 (226)
Q Consensus 205 ~l~~~~~~ 212 (226)
+.++..
T Consensus 300 --h~~f~~ 305 (345)
T cd07877 300 --HAYFAQ 305 (345)
T ss_pred --Chhhhh
Confidence 666654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=219.66 Aligned_cols=199 Identities=26% Similarity=0.410 Sum_probs=152.8
Q ss_pred CCCCCCcCcceeeeEEecCC--------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++||||+++++++.+.. ..++|+||+.+ +|...+.... ..+++..+..++.|+++||.|||+.|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~-- 135 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH-- 135 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 35789999999999885443 36999999965 7777765432 24999999999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccccccccccc-----------CCCCCCCCccCcccccCC-CCCCchhHHHHHH
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-----------KSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGV 140 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-----------~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~ 140 (226)
++|+||+|+||++++++.++|+|||.+.......... ....++..|+|||.+.+. .++.++|+||+|+
T Consensus 136 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 215 (311)
T cd07866 136 ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC 215 (311)
T ss_pred eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence 9999999999999999999999999886543221111 112345679999987654 4788999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhhCCccC---------------------CC-------CCCCCHHHHHHHHHHcccC
Q 027225 141 ILWELATLQQPWGNLNPAQVVAAVGFKGKRL---------------------EI-------PRNVNPHVASIIEACWANE 192 (226)
Q Consensus 141 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~~-------~~~~~~~~~~li~~~l~~~ 192 (226)
++++|++|..||...+.......+....... .. ....++.+.++|.+||+.+
T Consensus 216 il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 295 (311)
T cd07866 216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295 (311)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccC
Confidence 9999999999998766544333221110000 00 1234578999999999999
Q ss_pred CCCCCCHHHHHH
Q 027225 193 PWKRPSFSTIME 204 (226)
Q Consensus 193 p~~Rps~~~~l~ 204 (226)
|.+|||+.+++.
T Consensus 296 p~~R~t~~ell~ 307 (311)
T cd07866 296 PYKRLTASDALE 307 (311)
T ss_pred cccCcCHHHHhc
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=210.44 Aligned_cols=197 Identities=34% Similarity=0.532 Sum_probs=164.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+||+++++++......++++|++.+++|.+++..... ++...+..++.+++.++.+||+.+ ++|+||+|+
T Consensus 42 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ 116 (244)
T smart00220 42 KKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR---LSEDEARFYARQILSALEYLHSNG--IIHRDLKPE 116 (244)
T ss_pred HhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHH
Confidence 567999999999999998999999999999999999976442 889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN-LNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~ 160 (226)
||+++.++.++++|||.+....... ......+...|++||...+...+.++|+|++|++++++++|..||.. .+....
T Consensus 117 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~ 195 (244)
T smart00220 117 NILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL 195 (244)
T ss_pred HeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999999887654432 22344566789999999888788999999999999999999999977 444444
Q ss_pred HHHHhhCCccCCCCCC-CCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
................ ++.++.+++.+|+..+|.+||++.++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 196 FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 4444322222111111 8899999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=249.79 Aligned_cols=201 Identities=27% Similarity=0.417 Sum_probs=155.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh---cCCCCeEEeC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH---RRNPPIVHRD 77 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~i~h~d 77 (226)
|++++||||+++++++.+++..++||||+++|+|.+++.. +++..+..++.+++.|++||| +.+ ++|||
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~d 808 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGN 808 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCC
Confidence 4678999999999999999999999999999999999964 889999999999999999999 557 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
|||+||+++.++..++. ++....... .....++..|+|||++.+..++.++||||+|+++|+|++|+.||.....
T Consensus 809 lkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 809 LSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred CCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 99999999988877664 443322111 1122456789999999988899999999999999999999999853211
Q ss_pred --HHHHHHHhh--CCc------cCCC------CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 158 --AQVVAAVGF--KGK------RLEI------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 158 --~~~~~~~~~--~~~------~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
......... ... .... +.....++.+++.+||+.+|++|||+.++++.|+++.+..+
T Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 111111100 000 0001 11122357789999999999999999999999999987654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=210.75 Aligned_cols=193 Identities=24% Similarity=0.456 Sum_probs=157.8
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.|+||++++++|+++..+|+|||.+.||+|.+.+.++ +.+++.++.++...|+.||.|||.+| |+|||+||+||+
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiL 208 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENIL 208 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCcccee
Confidence 5999999999999999999999999999999999874 45999999999999999999999999 999999999999
Q ss_pred EcCCC---cEEEccCCCccccc-------ccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCC
Q 027225 85 VDKKY---TVKVCDFGLSRLKA-------NTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 85 ~~~~~---~~~l~df~~~~~~~-------~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~ 149 (226)
....+ -+||+||++..... ........+.|.-.|||||+.. ...|+.+.|.||||+++|-|++|.
T Consensus 209 C~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 209 CESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred ecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 97665 47999998764321 1112233566777999999864 234788999999999999999999
Q ss_pred CCCCCC-------C--------HHHHHHHHhhCCccCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 150 QPWGNL-------N--------PAQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 150 ~p~~~~-------~--------~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.||.+. + .......++ .+..++| ..+|.+.+++|..+|..++..|.++.++++
T Consensus 289 pPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ--EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 289 PPFVGHCGADCGWDRGEVCRVCQNKLFESIQ--EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccCccCCcCCccCCCccHHHHHHHHHHHh--ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 998432 1 122334443 3333444 468999999999999999999999999988
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=218.15 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=155.4
Q ss_pred CC-CCcCcceeeeEEecC----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 3 RL-RHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
++ +||||+++++++... ...++++|++. ++|.+++.... .+++..++.++.|++.||.+||+.| ++|+|
T Consensus 57 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~d 130 (332)
T cd07857 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN--VLHRD 130 (332)
T ss_pred HhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCC
Confidence 45 599999999975432 45788889885 58999887533 4899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
|+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||+|++++++++|..||
T Consensus 131 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf 210 (332)
T cd07857 131 LKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210 (332)
T ss_pred CCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence 999999999999999999998865332211 1122356778999998765 45789999999999999999999999
Q ss_pred CCCCHHHHHHHHhhC--------------------------Ccc---CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 153 GNLNPAQVVAAVGFK--------------------------GKR---LEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~--------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
...+.......+... ... .......+..+.+++.+||+.+|.+|||+.+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 211 KGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 776543322211100 000 011234578999999999999999999999999
Q ss_pred HHHHHhhc
Q 027225 204 ELLRPLIK 211 (226)
Q Consensus 204 ~~l~~~~~ 211 (226)
+ .++++
T Consensus 291 ~--~~~~~ 296 (332)
T cd07857 291 E--HPYLA 296 (332)
T ss_pred c--Chhhh
Confidence 7 67665
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=217.01 Aligned_cols=200 Identities=24% Similarity=0.406 Sum_probs=163.8
Q ss_pred CCCCCcCcceeeeEEe-cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+.|+||.||++||+|. +.+.+|-|.|||+|.+|.-|+..+. .+++.+++.|++||+.||.||.+..++|+|-||||
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKP 598 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKP 598 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCC
Confidence 4689999999999996 5577999999999999999998854 49999999999999999999999988999999999
Q ss_pred CcEEEc---CCCcEEEccCCCcccccccc-------cccCCCCCCCCccCcccccCC----CCCCchhHHHHHHHHHHHH
Q 027225 81 PNLLVD---KKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDE----PSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 81 ~nil~~---~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~----~~~~~~Dv~slG~~l~~l~ 146 (226)
.||++. .-|.+|++|||++..+.+.. .......|+.+|++||.+.-. ..+.+.||||+|+++|.++
T Consensus 599 gNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl 678 (775)
T KOG1151|consen 599 GNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL 678 (775)
T ss_pred ccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh
Confidence 999994 45689999999998755432 234456788999999988633 3578999999999999999
Q ss_pred hCCCCCCCCCH-HHHHHHHhh-CCc--cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 147 TLQQPWGNLNP-AQVVAAVGF-KGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 147 ~g~~p~~~~~~-~~~~~~~~~-~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.|+.||+.... .++.+.-.+ +.. ..+....++++.+++|++||+..-++|.+..++..
T Consensus 679 YGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 679 YGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 99999976543 333322211 122 22334678999999999999999999999998876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=222.82 Aligned_cols=206 Identities=33% Similarity=0.553 Sum_probs=173.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|.+|+||||++++++|..++.+++|+||++.|+|.+++.++.... ..-+....++.||++|++||.+.+ ++||||.+
T Consensus 589 LsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~ 665 (807)
T KOG1094|consen 589 LSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN--FVHRDLAT 665 (807)
T ss_pred HhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc--hhhccccc
Confidence 578999999999999999999999999999999999998864221 344556679999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccc--ccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT--LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~--g~~p~~~~~ 156 (226)
.|++++.++.+|++|||.++... ++........-...|+|+|.+....++.++|+|++|+.+||+++ ...||...+
T Consensus 666 rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 666 RNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred cceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 99999999999999999987432 22233334455678999999998889999999999999999865 577999888
Q ss_pred HHHHHHHHhhCCc------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 157 PAQVVAAVGFKGK------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 157 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
.++.......... .+..|.-++.++.+++.+||..+..+||+++++-..|++.
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 8877765543322 2345677899999999999999999999999999988764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=211.39 Aligned_cols=198 Identities=23% Similarity=0.332 Sum_probs=156.6
Q ss_pred cceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEc--
Q 027225 9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-- 86 (226)
Q Consensus 9 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~-- 86 (226)
++.+.++|...++.|+|+|.+ |.|+++++.+++ -..++...++.+.+||+.++++||+.+ ++|.||||+||++.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEecc
Confidence 567788899999999999988 669999999865 345899999999999999999999999 99999999999983
Q ss_pred ------------------CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q 027225 87 ------------------KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 87 ------------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 148 (226)
++..++++|||.++...... .....+..|.|||++.+.+++..+||||+|||++|+.+|
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 13358999999987654432 445667799999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHH-HhhCCc------------------cCCCC-------------------------CCCCHHHHHH
Q 027225 149 QQPWGNLNPAQVVAA-VGFKGK------------------RLEIP-------------------------RNVNPHVASI 184 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~-~~~~~~------------------~~~~~-------------------------~~~~~~~~~l 184 (226)
...|...+..+-... ....++ +...+ .....++.+|
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 988865544331111 110110 01000 0112479999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 185 IEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 185 i~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+++||..||.+|+|+.|++. +++++...+
T Consensus 386 l~~mL~fDP~~RiTl~EAL~--HpFF~~~~~ 414 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALS--HPFFARLTP 414 (415)
T ss_pred HHHHHccCccccccHHHHhc--CHHhhcCCC
Confidence 99999999999999999999 888887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=200.69 Aligned_cols=208 Identities=21% Similarity=0.294 Sum_probs=165.1
Q ss_pred CCCCCCcCcceeeeEEecC--------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|..++|+|++.++++|... ..+|+||++|+. +|.-++.+... +++..++..++.+++.||.|+|...
T Consensus 70 L~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k-- 144 (376)
T KOG0669|consen 70 LQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK-- 144 (376)
T ss_pred HHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh--
Confidence 4568999999999998532 349999999977 89999887533 3999999999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHh
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~ 147 (226)
|.|||+|+.|++++++|.++|.|||+++....... ....+.-+.+|++||.+.+. .++.+.|+|..||++.+|++
T Consensus 145 ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt 224 (376)
T KOG0669|consen 145 ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT 224 (376)
T ss_pred HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence 99999999999999999999999999965433211 12234457899999998765 48899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhCCccCC--------------------CC-------------CCCCHHHHHHHHHHcccCCC
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKRLE--------------------IP-------------RNVNPHVASIIEACWANEPW 194 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~~~--------------------~~-------------~~~~~~~~~li~~~l~~~p~ 194 (226)
+.+.+.+.+..+....+....+... ++ -.-+++..+++.+++..||.
T Consensus 225 rspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~ 304 (376)
T KOG0669|consen 225 RSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT 304 (376)
T ss_pred cCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc
Confidence 9999988777666555543222111 00 01235788999999999999
Q ss_pred CCCCHHHHHHHHHHhhcCCCC
Q 027225 195 KRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 195 ~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+|+++.++++ +.++...+.
T Consensus 305 kR~~ad~aln--h~~F~kdp~ 323 (376)
T KOG0669|consen 305 KRIDADQALN--HDFFWKDPM 323 (376)
T ss_pred cCcchHhhhc--hhhhhcCCc
Confidence 9999999998 666555443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=227.15 Aligned_cols=204 Identities=27% Similarity=0.501 Sum_probs=177.5
Q ss_pred CCCcCcceeeeEEec-----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 4 LRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 4 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
..|||++.++++|.. ++.+|+|||||.|||..|++++-. ...+.|+.+..|+..++.|+.+||.+. ++|+||
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDi 149 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDI 149 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecc
Confidence 489999999999853 355999999999999999998765 667999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-----CCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
|-.||+++.++.+||+|||.+.+............|++.|||||++... .++..+|+||||++..+|.-|.+|+-
T Consensus 150 kG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 150 KGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred cCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 9999999999999999999999888887778888999999999999643 46778999999999999999999998
Q ss_pred CCCHHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 154 NLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+.-+......+.... ..+.-|..++.++.++|..||..|..+||+..++++ ..+++.
T Consensus 230 DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~--hpFi~e 287 (953)
T KOG0587|consen 230 DMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK--HPFITE 287 (953)
T ss_pred CcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc--CCcccc
Confidence 877766655554222 223346788999999999999999999999999998 666664
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=221.41 Aligned_cols=199 Identities=35% Similarity=0.626 Sum_probs=176.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|-+|+|||++++|++..+ ....+|+|.++.|||.+.+++ ..+..+--.....++.||+.|+.||.+++ .+|||+-.
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAA 240 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAA 240 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhh
Confidence 347899999999999988 679999999999999999988 33556888888999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
.|+++-....+|++|||+.+..+... .......-...|.|||.+....++.++|||++|+.+|||++ |..||.+..
T Consensus 241 RNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 241 RNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred hhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 99999988899999999987644321 22223334558999999999999999999999999999998 688999999
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..++...+. ...++..|..++..++++++.||..+|.+|||+..|.+
T Consensus 321 g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 321 GIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 999999998 78888899999999999999999999999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=226.49 Aligned_cols=94 Identities=37% Similarity=0.608 Sum_probs=87.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++...+..|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||+.| |+|+||||+
T Consensus 59 ~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~ 133 (669)
T cd05610 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPD 133 (669)
T ss_pred HhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHH
Confidence 46799999999999999999999999999999999997643 3889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcc
Q 027225 82 NLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~ 100 (226)
||+++.++.++|+|||+++
T Consensus 134 NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 134 NMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=204.13 Aligned_cols=189 Identities=25% Similarity=0.434 Sum_probs=164.6
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||.+|-+..+|..+..++.|.||++||+|--.++++.. ++++.++.+...|..||.|||++| |+++|+|.+||+
T Consensus 309 n~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg--iiyrdlkldnvl 383 (593)
T KOG0695|consen 309 NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVL 383 (593)
T ss_pred CCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceE
Confidence 689999999999999999999999999999888877543 999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC---CCCHHH--
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG---NLNPAQ-- 159 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~---~~~~~~-- 159 (226)
++..|.+||+|+|.++..-.+.......++++.|.|||++.+..+....|+|+||++|++|+.|+.||. ..++++
T Consensus 384 ldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt 463 (593)
T KOG0695|consen 384 LDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT 463 (593)
T ss_pred EccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch
Confidence 999999999999999887777777888999999999999999999999999999999999999999994 222221
Q ss_pred -HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC
Q 027225 160 -VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 160 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 198 (226)
..-.+........+|..+|-....+++.-|+.||++|..
T Consensus 464 edylfqvilekqiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 464 EDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111122244556778888888889999999999999953
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=220.38 Aligned_cols=209 Identities=28% Similarity=0.411 Sum_probs=164.9
Q ss_pred CCCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
||+++|+|||+++++=+... ...+|||||.||||...+++......+++.+++.++..+..|+.|||++| |+
T Consensus 65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--Iv 142 (732)
T KOG4250|consen 65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IV 142 (732)
T ss_pred HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ce
Confidence 57899999999999776544 48899999999999999997554556999999999999999999999999 99
Q ss_pred EeCCCCCcEEE--cCCC--cEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCC
Q 027225 75 HRDLKSPNLLV--DKKY--TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 75 h~di~p~nil~--~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~ 149 (226)
||||||.||++ +.+| ..||+|||.++...+.. ......|+..|.+||.... ..++..+|.||+||++|+++||.
T Consensus 143 HRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 143 HRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE 221 (732)
T ss_pred eccCCCCcEEEeecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence 99999999988 3434 46999999988766543 5667889999999999984 77899999999999999999999
Q ss_pred CCCCCC----CHHHHHHHHhhCCcc-------------------CCCCCCCCH----HHHHHHHHHcccCCCCCC--CHH
Q 027225 150 QPWGNL----NPAQVVAAVGFKGKR-------------------LEIPRNVNP----HVASIIEACWANEPWKRP--SFS 200 (226)
Q Consensus 150 ~p~~~~----~~~~~~~~~~~~~~~-------------------~~~~~~~~~----~~~~li~~~l~~~p~~Rp--s~~ 200 (226)
.||... +..+....+..+.+. .+.+...++ .+-..+..+|.-+|.+|. ...
T Consensus 222 lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~ 301 (732)
T KOG4250|consen 222 LPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFD 301 (732)
T ss_pred CCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcc
Confidence 998432 222233333222221 122333343 345578889999999999 888
Q ss_pred HHHHHHHHhhcC
Q 027225 201 TIMELLRPLIKS 212 (226)
Q Consensus 201 ~~l~~l~~~~~~ 212 (226)
+....+..+++.
T Consensus 302 ~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 302 RFFAEVDDILNL 313 (732)
T ss_pred hHHHHHHHHHhh
Confidence 888888887764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=223.18 Aligned_cols=204 Identities=34% Similarity=0.644 Sum_probs=174.1
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-----------CC--CcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-----------VR--EMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-----------~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
+|+||+.++++|...+..++|.||+..|+|.++++..+ .. ..++..+...+++||+.|.+||++..
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~- 438 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP- 438 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 79999999999999999999999999999999998654 00 13888999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCccccccccccc---CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT- 147 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 147 (226)
++|||+-..||+++++..+|++|||+++......... ....-...|+|||.+....++.++||||+|+++||+++
T Consensus 439 -~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL 517 (609)
T KOG0200|consen 439 -CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL 517 (609)
T ss_pred -ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence 9999999999999999999999999998533322111 11113346999999999999999999999999999998
Q ss_pred CCCCCCCCC-HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 148 LQQPWGNLN-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 148 g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
|..||.+.. ..+... ....+.+...|...+.++.++++.||+.+|++||++.++.+.+...+.
T Consensus 518 G~~PYp~~~~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 518 GGTPYPGIPPTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCCcHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 688998865 455544 344777888899999999999999999999999999999999998654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=187.63 Aligned_cols=207 Identities=22% Similarity=0.323 Sum_probs=166.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+.++|.||++++++...++..-+|+|||.. .|..+...- ++.++.+.++.++.|++.||.++|+++ +.|+|+||
T Consensus 55 lkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkp 129 (292)
T KOG0662|consen 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKP 129 (292)
T ss_pred HHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCc
Confidence 4678999999999999999999999999965 898888753 234999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+|.+++.+|.+||.|||+++..+-+..-.....-+.+|.+|.++.+.. ++...|+||.||++.++.. |++.|.+.+..
T Consensus 130 qnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 130 QNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred ceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 999999999999999999987766544344556678999999998765 7888999999999999986 56667777766
Q ss_pred HHHHHHhhCCccCC------------------CC---------CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKRLE------------------IP---------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~~~------------------~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+....+-...+.+. ++ ..+...-+++++++|.-+|.+|.+++..++ ...+.
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq--hpyf~ 287 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ--HPYFS 287 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc--Ccccc
Confidence 65544422211111 01 123345688999999999999999999988 55555
Q ss_pred CCC
Q 027225 212 SPT 214 (226)
Q Consensus 212 ~~~ 214 (226)
...
T Consensus 288 d~s 290 (292)
T KOG0662|consen 288 DFS 290 (292)
T ss_pred ccC
Confidence 543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=214.25 Aligned_cols=189 Identities=25% Similarity=0.376 Sum_probs=156.8
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
.-+++-||++|-.|.+++++|+||+|++||++-+++-+.+ .|.+..++.++.++..|++++|..| ++||||||+|
T Consensus 685 EADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDN 759 (1034)
T KOG0608|consen 685 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDN 759 (1034)
T ss_pred hcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccc
Confidence 3467889999999999999999999999999999998855 4999999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCcccc---ccc--cccc-------------------------------------CCCCCCCCccC
Q 027225 83 LLVDKKYTVKVCDFGLSRLK---ANT--FLSS-------------------------------------KSAAGTPEWMA 120 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~---~~~--~~~~-------------------------------------~~~~~~~~~~~ 120 (226)
|++|.+|.+||+|||+|+-. .+. .... ....|++.|+|
T Consensus 760 ILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 760 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred eEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 99999999999999998520 000 0000 01237899999
Q ss_pred cccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCC
Q 027225 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRP 197 (226)
Q Consensus 121 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp 197 (226)
||++...+++..+|+||.|+++|+|+.|+.||...++.+....+......+. ....+++++.++|.++. -+++.|.
T Consensus 840 pevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 840 PEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999999999999999999999999999988887776655543433333 34688999999998876 4556664
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=231.50 Aligned_cols=201 Identities=21% Similarity=0.216 Sum_probs=145.0
Q ss_pred CCCCC-cCcceeeeEE-------ecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 2 KRLRH-PNIVLFMGAV-------TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 2 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
+.++| +||++++|+| .+.+.++.++|++ +++|.+++.... ..+++.++..++.||+.||.|||++| |
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--I 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG--I 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 56778 7999999988 3335678888987 569999997532 34899999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcE-------------------EEccCCCcccccccc--------c--------ccCCCCCCCCc
Q 027225 74 VHRDLKSPNLLVDKKYTV-------------------KVCDFGLSRLKANTF--------L--------SSKSAAGTPEW 118 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~-------------------~l~df~~~~~~~~~~--------~--------~~~~~~~~~~~ 118 (226)
+||||||+||+++..+.+ +++|||+++...... . ......+++.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654444 555555543211000 0 00012357789
Q ss_pred cCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC
Q 027225 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 119 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 198 (226)
+|||++.+..++.++||||+||++|+|++|..|+..... .......... ........+...+++.+||..+|.+||+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 999999988899999999999999999999888654221 1111111111 1111122456778999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 027225 199 FSTIMELLRPLIKS 212 (226)
Q Consensus 199 ~~~~l~~l~~~~~~ 212 (226)
+.++++ ..++..
T Consensus 259 ~~eil~--h~~~~~ 270 (793)
T PLN00181 259 MSELLQ--SEFINE 270 (793)
T ss_pred hHHHhh--chhhhh
Confidence 999998 555543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=221.69 Aligned_cols=197 Identities=27% Similarity=0.431 Sum_probs=155.3
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
-+||||+++++.-.+.+..|+..|.|.. +|.+++...+ ..........+..+.|+++||++||+.+ |+||||||+|
T Consensus 560 D~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQN 636 (903)
T KOG1027|consen 560 DEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQN 636 (903)
T ss_pred cCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCce
Confidence 3899999999999999999999999965 9999998742 1112222455778999999999999999 9999999999
Q ss_pred EEEcC---C--CcEEEccCCCccccccc---ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCC
Q 027225 83 LLVDK---K--YTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWG 153 (226)
Q Consensus 83 il~~~---~--~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~ 153 (226)
|+++. + .+++|+|||+++..... ........|+.+|+|||++.....+.++|+||+||++|+.++| ..||+
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99976 2 47899999999875433 2234456788999999999998888899999999999999987 88998
Q ss_pred CCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+.-..+..... -......+......+..+||.+|+..+|..||++.+|+.
T Consensus 717 d~~~R~~NIl~-~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 717 DSLERQANILT-GNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred chHHhhhhhhc-CccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 75544332221 122222223333338999999999999999999999984
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-33 Score=200.53 Aligned_cols=199 Identities=26% Similarity=0.439 Sum_probs=156.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC--CCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP--GVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDL 78 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di 78 (226)
+.-+.||||++++.+-.++..|+-||.++- ||..+...- -....+++..+-.+..-.+.||.||.. .. |+|||+
T Consensus 118 ks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDv 194 (361)
T KOG1006|consen 118 KSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDV 194 (361)
T ss_pred hhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccC
Confidence 445789999999999888999999999954 887665430 112348888888888899999999977 46 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+||+++..|.+||+|||.+....++.... ...|...|+|||.+.. .+++.++||||||++++|+.||..|+...+
T Consensus 195 KPSNILldr~G~vKLCDFGIcGqLv~SiAkT-~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 195 KPSNILLDRHGDVKLCDFGICGQLVDSIAKT-VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred ChhheEEecCCCEeeecccchHhHHHHHHhh-hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 9999999999999999999987766553333 3455668999999864 358999999999999999999999998765
Q ss_pred HH--HHHHHHhhCCccCCCCC---CCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PA--QVVAAVGFKGKRLEIPR---NVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~--~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.. ++.....-..+.+..+. .++.++..+|.-||..|-..||.+.++.+
T Consensus 274 svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 274 SVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 42 22222221222222333 48899999999999999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=193.56 Aligned_cols=207 Identities=27% Similarity=0.457 Sum_probs=176.4
Q ss_pred CCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCC-----CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKP-----GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
..+.|||+..+.+++.+ ....++++.+..-|+|..++... .....++-.+...++.|++.|++|||++| ++|
T Consensus 342 y~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViH 419 (563)
T KOG1024|consen 342 YGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIH 419 (563)
T ss_pred hcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--ccc
Confidence 34689999999998865 46689999999999999999832 11224666677788999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccc--cccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPW 152 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~--~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~ 152 (226)
.||-..|..+++.-++||+|-.+++.. .+.............||+||.+.+..++.++|+||||+++|||+| |+.|+
T Consensus 420 kDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py 499 (563)
T KOG1024|consen 420 KDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY 499 (563)
T ss_pred chhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc
Confidence 999999999999999999998887642 233222333334457999999999999999999999999999998 78899
Q ss_pred CCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
...++.+....++ ++.+..-|.+++++++.++.-||...|++||+.+++...|.++-.
T Consensus 500 aeIDPfEm~~ylk-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 500 AEIDPFEMEHYLK-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred cccCHHHHHHHHh-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 9999999999886 777888899999999999999999999999999999999988754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=212.38 Aligned_cols=198 Identities=28% Similarity=0.410 Sum_probs=165.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+++.||.||.+--.|+..+..++|||.+.|.-|.-++... .+++++.....+..||+.||.|||-++ |+|+||||
T Consensus 617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKP 692 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKP 692 (888)
T ss_pred HHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCc
Confidence 57899999999999999999999999999775555555543 345999999999999999999999999 99999999
Q ss_pred CcEEEcCCC---cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 027225 81 PNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN- 156 (226)
Q Consensus 81 ~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~- 156 (226)
+||++.... ++||+|||+++..+... ....-.|++.|+|||++.+.++...-|+||+|+++|.-++|..||+...
T Consensus 693 ENVLLas~~~FPQvKlCDFGfARiIgEks-FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 693 ENVLLASASPFPQVKLCDFGFARIIGEKS-FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hheeeccCCCCCceeeccccceeecchhh-hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 999996543 79999999999887653 3456689999999999999999999999999999999999999997532
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+.++... .-.....+.+++++..+||..+|+.+-.+|-|.+..+.
T Consensus 772 IndQIQNAa-FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 772 INDQIQNAA-FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhHHhhccc-cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 222222221 12234456789999999999999999999999988765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=195.44 Aligned_cols=199 Identities=25% Similarity=0.333 Sum_probs=158.9
Q ss_pred CCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
..+.|+||++++.+|.-. ...|+|||++.+ +|...+... ++-+.+..++.|++.|+.+||+.| |.|
T Consensus 70 ~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~--Iih 141 (369)
T KOG0665|consen 70 KCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILME-----LDHETISYILYQMLCGIKHLHSAG--IIH 141 (369)
T ss_pred hhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc--eee
Confidence 457999999999999533 459999999965 998888732 777888999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|||||+||++..+..+|+.|||+++..... ........+..|.|||++.+..+.+.+|+||+||++.+|++|...|.+.
T Consensus 142 RdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 142 RDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred cccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 999999999999999999999998764443 3344556677899999999999999999999999999999999988765
Q ss_pred CHHHHHHHHhhCCccC-----------------------------CC-----------CCCCCHHHHHHHHHHcccCCCC
Q 027225 156 NPAQVVAAVGFKGKRL-----------------------------EI-----------PRNVNPHVASIIEACWANEPWK 195 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~-----------------------------~~-----------~~~~~~~~~~li~~~l~~~p~~ 195 (226)
+.-+....+....+.+ .+ +..-....++++.+||..||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 5443322221111100 00 1122356899999999999999
Q ss_pred CCCHHHHHHHHHHhhc
Q 027225 196 RPSFSTIMELLRPLIK 211 (226)
Q Consensus 196 Rps~~~~l~~l~~~~~ 211 (226)
|.|+++++. +..++
T Consensus 301 Risv~daL~--HPY~~ 314 (369)
T KOG0665|consen 301 RISVDDALR--HPYIK 314 (369)
T ss_pred cccHHHHhc--CCeee
Confidence 999999998 66664
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=198.49 Aligned_cols=205 Identities=35% Similarity=0.563 Sum_probs=164.0
Q ss_pred CCCcCcceeeeEEecCCc----eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC------CCCe
Q 027225 4 LRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR------NPPI 73 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~------~~~i 73 (226)
|+|+||+.++..-..+.. +|+|++|++.|||.|++++.. ++.+...+++..++.||++||.. .++|
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaI 337 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAI 337 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchh
Confidence 699999999887654433 999999999999999999855 99999999999999999999963 2579
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCccccccc----ccccCCCCCCCCccCcccccCCC------CCCchhHHHHHHHHH
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSFGVILW 143 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~------~~~~~Dv~slG~~l~ 143 (226)
+|||||..||++.++|.+.+.|+|++...... ........|+..|||||++...- ....+||||+|.++|
T Consensus 338 AHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlW 417 (513)
T KOG2052|consen 338 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLW 417 (513)
T ss_pred hccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHH
Confidence 99999999999999999999999999754333 22345678899999999986542 245799999999999
Q ss_pred HHHhC----------CCCCC-----CCCHHHHHHHHhhCCccCCCCCCCC-----HHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 144 ELATL----------QQPWG-----NLNPAQVVAAVGFKGKRLEIPRNVN-----PHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 144 ~l~~g----------~~p~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
|++-. +.||- +...++.....-....++.+|..+. ..+..+++.||..||.-|.|+-.+.
T Consensus 418 EiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 418 EIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 99742 44663 3344444444444555666666554 3577789999999999999999999
Q ss_pred HHHHHhhcC
Q 027225 204 ELLRPLIKS 212 (226)
Q Consensus 204 ~~l~~~~~~ 212 (226)
+.|.++...
T Consensus 498 Ktl~~l~~~ 506 (513)
T KOG2052|consen 498 KTLAKLSNS 506 (513)
T ss_pred HHHHHHhcC
Confidence 999988753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=198.61 Aligned_cols=209 Identities=30% Similarity=0.466 Sum_probs=169.0
Q ss_pred CCCCcCcceeeeEEecCC----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC-------C
Q 027225 3 RLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN-------P 71 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-------~ 71 (226)
.++|+||+++++.-.... .+++|++|.+.|||.+++..+. ++|....+++..+++||+|||+.- +
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp 335 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKP 335 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCC
Confidence 479999999998776554 7999999999999999999765 999999999999999999999742 4
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCC------CCchhHHHHHHHHH
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPS------NEKSDIYSFGVILW 143 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~------~~~~Dv~slG~~l~ 143 (226)
+|+|||||..||++..++.+.|+|||++....... .......|+..|||||++.+.-. -.+.||||+|.++|
T Consensus 336 ~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 336 PIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW 415 (534)
T ss_pred ccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999997644222 22234678999999999976532 23689999999999
Q ss_pred HHHhCCCC------------CC-----CCCHHHHHHHHhhCCccCCCCCCC-----CHHHHHHHHHHcccCCCCCCCHHH
Q 027225 144 ELATLQQP------------WG-----NLNPAQVVAAVGFKGKRLEIPRNV-----NPHVASIIEACWANEPWKRPSFST 201 (226)
Q Consensus 144 ~l~~g~~p------------~~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~ 201 (226)
|+++...- |. ....++.......+..++.++..+ -..+++.+..||..|++.|.|+.=
T Consensus 416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 99986432 21 234445555555566666666543 367999999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 027225 202 IMELLRPLIKSPTP 215 (226)
Q Consensus 202 ~l~~l~~~~~~~~~ 215 (226)
+.+.+.++....+.
T Consensus 496 v~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 496 VEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHHhccCCc
Confidence 99999988887765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=215.46 Aligned_cols=209 Identities=31% Similarity=0.564 Sum_probs=183.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|.+++|||++++++++.... ..+|++++++|+|.++++.+.. .+-.+..+.|+.||++|+.|||.+. ++||||-.
T Consensus 752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaa 826 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAA 826 (1177)
T ss_pred HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhh
Confidence 46899999999999998766 8999999999999999997643 4888999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc--CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
.||++...+.+|+.|||++.......... ......+-|+|-|.+....++.++||||+|+.+||++| |..|+.+...
T Consensus 827 RNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 827 RNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred hheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 99999999999999999998654332221 22233457899999999999999999999999999998 8999999998
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+++-..+. .+.+++-|...+-++..++.+||..|+..||+++++...+.++.+....
T Consensus 907 ~eI~dlle-~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 907 EEIPDLLE-KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred HHhhHHHh-ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 88888876 5666888999999999999999999999999999999999999888654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=184.27 Aligned_cols=163 Identities=24% Similarity=0.342 Sum_probs=126.8
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCC
Q 027225 32 GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111 (226)
Q Consensus 32 ~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 111 (226)
|+|.+++..++ ..+++.+++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+...... .
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~ 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----Q 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----c
Confidence 68999997643 24999999999999999999999987 999999999999999 9987654432 1
Q ss_pred CCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhCCccC-----CCCCCCCH--HHHH
Q 027225 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRL-----EIPRNVNP--HVAS 183 (226)
Q Consensus 112 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~--~~~~ 183 (226)
..+++.|+|||++.+..++.++||||+|+++|+|++|..||...... ............. ..+..++. ++.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 24678999999999988999999999999999999999999654332 2111111111111 11223333 6999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 184 IIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 184 li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
++.+||..+|.+||++.++++.+.....
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=208.21 Aligned_cols=195 Identities=17% Similarity=0.173 Sum_probs=135.6
Q ss_pred ecCCceEEEEeecccCCHHHHhcCCCCC-----------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 17 TQPPNLSIVTEYLSRGSLYRLLHKPGVR-----------------EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 17 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
..+...++|+||+.+++|.+++...... .......+..++.|++.||+|||+++ |+|||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLK 282 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVK 282 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCC
Confidence 3456799999999999999998753210 01123456679999999999999999 9999999
Q ss_pred CCcEEEcC-CCcEEEccCCCccccccc-ccccCCCCCCCCccCcccccCCC----------------------CCCchhH
Q 027225 80 SPNLLVDK-KYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEP----------------------SNEKSDI 135 (226)
Q Consensus 80 p~nil~~~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~----------------------~~~~~Dv 135 (226)
|+||+++. ++.+||+|||++...... ........+++.|+|||.+.... +..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 579999999998653322 11223456678999999654221 2345699
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCC-----------cc--------CCCCCCCCHHHHHHHHHHcccCCCCC
Q 027225 136 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-----------KR--------LEIPRNVNPHVASIIEACWANEPWKR 196 (226)
Q Consensus 136 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~--------~~~~~~~~~~~~~li~~~l~~~p~~R 196 (226)
||+||++|+|+++..+..... ......+.... .. .......+....+||.+||+.||.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999999766543221 11111110000 00 00011123345689999999999999
Q ss_pred CCHHHHHHHHHHhhcCCCCC
Q 027225 197 PSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 197 ps~~~~l~~l~~~~~~~~~~ 216 (226)
||+.++++ ++++......
T Consensus 442 ~ta~e~L~--Hpff~~~~~~ 459 (566)
T PLN03225 442 ISAKAALA--HPYFDREGLL 459 (566)
T ss_pred CCHHHHhC--CcCcCCCCcc
Confidence 99999999 7888765543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=212.09 Aligned_cols=176 Identities=28% Similarity=0.506 Sum_probs=135.2
Q ss_pred CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCc
Q 027225 20 PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99 (226)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 99 (226)
..+||-||||+..++.++++++... -.....++++.+|+.||.|+|+.| ++||||||.|||++.++.+||+|||++
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccc
Confidence 4589999999998888888775421 147788999999999999999999 999999999999999999999999999
Q ss_pred cccc----------c--------cccccCCCCCCCCccCcccccCCC---CCCchhHHHHHHHHHHHHhCCCCCCCC-CH
Q 027225 100 RLKA----------N--------TFLSSKSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWGNL-NP 157 (226)
Q Consensus 100 ~~~~----------~--------~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~ 157 (226)
+... . .........|+.-|+|||++.+.. ++.|.|+||||++++||+. ||... ..
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER 821 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER 821 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH
Confidence 7511 0 001223456788999999997655 8999999999999999975 35432 23
Q ss_pred HHHHHHHhhCCccCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+....+ ....+.+ ..--+.-..+|.+|++.||.+|||+.|+++
T Consensus 822 a~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 822 ASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 33333332 2333322 222355678999999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=179.97 Aligned_cols=168 Identities=43% Similarity=0.679 Sum_probs=147.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++.++|++|+++++++......++++|++.+++|.+++.... ..++...+..++.+++.++.+||+.| ++|+||+|
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~ 120 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKP 120 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence 356789999999999999899999999999899999998642 23899999999999999999999999 99999999
Q ss_pred CcEEEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
.||+++. ++.++|+||+.+..................|.+||..... ..+.+.|+|++|++++++
T Consensus 121 ~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------- 187 (215)
T cd00180 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187 (215)
T ss_pred hhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------
Confidence 9999999 8999999999887554432223334567789999999877 788999999999999999
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 788999999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=202.79 Aligned_cols=199 Identities=32% Similarity=0.532 Sum_probs=173.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++.++||||+.|++.+...+..|+.||||.||+|++...-.+ .+++.++...+.+-+++|+|||+.| -.|||||-
T Consensus 66 ~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g--k~hRdiKG 140 (829)
T KOG0576|consen 66 LRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKG 140 (829)
T ss_pred eecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC--cccccccc
Confidence 467899999999999999999999999999999999988744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
.||++++.|.+|+.|||.+...+..-.....+.|++.|+|||+.. ...+...+|+|++|+...++-.-+.|..+.-+
T Consensus 141 anilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp 220 (829)
T KOG0576|consen 141 ANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP 220 (829)
T ss_pred cceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence 999999999999999999988888777788899999999999874 44578999999999999999888888776666
Q ss_pred HHHHHHHhhCC---ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKG---KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
........... ...+-+..+++.+.+|++.+|..+|++||+++.++.
T Consensus 221 mr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 221 MRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 55554443222 233445678999999999999999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=174.74 Aligned_cols=151 Identities=28% Similarity=0.510 Sum_probs=126.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~ 79 (226)
+...+|.+|.+|+....+...|+-||.+.. ||..+..+- ..+...++..+-+++..++.||.|||++ . ++|||+|
T Consensus 100 r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvK 176 (282)
T KOG0984|consen 100 RTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVK 176 (282)
T ss_pred cCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCC
Confidence 456889999999999889999999999954 888776541 1134589999999999999999999995 6 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD----EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|+||+++.+|++|++|||.+....++.... ...|...|+|||.+.. ..|+.++||||||+.+.||.+++.||...
T Consensus 177 PsNiLIn~~GqVKiCDFGIsG~L~dSiAkt-~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 177 PSNILINYDGQVKICDFGISGYLVDSIAKT-MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cceEEEccCCcEEEcccccceeehhhhHHH-HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999999999999999999987665553322 2345678999998853 36889999999999999999999999764
Q ss_pred C
Q 027225 156 N 156 (226)
Q Consensus 156 ~ 156 (226)
.
T Consensus 256 ~ 256 (282)
T KOG0984|consen 256 G 256 (282)
T ss_pred C
Confidence 3
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=175.59 Aligned_cols=194 Identities=23% Similarity=0.385 Sum_probs=153.3
Q ss_pred CCCC-CcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 2 KRLR-HPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 2 ~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+.+. ||||++++++..+. ...-+|+|++++.+...+... ++...++.++.+++.||.|+|+.| |.|||+
T Consensus 87 ~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~G--ImHRDV 158 (338)
T KOG0668|consen 87 QNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMG--IMHRDV 158 (338)
T ss_pred HhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcC--cccccC
Confidence 3455 89999999999765 458899999999888888765 888899999999999999999999 999999
Q ss_pred CCCcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCC-C-
Q 027225 79 KSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWG-N- 154 (226)
Q Consensus 79 ~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~-~- 154 (226)
||.|++++... .++|+|+|++.......+ ...+..+..|..||.+.... ++.+-|+|||||++..|+..+.||. +
T Consensus 159 KPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 159 KPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CcceeeechhhceeeeeecchHhhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 99999998654 689999999866544322 33455667889999998765 6888999999999999999988873 2
Q ss_pred CCHHHHHHHHhhCCcc----------C------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 155 LNPAQVVAAVGFKGKR----------L------------------------EIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~----------~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
.+.++.....+..+.. . .-...++++..+++.++|..|..+|+|++
T Consensus 238 dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 238 DNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred CCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence 3444433322211110 0 00124579999999999999999999999
Q ss_pred HHHH
Q 027225 201 TIME 204 (226)
Q Consensus 201 ~~l~ 204 (226)
|.+.
T Consensus 318 Eam~ 321 (338)
T KOG0668|consen 318 EAMA 321 (338)
T ss_pred HHhc
Confidence 9987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=199.97 Aligned_cols=198 Identities=20% Similarity=0.291 Sum_probs=160.0
Q ss_pred cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEc
Q 027225 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD 86 (226)
Q Consensus 7 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~ 86 (226)
-|+++++..|...+++|+|||-. ..+|.+.+.+.|..-.+....++.++.||+.||..|-..| ++|.||||+||+++
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVN 570 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEec
Confidence 47888999999999999999988 5699999998887777999999999999999999999999 99999999999998
Q ss_pred CCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q 027225 87 KKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165 (226)
Q Consensus 87 ~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 165 (226)
... .+||||||.+...... . .....-...|.|||++.|..|+...|+||+||++|++.||+..|.+.+..+......
T Consensus 571 E~k~iLKLCDfGSA~~~~en-e-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASEN-E-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cCcceeeeccCccccccccc-c-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 754 5799999987543321 1 111122347999999999999999999999999999999999998887777665443
Q ss_pred hCCccCCC----------------------------------------C-----------CCCC-------HHHHHHHHH
Q 027225 166 FKGKRLEI----------------------------------------P-----------RNVN-------PHVASIIEA 187 (226)
Q Consensus 166 ~~~~~~~~----------------------------------------~-----------~~~~-------~~~~~li~~ 187 (226)
...+..+- | ..++ ..+++|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 22221110 0 0111 478999999
Q ss_pred HcccCCCCCCCHHHHHHHHHHhhc
Q 027225 188 CWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 188 ~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
||..||.+|.|..++++ +.|++
T Consensus 729 ml~LdP~KRit~nqAL~--HpFi~ 750 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALK--HPFIT 750 (752)
T ss_pred HhccChhhcCCHHHHhc--CCccc
Confidence 99999999999999998 66654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=194.36 Aligned_cols=200 Identities=21% Similarity=0.193 Sum_probs=143.0
Q ss_pred CcceeeeEEec--------CCceEEEEeecccCCHHHHhcCCCC---------------------CCcCCHHHHHHHHHH
Q 027225 8 NIVLFMGAVTQ--------PPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYD 58 (226)
Q Consensus 8 ~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~---------------------~~~~~~~~~~~~~~~ 58 (226)
++++++++|.. ++..++|+||+.+++|.+++..... ...+++..+..++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 34677777753 3568999999999999998864210 112466788899999
Q ss_pred HHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCC--------
Q 027225 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPS-------- 129 (226)
Q Consensus 59 l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~-------- 129 (226)
++.+|.|+|+.+ ++|+||||+||+++.++.++|+|||++........ .......++.|++||.+.....
T Consensus 318 l~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~ 395 (507)
T PLN03224 318 VLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPA 395 (507)
T ss_pred HHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhh
Confidence 999999999999 99999999999999999999999999865332211 1112334678999998754221
Q ss_pred --------------CCchhHHHHHHHHHHHHhCCC-CCCCCCHHHH---------H--HHHhhCCccCCCCCCCCHHHHH
Q 027225 130 --------------NEKSDIYSFGVILWELATLQQ-PWGNLNPAQV---------V--AAVGFKGKRLEIPRNVNPHVAS 183 (226)
Q Consensus 130 --------------~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~~---------~--~~~~~~~~~~~~~~~~~~~~~~ 183 (226)
..+.|+||+||++++|++|.. |+........ . ................++..++
T Consensus 396 ~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~d 475 (507)
T PLN03224 396 MAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWD 475 (507)
T ss_pred hhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHH
Confidence 134699999999999999875 6643211110 0 0011111122334567899999
Q ss_pred HHHHHcccCC---CCCCCHHHHHHHHHHhhc
Q 027225 184 IIEACWANEP---WKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 184 li~~~l~~~p---~~Rps~~~~l~~l~~~~~ 211 (226)
++.+||..+| .+|+|+.|+++ +.++.
T Consensus 476 Li~~LL~~~~~~~~~RlSa~eaL~--Hp~f~ 504 (507)
T PLN03224 476 LACKLITKRDQANRGRLSVGQALS--HRFFL 504 (507)
T ss_pred HHHHHhccCCCCcccCCCHHHHhC--CCCcC
Confidence 9999999766 68999999998 66653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-28 Score=191.23 Aligned_cols=144 Identities=27% Similarity=0.428 Sum_probs=127.5
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecc-cCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+-.|+||++++++|++++++|+++|-.. |-+|++++..+. .+++.++.-++.|++.|+++||+.| |+|||||-+
T Consensus 625 ~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikde 699 (772)
T KOG1152|consen 625 KHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDE 699 (772)
T ss_pred hcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC--ceecccccc
Confidence 3459999999999999999999999665 678999998844 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||.++.+|.+||+|||.+...... ....+.|+..|.|||++.+..| ...-|+|+||+++|-++...+||-
T Consensus 700 nvivd~~g~~klidfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 700 NVIVDSNGFVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cEEEecCCeEEEeeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999988654433 2346788999999999999876 566899999999999999888874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=179.46 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=153.2
Q ss_pred CCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
..++|.|++..+|+..-. ...|+|+|.+.. +|..++-.. ..++.+.+.-++.||++||.|||+.+ |.||
T Consensus 107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHR 180 (449)
T KOG0664|consen 107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN--ILHR 180 (449)
T ss_pred HhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc--hhhc
Confidence 457899999888877533 238889998855 787777653 34889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCccccccc-ccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
||||.|.+++.+..+|++|||+++..... ........-+.+|+|||++.+.. ++.+.||||+||++.|++..+..|..
T Consensus 181 DIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 181 DIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred cCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 99999999999999999999999764432 12222334467899999998765 78999999999999999998888877
Q ss_pred CCHHHHHHHHhhCCccCCC--------------------------------CCCCCHHHHHHHHHHcccCCCCCCCHHHH
Q 027225 155 LNPAQVVAAVGFKGKRLEI--------------------------------PRNVNPHVASIIEACWANEPWKRPSFSTI 202 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 202 (226)
.++.+..+.+....+.++. +..-..+...++.+++..||.+|.+..+.
T Consensus 261 q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 261 AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 7766655544432222110 11223567789999999999999998887
Q ss_pred HHH
Q 027225 203 MEL 205 (226)
Q Consensus 203 l~~ 205 (226)
+..
T Consensus 341 ~~~ 343 (449)
T KOG0664|consen 341 LQH 343 (449)
T ss_pred ccc
Confidence 763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=170.19 Aligned_cols=192 Identities=24% Similarity=0.382 Sum_probs=145.5
Q ss_pred CCcCcceeee-EEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMG-AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~-~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.|.||+..|+ .|+..+.++.++||++.|+|.+-+...| +-+.....++.|+++||.|+|+.+ ++|||||.+||
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNi 152 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENI 152 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceE
Confidence 5889998776 5667778999999999999999998766 778888899999999999999999 99999999999
Q ss_pred EEcC--CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 027225 84 LVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFGVILWELATLQQPWGNL- 155 (226)
Q Consensus 84 l~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~~~- 155 (226)
++-+ .-++||+|||.++..+..-.. ......|.+||..... .....+|+|+||++++.+++|+.||...
T Consensus 153 Lif~~df~rvKlcDFG~t~k~g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 153 LIFDADFYRVKLCDFGLTRKVGTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred EEecCCccEEEeeecccccccCceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 9943 338999999998765554322 2234468888876432 2356799999999999999999999632
Q ss_pred --CHHHHHHHHhhCCccCCCC---CCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 156 --NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
++.-..............| ..+++.+..+.++-|..++++|-.+.++.++
T Consensus 230 ~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 230 IMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2222222222222333333 4678899999999999999999555444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=199.06 Aligned_cols=204 Identities=25% Similarity=0.348 Sum_probs=165.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|||++..++.+.+.....-+||||++ +|+.++...+ .++..++..++.||+.|+.|+|..| ++|+|+|++
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~e 449 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLE 449 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccc
Confidence 368999999988888777776666999999 9999998753 3889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|++++.+|.+|++|||.+.......+ ......+...|+|||++.+..+.. ..|+||.|+++..|.+|+.||....
T Consensus 450 nll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 450 NLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred cEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 99999999999999998865444333 234567788999999999888754 5899999999999999999997654
Q ss_pred HHHHHH-HH------hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 157 PAQVVA-AV------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 157 ~~~~~~-~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+... .. ....+...+...++...+.+|.+||+.+|.+|.|+++|++ .+|++..
T Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~i 591 (601)
T KOG0590|consen 530 KSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRSI 591 (601)
T ss_pred ccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhhc
Confidence 443321 11 1111222334567889999999999999999999999999 7777654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=165.97 Aligned_cols=159 Identities=37% Similarity=0.577 Sum_probs=132.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|+|++++++++......++++|++.+++|.+++...... +++..+..++.+++.++.+||+.+ ++|+|++|+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ 127 (225)
T smart00221 52 KKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPE 127 (225)
T ss_pred HhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 4678999999999999989999999999999999999864321 789999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccc-cCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGN-LNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~ 158 (226)
||+++.++.++|+|||.+....... .......+...|++||.. ....++.++|+|++|++++++++|+.||.. .+..
T Consensus 128 ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 128 NILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred HEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 9999999999999999887654432 112233456689999998 566677899999999999999999999977 3433
Q ss_pred -HHHHHH
Q 027225 159 -QVVAAV 164 (226)
Q Consensus 159 -~~~~~~ 164 (226)
...+.+
T Consensus 208 ~~~~~~~ 214 (225)
T smart00221 208 SLLSDVW 214 (225)
T ss_pred HHHHHHH
Confidence 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=172.43 Aligned_cols=76 Identities=26% Similarity=0.432 Sum_probs=66.2
Q ss_pred CcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCCC
Q 027225 6 HPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKS 80 (226)
Q Consensus 6 h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~p 80 (226)
-.+||+++|.|.. +.+.|+|+|+. |.+|..++.... ...++...+.+|+.|++.||.|||.. | |+|.||||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKP 216 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKP 216 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCc
Confidence 4689999999964 46899999998 779999887644 23389999999999999999999984 8 99999999
Q ss_pred CcEEE
Q 027225 81 PNLLV 85 (226)
Q Consensus 81 ~nil~ 85 (226)
+||++
T Consensus 217 ENvLl 221 (590)
T KOG1290|consen 217 ENVLL 221 (590)
T ss_pred ceeee
Confidence 99998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=163.18 Aligned_cols=197 Identities=24% Similarity=0.348 Sum_probs=149.7
Q ss_pred CCCcCcceeeeEEec---------------------------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHH
Q 027225 4 LRHPNIVLFMGAVTQ---------------------------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56 (226)
Q Consensus 4 l~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~ 56 (226)
-+||||++++.+|.+ ....|+||..+.. +|..++..+. .+....+-++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~l 347 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVIL 347 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHH
Confidence 389999999998843 2348999998865 9999998654 6677777799
Q ss_pred HHHHHHHHHHhcCCCCeEEeCCCCCcEEE--cCCC--cEEEccCCCccccccc------ccccCCCCCCCCccCcccccC
Q 027225 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKY--TVKVCDFGLSRLKANT------FLSSKSAAGTPEWMAPEVLRD 126 (226)
Q Consensus 57 ~~l~~~l~~lH~~~~~i~h~di~p~nil~--~~~~--~~~l~df~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~ 126 (226)
.|+++|+.|||++| ++|+|+|.+||++ ++++ .+.+.|||.+--.... ....-...|+-..+|||+...
T Consensus 348 aQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999999 9999999999998 4443 5789999965322211 111223456678899999875
Q ss_pred CC------CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 127 EP------SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 127 ~~------~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
.. ...++|.|+.|.+.||+++..+||-...........-.....+..+..+++.+++++..+|+.||++|++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 43 257899999999999999999998653322222111224456677899999999999999999999999987
Q ss_pred HHHHHHH
Q 027225 201 TIMELLR 207 (226)
Q Consensus 201 ~~l~~l~ 207 (226)
=..+.|+
T Consensus 506 iAANvl~ 512 (598)
T KOG4158|consen 506 IAANVLN 512 (598)
T ss_pred HHHhHHH
Confidence 6665554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=169.32 Aligned_cols=196 Identities=26% Similarity=0.372 Sum_probs=149.5
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEE
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~ 85 (226)
+.||+++.+++..++...+|+||++.....++... ++..++..+++.++.||.++|++| |+||||||+|+++
T Consensus 94 ~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~ 165 (418)
T KOG1167|consen 94 SDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLY 165 (418)
T ss_pred chhhhcchhhhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCcccccc
Confidence 57899999999999999999999999999999887 788999999999999999999999 9999999999999
Q ss_pred c-CCCcEEEccCCCcccc-c--------c------cc------------------cc-----------cCCCCCCCCccC
Q 027225 86 D-KKYTVKVCDFGLSRLK-A--------N------TF------------------LS-----------SKSAAGTPEWMA 120 (226)
Q Consensus 86 ~-~~~~~~l~df~~~~~~-~--------~------~~------------------~~-----------~~~~~~~~~~~~ 120 (226)
+ ..++-.|+|||++... . . .. .. .-...|+++|.|
T Consensus 166 n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa 245 (418)
T KOG1167|consen 166 NRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA 245 (418)
T ss_pred ccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc
Confidence 7 4678899999998610 0 0 00 00 001237899999
Q ss_pred cccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHH-HHHhhC-----------Ccc----------------
Q 027225 121 PEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNL-NPAQVV-AAVGFK-----------GKR---------------- 170 (226)
Q Consensus 121 PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~-~~~~~~-----------~~~---------------- 170 (226)
||++...+ .+.+.|+||.|+++..+++++.||... +..+.. ...... .+.
T Consensus 246 PEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~ 325 (418)
T KOG1167|consen 246 PEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELR 325 (418)
T ss_pred hHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHH
Confidence 99987654 678999999999999999999998422 111110 000000 000
Q ss_pred -----C----------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 171 -----L----------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 171 -----~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
. ......+..+.+++.+|+..||.+|.|+++.++ +.++.
T Consensus 326 ~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk--HpFF~ 385 (418)
T KOG1167|consen 326 VNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK--HPFFD 385 (418)
T ss_pred hchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc--CcCCc
Confidence 0 001123458999999999999999999999997 55554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-23 Score=165.87 Aligned_cols=210 Identities=33% Similarity=0.567 Sum_probs=166.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|.|+.++++.+.++...++|.+||..|+|.+.+...... +++.....++..++.|+.|+|.... .+|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--LDYFFILSFIRDISKGLAYLHNSPI-GYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--ccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecc
Confidence 68999999999999999999999999999999999999874432 8888888999999999999999872 39999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCC-------CCCchhHHHHHHHHHHHHhCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEP-------SNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~-------~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
.|.+++..-.+|++|||+....... ............|.|||.+.+.. .+.+.|+||+|++++++++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999988665421 11111122345789999987642 35679999999999999999999
Q ss_pred CCCC----CHHHHHHHHhhCCcc---CCCC--CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 152 WGNL----NPAQVVAAVGFKGKR---LEIP--RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 152 ~~~~----~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
|... ++.++...+...... +.++ ....+++..+++.||..+|.+||+++++...++.+.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9652 333455554431221 1111 145567999999999999999999999999998887764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=152.36 Aligned_cols=202 Identities=33% Similarity=0.711 Sum_probs=169.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|+-+.||||+.+++.|....+..+|..|++.|||...+.... .-..+..++.+++..++.|.+|||+..+-+.--.++.
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns 319 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNS 319 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhccc
Confidence 355789999999999999999999999999999999998754 4457788899999999999999999864344446899
Q ss_pred CcEEEcCCCcEEEc--cCCCcccccccccccCCCCCCCCccCcccccCCC---CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVC--DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
..|++|++...+++ |-.++ .........+.|++||.+...+ .-.++|+||+++++|++.|...||.+.
T Consensus 320 ~hvmidedltarismad~kfs-------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 320 KHVMIDEDLTARISMADTKFS-------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred ceEEecchhhhheecccceee-------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 99999998766653 32221 1122334467899999998664 346799999999999999999999999
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
.+-+.--.+...+-+..+|..++..+..+++-|.+.||.+||.+..++-.|+++.
T Consensus 393 spmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 393 SPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 8888877887788899999999999999999999999999999999998887764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-22 Score=155.70 Aligned_cols=203 Identities=21% Similarity=0.251 Sum_probs=162.0
Q ss_pred cCcceeeeEE-ecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEE
Q 027225 7 PNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 7 ~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~ 85 (226)
+++.++++.+ ..+...|+||+.+ |.+|.++..... .+.++...+..++.|++.+|+++|+.| ++||||||+|+.+
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~ 155 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVV 155 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeee
Confidence 6889999999 5788899999988 789999997665 556999999999999999999999999 9999999999999
Q ss_pred cCC-----CcEEEccCCCcc--ccccccc-------c-cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC
Q 027225 86 DKK-----YTVKVCDFGLSR--LKANTFL-------S-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 86 ~~~-----~~~~l~df~~~~--~~~~~~~-------~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+.. ..+.+.|||+++ ....... . .....|+..|.++..+.+...+.+.|+||++.++.++..|..
T Consensus 156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 865 358999999998 3221111 1 123458899999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhhCCccCC---CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLE---IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
||.................... .....+.++..+...+-+.+..++|++..+...+++.....
T Consensus 236 PW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 236 PWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred CCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 9976553222222211111111 23446678888888888899999999999999998887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-25 Score=184.28 Aligned_cols=194 Identities=19% Similarity=0.233 Sum_probs=148.1
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
..++||++++......++..|+|-+|+.. +|.|.+..+ +.+..-+-..++.||+.||..+|..| |+|||||.+|
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsEN 150 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSEN 150 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccce
Confidence 46899999999988888889999999976 999999874 44888889999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCccccccc-------ccccCCCCCCCCccCcccccCCC-----------CCCchhHHHHHHHHHH
Q 027225 83 LLVDKKYTVKVCDFGLSRLKANT-------FLSSKSAAGTPEWMAPEVLRDEP-----------SNEKSDIYSFGVILWE 144 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~Dv~slG~~l~~ 144 (226)
|+++.-+.+.|+||...+...-+ ...........+|+|||.+.... .+.+.|+||+||+++|
T Consensus 151 ILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaE 230 (1431)
T KOG1240|consen 151 ILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAE 230 (1431)
T ss_pred EEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHH
Confidence 99999999999999876542211 11122334556899999886522 4678999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhhC--CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 145 LAT-LQQPWGNLNPAQVVAAVGFK--GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 145 l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
+++ |+++|.- .+...+.... ....-+..--+..++.+|..|++.||.+|.++++.++.
T Consensus 231 Lf~Eg~PlF~L---SQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 231 LFLEGRPLFTL---SQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhcCCCcccH---HHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 987 5777741 1111111100 00000111234578999999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-20 Score=147.01 Aligned_cols=202 Identities=32% Similarity=0.480 Sum_probs=159.8
Q ss_pred CCCCCc-CcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHP-NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++.|+ +|+++.+++......+++++++.++++.+++........+.......++.|++.++.++|+.+ ++|+|++|
T Consensus 52 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp 129 (384)
T COG0515 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKP 129 (384)
T ss_pred HHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence 356777 799999999777778999999999999977775431124899999999999999999999999 99999999
Q ss_pred CcEEEcCCC-cEEEccCCCccccccccc------ccCCCCCCCCccCcccccC---CCCCCchhHHHHHHHHHHHHhCCC
Q 027225 81 PNLLVDKKY-TVKVCDFGLSRLKANTFL------SSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 81 ~nil~~~~~-~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+||+++..+ .+++.|||.+........ ......++..|++||...+ .......|+|++|++++++++|..
T Consensus 130 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~ 209 (384)
T COG0515 130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209 (384)
T ss_pred HHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 999999988 799999998874433321 2355677889999999987 567889999999999999999999
Q ss_pred CCCCCCH----HHHHHHHhhCCcc-CCCCC--CC----CHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 151 PWGNLNP----AQVVAAVGFKGKR-LEIPR--NV----NPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 151 p~~~~~~----~~~~~~~~~~~~~-~~~~~--~~----~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
||..... .+....+...... ..... .. ...+.+++.+++..+|..|.+..+....
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 210 PFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 9876653 3444444333322 11111 11 2579999999999999999998887763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-22 Score=148.70 Aligned_cols=163 Identities=20% Similarity=0.253 Sum_probs=109.3
Q ss_pred eEEEEeecccCCHHHHhcC----CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCC
Q 027225 22 LSIVTEYLSRGSLYRLLHK----PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG 97 (226)
Q Consensus 22 ~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~ 97 (226)
.+++|+-.. ++|.+++.. ..............+..|+++.+++||..| ++|+||+|+|++++.+|.+.|+||+
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCCCCEEEcChH
Confidence 577888774 488887652 111222444555677789999999999999 9999999999999999999999998
Q ss_pred CcccccccccccCCCCCCCCccCcccccCC--------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCc
Q 027225 98 LSRLKANTFLSSKSAAGTPEWMAPEVLRDE--------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169 (226)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 169 (226)
.....+..... ...+..|.+||..... .++.+.|.|+||+++|.++++..||+.......... .
T Consensus 191 ~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~ 262 (288)
T PF14531_consen 191 SLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----D 262 (288)
T ss_dssp GEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----G
T ss_pred HHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----c
Confidence 77655543222 1223578899876432 357889999999999999999999986654322211 1
Q ss_pred cCCCCCCCCHHHHHHHHHHcccCCCCC
Q 027225 170 RLEIPRNVNPHVASIIEACWANEPWKR 196 (226)
Q Consensus 170 ~~~~~~~~~~~~~~li~~~l~~~p~~R 196 (226)
-..+. .++..+++||..+|+.||.+|
T Consensus 263 f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 263 FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 12333 899999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-22 Score=158.92 Aligned_cols=178 Identities=28% Similarity=0.436 Sum_probs=155.8
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.||.++++.-.++.+...+++.++..||.|...+... .++++.....+...++-+++++|+.+ ++|+|+|++||+
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enil 129 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVL 129 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH--HHHhccccccee
Confidence 4899999999999999999999999999999998874 45899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.+|.+++.|||.++........ +++..|+|||++. +....+|.||+|++++++++|..||.. ++...+
T Consensus 130 ld~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I 199 (612)
T KOG0603|consen 130 LLLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI 199 (612)
T ss_pred ecccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH
Confidence 999999999999998765544332 7788999999999 567889999999999999999999987 444434
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF 199 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 199 (226)
-......|...+...++++..++..+|..|.-.
T Consensus 200 --l~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 200 --LKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --hhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 334566788899999999999999999999655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-20 Score=137.49 Aligned_cols=202 Identities=16% Similarity=0.284 Sum_probs=166.2
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
-.++|..++-+..++.+..+|+|.. |.||.|+..-++.+ |+...+.-++.|++.-++++|++. +++|||||+|++
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFL 156 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFL 156 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc--eeecccCcccee
Confidence 3578889998889999999999988 78999998866544 999999999999999999999999 999999999999
Q ss_pred EcCCC-----cEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 85 VDKKY-----TVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 85 ~~~~~-----~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
++..+ .+.++|||+++...++.+ ......|+-.||+-....++..+.+.|+-|||.++.+.+-|..||
T Consensus 157 IGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW 236 (449)
T KOG1165|consen 157 IGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 236 (449)
T ss_pred ecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence 97543 589999999987555432 233456788999999999999999999999999999999999999
Q ss_pred CCCCH---HHHHHHHhhCCccCCC-----CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 153 GNLNP---AQVVAAVGFKGKRLEI-----PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 153 ~~~~~---~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.+... .+-.+.+. ...... -.+++.++...+.-.-..+-.+-|+++-+...+.+++...
T Consensus 237 QGLKA~tnK~kYeKIG--e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 237 QGLKADTNKEKYEKIG--ETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ccccCcchHHHHHHhc--cccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 76543 33344442 222222 2568889999999888999999999999999998887653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=148.14 Aligned_cols=171 Identities=25% Similarity=0.393 Sum_probs=130.6
Q ss_pred CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCc
Q 027225 20 PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99 (226)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 99 (226)
.++|+.|++|.-.+|.+++.++......+......++.|+..++.| +| .+|+|++|.||++..+..++++|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 3589999999999999999876666678889999999999999999 88 999999999999999999999999998
Q ss_pred ccccccc------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhhCCccC-
Q 027225 100 RLKANTF------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRL- 171 (226)
Q Consensus 100 ~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~- 171 (226)
....... .......++..|++||.+.+..++.++|+|+||+++++++.. ...+... .....+. .+..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r-~g~ip~ 479 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIR-DGIIPP 479 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhh-cCCCCh
Confidence 6543322 223345678999999999999999999999999999999982 2222111 1111111 11111
Q ss_pred CCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 172 EIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 172 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
.+...+ ++-.+|+.+++.+.|.+||++.
T Consensus 480 ~~~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 480 EFLQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred HHhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 122233 3446899999999999999443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.2e-19 Score=127.34 Aligned_cols=203 Identities=20% Similarity=0.293 Sum_probs=158.7
Q ss_pred cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEc
Q 027225 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD 86 (226)
Q Consensus 7 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~ 86 (226)
..|..+..++.++.+..+||+.. |.||.++.+-... .++...++-++-|++.-++|+|.++ ++||||||+|++.+
T Consensus 71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMG 145 (341)
T KOG1163|consen 71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMG 145 (341)
T ss_pred CCCchhhhhccccccceeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeec
Confidence 34555667788889999999988 8899999886543 3999999999999999999999999 99999999999996
Q ss_pred C---CCcEEEccCCCcccccccc-------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 87 K---KYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 87 ~---~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
- -.++.|+|||+++..-+.. .......|+-.|.+-....+...+.+.|+-|+|.++.++.-|..||.+..
T Consensus 146 lgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 146 LGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 3 3478999999997644332 22334456677777666666667889999999999999999999998764
Q ss_pred HHH---HHHHHhhCCccCC-----CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 157 PAQ---VVAAVGFKGKRLE-----IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 157 ~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
... ..+.+. ....+ +-..+|.++.-.+.-|-...-++-|+..-+.+.++-+++....+
T Consensus 226 a~tk~QKyEkI~--EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~ 291 (341)
T KOG1163|consen 226 AATKKQKYEKIS--EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ 291 (341)
T ss_pred hhhHHHHHHHHH--HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence 432 223332 22222 23678999999999999999999999999999888887765443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.7e-18 Score=131.75 Aligned_cols=110 Identities=20% Similarity=0.206 Sum_probs=82.8
Q ss_pred CCCCCCcCcce-eeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC-
Q 027225 1 MKRLRHPNIVL-FMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL- 78 (226)
Q Consensus 1 l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di- 78 (226)
|++++|+||++ +++ .+..|+||||+.|++|... .. .. ...++.+++.+|.+||+.| ++||||
T Consensus 75 L~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~ 138 (365)
T PRK09188 75 LKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG--ITHNDLA 138 (365)
T ss_pred HHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCC
Confidence 46789999985 444 2458999999999999732 11 11 1357889999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccccc--------CCCCCCCCccCcccccC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--------KSAAGTPEWMAPEVLRD 126 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~ 126 (226)
||+||+++.++.++|+|||++.......... ....++..|.+||.+..
T Consensus 139 KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 139 KPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999999999999987544332111 12334567889988764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.2e-18 Score=142.12 Aligned_cols=137 Identities=31% Similarity=0.478 Sum_probs=113.6
Q ss_pred HHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccc---------------ccccCCCCCCCCccCcc
Q 027225 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---------------FLSSKSAAGTPEWMAPE 122 (226)
Q Consensus 58 ~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~---------------~~~~~~~~~~~~~~~PE 122 (226)
+++.+++|+|+-| |+|+|+||+|.+++.-|.+|++|||+....... .......++++.|+|||
T Consensus 151 dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 3478999999999 999999999999999999999999988642211 11123447899999999
Q ss_pred cccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhC-CccCCCCCCCCHHHHHHHHHHcccCCCCC
Q 027225 123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKR 196 (226)
Q Consensus 123 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R 196 (226)
++...+|...+|+|++|+++|+.+.|+.||.+.++++........ ...++-...++++.+++|..+|..+|..|
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 999999999999999999999999999999999998876554322 22333345678999999999999999999
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-18 Score=126.27 Aligned_cols=119 Identities=17% Similarity=0.241 Sum_probs=89.6
Q ss_pred CCCCCcCcceeeeEEecC--------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 2 KRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
.++.|++|..+.+++... +..+++|||++|.+|.++.. +++. ...++..++..+|+.| +
T Consensus 90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH~~g--i 156 (232)
T PRK10359 90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLHQHG--M 156 (232)
T ss_pred HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHHHcC--C
Confidence 467899999999886533 35899999999999988732 3332 4559999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
+|||++|+||+++.+| ++++|||............ .......+..++|+|+||+.+..+.
T Consensus 157 ~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 157 VSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999999999988 9999999765432211100 0222334557899999999877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=118.82 Aligned_cols=137 Identities=18% Similarity=0.203 Sum_probs=100.8
Q ss_pred CCCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC-
Q 027225 1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL- 78 (226)
Q Consensus 1 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di- 78 (226)
|+++. |++|++++++ +..++++||+.|.+|...... ....++.|++.+|.++|+.| ++|+||
T Consensus 55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G--IvHrDL~ 118 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG--VAHNDLA 118 (218)
T ss_pred HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc--CccCCCC
Confidence 35674 4889999886 457999999999998754321 11346789999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccc-------------cCCCCCCCCccCcccccCC-CCC-CchhHHHHHHHHH
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLS-------------SKSAAGTPEWMAPEVLRDE-PSN-EKSDIYSFGVILW 143 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~~-~~~-~~~Dv~slG~~l~ 143 (226)
+|+||+++.++.++|+|||++......... ......++.+++|+...-. ..+ ...+.++.|.-+|
T Consensus 119 kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~ 198 (218)
T PRK12274 119 KEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVY 198 (218)
T ss_pred CcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHH
Confidence 799999999999999999998743322210 0011245667777654433 122 5678899999999
Q ss_pred HHHhCCCCCC
Q 027225 144 ELATLQQPWG 153 (226)
Q Consensus 144 ~l~~g~~p~~ 153 (226)
.++|+..+.-
T Consensus 199 ~~~~~~~~~~ 208 (218)
T PRK12274 199 RFVTRRVLHW 208 (218)
T ss_pred HHHhccCCcc
Confidence 9999988753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-16 Score=128.91 Aligned_cols=136 Identities=21% Similarity=0.305 Sum_probs=109.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~ 79 (226)
|+.++||||++|++.++.++..|+|+|.+. .|..++.+ +....+..-+.||+.||.|||. .+ ++|+||+
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~ 132 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVC 132 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEe
Confidence 578999999999999999999999999984 78888877 4466777788999999999985 67 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 148 (226)
-++|+++..|.++|++|.....................|..|+.+.... -..|.|.|||++++++.|
T Consensus 133 ~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 133 KDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 9999999999999999988765444332222233333566676554433 457999999999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5e-17 Score=139.09 Aligned_cols=185 Identities=17% Similarity=0.177 Sum_probs=140.6
Q ss_pred ceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEc---
Q 027225 10 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD--- 86 (226)
Q Consensus 10 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~--- 86 (226)
..+.....-.+..++|+||.+.|+|.++++. .+.+++..+..+..|++..+++||..+ |+||||||+|+++.
T Consensus 757 ~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 757 MHISSAHVFQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREI 831 (974)
T ss_pred HHHHHHHccCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeeccc
Confidence 3333444456779999999999999999995 455999999999999999999999999 99999999999994
Q ss_pred ----CCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 87 ----KKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 87 ----~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
.+..++|+|||.+-.+.-.. ......+++..+-.+|+..|+.++...|.|.|+.+++.|+.|+.--
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------- 903 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------- 903 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------
Confidence 23468999999886543221 2234456678899999999999999999999999999999985321
Q ss_pred HHHHhhCCccCC----CCCCCCHH-HHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 161 VAAVGFKGKRLE----IPRNVNPH-VASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 161 ~~~~~~~~~~~~----~~~~~~~~-~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
. ..+.... ++..+..+ -.+++..+|+.|-..=|.+.++...++.++.
T Consensus 904 ---~-~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 904 ---V-KNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ---h-cCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1 1111111 22333333 4568888888666666999999988887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.8e-18 Score=142.27 Aligned_cols=202 Identities=23% Similarity=0.353 Sum_probs=161.8
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCcEE
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~i~h~di~p~nil 84 (226)
|+|++..++...+.+..+++.++..|+++.+-+.... ....+......++.|+..++.|+| ..+ +.|+|++|+|.+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSL 156 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccch
Confidence 9999999999999999999999999999999884211 112666677779999999999999 899 999999999999
Q ss_pred EcCCC-cEEEccCCCcccccc---cccccCCCCC-CCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 85 VDKKY-TVKVCDFGLSRLKAN---TFLSSKSAAG-TPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 85 ~~~~~-~~~l~df~~~~~~~~---~~~~~~~~~~-~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
++.++ .++..|||++..... .........+ +..|.|||...+. ......|+||.|+++..+++|..||......
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99999 999999999976544 2223344566 8899999999884 3467899999999999999999999765544
Q ss_pred HHHHHHhhCCc---cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGK---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
........... ....+..++....+++.+++..+|..|.+.+++.. ..++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~--d~~~~~ 291 (601)
T KOG0590|consen 237 DGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL--DNWLSS 291 (601)
T ss_pred cccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc--cccccc
Confidence 43222211111 34556788899999999999999999999999877 555444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-16 Score=115.15 Aligned_cols=74 Identities=23% Similarity=0.225 Sum_probs=63.0
Q ss_pred eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL-HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 22 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-H~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
.++||||++|+++....... ..++...+..++.|++.+|.++ |+.| ++|+||||+||++++ +.++|+|||++.
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~-~~v~LiDFG~a~ 165 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD-GKLYIIDVSQSV 165 (190)
T ss_pred CEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC-CcEEEEEccccc
Confidence 48999999987776543322 2388999999999999999999 7999 999999999999984 789999999875
Q ss_pred c
Q 027225 101 L 101 (226)
Q Consensus 101 ~ 101 (226)
.
T Consensus 166 ~ 166 (190)
T cd05147 166 E 166 (190)
T ss_pred c
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.5e-17 Score=121.22 Aligned_cols=197 Identities=23% Similarity=0.367 Sum_probs=139.1
Q ss_pred CCCCcCcceeeeEEecCC-----ceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 3 RLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++.|.||+++..||.+.+ ...+++||+..|++.+++++... .+.+....-.+|+.||++||.|||+..++++|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 567999999999996543 47888999999999999986322 345778888899999999999999998899999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCc--cccccc--ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCC-
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLS--RLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP- 151 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~--~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p- 151 (226)
++..+.|++..+|-+|+.--.-. ...... ........+.++|.+||.-..-..+.++|||++|+...+|..+..-
T Consensus 203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~ 282 (458)
T KOG1266|consen 203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQS 282 (458)
T ss_pred CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheecc
Confidence 99999999999988887532211 111111 1112233456788899876666667889999999999999876442
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
-++....+....+... ..... ..--++++.+|++..|..||++++++-
T Consensus 283 tnseS~~~~ee~ia~~--i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 283 TNSESKVEVEENIANV--IIGLE---NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred CCCcceeehhhhhhhh--eeecc---CccccCcCcccccCCCCCCcchhhhhc
Confidence 2222222222111100 00111 122356899999999999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.8e-16 Score=113.66 Aligned_cols=85 Identities=20% Similarity=0.300 Sum_probs=68.6
Q ss_pred CCcCcceeeeEEecCC---c-eEEEEee--cccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHH-HHHhcCCCCeEEeC
Q 027225 5 RHPNIVLFMGAVTQPP---N-LSIVTEY--LSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM-NYLHRRNPPIVHRD 77 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~---~-~~lv~e~--~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l-~~lH~~~~~i~h~d 77 (226)
+||||++++++++.+. . +.+|+|| +.+++|.+++.+.. +++. ..++.+++.++ +|||+++ |+|+|
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~--IvhrD 130 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR--IVTME 130 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC--EeecC
Confidence 6899999999998874 3 3378999 45799999997632 5555 35677888777 9999999 99999
Q ss_pred CCCCcEEEcCC----CcEEEccCC
Q 027225 78 LKSPNLLVDKK----YTVKVCDFG 97 (226)
Q Consensus 78 i~p~nil~~~~----~~~~l~df~ 97 (226)
|||+||+++.. ++++|+|++
T Consensus 131 lKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 131 LKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred CCHHHEEEeccCCCCCcEEEEECC
Confidence 99999999743 379999954
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-16 Score=112.72 Aligned_cols=92 Identities=18% Similarity=0.177 Sum_probs=70.9
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHH-hcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCC
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL-LHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS 80 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p 80 (226)
++.|+++.....+... ..++||||++|+++... +... .++......++.|++.++.++|+ .| ++|+||||
T Consensus 75 ~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP 146 (190)
T cd05145 75 RLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSE 146 (190)
T ss_pred HHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCh
Confidence 3456666443333332 24899999998755433 3322 37788999999999999999999 99 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccc
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKA 103 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~ 103 (226)
+||+++ ++.++|+|||++....
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhEEEE-CCCEEEEEcccceecC
Confidence 999999 7899999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-14 Score=106.01 Aligned_cols=89 Identities=26% Similarity=0.474 Sum_probs=76.5
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
++.|++|.....++.+.+..+++|||++|++|.+++.... . ....++.+++.+|.++|+.| ++|+|++|.|
T Consensus 55 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~N 125 (211)
T PRK14879 55 RARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSN 125 (211)
T ss_pred HHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCccc
Confidence 4567788777777777778999999999999999987522 2 77889999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCccc
Q 027225 83 LLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~ 101 (226)
|+++ ++.++++|||.+..
T Consensus 126 il~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 126 MILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEE-CCCEEEEECCcccC
Confidence 9999 77899999997643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.3e-14 Score=115.55 Aligned_cols=192 Identities=26% Similarity=0.234 Sum_probs=148.3
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHH----HHHHHhcCCCCeEEeCCCC
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK----GMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~----~l~~lH~~~~~i~h~di~p 80 (226)
.|+|.++....++..+..++-+|.|. .+|.++..... ..+.....+..+.+... |+.++|+.+ ++|.+++|
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp 250 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKP 250 (524)
T ss_pred ccccccccCcccccCCcceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc--ccccccch
Confidence 68899998999999999999999995 69999887643 23777788888888888 999999999 99999999
Q ss_pred CcEEEcCC-CcEEEccCCCccccccccccc-----CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKK-YTVKVCDFGLSRLKANTFLSS-----KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~-~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
.||+...+ ..++++||++........... ....+...|++||...+. ++...|+|++|.++.+..++......
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccC
Confidence 99999998 899999999987766553222 223677789999998887 78899999999999998887554422
Q ss_pred C-CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 155 L-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 155 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
. +..-..... .....++-...+.++...+..|++.++..|++.+.+.+
T Consensus 330 g~~~~W~~~r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 330 GKNSSWSQLRQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CCCCCcccccc--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 2 111111000 11122333456677888999999999999999888776
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.6e-14 Score=116.84 Aligned_cols=86 Identities=26% Similarity=0.398 Sum_probs=75.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++|++++....++.+....++||||++|++|.+++. ....++.+++.+|.+||+.| ++||||||+
T Consensus 391 ~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~ 457 (535)
T PRK09605 391 SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTS 457 (535)
T ss_pred HhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChH
Confidence 46789999988877777777899999999999999875 24568899999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccc
Q 027225 82 NLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~ 101 (226)
||++ +++.++++|||.++.
T Consensus 458 NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 458 NFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HEEE-ECCcEEEEeCccccc
Confidence 9999 567999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.1e-14 Score=102.20 Aligned_cols=86 Identities=26% Similarity=0.422 Sum_probs=70.0
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
.++|+++....-++...+..++||||++|++|.+++.... . .++.+++.+|.++|+.| ++|+|++|.|
T Consensus 53 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~N 120 (199)
T TIGR03724 53 RARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG--IVHGDLTTSN 120 (199)
T ss_pred HHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC--eecCCCCcce
Confidence 3456665544444555667899999999999999876522 1 68889999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCccc
Q 027225 83 LLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~ 101 (226)
|+++ ++.++++|||.+..
T Consensus 121 il~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 121 IIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEE-CCcEEEEECCCCcC
Confidence 9999 78999999998644
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-13 Score=103.48 Aligned_cols=89 Identities=21% Similarity=0.279 Sum_probs=69.5
Q ss_pred CCCCcCc--ceeeeEEecCCc----eEEEEeeccc-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 3 RLRHPNI--VLFMGAVTQPPN----LSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 3 ~l~h~~i--~~~~~~~~~~~~----~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
+++|++| ++.+++...+.. .++|+|+++| .+|.+++.... ++... +.+++.+|.+||+.| |+|
T Consensus 96 ~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~~----~~~i~~~l~~lH~~G--I~H 165 (239)
T PRK01723 96 QLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP----LSEEQ----WQAIGQLIARFHDAG--VYH 165 (239)
T ss_pred HHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC----CCHHH----HHHHHHHHHHHHHCC--CCC
Confidence 4566664 677776543322 3599999997 69999886532 45443 568999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
+||+|.||+++.++.++|+|||.+..
T Consensus 166 rDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 166 ADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999988999999997643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.7e-13 Score=101.43 Aligned_cols=76 Identities=24% Similarity=0.253 Sum_probs=63.4
Q ss_pred ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 21 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
..++||||+.|++|........ ......+..++.|++.++.+||+.|. ++|+||+|+||+++ ++.++|+|||.+.
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~-iiH~Dikp~NIli~-~~~i~LiDFg~a~ 196 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGE-LVHGDLSEYNILVH-DGKVVIIDVSQSV 196 (237)
T ss_pred CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCC-EEeCCCChhhEEEE-CCCEEEEEChhhh
Confidence 3589999999988877653322 25666778899999999999999863 99999999999999 7899999999875
Q ss_pred c
Q 027225 101 L 101 (226)
Q Consensus 101 ~ 101 (226)
.
T Consensus 197 ~ 197 (237)
T smart00090 197 E 197 (237)
T ss_pred c
Confidence 4
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-12 Score=96.00 Aligned_cols=71 Identities=21% Similarity=0.295 Sum_probs=60.7
Q ss_pred CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCc
Q 027225 20 PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99 (226)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 99 (226)
...++||||++|++|...... .....++.+++.++.++|+.| ++|+||+|+||++++++.++|+|||.+
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~~~liDfg~~ 172 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEKIYIIDWPQM 172 (198)
T ss_pred CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCcEEEEECCcc
Confidence 446899999999998766431 234568889999999999999 999999999999999999999999987
Q ss_pred cc
Q 027225 100 RL 101 (226)
Q Consensus 100 ~~ 101 (226)
..
T Consensus 173 ~~ 174 (198)
T cd05144 173 VS 174 (198)
T ss_pred cc
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.2e-12 Score=109.17 Aligned_cols=190 Identities=25% Similarity=0.338 Sum_probs=149.6
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEE
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~ 85 (226)
+|-++...-.+......++++++..+++|...+.+-+ ..+.+..+.....++.++++||... +.|+|++|.|.+.
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLI 937 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch--hhcccccccchhh
Confidence 3444444333455677999999999999999998755 3677777788889999999999998 9999999999999
Q ss_pred cCCCcEEEccCCCccccccc---------------------------c----cccCCCCCCCCccCcccccCCCCCCchh
Q 027225 86 DKKYTVKVCDFGLSRLKANT---------------------------F----LSSKSAAGTPEWMAPEVLRDEPSNEKSD 134 (226)
Q Consensus 86 ~~~~~~~l~df~~~~~~~~~---------------------------~----~~~~~~~~~~~~~~PE~~~~~~~~~~~D 134 (226)
..++..++.+|+.....+.. . .......+++.|.+||...+......+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 99999999998733211000 0 0011234678999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 135 IYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 135 v~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
+|++|+++++.++|..||+...+.++...+.... .....+...+.+.++++...+..++.+|..+.
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999999998888776553222 23344567889999999999999999997776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-12 Score=106.54 Aligned_cols=148 Identities=16% Similarity=0.267 Sum_probs=108.2
Q ss_pred HHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc-----c----CCCCCCCCccCcccccC
Q 027225 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-----S----KSAAGTPEWMAPEVLRD 126 (226)
Q Consensus 56 ~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~----~~~~~~~~~~~PE~~~~ 126 (226)
+.+.+.|+.++|..- +++|++|.|++|.++.++.+|+..|+++......... . .-......|.|||++.+
T Consensus 105 l~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 446668899999862 3999999999999999999999999987643331111 0 01123457999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH--HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 127 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNP--AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 127 ~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
...+.++|+||+|+.+|.+.. |+..+...+. ................+..+++++++-+.+++..++..||++.++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 888999999999999999984 4444433321 2222222223334445678999999999999999999999877766
Q ss_pred H
Q 027225 204 E 204 (226)
Q Consensus 204 ~ 204 (226)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.3e-10 Score=91.13 Aligned_cols=188 Identities=17% Similarity=0.240 Sum_probs=130.0
Q ss_pred eEEEEeecccC-CHHHHhc---CCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCC
Q 027225 22 LSIVTEYLSRG-SLYRLLH---KPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG 97 (226)
Q Consensus 22 ~~lv~e~~~~~-sL~~~~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~ 97 (226)
.-++|+.+.|. ....+++ ++...+...|.........|+.+.+.||..| ..-||++++|+++++++.+.|.|-+
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEccc
Confidence 55666666653 3333333 2233456889999999999999999999999 9999999999999999999999876
Q ss_pred CcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhC-CCCCCCC-------CHHHHHHH-
Q 027225 98 LSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATL-QQPWGNL-------NPAQVVAA- 163 (226)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~-------~~~~~~~~- 163 (226)
......+ ........+...|.+||.-. +..-+...|.|.||+++++++.| ++||.+. ++.+....
T Consensus 163 sfqi~~n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQINAN-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeeccC-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 5433322 22233456778999999754 33446789999999999999887 8898542 22221110
Q ss_pred ------HhhCCccCCCC-----CCCCHHHHHHHHHHcccC--CCCCCCHHHHHHHHHHhhcC
Q 027225 164 ------VGFKGKRLEIP-----RNVNPHVASIIEACWANE--PWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 164 ------~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~--p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+...+..+.| .-+++.+..+..+|+... +.-|||++-.+..|..+-.+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00011111112 245789999999999543 56899999888777655443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-11 Score=85.91 Aligned_cols=82 Identities=18% Similarity=0.268 Sum_probs=70.1
Q ss_pred cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC---CCCeEEeCCCCCcE
Q 027225 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR---NPPIVHRDLKSPNL 83 (226)
Q Consensus 7 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~i~h~di~p~ni 83 (226)
.++++++.+....+..++++||+.++++..+ +......++.++..++..+|.. + ++|+|++|.||
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~--i~H~Dl~~~Ni 120 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLV--LCHGDLHPGNI 120 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceE--EEecCCCcceE
Confidence 5888888888888889999999988766554 3455566788999999999984 7 99999999999
Q ss_pred EEcCCCcEEEccCCCcc
Q 027225 84 LVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~ 100 (226)
++++.+.++++||+.+.
T Consensus 121 l~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 121 LVDDGKILGIIDWEYAG 137 (155)
T ss_pred EEECCcEEEEEeccccc
Confidence 99998899999999764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.4e-11 Score=85.35 Aligned_cols=75 Identities=23% Similarity=0.222 Sum_probs=58.7
Q ss_pred ceEEEEeecccCCHHH-HhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCCCcEEEcCCCcEEEccCCC
Q 027225 21 NLSIVTEYLSRGSLYR-LLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 98 (226)
Q Consensus 21 ~~~lv~e~~~~~sL~~-~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p~nil~~~~~~~~l~df~~ 98 (226)
..++|+||++++.+.. .+.... . ...+..++.+++.++.++|. .| ++|+||+|+||+++ ++.++++|||.
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~~~~liDfg~ 160 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DGKVYIIDVPQ 160 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CCcEEEEECcc
Confidence 4689999999854321 111111 1 15677899999999999999 99 99999999999999 88999999998
Q ss_pred ccccc
Q 027225 99 SRLKA 103 (226)
Q Consensus 99 ~~~~~ 103 (226)
+....
T Consensus 161 a~~~~ 165 (187)
T cd05119 161 AVEID 165 (187)
T ss_pred ccccc
Confidence 75433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-09 Score=87.17 Aligned_cols=176 Identities=17% Similarity=0.259 Sum_probs=127.6
Q ss_pred CCCCCcCcceeeeEEe----cCCceEEEEeecc-cCCHHHHhcCCC------------CCCcCCHHHHHHHHHHHHHHHH
Q 027225 2 KRLRHPNIVLFMGAVT----QPPNLSIVTEYLS-RGSLYRLLHKPG------------VREMLDERRRLNMAYDVAKGMN 64 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~-~~sL~~~~~~~~------------~~~~~~~~~~~~~~~~l~~~l~ 64 (226)
+++.|+|+|++-++|. .+..+++|++|++ .++|.++.-... .+...+++.+|.++.||..||.
T Consensus 328 kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~ 407 (655)
T KOG3741|consen 328 KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALY 407 (655)
T ss_pred HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHH
Confidence 5788999999999886 3456999999998 467777653211 1124778999999999999999
Q ss_pred HHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHH
Q 027225 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144 (226)
Q Consensus 65 ~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 144 (226)
++|+.| ++-+-+.+.+|+++.+.+++++.-|......... . +.+.+ ..+.|.-.||.+++.
T Consensus 408 sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------~--~~le~---~Qq~D~~~lG~ll~a 468 (655)
T KOG3741|consen 408 SIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------T--EPLES---QQQNDLRDLGLLLLA 468 (655)
T ss_pred HHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCC------------C--cchhH---HhhhhHHHHHHHHHH
Confidence 999999 9999999999999999899987655432211110 0 11111 246799999999999
Q ss_pred HHhCCCC-CCCCCHHHH-HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 145 LATLQQP-WGNLNPAQV-VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 145 l~~g~~p-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+.+|..= |......+. .. .+...++.++++++.-....++++ -++++++.++
T Consensus 469 LAt~~~ns~~~d~~~~s~~~---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 469 LATGTENSNRTDSTQSSHLT---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HhhcccccccccchHHHHHH---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 9999542 222222211 11 234678999999999999999987 6788888654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.1e-11 Score=97.68 Aligned_cols=189 Identities=22% Similarity=0.201 Sum_probs=139.0
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.|.+++.++..|.+.+..|+--|||+++++.....- ..++.+..++.+..|++.++.++|+.. ++|+|++|+||+
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~ 398 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNIL 398 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh--hhccccccccee
Confidence 578888888889888888899999999988777732 445888999999999999999999999 999999999999
Q ss_pred EcCC-CcEEEccCCCcccccccccccCCCCCCCCcc--CcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 85 VDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWM--APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 85 ~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~--~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
+..+ +..++.||+..+...-. .....+...+. ++.......+..+.|++++|.-+.+.+++...-...+.
T Consensus 399 i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---- 471 (524)
T KOG0601|consen 399 ISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---- 471 (524)
T ss_pred eccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----
Confidence 9886 67889999876542211 12222223333 44444555678899999999999999988653222111
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
.................++..+.+.+...++..||.+.++..+.
T Consensus 472 -~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 472 -SLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred -ceeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 11112222223334448899999999999999999988876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.1e-10 Score=81.22 Aligned_cols=85 Identities=21% Similarity=0.192 Sum_probs=63.4
Q ss_pred CcceeeeEEecCCceEEEEeecccCCHH-HHhcCCCCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCeEEeCCCCCcEEE
Q 027225 8 NIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVAKGMNYL-HRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 8 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~-~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-H~~~~~i~h~di~p~nil~ 85 (226)
++.+++++ ...++||||+.++.+. ..+.+. .++.++...+..+++.++..+ |+.| ++|||+++.||++
T Consensus 89 ~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~ 158 (197)
T cd05146 89 PCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLW 158 (197)
T ss_pred CCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 34455554 4579999999765442 223221 255566777889999999998 8999 9999999999999
Q ss_pred cCCCcEEEccCCCccccc
Q 027225 86 DKKYTVKVCDFGLSRLKA 103 (226)
Q Consensus 86 ~~~~~~~l~df~~~~~~~ 103 (226)
++ +.+.++||+.+....
T Consensus 159 ~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 HD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EC-CcEEEEECCCceeCC
Confidence 75 589999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.8e-09 Score=75.84 Aligned_cols=73 Identities=30% Similarity=0.454 Sum_probs=62.1
Q ss_pred EEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEc
Q 027225 15 AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVC 94 (226)
Q Consensus 15 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~ 94 (226)
+..+.+...++|||++|..|.+.+... ...++..+-.-+.-||..| |+|||+.++||+++.++ +.++
T Consensus 67 ~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 67 YDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred EEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEE
Confidence 345566789999999999999998763 1357778888899999999 99999999999999874 9999
Q ss_pred cCCCcc
Q 027225 95 DFGLSR 100 (226)
Q Consensus 95 df~~~~ 100 (226)
|||++.
T Consensus 134 DfGLg~ 139 (204)
T COG3642 134 DFGLGE 139 (204)
T ss_pred ECCccc
Confidence 999874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-09 Score=81.14 Aligned_cols=77 Identities=23% Similarity=0.186 Sum_probs=64.3
Q ss_pred ceEEEEeecccC-CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcC-------CCcEE
Q 027225 21 NLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-------KYTVK 92 (226)
Q Consensus 21 ~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~-------~~~~~ 92 (226)
..++|+|++++. +|.+++.... ....+......++.+++..+..||..| ++|+|+++.||+++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence 478999999875 8999986532 223566777889999999999999999 999999999999975 45789
Q ss_pred EccCCCcc
Q 027225 93 VCDFGLSR 100 (226)
Q Consensus 93 l~df~~~~ 100 (226)
|+||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.5e-09 Score=88.30 Aligned_cols=78 Identities=23% Similarity=0.298 Sum_probs=59.5
Q ss_pred CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHH-HHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCC
Q 027225 19 PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK-GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG 97 (226)
Q Consensus 19 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~-~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~ 97 (226)
....++||||++|++|.++....... .+ ...++..++. .+..+|..| ++|+|++|.||+++.+++++++|||
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG 302 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFG 302 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCC
Confidence 34579999999999998876532111 22 2335555555 467889999 9999999999999999999999999
Q ss_pred Cccccc
Q 027225 98 LSRLKA 103 (226)
Q Consensus 98 ~~~~~~ 103 (226)
.+....
T Consensus 303 ~~~~l~ 308 (437)
T TIGR01982 303 IVGRLS 308 (437)
T ss_pred CeeECC
Confidence 886543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.5e-09 Score=76.01 Aligned_cols=88 Identities=25% Similarity=0.262 Sum_probs=71.5
Q ss_pred cceeeeEEecCC----ceEEEEeeccc-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 9 IVLFMGAVTQPP----NLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 9 i~~~~~~~~~~~----~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
+.+.+.+.+... ..++|+|++++ .+|.+++..... .+......++.++...+.-||..| ++|+|+++.||
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NI 149 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNI 149 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccE
Confidence 345666665532 35899999987 489999987432 667777889999999999999999 99999999999
Q ss_pred EEcCCC---cEEEccCCCccc
Q 027225 84 LVDKKY---TVKVCDFGLSRL 101 (226)
Q Consensus 84 l~~~~~---~~~l~df~~~~~ 101 (226)
+++.++ .+.++||+.+..
T Consensus 150 Lv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 150 LVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEeCCCCceeEEEEcchhcee
Confidence 999887 899999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.8e-09 Score=75.09 Aligned_cols=75 Identities=20% Similarity=0.224 Sum_probs=56.8
Q ss_pred ceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe-----EEeCCCCCcEE
Q 027225 10 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI-----VHRDLKSPNLL 84 (226)
Q Consensus 10 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i-----~h~di~p~nil 84 (226)
.+++.+.. ...++|||+++|.++.+. . ... ...+.+++.+|..||+.+ + +|+|++|.||+
T Consensus 56 P~~~~~~~--~~~~lv~e~i~G~~l~~~--~-----~~~----~~~~~~l~~~l~~LH~~~--~~~~~~~HgD~~~~Nil 120 (170)
T cd05151 56 PKLYYFDP--ETGVLITEFIEGSELLTE--D-----FSD----PENLEKIAKLLKKLHSSP--LPDLVPCHNDLLPGNFL 120 (170)
T ss_pred CceEEEeC--CCCeEEEEecCCCccccc--c-----ccC----HHHHHHHHHHHHHHhCCC--CCCceeecCCCCcCcEE
Confidence 45555443 346899999999877643 0 011 235678999999999987 6 99999999999
Q ss_pred EcCCCcEEEccCCCcc
Q 027225 85 VDKKYTVKVCDFGLSR 100 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~ 100 (226)
++ ++.++++||+.+.
T Consensus 121 ~~-~~~~~liDf~~a~ 135 (170)
T cd05151 121 LD-DGRLWLIDWEYAG 135 (170)
T ss_pred EE-CCeEEEEeccccc
Confidence 99 5689999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.7e-08 Score=70.92 Aligned_cols=84 Identities=19% Similarity=0.295 Sum_probs=64.4
Q ss_pred EEecCCceEEEEeeccc-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCC-c--
Q 027225 15 AVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-T-- 90 (226)
Q Consensus 15 ~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~-~-- 90 (226)
++.+.....++|||++| .++.+++...... ....+....++..+-..+.-||.++ ++||||..+||++..++ +
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCc
Confidence 45666778999999976 4777777654322 1333333788999999999999999 99999999999996554 3
Q ss_pred EEEccCCCccc
Q 027225 91 VKVCDFGLSRL 101 (226)
Q Consensus 91 ~~l~df~~~~~ 101 (226)
+.++|||++..
T Consensus 155 ~~lIdfgls~~ 165 (229)
T KOG3087|consen 155 PILIDFGLSSV 165 (229)
T ss_pred eEEEeecchhc
Confidence 48999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-08 Score=73.44 Aligned_cols=83 Identities=28% Similarity=0.314 Sum_probs=53.9
Q ss_pred CcceeeeEEecCCceEEEEeecc--cCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHH-HhcCCCCeEEeCCCCCcEE
Q 027225 8 NIVLFMGAVTQPPNLSIVTEYLS--RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY-LHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 8 ~i~~~~~~~~~~~~~~lv~e~~~--~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~-lH~~~~~i~h~di~p~nil 84 (226)
++.+++++- ..++||||++ |..+..+.... ++.+....++.+++..+.. +|..| ++|||+++.||+
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIl 139 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNIL 139 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEE
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEE
Confidence 355555542 3689999998 65565544331 2234455677788885555 58999 999999999999
Q ss_pred EcCCCcEEEccCCCcccc
Q 027225 85 VDKKYTVKVCDFGLSRLK 102 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~ 102 (226)
++++ .+.++|||.+...
T Consensus 140 v~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EETT-CEEE--GTTEEET
T ss_pred eecc-eEEEEecCcceec
Confidence 9988 8999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.6e-09 Score=85.29 Aligned_cols=74 Identities=22% Similarity=0.242 Sum_probs=53.9
Q ss_pred CceEEEEeecccCCHHHH--hcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCC----cEE
Q 027225 20 PNLSIVTEYLSRGSLYRL--LHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----TVK 92 (226)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~--~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~----~~~ 92 (226)
...++||||+.|+++.++ +...+ ..+.+.+..+..++.|++ ..| ++|+|++|.||+++.+| +++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~ 304 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYI 304 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEE
Confidence 457899999999999875 33322 112244444444555544 588 99999999999999888 999
Q ss_pred EccCCCcccc
Q 027225 93 VCDFGLSRLK 102 (226)
Q Consensus 93 l~df~~~~~~ 102 (226)
++|||.....
T Consensus 305 llDFGivg~l 314 (537)
T PRK04750 305 ALDFGIVGSL 314 (537)
T ss_pred EEecceEEEC
Confidence 9999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-07 Score=69.39 Aligned_cols=65 Identities=22% Similarity=0.408 Sum_probs=52.2
Q ss_pred ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCc
Q 027225 21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99 (226)
Q Consensus 21 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 99 (226)
..++++||++|..|.+... +++ .+...+.+++..+|+.| ++|||.+|.|++++++ .++++|++..
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC-cEEEEECccc
Confidence 3678999999988877643 222 24456778899999999 9999999999999976 5999999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.5e-06 Score=60.83 Aligned_cols=89 Identities=20% Similarity=0.206 Sum_probs=70.7
Q ss_pred CCC-cCcceeeeEEecCCceEEEEeecccCCHHHH---hcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC--CCCeEEeC
Q 027225 4 LRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL---LHKPGVREMLDERRRLNMAYDVAKGMNYLHRR--NPPIVHRD 77 (226)
Q Consensus 4 l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~~i~h~d 77 (226)
+++ +++++++|+|- .++|.|+...+++... +.... ..+|..+.+++.++++.+++++.. |. +.-.|
T Consensus 16 l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~---~~~w~~R~~iA~~lL~~l~~l~~~~~~~-~~lcD 87 (188)
T PF12260_consen 16 LQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFL---QSPWEQRAKIALQLLELLEELDHGPLGF-FYLCD 87 (188)
T ss_pred cCCCCCCCCeeeECC----CEEEEEeecCcccccccccccccc---ccCHHHHHHHHHHHHHHHHHHhcCCCCc-EEEee
Confidence 444 59999999993 4789999987766532 11111 278999999999999999999883 22 88999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcc
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~ 100 (226)
++++|+-++++++++++|.+...
T Consensus 88 v~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 88 VSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cchHHeEEeCCCcEEEEechhcc
Confidence 99999999999999999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.49 E-value=7.5e-07 Score=66.02 Aligned_cols=90 Identities=23% Similarity=0.274 Sum_probs=65.2
Q ss_pred cCcceeeeEEecC---CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC--------------
Q 027225 7 PNIVLFMGAVTQP---PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-------------- 69 (226)
Q Consensus 7 ~~i~~~~~~~~~~---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-------------- 69 (226)
..+.+++.+.... +..++|+|+++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~ 132 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPG 132 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCC
Confidence 3456677776654 367899999999888776532 1256666666777777777777642
Q ss_pred ----------------------------------------CCCeEEeCCCCCcEEEcC--CCcEEEccCCCcc
Q 027225 70 ----------------------------------------NPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSR 100 (226)
Q Consensus 70 ----------------------------------------~~~i~h~di~p~nil~~~--~~~~~l~df~~~~ 100 (226)
...++|+|+++.||+++. ++.+.++||+.+.
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 133 GYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred chHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 123799999999999998 5668999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1e-06 Score=77.34 Aligned_cols=195 Identities=19% Similarity=0.240 Sum_probs=133.7
Q ss_pred CCCCCCcCcceeeeEEecCCc----eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
+++..|+|+..++.|..++.. ..+..|+|...++.+.+..-+ ..+....+.+..++..++.++|+.. ..|.
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v 310 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSLS--LEHV 310 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHhc--ccee
Confidence 356799999999998876543 335568888889988888754 3888999999999999999999987 7676
Q ss_pred CCCCC---cEEEcCCCcEEEc--cCCCcccccccccccCCCCCCCCccCcccccCCCC--CCchhHHHHHHHHHHHHhCC
Q 027225 77 DLKSP---NLLVDKKYTVKVC--DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 77 di~p~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Dv~slG~~l~~l~~g~ 149 (226)
-+..+ +.-.+.++....+ ||+......+.... ........+.++|....... ....|+|++|.....+..|.
T Consensus 311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred EEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 66666 4444556666666 88877655543221 22223345667776655443 34579999999999888875
Q ss_pred CCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 150 QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.+-...-.. . .-.+.....+..+...+|+..++++|+++.+++. ..+++...
T Consensus 390 ~i~~~~~~~--~---------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~--~~f~~~~~ 441 (1351)
T KOG1035|consen 390 DISEKSAVP--V---------SLLDVLSTSELLDALPKCLDEDSEERLSALELLT--HPFLRFPT 441 (1351)
T ss_pred cccccccch--h---------hhhccccchhhhhhhhhhcchhhhhccchhhhhh--chhccccc
Confidence 543211100 0 0011222237889999999999999999999998 44544433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.1e-06 Score=63.99 Aligned_cols=76 Identities=21% Similarity=0.140 Sum_probs=63.6
Q ss_pred eEEEEeecc-cCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCc--EEEccCCC
Q 027225 22 LSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGL 98 (226)
Q Consensus 22 ~~lv~e~~~-~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~--~~l~df~~ 98 (226)
.++|+|-+. ..+|.+++.+... ...+......++.++..++.-||..| +.|+|+.+.||+++.+|. ++++||..
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 789999765 3689998876542 24677777889999999999999999 999999999999986677 99999986
Q ss_pred cc
Q 027225 99 SR 100 (226)
Q Consensus 99 ~~ 100 (226)
++
T Consensus 177 ~r 178 (216)
T PRK09902 177 SR 178 (216)
T ss_pred cc
Confidence 54
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.8e-06 Score=64.64 Aligned_cols=72 Identities=28% Similarity=0.327 Sum_probs=55.3
Q ss_pred CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCC
Q 027225 19 PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 98 (226)
Q Consensus 19 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~ 98 (226)
.+...+|||+++|..|....- +.+..-.++..|+..+...-..| ++|||+++-||+++++|.+.++||-.
T Consensus 179 ~nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 179 WNRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred cccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCCEEEEeCcc
Confidence 456899999999966655531 23333445666666666666889 99999999999999999999999976
Q ss_pred cc
Q 027225 99 SR 100 (226)
Q Consensus 99 ~~ 100 (226)
+.
T Consensus 249 ~v 250 (304)
T COG0478 249 AV 250 (304)
T ss_pred cc
Confidence 54
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=54.52 Aligned_cols=28 Identities=25% Similarity=0.234 Sum_probs=25.1
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
.++|||++|.||++++++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 489999999999999988 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.1e-06 Score=72.83 Aligned_cols=198 Identities=21% Similarity=0.262 Sum_probs=123.9
Q ss_pred CCCCCCcC-cceeeeEEecCCceEEEEeecccC-CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPN-IVLFMGAVTQPPNLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|.+++||| .+.+++-++-+...++.++++.++ +-....... .-.+...+....+..-+.+++++|+.- =+|+|
T Consensus 287 LdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d- 361 (829)
T KOG0576|consen 287 LDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY--KVHRD- 361 (829)
T ss_pred HHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccccc--ccCcc-
Confidence 45789999 777777777778899999999876 222222110 111334445556667778899999885 46776
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+... +..+..+|+......... ......+++.+++||+.....+..+.|+|++|.-..++.-|..|-.. +.
T Consensus 362 ---~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~ 434 (829)
T KOG0576|consen 362 ---NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PP 434 (829)
T ss_pred ---cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Cc
Confidence 665555 578999999876655543 23456678899999999998899999999999766677666555322 11
Q ss_pred HHHHHHhhCCccCCCC--CCCCHHHH-HHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIP--RNVNPHVA-SIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~--~~~~~~~~-~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.....+......+.+. ..+++... ++...|+...|..|+..-+.+- .+++.+
T Consensus 435 ~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacf--sKvfng 489 (829)
T KOG0576|consen 435 AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACF--SKVFNG 489 (829)
T ss_pred cccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHH--HHHhcc
Confidence 1111110000000000 11222222 3667788888888877766654 555544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00034 Score=52.79 Aligned_cols=29 Identities=28% Similarity=0.334 Sum_probs=25.4
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
.++|+|+.|.||++++++...|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 39999999999999998777899998653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00015 Score=53.92 Aligned_cols=76 Identities=22% Similarity=0.212 Sum_probs=55.2
Q ss_pred ceEEEEeecccCC-HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCCCcEEEcCCCcEEEccCCC
Q 027225 21 NLSIVTEYLSRGS-LYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 98 (226)
Q Consensus 21 ~~~lv~e~~~~~s-L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p~nil~~~~~~~~l~df~~ 98 (226)
...+||||+.... -.-.+..- .+..++...+..++++.+.-|-. .+ ++|+||+.-||++. ++.+.++|++.
T Consensus 140 ~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~Q 212 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQ 212 (268)
T ss_pred CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECcc
Confidence 4689999996531 11112221 13333677778888988888876 78 99999999999999 67999999998
Q ss_pred ccccc
Q 027225 99 SRLKA 103 (226)
Q Consensus 99 ~~~~~ 103 (226)
+....
T Consensus 213 aV~~~ 217 (268)
T COG1718 213 AVTID 217 (268)
T ss_pred ccccC
Confidence 75444
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00039 Score=57.83 Aligned_cols=77 Identities=17% Similarity=0.282 Sum_probs=54.7
Q ss_pred ecCCceEEEEeecccCCHHHHh--cCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEc
Q 027225 17 TQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVC 94 (226)
Q Consensus 17 ~~~~~~~lv~e~~~~~sL~~~~--~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~ 94 (226)
+......++|||+.|-.+.+.. ...+ .+...+.....++. +..+=..| ++|.|.+|.||+++.+|++.+.
T Consensus 236 e~t~~~VLtmE~i~Gi~i~d~~~l~~~g----~d~k~ia~~~~~~f--~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~l 307 (517)
T COG0661 236 EYTTRRVLTMEWIDGIKISDIAALKSAG----IDRKELAELLVRAF--LRQLLRDG--FFHADPHPGNILVRSDGRIVLL 307 (517)
T ss_pred hccCCcEEEEEeeCCEecccHHHHHhcC----CCHHHHHHHHHHHH--HHHHHhcC--ccccCCCccceEEecCCcEEEE
Confidence 3345689999999999998874 4433 44444333222221 23333467 9999999999999999999999
Q ss_pred cCCCccc
Q 027225 95 DFGLSRL 101 (226)
Q Consensus 95 df~~~~~ 101 (226)
|||....
T Consensus 308 DfGi~g~ 314 (517)
T COG0661 308 DFGIVGR 314 (517)
T ss_pred cCcceec
Confidence 9998654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.41 E-value=8.7e-06 Score=73.94 Aligned_cols=200 Identities=13% Similarity=0.035 Sum_probs=129.2
Q ss_pred CCCCcCcceeeeEEe--cCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcC---CCCeEEe
Q 027225 3 RLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRR---NPPIVHR 76 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~i~h~ 76 (226)
...|+++.....-.. +...-+..++++.+|.+.+.+-+... .+.+....+.....+.+....-+|+. |.-.+|.
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence 456777766555443 23447888999999999999875432 33455566655555656666665553 2236788
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
++++.|.++..+-++++.++|+.+.........+...+++.|+.|++.+.-.++.++|+|..|+-+|....|..++....
T Consensus 1365 ~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~fl 1444 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFL 1444 (2724)
T ss_pred hhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHH
Confidence 99999999999999999999998733333333445566778899999888888888999999999998887766653222
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
.......+ ......+.+...+.+.......+|-.+...||.-..++
T Consensus 1445 q~~Lkgii-dn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isl 1490 (2724)
T KOG1826|consen 1445 QPALKGII-DNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISL 1490 (2724)
T ss_pred HHHHcCcc-cccccccccccCCCcccHHHHHHHHHHhhhcchhhhhc
Confidence 11111111 12222233444445555555555555666666544433
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0023 Score=46.61 Aligned_cols=82 Identities=27% Similarity=0.370 Sum_probs=60.4
Q ss_pred CCCcCcceeeeEEecCCceEEEEeeccc------CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSR------GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~------~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
..+.+|.+++|+.+.+...-+|+|.+.. .+|.+++.+.+ ++. ... ..+-.-..+|-..+ |+.+|
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~---~~L~~f~~~l~~~~--Iv~~d 143 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELR---QALDEFKRYLLDHH--IVIRD 143 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHH---HHHHHHHHHHHHcC--CeecC
Confidence 4678999999999999999999987653 46788886543 555 333 34445556777888 99999
Q ss_pred CCCCcEEEcCCC----cEEEcc
Q 027225 78 LKSPNLLVDKKY----TVKVCD 95 (226)
Q Consensus 78 i~p~nil~~~~~----~~~l~d 95 (226)
++|.||++.... .+.++|
T Consensus 144 l~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCcccEEEEecCCCceEEEEEe
Confidence 999999996432 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00059 Score=56.05 Aligned_cols=146 Identities=21% Similarity=0.260 Sum_probs=87.0
Q ss_pred CCCCCCcCcceeeeEEecC-CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|+.+.|+|...++++-.-. ....+|+|++ +.||.++...+. .-... +. .++ +.|-
T Consensus 36 lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~----l~~~s-------~~-------~~~--~~~~--- 91 (725)
T KOG1093|consen 36 LKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN----LKDES-------LL-------AHG--VLHL--- 91 (725)
T ss_pred HHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc----cchhh-------hc-------ccc--ccee---
Confidence 4678999999999987543 3478889998 559999987643 11111 11 233 3332
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
| .++.+| .+. .. . |-. ...++|||++|.++.++..|..-+...+..+
T Consensus 92 --~-------~~~~td-~~~----t~---~-----------~~~-----~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~ 138 (725)
T KOG1093|consen 92 --N-------IIYITD-HFL----TK---Y-----------PSP-----IGPKSDVWSLGFIILELYLGISLEAELTESE 138 (725)
T ss_pred --h-------hhhccc-ccc----cc---C-----------CCC-----CCcchhhhhHHHHHHHHHHhhHHHHHHHHHH
Confidence 1 222222 000 00 0 000 1149999999999999999987776655444
Q ss_pred HHHHHhhCCc-cCC---------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 160 VVAAVGFKGK-RLE---------IPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 160 ~~~~~~~~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
....+..... ..+ +....+.-+.++..+|+...|..||...++.
T Consensus 139 ~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 139 YLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 3333321111 111 1124567788899999999999888655544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00065 Score=53.51 Aligned_cols=104 Identities=20% Similarity=0.262 Sum_probs=71.2
Q ss_pred CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCc
Q 027225 20 PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99 (226)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 99 (226)
.+.|++|++. |+++...- ....+++..++++.+..+.-+...- +.-|+|+.-.||+++ +|++.|+||.++
T Consensus 299 ~y~yl~~kdh-gt~is~ik-------~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIK-------ADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred eEEEEEEecC-Cceeeeee-------cccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-cCceEEEEeeee
Confidence 4567778876 44543322 2567888899999999999888763 389999999999999 899999999988
Q ss_pred ccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHH
Q 027225 100 RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139 (226)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 139 (226)
+.......... ...-.|-.+.|.. +..-+||-+-
T Consensus 369 Rl~~~q~~isy-----~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 369 RLSYSQGIISY-----NRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred ecccCCceeec-----cccCchhhhcCcc-ceeeeHHHHH
Confidence 75333221111 1233444555443 5667777744
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0021 Score=57.10 Aligned_cols=30 Identities=33% Similarity=0.517 Sum_probs=24.2
Q ss_pred CeEEeCCCCCcEEEcC-CCc-EEEccCCCccc
Q 027225 72 PIVHRDLKSPNLLVDK-KYT-VKVCDFGLSRL 101 (226)
Q Consensus 72 ~i~h~di~p~nil~~~-~~~-~~l~df~~~~~ 101 (226)
.++|||+++.||+++. ++. .-+.|++.++.
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3999999999999975 334 57899988764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0023 Score=53.37 Aligned_cols=73 Identities=18% Similarity=0.310 Sum_probs=52.3
Q ss_pred CceEEEEeecccCCHHHH--hcCCCCCCcCCHHHHHHHHHHHHHHHHH-HhcCCCCeEEeCCCCCcEEEcC----CCcEE
Q 027225 20 PNLSIVTEYLSRGSLYRL--LHKPGVREMLDERRRLNMAYDVAKGMNY-LHRRNPPIVHRDLKSPNLLVDK----KYTVK 92 (226)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~--~~~~~~~~~~~~~~~~~~~~~l~~~l~~-lH~~~~~i~h~di~p~nil~~~----~~~~~ 92 (226)
...+++|||++|..+.+. +.+.+ ++... ++..+.++... +=..| ++|+|-+|.||+++. ++++.
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~---i~~~l~~~~~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~iv 345 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRG----ISPHD---ILNKLVEAYLEQIFKTG--FFHADPHPGNILVRPNPEGDEEIV 345 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcC----CCHHH---HHHHHHHHHHHHHHhcC--CccCCCCCCcEEEecCCCCCccEE
Confidence 358999999999877554 44544 55554 34445554333 33467 999999999999983 56899
Q ss_pred EccCCCccc
Q 027225 93 VCDFGLSRL 101 (226)
Q Consensus 93 l~df~~~~~ 101 (226)
+.|||+...
T Consensus 346 llDhGl~~~ 354 (538)
T KOG1235|consen 346 LLDHGLYAV 354 (538)
T ss_pred EEccccccc
Confidence 999998754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0027 Score=49.56 Aligned_cols=33 Identities=33% Similarity=0.546 Sum_probs=28.8
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCccccc
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 103 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~ 103 (226)
+.++|||+++.|++++.++.+-+.||+.+....
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 369999999999999999889999999876533
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0012 Score=51.44 Aligned_cols=70 Identities=20% Similarity=0.239 Sum_probs=54.4
Q ss_pred CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCC
Q 027225 19 PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 98 (226)
Q Consensus 19 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~ 98 (226)
.+..++|||++.|..|.....- .+... +...++..|--|-.+| ++|||.+--||++++++.++++||-.
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred ccceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEecCCCEEEeechH
Confidence 3457999999998777665432 23333 4456666777888999 99999999999999999999999965
Q ss_pred c
Q 027225 99 S 99 (226)
Q Consensus 99 ~ 99 (226)
.
T Consensus 249 m 249 (465)
T KOG2268|consen 249 M 249 (465)
T ss_pred h
Confidence 4
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0081 Score=44.34 Aligned_cols=38 Identities=26% Similarity=0.290 Sum_probs=32.5
Q ss_pred HHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCC
Q 027225 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG 97 (226)
Q Consensus 60 ~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~ 97 (226)
+.+|.-.|+......|||..|+||+.|+.|.+||.|=+
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 46678889654449999999999999999999999965
|
The function of this family is unknown. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.021 Score=44.48 Aligned_cols=28 Identities=21% Similarity=0.333 Sum_probs=22.0
Q ss_pred CCCeEEeCCCCCcEEEcCC-Cc-EEEccCC
Q 027225 70 NPPIVHRDLKSPNLLVDKK-YT-VKVCDFG 97 (226)
Q Consensus 70 ~~~i~h~di~p~nil~~~~-~~-~~l~df~ 97 (226)
+++++|||+.+.||+++.+ +. +.+.|..
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence 4569999999999999864 44 6677765
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.0079 Score=46.09 Aligned_cols=53 Identities=19% Similarity=0.238 Sum_probs=41.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcC--CCCeEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 47 LDERRRLNMAYDVAKGMNYLHRR--NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 47 ~~~~~~~~~~~~l~~~l~~lH~~--~~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
.+.......+..+-.++..++.. - ++|+|+.|+|++.++.+.++|+||..+..
T Consensus 129 ~~~~~~~~~~~~l~~~l~~~~~~~~v--~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 129 RDNHLLRKKLKELRRALEEVPKDDLV--PCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred hhhHHHHHHHHHHHHHhhhcCCCcee--eecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444455666666777777665 4 99999999999999988999999987754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.0093 Score=44.62 Aligned_cols=28 Identities=32% Similarity=0.527 Sum_probs=25.2
Q ss_pred eEEeCCCCCcEEEcC-CCcEEEccCCCcc
Q 027225 73 IVHRDLKSPNLLVDK-KYTVKVCDFGLSR 100 (226)
Q Consensus 73 i~h~di~p~nil~~~-~~~~~l~df~~~~ 100 (226)
++|+|+.+.||+++. ++.+.++||..+.
T Consensus 172 l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 172 FCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.017 Score=45.00 Aligned_cols=29 Identities=24% Similarity=0.386 Sum_probs=25.6
Q ss_pred CeEEeCCCCCcEEEcCC----CcEEEccCCCcc
Q 027225 72 PIVHRDLKSPNLLVDKK----YTVKVCDFGLSR 100 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~----~~~~l~df~~~~ 100 (226)
.++|+|+.+.||+++++ +.+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 39999999999999984 789999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.013 Score=43.90 Aligned_cols=28 Identities=39% Similarity=0.446 Sum_probs=24.2
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
++|||+++.||++++++..-++||+.+.
T Consensus 166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 166 WFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred EEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 8999999999999877556799999754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.0096 Score=44.20 Aligned_cols=27 Identities=33% Similarity=0.570 Sum_probs=19.6
Q ss_pred eEEeCCCCCcEEEc-CCCcEEEccCCCc
Q 027225 73 IVHRDLKSPNLLVD-KKYTVKVCDFGLS 99 (226)
Q Consensus 73 i~h~di~p~nil~~-~~~~~~l~df~~~ 99 (226)
++|+|++|.||+++ +++.+.++||+.+
T Consensus 168 ~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 168 LIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp EE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred EEEeccccccceeeeccceeEEEecccc
Confidence 99999999999999 6667789999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.019 Score=45.00 Aligned_cols=28 Identities=32% Similarity=0.438 Sum_probs=25.4
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
++|+|+++.||++++++...++||+.+.
T Consensus 189 l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 189 VIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCCCCcCcEEEECCceEEEeeccccc
Confidence 9999999999999998767899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.012 Score=42.26 Aligned_cols=29 Identities=17% Similarity=0.266 Sum_probs=25.4
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
..+|+|+.|.|+++++++ ++++|++.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998887 99999998754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.032 Score=43.63 Aligned_cols=26 Identities=31% Similarity=0.478 Sum_probs=23.6
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLS 99 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~ 99 (226)
++|||+.+.||+++. +.+.++||+.+
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECccc
Confidence 999999999999988 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.019 Score=44.58 Aligned_cols=29 Identities=31% Similarity=0.385 Sum_probs=25.8
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|||+.|.||++++++.+.++||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999987778999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.01 Score=43.75 Aligned_cols=29 Identities=34% Similarity=0.568 Sum_probs=20.9
Q ss_pred eEEeCCCCCcEEE-cCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLV-DKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~-~~~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||++ +.++.++++||..+..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 9999999999999 8888999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.036 Score=43.56 Aligned_cols=29 Identities=24% Similarity=0.315 Sum_probs=25.1
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.|.||+++++...-++||+.++.
T Consensus 189 liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 189 VIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCCCCCCCcEEEECCceEEEEecccccC
Confidence 99999999999999775568999997753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.019 Score=43.68 Aligned_cols=28 Identities=25% Similarity=0.342 Sum_probs=24.8
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.|.||++++++ +.++||+.+..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999999876 78999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.057 Score=43.05 Aligned_cols=28 Identities=21% Similarity=0.553 Sum_probs=24.9
Q ss_pred eEEeCCCCCcEEEcC-CCcEEEccCCCcc
Q 027225 73 IVHRDLKSPNLLVDK-KYTVKVCDFGLSR 100 (226)
Q Consensus 73 i~h~di~p~nil~~~-~~~~~l~df~~~~ 100 (226)
++|+|+++.||++++ ++.+.++||..+.
T Consensus 202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 202 FCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred EEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 899999999999986 4689999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.057 Score=41.85 Aligned_cols=28 Identities=29% Similarity=0.300 Sum_probs=19.0
Q ss_pred CCCeEEeCCCCCcEEEcCCCcEEEccCC
Q 027225 70 NPPIVHRDLKSPNLLVDKKYTVKVCDFG 97 (226)
Q Consensus 70 ~~~i~h~di~p~nil~~~~~~~~l~df~ 97 (226)
.++.+||||-+.|++++.+|...|.|=+
T Consensus 187 ~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 187 KPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp --EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred CceeeEcCccccceeecCCCCceeeccc
Confidence 3579999999999999999989998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.038 Score=42.58 Aligned_cols=30 Identities=23% Similarity=0.470 Sum_probs=24.7
Q ss_pred CeEEeCCCCCcEEEcCCCc-EEEccCCCccc
Q 027225 72 PIVHRDLKSPNLLVDKKYT-VKVCDFGLSRL 101 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~-~~l~df~~~~~ 101 (226)
.++|||++|.||++++++. .-++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 46999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.083 Score=41.42 Aligned_cols=28 Identities=21% Similarity=0.288 Sum_probs=26.0
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
++|+|+.++|++++.++.+.++||..++
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 9999999999999999899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.16 Score=36.98 Aligned_cols=27 Identities=33% Similarity=0.460 Sum_probs=23.2
Q ss_pred eEEeCCCCCcEEEcCCC-----cEEEccCCCc
Q 027225 73 IVHRDLKSPNLLVDKKY-----TVKVCDFGLS 99 (226)
Q Consensus 73 i~h~di~p~nil~~~~~-----~~~l~df~~~ 99 (226)
++|||+.+.|+++..++ .+.++||..+
T Consensus 122 l~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~ 153 (196)
T smart00587 122 LNHGDLWANNIMFKYDDEGKPEDVALIDFQLS 153 (196)
T ss_pred EeeCCCCccceeeccCCCCCccceEEEecccC
Confidence 99999999999997543 5899999865
|
subfamily of choline kinases |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.12 E-value=0.067 Score=42.23 Aligned_cols=52 Identities=23% Similarity=0.215 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHH---HHh-cCCCCeEEeCCCCCcEEEcCC------------------CcEEEccCCCccccc
Q 027225 50 RRRLNMAYDVAKGMN---YLH-RRNPPIVHRDLKSPNLLVDKK------------------YTVKVCDFGLSRLKA 103 (226)
Q Consensus 50 ~~~~~~~~~l~~~l~---~lH-~~~~~i~h~di~p~nil~~~~------------------~~~~l~df~~~~~~~ 103 (226)
+-++.++.|++--.- .+- ..+ .+|.||||+||++-++ -.++|.||+++...+
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~n--F~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTN--FLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcce--eeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 344556667665432 232 357 9999999999998322 235778888775433
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.13 Score=38.45 Aligned_cols=29 Identities=21% Similarity=0.256 Sum_probs=24.6
Q ss_pred cCcceeeeEEecCCceEEEEeecccCCHH
Q 027225 7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLY 35 (226)
Q Consensus 7 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 35 (226)
-.+.+++.+..+..+.|+|+||.+.+.+.
T Consensus 71 i~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 71 ITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 46778899999999999999999976654
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.079 Score=41.66 Aligned_cols=37 Identities=22% Similarity=0.139 Sum_probs=25.6
Q ss_pred HHHHHHHHHHHHHHHHHH---h-cCCCCeEEeCCCCCcEEEcC
Q 027225 49 ERRRLNMAYDVAKGMNYL---H-RRNPPIVHRDLKSPNLLVDK 87 (226)
Q Consensus 49 ~~~~~~~~~~l~~~l~~l---H-~~~~~i~h~di~p~nil~~~ 87 (226)
.+-++.++.|++--.-.+ - ..+ .+|.||||+||++-+
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~n--F~H~DLKPdNILiFd 318 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDN--FLHVDLKPDNILIFD 318 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcce--eeeccCCCCcEEEec
Confidence 344556777776655333 2 347 999999999999843
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.23 Score=42.84 Aligned_cols=86 Identities=19% Similarity=0.076 Sum_probs=66.5
Q ss_pred CCcCcceeeeEEecCCceEEEEeeccc-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
++.||.+++++|...+.-++++|+... .+|.+...... .+.-+...|++||++-=.-|...| ++-.=+.++|+
T Consensus 178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~~----~~~l~~l~Wl~q~~~LW~~l~~~~--~~~sll~~~nl 251 (645)
T PRK14559 178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQT----LPTLQILYWLNQMTQLWKALEPWG--CCQSLLELENL 251 (645)
T ss_pred ccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhcC----CcHHHHHHHHHHHHHHHHHHHhcC--eehhccchhhe
Confidence 345699999999988888888887642 33444444321 566788899999999999999999 99999999999
Q ss_pred EEcCCCcEEEccC
Q 027225 84 LVDKKYTVKVCDF 96 (226)
Q Consensus 84 l~~~~~~~~l~df 96 (226)
.++.+..+.|..+
T Consensus 252 rv~~~~~~~l~~l 264 (645)
T PRK14559 252 RVDEDQTLGLQQL 264 (645)
T ss_pred eeCCCceehHhhh
Confidence 9987666666554
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.057 Score=42.67 Aligned_cols=28 Identities=32% Similarity=0.470 Sum_probs=25.1
Q ss_pred eEEeCCCCCcEEEcCCCc-EEEccCCCcc
Q 027225 73 IVHRDLKSPNLLVDKKYT-VKVCDFGLSR 100 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~-~~l~df~~~~ 100 (226)
++|+|+.|.||+++.+.. +.++||+-++
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 799999999999999875 8899998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.068 Score=42.36 Aligned_cols=29 Identities=28% Similarity=0.432 Sum_probs=25.2
Q ss_pred eEEeCCCCCcEEEcC-CCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDK-KYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~-~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||++++ ++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 56899999987743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.67 Score=37.86 Aligned_cols=28 Identities=25% Similarity=0.411 Sum_probs=23.4
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCc
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~ 99 (226)
.+.+|||+.+.||+++.++ .+++|-.++
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 4699999999999999875 888886644
|
|
| >PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.13 Score=40.91 Aligned_cols=82 Identities=18% Similarity=0.243 Sum_probs=43.3
Q ss_pred CCcCcceeeeEEecCCceEEEEeeccc-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.||+.++. .+-.+++.+.+.++.-+. .++.. +.+ .+..+.++++.+ +.+|.. |... -+|--++|+|+
T Consensus 21 ~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~-i~~------~~~~eklr~~~n-i~~l~~-~~~~--~~~f~l~P~Nl 88 (359)
T PF10140_consen 21 HDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEE-IKK------LDKSEKLRLLIN-IAALKE-HLNS--RYTFILHPENL 88 (359)
T ss_dssp --TTB--E-EEEE-SSEEEEEE---TTSEEGGG-GGG------S-HHHHHHHHHH-GGGGGG-GGGS--SEE---SGGGE
T ss_pred cCcccCCc-eEEEeCCEEEEEEEcCcccCcHHH-HHh------cCHHHHHHHHHH-HHHHHH-HhcC--ceeEEEechhe
Confidence 67888874 555566666666664432 23332 333 778888888888 444432 2333 56889999999
Q ss_pred EEcCCCcEEEccCCC
Q 027225 84 LVDKKYTVKVCDFGL 98 (226)
Q Consensus 84 l~~~~~~~~l~df~~ 98 (226)
+++.++.+++...|.
T Consensus 89 ~fd~~~~p~i~hrGi 103 (359)
T PF10140_consen 89 VFDKNLMPKILHRGI 103 (359)
T ss_dssp EE-TTS-EEES--EE
T ss_pred EEcCCCCEEEEEcCC
Confidence 999999999988775
|
This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.41 E-value=0.25 Score=39.10 Aligned_cols=27 Identities=22% Similarity=0.303 Sum_probs=23.1
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||+++ + .+.++||+.++.
T Consensus 198 liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 198 RLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 89999999999995 4 578999997653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.30 E-value=0.36 Score=44.30 Aligned_cols=29 Identities=31% Similarity=0.523 Sum_probs=24.7
Q ss_pred eEEeCCCCCcEEEcCCC--cEE-EccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKY--TVK-VCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~--~~~-l~df~~~~~ 101 (226)
++|+|++++||+++.++ ++. |+|||-+..
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 99999999999998875 554 999997754
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=91.16 E-value=3.4 Score=33.12 Aligned_cols=81 Identities=15% Similarity=0.122 Sum_probs=54.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC
Q 027225 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126 (226)
Q Consensus 47 ~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 126 (226)
+....-++++.+.+..|..+... -.|--+.|+||+++.++.+.+..+|+-... ||=
T Consensus 82 ~~k~~Klr~a~~~I~~l~e~~~t---r~~~~laPeNilf~~~l~p~~vH~Glk~~l-----------------pPy---- 137 (434)
T COG4499 82 KEKTRKLRLALQNIATLSELNNT---RYTFFLAPENILFDGGLTPFFVHRGLKNSL-----------------PPY---- 137 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcc---ceeEEecchheEEcCCCceEEEecchhccC-----------------CCC----
Confidence 55566666677777777766433 447778999999999999999999864211 110
Q ss_pred CCCCCchhHH-HHHHHHHHHHhCCCCCC
Q 027225 127 EPSNEKSDIY-SFGVILWELATLQQPWG 153 (226)
Q Consensus 127 ~~~~~~~Dv~-slG~~l~~l~~g~~p~~ 153 (226)
.....++| .+-+++..++.|..+|.
T Consensus 138 --e~tee~f~~~ykA~~~~~fn~k~~Fe 163 (434)
T COG4499 138 --EMTEERFLKEYKALAIYAFNGKFSFE 163 (434)
T ss_pred --CCCHHHHHHHHHHHHHHHHcCCccHH
Confidence 11223444 66777778888888774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 226 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-117 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-115 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-32 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-32 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-32 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-32 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-32 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-31 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-31 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-31 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-31 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-31 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-31 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-31 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-31 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-31 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-31 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-31 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-31 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-31 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-31 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-31 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-31 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-31 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-31 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-31 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-30 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-30 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-30 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-30 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-30 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-30 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-29 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-29 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-29 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-29 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-29 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-28 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-28 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-28 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-28 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-28 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-28 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-28 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-28 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-28 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-28 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-28 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-28 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-28 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-28 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-28 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-28 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-28 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-28 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-28 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-28 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-28 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-28 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-28 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-28 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-28 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-28 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-28 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-28 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-28 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-28 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-28 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-28 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-28 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-28 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-28 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-28 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-28 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-28 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-27 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-27 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-27 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-27 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-27 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-27 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-27 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-27 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-27 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-27 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-27 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-27 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-27 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-27 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-27 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-27 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-27 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-27 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-27 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-27 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-27 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-27 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-27 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-27 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-27 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-26 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-26 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-26 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-26 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-26 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-26 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-26 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-26 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-26 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-26 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-26 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-26 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-26 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-26 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-26 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-26 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-26 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-26 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-26 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-26 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-26 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-26 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-26 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-26 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-26 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-26 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-26 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-25 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-25 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-25 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-25 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-25 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-25 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-25 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-25 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-25 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-25 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-25 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-25 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-25 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-25 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-25 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-25 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-25 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-25 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-25 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-25 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-25 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-25 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-25 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-25 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-25 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-25 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-25 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-25 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-25 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-25 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-25 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-25 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-24 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-24 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-24 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-24 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-24 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-24 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-24 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-24 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-23 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-23 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-23 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-23 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-23 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-23 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-23 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-23 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-23 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-23 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-23 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-23 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-23 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-23 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-23 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-23 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-23 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-23 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-23 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-23 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-23 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-22 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-22 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-22 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-22 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-21 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-20 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-20 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-20 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-20 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-20 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-20 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-20 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-20 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-20 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-20 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-20 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-20 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-20 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-20 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-20 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-20 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-19 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-18 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-18 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-139
Identities = 199/222 (89%), Positives = 210/222 (94%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KGMNYLH RNPPIVHR+LKSPNLLVDKKYTVKVCDFGLSRLKA+TFLSSKSAAGTPEWMA
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
VA+IIE CW NEPWKRPSF+TIM+LLRPLIKS P P+ +D+
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-120
Identities = 80/218 (36%), Positives = 117/218 (53%), Gaps = 15/218 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
L+HPNI+ G + PNL +V E+ G L R+L + + +N A +A
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIA 115
Query: 61 KGMNYLHRRNP-PIVHRDLKSPNLLVDKKY--------TVKVCDFGLSRLKANTFLSSKS 111
+GMNYLH PI+HRDLKS N+L+ +K +K+ DFGL+R T + S
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMS 173
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
AAG WMAPEV+R ++ SD++S+GV+LWEL T + P+ ++ V V L
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209
IP A ++E CW +P RPSF+ I++ L +
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-119
Identities = 63/214 (29%), Positives = 117/214 (54%), Gaps = 11/214 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
++ HPN++ +GA PP + +++T ++ GSLY +LH+ ++D+ + + A D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALD 119
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+A+GM +LH P I L S ++++D+ T ++ + S P W
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAW 174
Query: 119 MAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
+APE L+ +P + +D++SF V+LWEL T + P+ +L+ ++ V +G R IP
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209
++PHV+ +++ C +P KRP F I+ +L +
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-116
Identities = 75/218 (34%), Positives = 115/218 (52%), Gaps = 16/218 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M L HPNIV G + PP +V E++ G LY L + +L + D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSRLKANTFLSSKSAAGT 115
G+ Y+ +NPPIVHRDL+SPN+ + KV DFGLS+ ++ G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGN 189
Query: 116 PEWMAPEVL--RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKGKRL 171
+WMAPE + +E EK+D YSF +IL+ + T + P+ + ++ + + +G R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209
IP + P + ++IE CW+ +P KRP FS I++ L L
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-115
Identities = 74/226 (32%), Positives = 118/226 (52%), Gaps = 8/226 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ R+ HPNIV GA P + +V EY GSLY +LH ++ +
Sbjct: 55 LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 61 KGMNYLHRRNP-PIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEW 118
+G+ YLH P ++HRDLK PNLL+ TV K+CDFG + ++K G+ W
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAW 169
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNV 177
MAPEV +EK D++S+G+ILWE+ T ++P+ + PA + G R + +N+
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
+ S++ CW+ +P +RPS I++++ L++ P P
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-114
Identities = 72/241 (29%), Positives = 108/241 (44%), Gaps = 20/241 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ L HPN++ F+G + + L+ +TEY+ G+L ++ + +R++ A D+A
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIA 118
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------------KANTF 106
GM YLH N I+HRDL S N LV + V V DFGL+RL K
Sbjct: 119 SGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 166
+ G P WMAPE++ +EK D++SFG++L E+ + P + +
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236
Query: 167 K-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ-PSPTDMPL 224
+ P N P I C +P KRPSF + L L P +
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296
Query: 225 L 225
L
Sbjct: 297 L 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-113
Identities = 77/220 (35%), Positives = 127/220 (57%), Gaps = 14/220 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+++ RH NI+LFMG T P L+IVT++ SLY LH + + ++ +++A A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTA 130
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
+GM+YLH ++ I+HRDLKS N+ + + TVK+ DFGL+ K+ S + +G+ W
Sbjct: 131 RGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 119 MAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKR---L 171
MAPEV+R + SN +SD+Y+FG++L+EL T Q P+ N+N Q++ VG
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
++ N + ++ C + +RPSF I+ + L +
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 325 bits (834), Expect = e-113
Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 19/236 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ RH N+VLFMGA PP+L+I+T +LY ++ + +LD + +A ++
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIV 140
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS-----AAGT 115
KGM YLH + I+H+DLKS N+ D V + DFGL + + G
Sbjct: 141 KGMGYLHAKG--ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 116 PEWMAPEVLR---------DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 166
+APE++R P ++ SD+++ G I +EL + P+ ++ +G
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 167 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
K + ++ I+ CWA E +RP+F+ +M++L L K P
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 1e-98
Identities = 71/256 (27%), Positives = 109/256 (42%), Gaps = 44/256 (17%)
Query: 1 MKRLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+RH NI+ F+ A + L ++T+Y GSLY L LD + L +A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLA 140
Query: 57 YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----F 106
Y G+ +LH + P I HRDLKS N+LV K T + D GL+ +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 107 LSSKSAAGTPEWMAPEVL------RDEPSNEKSDIYSFGVILWELAT----------LQQ 150
+ + GT +M PEVL S +D+YSFG+ILWE+A Q
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
Query: 151 PWGNLNPAQ-----VVAAVGFKGKRLEIPRNVNPH-----VASIIEACWANEPWKRPSFS 200
P+ +L P+ + V K R P + + ++ CWA+ P R +
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 201 TIMELLRPLIKSPTPQ 216
+ + L + +S +
Sbjct: 321 RVKKTLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 4e-98
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 44/249 (17%)
Query: 1 MKRLRHPNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
LRH NI+ F+ + L ++T Y GSLY L LD L +
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIV 111
Query: 57 YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---- 106
+A G+ +LH + P I HRDLKS N+LV K + D GL+ + + +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 107 LSSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSFGVILWELAT----------LQQ 150
+ + GT +MAPEVL + S ++ DI++FG++LWE+A +
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 151 PWGNLNP-----AQVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWANEPWKRPSFS 200
P+ ++ P + V +R IP +A +++ CW P R +
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 201 TIMELLRPL 209
I + L +
Sbjct: 292 RIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 3e-92
Identities = 69/252 (27%), Positives = 108/252 (42%), Gaps = 44/252 (17%)
Query: 1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
LRH NI+ F+ A + L +V++Y GSL+ L+ R + + +A
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145
Query: 57 YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----F 106
A G+ +LH + P I HRDLKS N+LV K T + D GL+ +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 107 LSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELATL----------QQ 150
++ GT +MAPEVL D S +++DIY+ G++ WE+A Q
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 151 PWGNLNPA-----QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWANEPWKRPSFS 200
P+ +L P+ ++ V + R IP +A I+ CW R +
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
Query: 201 TIMELLRPLIKS 212
I + L L +
Sbjct: 326 RIKKTLSQLSQQ 337
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 5e-91
Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 44/252 (17%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+ ++H NI+ F+GA + + L ++T + +GSL L ++ ++A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIA 127
Query: 57 YDVAKGMNYLH--------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTF 106
+A+G+ YLH P I HRD+KS N+L+ T + DFGL+ +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 107 LSSKSAAGTPEWMAPEVLRDEP-----SNEKSDIYSFGVILWELATLQQPWGNLNPA--- 158
+ GT +MAPEVL + + D+Y+ G++LWELA+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 159 -------------QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWANEPWKRPSFS 200
+ V K KR + H + IE CW ++ R S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 201 TIMELLRPLIKS 212
+ E + + +
Sbjct: 308 CVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-82
Identities = 65/274 (23%), Positives = 100/274 (36%), Gaps = 55/274 (20%)
Query: 1 MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
+ + H NI F+ + +V EY GSL + L D +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRL 116
Query: 56 AYDVAKGMNYLH-------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL- 107
A+ V +G+ YLH P I HRDL S N+LV T + DFGLS L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 108 -------SSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELA---TLQQ 150
++ S GT +MAPEVL E + ++ D+Y+ G+I WE+ T
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 151 PWGNLNPAQV---------------VAAVGFKGKRLEIPRNVNPH------VASIIEACW 189
P ++ Q+ V + +R + P + + IE CW
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 190 ANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
+ R + E + L+ S +
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-66
Identities = 73/221 (33%), Positives = 113/221 (51%), Gaps = 16/221 (7%)
Query: 1 MKRLRHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+K L+HPNIV F + V + +VTE ++ G+L L + V + + +
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWC 135
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGT 115
+ KG+ +LH R PPI+HRDLK N+ + +VK+ D GL+ LK +F +K+ GT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGT 193
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIP 174
PE+MAPE+ +E +E D+Y+FG+ + E+AT + P+ N AQ+ V K
Sbjct: 194 PEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPT 214
+ P V IIE C +R S +LL + T
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYSIK---DLLNHAFFQEET 290
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-64
Identities = 80/216 (37%), Positives = 111/216 (51%), Gaps = 8/216 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+ HPNIV +G TQ + IV E + G L G L + L M D A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAA 223
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
GM YL + +HRDL + N LV +K +K+ DFG+SR + +S P +W
Sbjct: 224 AGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE L + +SD++SFG++LWE +L P+ NL+ Q V KG RL P
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELC 340
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
V ++E CWA EP +RPSFSTI + L+ + K
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-62
Identities = 70/218 (32%), Positives = 114/218 (52%), Gaps = 7/218 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+L+H +V VTQ P I+TEY+ GSL L P L + L+MA +A
Sbjct: 62 MKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIA 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+GM ++ RN +HRDL++ N+LV + K+ DFGL+RL + +++ A P +W
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE + KSD++SFG++L E+ T + P+ + +V+ + +G R+ P N
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 236
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ ++ CW P RP+F + +L + Q
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-62
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 9/216 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + +P++ +G + ++T+ + G L + + ++ + + LN +A
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
KGMNYL R +VHRDL + N+LV VK+ DFGL++ L A P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
MA E + +SD++S+GV +WEL T +P+ + +++ + + KG+RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
V I+ CW + RP F ++ + + P
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 7e-62
Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 7/215 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L HP +V G + + +VTE++ G L L R + L M DV
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+GM YL ++HRDL + N LV + +KV DFG++R + +S + P +W
Sbjct: 115 EGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+PEV + KSD++SFGV++WE+ + + P+ N + ++VV + G RL PR +
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 231
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
HV I+ CW P RP+FS ++ L + +S
Sbjct: 232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-61
Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 7/223 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRH +V V++ P IVTEY+S+GSL L + L + ++MA +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIA 290
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + +++ A P +W
Sbjct: 291 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE KSD++SFG++L EL T + P+ + +V+ V +G R+ P
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 407
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221
+ ++ CW EP +RP+F + L S PQ P +
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-61
Identities = 75/218 (34%), Positives = 119/218 (54%), Gaps = 6/218 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK ++HPN+V +G T+ P I+TE+++ G+L L + R+ + L MA ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 121
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
M YL ++N +HRDL + N LV + + VKV DFGLSRL ++ + A P +W
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE L + KSD+++FGV+LWE+AT P+ ++ +QV + K R+E P
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
V ++ ACW P RPSF+ I + + + +
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-61
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 7/215 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M L H +V G T+ + I+TEY++ G L L + R ++ L M DV
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVC 130
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+ M YL + +HRDL + N LV+ + VKV DFGLSR + +S + P W
Sbjct: 131 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
PEVL + KSDI++FGV++WE+ +L + P+ ++ + +G RL P +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 247
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
V +I+ +CW + +RP+F ++ + ++
Sbjct: 248 EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 4e-61
Identities = 73/218 (33%), Positives = 119/218 (54%), Gaps = 6/218 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK ++HPN+V +G T+ P I+TE+++ G+L L + R+ + L MA ++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 328
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
M YL ++N +HR+L + N LV + + VKV DFGLSR + +T+ + A +W
Sbjct: 329 SAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE L + KSD+++FGV+LWE+AT P+ ++ +QV + K R+E P
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 445
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
V ++ ACW P RPSF+ I + + + +
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 6e-61
Identities = 74/213 (34%), Positives = 115/213 (53%), Gaps = 7/213 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L HP +V F G ++ + IVTEY+S G L L G + L+ + L M YDV
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVC 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+GM +L +HRDL + N LVD+ VKV DFG++R + S P +W
Sbjct: 115 EGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APEV + KSD+++FG+++WE+ +L + P+ ++VV V +G RL P +
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLAS 231
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
+ I+ +CW P KRP+F ++ + PL +
Sbjct: 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-60
Identities = 66/218 (30%), Positives = 117/218 (53%), Gaps = 7/218 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK L+H +V VT+ P I+TE++++GSL L + ++ + +A
Sbjct: 237 MKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIA 294
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+GM ++ +RN +HRDL++ N+LV K+ DFGL+R+ + +++ A P +W
Sbjct: 295 EGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 352
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE + KSD++SFG++L E+ T + P+ ++ +V+ A+ +G R+ P N
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCP 411
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ +I+ CW N P +RP+F I +L + Q
Sbjct: 412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 5e-60
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 8/218 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++ HP+IV +G +T+ P I+ E + G L L + LD + AY ++
Sbjct: 70 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLS 126
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+ YL + VHRD+ + N+LV VK+ DFGLSR ++ S P +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE + SD++ FGV +WE+ +P+ + V+ + G+RL +P N
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
P + S++ CWA +P +RP F+ + L +++ Q
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 8e-60
Identities = 76/216 (35%), Positives = 117/216 (54%), Gaps = 11/216 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
M +LRH N+V +G + + L IVTEY+++GSL L G R +L L + DV
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 126
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
+ M YL N VHRDL + N+LV + KV DFGL++ ++T + K P +W
Sbjct: 127 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKW 180
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG +++ P
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 239
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
P V +++ CW + RPSF + E L +
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 8e-60
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 8/218 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK L HP+IV +G + + P I+ E G L L + + L + + +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQIC 123
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
K M YL N VHRD+ N+LV VK+ DFGLSR + S P +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+PE + SD++ F V +WE+ + +QP+ L V+ + KG RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
P + +++ CW +P RP F+ ++ L + +
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 9e-60
Identities = 72/229 (31%), Positives = 110/229 (48%), Gaps = 19/229 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-------------HKPGVREML 47
+ L+H +IV F G L +V EY+ G L + L + L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTF 106
+ L++A +A GM YL ++ VHRDL + N LV VK+ DFG+SR + + +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
P WM PE + +SD++SFGVILWE+ T +QPW L+ +V+ +
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
+G+ LE PR V ++ CW EP +R + I ++L L K+
Sbjct: 249 T-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-59
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 15/233 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLY---RLLHKPGVREMLDERR 51
MK HP++ +G + P ++ ++ G L+ L +
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
+ D+A GM YL RN +HRDL + N ++ + TV V DFGLSR + + +
Sbjct: 139 LVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
A+ P +W+A E L D SD+++FGV +WE+ T Q P+ + A++ + G
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GG 255
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221
RL+ P V ++ CW+ +P +RPSF+ + L ++ + + D
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-59
Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 7/223 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRH +V V++ P IVTEY+S+GSL L + L + ++MA +A
Sbjct: 316 MKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIA 373
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + +++ A P +W
Sbjct: 374 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 431
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE KSD++SFG++L EL T + P+ + +V+ V +G R+ P
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 490
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221
+ ++ CW EP +RP+F + L S PQ P +
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-59
Identities = 75/230 (32%), Positives = 112/230 (48%), Gaps = 18/230 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL------------HKPGVREMLD 48
+ L+H +IV F G T+ L +V EY+ G L R L + L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 49 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFL 107
+ L +A VA GM YL + VHRDL + N LV + VK+ DFG+SR + + +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 108 SSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 165
P WM PE + +SD++SFGV+LWE+ T +QPW L+ + + +
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274
Query: 166 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215
+G+ LE PR P V +I+ CW EP +R S + L+ L ++P
Sbjct: 275 -QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-59
Identities = 64/234 (27%), Positives = 110/234 (47%), Gaps = 13/234 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKPGVREMLDERRRLNMA 56
+ + H NIV +G Q I+ E ++ G L L +P L L++A
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSA 112
D+A G YL + +HRD+ + N L+ K+ DFG++R + ++
Sbjct: 147 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
A P +WM PE + K+D +SFGV+LWE+ +L P+ + + +V+ V G R
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGR 263
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 224
++ P+N V I+ CW ++P RP+F+ I+E + + P + +
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 317
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-59
Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 9/217 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ L H +IV +G L +VT+YL GSL + + R L + LN +A
Sbjct: 69 IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIA 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
KGM YL +VHR+L + N+L+ V+V DFG++ L + S A TP +W
Sbjct: 126 KGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
MA E + +SD++S+GV +WEL T +P+ L A+V + KG+RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214
V ++ CW + RP+F + + + P
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-59
Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 13/233 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------PGVREMLDERRRL 53
MK ++V +G V+Q ++ E ++RG L L V + +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSA 112
MA ++A GM YL+ VHRDL + N +V + +TVK+ DFG++R + +
Sbjct: 142 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
P WM+PE L+D SD++SFGV+LWE+ATL +QP+ L+ QV+ V +G
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGL 258
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
L+ P N + ++ CW P RPSF I+ ++ ++ + S
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 311
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-59
Identities = 64/229 (27%), Positives = 113/229 (49%), Gaps = 12/229 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
M+ L HPN++ +G + P ++ Y+ G L + + P + + ++ V
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQV 133
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGT-P 116
A+GM YL + VHRDL + N ++D+ +TVKV DFGL+R + + P
Sbjct: 134 ARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
+W A E L+ KSD++SFGV+LWEL T P+ +++P + + +G+RL P
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQP 250
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
+ +++ CW +P RP+F ++ + ++ S +P
Sbjct: 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV-SALLGDHYVQLP 298
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-58
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 9/216 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + +P++ +G + ++T+ + G L + + ++ + + LN +A
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
KGMNYL R +VHRDL + N+LV VK+ DFGL++ L A P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
MA E + +SD++S+GV +WEL T +P+ + +++ + + KG+RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
V I+ CW + RP F ++ + + P
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-58
Identities = 75/216 (34%), Positives = 117/216 (54%), Gaps = 11/216 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
M +LRH N+V +G + + L IVTEY+++GSL L G R +L L + DV
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 298
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
+ M YL N VHRDL + N+LV + KV DFGL++ ++T + K P +W
Sbjct: 299 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKW 352
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG +++ P
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 411
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
P V +++ CW + RP+F + E L +
Sbjct: 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-58
Identities = 74/226 (32%), Positives = 112/226 (49%), Gaps = 9/226 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HPNI+ G VT+ IVTEY+ GSL L + + M V
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVG 161
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT--P-E 117
GM YL VHRDL + N+LVD KV DFGLSR+ + ++ + G P
Sbjct: 162 AGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + SD++SFGV++WE+ ++P+ N+ V+++V +G RL P
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
+ ++ CW + +RP FS I+ +L LI+SP + +
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-58
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 11/222 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
MK HPN++ +G + + +V Y+ G L + + + V
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQV 137
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAAGT-P 116
AKGM YL + VHRDL + N ++D+K+TVKV DFGL+R + P
Sbjct: 138 AKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
+WMA E L+ + KSD++SFGV+LWEL T P+ ++N + + +G+RL P
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQP 254
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ ++ CW + RPSFS ++ + + + +
Sbjct: 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-58
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M L H N++ G V PP + +VTE GSL L K + A VA
Sbjct: 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVA 131
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
+GM YL + +HRDL + NLL+ + VK+ DFGL R + + + P
Sbjct: 132 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE L+ + SD + FGV LWE+ T Q+PW LN +Q++ + +G+RL P +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELL 206
+ +++ CWA++P RP+F + + L
Sbjct: 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-58
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 13/234 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKPGVREMLDERRRLNMA 56
+ + H NIV +G Q I+ E ++ G L L +P L L++A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSA 112
D+A G YL + +HRD+ + N L+ K+ DFG++R + +
Sbjct: 188 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
A P +WM PE + K+D +SFGV+LWE+ +L P+ + + +V+ V G R
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGR 304
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 224
++ P+N V I+ CW ++P RP+F+ I+E + + P + +
Sbjct: 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 358
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 5e-58
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 8/218 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++ HP+IV +G +T+ P I+ E + G L L + LD + AY ++
Sbjct: 445 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLS 501
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
+ YL + VHRD+ + N+LV VK+ DFGLSR ++ S P +WM
Sbjct: 502 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE + SD++ FGV +WE+ +P+ + V+ + G+RL +P N
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 618
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
P + S++ CWA +P +RP F+ + L +++ Q
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 7e-58
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 14/223 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLY---RLLHKPGVREMLDERRR 52
MK HPN++ +G + P ++ ++ G L+ + + +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 111
L D+A GM YL RN +HRDL + N ++ TV V DFGLS+ + + +
Sbjct: 150 LKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
A P +W+A E L D KSD+++FGV +WE+AT P+ + ++ + G
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HGH 266
Query: 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
RL+ P + + I+ +CW +P RP+FS + L L++S
Sbjct: 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-57
Identities = 62/220 (28%), Positives = 113/220 (51%), Gaps = 10/220 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L +P IV +G + +V E G L++ L + + + V+
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVS 120
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
GM YL +N VHRDL + N+L+ ++ K+ DFGLS+ +++ +++SA P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + +SD++S+GV +WE + Q+P+ + +V+A + +GKR+E P
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 237
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
P + +++ CW + RP F T+ + +R S +
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-57
Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 9/219 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + H NI+ G +++ + I+TEY+ G+L + L + + + M +A
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIA 157
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT--P-E 117
GM YL N VHRDL + N+LV+ KV DFGLSR+ + ++ + +G P
Sbjct: 158 AGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + SD++SFG+++WE+ T ++P+ L+ +V+ A+ G RL P +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 274
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215
+ ++ CW E +RP F+ I+ +L LI++P
Sbjct: 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-57
Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K L+H NIV + G + ++ EYL GSL L K +E +D + L
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 122
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
+ KGM YL + +HRDL + N+LV+ + VK+ DFGL+++ + F K +P
Sbjct: 123 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL----------------QQPWGNLNPAQ 159
W APE L + + SD++SFGV+L+EL T G +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
++ + RL P + I+ CW N +RPSF + + + +
Sbjct: 241 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-57
Identities = 74/234 (31%), Positives = 120/234 (51%), Gaps = 20/234 (8%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
MK + +H NI+ +GA TQ L ++ EY S+G+L Y E
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
L + ++ AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 107 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
K+ G P +WMAPE L D +SD++SFGV+LWE+ TL P+ + ++
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217
+ +G R++ P N + ++ CW P +RP+F ++E L ++ + Q
Sbjct: 306 LK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-57
Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 11/222 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
MK HPN++ +G + + +V Y+ G L + + + V
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQV 201
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGT--P 116
AKGM +L + VHRDL + N ++D+K+TVKV DFGL+R + F S + G P
Sbjct: 202 AKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
+WMA E L+ + KSD++SFGV+LWEL T P+ ++N + + +G+RL P
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQP 318
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ ++ CW + RPSFS ++ + + + +
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-56
Identities = 66/246 (26%), Positives = 103/246 (41%), Gaps = 41/246 (16%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------------- 40
M +PNIV +G + ++ EY++ G L L
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 41 -PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
L +L +A VA GM YL R VHRDL + N LV + VK+ DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 100 R---------LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-Q 149
R N + + WM PE + +SD++++GV+LWE+ +
Sbjct: 222 RNIYSADYYKADGNDAIPIR-------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 150 QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209
QP+ + +V+ V G L P N + +++ CW+ P RPSF +I +L+ +
Sbjct: 275 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333
Query: 210 IKSPTP 215
+
Sbjct: 334 CERAEG 339
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-56
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
RL+HPN+V +G VT+ LS++ Y S G L+ L V+ L
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTF 106
+ +++ +A GM YL + +VH+DL + N+LV K VK+ D GL R + A +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
+ P WMAPE + + SDI+S+GV+LWE+ + QP+ + VV +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ L P + V +++ CW P +RP F I LR
Sbjct: 244 R-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-56
Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 9/225 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HPNI+ G VT+ + IVTEY+ GSL L K + + M +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIA 157
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT--P-E 117
GM YL VHRDL + N+L++ KV DFGL R+ + ++ + G P
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W +PE + SD++S+G++LWE+ + ++P+ ++ V+ AV +G RL P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221
+ ++ CW + RP F I+ +L LI++P T
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITS 319
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-56
Identities = 57/212 (26%), Positives = 115/212 (54%), Gaps = 6/212 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ ++HPNIV + + + +L IV +Y G L++ ++ + E + L+ +
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQIC 135
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ ++H R I+HRD+KS N+ + K TV++ DFG++R+ +T +++ GTP +++
Sbjct: 136 LALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+ ++P N KSDI++ G +L+EL TL+ + + +V + G + + +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYD 252
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+ S++ + P RPS ++I+E + I
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILE--KGFIAK 282
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-56
Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 11/221 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++L +P IV +G + +V E G L + L + + ++ + + + V+
Sbjct: 72 MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 127
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
GM YL N VHRDL + N+L+ ++ K+ DFGLS+ + +++ P +
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + KSD++SFGV++WE + Q+P+ + ++V A + KG+R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217
+ ++ CW + RP F+ + LR +
Sbjct: 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-56
Identities = 67/233 (28%), Positives = 103/233 (44%), Gaps = 26/233 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K L+H NIV + G L ++ EYL GSL L K +E +D + L
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 153
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAG-TP 116
+ KGM YL + +HRDL + N+LV+ + VK+ DFGL++ L + G +P
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL----------------QQPWGNLNPAQ 159
W APE L + + SD++SFGV+L+EL T G +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
++ + RL P + I+ CW N +RPSF + + +
Sbjct: 272 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-56
Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 19/233 (8%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGVREMLD 48
M L +H NIV +GA T + ++TEY G L L +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 49 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTF 106
R L+ + VA+GM +L +N +HRD+ + N+L+ + K+ DFGL+R + +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVVAAV 164
+ +A +WMAPE + D +SD++S+G++LWE+ +L P+ G L ++ V
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217
G ++ P ++ SI++ACWA EP RP+F I L+ + +
Sbjct: 281 K-DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-56
Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL---------------------YRLLH 39
+K++ HP+++ GA +Q L ++ EY GSL
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 40 KPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
L ++ A+ +++GM YL +VHRDL + N+LV + +K+ DFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 100 RLKANTFLSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
R K + G P +WMA E L D +SD++SFGV+LWE+ TL P+ +
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
P ++ + G R+E P N + + ++ CW EP KRP F+ I + L ++
Sbjct: 258 PERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-56
Identities = 71/234 (30%), Positives = 119/234 (50%), Gaps = 20/234 (8%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
MK + +H NI+ +GA TQ L ++ EY S+G+L Y E
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
+ + ++ Y +A+GM YL + +HRDL + N+LV + +K+ DFGL+R N
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 107 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
K+ G P +WMAPE L D +SD++SFGV++WE+ TL P+ + ++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217
+ +G R++ P N + ++ CW P +RP+F ++E L ++ T +
Sbjct: 272 LK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-55
Identities = 69/230 (30%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
+ +L HPNI+ +GA L + EY G+L
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
L ++ L+ A DVA+GM+YL ++ +HRDL + N+LV + Y K+ DFGLSR +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-GQEVY 195
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 165
+ WMA E L SD++S+GV+LWE+ +L P+ + A++ +
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 166 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215
+G RLE P N + V ++ CW +P++RPSF+ I+ L +++
Sbjct: 256 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-55
Identities = 71/233 (30%), Positives = 119/233 (51%), Gaps = 20/233 (8%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
MK + +H NI+ +GA TQ L ++ EY S+G+L Y E
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
+ + ++ Y +A+GM YL + +HRDL + N+LV + +K+ DFGL+R N
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 107 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
K+ G P +WMAPE L D +SD++SFGV++WE+ TL P+ + ++
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ +G R++ P N + ++ CW P +RP+F ++E L ++ T +
Sbjct: 318 LK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-55
Identities = 71/231 (30%), Positives = 111/231 (48%), Gaps = 25/231 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
++ L H NIV + G T+ + ++ E+L GSL L K + ++ +++L A
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQ 134
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
+ KGM+YL R VHRDL + N+LV+ ++ VK+ DFGL++ + + K +P
Sbjct: 135 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL---------------QQPWGNLNPAQV 160
W APE L SD++SFGV L EL T G + ++
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
V + +GKRL P N V ++ CW +P R SF ++E L+K
Sbjct: 253 VNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-54
Identities = 72/217 (33%), Positives = 111/217 (51%), Gaps = 9/217 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAY 57
++ L+HPNIV + + N L IV EY G L ++ K R+ LDE L +
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 58 DVAKGMNYLHRRNPP---IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ + HRR+ ++HRDLK N+ +D K VK+ DFGL+R+ + +K+ G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
TP +M+PE + NEKSDI+S G +L+EL L P+ + ++ + +GK IP
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIP 237
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
+ + II + + RPS I+E PLI
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILE--NPLIL 272
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-54
Identities = 63/225 (28%), Positives = 115/225 (51%), Gaps = 10/225 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L +P IV +G + +V E G L++ L RE + + + V+
Sbjct: 390 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVS 446
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
GM YL +N VHR+L + N+L+ ++ K+ DFGLS+ +++ +++SA P +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + +SD++S+GV +WE + Q+P+ + +V+A + +GKR+E P
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221
P + +++ CW + RP F T+ + +R S +
Sbjct: 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-54
Identities = 72/235 (30%), Positives = 121/235 (51%), Gaps = 22/235 (9%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVRE 45
+ + H N+V +GA T+P L ++ E+ G+L Y++ + ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 46 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN 104
L + ++ VAKGM +L R +HRDL + N+L+ +K VK+CDFGL+R + +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 105 TFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVV 161
K A P +WMAPE + D +SD++SFGV+LWE+ +L P+ G +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ +G R+ P P + + CW EP +RP+FS ++E L L+++ Q
Sbjct: 262 RRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-54
Identities = 73/239 (30%), Positives = 105/239 (43%), Gaps = 23/239 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K L IV + G P +L +V EYL G L L + R LD R L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQ 135
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
+ KGM YL R VHRDL + N+LV+ + VK+ DFGL++L + + +P
Sbjct: 136 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGF-------- 166
W APE L D + +SD++SFGV+L+EL T + +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 167 -----KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPT 220
+G+RL P V +++ CWA P RPSFS + L L +
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-54
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L H ++VL G +V E++ GSL L K + ++ +L +A +A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLA 123
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSA 112
M++L ++H ++ + N+L+ ++ +K+ D G+S + K
Sbjct: 124 AAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLPKDI 176
Query: 113 AGTP-EWMAPEVLRDEPS-NEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
W+ PE + + + N +D +SFG LWE+ + +P L+ + +
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRH 235
Query: 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+L P+ +A++I C EP RPSF I+ L L
Sbjct: 236 QLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-54
Identities = 66/241 (27%), Positives = 114/241 (47%), Gaps = 32/241 (13%)
Query: 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
++ L H +I+ + G +L +V EY+ GSL L H G+ ++L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL------FA 140
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
+ +GM YLH ++ +HRDL + N+L+D VK+ DFGL++ + + + +
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 115 TP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL---------------QQPWGNLNPA 158
+P W APE L++ SD++SFGV L+EL T G +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ-P 217
++ + +G+RL P V +++ CW E RP+F ++ +L+ + + Q P
Sbjct: 259 RLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
Query: 218 S 218
S
Sbjct: 318 S 318
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-54
Identities = 71/236 (30%), Positives = 109/236 (46%), Gaps = 23/236 (9%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL---------------HKPGVR 44
+ L H NIV +GA T ++TEY G L L
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 45 EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN 104
LD L+ +Y VAKGM +L +N +HRDL + N+L+ K+CDFGL+R N
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 105 TFLSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQV 160
P +WMAPE + + +SD++S+G+ LWEL +L P+ G ++
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ +G R+ P + + I++ CW +P KRP+F I++L+ I T
Sbjct: 258 YKMIK-EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNH 312
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-53
Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 9/222 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
+K+L HPN++ + + + L+IV E G L R++ + ++ ER +
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ ++H R ++HRD+K N+ + VK+ D GL R ++ ++ S GTP +M
Sbjct: 146 CSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWG--NLNPAQVVAAVGFKGKRLEIPRNV 177
+PE + + N KSDI+S G +L+E+A LQ P+ +N + + + +P +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSDH 262
Query: 178 -NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218
+ + ++ C +P KRP + + ++ S
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRMHACTASS 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-53
Identities = 71/239 (29%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL--------------------YRLLH 39
M +L H NIV +GA T + ++ EY G L + L
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 40 KPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
+ +L L AY VAKGM +L ++ VHRDL + N+LV VK+CDFGL+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 100 RLKANTFLSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNL 155
R + P +WMAPE L + KSD++S+G++LWE+ +L P+ G
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214
A + G +++ P + I+++CWA + KRPSF + L +
Sbjct: 280 VDANFYKLIQ-NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-51
Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 30/233 (12%)
Query: 1 MKRLRHPNIVLFMGA----------------VTQPPNLSIVTEYLSRGSLYRLLHKPGVR 44
+ +L H NIV + G ++ L I E+ +G+L + + K
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-G 116
Query: 45 EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKA 103
E LD+ L + + KG++Y+H + +++RDLK N+ + VK+ DFGL LK
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163
+ + GT +M+PE + + ++ D+Y+ G+IL EL + A +
Sbjct: 175 DGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------TAFETSK 226
Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ I + ++++ + +P RP+ S I+ + +P+
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR--TLTVWKKSPE 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-50
Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 15/214 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
L P IV GAV + P ++I E L GSL +L+ + G L E R L
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQAL 160
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSR-----LKANTFLSSKSAAG 114
+G+ YLH R I+H D+K+ N+L+ +CDFG + + L+ G
Sbjct: 161 EGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEI 173
T MAPEV+ +P + K DI+S ++ + PW + + + EI
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
P + P A I+ EP R S EL R
Sbjct: 279 PPSCAPLTAQAIQEGLRKEPVHRASAM---ELRR 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-48
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 16/215 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
K +HP V A + L + TE SL + G L E + D
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS--LPEAQVWGYLRDTL 167
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ +LH + +VH D+K N+ + + K+ DFGL + T + + G P +MA
Sbjct: 168 LALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMA 224
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
PE+L+ +D++S G+ + E+A + Q + +G E ++
Sbjct: 225 PELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSS 279
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLR-PLIKSP 213
+ S++ +P R + LL P+++ P
Sbjct: 280 ELRSVLVMMLEPDPKLRAT---AEALLALPVLRQP 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-47
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 12/228 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
K L+H NIV ++G+ ++ + I E + GSL LL +E+ +
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+G+ YLH IVHRD+K N+L++ +K+ DFG S+ A +++ GT ++M
Sbjct: 133 EGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190
Query: 120 APEVLRDEPS--NEKSDIYSFG-VILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIPR 175
APE++ P + +DI+S G I+ E+AT + P+ L P + VG EIP
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
+++ + I C+ +P KR +LL +K + +
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-46
Identities = 50/236 (21%), Positives = 89/236 (37%), Gaps = 31/236 (13%)
Query: 1 MKRLRHPNIVLFMGA------------VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLD 48
+ +L HP IV + A + L I + + +L ++ E +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 49 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 108
L++ +A+ + +LH + ++HRDLK N+ VKV DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 109 SK------------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
GT +M+PE + + K DI+S G+IL+EL L +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQME 232
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+ + V K + P +++ + P +RP I+E + +
Sbjct: 233 RVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFED 285
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-46
Identities = 43/234 (18%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
+H ++V + A + ++ I EY + GSL + + + E ++ V
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDK-------------------KYTVKVCDFGLSR 100
+G+ Y+H + +VH D+K N+ + + K K+ D G
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 101 LKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159
++ + G ++A EVL+ + K+DI++ + + A + N +
Sbjct: 183 RISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKS 212
+ +G+ IP+ ++ +++ +P +RPS M L++ ++ S
Sbjct: 239 EIR----QGRLPRIPQVLSQEFTELLKVMIHPDPERRPS---AMALVKHSVLLS 285
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-45
Identities = 46/241 (19%), Positives = 94/241 (39%), Gaps = 27/241 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVR-EMLDERRRLNM 55
+ HPNI+ + + ++ + RG+L+ + + + L E + L +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-- 113
+ +G+ +H HRDLK N+L+ + + D G S+ A
Sbjct: 140 LLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 114 -------GTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQP--WGNLNPAQVV 161
T + APE+ +E++D++S G +L+ + + P V
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 162 AAVGFKGKRLEIPRN--VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219
AV +L IP++ + + ++ + +P +RP ++ L ++ P P
Sbjct: 258 LAV---QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE-ALQPPAPGQHT 313
Query: 220 T 220
T
Sbjct: 314 T 314
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-45
Identities = 70/250 (28%), Positives = 110/250 (44%), Gaps = 31/250 (12%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPNLS-------IVTEYLSRGSLYRLLHKPGVREMLDERRR 52
MK+L HPNIV F A + S ++ L +G L L K R L
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
L + Y + + ++HR+ PPI+HRDLK NLL+ + T+K+CDFG + ++ S SA
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 113 A------------GTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157
TP + PE++ + P EK DI++ G IL+ L Q P+ +
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 158 AQVVAAVGFKGKRLEIPRNVN--PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215
++V + IP + S+I A P +R S + ++ L+ + +
Sbjct: 259 LRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
Query: 216 QPSPTDMPLL 225
P LL
Sbjct: 313 NPKSPITELL 322
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-43
Identities = 53/240 (22%), Positives = 100/240 (41%), Gaps = 30/240 (12%)
Query: 1 MKRLRHPN--IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+ +L+ + I+ + +V E L L K ++ +D R + +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKN 135
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTP 116
+ + ++ +H+ IVH DLK N L+ +K+ DFG++ T + S GT
Sbjct: 136 MLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 117 EWMAPEVLRDEPS-----------NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV 164
+M PE ++D S + KSD++S G IL+ + + P+ + N + A+
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIK---SPTPQPSPT 220
+E P + +++ C +P +R S ELL P ++ P Q +
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP---ELLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 27/237 (11%)
Query: 1 MKRLRHPN--IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+ +L+ + I+ + +V E L L K ++ +D R + +
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKN 116
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTP 116
+ + ++ +H+ IVH DLK N L+ +K+ DFG++ T + S GT
Sbjct: 117 MLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 117 EWMAPEVLRDEPS-----------NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV 164
+M PE ++D S + KSD++S G IL+ + + P+ + N + A+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPT 220
+E P + +++ C +P +R +I ELL P ++ T +
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQIQTHPVNQM 287
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-43
Identities = 51/237 (21%), Positives = 99/237 (41%), Gaps = 27/237 (11%)
Query: 1 MKRLRHPN--IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+ +L+ + I+ + +V E L L K ++ +D R + +
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKN 163
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTP 116
+ + ++ +H+ IVH DLK N L+ +K+ DFG++ T + S G
Sbjct: 164 MLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 117 EWMAPEVLRDEPSN-----------EKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV 164
+M PE ++D S+ KSD++S G IL+ + + P+ + N + A+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPT 220
+E P + +++ C +P +R +I ELL P ++ T +
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQIQTHPVNQM 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-43
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 44/244 (18%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS-------------IVTEYLSRGSLYRLLHKPGVREML 47
+ L H +V + A + N I EY G+LY L+H +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--Q 113
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
+ + + ++Y+H + I+HRDLK N+ +D+ VK+ DFGL++ +
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 108 SS--------------KSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPW 152
SA GT ++A EVL NEK D+YS G+I +E+
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FS 229
Query: 153 GNLNPAQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIMELLR- 207
+ ++ + + +E P N II ++P KRP LL
Sbjct: 230 TGMERVNILKKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNS 284
Query: 208 PLIK 211
+
Sbjct: 285 GWLP 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-41
Identities = 73/233 (31%), Positives = 114/233 (48%), Gaps = 39/233 (16%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ + P + + G+ + L I+ EYL GS LL +PG LDE + + ++
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREIL 129
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
KG++YLH +HRD+K+ N+L+ + VK+ DFG++ ++K NTF G
Sbjct: 130 KGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VG 181
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
TP WMAPEV++ + K+DI+S G+ ELA + P L+P +V+ IP
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIP 232
Query: 175 RNVNPHVAS--------IIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPS 218
+N P + +EAC EP RP+ ELL+ I + S
Sbjct: 233 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK---ELLKHKFILRNAKKTS 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 3e-41
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 17/223 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ P IV F GA +SI E++ GSL ++L K G + E+ ++ V
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVI 141
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG----LSRLKANTFLSSKSAAGTP 116
KG+ YL ++ I+HRD+K N+LV+ + +K+CDFG L AN+F GT
Sbjct: 142 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------VGTR 194
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
+M+PE L+ + +SDI+S G+ L E+A + P + ++ G ++E
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF---GCQVEGDAA 251
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219
P I ELL ++ P P+
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-41
Identities = 58/172 (33%), Positives = 95/172 (55%), Gaps = 5/172 (2%)
Query: 44 REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LK 102
++ L + ++ VAKGM +L R +HRDL + N+L+ +K VK+CDFGL+R +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 103 ANTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQV 160
+ K A P +WMAPE + D +SD++SFGV+LWE+ +L P+ + +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+G R+ P P + + CW EP +RP+FS ++E L L+++
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-06
Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 11/102 (10%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+ + H N+V +GA T+P L ++ E+ G+L L +R + Y
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS---------KRNEFVPYK 129
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100
+ + DLK + + F +
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-41
Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 23/230 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ ++PNIV ++ + L +V EYL+ GSL ++ + +DE + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECL 126
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
+ + +LH ++HRD+KS N+L+ +VK+ DFG + K +T G
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VG 178
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEI 173
TP WMAPEV+ + K DI+S G++ E+ + P+ N NP + + + G L+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
P ++ + C + KR S ELL+ +K P S T +
Sbjct: 239 PEKLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHQFLKIAKPLSSLTPL 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-41
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 27/231 (11%)
Query: 1 MKRLRHPNIV-LFMGAV---TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+K+L H NIV LF A+ T + ++ E+ GSLY +L +P L E L +
Sbjct: 61 LKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKS 111
DV GMN+L IVHR++K N++ D + K+ DFG +R L+ + S
Sbjct: 119 RDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174
Query: 112 AAGTPEWMAPEVLRDEPS--------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163
GT E++ P++ D++S GV + AT P+ +
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 164 VGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
V +K GK V I+ S + LL P++
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-RGLQVLLTPVLA 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-41
Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 21/230 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++ P++V + G+ + +L IV EY GS+ ++ L E +
Sbjct: 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTL 135
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
KG+ YLH +HRD+K+ N+L++ + K+ DFG++ K NT + G
Sbjct: 136 KGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------G 187
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEI 173
TP WMAPEV+++ N +DI+S G+ E+A + P+ +++P + + +
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK 247
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
P + + ++ C P +R + + +LL+ P ++S D+
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRATAT---QLLQHPFVRSAKGVSILRDL 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-40
Identities = 44/225 (19%), Positives = 86/225 (38%), Gaps = 21/225 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M N V + + L I + + +L +++ E + L++ +A
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA------- 113
+ + +LH + ++HRDLK N+ VKV DFGL
Sbjct: 175 EAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 114 -----GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 168
GT +M+PE + + K DI+S G+IL+EL + +++ V
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRIITDVR-NL 289
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKS 212
K + P +++ + P +RP +++ + ++
Sbjct: 290 KFPLLFTQKYPQEHMMVQDMLSPSPTERPE---ATDIIENAIFEN 331
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-40
Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 23/230 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ +H N+V + L ++ E+L G+L ++ + L+E + + V
Sbjct: 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVL 151
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
+ + YLH + ++HRD+KS ++L+ VK+ DFG K + G
Sbjct: 152 QALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL------VG 203
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEI 173
TP WMAPEV+ + DI+S G+++ E+ + P+ + +P Q + + +L+
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 263
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
V+P + +E +P +R + ELL P + +
Sbjct: 264 SHKVSPVLRDFLERMLVRDPQERATAQ---ELLDHPFLLQTGLPECLVPL 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 27/231 (11%)
Query: 1 MKRLRHPNIV-LFMGAV---TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+K+L H NIV LF A+ T + ++ E+ GSLY +L +P L E L +
Sbjct: 61 LKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKS 111
DV GMN+L IVHR++K N++ D + K+ DFG +R L+ + S
Sbjct: 119 RDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174
Query: 112 AAGTPEWMAPEVLRDEPS--------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163
GT E++ P++ D++S GV + AT P+ +
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 164 VGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
V +K GK V I+ S + LL P++
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-RGLQVLLTPVLA 284
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-39
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDVAK 61
RHP++V +G + + ++ +Y+ G+L R L+ + +RL + A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPEW 118
G++YLH I+HRD+KS N+L+D+ + K+ DFG+S+ T LS+ GT +
Sbjct: 151 GLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGTLGY 207
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELAT------LQQPWGNLNPAQVVAAVGFKGKRLE 172
+ PE EKSD+YSFGV+L+E+ P +N A+ G+ +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 173 I--PR---NVNPH----VASIIEACWANEPWKRPSFSTIMELL 206
I P + P C A RPS ++ L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 19/222 (8%)
Query: 1 MKRLRHPNIV-LF-----MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
MK+L HPN+V + + + EY G L + L++ L E
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSK 110
+ D++ + YLH I+HRDLK N+++ K+ D G ++ L
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--T 181
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGK 169
GT +++APE+L + D +SFG + +E T +P+ N P Q V + K
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV--REK 239
Query: 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
E + ++ + P L ++
Sbjct: 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQ 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-39
Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ HP IV +GA L I+ E+ G++ ++ + + L E + + +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQML 127
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
+ +N+LH + I+HRDLK+ N+L+ + +++ DFG+S K ++F+ G
Sbjct: 128 EALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------G 179
Query: 115 TPEWMAPEV-----LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
TP WMAPEV ++D P + K+DI+S G+ L E+A ++ P LNP +V+ +
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239
Query: 170 -RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
L P + ++ P RPS + +LL P + S T + ++
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAA---QLLEHPFVSSITSNKALREL 291
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-38
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 9/204 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
LRHPNI+ G + ++ EY G++YR L K DE+R ++A
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELA 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
++Y H + ++HRD+K NLL+ +K+ DFG S ++ GT +++
Sbjct: 120 NALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLP 175
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE++ +EK D++S GV+ +E + P+ + + + + P V
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVE-FTFPDFVTEG 233
Query: 181 VASIIEACWANEPWKRPSFSTIME 204
+I + P +RP ++E
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVLE 257
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-38
Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 24/228 (10%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
+ +H N+V +G + +L +V Y+ GSL L L R +A A G
Sbjct: 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPEWM 119
+N+LH +HRD+KS N+L+D+ +T K+ DFGL+R A T ++S+ GT +M
Sbjct: 146 INFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYM 202
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN--- 176
APE LR E KSDIYSFGV+L E+ T Q++ + K + + +
Sbjct: 203 APEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIED 259
Query: 177 -VNP-----------HVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
++ + S+ C + KRP + +LL+ + S
Sbjct: 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 5e-38
Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 21/188 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
K HPNIV + L +VT +++ GS L+ + ++E + V
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVL 138
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANT-FLSSKSAA 113
K ++Y+H VHR +K+ ++L+ V + + + K +
Sbjct: 139 KALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 114 GTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
W++PEVL+ + KSDIYS G+ ELA P+ ++ Q++ L
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---------L 247
Query: 172 EIPRNVNP 179
E P
Sbjct: 248 EKLNGTVP 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-37
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 14/223 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
LRHPNI+ + ++ E+ RG LY+ L K G DE+R ++A
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELA 124
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
++Y H R ++HRD+K NLL+ K +K+ DFG S + ++ GT +++
Sbjct: 125 DALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLP 180
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE++ + +EK D++ GV+ +E P+ + + + + L+ P ++
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI-VNVD-LKFPPFLSDG 238
Query: 181 VASIIEACWANEPWKRPSFSTIME-----LLRPLIKSPTPQPS 218
+I P +R +ME + P Q +
Sbjct: 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-37
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K P IV G ++ I E + + G + ER M +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP---IPERILGKMTVAIV 134
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-----RLKANTFLSSKSAAGT 115
K + YL ++ ++HRD+K N+L+D++ +K+CDFG+S + AG
Sbjct: 135 KALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS------AGC 187
Query: 116 PEWMAPEVLRDEPSNE-----KSDIYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKG 168
+MAPE + + ++D++S G+ L ELAT Q P+ N + + +
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
L + S ++ C + KRP ++ +LL IK + D+
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN---KLLEHSFIKR--YETLEVDV 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-37
Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 23/233 (9%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
++ HPN++ + I E + +L + + + +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH--LGLEPITLLQQT 127
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSRL---KANTFLSSKS 111
G+ +LH N IVHRDLK N+L+ + DFGL + ++F
Sbjct: 128 TSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 112 AAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG-F 166
GT W+APE+L ++ DI+S G + + + + P+G Q +G
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC 245
Query: 167 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPS 218
L ++ + +IE A +P KRP + +L+ P S Q
Sbjct: 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHPFFWSLEKQLQ 295
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-37
Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 37/237 (15%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-----HKPGVREMLDERRRLNM 55
M + HPNIV + + L +V + LS GS+ ++ +LDE +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-----------RLKAN 104
+V +G+ YLH+ +HRD+K+ N+L+ + +V++ DFG+S
Sbjct: 127 LREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 105 TFLSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163
TF GTP WMAPEV+ + + K+DI+SFG+ ELAT P+ P +V+
Sbjct: 185 TF------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 164 VGFKGK-RLEIPRNVNPHVA-------SIIEACWANEPWKRPSFSTIMELLR-PLIK 211
LE + +I C +P KRP+ + ELLR +
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA---ELLRHKFFQ 292
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-36
Identities = 51/149 (34%), Positives = 85/149 (57%), Gaps = 5/149 (3%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDVAK 61
H N++ G P +V Y++ GS+ L +P + LD +R +A A+
Sbjct: 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 62 GMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
G+ YLH +P I+HRD+K+ N+L+D+++ V DFGL++L +T +++ GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGH 201
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELAT 147
+APE L S+EK+D++ +GV+L EL T
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-35
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 36/239 (15%)
Query: 5 RHPNIVLFMGA------VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
H NI + GA L +V E+ GS+ L+ K L E + +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICRE 137
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+ +G+++LH+ ++HRD+K N+L+ + VK+ DFG+S T + GTP W
Sbjct: 138 ILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195
Query: 119 MAPEVLRDEPS-----NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
MAPEV+ + + + KSD++S G+ E+A P +++P + + F I
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FL-----I 246
Query: 174 PRNVNPHVASI---------IEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
PRN P + S IE+C +RP +L++ P I+ +
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKHPFIRDQPNERQVRIQ 302
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 38/237 (16%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+++LRHPN + + G + +V EY GS LL ++ L E + +
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGAL 164
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS--RLKANTFLSSKSAAGTPEW 118
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + AN+F GTP W
Sbjct: 165 QGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYW 216
Query: 119 MAPEV---LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
MAPEV + + + K D++S G+ ELA + P N+N + I +
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQ 267
Query: 176 NVNPHVA---------SIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 222
N +P + + +++C P RP+ LL+ + P D+
Sbjct: 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE---VLLKHRFVLRERPPTVIMDL 321
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-35
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----REMLDERRRLNM 55
+ +++ + G +T + I+ EY+ S+ + V + + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
V +Y+H I HRD+K N+L+DK VK+ DFG S + + K + GT
Sbjct: 157 IKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSRGT 213
Query: 116 PEWMAPEVLRDEP--SNEKSDIYSFGVILWEL 145
E+M PE +E + K DI+S G+ L+ +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-35
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
M+ + P V F GA+ + ++ I E + S Y+ + G + E +A
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT--IPEDILGKIAVS 117
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAA 113
+ K + +LH + ++HRD+K N+L++ VK+CDFG+S + + A
Sbjct: 118 IVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------A 170
Query: 114 GTPEWMAPEVLRDEPS----NEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKG 168
G +MAPE + E + + KSDI+S G+ + ELA L+ P+ P Q + V
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV---- 226
Query: 169 KRLEIPR----NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 211
P+ + C +RP++ EL++ P
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYP---ELMQHPFFT 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-34
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 8/221 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+L+HP+I+ + +V E G + R L E + + +
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQII 122
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
GM YLH I+HRDL NLL+ + +K+ DFGL+ + GTP +++
Sbjct: 123 TGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+ +SD++S G + + L + P+ + V E+P ++
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIE 238
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221
+I P R S S++++ P + + S +
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLD--HPFMSRNSSTKSKDE 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-34
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYD 58
M+ P IV F GA+ + + I E +S S + + +++ E +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
K +N+L N I+HRD+K N+L+D+ +K+CDFG+S ++ ++ AG +
Sbjct: 134 TVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPY 191
Query: 119 MAPEVLRDEPSNE----KSDIYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKGKRLE 172
MAPE + S + +SD++S G+ L+ELAT + P+ N Q+ V +L
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 173 IPRNVN--PHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 211
P + + C + KRP + ELL+ P I
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYK---ELLKHPFIL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-34
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 7/204 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ L H ++V F G + +V E R SL L + R+ L E +
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G YLHR ++HRDLK NL +++ VK+ DFGL+ K GTP ++A
Sbjct: 126 LGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVL + + + D++S G I++ L + P+ + + K IP+++NP
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPV 241
Query: 181 VASIIEACWANEPWKRPSFSTIME 204
AS+I+ +P RP+ + ++
Sbjct: 242 AASLIQKMLQTDPTARPTINELLN 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-33
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ L H ++V F G + +V E R SL L + R+ L E +
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 151
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G YLHR ++HRDLK NL +++ VK+ DFGL+ K GTP ++A
Sbjct: 152 LGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--------- 171
PEVL + + + D++S G I++ L G P F+ L
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLV-----GKP-P--------FETSCLKETYLRIKK 255
Query: 172 ---EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
IP+++NP AS+I+ +P RP+ + ++
Sbjct: 256 NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-33
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 13/220 (5%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
+L H NIV + + +V EY+ +L + G L +N + G
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDG 123
Query: 63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAP 121
+ + H IVHRD+K N+L+D T+K+ DFG+++ L + + GT ++ +P
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
E + E ++E +DIYS G++L+E+ + P+ +A + + +V +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-IAIKHIQDSVPNVTTDVRKDI 240
Query: 182 A----SIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217
++I + R + TI E+ L
Sbjct: 241 PQSLSNVILRATEKDKANR--YKTIQEMKDDLSSVLHENR 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-32
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
MK L HPNIV + L ++ EY S G ++ L G ++E E R +
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE--KEARSK--FRQI 123
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
+ Y H++ IVHRDLK+ NLL+D +K+ DFG S L + G P +
Sbjct: 124 VSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPY 179
Query: 119 MAPEVLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APE+ + + + + D++S GVIL+ L + P+ N ++ V + IP +
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYM 237
Query: 178 NPHVASIIEACWANEPWKRPSFSTIME 204
+ ++++ P KR + IM+
Sbjct: 238 STDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 50/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 1 MKRLRHPNIV-LFMGAVTQPPN---LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+K+L HPN+V L V PN L +V E +++G + + + E D+ R
Sbjct: 90 LKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE--DQARFY--F 143
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
D+ KG+ YLH + I+HRD+K NLLV + +K+ DFG+S ++ L + G
Sbjct: 144 QDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVG 199
Query: 115 TPEWMAPEVLRDEPSN---EKSDIYSFGVIL 142
TP +MAPE L + + D+++ GV L
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-32
Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 13/147 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
++L+HPNIV ++ + +V + ++ G L+ ++ RE E + +
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQI 114
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSR-LKANTFLSSKSAAGT 115
+ + Y H IVHR+LK NLL+ K VK+ DFGL+ + + AGT
Sbjct: 115 LESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGT 170
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
P +++PEVL+ +P ++ DI++ GVIL
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-32
Identities = 47/146 (32%), Positives = 77/146 (52%), Gaps = 12/146 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K+++H NIV + +V + +S G L+ R+L + + E+ + V
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQV 115
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
+ YLH IVHRDLK NLL ++ + + DFGLS+++ N + +A GTP
Sbjct: 116 LSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTP 171
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
++APEVL +P ++ D +S GVI
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-32
Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K L HPNI+ N+ IV E G L R++ + L E + +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
+ Y H ++ +VH+DLK N+L +K+ DFGL+ K++ +AAGT
Sbjct: 134 MNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGT 189
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
+MAPEV + K DI+S GV++
Sbjct: 190 ALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
++ +RHPNI+ ++ ++ E +S G L+ L K E L E +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQI 117
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
G++YLH + I H DLK N+++ +K+ DFG++ ++A K+ G
Sbjct: 118 LDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFG 173
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
TPE++APE++ EP ++D++S GVI
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 6/146 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
L+HP+IV + + L +V E++ L ++ + + E + +
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
+ + Y H N I+HRD+K +L+ + VK+ FG++ + L + GTP
Sbjct: 140 LEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
+MAPEV++ EP + D++ GVIL
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-31
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K ++HPN++ ++ ++ E ++ G L+ L K E L E +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQI 123
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
G+ YLH I H DLK N+++ K +K+ DFGL+ + K+ G
Sbjct: 124 LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFG 179
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
TPE++APE++ EP ++D++S GVI
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-31
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
++++ HPNI+ ++ ++ E +S G L+ L K E L E + +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQI 124
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
G+NYLH + I H DLK N+++ +K+ DFGL+ ++ K+ G
Sbjct: 125 LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
TPE++APE++ EP ++D++S GVI
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-31
Identities = 34/239 (14%), Positives = 76/239 (31%), Gaps = 27/239 (11%)
Query: 4 LRHPNIVLFMGAVTQPPNLSIVTEYL----SRGSLYR----LLHKPGVREMLDERRRLNM 55
++ P + ++ +++ + + +L LL + L RL +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
V + + LH +VH L+ ++++D++ V + F A+
Sbjct: 217 TLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFA 274
Query: 115 TPEWMAPEVLRDEPSNEK-----SDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
PE A +L + D ++ G+ ++ + P + +
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI----- 329
Query: 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME-----LLRPLIKSPTPQPSPTDMP 223
+N+ V +++E R ME LR + + P P
Sbjct: 330 -FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEP 387
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-31
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
++++ HPNI+ +V + + +G L+ L K L E+ +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRA 132
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPE 117
+ + + LH+ N IVHRDLK N+L+D +K+ DFG S L L + GTP
Sbjct: 133 LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 188
Query: 118 WMAPEVLRDEPS------NEKSDIYSFGVIL 142
++APE++ + ++ D++S GVI+
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-31
Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 11/146 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
M +L H N++ A ++ +V EY+ G L+ R++ + L E + +
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQI 196
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
+G+ ++H+ I+H DLK N+L + +K+ DFGL+R K L K GTP
Sbjct: 197 CEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTP 252
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
E++APEV+ + + +D++S GVI
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-31
Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+ RL HPNI+ P +S+V E ++ G L+ R++ K ER + +
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQI 157
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
+ + YLH IVHRDLK NLL +K+ DFGLS+ ++ + K+ GT
Sbjct: 158 LEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGT 213
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
P + APE+LR + D++S G+I
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-31
Identities = 42/148 (28%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
++++ H N++ ++ ++ E +S G L+ L K E L E + +
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQI 124
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
G+NYLH + I H DLK N+++ +K+ DFGL+ ++ K+ G
Sbjct: 125 LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
TPE++APE++ EP ++D++S GVI
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-31
Identities = 56/236 (23%), Positives = 110/236 (46%), Gaps = 26/236 (11%)
Query: 3 RLRHPNIV-LFMGAVTQPPNLS---IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
L HP IV ++ + P IV EY+ +L ++H G + +R + + D
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIAD 124
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGT 115
+ +N+ H+ I+HRD+K N+++ VKV DFG++R N+ + + GT
Sbjct: 125 ACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
++++PE R + + +SD+YS G +L+E+ T + P+ +P V ++ R +
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVREDPIP 238
Query: 176 ------NVNPHVASIIEACWANEPWKRPSFSTIMELLRPL--IKSPTPQPSPTDMP 223
++ + +++ A P R + T E+ L + + P +P +
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENR--YQTAAEMRADLVRVHNGEPPEAPKVLT 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-31
Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 29/233 (12%)
Query: 3 RLRHPNIVLFMGAV----TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
RL+ P++V + L + ++ L +L + G L R + +
Sbjct: 90 RLQEPHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQ 142
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-GTPE 117
+ ++ H HRD+K N+LV + DFG++ + L+ GT
Sbjct: 143 IGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR-- 175
+MAPE + + ++DIY+ +L+E T P+ + + A + IPR
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-----NQAIPRPS 255
Query: 176 ----NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK--SPTPQPSPTDM 222
+ ++I A P R + T +L + Q TD+
Sbjct: 256 TVRPGIPVAFDAVIARGMAKNPEDR--YVTCGDLSAAAHAALATADQDRATDI 306
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-30
Identities = 53/147 (36%), Positives = 79/147 (53%), Gaps = 14/147 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K+L HPNI+ + + IV E + G L+ ++ R+ E + V
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQV 130
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
G+ Y+H+ N IVHRDLK N+L+ +K +K+ DFGLS + NT + K GT
Sbjct: 131 FSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGT 186
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
++APEVLR +EK D++S GVIL
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-30
Identities = 34/237 (14%), Positives = 73/237 (30%), Gaps = 33/237 (13%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEY-LSRGSLYR----LLHKPGVREMLDERRRLNM 55
+K + ++ LS Y + +L LL + L RL +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
V + + LH +VH L+ ++++D++ V + F + + S + +
Sbjct: 212 TLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV-RDGARVVS---SVS 265
Query: 116 PEWMAPEVLRDE-----------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
+ PE+ D ++ G++++ + P
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-- 323
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME-----LLRPLIKSPTPQ 216
+N+ V +++E R ME LR + + P
Sbjct: 324 ----WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 376
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-30
Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 13/147 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
++L+HPNIV ++ + +V + ++ G L+ ++ RE E + +
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQI 137
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
+ + Y H IVHR+LK NLL+ K VK+ DFGL+ + + AGT
Sbjct: 138 LESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGT 193
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
P +++PEVL+ +P ++ DI++ GVIL
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-30
Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
MK L HPNI+ ++ +V E + G L+ R++HK + E + DV
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDV 115
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
+ Y H+ N + HRDLK N L +K+ DFGL+ K + ++ GT
Sbjct: 116 LSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGT 171
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
P +++P+VL + D +S GV++
Sbjct: 172 PYYVSPQVLE-GLYGPECDEWSAGVMM 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 11/146 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
M +L HP ++ A + ++ E+LS G L+ R+ + + E +N
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQA 158
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
+G+ ++H + IVH D+K N++ + K +VK+ DFGL+ L + + K T
Sbjct: 159 CEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATA 214
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
E+ APE++ EP +D+++ GV+
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 51/252 (20%), Positives = 98/252 (38%), Gaps = 40/252 (15%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE----MLDERRRLNM 55
+ HPN++ + + T L I E + +L L+ V + + E +++
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-------------YTVKVCDFGLSRL- 101
+A G+ +LH I+HRDLK N+LV + + DFGL +
Sbjct: 121 LRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 102 ---KANTFLSSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELATLQQP 151
+++ + + +GT W APE+L + DI+S G + + + + +
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 152 --WGNLNPAQVV--AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ + + R++ +I ++P KRP T M++LR
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP---TAMKVLR 295
Query: 208 -PLIKSPTPQPS 218
PL + +
Sbjct: 296 HPLFWPKSKKLE 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 11/146 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
M LRHP +V A + ++ E++S G L+ ++ + + E + V
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQV 264
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
KG+ ++H N VH DLK N++ K +K+ DFGL+ L + K GT
Sbjct: 265 CKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTA 320
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
E+ APEV +P +D++S GV+
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-30
Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 1 MKRLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
++ + P ++ + ++ EY + G ++ L + EM+ E + +
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQ 139
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
+ +G+ YLH+ N IVH DLK N+L+ +K+ DFG+SR + L + G
Sbjct: 140 ILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMG 195
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
TPE++APE+L +P +D+++ G+I
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-30
Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+ L+HPNIV ++++ + ++ + ++ G L+ ++ RE E + +
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQI 119
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
+ + + H+ +VHR+LK NLL+ K VK+ DFGL+ + AGTP
Sbjct: 120 LEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
+++PEVLR +P + D+++ GVIL
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 17/151 (11%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
++++ HP+I+ + + + +V + + +G L+ L K L E+ ++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRS 208
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPE 117
+ + +++LH N IVHRDLK N+L+D +++ DFG S L+ L + GTP
Sbjct: 209 LLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPG 264
Query: 118 WMAPEVLRDEPS------NEKSDIYSFGVIL 142
++APE+L+ ++ D+++ GVIL
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 11/147 (7%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
+K HPNIV + +V E L+ G L+ R+ ++ E +
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRK 114
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
+ ++++H +VHRDLK NLL + +K+ DFG +RLK K+ T
Sbjct: 115 LVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
+ APE+L +E D++S GVIL
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-29
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 24/156 (15%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRR-----LN 54
K L H N+V F G + + EY S G L+ R+ G+ E + +R +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMA 116
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSK 110
G+ YLH I HRD+K NLL+D++ +K+ DFGL+ + L
Sbjct: 117 -------GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--N 165
Query: 111 SAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWEL 145
GT ++APE+L+ E D++S G++L +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 70/236 (29%), Positives = 109/236 (46%), Gaps = 24/236 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K L HPNI+ +VTE+ G L+ ++++ R DE N+ +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQI 155
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGT 115
G+ YLH+ N IVHRD+K N+L++ K +K+ DFGLS + L + GT
Sbjct: 156 LSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGT 211
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKGK-RLEI 173
++APEVL+ + NEK D++S GVI++ L P G N ++ V KGK +
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-NDQDIIKKV-EKGKYYFDF 268
Query: 174 PR--NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDMPLLT 226
N++ +I+ + KR T E L IK + +D L
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKKYANNINKSDQKTLC 321
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-29
Identities = 26/162 (16%), Positives = 57/162 (35%), Gaps = 21/162 (12%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR--EMLDERRRLNMAYD 58
+K + F A +V E S G+L ++ +++ + ++ A
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLV-----------DKKYTVKVCDFGLSR----LKA 103
+ + +H I+H D+K N ++ D + + D G S
Sbjct: 181 MLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + T + E+L ++P N + D + ++ +
Sbjct: 239 GTIF--TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K+L HP I+ + IV E + G L+ +++ + L E Y +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQM 248
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
+ YLH I+HRDLK N+L+ ++ +K+ DFG S+ L + + ++ GT
Sbjct: 249 LLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGT 304
Query: 116 PEWMAPEVLRDEPS---NEKSDIYSFGVIL 142
P ++APEVL + N D +S GVIL
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 69/235 (29%), Positives = 109/235 (46%), Gaps = 24/235 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K+L HPNI+ +V E + G L+ ++ R+ E + V
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQV 135
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAGT 115
G+ Y+H+ IVHRDLK NLL++ K +++ DFGLS +A+ + K GT
Sbjct: 136 LSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGT 191
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKGK-RLEI 173
++APEVL +EK D++S GVIL+ L + P G N ++ V KGK E+
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKV-EKGKYTFEL 248
Query: 174 PR--NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDMPLL 225
P+ V+ +I P R + + L I++ T + D+P L
Sbjct: 249 PQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYTKEQISVDVPSL 300
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 35/146 (23%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+ RH NI+ + L ++ E++S ++ R+ L+ER ++ + V
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQV 111
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
+ + +LH N I H D++ N++ + T+K+ +FG +R LK + P
Sbjct: 112 CEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAP 167
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
E+ APEV + + + +D++S G ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-29
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K RHP+I+ ++ P + +V EY+S G L+ + V E E RRL +
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE--MEARRL--FQQI 120
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
++Y HR +VHRDLK N+L+D K+ DFGLS + FL +++ G+P +
Sbjct: 121 LSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNY 176
Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APEV+ + + DI+S GVIL+ L P+ + + + + G IP +
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGV-FYIPEYL 234
Query: 178 NPHVASIIEACWANEPWKRPSFSTIME 204
N VA+++ +P KR + I E
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-29
Identities = 54/150 (36%), Positives = 81/150 (54%), Gaps = 14/150 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K+L HPNI+ + + IV E + G L+ ++ R+ E + V
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQV 130
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAGT 115
G+ Y+H+ N IVHRDLK N+L++ K +K+ DFGLS + NT + K GT
Sbjct: 131 FSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGT 186
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
++APEVLR +EK D++S GVIL+ L
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVILYIL 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-29
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 24/156 (15%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRR-----LN 54
K L H N+V F G + + EY S G L+ R+ G+ E + +R +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMA 116
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSK 110
G+ YLH I HRD+K NLL+D++ +K+ DFGL+ + L
Sbjct: 117 -------GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--N 165
Query: 111 SAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWEL 145
GT ++APE+L+ E D++S G++L +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-29
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K+L HP I+ + IV E + G L+ +++ + L E Y +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQM 123
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGT 115
+ YLH I+HRDLK N+L+ + +K+ DFG S+ L + + ++ GT
Sbjct: 124 LLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGT 179
Query: 116 PEWMAPEVLRDEPS---NEKSDIYSFGVIL 142
P ++APEVL + N D +S GVIL
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-28
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
M RL HP V L Y G L + + K G DE R A ++
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTA-EI 139
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKS 111
+ YLH + I+HRDLK N+L+++ +++ DFG +++ +AN+F+
Sbjct: 140 VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV---- 193
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---G 168
GT ++++PE+L ++ + + SD+++ G I+++L P+ N + F+
Sbjct: 194 --GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIK 246
Query: 169 KRLEIPRNVNPHVASIIEACWANEPWKR 196
+ P P ++E + KR
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 55/150 (36%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K L HPNI+ N +V E G L+ ++H R +E + V
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQV 145
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAGT 115
G+ YLH+ N IVHRDLK NLL++ K +K+ DFGLS + + + K GT
Sbjct: 146 LSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGT 201
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
++APEVLR + +EK D++S GVIL+ L
Sbjct: 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-28
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS-LY-RLLHKPGVREMLDERRRLNMAYD 58
+ R+ H NI+ + +V E G L+ + P + E +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE--PLASYI--FRQ 138
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPE 117
+ + YL ++ I+HRD+K N+++ + +T+K+ DFG + + + GT E
Sbjct: 139 LVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIE 194
Query: 118 WMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
+ APEVL P + +++S GV L+ L + P+ L + V A + P
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYL 246
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIME 204
V+ + S++ P +R + ++
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 1 MKRLRHPNIV-LF--MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDE--RRRLNM 55
++RLRH N++ L + + +V EY G +EMLD +R +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEE-KQKMYMVMEYCVCGM----------QEMLDSVPEKRFPV 108
Query: 56 AYDVAK--------GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KA 103
A G+ YLH + IVH+D+K NLL+ T+K+ G++ A
Sbjct: 109 --CQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
+ +++ G+P + PE+ S K DI+S GV L+ + T P+ N ++
Sbjct: 165 DDTC--RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF 222
Query: 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME-----LLRPLIKSPTPQ 216
+G KG IP + P ++ +++ EP KR S I + P ++P P
Sbjct: 223 ENIG-KGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280
Query: 217 PSPTD 221
P D
Sbjct: 281 PPSPD 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-28
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+ + + H N++ + + +V E + GS+ +HK R +E + DV
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDV 120
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSS------ 109
A +++LH + I HRDLK N+L ++ VK+CDF L +K N S
Sbjct: 121 ASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKS-----DIYSFGVIL 142
+ G+ E+MAPEV+ D++S GVIL
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-28
Identities = 55/150 (36%), Positives = 81/150 (54%), Gaps = 13/150 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+ LRHPNIV F + P +L+I+ EY S G LY R+ + E DE R +
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE--DEARFFFQ--QL 125
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL-KANTFLSSKSAAGTP 116
G++Y H I HRDLK N L+D +K+CDFG S+ ++ KS GTP
Sbjct: 126 LSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTP 181
Query: 117 EWMAPEVLRDEPSN-EKSDIYSFGVILWEL 145
++APEVL + + + +D++S GV L+ +
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVM 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 1 MKRL-RHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLN 54
+ P+IV + L I+ E + G L+ R+ + ER
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA--FTEREAAE 132
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKS 111
+ D+ + +LH N I HRD+K NLL +K +K+ DFG ++ L ++
Sbjct: 133 IMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QT 188
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
TP ++APEVL E ++ D++S GVI+
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-28
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
+ R +HPNI+ + +VTE + G L + + ++ ER + + +
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR---QKFFSEREASAVLFTI 125
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
K + YLH + +VHRDLK N+L ++++CDFG ++ + T
Sbjct: 126 TKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT 183
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
++APEVL + + DI+S GV+L
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 49/239 (20%), Positives = 90/239 (37%), Gaps = 29/239 (12%)
Query: 1 MKRLR----HPNIVLFMGAVTQPPNLSIVTEYLSRGS-LYRLLHKPGVREMLDERRRLNM 55
+ ++ HP ++ + +V E L+ + + G L E
Sbjct: 88 LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCF 144
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAG 114
V + + H R +VHRD+K N+L+D + K+ DFG L + G
Sbjct: 145 FGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDG 200
Query: 115 TPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
T + PE + + ++S G++L+++ P+ +++ A L
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EILEA------ELHF 252
Query: 174 PRNVNPHVASIIEACWANEPWKRPSFSTIME-------LLRPLIKSPTPQPSPTDMPLL 225
P +V+P ++I C A +P RPS I+ + P+P LL
Sbjct: 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-27
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K LRHP+I+ +T P ++ +V EY G L+ ++ K + E DE RR +
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE--DEGRRF--FQQI 117
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
+ Y HR IVHRDLK NLL+D VK+ DFGLS + FL K++ G+P +
Sbjct: 118 ICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNY 173
Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APEV+ + + + D++S G++L+ + + P+ + + V +P +
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCV-YVMPDFL 231
Query: 178 NPHVASIIEACWANEPWKRPSFSTIME 204
+P S+I +P +R + I
Sbjct: 232 SPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-27
Identities = 71/261 (27%), Positives = 109/261 (41%), Gaps = 52/261 (19%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
HP + NL V EYL+ G L + D R A ++ G+
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQ 132
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEW 118
+LH + IV+RDLK N+L+DK +K+ DFG+ + K NTF GTP++
Sbjct: 133 FLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------CGTPDY 184
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+APE+L + N D +SFGV+L+E+ Q P+ + ++ ++ + PR +
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLE 242
Query: 179 PHVASIIEACWANEPWKR----------PSFSTI--MELLR--------PLIKSP----- 213
++ + EP KR P F I EL R P +KSP
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSN 302
Query: 214 --------TPQPSPTDMPLLT 226
P+ S D L+
Sbjct: 303 FDKEFLNEKPRLSFADRALIN 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-27
Identities = 47/190 (24%), Positives = 70/190 (36%), Gaps = 47/190 (24%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE--------------- 45
MK+L HPNI + +V E G L L+
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 46 ----------------------MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
+ E+ N+ + ++YLH + I HRD+K N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENF 199
Query: 84 LVDKK--YTVKVCDFGLSRL----KANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDI 135
L + +K+ DFGLS+ + + AGTP ++APEVL +E K D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 136 YSFGVILWEL 145
+S GV+L L
Sbjct: 260 WSAGVLLHLL 269
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-27
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
++ RHP + A L V EY + G L+ L + V E R R A ++
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGA-EI 114
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAA 113
+ YLH R+ +V+RD+K NL++DK +K+ DFGL + TF
Sbjct: 115 VSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------C 166
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
GTPE++APEVL D D + GV+++E+ + P+ N + ++ + + +
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRF 224
Query: 174 PRNVNPHVASIIEACWANEPWKR 196
PR ++P S++ +P +R
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 31/234 (13%)
Query: 3 RLRHPNIVL-----FMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
+ HP+IV P IV EY+ SL R + L +
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLL 189
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
++ ++YLH +V+ DLK N+++ ++ +K+ D G S GTP
Sbjct: 190 EILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPG 242
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
+ APE++R P+ +DIY+ G L L + L+
Sbjct: 243 FQAPEIVRTGPT-VATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP----VLKTY--- 294
Query: 178 NPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKSPTPQPSPTDMPLLT 226
++ +P +R + + + +LR ++ T P P + +
Sbjct: 295 -DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFS 347
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
+K RHP+I+ ++ P ++ +V EY+S G L+ + + E E RRL +
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE--KESRRL--FQQI 125
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
G++Y HR +VHRDLK N+L+D K+ DFGLS + FL +++ G+P +
Sbjct: 126 LSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNY 181
Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
APEV+ + + DI+S GVIL+ L P+ + + + + P+ +
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYL 239
Query: 178 NPHVASIIEACWANEPWKRPSFSTIME 204
NP V S+++ +P KR + I E
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 1 MKRL-RHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLN 54
R + P+IV + L IV E L G L+ R+ + + ER
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASE 165
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSK 110
+ + + + YLH N I HRD+K NLL +K+ DFG ++ ++ L
Sbjct: 166 IMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--T 221
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
+ TP ++APEVL E ++ D++S GVI+
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-26
Identities = 27/219 (12%), Positives = 54/219 (24%), Gaps = 21/219 (9%)
Query: 1 MKRLRHPNIVLFMGA--VTQPPNLSIVTEYL--SRGSLYRLLHKPGV-REMLDERRRLNM 55
+ P N ++ L+ L V R +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
+ + L + +VH NL + + + D A+
Sbjct: 200 TAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSV 253
Query: 116 PEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ-------VVAAVG 165
P AP + + G+ ++ + L P+G + P + G
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313
Query: 166 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ V ++I + +R ME
Sbjct: 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 17/199 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
+ I A L +V EY G L LL K G R + R +A ++
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER--IPAEMARFYLA-EI 171
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEW 118
++ +HR VHRD+K N+L+D+ +++ DFG +L+A+ + S A GTP++
Sbjct: 172 VMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 119 MAPEVLRDEPSNEKSDIY-------SFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
++PE+L+ + Y + GV +E+ Q P+ + A+ + + L
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 172 EIP---RNVNPHVASIIEA 187
+P V I+
Sbjct: 290 SLPLVDEGVPEEARDFIQR 308
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ + P +V + NL +V EY++ G ++ L + G E A +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIV 151
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
YLH + +++RDLK NLL+D++ ++V DFG ++ + T GTPE
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPE 203
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
+APE++ + N+ D ++ GV+++E+A P+ P Q+ + GK + P +
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGK-VRFPSHF 261
Query: 178 NPHVASIIEACWANEPWKR 196
+ + ++ + KR
Sbjct: 262 SSDLKDLLRNLLQVDLTKR 280
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
+ + HP IV A L ++ ++L G L+ L K M E + +A ++
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLA-EL 135
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAA 113
A +++LH I++RDLK N+L+D++ +K+ DFGLS+ KA +F
Sbjct: 136 ALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------ 187
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
GT E+MAPEV+ + +D +SFGV+++E+ T P+ + + + + +L +
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGM 245
Query: 174 PRNVNPHVASIIEACWANEPWKR 196
P+ ++P S++ + P R
Sbjct: 246 PQFLSPEAQSLLRMLFKRNPANR 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 15/197 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
+ I A NL +V +Y G L LL K R L E R +A ++
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR--LPEEMARFYLA-EM 184
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEW 118
++ +H+ + VHRD+K N+L+D +++ DFG +L + + S A GTP++
Sbjct: 185 VIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 119 MAPEVLRDEPSNEKS-----DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
++PE+L+ + D +S GV ++E+ + P+ + + + +R +
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302
Query: 174 PR---NVNPHVASIIEA 187
P +V+ + +I
Sbjct: 303 PTQVTDVSENAKDLIRR 319
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 54/240 (22%), Positives = 105/240 (43%), Gaps = 36/240 (15%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
+ P + L V EY++ G L + + G E + A ++A G+
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLF 456
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEW 118
+L + I++RDLK N+++D + +K+ DFG+ + TF GTP++
Sbjct: 457 FLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDY 508
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+APE++ +P + D ++FGV+L+E+ Q P+ + ++ ++ + P++++
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMS 566
Query: 179 PHVASIIEACWANEPWKR--------------PSFSTI--MELLRPLIKSP-TPQPSPTD 221
+I + P KR F I +L R I+ P P+ S +
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRN 626
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 8/197 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
++ RHP + + L V EY + G L+ L + V E R R A ++
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGA-EI 257
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
++YLH +V+RDLK NL++DK +K+ DFGL + + K+ GTPE++
Sbjct: 258 VSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
APEVL D D + GV+++E+ + P+ N + ++ + + + PR + P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLGP 374
Query: 180 HVASIIEACWANEPWKR 196
S++ +P +R
Sbjct: 375 EAKSLLSGLLKKDPKQR 391
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
++ ++HP IV + A L ++ EYLS G L+ L + G + E +A ++
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLA-EI 130
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAA 113
+ + +LH++ I++RDLK N++++ + VK+ DFGL + +TF
Sbjct: 131 SMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------ 182
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
GT E+MAPE+L N D +S G +++++ T P+ N + + + +L +
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--LKCKLNL 240
Query: 174 PRNVNPHVASIIEACWANEPWKR 196
P + +++ R
Sbjct: 241 PPYLTQEARDLLKKLLKRNAASR 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 40/212 (18%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 1 MKRLRH--PNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAY 57
+K++ ++ + +P + ++ E L+ + + G L E + +
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFW 156
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
V + + + H ++HRD+K N+L+D + +K+ DFG L +T GT
Sbjct: 157 QVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTR 212
Query: 117 EWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNL---NPAQVVAAVGFKGKRLE 172
+ PE +R + ++S G++L+++ G++ + +++ ++
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIRG------QVF 261
Query: 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ V+ +I C A P RP+F I
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVA 60
K ++HP +V + L V +Y++ G L+ L + E R R A ++A
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAA-EIA 149
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAG 114
+ YLH N IV+RDLK N+L+D + + + DFGL + +TF G
Sbjct: 150 SALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF------CG 201
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
TPE++APEVL +P + D + G +L+E+ P+ + N A++ + K L++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLK 259
Query: 175 RNVNPHVASIIEACWANEPWKR 196
N+ ++E + KR
Sbjct: 260 PNITNSARHLLEGLLQKDRTKR 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 47/203 (23%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ L HP +V + ++ +V + L G L L + +E +L + ++
Sbjct: 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFIC-ELV 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
++YL + I+HRD+K N+L+D+ V + DF ++ L T +++ + GT +M
Sbjct: 126 MALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYM 181
Query: 120 APEVLRDEPSNEKS---DIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLEI 173
APE+ S D +S GV +EL ++P+ + + ++V F+ +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTY 239
Query: 174 PRNVNPHVASIIEACWANEPWKR 196
P + + S+++ P +R
Sbjct: 240 PSAWSQEMVSLLKKLLEPNPDQR 262
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-24
Identities = 46/198 (23%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
+ P + L V EY++ G L + + G E + A ++A G+
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLF 135
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEW 118
+L + I++RDLK N+++D + +K+ DFG+ + TF GTP++
Sbjct: 136 FLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDY 187
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+APE++ +P + D ++FGV+L+E+ Q P+ + ++ ++ + P++++
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMS 245
Query: 179 PHVASIIEACWANEPWKR 196
+I + P KR
Sbjct: 246 KEAVAICKGLMTKHPGKR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-24
Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
HP + P L V E+++ G L + K DE R R A ++ +
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAA-EIISAL 137
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPE 117
+LH + I++RDLK N+L+D + K+ DFG+ + TF GTP+
Sbjct: 138 MFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF------CGTPD 189
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
++APE+L++ D ++ GV+L+E+ P+ N + A+ + P +
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWL 247
Query: 178 NPHVASIIEACWANEPWKR 196
+ I+++ P R
Sbjct: 248 HEDATGILKSFMTKNPTMR 266
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-24
Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 11/183 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M P +V A L +V EY+ G L L+ V E + R A +V
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVV 178
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
++ +H +HRD+K N+L+DK +K+ DFG ++ + +A GTP+++
Sbjct: 179 LALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 120 APEVLRDEPSNEK----SDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
+PEVL+ + + D +S GV L+E+ P+ + + + L P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296
Query: 176 NVN 178
+ +
Sbjct: 297 DND 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 4e-24
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 7/199 (3%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE-MLDERRRLNMAYDVA 60
++ IV A +L +V ++ G + ++ E R + +
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ +LH+RN I++RDLK N+L+D V++ D GL+ +K AGTP +MA
Sbjct: 300 SGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEIPRNV 177
PE+L E + D ++ GV L+E+ + P+ + + + + P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKF 416
Query: 178 NPHVASIIEACWANEPWKR 196
+P EA +P KR
Sbjct: 417 SPASKDFCEALLQKDPEKR 435
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-24
Identities = 46/202 (22%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
+++ +V A L +V ++ G L ++ G + E R + A ++
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICC 297
Query: 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAAGTP 116
G+ LHR IV+RDLK N+L+D +++ D GL+ GT
Sbjct: 298 GLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------VGTV 349
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--GKRLEIP 174
+MAPEV+++E D ++ G +L+E+ Q P+ V E
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
Query: 175 RNVNPHVASIIEACWANEPWKR 196
+P S+ +P +R
Sbjct: 410 ERFSPQARSLCSQLLCKDPAER 431
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-24
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ + HP I+ G + ++ +Y+ G L+ LL K A +V
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVC 116
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
+ YLH ++ I++RDLK N+L+DK +K+ DFG ++ T GTP+
Sbjct: 117 LALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL------CGTPD 168
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEIP 174
++APEV+ +P N+ D +SFG++++E+ P+ + N + ++ L P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRFP 223
Query: 175 RNVNPHVASIIEACWANEPWKR 196
N V ++ + +R
Sbjct: 224 PFFNEDVKDLLSRLITRDLSQR 245
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-23
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ P IV A P LS + + ++ G L+ L + GV E A ++
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEII 302
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTP 116
G+ ++H R +V+RDLK N+L+D+ V++ D GL+ K + GT
Sbjct: 303 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTH 354
Query: 117 EWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLE 172
+MAPEVL+ + + S D +S G +L++L P+ + ++ +E
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVE 412
Query: 173 IPRNVNPHVASIIEACWANEPWKR 196
+P + +P + S++E + +R
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-23
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
HP +V L V EY++ G L + + L E R A +++ +
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSA-EISLAL 123
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPE 117
NYLH R I++RDLK N+L+D + +K+ D+G+ + +TF GTP
Sbjct: 124 NYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPN 175
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKG---KR 170
++APE+LR E D ++ GV+++E+ + P+ + + F+ K+
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235
Query: 171 LEIPRNVNPHVASIIEACWANEPWKR 196
+ IPR+++ AS++++ +P +R
Sbjct: 236 IRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
HP +V L V EY++ G L + + L E R A +++ +
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSA-EISLAL 166
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPE 117
NYLH R I++RDLK N+L+D + +K+ D+G+ + +TF GTP
Sbjct: 167 NYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPN 218
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKG---KR 170
++APE+LR E D ++ GV+++E+ + P+ + + F+ K+
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278
Query: 171 LEIPRNVNPHVASIIEACWANEPWKR 196
+ IPR+++ AS++++ +P +R
Sbjct: 279 IRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-22
Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
+ P +V A L ++ +Y++ G L+ L + E ++ + ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVG-EIVLAL 172
Query: 64 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-------KANTFLSSKSAAGTP 116
+LH+ I++RD+K N+L+D V + DFGLS+ +A F GT
Sbjct: 173 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------GTI 224
Query: 117 EWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRL 171
E+MAP+++R S ++ D +S GV+++EL T P+ A + +
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEP 283
Query: 172 EIPRNVNPHVASIIEACWANEPWKR 196
P+ ++ +I+ +P KR
Sbjct: 284 PYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-22
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + L++V E+ + L + LD + + +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD--LDPEIVKSFLFQLL 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
KG+ + H RN ++HRDLK NLL+++ +K+ +FGL+R + E
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVT 164
Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELATLQQP 151
W P+VL + D++S G I ELA +P
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-21
Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+L+HPN+V + + L +V EY ++ L + + E ++ +
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR--GVPEHLVKSITWQTL 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+ +N+ H+ N +HRD+K N+L+ K +K+CDFG +RL L+ S E
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVAT 165
Query: 118 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 149
W +PE+L D D+++ G + EL +
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 16/155 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K+LRH N+V + + +V E++ ++ L LD + + +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQII 134
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
G+ + H N I+HRD+K N+LV + VK+CDFG +R L++ E
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVAT 187
Query: 118 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 149
W APE+L D + D+++ G ++ E+ +
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-20
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L HPNIV + + L++V E++ + L ++L + + + Y +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLL 129
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+G+ + H+ I+HRDLK NLL++ +K+ DFGL+R + T E
Sbjct: 130 RGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVT 182
Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
W AP+VL + DI+S G I E+ T
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-20
Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM---LDERRRLNMAY 57
MK L+H NIV + L++V E++ L + + V L+ +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
+ +G+ + H I+HRDLK NLL++K+ +K+ DFGL+R + E
Sbjct: 116 QLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSE 168
Query: 118 ----WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
W AP+VL + + DI+S G IL E+ T
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-20
Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 16/153 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + L +V E+L + L +LL + +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
G+ Y H R ++HRDLK NLL++++ +K+ DFGL+R T E
Sbjct: 111 NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVT 163
Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
W AP+VL + DI+S G I E+
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-20
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
MK + H NI+ + T +L IV E + +L +++ LD R
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSY 131
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + G+ +LH I+HRDLK N++V T+K+ DFGL+R +F+ +
Sbjct: 132 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 188
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + APEV+ E DI+S G I+ E+
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-20
Identities = 38/151 (25%), Positives = 57/151 (37%), Gaps = 35/151 (23%)
Query: 1 MKRL-RHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLN 54
R + P+IV + L IV E L G L+ R+ + + ER
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASE 121
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKS 111
+ + + + YLH N I HRD+K NLL +K+ DFG
Sbjct: 122 IMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------- 166
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
A E E ++ D++S GVI+
Sbjct: 167 --------AKETTG-EKYDKSCDMWSLGVIM 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-20
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 16/153 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + +L++V EYL + L + L G + + + +
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+G+ Y HR+ ++HRDLK NLL++++ +K+ DFGL+R K S + E
Sbjct: 111 RGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVT 163
Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
W P++L + + D++ G I +E+AT
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 15/151 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
MK + H NI+ + T L +V E + +L +++ LD R
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSY 168
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + G+ +LH I+HRDLK N++V T+K+ DFGL+R +F+ +
Sbjct: 169 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 225
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
T + APEV+ E DI+S G I+ E+
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-19
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ L HPNI+ + A N+S+V +++ L ++ + L
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV--LTPSHIKAYMLMTL 122
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
+G+ YLH+ I+HRDLK NLL+D+ +K+ DFGL++ S + A T +
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVT 175
Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
W APE+L D+++ G IL EL
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-18
Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 1 MKRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR 52
++ L+H N+V + ++ +V ++ L LL V+ L E +R
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
+ + G+ Y+HR I+HRD+K+ N+L+ + +K+ DFGL+R + +S+
Sbjct: 129 V--MQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPN 183
Query: 113 AGTPE----WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
T W PE+L E D++ G I+ E+ T
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-18
Identities = 41/158 (25%), Positives = 63/158 (39%), Gaps = 22/158 (13%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NI+ + L ++ EY L + + K + R + Y +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLI 142
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFLSSKSAAGT 115
G+N+ H R +HRDLK NLL+ +K+ DFGL+R T
Sbjct: 143 NGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFT 195
Query: 116 PE----WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
E W PE+L + DI+S I E+
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-18
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+K +H NI+ + +P + I+ E + L+R++ + + D+ +
Sbjct: 63 LKHFKHENIITIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVIST---QMLSDDHIQYF 117
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + + LH N ++HRDLK NLL++ +KVCDFGL+R+ + + G
Sbjct: 118 I-YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 115 TPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
M APEV+ + D++S G IL EL
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 1 MKRLRHPNIV-----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
++ HPN+V + + L++V E++ + L L K + E + M
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
+ + +G+++LH +VHRDLK N+LV +K+ DFGL+R+ S A T
Sbjct: 127 -FQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY------SFQMALT 177
Query: 116 PE----WM-APEVLRDEPSNEKSDIYSFGVILWELAT 147
W APEVL D++S G I E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 34/152 (22%), Positives = 62/152 (40%), Gaps = 14/152 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+ HPNI+ +VTE + L +++H R ++ +
Sbjct: 83 LNHFHHPNILGLRDIFV-HFEEPAMHKLYLVTELMRT-DLAQVIHDQ--RIVISPQHIQY 138
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
Y + G++ LH +VHRDL N+L+ + +CDF L+R +
Sbjct: 139 FMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT- 195
Query: 115 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
+ APE++ K D++S G ++ E+
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-17
Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 18/152 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+K ++H N++ + T +L +V ++ L +++ +E+ +
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK----FSEEKIQYL 131
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + KG+ Y+H +VHRDLK NL V++ +K+ DFGL+R A+ ++
Sbjct: 132 V-YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV-- 185
Query: 115 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
T + APEV+ ++ DI+S G I+ E+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-17
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 24/159 (15%)
Query: 1 MKRLRHPNIV-----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
++ HPN+V + +++V E++ + L L K + E + M
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAA 113
+G+++LH IVHRDLK N+LV TVK+ DFGL+R+ +
Sbjct: 127 -RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL------- 176
Query: 114 GTPE----WM-APEVLRDEPSNEKSDIYSFGVILWELAT 147
TP W APEVL D++S G I E+
Sbjct: 177 -TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+K +RH N++ + T L +V ++ L +L+ ++ ++R +
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH---EKLGEDRIQFL 133
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + KG+ Y+H I+HRDLK NL V++ +K+ DFGL+R +A++ ++
Sbjct: 134 V-YQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVV-- 187
Query: 115 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
T + APEV+ + ++ DI+S G I+ E+
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-17
Identities = 23/222 (10%), Positives = 57/222 (25%), Gaps = 39/222 (17%)
Query: 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
R+ P + + V +V E++ GSL + + +A
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAA 141
Query: 63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 122
+ HR + + V V +
Sbjct: 142 ADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------- 177
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKRLEIPRNVNPHV 181
+N + DI G L+ L + P +A + P +++ +
Sbjct: 178 -----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 182 ----ASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219
+++ + R + + + + + + +
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLG 274
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-17
Identities = 41/152 (26%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+K ++H N++ + T +L +VT + L ++ +++ D+ +
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC---QKLTDDHVQFL 137
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + +G+ Y+H + I+HRDLK NL V++ +K+ DFGL+R ++ A
Sbjct: 138 I-YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVA-- 191
Query: 115 TPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
T + APE++ + N+ DI+S G I+ EL
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 36/174 (20%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+ RL+ I+ + P +L IV E L +L P L E
Sbjct: 79 LNRLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP---IFLTEEHIKT 133
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y++ G N++H I+HRDLK N L+++ +VKVCDFGL+R + ++
Sbjct: 134 ILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 115 TPEWM----------------------APEVLRDEPS-NEKSDIYSFGVILWEL 145
APE++ + + + DI+S G I EL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 38/163 (23%), Positives = 70/163 (42%), Gaps = 23/163 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
M+ ++HPN+V + L++V EY+ ++YR H +++ +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK 144
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSA 112
Y + + + Y+H I HRD+K NLL+D +K+ DFG ++ +
Sbjct: 145 LYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGE 196
Query: 113 AGTPE----WM-APEVLRDEPS-NEKSDIYSFGVILWELATLQ 149
+ APE++ + DI+S G ++ EL Q
Sbjct: 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-16
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 32/162 (19%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+ R RH NI+ + P + IV + + LY+LL + + ++
Sbjct: 79 LLRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYF 133
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R +
Sbjct: 134 L-YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHD 183
Query: 115 TPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
++ APE++ + + DI+S G IL E+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-16
Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 33/172 (19%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKPGVREMLDERRRLNMA-- 56
++ L+HPN++ + + + +Y L+ ++ + + +L
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 57 ----YDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-----LKA 103
Y + G++YLH ++HRDLK N+LV ++ VK+ D G +R LK
Sbjct: 131 KSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 104 NTFLSSKSAAGTPE----WM-APEVLRDEPSNEKS-DIYSFGVILWELATLQ 149
P W APE+L K+ DI++ G I EL T +
Sbjct: 189 LA-------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-16
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
M++L H NIV L++V +Y+ ++YR+ H ++ L
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSR-LKANTFLSSKS 111
Y + + + Y+H I HRD+K NLL+D +K+CDFG ++ L S
Sbjct: 160 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 112 AAGTPEWM-APEV-LRDEPSNEKSDIYSFGVILWELATLQ 149
+ + APE+ D++S G +L EL Q
Sbjct: 218 CSR---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-15
Identities = 32/142 (22%), Positives = 59/142 (41%), Gaps = 13/142 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+ RL H ++V + + P ++ +V E +L P + + +
Sbjct: 106 LNRLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP--VYLTELHIKTL 161
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y++ G+ Y+H I+HRDLK N LV++ +VKVCDFGL+R +
Sbjct: 162 L-YNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 115 TPEWMAPEVLRDEPSNEKSDIY 136
+P ++ +
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQL 240
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-15
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 24/165 (14%)
Query: 1 MKRLRHPNIV----LFMGAVTQPPN---LSIVTEYLSRGSLYRLL--HKPGVREMLDERR 51
+ L HPNIV F + L++V EY+ +L+R +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILI 131
Query: 52 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSK 110
++ + + + + + LH + + HRD+K N+LV++ T+K+CDFG ++ S
Sbjct: 132 KVFL-FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSP 184
Query: 111 SAAGTPEWM-----APEVLRDEPSNEKS-DIYSFGVILWELATLQ 149
S APE++ + DI+S G I E+ +
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-15
Identities = 38/157 (24%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 1 MKRLR-HPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
++ LR PNI+ V P ++V E+++ +L + D R M Y
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM-Y 137
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-KANTFLSSKSAAGT 115
++ K ++Y H I+HRD+K N+++D ++ +++ D+GL+ + + A +
Sbjct: 138 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--S 193
Query: 116 PEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQP 151
+ PE+L D + S D++S G +L + ++P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 42/172 (24%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS---------------IVTEYLSRGSLYRLLHKPGVRE 45
++RL H NIV + P IV EY+ L +L +
Sbjct: 62 IRRLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GP 116
Query: 46 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKAN 104
+L+E RL M Y + +G+ Y+H N ++HRDLK NL ++ + +K+ DFGL+R
Sbjct: 117 LLEEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR---- 169
Query: 105 TFLSSKSAAGTPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
+ +P +L + + D+++ G I E+
Sbjct: 170 ---IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-14
Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 34/171 (19%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPNLS---IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+ L H NIV + V + N +V +Y+ L+ ++ +L+ + +
Sbjct: 62 LTELSGHENIVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVV 115
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----------LKANT 105
Y + K + YLH ++HRD+K N+L++ + VKV DFGLSR + +
Sbjct: 116 YQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 106 FLSSKSAAGTPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
++++ + APE+L + D++S G IL E+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-13
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 28/170 (16%)
Query: 24 IVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82
+V E L +L L+ K R + L ++ ++ + G++Y+HRR I+H D+K N
Sbjct: 107 MVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHRRCG-IIHTDIKPEN 162
Query: 83 LLVD------KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIY 136
+L++ +K+ D G + + +S T E+ +PEVL P +DI+
Sbjct: 163 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ---TREYRSPEVLLGAPWGCGADIW 219
Query: 137 SFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIE 186
S +++EL T G+ F+ + H+A IIE
Sbjct: 220 STACLIFELIT-----GD---------FLFEPDEGHSYTKDDDHIAQIIE 255
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-12
Identities = 38/129 (29%), Positives = 59/129 (45%), Gaps = 13/129 (10%)
Query: 24 IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
+V E LS +LY LL R + R A + + +L I+H DLK N+
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 84 LV--DKKYTVKVCDFGLSRLKAN---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
L+ K+ +K+ DFG S ++ S+ + +PEVL P + D++S
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRSPEVLLGMPYDLAIDMWSL 244
Query: 139 GVILWELAT 147
G IL E+ T
Sbjct: 245 GCILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 15/129 (11%)
Query: 24 IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
+ E LS +LY L+ K + R A+ + + ++ LH+ I+H DLK N+
Sbjct: 176 MTFELLSM-NLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALHKNR--IIHCDLKPENI 231
Query: 84 LV--DKKYTVKVCDFGLSRLKAN---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
L+ + +KV DFG S + T++ S+ + APEV+ D++S
Sbjct: 232 LLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------YRAPEVILGARYGMPIDMWSL 285
Query: 139 GVILWELAT 147
G IL EL T
Sbjct: 286 GCILAELLT 294
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-11
Identities = 39/192 (20%), Positives = 74/192 (38%), Gaps = 49/192 (25%)
Query: 1 MKRLRHPNIV--------------------------------LFMGAVTQPPN------L 22
MK L H NI+ + + N L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 23 SIVTEYLSRGSLYRLLHKPGVR--EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
+++ EY+ +L+++L + + + Y + + + ++H I HRD+K
Sbjct: 114 NVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG--ICHRDIKP 169
Query: 81 PNLLVD-KKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYS 137
NLLV+ K T+K+CDFG ++ L + + + + APE++ D++S
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWS 227
Query: 138 FGVILWELATLQ 149
G + EL +
Sbjct: 228 IGCVFGELILGK 239
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-08
Identities = 31/146 (21%), Positives = 57/146 (39%), Gaps = 32/146 (21%)
Query: 24 IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN- 82
I E L + + + L + + R +MAY + + +LH + H DLK N
Sbjct: 99 IAFELLGK-NTFEFLKENNFQPYPLPHVR-HMAYQLCHALRFLHENQ--LTHTDLKPENI 154
Query: 83 LLVDKKYT------------------VKVCDFG---LSRLKANTFLSSKSAAGTPEWMAP 121
L V+ ++ ++V DFG T ++++ + P
Sbjct: 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH------YRPP 208
Query: 122 EVLRDEPSNEKSDIYSFGVILWELAT 147
EV+ + + D++S G IL+E
Sbjct: 209 EVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 6e-08
Identities = 35/173 (20%), Positives = 58/173 (33%), Gaps = 55/173 (31%)
Query: 24 IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
+V E L L + + K + L + V +G++YLH + I+H D+K N+
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQ-GLPLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENI 178
Query: 84 LV-------------------------------------------------DKKYTVKVC 94
L+ +K VK+
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 95 DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
D G + F T ++ + EVL N +DI+S + +ELAT
Sbjct: 239 DLGNACWVHKHFTEDIQ---TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-08
Identities = 41/146 (28%), Positives = 59/146 (40%), Gaps = 32/146 (21%)
Query: 24 IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN- 82
IV E L S Y + + G + R MAY + K +N+LH + H DLK N
Sbjct: 94 IVFELLGL-STYDFIKENGFLPFRLDHIR-KMAYQICKSVNFLHSNK--LTHTDLKPENI 149
Query: 83 LLVDKKYT------------------VKVCDFG---LSRLKANTFLSSKSAAGTPEWMAP 121
L V YT +KV DFG +T +S++ + AP
Sbjct: 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH------YRAP 203
Query: 122 EVLRDEPSNEKSDIYSFGVILWELAT 147
EV+ ++ D++S G IL E
Sbjct: 204 EVILALGWSQPCDVWSIGCILIEYYL 229
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 34/153 (22%), Positives = 64/153 (41%), Gaps = 40/153 (26%)
Query: 24 IVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82
++ E L SLY ++ + +++ + ++ K +NYL + + + H DLK N
Sbjct: 113 LIFEPLGP-SLYEIITRNNYNGFHIEDIKL--YCIEILKALNYLRKMS--LTHTDLKPEN 167
Query: 83 -LLVDKKYT------------------------VKVCDFG---LSRLKANTFLSSKSAAG 114
LL D + +K+ DFG + ++++
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ--- 224
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
+ APEV+ + + SD++SFG +L EL T
Sbjct: 225 ---YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-05
Identities = 13/82 (15%), Positives = 26/82 (31%), Gaps = 5/82 (6%)
Query: 19 PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78
L IV E+ G + ++ ++ + + + HRDL
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEAS-LRFEHRDL 188
Query: 79 KSPNLLVDKKYTVKVCDFGLSR 100
N+L+ K K+ +
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-05
Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 13/101 (12%)
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRL-------KANTFLSSKSAAGT 115
Y+H VH D+K+ NLL++ K +V D+GL+ KA + GT
Sbjct: 167 YIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224
Query: 116 PEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155
E+ + + PS + D+ G + + T PW +
Sbjct: 225 IEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 15/108 (13%)
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRL-------KANTFLSSKSAAGT 115
Y+H VH D+K+ NLL+ K +V D+GLS K K GT
Sbjct: 166 YIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223
Query: 116 PEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNL--NPAQV 160
E+ + + + S +SD+ G + + PW +P V
Sbjct: 224 IEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 14/104 (13%)
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSR--LKANT-----FLSSKSA 112
+H ++ +V+RD+K N L+ + + + V DFG+ + T + K+
Sbjct: 121 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
+GT +M+ + + D+ + G + PW L
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 22/104 (21%), Positives = 44/104 (42%), Gaps = 14/104 (13%)
Query: 65 YLHRRNPPIVHRDLKSPNLLV-----DKKYTVKVCDFGLSR--LKANT-----FLSSKSA 112
Y+H +N +++RD+K N L+ + + + DF L++ + T + KS
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
GT +M+ + + + D+ + G + PW L
Sbjct: 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 6e-04
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 21/105 (20%)
Query: 65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRLKANT-------FLSSKSAAGT 115
+LH VH ++ + N+ VD + +V +G + + S G
Sbjct: 174 FLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD 231
Query: 116 PEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL 155
E+++ D PS +SD+ S G + + PW N
Sbjct: 232 LEFIS----MDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 226 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.69 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.5 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.74 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.53 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.98 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.49 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.64 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.25 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 96.18 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.9 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 95.68 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 93.09 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.04 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 92.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 92.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.41 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 88.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 88.53 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=340.45 Aligned_cols=208 Identities=25% Similarity=0.480 Sum_probs=185.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||++++++|.+++.+|+|||||+||+|.+++.+.. +++.+++.++.||+.||+|||++| |+||||||
T Consensus 125 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 198 (346)
T 4fih_A 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKS 198 (346)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCH
Confidence 357899999999999999999999999999999999997643 999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+|||++.+|.+||+|||+++.............|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+.
T Consensus 199 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 278 (346)
T 4fih_A 199 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 278 (346)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 99999999999999999998766555555677899999999999999999999999999999999999999999888887
Q ss_pred HHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
...+.... .....+..+++++.+||.+||+.||++|||+.|+++ +.+++...++
T Consensus 279 ~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~~p 333 (346)
T 4fih_A 279 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP 333 (346)
T ss_dssp HHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCCG
T ss_pred HHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCCCC
Confidence 77665332 233445678999999999999999999999999999 8888876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=333.45 Aligned_cols=207 Identities=25% Similarity=0.452 Sum_probs=181.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++++++++|+|||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++| |+||||||
T Consensus 86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKP 160 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKP 160 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCH
Confidence 478999999999999999999999999999999999998744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++.++.+||+|||+++..... ........|++.|+|||++.+..++.++|+||+||++|+|++|..||...+..
T Consensus 161 eNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 240 (311)
T 4aw0_A 161 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999865422 23345668999999999999998999999999999999999999999998888
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH--H--HHhhcCCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL--L--RPLIKSPT 214 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~--l--~~~~~~~~ 214 (226)
+....+.. ....++..+++++++||.+||+.||++|||++|+++. + +.++++..
T Consensus 241 ~~~~~i~~--~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 241 LIFAKIIK--LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHHHHHH--TCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHHc--CCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 87777643 3456778899999999999999999999999986421 1 45666543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=335.25 Aligned_cols=210 Identities=29% Similarity=0.422 Sum_probs=180.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|||||++++++.+++..|+|||||+||+|.+++.+.+ .+++..+..++.|++.||+|||++| |+||||||
T Consensus 104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 178 (336)
T 4g3f_A 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKA 178 (336)
T ss_dssp TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCH
Confidence 578999999999999999999999999999999999998744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCC-cEEEccCCCcccccccc-----cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKKY-TVKVCDFGLSRLKANTF-----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~~-~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+|||++.+| .+||+|||+++...... .......|++.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 179 ~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp GGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred HHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 999999887 69999999997643321 122345789999999999999999999999999999999999999987
Q ss_pred CCHHHHHHHHhhCCc-cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 155 LNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
.+..+....+..... ....+..+++++.++|.+||+.||.+|||+.|+++.|..++.....
T Consensus 259 ~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 259 YFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp TCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred CCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 766555555543332 2356788999999999999999999999999999999888765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=340.24 Aligned_cols=200 Identities=28% Similarity=0.534 Sum_probs=178.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+|||||+||+|.+++...+ ...+++.+++.++.||+.||+|||++| |+||||||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 153 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKS 153 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCG
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCH
Confidence 357899999999999999999999999999999999997543 334899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+|||++.+|.+||+|||+++.............|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 154 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 233 (350)
T 4b9d_A 154 QNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233 (350)
T ss_dssp GGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 99999999999999999998665443333445689999999999999999999999999999999999999999888887
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
...+.. ......+..+++++.+||.+||+.||.+|||++|+++
T Consensus 234 ~~~i~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 234 VLKIIS-GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHc-CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 777653 3344567789999999999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=330.69 Aligned_cols=204 Identities=26% Similarity=0.433 Sum_probs=180.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+|||||+||+|.+++.+.+ .+++.++..++.||+.||+|||++| |+||||||
T Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 154 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKP 154 (304)
T ss_dssp CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCG
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCH
Confidence 578999999999999999999999999999999999998744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.+|.+||+|||+++.............|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..+.
T Consensus 155 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 234 (304)
T 3ubd_A 155 ENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234 (304)
T ss_dssp GGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH
Confidence 99999999999999999998655544455567899999999999999999999999999999999999999999888887
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhcCC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKSP 213 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~~~ 213 (226)
...+.. .....|..+|+++.+||.+||+.||++||| ++|+++ ++++++.
T Consensus 235 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~--Hp~f~~i 288 (304)
T 3ubd_A 235 MTMILK--AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR--HSFFSTI 288 (304)
T ss_dssp HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT--SGGGTTC
T ss_pred HHHHHc--CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc--CccccCC
Confidence 777643 345678889999999999999999999998 467877 5666543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=341.56 Aligned_cols=208 Identities=25% Similarity=0.480 Sum_probs=185.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++|||||+++++|.+++.+|+|||||+||+|.+++.... +++.++..++.||+.||+|||++| |+||||||
T Consensus 202 l~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp 275 (423)
T 4fie_A 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKS 275 (423)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCST
T ss_pred HHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC--eecccCCH
Confidence 457899999999999999999999999999999999997543 999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+|||++.+|.+||+|||+++.............|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 276 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 355 (423)
T 4fie_A 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 355 (423)
T ss_dssp TTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 99999999999999999998766554555667899999999999999999999999999999999999999999888887
Q ss_pred HHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
...+.... .....+..+++++++||.+||..||++|||+.|+++ +.+++...++
T Consensus 356 ~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~~~p 410 (423)
T 4fie_A 356 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP 410 (423)
T ss_dssp HHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCCG
T ss_pred HHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCCCCC
Confidence 77665432 234456789999999999999999999999999999 8888876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=329.65 Aligned_cols=210 Identities=36% Similarity=0.616 Sum_probs=179.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC------------CCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------------REMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
|++++|||||+++++|.+.+..|+|||||++|+|.+++.+... ...+++.++..++.|++.||+|||+
T Consensus 97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 4789999999999999999999999999999999999976431 2358999999999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
++ |+||||||+||+++.++.+||+|||+++..... ........+++.|+|||++.+..++.++|||||||++|||+
T Consensus 177 ~~--iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ell 254 (329)
T 4aoj_A 177 LH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254 (329)
T ss_dssp TT--CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CC--eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHH
Confidence 99 999999999999999999999999999754332 22233456788999999999999999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
| |+.||...+..+....+. ...+...|..+++++.+++.+||+.||++|||+.+|++.|+.+.+..
T Consensus 255 t~G~~Pf~~~~~~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 255 TYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp TTSCCTTCSSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred cCCCCCCCCCCHHHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 9 899999988888777665 34566778899999999999999999999999999999999998763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=329.82 Aligned_cols=211 Identities=34% Similarity=0.581 Sum_probs=186.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC----------CCCcCCHHHHHHHHHHHHHHHHHHhcCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----------VREMLDERRRLNMAYDVAKGMNYLHRRN 70 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 70 (226)
|++++|||||+++++|.+++..|+|||||++|+|.+++.+.+ ....+++.++..++.|++.||+|||+++
T Consensus 69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 478999999999999999999999999999999999997532 1345999999999999999999999999
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT- 147 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 147 (226)
|+||||||+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||+||++|+|+|
T Consensus 149 --iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~ 226 (299)
T 4asz_A 149 --FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 226 (299)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999997543321 22233457889999999999999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
|+.||.+.+..++...+. .......|..+++++.+++.+||+.||++|||+.+|.+.|+++.+..|
T Consensus 227 G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 227 GKQPWYQLSNNEVIECIT-QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp TCCTTTTSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred CCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 899999998888877765 345567788999999999999999999999999999999999887644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=322.16 Aligned_cols=210 Identities=34% Similarity=0.588 Sum_probs=172.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+ +..++|||||++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||
T Consensus 86 l~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp 160 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKS 160 (307)
T ss_dssp HTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCS
T ss_pred HHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCH
Confidence 478999999999998865 56899999999999999997643 24999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCC---CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|||+++++.+||+|||+++..... ........|++.|+|||++.+. .++.++|||||||++|+|+||+.||.+.
T Consensus 161 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 161 NNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp SSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred HHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999764332 2233456789999999998643 4788999999999999999999999876
Q ss_pred CHHHHHHHHhhCC-c---cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 156 NPAQVVAAVGFKG-K---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 156 ~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+............ . ....+..+++++.+++.+||+.||++|||+.+|++.|+.+....+.
T Consensus 241 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 241 NNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred ChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 6544433332222 2 2234567899999999999999999999999999999988776544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=325.29 Aligned_cols=207 Identities=32% Similarity=0.543 Sum_probs=183.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
++++|||||+++++|.+++..++|||||++|+|.+++..+.. ...+++..+..++.|++.||+|||+
T Consensus 84 ~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 163 (308)
T 4gt4_A 84 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 163 (308)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 578999999999999999999999999999999999965321 2358999999999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
++ ++||||||+||++++++.+||+|||+++..... ........+++.|+|||++.+..++.++||||+||++|||+
T Consensus 164 ~~--iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 164 HH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp TT--CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CC--CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence 99 999999999999999999999999998754332 22234456788999999999999999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
| |..||.+.+..++...+. .....+.|..+++++.+++.+||+.||.+|||+.+|++.|+++.+
T Consensus 242 t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 242 SYGLQPYCGYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp TTTCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred hCCCCCCCCCCHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 8 899999999888887775 455667788999999999999999999999999999999988743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=319.91 Aligned_cols=201 Identities=27% Similarity=0.502 Sum_probs=169.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+ +|+|.+++.+++ .+++.++..++.||+.||+|||++| |+||||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP 140 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKP 140 (275)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCT
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCh
Confidence 35789999999999999999999999999 679999988744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.+||+|||+++...... ......|++.|+|||++.+..+ +.++|+||+||++|+|++|+.||.+.+..+
T Consensus 141 ~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~ 219 (275)
T 3hyh_A 141 ENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219 (275)
T ss_dssp TTEEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHeEECCCCCEEEeecCCCeecCCCC-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999999997654432 2345678999999999998876 579999999999999999999999888877
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+.. ....++..++++++++|.+||+.||++|||++|+++ +++++.
T Consensus 220 ~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k~ 268 (275)
T 3hyh_A 220 LFKNISN--GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFKV 268 (275)
T ss_dssp HHHHHHH--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHHT
T ss_pred HHHHHHc--CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc--Cccccc
Confidence 7766643 445667889999999999999999999999999999 777764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=321.16 Aligned_cols=204 Identities=32% Similarity=0.552 Sum_probs=172.0
Q ss_pred CCCCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|++++|||||+++++|.+ ++.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++|++|+||
T Consensus 79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHR 155 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCC
T ss_pred HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCEEec
Confidence 467899999999999865 345899999999999999998743 4999999999999999999999987679999
Q ss_pred CCCCCcEEEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 77 DLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 77 di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||||+|||++. +|.+||+|||+++..... ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus 156 DlKp~NILl~~~~g~vKl~DFGla~~~~~~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 156 DLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccChhheeEECCCCCEEEEeCcCCEeCCCC--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999974 789999999999754332 2345678999999999876 4899999999999999999999999765
Q ss_pred C-HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 156 N-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 156 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+ .......+.........+...++++.+||.+||+.||++|||+.++++ +++++.
T Consensus 233 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~~ 288 (290)
T 3fpq_A 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQE 288 (290)
T ss_dssp SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC-
T ss_pred CcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccC
Confidence 4 444555554333344556778899999999999999999999999998 777764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=323.17 Aligned_cols=210 Identities=32% Similarity=0.587 Sum_probs=178.2
Q ss_pred CCCCC-cCcceeeeEEecC-CceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHH
Q 027225 2 KRLRH-PNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYL 66 (226)
Q Consensus 2 ~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~l 66 (226)
++++| ||||+++++|.+. +..++|||||++|+|.+++++... ...+++..+..++.|++.||+||
T Consensus 122 ~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL 201 (353)
T 4ase_A 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 201 (353)
T ss_dssp HHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred HHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence 34555 9999999999764 568999999999999999975321 23589999999999999999999
Q ss_pred hcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHH
Q 027225 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144 (226)
Q Consensus 67 H~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 144 (226)
|+++ |+||||||+||++++++.+||+|||+++...... .......+++.|+|||++.+..++.++||||+||++||
T Consensus 202 H~~~--iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~E 279 (353)
T 4ase_A 202 ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 279 (353)
T ss_dssp HHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hhCC--eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHH
Confidence 9999 9999999999999999999999999997543221 22334457889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 145 LAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 145 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
|+| |..||.+.+..+..........++..|..+++++.+++.+||+.||.+|||+.+|++.|+++++..
T Consensus 280 l~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 280 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 998 899998866544443333455677788899999999999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=307.13 Aligned_cols=206 Identities=24% Similarity=0.385 Sum_probs=160.0
Q ss_pred CCCCCCcCcceeeeEEecCC------------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
|++++||||++++++|.+.+ ..|+|||||++|+|.+++...+......+..++.++.||+.||+|||+
T Consensus 57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~ 136 (299)
T 4g31_A 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS 136 (299)
T ss_dssp HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999997544 379999999999999999876655556778899999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc------------ccCCCCCCCCccCcccccCCCCCCchhHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL------------SSKSAAGTPEWMAPEVLRDEPSNEKSDIY 136 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~ 136 (226)
+| |+||||||+||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++|||
T Consensus 137 ~~--IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw 214 (299)
T 4g31_A 137 KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF 214 (299)
T ss_dssp TT--CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHH
T ss_pred Cc--CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHH
Confidence 99 99999999999999999999999999876443211 11234689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 137 SFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 137 slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
||||++|+|++ ||...... .....+. ....+......++...++|.+||+.||.+|||+.++++ ++++++..
T Consensus 215 SlGvilyell~---Pf~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~~~~~~~ 287 (299)
T 4g31_A 215 SLGLILFELLY---PFSTQMERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHHS---CCSSHHHHHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGCCC-
T ss_pred HHHHHHHHHcc---CCCCccHHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhCCCC
Confidence 99999999996 66543221 1222221 12222223345678899999999999999999999999 78887754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=301.30 Aligned_cols=206 Identities=31% Similarity=0.461 Sum_probs=163.0
Q ss_pred CCCCCCcCcceeeeEEecCC----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-------
Q 027225 1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR------- 69 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~------- 69 (226)
+++++||||+++++++.+++ ..|+||||+++|+|.+++.+.. ++++.+..++.|++.||+|||++
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~ 126 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCC
Confidence 35789999999999998654 4799999999999999998654 89999999999999999999987
Q ss_pred -CCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccCC------CCCCchhHHHH
Q 027225 70 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSF 138 (226)
Q Consensus 70 -~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~------~~~~~~Dv~sl 138 (226)
+ |+||||||+|||++.++.+||+|||+++....... ......|++.|+|||++.+. .++.++|||||
T Consensus 127 ~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 127 PA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CC--EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred CC--EeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 7 99999999999999999999999999876443321 12245689999999999765 24678999999
Q ss_pred HHHHHHHHhCCCCCCCC---------------CHHHHHHHHhhCCccCCCCCC-----CCHHHHHHHHHHcccCCCCCCC
Q 027225 139 GVILWELATLQQPWGNL---------------NPAQVVAAVGFKGKRLEIPRN-----VNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 139 G~~l~~l~~g~~p~~~~---------------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps 198 (226)
||++|+|+||..|+... ...+..........++.+|.. .+..+.+++.+||+.||++|||
T Consensus 205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt 284 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC
Confidence 99999999997655321 122333333223333444432 2357899999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 027225 199 FSTIMELLRPLIKS 212 (226)
Q Consensus 199 ~~~~l~~l~~~~~~ 212 (226)
+.+|++.|+++.+.
T Consensus 285 ~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 285 ALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999998765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=300.63 Aligned_cols=220 Identities=90% Similarity=1.427 Sum_probs=181.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++.+.+....+++..++.++.|++.||+|||+.|++++||||||+
T Consensus 89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~ 168 (309)
T 3p86_A 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168 (309)
T ss_dssp HHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGG
T ss_pred HhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChh
Confidence 56899999999999999999999999999999999998765444599999999999999999999998877999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 169 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~ 248 (309)
T 3p86_A 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248 (309)
T ss_dssp GEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred hEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999876554444445567888999999999998999999999999999999999999999988888
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 221 (226)
............+..+++++.++|.+||+.||.+|||+.++++.|+++++...+++.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~~~ 308 (309)
T 3p86_A 249 AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308 (309)
T ss_dssp HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----------
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCccc
Confidence 777767777888899999999999999999999999999999999999999888776654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=298.72 Aligned_cols=199 Identities=24% Similarity=0.337 Sum_probs=161.4
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.||||++++++|.++++.|+||||++||+|.+++.. +++.+++.++.||+.||+|||++| |+||||||+||+
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiL 149 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFL 149 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeE
Confidence 699999999999999999999999999999999953 899999999999999999999999 999999999999
Q ss_pred EcCC-CcEEEccCCCcccccccc----------------------------cccCCCCCCCCccCcccccCCC-CCCchh
Q 027225 85 VDKK-YTVKVCDFGLSRLKANTF----------------------------LSSKSAAGTPEWMAPEVLRDEP-SNEKSD 134 (226)
Q Consensus 85 ~~~~-~~~~l~df~~~~~~~~~~----------------------------~~~~~~~~~~~~~~PE~~~~~~-~~~~~D 134 (226)
++.+ +.+||+|||+++...... .......|++.|+|||++.+.. ++.++|
T Consensus 150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D 229 (361)
T 4f9c_A 150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID 229 (361)
T ss_dssp EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHH
T ss_pred EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc
Confidence 9876 799999999986533221 1112346899999999998764 789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhC----------------------------------------------
Q 027225 135 IYSFGVILWELATLQQPWGNL-NPAQVVAAVGFK---------------------------------------------- 167 (226)
Q Consensus 135 v~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~---------------------------------------------- 167 (226)
+||+||++|+|++|+.||... +..+....+...
T Consensus 230 iWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~ 309 (361)
T 4f9c_A 230 MWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLT 309 (361)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------
T ss_pred hhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccc
Confidence 999999999999999998543 332222211100
Q ss_pred ------CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 168 ------GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 168 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.........+++++.+||.+||+.||++|+|++|+++ ++++++.
T Consensus 310 ~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~--Hp~f~~i 359 (361)
T 4f9c_A 310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM 359 (361)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGTTC
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCCC
Confidence 0001123467899999999999999999999999999 8888764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=302.41 Aligned_cols=206 Identities=21% Similarity=0.338 Sum_probs=171.1
Q ss_pred CCCCCCcCcceeeeEEec------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||+++++++.. .+..|+|||||+ |+|.+++.+.+ .+++..+..++.||+.||.|||++| |+
T Consensus 107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~--ii 180 (398)
T 4b99_A 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ--VI 180 (398)
T ss_dssp HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT--CB
T ss_pred HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc--Cc
Confidence 357899999999998753 367899999996 58999998743 4999999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCccccccc----ccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~ 149 (226)
||||||+||+++.+|.+|++|||+++..... ........|++.|+|||++.+.. ++.++|+||+||++|+|++|+
T Consensus 181 HRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~ 260 (398)
T 4b99_A 181 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260 (398)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence 9999999999999999999999999764332 22334568899999999988764 689999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhhCCccCC-----------------------------CCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 150 QPWGNLNPAQVVAAVGFKGKRLE-----------------------------IPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
.||.+.+..+....+........ ....+++++.+||.+||..||.+|||+.
T Consensus 261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 99998887776655432211110 1135789999999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 027225 201 TIMELLRPLIKSPT 214 (226)
Q Consensus 201 ~~l~~l~~~~~~~~ 214 (226)
|+++ +.+++...
T Consensus 341 e~L~--Hp~f~~~~ 352 (398)
T 4b99_A 341 AALR--HPFLAKYH 352 (398)
T ss_dssp HHTT--SGGGTTTC
T ss_pred HHhc--CHhhCcCC
Confidence 9999 88888653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=315.60 Aligned_cols=200 Identities=26% Similarity=0.423 Sum_probs=173.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||++++++|.+.+++|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+
T Consensus 247 ~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPe 321 (689)
T 3v5w_A 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 321 (689)
T ss_dssp SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGG
T ss_pred hhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchH
Confidence 56799999999999999999999999999999999998744 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC---CH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNL---NP 157 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~---~~ 157 (226)
||+++.+|.+||+|||+++..... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+. +.
T Consensus 322 NILld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~ 399 (689)
T 3v5w_A 322 NILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399 (689)
T ss_dssp GEEECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH
T ss_pred HeEEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999999765443 2345689999999999964 57899999999999999999999999653 23
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~~ 212 (226)
.++...+ ......+|..+|+++++||.+||+.||.+|++ ++++++ +.++++
T Consensus 400 ~~i~~~i--~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF~~ 455 (689)
T 3v5w_A 400 HEIDRMT--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFRS 455 (689)
T ss_dssp HHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGGTT
T ss_pred HHHHHhh--cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--CccccC
Confidence 3333333 33455678889999999999999999999998 688887 666654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=315.63 Aligned_cols=214 Identities=25% Similarity=0.400 Sum_probs=183.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||++++++|.+++.+|+|||||.||+|.+++.+.. ..+++.++..++.||+.||.|||++| |+||||||
T Consensus 208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp 283 (573)
T 3uto_A 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKP 283 (573)
T ss_dssp HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCh
Confidence 357899999999999999999999999999999999996532 34999999999999999999999999 99999999
Q ss_pred CcEEEcCC--CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++.+ +.+||+|||+++..... .......|++.|+|||++.+..++.++|+||+||++|+|++|..||.+.+..
T Consensus 284 ~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 284 ENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp GGEEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred hhccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 99999854 79999999999765433 2233457899999999999999999999999999999999999999999888
Q ss_pred HHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCC
Q 027225 159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221 (226)
Q Consensus 159 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 221 (226)
+....+....... ..+..+++++++||.+||+.||.+|||+.|+++ +.+++.......+..
T Consensus 363 ~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~~~~~~~~~~~ 425 (573)
T 3uto_A 363 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPGNAPGRDSQ 425 (573)
T ss_dssp HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTSCCCCTTTTCE
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcCCCCCCCchhh
Confidence 8877775443322 234678999999999999999999999999999 788876554444433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=283.98 Aligned_cols=208 Identities=26% Similarity=0.474 Sum_probs=181.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++||||+.+++|.+++.+.. +++..+..++.|++.||.|||++| ++|+||||+
T Consensus 72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~ 145 (297)
T 3fxz_A 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSD 145 (297)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHH
Confidence 46799999999999999999999999999999999998643 899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....
T Consensus 146 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 225 (297)
T 3fxz_A 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (297)
T ss_dssp GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred HEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999876555444445567889999999999988999999999999999999999999888776655
Q ss_pred HHHhh-CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 162 AAVGF-KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 162 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
..+.. .......+..++..+.++|.+||+.||.+|||+.++++ +.+++...+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~~~~ 280 (297)
T 3fxz_A 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAKPLS 280 (297)
T ss_dssp HHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCCGG
T ss_pred HHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhcccCccc
Confidence 44432 23344556789999999999999999999999999999 78877655443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=281.82 Aligned_cols=213 Identities=34% Similarity=0.578 Sum_probs=180.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||||
T Consensus 104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp 179 (325)
T 3kul_A 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAA 179 (325)
T ss_dssp HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCc
Confidence 467899999999999999999999999999999999997542 24999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++++|++ |..||...+
T Consensus 180 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 180 RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp GGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999876543221 1222334567999999998888999999999999999999 999999888
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
..+....+. .......+..+++++.++|.+||..||.+|||+.++++.|+.+++.......
T Consensus 260 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~ 320 (325)
T 3kul_A 260 NRDVISSVE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320 (325)
T ss_dssp HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred HHHHHHHHH-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence 887777665 3445566788999999999999999999999999999999999987665443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=282.44 Aligned_cols=201 Identities=27% Similarity=0.496 Sum_probs=177.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| ++||||||+
T Consensus 60 ~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~ 134 (337)
T 1o6l_A 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLE 134 (337)
T ss_dssp HSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGG
T ss_pred HhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHH
Confidence 56899999999999999999999999999999999998643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.+|.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 135 NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 214 (337)
T 1o6l_A 135 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp GEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred HEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999999876443333344566789999999999988999999999999999999999999988877776
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhc
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIK 211 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~ 211 (226)
..+.. ....++..+++++.++|.+||+.||.+|| +++++++ +.+++
T Consensus 215 ~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~--h~~f~ 265 (337)
T 1o6l_A 215 ELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--HRFFL 265 (337)
T ss_dssp HHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred HHHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc--CCCcC
Confidence 66643 34556788999999999999999999999 8999987 45543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=281.31 Aligned_cols=202 Identities=28% Similarity=0.480 Sum_probs=177.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++...+..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++| ++||||||+
T Consensus 69 ~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~ 143 (328)
T 3fe3_A 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAE 143 (328)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred HhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHH
Confidence 56799999999999999999999999999999999997643 3999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.++|+|||++...... .......+++.|+|||++.+..+. .++|+||+|+++++|++|..||.+.+..+.
T Consensus 144 NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 222 (328)
T 3fe3_A 144 NLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222 (328)
T ss_dssp GEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998754433 223455688999999999888764 789999999999999999999999888877
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
...+.. .....+..+++++.++|.+||+.||.+|||++++++ +.+++..
T Consensus 223 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~~ 271 (328)
T 3fe3_A 223 RERVLR--GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK--DRWINAG 271 (328)
T ss_dssp HHHHHH--CCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTTTT
T ss_pred HHHHHh--CCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhcCC
Confidence 776643 344567789999999999999999999999999999 7777653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=283.75 Aligned_cols=208 Identities=31% Similarity=0.592 Sum_probs=179.6
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
+++ +||||+++++++.+++..|+|+||+.+|+|.+++..... ...+++..+..++.||+.||.|||
T Consensus 141 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 220 (370)
T 2psq_A 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220 (370)
T ss_dssp HHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 356 899999999999999999999999999999999986431 234899999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
++| ++||||||+||+++.++.+||+|||++....... .......+++.|+|||++.+..++.++|+||||+++|+|
T Consensus 221 ~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 298 (370)
T 2psq_A 221 SQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298 (370)
T ss_dssp HTT--EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred hCC--eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHH
Confidence 999 9999999999999999999999999987544322 122234456789999999998899999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 146 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
++ |..||...+..+....+. .......+..++.++.++|.+||+.||.+|||+.++++.|++++..
T Consensus 299 lt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 299 FTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 99 999999888777666554 3445566788999999999999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=279.01 Aligned_cols=204 Identities=26% Similarity=0.451 Sum_probs=176.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++||||+.|++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||||
T Consensus 69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp 143 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKP 143 (361)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 467899999999999999999999999999999999998643 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCC----cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 81 PNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
+||+++.++ .++|+|||++...... .......+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+
T Consensus 144 ~NIll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp GGEEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred HHEEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998777 7999999998765443 22344568899999999999889999999999999999999999999888
Q ss_pred HHHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 157 PAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..+....+....... ..+..++.++.++|.+||..||.+|||+.++++ +.+++.
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~~ 278 (361)
T 2yab_A 223 KQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR--HPWITP 278 (361)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTSC
T ss_pred HHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CcCcCC
Confidence 877776664332221 223578999999999999999999999999998 666654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=270.46 Aligned_cols=207 Identities=33% Similarity=0.616 Sum_probs=180.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+++++|.+++.... ..+++..++.++.|++.||.+||+.| ++|+||+|
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp 134 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAA 134 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcch
Confidence 357899999999999999999999999999999999997643 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+..
T Consensus 135 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 135 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp GGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred heEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999987544332 22333445668999999998889999999999999999999 99999998888
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+. .......+...++++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 215 EVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHh-cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 7776665 3344556777899999999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=275.14 Aligned_cols=199 Identities=26% Similarity=0.492 Sum_probs=176.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..|+||||+.|++|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||||+
T Consensus 61 ~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~ 135 (318)
T 1fot_A 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPE 135 (318)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGG
T ss_pred hhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChh
Confidence 46899999999999999999999999999999999998743 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.+|.++|+|||++...... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 136 NIll~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 212 (318)
T 1fot_A 136 NILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212 (318)
T ss_dssp GEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred eEEEcCCCCEEEeecCcceecCCc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999998764432 33456789999999999988999999999999999999999999988877766
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
..+.. ....++..+++++.++|.+||+.||.+|| +++++++ +.++++
T Consensus 213 ~~i~~--~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f~~ 264 (318)
T 1fot_A 213 EKILN--AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFKE 264 (318)
T ss_dssp HHHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGSS
T ss_pred HHHHh--CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--CccccC
Confidence 66543 34566788999999999999999999999 8999997 566553
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=274.24 Aligned_cols=206 Identities=25% Similarity=0.461 Sum_probs=178.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++...+..++||||+.+++|.+++.+.. +++..+..++.|++.||.|||+.| ++|+||||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp 169 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG--VIHRDIKS 169 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 467899999999999999999999999999999999987543 899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+.
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999987655443334456788999999999988899999999999999999999999988877766
Q ss_pred HHHHhhCCc-cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
...+..... ....+..+++++.++|.+||+.||.+|||+.++++ ..++....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~~~ 302 (321)
T 2c30_A 250 MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQTG 302 (321)
T ss_dssp HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGGGCC
T ss_pred HHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc--ChhhccCC
Confidence 655543322 22334568899999999999999999999999998 67766543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=285.60 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=177.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||+.||+|.+.+...+ .+++..+..++.||+.||.|||++| ++||||||+
T Consensus 65 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~ 139 (444)
T 3soa_A 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPE 139 (444)
T ss_dssp HHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSST
T ss_pred HhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence 56899999999999999999999999999999999998743 4999999999999999999999999 999999999
Q ss_pred cEEEc---CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++ +++.++|+|||++..............+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+..
T Consensus 140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~ 219 (444)
T 3soa_A 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219 (444)
T ss_dssp TEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH
Confidence 99998 467899999999976655444445567899999999999988999999999999999999999999988888
Q ss_pred HHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
+....+........ ....+++++.++|.+||+.||.+|||+.++++ +.++
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--hp~~ 271 (444)
T 3soa_A 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK--HPWI 271 (444)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SCTT
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccc
Confidence 77777654443322 23578999999999999999999999999998 5554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=275.41 Aligned_cols=209 Identities=32% Similarity=0.581 Sum_probs=180.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC---------------------CCcCCHHHHHHHHHHH
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYDV 59 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---------------------~~~~~~~~~~~~~~~l 59 (226)
|++++||||+++++++.+++..++|+||+.+++|.+++..... ...+++..++.++.|+
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999986432 2348999999999999
Q ss_pred HHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHH
Q 027225 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYS 137 (226)
Q Consensus 60 ~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 137 (226)
+.||.|||++| ++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||
T Consensus 160 ~~~l~~lH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 237 (314)
T 2ivs_A 160 SQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWS 237 (314)
T ss_dssp HHHHHHHHHTT--EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHH
T ss_pred HHHHHHHHHCC--CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHH
Confidence 99999999999 99999999999999999999999999875433221 223344567899999998888899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 138 FGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 138 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
||+++++|++ |..||...+..+...... .......+..+++++.++|.+||+.||.+|||+.++++.|++++..
T Consensus 238 lG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 238 FGVLLWEIVTLGGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9999999999 999998888777666554 3345566788999999999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=272.98 Aligned_cols=201 Identities=26% Similarity=0.411 Sum_probs=171.2
Q ss_pred CCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++++||||+++++++.+ .+..++||||+++++|.++.... .+++..++.++.|++.||.|||++| ++|+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk 164 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIK 164 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCC
Confidence 57899999999999986 56799999999999998876543 4999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|+||+++.++.++|+|||++..............+++.|+|||.+.+.. .+.++|+||||+++++|++|..||...+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999876554433344567889999999998765 3678999999999999999999999887
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
.......+............+++++.++|.+||+.||.+|||+.++++ +.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~--hp~~ 296 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL--HPWV 296 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--CHHH
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc--Cccc
Confidence 776666655444444445678999999999999999999999999987 4444
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=280.89 Aligned_cols=192 Identities=28% Similarity=0.453 Sum_probs=172.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++.+.+..|+||||+.||+|.+++.+.+ .+++..++.++.||+.||+|||++| ++||||||+
T Consensus 94 ~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~ 168 (373)
T 2r5t_A 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPE 168 (373)
T ss_dssp CCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred HhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHH
Confidence 56899999999999999999999999999999999998643 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.+|.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 169 NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 248 (373)
T 2r5t_A 169 NILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248 (373)
T ss_dssp GEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH
T ss_pred HEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999999999999876444444455667899999999999998999999999999999999999999988887777
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
..+.. ....++..++.++.++|.+||+.||.+||++.
T Consensus 249 ~~i~~--~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 249 DNILN--KPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHH--SCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHh--cccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 66643 34456778999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=271.11 Aligned_cols=213 Identities=22% Similarity=0.403 Sum_probs=176.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++||||+++++|.+++.+.+ .+++..+..++.|++.||.|||++| ++|+||||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp 139 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKP 139 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 367899999999999999999999999999999999998743 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+...
T Consensus 140 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 140 QNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp GGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred HHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999999987654332 22334567889999999999889999999999999999999999999887766
Q ss_pred HHHHHhhCCcc---CCCCCCCCHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHhhcCCCCCCC
Q 027225 160 VVAAVGFKGKR---LEIPRNVNPHVASIIEACWANEPWKRP-SFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 160 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~~~~~~~~~ 218 (226)
........... ...+..+++.+.++|.+||+.||.+|| +++++.+.|+.++.+......
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 220 IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 54443322211 123567899999999999999999998 999999999998877654443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=281.36 Aligned_cols=199 Identities=25% Similarity=0.442 Sum_probs=172.2
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+.+..|+||||+.||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||+
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIL 156 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVL 156 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEE
Confidence 79999999999999999999999999999999998743 4999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.++.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 157 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 236 (353)
T 3txo_A 157 LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236 (353)
T ss_dssp ECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999876444434445667899999999999888999999999999999999999999998888877766
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH------HHHHHHHHHhhcC
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF------STIMELLRPLIKS 212 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~~l~~l~~~~~~ 212 (226)
.. .....+..+++++.++|.+||+.||.+||++ +++++ +.++++
T Consensus 237 ~~--~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f~~ 286 (353)
T 3txo_A 237 LN--DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFFKE 286 (353)
T ss_dssp HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGGTT
T ss_pred Hc--CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCcccC
Confidence 43 4455677899999999999999999999998 78887 566554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=277.81 Aligned_cols=198 Identities=24% Similarity=0.455 Sum_probs=174.9
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+.+..|+||||+.||+|.+++.+.+ .+++..++.++.|++.||.|||++| ++||||||+||+
T Consensus 79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIl 153 (353)
T 2i0e_A 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM 153 (353)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEE
Confidence 89999999999999999999999999999999998643 3999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.+|.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 154 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 233 (353)
T 2i0e_A 154 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233 (353)
T ss_dssp ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999876443333445667899999999999988999999999999999999999999988887777666
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhc
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIK 211 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~ 211 (226)
.. ....++..+++++.++|.+||+.||.+||+ ++++++ +.+++
T Consensus 234 ~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~--h~~f~ 281 (353)
T 2i0e_A 234 ME--HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--HAFFR 281 (353)
T ss_dssp HH--CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT--SGGGT
T ss_pred Hh--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc--Ccccc
Confidence 43 345567889999999999999999999995 577776 45544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=281.45 Aligned_cols=212 Identities=32% Similarity=0.592 Sum_probs=183.4
Q ss_pred CC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
++ +||||+++++++.+++..++||||+.+++|.+++..... ...+++..++.++.|++.||.|||+
T Consensus 130 ~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 209 (382)
T 3tt0_A 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209 (382)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 45 899999999999999999999999999999999976431 2359999999999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
.| ++|+||||+||+++.++.++|+|||.+....... .......++..|+|||++.+..++.++||||||+++++|+
T Consensus 210 ~~--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 210 KK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp TT--CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred CC--EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 99 9999999999999999999999999987654322 2223344567899999999988999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
+ |..||...+..+....+. .......+..+++++.++|.+||+.||.+|||+.++++.|++++.....+.
T Consensus 288 t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 288 TLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp TTSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred hCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 9 999999888877776664 444556678899999999999999999999999999999999987655444
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=279.10 Aligned_cols=200 Identities=28% Similarity=0.474 Sum_probs=175.8
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.+||||+++++++.+.+..|+||||+.||+|.+++.+.+ .+++..+..++.|++.||+|||++| ++||||||+||
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NI 149 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNI 149 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGE
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhE
Confidence 389999999999999999999999999999999998643 3999999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
+++.+|.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 150 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 229 (345)
T 1xjd_A 150 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 229 (345)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999999987644333334566789999999999998899999999999999999999999999888877776
Q ss_pred HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH-HHHHHHHHhhcC
Q 027225 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIMELLRPLIKS 212 (226)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~~l~~~~~~ 212 (226)
+.. .....+..+++++.++|.+||..||.+||++. ++++ +.++++
T Consensus 230 i~~--~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~--hp~f~~ 275 (345)
T 1xjd_A 230 IRM--DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ--HPLFRE 275 (345)
T ss_dssp HHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG--SGGGTT
T ss_pred HHh--CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc--CccccC
Confidence 643 34456778999999999999999999999998 7775 445443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=266.87 Aligned_cols=205 Identities=31% Similarity=0.656 Sum_probs=179.0
Q ss_pred CCCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++.+. +..++|+||+++++|.+++.+.. ...+++..++.++.|++.||.|||+.|..++|+||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di 139 (271)
T 3kmu_A 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL 139 (271)
T ss_dssp GCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred HHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence 4678999999999999887 77999999999999999998754 33589999999999999999999998767999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCC---chhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNE---KSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.+++.||+++.... .....+++.|+|||.+.+...+. ++|+||||+++++|++|..||...
T Consensus 140 kp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 140 NSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp SGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999999999887754322 22345678999999998765544 799999999999999999999998
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+..+..............+..+++++.+++.+||+.||.+|||+.++++.|+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 215 SNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 88887777766777777888999999999999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=277.26 Aligned_cols=200 Identities=24% Similarity=0.416 Sum_probs=177.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..|+||||+.|++|.+++.+.+ .+++..++.++.||+.||+|||++| ++||||||
T Consensus 95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp 169 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKP 169 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCcc
Confidence 467899999999999999999999999999999999998743 3999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.+|.++|+|||++...... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 170 ~NIll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 246 (350)
T 1rdq_E 170 ENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ceEEECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence 9999999999999999998765432 2345678899999999998899999999999999999999999998888777
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhcC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~~ 212 (226)
...+.. ....++..+++++.++|.+||+.||.+||+ ++++++ +.+++.
T Consensus 247 ~~~i~~--~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--h~~f~~ 299 (350)
T 1rdq_E 247 YEKIVS--GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFAT 299 (350)
T ss_dssp HHHHHH--CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGTT
T ss_pred HHHHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--CcCcCC
Confidence 766643 345667889999999999999999999998 899987 566543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=268.99 Aligned_cols=206 Identities=35% Similarity=0.649 Sum_probs=178.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+++++|.+++...+ ..+++..++.++.|++.||.+||+.| ++|+||+|+
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~ 133 (268)
T 3sxs_A 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAAR 133 (268)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGG
T ss_pred HhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcc
Confidence 46789999999999999999999999999999999997642 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus 134 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (268)
T 3sxs_A 134 NCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213 (268)
T ss_dssp GEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence 9999999999999999987544332 22233445667999999998888999999999999999999 999999888777
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
...... .......+...++++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 214 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 214 VVLKVS-QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHH-TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHH-cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 766654 3444555677899999999999999999999999999999988654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=276.03 Aligned_cols=202 Identities=24% Similarity=0.424 Sum_probs=172.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||+.+++|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||||+
T Consensus 76 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~ 150 (327)
T 3a62_A 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPE 150 (327)
T ss_dssp HHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTT
T ss_pred HhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHH
Confidence 46799999999999999999999999999999999998643 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 151 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 230 (327)
T 3a62_A 151 NIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230 (327)
T ss_dssp TEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred HeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999999875443333344556789999999999888999999999999999999999999988877766
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
..+.. .....+..++.++.++|.+||+.||.+|| ++.++++ +.+++.
T Consensus 231 ~~i~~--~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f~~ 282 (327)
T 3a62_A 231 DKILK--CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFFRH 282 (327)
T ss_dssp HHHHH--TCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGGSS
T ss_pred HHHHh--CCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCcccC
Confidence 65533 34456778999999999999999999999 7888887 566654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=280.39 Aligned_cols=208 Identities=32% Similarity=0.609 Sum_probs=170.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++||||+++++|.+++.+.+ ..+++.++..++.|++.||.|||+.| ++||||||
T Consensus 100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 175 (373)
T 2qol_A 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAA 175 (373)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCc
Confidence 468899999999999999999999999999999999998653 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccc---cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||++++++++ |..||...+
T Consensus 176 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp GGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999998765432211 112233567999999998889999999999999999998 999998888
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+....+. .......+..++.++.+++.+||+.||.+||++.++++.|+++++..
T Consensus 256 ~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 256 NQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHH-TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHH-cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 777766654 33445556788999999999999999999999999999999997653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=285.70 Aligned_cols=203 Identities=27% Similarity=0.496 Sum_probs=177.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~ 79 (226)
|++++||||+++++++.+.+..++||||+++++|.+++.+.+ .+++..+..++.|++.||+|||+ .| |+|||||
T Consensus 202 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlk 276 (446)
T 4ejn_A 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLK 276 (446)
T ss_dssp CCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCC
T ss_pred HHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCC
Confidence 567899999999999999999999999999999999997643 49999999999999999999998 99 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.++.++|+|||++..............+++.|+|||++.+..++.++|+||||+++++|++|..||...+..+
T Consensus 277 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 356 (446)
T 4ejn_A 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356 (446)
T ss_dssp GGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 99999999999999999998764444344455678999999999999889999999999999999999999999888877
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
....+.. ....++..+++++.++|.+||+.||.+|| +++++++ +.++++
T Consensus 357 ~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~~ 410 (446)
T 4ejn_A 357 LFELILM--EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFAG 410 (446)
T ss_dssp HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGTT
T ss_pred HHHHHHh--CCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--CccccC
Confidence 7766643 34456788999999999999999999999 9999998 556554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=272.42 Aligned_cols=208 Identities=26% Similarity=0.361 Sum_probs=171.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||||+
T Consensus 74 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~ 148 (311)
T 3niz_A 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQ 148 (311)
T ss_dssp HHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchH
Confidence 467999999999999999999999999986 8888877643 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.++|+|||.+..............+++.|+|||++.+ ..++.++|+||+|+++++|++|..||...+..+.
T Consensus 149 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (311)
T 3niz_A 149 NLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228 (311)
T ss_dssp GEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH
T ss_pred hEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999999766544444445567889999999876 4578999999999999999999999977655444
Q ss_pred HHHHhhCCccC----------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 161 VAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
...+....... .....+++++.++|.+||+.||.+|||+.++++ +.++++
T Consensus 229 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 306 (311)
T 3niz_A 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN--HPYFKD 306 (311)
T ss_dssp HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTT
T ss_pred HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccccc
Confidence 33332110000 012357889999999999999999999999999 889888
Q ss_pred CCCC
Q 027225 213 PTPQ 216 (226)
Q Consensus 213 ~~~~ 216 (226)
..++
T Consensus 307 ~~~~ 310 (311)
T 3niz_A 307 LDPQ 310 (311)
T ss_dssp SCTT
T ss_pred CCcc
Confidence 7654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=282.36 Aligned_cols=206 Identities=38% Similarity=0.617 Sum_probs=178.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+++|+|.+++...+ ..+++..+..++.|++.||+|||++| ++||||+|
T Consensus 166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp 241 (377)
T 3cbl_A 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAA 241 (377)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCH
Confidence 468899999999999999999999999999999999997642 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc--CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.+||+|||++.......... ....++..|+|||.+.+..++.++||||||+++++|++ |..||...+.
T Consensus 242 ~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred HHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987543321111 11223457999999988888999999999999999998 9999998888
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
.+....+. .......+..+++++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 322 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 322 QQTREFVE-KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 77766654 445566778899999999999999999999999999999998865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=277.70 Aligned_cols=210 Identities=31% Similarity=0.541 Sum_probs=178.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC---------------------CCcCCHHHHHHHHHHHH
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYDVA 60 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~ 60 (226)
++++||||+++++++.+++..++||||+.+++|.+++..... ...+++.+++.++.|++
T Consensus 105 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 184 (343)
T 1luf_A 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184 (343)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHH
Confidence 578999999999999999999999999999999999976321 14589999999999999
Q ss_pred HHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHH
Q 027225 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138 (226)
Q Consensus 61 ~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 138 (226)
.||.|||++| ++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+|||
T Consensus 185 ~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 185 AGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp HHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHhCC--eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 9999999999 9999999999999999999999999987543321 22233455778999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 139 GVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 139 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
|+++|+|++ |..||...+..+....+. .......+..+++++.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 263 G~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 263 GVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHHHHHHHhcCCCcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 999999999 999999888877766654 344456678899999999999999999999999999999999877543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=276.71 Aligned_cols=208 Identities=19% Similarity=0.337 Sum_probs=176.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++||||+++++|.+++...+ ..+++..++.++.|++.||.|||+.| ++|+||||+
T Consensus 56 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~ 131 (321)
T 1tki_A 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPE 131 (321)
T ss_dssp HHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHH
Confidence 46799999999999999999999999999999999997643 24899999999999999999999999 999999999
Q ss_pred cEEEcC--CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 82 NLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
||+++. ++.++|+|||.+....... ......+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+..+
T Consensus 132 NIl~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 132 NIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp GEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred HEEEccCCCCCEEEEECCCCeECCCCC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 999987 7899999999987654321 1223456889999999998888999999999999999999999999888877
Q ss_pred HHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 160 VVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 160 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
....+........ ....++.++.++|.+||..||.+|||+.++++ +.+++.....
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~~~~~ 267 (321)
T 1tki_A 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQKIER 267 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHSCGGG
T ss_pred HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc--ChhhccCccc
Confidence 7666643332221 22478999999999999999999999999999 7777665433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=267.63 Aligned_cols=208 Identities=23% Similarity=0.357 Sum_probs=168.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+.+ ++.+.+... ...+++..++.++.|++.||.|||++| ++|+||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp 129 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKP 129 (292)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 4678999999999999999999999999987 555555432 224999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQP-WGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p-~~~~~~~ 158 (226)
+||+++.++.++|+|||.+..............++..|+|||++.+.. ++.++|+||+|+++++|++|..| |...+..
T Consensus 130 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~ 209 (292)
T 3o0g_A 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp GGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred HHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 999999999999999999976654444445567788999999998766 79999999999999999988777 4555554
Q ss_pred HHHHHHhhCCc---------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGK---------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+....+..... .......+++++.++|.+||+.||.+|||++++++ +.+++
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~ 287 (292)
T 3o0g_A 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFS 287 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGT
T ss_pred HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--Ccccc
Confidence 44433321100 01122357899999999999999999999999999 88888
Q ss_pred CCCC
Q 027225 212 SPTP 215 (226)
Q Consensus 212 ~~~~ 215 (226)
+..+
T Consensus 288 ~~~p 291 (292)
T 3o0g_A 288 DFCP 291 (292)
T ss_dssp TC--
T ss_pred cCCC
Confidence 7654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=268.58 Aligned_cols=206 Identities=31% Similarity=0.555 Sum_probs=179.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++.... ..+++..++.++.|++.||.+||++| ++|+||||+
T Consensus 74 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~ 149 (283)
T 3gen_A 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAAR 149 (283)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGG
T ss_pred hcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccc
Confidence 57899999999999999999999999999999999997632 23999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus 150 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 150 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp GEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 9999999999999999987544332 22233445678999999998889999999999999999998 999999888877
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+. .......+...++.+.+++.+||+.||.+|||+.++++.|++++.+
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 230 TAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHh-cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 776665 3344556778899999999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=277.77 Aligned_cols=213 Identities=31% Similarity=0.522 Sum_probs=175.8
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCC--------------------CcCCHHHHHHHHHHHH
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR--------------------EMLDERRRLNMAYDVA 60 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~--------------------~~~~~~~~~~~~~~l~ 60 (226)
+++ +||||+++++++.+.+..++||||+++++|.+++...... ..+++..++.++.|++
T Consensus 103 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 182 (344)
T 1rjb_A 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182 (344)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred HhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHH
Confidence 345 8999999999999999999999999999999999864321 3479999999999999
Q ss_pred HHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHH
Q 027225 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138 (226)
Q Consensus 61 ~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 138 (226)
.||.|||+.| ++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+|||
T Consensus 183 ~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 183 KGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp HHHHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHhCC--cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 9999999999 99999999999999999999999999875433211 1223344668999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 139 GVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 139 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
|+++++|++ |..||.....................+..+++++.+++.+||+.||.+|||+.++++.|+.++...+..
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 999999998 999998776555444444445555667788999999999999999999999999999999998875543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=275.02 Aligned_cols=199 Identities=26% Similarity=0.478 Sum_probs=170.4
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+++..|+||||+.+|+|.+++.+.+ .+++..++.++.|++.||+|||++| ++||||||+||+
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIl 142 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL 142 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEE
Confidence 89999999999999999999999999999999998643 4999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL--------- 155 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~--------- 155 (226)
++.++.++|+|||++..............+++.|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus 143 l~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 222 (345)
T 3a8x_A 143 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222 (345)
T ss_dssp ECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------
T ss_pred ECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc
Confidence 99999999999999876443333445567899999999999988999999999999999999999999642
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH------HHHHHHHHHhhcC
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF------STIMELLRPLIKS 212 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~~l~~l~~~~~~ 212 (226)
+.......+ ......++..++.++.++|.+||+.||.+||++ .++++ +.+++.
T Consensus 223 ~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--hp~f~~ 281 (345)
T 3a8x_A 223 TEDYLFQVI--LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFFRN 281 (345)
T ss_dssp CHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--SGGGTT
T ss_pred cHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--CCccCC
Confidence 222233333 234456778899999999999999999999995 67776 566654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=275.04 Aligned_cols=215 Identities=28% Similarity=0.495 Sum_probs=171.2
Q ss_pred CCCCCCcCcceeeeEEecCCce------EEEEeecccCCHHHHhcCCCC---CCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNL------SIVTEYLSRGSLYRLLHKPGV---REMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
+++++||||+++++++.+.+.. ++|+||+.+++|.+++..... ...+++..++.++.|++.||.|||++|
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~- 157 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 4678999999999999877655 999999999999999864221 124899999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-C
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L 148 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 148 (226)
++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++ |
T Consensus 158 -ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 158 -FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp -CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCC
Confidence 9999999999999999999999999987543322 11223344668999999998889999999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
..||...+..+....+. .......+..+++++.+++.+||+.||.+|||+.++++.|++++......+.
T Consensus 237 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 237 QTPYAGIENAEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCccccChHHHHHHHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 99999888777666554 3445566778999999999999999999999999999999999887655554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=272.12 Aligned_cols=204 Identities=26% Similarity=0.434 Sum_probs=174.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..++.++.|++.||.|||+.| ++|+||||+
T Consensus 69 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~ 143 (326)
T 2y0a_A 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPE 143 (326)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHH
Confidence 46789999999999999999999999999999999997643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCC----cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 82 NLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
||+++.++ .++|+|||.+....... ......+++.|+|||++.+..++.++|+||||+++++|++|..||...+.
T Consensus 144 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred HEEEecCCCCCCCEEEEECCCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99998877 79999999987654322 23345678899999999988899999999999999999999999988877
Q ss_pred HHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.+....+....... .....++..+.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~ 278 (326)
T 2y0a_A 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIKPK 278 (326)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTSCC
T ss_pred HHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--CCCccCC
Confidence 77666554332221 123578999999999999999999999999998 6666543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=287.15 Aligned_cols=215 Identities=34% Similarity=0.587 Sum_probs=181.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+ +..++||||+.+|+|.+++.... ...+++..+..++.|++.||+|||++| ++||||+|+
T Consensus 234 ~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~ 309 (452)
T 1fmk_A 234 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA 309 (452)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred HhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChh
Confidence 56899999999999976 67999999999999999997532 234899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+
T Consensus 310 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 389 (452)
T 1fmk_A 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389 (452)
T ss_dssp GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred hEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987644321 11223344568999999988889999999999999999999 999999888877
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 221 (226)
....+. ...+...+..+++++.+++.+||+.||.+|||++++++.|++++....++..|.+
T Consensus 390 ~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~~ 450 (452)
T 1fmk_A 390 VLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450 (452)
T ss_dssp HHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred HHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccccc
Confidence 776664 4455667788999999999999999999999999999999999999888776653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=271.86 Aligned_cols=213 Identities=33% Similarity=0.622 Sum_probs=181.4
Q ss_pred CCCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHH
Q 027225 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYL 66 (226)
Q Consensus 1 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~l 66 (226)
|+++ +||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3567 89999999999999999999999999999999998643 224599999999999999999999
Q ss_pred hcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 67 H~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
|++| ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++++|+
T Consensus 159 H~~~--ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (327)
T 1fvr_A 159 SQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235 (327)
T ss_dssp HHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred HhCC--ccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH
Confidence 9999 999999999999999999999999998643322 1222334567899999998888899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
+ |..||...+..+....+. .......+..+++++.++|.+||+.||.+|||+.++++.|++++.......
T Consensus 236 t~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 236 SLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp TTSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred cCCCCCCCCCcHHHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 8 999999888877766654 333455677889999999999999999999999999999999988765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=277.95 Aligned_cols=199 Identities=26% Similarity=0.478 Sum_probs=170.8
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+++..|+||||+.||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||+
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NIL 185 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL 185 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEE
Confidence 89999999999999999999999999999999998743 4999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-------- 156 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------- 156 (226)
++.+|.++|+|||+++.............+++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 186 l~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~ 265 (396)
T 4dc2_A 186 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265 (396)
T ss_dssp ECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred ECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence 999999999999998764444444556678999999999999999999999999999999999999995321
Q ss_pred -HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH------HHHHHHHHHhhcC
Q 027225 157 -PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF------STIMELLRPLIKS 212 (226)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~~l~~l~~~~~~ 212 (226)
.......+ ......++..+++++.++|.+||+.||.+||++ .++++ +.+++.
T Consensus 266 ~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~--Hpff~~ 324 (396)
T 4dc2_A 266 TEDYLFQVI--LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFFRN 324 (396)
T ss_dssp CHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH--STTTTT
T ss_pred hHHHHHHHH--hccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc--CccccC
Confidence 12222233 334556788899999999999999999999985 57766 556554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=269.47 Aligned_cols=205 Identities=30% Similarity=0.585 Sum_probs=166.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++. ++..++||||+.+++|.+++...+ ..+++..++.++.|++.||.|||+.| ++|+||||+
T Consensus 71 ~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~ 145 (281)
T 1mp8_A 71 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 145 (281)
T ss_dssp HTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred HhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHH
Confidence 5789999999999985 457899999999999999997643 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..+
T Consensus 146 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~ 225 (281)
T 1mp8_A 146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225 (281)
T ss_dssp GEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred HEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence 99999999999999999876543321 1223344568999999988888999999999999999996 999998877766
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+. .......+..+++++.+++.+||+.||.+|||+.++++.|++++..
T Consensus 226 ~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 226 VIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 666554 3344566788999999999999999999999999999999988753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=285.14 Aligned_cols=212 Identities=30% Similarity=0.564 Sum_probs=182.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++. .+..++||||+.+|+|.+++.... ...+++..+..++.|++.||+|||++| ++||||||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp 312 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRA 312 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSG
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCH
Confidence 46889999999999987 567999999999999999998642 224889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++++|++ |..||...+..
T Consensus 313 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp GGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred HHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654322 11223344668999999998889999999999999999999 99999988887
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
+....+. .......+..+++++.++|.+||+.||.+|||+++|++.|+++++....+.
T Consensus 393 ~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~ 450 (454)
T 1qcf_A 393 EVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY 450 (454)
T ss_dssp HHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSS
T ss_pred HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccc
Confidence 7776665 334556678899999999999999999999999999999999998766553
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=281.42 Aligned_cols=202 Identities=31% Similarity=0.562 Sum_probs=176.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++...+..|+|+||+.+++|.+++.+.+ .+++..++.++.|++.||.|||+.| ++||||||
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp 144 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKP 144 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccH
Confidence 467899999999999999999999999999999999998743 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||++...... .......+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+...
T Consensus 145 ~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 145 ENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp GGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred HHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999999998765432 22345578899999999988765 679999999999999999999999887776
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+. ......+..+++++.++|.+||+.||.+|||+.++++ +.+++.
T Consensus 224 ~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~~ 272 (476)
T 2y94_A 224 LFKKIC--DGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFKQ 272 (476)
T ss_dssp HHHHHH--TTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHHT
T ss_pred HHHHHh--cCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhhh
Confidence 666553 3344567789999999999999999999999999998 566654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=264.88 Aligned_cols=206 Identities=33% Similarity=0.619 Sum_probs=178.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+++++|.+++.... ..+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ 133 (267)
T 3t9t_A 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAAR 133 (267)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGG
T ss_pred HhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchh
Confidence 57899999999999999999999999999999999997643 34899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus 134 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 134 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp GEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred eEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence 9999999999999999987644321 12233445678999999998888999999999999999999 899999888777
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+. .......+..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 214 ~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 214 VVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHh-cCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 766664 3334455677899999999999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=268.29 Aligned_cols=206 Identities=23% Similarity=0.429 Sum_probs=152.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||+|
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p 140 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTL 140 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCG
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 367899999999999999999999999999999999998642 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..+.
T Consensus 141 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 220 (278)
T 3cok_A 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220 (278)
T ss_dssp GGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred HHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence 99999999999999999987655433333345678899999999988889999999999999999999999987665444
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.... .......+..++.++.++|.+||+.||.+|||+.++++ +.++....
T Consensus 221 ~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~~ 270 (278)
T 3cok_A 221 LNKV--VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMSRNS 270 (278)
T ss_dssp ---C--CSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--STTTC---
T ss_pred HHHH--hhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc--CccccCCC
Confidence 4333 22334566778999999999999999999999999998 67776544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=274.01 Aligned_cols=205 Identities=31% Similarity=0.515 Sum_probs=174.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++. ++..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||+.| ++||||||+
T Consensus 70 ~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~ 144 (325)
T 3kex_A 70 GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAAR 144 (325)
T ss_dssp HTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSST
T ss_pred hcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchh
Confidence 4679999999999986 456999999999999999997642 34899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 145 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 224 (325)
T 3kex_A 145 NVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224 (325)
T ss_dssp TEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred eEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence 99999999999999999876543221 2233455678999999998889999999999999999999 99999888777
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+. .......+..++.++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 225 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 225 EVPDLLE-KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHHH-TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHH-cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 7666654 3445566777899999999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=275.85 Aligned_cols=202 Identities=27% Similarity=0.436 Sum_probs=172.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||+.+++|.+++...+ .+++..+..++.||+.||.|||++| ++|+||||+
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~ 157 (362)
T 2bdw_A 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPE 157 (362)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGG
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchH
Confidence 46899999999999999999999999999999999998643 4899999999999999999999999 999999999
Q ss_pred cEEEcCCC---cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++.++ .++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..
T Consensus 158 NIll~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 236 (362)
T 2bdw_A 158 NLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236 (362)
T ss_dssp GEEESCSSTTCCEEECCCTTCBCCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCCEEEeecCcceEecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99997644 59999999987654332 233456889999999999988999999999999999999999999988877
Q ss_pred HHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+....+........ ....+++++.++|.+||+.||.+|||+.++++ ..++.
T Consensus 237 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~ 289 (362)
T 2bdw_A 237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWIC 289 (362)
T ss_dssp HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SHHHH
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CcccC
Confidence 77766654433222 22468999999999999999999999999998 44443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=282.84 Aligned_cols=205 Identities=36% Similarity=0.660 Sum_probs=176.5
Q ss_pred CCCCCCcCcceeeeEEecCC-ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+.+ ..++||||+.+|+|.+++...+ ...+++..+..++.|++.||+|||++| ++||||+
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlk 316 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLA 316 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCC
Confidence 35789999999999987665 7999999999999999998644 234799999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
|+||+++.++.+||+|||++....... ....++..|+|||.+.+..++.++||||||+++++|++ |..||...+..
T Consensus 317 p~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 317 ARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred HhhEEECCCCCEEEeeCCCcccccccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999987543321 22345678999999999889999999999999999998 99999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+. ...+...+..+++++.++|.+||+.||.+|||+.++++.|+++...
T Consensus 394 ~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 394 DVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp THHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 6666554 4455677888999999999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=274.53 Aligned_cols=208 Identities=33% Similarity=0.533 Sum_probs=169.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++|+||+.+++|.+++.... ..+++.++..++.|++.||+|||+.| ++|+||||
T Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp 136 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNS 136 (310)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCST
T ss_pred HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCc
Confidence 467899999999999999999999999999999999998643 23999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccccc--------------CCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--------------KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~--------------~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
+||+++.++.++|+|||.+.......... ....+++.|+|||.+.+..++.++||||+|+++++|+
T Consensus 137 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 216 (310)
T 3s95_A 137 HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216 (310)
T ss_dssp TSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence 99999999999999999987643322111 1446788999999999998999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHH-hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 147 TLQQPWGNLNPAQVVAAV-GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 147 ~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+|..|+............ .........+..+++++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 217 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 217 GRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999988643221100000 000011234567889999999999999999999999999999887654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=266.61 Aligned_cols=206 Identities=26% Similarity=0.514 Sum_probs=176.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp 137 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKP 137 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCG
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCCh
Confidence 367899999999999999999999999999999999998643 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+.
T Consensus 138 ~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 215 (279)
T 3fdn_A 138 ENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215 (279)
T ss_dssp GGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred HhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH
Confidence 9999999999999999987544332 22344678899999999998889999999999999999999999998887777
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
...+.. .....+..++.++.++|.+||+.||.+|||+.++++ +.+++.....+
T Consensus 216 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~~~~~ 268 (279)
T 3fdn_A 216 YKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITANSSKP 268 (279)
T ss_dssp HHHHHH--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHHCSSC
T ss_pred HHHHHh--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCCccCc
Confidence 665532 344567789999999999999999999999999999 67766544433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=281.07 Aligned_cols=209 Identities=29% Similarity=0.489 Sum_probs=178.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
++++||||+++++++.+.+..++||||+.+|+|.+++.... ....+++..++.++.|++.||.|||++| ++|||
T Consensus 129 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrD 206 (367)
T 3l9p_A 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRD 206 (367)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred HhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence 46799999999999999999999999999999999997532 1235899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC---cEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 027225 78 LKSPNLLVDKKY---TVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP 151 (226)
Q Consensus 78 i~p~nil~~~~~---~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p 151 (226)
|||+||+++.++ .++|+|||++....... .......+++.|+|||++.+..++.++|||||||++++|++ |..|
T Consensus 207 lkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 286 (367)
T 3l9p_A 207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286 (367)
T ss_dssp CCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999998555 59999999987533221 22223445778999999988889999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
|...+..+....+. .......+..++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 287 f~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 287 YPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp STTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 99988887777665 44455667789999999999999999999999999999998887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=272.28 Aligned_cols=209 Identities=31% Similarity=0.598 Sum_probs=174.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..++.++.|++.||.+||+.| ++|+||+|+
T Consensus 101 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~ 176 (333)
T 1mqb_A 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAAR 176 (333)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred HhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChh
Confidence 57899999999999999999999999999999999997642 34999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.
T Consensus 177 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999999999999876443211 1122334567999999998889999999999999999998 9999988887
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
.+....+. .......+..++.++.+++.+||+.||.+||++.++++.|+++++....
T Consensus 257 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 257 HEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp HHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HHHHHHHH-CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 77766664 3344556778999999999999999999999999999999998765443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=268.42 Aligned_cols=211 Identities=29% Similarity=0.514 Sum_probs=180.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++ +.+..++|+|++.+++|.+++.... ..+++..++.++.|++.||.+||+.| ++|+||+|+
T Consensus 65 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~ 139 (287)
T 1u59_A 65 HQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAAR 139 (287)
T ss_dssp HHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchh
Confidence 467999999999999 4566999999999999999997532 34999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.
T Consensus 140 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 140 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp GEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred eEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999987643321 11223345678999999988888999999999999999998 9999988877
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
.+....+. .......+..+++++.++|.+||+.||.+||++.++++.|++++.+......
T Consensus 220 ~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 220 PEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHHh-cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 77666554 3445567788999999999999999999999999999999999877655544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=266.25 Aligned_cols=202 Identities=39% Similarity=0.688 Sum_probs=169.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNP-PIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~i~h~di~p 80 (226)
++++||||+++++++.+++..++|+||+++++|.+++... .+++..++.++.|++.||.|||++|. +++|+||+|
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp 136 (271)
T 3dtc_A 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136 (271)
T ss_dssp HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch
Confidence 4579999999999999999999999999999999999753 38999999999999999999999872 277999999
Q ss_pred CcEEEcC--------CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 81 PNLLVDK--------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 81 ~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
+||+++. ++.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus 137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (271)
T 3dtc_A 137 SNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214 (271)
T ss_dssp GGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHEEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999986 6789999999987544332 22446788999999999888999999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
...+.................+..+++++.+++.+||+.||.+|||+.++++.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 215 RGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 998887777777666666777889999999999999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=272.17 Aligned_cols=205 Identities=25% Similarity=0.374 Sum_probs=171.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++|+||||+
T Consensus 60 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~ 134 (323)
T 3tki_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPE 134 (323)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchH
Confidence 46799999999999999999999999999999999998743 3999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++.++.++|+|||.+...... ........+++.|+|||++.+..+ +.++|+||||+++++|++|..||...+..
T Consensus 135 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp GEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred HEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 999999999999999998754322 222335578899999999987764 67899999999999999999999765543
Q ss_pred -HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..................+++++.++|.+||+.||.+|||+.++++ ..++...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~~ 268 (323)
T 3tki_A 215 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNKP 268 (323)
T ss_dssp SHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTCC
T ss_pred HHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhccc
Confidence 2222222233333344678999999999999999999999999998 6776543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=267.27 Aligned_cols=213 Identities=32% Similarity=0.592 Sum_probs=177.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+ +..++|+||+.+++|.+++.... ...+++..+..++.|++.||.+||++| ++|+||+|+
T Consensus 63 ~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~ 138 (279)
T 1qpc_A 63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAA 138 (279)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHh
Confidence 46799999999999874 46899999999999999997632 124899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+
T Consensus 139 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 218 (279)
T 1qpc_A 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (279)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred hEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH
Confidence 9999999999999999987654332 22233445678999999988888999999999999999999 899999888777
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~ 219 (226)
....+. .......+..++.++.+++.+||+.||.+|||+.++++.|++++.....+..|
T Consensus 219 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 219 VIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277 (279)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC------
T ss_pred HHHHHh-cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence 666654 33445567789999999999999999999999999999999998877666554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=281.43 Aligned_cols=204 Identities=23% Similarity=0.375 Sum_probs=176.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||++||+|.+++.+.. +++..++.++.|++.||+|||++| |+||||||+
T Consensus 124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~ 197 (410)
T 3v8s_A 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPD 197 (410)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHH
Confidence 45799999999999999999999999999999999997643 899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+++.+|.+||+|||++....... .......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+
T Consensus 198 NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 198 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred HeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999987654332 2334567899999999998765 6789999999999999999999999988
Q ss_pred HHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCCC--CCCHHHHHHHHHHhhcCC
Q 027225 157 PAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWK--RPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~~~ 213 (226)
..+....+.........+ ..++++++++|.+||+.+|.+ ||+++++++ +.++++.
T Consensus 278 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~~~ 336 (410)
T 3v8s_A 278 LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFKND 336 (410)
T ss_dssp HHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGCCS
T ss_pred hhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc--CccccCC
Confidence 877777665433333333 478999999999999999988 999999999 7777664
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=268.65 Aligned_cols=211 Identities=32% Similarity=0.638 Sum_probs=170.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc---CCCCeEEeCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR---RNPPIVHRDL 78 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~i~h~di 78 (226)
++++||||+++++++.+ ..++||||+++++|.+++........++...++.++.|++.||.|||+ +| ++|+||
T Consensus 56 ~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dl 131 (307)
T 2eva_A 56 SRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDL 131 (307)
T ss_dssp HHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCC
T ss_pred hcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCC
Confidence 46799999999998874 489999999999999999876544568999999999999999999999 78 999999
Q ss_pred CCCcEEEcCCCc-EEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 79 KSPNLLVDKKYT-VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 79 ~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
||+||+++.++. ++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++++|++|+.||.....
T Consensus 132 kp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 132 KPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp SGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred ChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 999999998886 799999998654332 2234578899999999998899999999999999999999999976433
Q ss_pred HH-HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCC
Q 027225 158 AQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219 (226)
Q Consensus 158 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~ 219 (226)
.. ..............+..++..+.+++.+||+.||.+|||+.++++.|+.+.+..+....|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 209 PAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp SHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred cHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 22 122222244455667789999999999999999999999999999999987765544433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=266.35 Aligned_cols=205 Identities=23% Similarity=0.326 Sum_probs=166.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++|+|++.+ +|.+++.... ..+++..+..++.|++.||.|||++| ++|+||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 128 (288)
T 1ob3_A 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKP 128 (288)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 4678999999999999999999999999976 9999987643 23899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............+++.|+|||++.+. .++.++|+||+|+++++|++|..||...+..+
T Consensus 129 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (288)
T 1ob3_A 129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (288)
T ss_dssp GGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999987654433333445678899999999764 47899999999999999999999998877665
Q ss_pred HHHHHhhCCcc---------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKR---------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+...... ......+++++.++|.+||+.||.+|||+.++++ +.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~ 286 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFKE 286 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGGC
T ss_pred HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccchhh
Confidence 54433211000 0122457899999999999999999999999998 677654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=279.63 Aligned_cols=206 Identities=33% Similarity=0.603 Sum_probs=174.3
Q ss_pred CCcCcceeeeEEecCCc-eEEEEeecccCCHHHHhcCCCC----------------------------------------
Q 027225 5 RHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGV---------------------------------------- 43 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~---------------------------------------- 43 (226)
+||||+++++++.+.+. .++|+||+.+|+|.+++.....
T Consensus 84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 78999999999987654 9999999999999999986432
Q ss_pred -----------------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 44 -----------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 44 -----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 241 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 241 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEecccee
Confidence 122899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCC
Q 027225 101 LKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177 (226)
Q Consensus 101 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (226)
...... .......++..|+|||++.+..++.++||||||+++++|++ |..||...+..+..............+..+
T Consensus 242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (359)
T 3vhe_A 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 321 (359)
T ss_dssp CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTC
T ss_pred eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCC
Confidence 543221 12233445678999999998889999999999999999998 999998776555444444455566777889
Q ss_pred CHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 178 ~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
++++.+++.+||+.||.+|||+.++++.|+.++.+
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=286.96 Aligned_cols=208 Identities=35% Similarity=0.619 Sum_probs=180.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++| ++||||||+
T Consensus 271 ~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~ 347 (495)
T 1opk_A 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAAR 347 (495)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChh
Confidence 56899999999999999999999999999999999998643 334899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+
T Consensus 348 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~ 427 (495)
T 1opk_A 348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427 (495)
T ss_dssp GEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred hEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654321 22223344568999999998888999999999999999999 999999888777
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
....+. .......+..+++++.++|.+||+.||.+|||+.++++.|+.++...
T Consensus 428 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 428 VYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred HHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 666554 44456677889999999999999999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=267.23 Aligned_cols=211 Identities=29% Similarity=0.604 Sum_probs=177.7
Q ss_pred CCCCCcCcceeeeEEecCCce-EEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++||||+++++++.+.+.. ++|+||+.+++|.+++.... ..+++..++.++.|++.||+|||++| ++|+||||
T Consensus 77 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp 152 (298)
T 3pls_A 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAA 152 (298)
T ss_dssp HTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred HhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCc
Confidence 578999999999999876655 99999999999999998643 34899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc----cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~ 155 (226)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++| ..||...
T Consensus 153 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp GGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 99999999999999999987543321 222334556789999999998899999999999999999995 5556666
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
+..+....+. .......+..++.++.+++.+||+.||.+|||+.++++.|++++.......
T Consensus 233 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 233 DPFDLTHFLA-QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CHHHHHHHhh-cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 6665555554 444556677899999999999999999999999999999999988765444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=266.95 Aligned_cols=203 Identities=28% Similarity=0.464 Sum_probs=178.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+.+++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||+|+
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ 144 (294)
T 2rku_A 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 144 (294)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChH
Confidence 57899999999999999999999999999999999987643 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||......+..
T Consensus 145 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 224 (294)
T 2rku_A 145 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 224 (294)
T ss_dssp GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred hEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999876554333344556788999999999888899999999999999999999999988877665
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+. ......+..+++++.+++.+||+.||.+|||+.++++ +.++++.
T Consensus 225 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~~ 272 (294)
T 2rku_A 225 LRIK--KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSG 272 (294)
T ss_dssp HHHH--TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTS
T ss_pred HHHh--hccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh--ChheecC
Confidence 5553 3344567789999999999999999999999999999 6666654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=267.20 Aligned_cols=205 Identities=28% Similarity=0.514 Sum_probs=176.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++ +.+..++|+|++.+++|.+++...+ .+++..++.++.|++.||.+||+.| ++|+||+|+
T Consensus 73 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~ 146 (291)
T 1xbb_A 73 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 146 (291)
T ss_dssp HTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcc
Confidence 578999999999999 5667999999999999999998743 3999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.
T Consensus 147 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp GEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred eEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999875433211 1222334578999999988888899999999999999999 9999998888
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.+....+. .......+..+++++.++|.+||+.||.+|||+.++++.|++++...
T Consensus 227 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 227 SEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 77766654 34455667889999999999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=274.80 Aligned_cols=206 Identities=23% Similarity=0.368 Sum_probs=169.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++||||+++++++.+++..|+||||+++++|.+++.+.. ....+++..+..++.||+.||.|||++| ++|+||||
T Consensus 81 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp 158 (351)
T 3c0i_A 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKP 158 (351)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCh
Confidence 46799999999999999999999999999999988876422 1234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCc---EEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++. ++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 159 ~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (351)
T 3c0i_A 159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238 (351)
T ss_dssp GGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH
T ss_pred HHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH
Confidence 9999986654 9999999997765543334456788999999999988899999999999999999999999987543
Q ss_pred HHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+....... .....++.++.++|.+||+.||.+|||+.++++ +.+++.
T Consensus 239 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~~ 292 (351)
T 3c0i_A 239 -RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN--HPWLKE 292 (351)
T ss_dssp -HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHT
T ss_pred -HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--ChhhcC
Confidence 3333332222111 112568999999999999999999999999997 455443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=273.25 Aligned_cols=206 Identities=25% Similarity=0.406 Sum_probs=153.7
Q ss_pred CCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++. ||||+++++++.+++..|+||||+++++|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||||+
T Consensus 61 ~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~ 135 (325)
T 3kn6_A 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPE 135 (325)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHH
Confidence 454 9999999999999999999999999999999998743 4999999999999999999999999 999999999
Q ss_pred cEEEcCCC---cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-
Q 027225 82 NLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP- 157 (226)
Q Consensus 82 nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~- 157 (226)
||+++.++ .++|+|||++..............+++.|+|||++.+..++.++|+||+|+++++|++|..||...+.
T Consensus 136 NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 215 (325)
T 3kn6_A 136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215 (325)
T ss_dssp GEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----
T ss_pred HEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 99998766 89999999987655444444455678899999999998899999999999999999999999976432
Q ss_pred ------HHHHHHHhhCCccCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 158 ------AQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 158 ------~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
.+....+. ......+ ..+++++.++|.+||+.||.+|||+.++++ +++++.....+
T Consensus 216 ~~~~~~~~~~~~i~--~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~~~~~~ 281 (325)
T 3kn6_A 216 LTCTSAVEIMKKIK--KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQDGSQLS 281 (325)
T ss_dssp --CCCHHHHHHHHT--TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCTTCCCC
T ss_pred cccccHHHHHHHHH--cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--ChhhccCccCC
Confidence 33344442 2222222 358999999999999999999999999998 78887654433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=272.82 Aligned_cols=211 Identities=33% Similarity=0.553 Sum_probs=177.1
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC---------------CCcCCHHHHHHHHHHHHHHHHH
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------REMLDERRRLNMAYDVAKGMNY 65 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~ 65 (226)
+++ +||||+++++++.+++..++|+||+++++|.+++..... ...+++..++.++.|++.||.|
T Consensus 81 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 160 (313)
T 1t46_A 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (313)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred hhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 345 899999999999999999999999999999999976432 1248999999999999999999
Q ss_pred HhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHH
Q 027225 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILW 143 (226)
Q Consensus 66 lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 143 (226)
||++| ++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||++++
T Consensus 161 lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 238 (313)
T 1t46_A 161 LASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (313)
T ss_dssp HHHTT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHCC--eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHH
Confidence 99999 99999999999999999999999999876443321 122334456899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 144 ELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 144 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
+|++ |..||.....................+..++.++.++|.+||+.||.+|||+.++++.|++++.+..
T Consensus 239 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 9998 9999987665444333333344445567889999999999999999999999999999999887643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=276.63 Aligned_cols=210 Identities=15% Similarity=0.263 Sum_probs=169.9
Q ss_pred CCCCCcCcceeeeEEecC----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 2 KRLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
++++||||+++++++.+. ...++||||+ +++|.+++...+ ..+++..++.++.|++.||.|||+.| ++|||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrD 177 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE--YVHGD 177 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEec
Confidence 568999999999999764 4589999999 999999998642 34999999999999999999999999 99999
Q ss_pred CCCCcEEEc--CCCcEEEccCCCcccccccccc-------cCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q 027225 78 LKSPNLLVD--KKYTVKVCDFGLSRLKANTFLS-------SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 78 i~p~nil~~--~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 148 (226)
|||+||+++ .++.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 178 lkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 257 (364)
T 3op5_A 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257 (364)
T ss_dssp CCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999 8899999999999754432211 1233488899999999999899999999999999999999
Q ss_pred CCCCCCCCHH-HHHHHHhhC--Ccc------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 149 QQPWGNLNPA-QVVAAVGFK--GKR------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 149 ~~p~~~~~~~-~~~~~~~~~--~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
..||...... ......... ... ......++.++.+++..||+.+|.+||++.++++.|+++++.....
T Consensus 258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 9999753222 211111100 000 0112578999999999999999999999999999999998765443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=265.75 Aligned_cols=202 Identities=27% Similarity=0.505 Sum_probs=176.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+++++|.+++...+ .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 69 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ 143 (284)
T 2vgo_A 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK--VIHRDIKPE 143 (284)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGG
T ss_pred hcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHH
Confidence 57899999999999999999999999999999999998643 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+..
T Consensus 144 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 221 (284)
T 2vgo_A 144 NLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221 (284)
T ss_dssp GEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred HEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH
Confidence 999999999999999988654432 223456788999999999988899999999999999999999999988776665
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
..+. ......+..++.++.++|.+||+.||.+|||+.++++ +.+++...
T Consensus 222 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~~~ 270 (284)
T 2vgo_A 222 RRIV--NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKANS 270 (284)
T ss_dssp HHHH--TTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHHHC
T ss_pred HHHh--ccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHhhc
Confidence 5553 3344567789999999999999999999999999998 56655443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=274.53 Aligned_cols=206 Identities=24% Similarity=0.417 Sum_probs=175.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||||
T Consensus 102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp 177 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKP 177 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccch
Confidence 467899999999999999999999999999999999997643 24899999999999999999999999 99999999
Q ss_pred CcEEEcC--CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++. ++.++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..
T Consensus 178 ~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 178 ENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp GGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred HHeEEecCCCCceEEEecccceecCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 9999974 5689999999987654321 122346788999999999988999999999999999999999999988877
Q ss_pred HHHHHHhhCCcc--CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+....+...... ......+++++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 257 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 311 (387)
T 1kob_A 257 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLKGD 311 (387)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTSSC
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--CccccCC
Confidence 766655433322 2234578999999999999999999999999998 6676654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=272.19 Aligned_cols=203 Identities=28% Similarity=0.460 Sum_probs=178.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..++.++.|++.||.|||++| ++|+||+|+
T Consensus 96 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~ 170 (335)
T 2owb_A 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 170 (335)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCch
Confidence 57899999999999999999999999999999999987643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||......+..
T Consensus 171 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 250 (335)
T 2owb_A 171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 250 (335)
T ss_dssp GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred hEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 99999999999999999876554433344566788999999999888899999999999999999999999988776665
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+.. .....+..+++++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 251 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~~ 298 (335)
T 2owb_A 251 LRIKK--NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSG 298 (335)
T ss_dssp HHHHH--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTS
T ss_pred HHHhc--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccCC
Confidence 55532 334567789999999999999999999999999998 6666653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=269.24 Aligned_cols=207 Identities=35% Similarity=0.626 Sum_probs=179.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+.+++|.+++.... ...+++..++.++.|++.||.+||+.| ++|+||+|+
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~ 140 (288)
T 3kfa_A 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAAR 140 (288)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGG
T ss_pred HhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcc
Confidence 56899999999999999999999999999999999998644 345899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+
T Consensus 141 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~ 220 (288)
T 3kfa_A 141 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220 (288)
T ss_dssp GEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred eEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987644322 12223334567999999998889999999999999999999 999998887776
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
...... .......+..+++.+.+++.+||..||.+|||+.++++.|++++.+
T Consensus 221 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 221 VYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHh-ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 666554 3445566788999999999999999999999999999999988764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=272.25 Aligned_cols=209 Identities=31% Similarity=0.580 Sum_probs=179.1
Q ss_pred CC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHhc
Q 027225 3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR 68 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~ 68 (226)
++ +||||+++++++.+.+..++|+||+.+++|.+++..... ...+++..++.++.|++.||.|||+
T Consensus 96 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 175 (334)
T 2pvf_A 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175 (334)
T ss_dssp HHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 45 899999999999999999999999999999999986432 1248999999999999999999999
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
.| ++|+||||+||+++.++.++|+|||.+....... .......++..|+|||++.+..++.++|+||||+++++|+
T Consensus 176 ~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 253 (334)
T 2pvf_A 176 QK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253 (334)
T ss_dssp TT--EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CC--eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHH
Confidence 99 9999999999999999999999999987544322 1223334567899999998888899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 147 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
+ |..||...+..+....+.. ......+..++.++.++|.+||+.||.+|||+.++++.|+++++...
T Consensus 254 t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 254 TLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp TTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hCCCCCcCcCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 9 9999998887776665543 33455677899999999999999999999999999999999976544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=275.22 Aligned_cols=211 Identities=30% Similarity=0.550 Sum_probs=169.8
Q ss_pred CCCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+ ++..++|+||+.+++|.+++.+.+ ..+++..++.++.|++.||.|||++| ++|||||
T Consensus 144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlk 219 (373)
T 3c1x_A 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLA 219 (373)
T ss_dssp STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccc
Confidence 578899999999998754 567899999999999999997643 23889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN 154 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~ 154 (226)
|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 220 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 220 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp GGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred hheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 9999999999999999999875432211 1123345668999999998889999999999999999999 6778877
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
.+..+....+. .......+..++.++.+++.+||+.||.+|||+.++++.|++++......
T Consensus 300 ~~~~~~~~~~~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 300 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp SCSSCHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 66555554443 34445567789999999999999999999999999999999998776544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=276.25 Aligned_cols=202 Identities=28% Similarity=0.510 Sum_probs=171.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+||+ +|+|.+++...+ .+++..++.++.|++.||.|||+.| ++||||||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp 136 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKP 136 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCST
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCch
Confidence 46789999999999999999999999999 679998887643 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||++...... .......+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||.......
T Consensus 137 ~NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 137 ENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp TTEEECTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred hhEEEcCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 9999999999999999998765433 22345568899999999988765 689999999999999999999997654433
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
....+ .......+..+++++.++|.+||+.||.+|||+.++++ ..+++..
T Consensus 216 ~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~~ 265 (336)
T 3h4j_B 216 LFKKV--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFNVN 265 (336)
T ss_dssp CBCCC--CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHHTT
T ss_pred HHHHH--HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh--ChhhccC
Confidence 22211 23344567789999999999999999999999999999 6776653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=271.55 Aligned_cols=206 Identities=28% Similarity=0.444 Sum_probs=165.4
Q ss_pred CCCCCCcCcceeeeEEecCCc----eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-------
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR------- 69 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~------- 69 (226)
|++++||||+++++++.+... .++||||+++|+|.+++.... +++..+..++.|++.||.|||+.
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~ 147 (322)
T 3soc_A 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDG 147 (322)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTE
T ss_pred HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccc
Confidence 578899999999999987543 799999999999999997643 89999999999999999999999
Q ss_pred ---CCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCC-----CCCCchhHHHHH
Q 027225 70 ---NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFG 139 (226)
Q Consensus 70 ---~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG 139 (226)
| ++|+||||+||+++.++.+||+|||.+........ ......+++.|+|||++.+. .++.++||||||
T Consensus 148 ~~~~--ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 148 HKPA--ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp EECE--EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred cCCC--EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 9 99999999999999999999999999876443322 22335678999999999874 345678999999
Q ss_pred HHHHHHHhCCCCCCCCC----------------HHHHHHHHhhCCccCCCCC-----CCCHHHHHHHHHHcccCCCCCCC
Q 027225 140 VILWELATLQQPWGNLN----------------PAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 140 ~~l~~l~~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps 198 (226)
+++|+|++|+.||.... .................+. ..+.++.++|.+||+.||.+|||
T Consensus 226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC
Confidence 99999999999986432 2222222222222222222 12356999999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 027225 199 FSTIMELLRPLIKS 212 (226)
Q Consensus 199 ~~~~l~~l~~~~~~ 212 (226)
+.++++.|+++.+.
T Consensus 306 ~~ell~~L~~l~~~ 319 (322)
T 3soc_A 306 AGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=270.53 Aligned_cols=208 Identities=33% Similarity=0.560 Sum_probs=178.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------VREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
|++++||||+++++++.+.+..++||||+.+++|.+++...+ ....+++..++.++.|++.||.+||++| +
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i 159 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--F 159 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence 467899999999999999999999999999999999987521 1134799999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ 150 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~ 150 (226)
+|+||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 160 ~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 239 (322)
T 1p4o_A 160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239 (322)
T ss_dssp BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred ccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999987543322 12223345678999999988889999999999999999999 899
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
||...+..+....+. .......+..++.++.++|.+||+.||.+|||+.++++.|++.+.
T Consensus 240 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 240 PYQGLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ccccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 999888777666654 334455677899999999999999999999999999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=266.75 Aligned_cols=209 Identities=23% Similarity=0.316 Sum_probs=172.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
|++++||||+++++++.+++..++|+||+. ++|.+++.... ....+++..+..++.|++.||.|||+.| ++|+|
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~D 133 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRD 133 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCC
Confidence 467899999999999999999999999997 59999886421 1234899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|||+||+++.++.++|+|||.+..............+++.|+|||++.+. .++.++|+||||+++++|++|..||...+
T Consensus 134 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 134 LKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987655443334455678899999999764 57899999999999999999999998887
Q ss_pred HHHHHHHHhhCCc--------------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 157 PAQVVAAVGFKGK--------------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 157 ~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+....+..... ....+..++.++.++|.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 7665544321100 00112357889999999999999999999999998
Q ss_pred HHHHhhcCCC
Q 027225 205 LLRPLIKSPT 214 (226)
Q Consensus 205 ~l~~~~~~~~ 214 (226)
..+++...
T Consensus 294 --hp~f~~~~ 301 (317)
T 2pmi_A 294 --HPWFAEYY 301 (317)
T ss_dssp --SGGGGGGC
T ss_pred --Chhhhccc
Confidence 66666543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=262.57 Aligned_cols=202 Identities=37% Similarity=0.716 Sum_probs=170.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.. ++|+||+.+++|.+++.+.. ..+++..+..++.|++.||+|||+.|.+++|+||||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp 152 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS 152 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSG
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCc
Confidence 36789999999999997654 79999999999999886543 349999999999999999999999886799999999
Q ss_pred CcEEEcCCCc-----EEEccCCCcccccccccccCCCCCCCCccCccccc--CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 81 PNLLVDKKYT-----VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 81 ~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
+||+++.++. ++|+|||.+...... .....+++.|+|||.+. ...++.++|+||+|+++++|++|..||.
T Consensus 153 ~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 153 PNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp GGEEESCCCTTCSCCEEECCCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ceEEEeccCCCCceeEEeCCCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999988776 999999998754432 33456788999999984 4446789999999999999999999997
Q ss_pred CCCHHHH--HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 154 NLNPAQV--VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 154 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
..+.... .............+..+++++.++|.+||+.||.+|||+.++++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 6554333 4444445556677888999999999999999999999999999999764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=266.88 Aligned_cols=211 Identities=31% Similarity=0.549 Sum_probs=175.4
Q ss_pred CCCCCCcCcceeeeEEe-cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++. .++..++|+||+.+++|.+++.+.. ..+++..++.++.|++.||.+||++| ++|+|||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dik 155 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLA 155 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCc
Confidence 35789999999999864 5567899999999999999997643 34899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN 154 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~ 154 (226)
|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||..
T Consensus 156 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 156 ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999875443221 1223345668999999998889999999999999999999 5667776
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
.+..+...... .......+..++.++.+++.+||+.||.+|||+.++++.|++++......
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 236 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp SCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred CCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 66555554443 34445557788999999999999999999999999999999998876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=271.36 Aligned_cols=205 Identities=27% Similarity=0.526 Sum_probs=175.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.. .++|+|++.+|+|.+++.... ..+++..++.++.|++.||.|||++| ++||||||+
T Consensus 72 ~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~ 146 (327)
T 3poz_A 72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAAR 146 (327)
T ss_dssp HHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred HhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChh
Confidence 4689999999999998754 889999999999999998643 24999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++++|++ |..||...+..
T Consensus 147 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 226 (327)
T 3poz_A 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp GEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred eEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence 99999999999999999876443222 1223344668999999999889999999999999999999 99999988777
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+...... .......+..++.++.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 227 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 227 EISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GHHHHHH-TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 6666554 3445566778999999999999999999999999999999988764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=272.44 Aligned_cols=196 Identities=23% Similarity=0.384 Sum_probs=167.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..|+|+||+.||+|.+++.+.+ .+++..+..++.||+.||.|||+.| |+||||||
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp 143 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR--IIHRDMKP 143 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcH
Confidence 357899999999999999999999999999999999998743 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNLN- 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~- 156 (226)
+||+++.+|.++|+|||++...... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+
T Consensus 144 ~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 144 DNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred HHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999998765432 23345678999999999874 347889999999999999999999996432
Q ss_pred --HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-HHHHHH
Q 027225 157 --PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-FSTIME 204 (226)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~l~ 204 (226)
..+....+ .......+..++.++.++|.+||+.||.+||+ ++++++
T Consensus 223 ~~~~~~~~~~--~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 223 TSSKEIVHTF--ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccHHHHHHHH--hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 33333333 33455667889999999999999999999998 777775
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=270.01 Aligned_cols=206 Identities=28% Similarity=0.534 Sum_probs=172.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.... .++|+|++.+++|.+++.... ..+++..++.++.|++.||.|||++| ++|+||||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp 145 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCH
Confidence 46789999999999998765 889999999999999997643 24999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 146 ~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred HHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 999999999999999999876433221 1223344668999999999889999999999999999999 9999998887
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+. .......+..++.++.++|.+||..||.+|||+.++++.|+++...
T Consensus 226 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 226 SEISSILE-KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GGHHHHHH-TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 77666554 4445566778999999999999999999999999999999988754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=267.20 Aligned_cols=213 Identities=18% Similarity=0.273 Sum_probs=167.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp 162 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKP 162 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCCh
Confidence 467899999999999999999999999999999999998643 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++|..||...+...
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (309)
T 2h34_A 163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242 (309)
T ss_dssp GGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred HHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence 99999999999999999886544332 22234467889999999998888999999999999999999999998876654
Q ss_pred HHHHHhhCCc-cCCCCCCCCHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHhhcCCCCCCC
Q 027225 160 VVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRP-SFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 160 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~~~~~~~~~ 218 (226)
....+..... ....+..++.++.++|.+||+.||.+|| +++++++.|++++........
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~ 303 (309)
T 2h34_A 243 MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303 (309)
T ss_dssp HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-------
T ss_pred HHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccch
Confidence 4444432222 2245677899999999999999999999 999999999999887654443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=267.62 Aligned_cols=209 Identities=23% Similarity=0.370 Sum_probs=168.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+.+ +|.+++...+ ..+++..+..++.|++.||.|||+.| ++|+||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp 128 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKP 128 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCG
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCH
Confidence 4678999999999999999999999999975 8988887643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.++|+|||.+..............++..|+|||++.+ ..++.++|+||+|+++++|++|..||...+..+
T Consensus 129 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 129 QNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp GGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999998765544333445567889999999876 457899999999999999999999999888766
Q ss_pred HHHHHhhCCccC----------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 VVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
....+....... .....+++++.++|.+||+.||.+|||++++++ ..++.
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~ 286 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK--HPFFL 286 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGG
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc--Chhhh
Confidence 554443211110 012357889999999999999999999999999 77776
Q ss_pred CCCCC
Q 027225 212 SPTPQ 216 (226)
Q Consensus 212 ~~~~~ 216 (226)
+....
T Consensus 287 ~~~~~ 291 (324)
T 3mtl_A 287 SLGER 291 (324)
T ss_dssp GGCST
T ss_pred hcccc
Confidence 65443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=266.84 Aligned_cols=206 Identities=33% Similarity=0.521 Sum_probs=170.8
Q ss_pred CCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++++||||+++++++.+. ...++|+||+.+++|.+++.... ..+++..++.++.|++.||++||++| ++|+|||
T Consensus 78 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dik 153 (302)
T 4e5w_A 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA 153 (302)
T ss_dssp HTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred HhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCc
Confidence 578999999999999876 66899999999999999996532 23999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL- 155 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~- 155 (226)
|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++|..|+...
T Consensus 154 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 999999999999999999987654332 2233455677799999998888889999999999999999998875321
Q ss_pred -------------CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 156 -------------NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 156 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
..................+..+++++.++|.+||+.||.+|||+.++++.|+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 11112222222444556678899999999999999999999999999999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=268.51 Aligned_cols=209 Identities=31% Similarity=0.497 Sum_probs=168.6
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++.. ....++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Di 140 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDL 140 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCC
Confidence 357899999999999854 356999999999999999997643 24899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||+|+++++|++|..|+...
T Consensus 141 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 141 ATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp SGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred CHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 99999999999999999999876443221 122334456799999999888999999999999999999999988643
Q ss_pred CHHH---------------HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 NPAQ---------------VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.... ..............+..+++++.+++.+||+.||.+|||+.++++.|+++....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 221 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 2211 111111234455667889999999999999999999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=270.34 Aligned_cols=209 Identities=22% Similarity=0.281 Sum_probs=173.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||||+
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 141 (346)
T 1ua2_A 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPN 141 (346)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred hhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHH
Confidence 467899999999999999999999999986 8988887643 34889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.++|+|||.+..............+++.|+|||++.+. .++.++|+||||+++++|++|..||...+..+.
T Consensus 142 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~ 221 (346)
T 1ua2_A 142 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 221 (346)
T ss_dssp GEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999999999987665444444556778999999998764 478899999999999999999999988777665
Q ss_pred HHHHhhCCccCC--------------------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 161 VAAVGFKGKRLE--------------------------IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 161 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
...+........ ....++.++.++|.+||+.||.+|||+.++++ ..+++..+
T Consensus 222 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~~~ 299 (346)
T 1ua2_A 222 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNRP 299 (346)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSSS
T ss_pred HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--ChhhhcCC
Confidence 544322111000 01456789999999999999999999999999 78887755
Q ss_pred CCC
Q 027225 215 PQP 217 (226)
Q Consensus 215 ~~~ 217 (226)
.+.
T Consensus 300 ~~~ 302 (346)
T 1ua2_A 300 GPT 302 (346)
T ss_dssp CCC
T ss_pred CCC
Confidence 443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=272.72 Aligned_cols=204 Identities=26% Similarity=0.374 Sum_probs=172.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||||
T Consensus 140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 215 (373)
T 2x4f_A 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKP 215 (373)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCH
Confidence 467899999999999999999999999999999999886532 24899999999999999999999999 99999999
Q ss_pred CcEEE--cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLV--DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||++ +.++.++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++++|++|..||...+..
T Consensus 216 ~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 294 (373)
T 2x4f_A 216 ENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294 (373)
T ss_dssp GGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred HHEEEecCCCCcEEEEeCCCceecCCcc-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999 567789999999987654332 233456788999999999888899999999999999999999999988877
Q ss_pred HHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+....+....... .....+++++.++|.+||+.||.+|||+.++++ ..+++
T Consensus 295 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~--hp~~~ 347 (373)
T 2x4f_A 295 ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK--HPWLS 347 (373)
T ss_dssp HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred HHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcCcC
Confidence 7666554332221 223578999999999999999999999999998 44443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=276.92 Aligned_cols=205 Identities=23% Similarity=0.311 Sum_probs=172.5
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||+.||+|.+++.+.+ ..+++..++.++.|++.||+|||++| |+||||||+
T Consensus 116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~ 191 (412)
T 2vd5_A 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPD 191 (412)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHH
Confidence 35789999999999999999999999999999999997643 24999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCccccc-------CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR-------DEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||+++.++.+||+|||++........ ......+++.|+|||++. +..++.++|+|||||++|+|++|+.||.
T Consensus 192 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 99999999999999999876543322 233457899999999987 3457899999999999999999999999
Q ss_pred CCCHHHHHHHHhhCCccCC---CCCCCCHHHHHHHHHHcccCCCCC---CCHHHHHHHHHHhhcCC
Q 027225 154 NLNPAQVVAAVGFKGKRLE---IPRNVNPHVASIIEACWANEPWKR---PSFSTIMELLRPLIKSP 213 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R---ps~~~~l~~l~~~~~~~ 213 (226)
..+..+....+........ .+..++++++++|.+||. +|.+| |+++++++ +.++++.
T Consensus 272 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~~i 334 (412)
T 2vd5_A 272 ADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFFGL 334 (412)
T ss_dssp CSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGTTC
T ss_pred CCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcCCC
Confidence 8888777666543222222 236799999999999999 99998 58999988 7777654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=267.90 Aligned_cols=210 Identities=30% Similarity=0.519 Sum_probs=171.8
Q ss_pred CCCCCcCcceeeeEEecCC-----ceEEEEeecccCCHHHHhcCC---CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 2 KRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKP---GVREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
++++||||+++++++.+.+ ..++|+||+.+++|.+++... .....+++..++.++.|++.||.|||+.| +
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i 168 (313)
T 3brb_A 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--F 168 (313)
T ss_dssp HTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--C
T ss_pred hcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 5789999999999998754 359999999999999998432 12345999999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ 150 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~ 150 (226)
+|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 169 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 248 (313)
T 3brb_A 169 LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248 (313)
T ss_dssp CCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999987543321 12223445678999999999889999999999999999999 889
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
||...+..+...... .......+..+++++.++|.+||+.||.+|||+.++++.|++++...+
T Consensus 249 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 249 PYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp SSTTCCGGGHHHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCccCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 998877766665554 344556678899999999999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=263.52 Aligned_cols=207 Identities=35% Similarity=0.644 Sum_probs=161.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++ ..+..++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||||
T Consensus 74 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp 148 (289)
T 3og7_A 74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKS 148 (289)
T ss_dssp HTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 4688999999999965 4566899999999999999997543 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.++|+|||.+...... ........++..|+|||.+. +..++.++|+||||+++++|++|..||...
T Consensus 149 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 149 NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp GGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 9999999999999999998654321 12223446788999999986 555778999999999999999999999875
Q ss_pred CHHH-HHHHHhhCCc---cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 156 NPAQ-VVAAVGFKGK---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 156 ~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+..+ .......... .......+++++.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 229 NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp CCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred chHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 5443 3333322221 1223457889999999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=278.61 Aligned_cols=206 Identities=21% Similarity=0.341 Sum_probs=176.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||++++++|.+++..|+||||+.+|+|.+++.+.. ..+++..++.++.|++.||.|||+.| |+||||||+
T Consensus 129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~ 204 (437)
T 4aw2_A 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPD 204 (437)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHH
Confidence 45789999999999999999999999999999999998632 24999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++.+||+|||++....... .......+++.|+|||++. ...++.++|+||+|+++|+|++|+.||...
T Consensus 205 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred HeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999986544332 2233457899999999987 455789999999999999999999999998
Q ss_pred CHHHHHHHHhhCCccCCCC---CCCCHHHHHHHHHHcccCCCC--CCCHHHHHHHHHHhhcCC
Q 027225 156 NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWK--RPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~~~ 213 (226)
+..+....+........++ ..+++++.+||++||..+|++ |++++++++ +.++++.
T Consensus 285 ~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~~i 345 (437)
T 4aw2_A 285 SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFSGI 345 (437)
T ss_dssp SHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGTTC
T ss_pred ChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccCCC
Confidence 8877776664333333333 458999999999999888888 999999998 7787653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=272.73 Aligned_cols=205 Identities=21% Similarity=0.284 Sum_probs=167.4
Q ss_pred CCCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 2 KRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
++++||||+++++++.+ ....|+||||+ +++|.+++...+ .+++..++.++.|++.||.|||+.| ++|+|
T Consensus 103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~D 176 (345)
T 2v62_A 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGD 176 (345)
T ss_dssp HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence 46799999999999987 67899999999 899999998744 4999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC--cEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q 027225 78 LKSPNLLVDKKY--TVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 78 i~p~nil~~~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 148 (226)
|||+||+++.++ .++|+|||.+........ ......++..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999877 999999999875432211 11345678899999999998899999999999999999999
Q ss_pred CCCCCC--CCHHHHHHHHhhCCccC-------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 149 QQPWGN--LNPAQVVAAVGFKGKRL-------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 149 ~~p~~~--~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..||.. .+............... .....++.++.++|.+||+.||.+|||++++++.|+++...
T Consensus 257 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 257 KLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp SCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred CCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 999954 22222222111110100 01227899999999999999999999999999999876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=288.18 Aligned_cols=215 Identities=35% Similarity=0.590 Sum_probs=184.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+ +..++||||+.+|+|.+++.... ...+++.+++.++.||+.||+|||++| ++||||+|
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp 391 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRA 391 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCH
Confidence 356899999999999976 67999999999999999997532 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 392 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 392 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp GGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred hhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654321 11223344668999999988889999999999999999999 89999988887
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPT 220 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~ 220 (226)
+....+. ...+...+..++.++.++|.+||+.||++|||+++|++.|++++....++..+.
T Consensus 472 ~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~ 532 (535)
T 2h8h_A 472 EVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532 (535)
T ss_dssp HHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC-
T ss_pred HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCcc
Confidence 7776664 444556678899999999999999999999999999999999999988877654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=267.43 Aligned_cols=214 Identities=31% Similarity=0.537 Sum_probs=170.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+.+..++|+||+.+++|.+++...+ ..+++..++.++.|++.||.|||+.| ++|+||+|
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp 158 (319)
T 2y4i_B 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKS 158 (319)
T ss_dssp GTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCS
T ss_pred HhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCh
Confidence 467899999999999999999999999999999999998743 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc-----ccccCCCCCCCCccCcccccC---------CCCCCchhHHHHHHHHHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT-----FLSSKSAAGTPEWMAPEVLRD---------EPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~---------~~~~~~~Dv~slG~~l~~l~ 146 (226)
+||+++ ++.++|+|||.+...... ........++..|+|||.+.+ ..++.++|+||||+++++|+
T Consensus 159 ~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 159 KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp TTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred hhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 999998 679999999987653221 112223446778999999875 34678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCC
Q 027225 147 TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 219 (226)
Q Consensus 147 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~ 219 (226)
+|..||...+.................+..++.++.+++.+||..||.+|||+.++++.|+++.+.....+.|
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~ 310 (319)
T 2y4i_B 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310 (319)
T ss_dssp HSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred hCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence 9999999888877766665443333334568899999999999999999999999999999998876665554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=270.62 Aligned_cols=212 Identities=27% Similarity=0.455 Sum_probs=170.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+.+..++|+||+.+++|.+++..... ...+++..++.++.|++.||.|||++| ++|+|||
T Consensus 89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlk 166 (321)
T 2qkw_B 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVK 166 (321)
T ss_dssp GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCC
Confidence 4678999999999999999999999999999999999976432 235899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|+.||.....
T Consensus 167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 9999999999999999999875432211 12233467899999999888899999999999999999999999865433
Q ss_pred HHHHH------HHhhCCc-----cC----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 158 AQVVA------AVGFKGK-----RL----EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 158 ~~~~~------~~~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.+... ....... .. ..+...+..+.+++.+||+.||++|||+.++++.|+.+++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 21110 0000000 01 1122345679999999999999999999999999999887543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=269.17 Aligned_cols=201 Identities=25% Similarity=0.462 Sum_probs=169.4
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+++..|+||||+.||+|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||||+||+
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl 148 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNIL 148 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEE
Confidence 79999999999999999999999999999999998744 4999999999999999999999999 999999999999
Q ss_pred EcCC----CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC---CCH
Q 027225 85 VDKK----YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---LNP 157 (226)
Q Consensus 85 ~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~---~~~ 157 (226)
+.++ +.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||.. .+.
T Consensus 149 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 228 (342)
T 2qr7_A 149 YVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228 (342)
T ss_dssp ESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH
T ss_pred EecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH
Confidence 8543 359999999997655444444556778999999999887788899999999999999999999975 344
Q ss_pred HHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+....... ..+..+++++.++|.+||..||.+|||+.++++ +.++..
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~~ 283 (342)
T 2qr7_A 229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWIVH 283 (342)
T ss_dssp HHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHT
T ss_pred HHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCeecC
Confidence 55555554332222 234678999999999999999999999999998 555543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=286.29 Aligned_cols=209 Identities=29% Similarity=0.515 Sum_probs=177.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.. +..++||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++| ++||||||
T Consensus 390 l~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp 464 (613)
T 2ozo_A 390 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAA 464 (613)
T ss_dssp HTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred HHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCH
Confidence 467899999999999986 56999999999999999997542 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.+||+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+
T Consensus 465 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp GGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred HHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999999876432211 1122234568999999998889999999999999999998 999999888
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
..+....+. .......+..+++++.++|.+||+.||.+||++.++++.|+.++.....
T Consensus 545 ~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 545 GPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp SHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 777776664 4456677888999999999999999999999999999999998665443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=263.86 Aligned_cols=207 Identities=17% Similarity=0.232 Sum_probs=172.5
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+|+|++++++++.+....++|+||+ +++|.+++...+ ..+++..+..++.|++.||+|||++| ++|+||||+||+
T Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 138 (298)
T 1csn_A 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFL 138 (298)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEE
T ss_pred cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEE
Confidence 7999999999999999999999999 899999998643 23999999999999999999999999 999999999999
Q ss_pred EcCCCc-----EEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 85 VDKKYT-----VKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 85 ~~~~~~-----~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
++.++. ++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||
T Consensus 139 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 139 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence 987765 99999999876543322 123456788999999999988999999999999999999999999
Q ss_pred CCCC---HHHHHHHHhhC---CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 153 GNLN---PAQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 153 ~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
...+ ..+....+... .........+++++.+++.+||+.||.+|||+.++++.|++++......
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 219 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp SSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred chhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 7743 33333222211 1122234578999999999999999999999999999999998765544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=267.96 Aligned_cols=207 Identities=25% Similarity=0.430 Sum_probs=168.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+.+++|.+++...+ ..+++..+..++.|++.||.|||++| ++|+||||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp 141 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCA 141 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCc
Confidence 357899999999999999999999999999999999998643 23899999999999999999999999 99999999
Q ss_pred CcEEEcCCCc--------EEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhC-CC
Q 027225 81 PNLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATL-QQ 150 (226)
Q Consensus 81 ~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g-~~ 150 (226)
+||+++.++. ++|+|||.+....... ...++..|+|||.+.+ ..++.++|+||+|+++++|++| ..
T Consensus 142 ~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp GGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEecCCcccccccceeeeccCcccccccCcc----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 9999998887 9999999886543321 1234567999999987 6688999999999999999995 55
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
|+...+......... .....+...++++.+++.+||+.||.+|||+.++++.|++++......+.
T Consensus 218 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~ 282 (289)
T 4fvq_A 218 PLSALDSQRKLQFYE---DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282 (289)
T ss_dssp TTTTSCHHHHHHHHH---TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred CccccchHHHHHHhh---ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence 666655554444332 34445667788999999999999999999999999999999887665543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=267.10 Aligned_cols=211 Identities=25% Similarity=0.426 Sum_probs=166.2
Q ss_pred CCCCCCcCcceeeeEEecCCc----eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
+++++||||+++++++..... .|+||||+++++|.+++...+ .+++..++.++.|++.||+|||++| ++|+
T Consensus 66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~ 140 (311)
T 3ork_A 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG--IIHR 140 (311)
T ss_dssp CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCC
T ss_pred HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCcC
Confidence 568899999999999976654 499999999999999998643 4999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus 141 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp CCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999987544321 12233457889999999999889999999999999999999999999
Q ss_pred CCCHHHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH-HHHHHhhcCCCCC
Q 027225 154 NLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIM-ELLRPLIKSPTPQ 216 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l-~~l~~~~~~~~~~ 216 (226)
..+..+............ .....++.++.++|.+||+.||.+||+..+++ ..+.+.....++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~ 286 (311)
T 3ork_A 221 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286 (311)
T ss_dssp CSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCS
T ss_pred CCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCC
Confidence 888766655443332221 12356899999999999999999998665554 5555555544433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=266.94 Aligned_cols=215 Identities=24% Similarity=0.441 Sum_probs=165.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++||||+++++++.+++..++|+||+.+++|.+++.... ....+++..++.++.|++.||.+||+.| ++|+||+|
T Consensus 87 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p 164 (310)
T 2wqm_A 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKP 164 (310)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred HhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcH
Confidence 57899999999999999999999999999999999987421 1334899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--PA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~ 158 (226)
+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||.... ..
T Consensus 165 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 244 (310)
T 2wqm_A 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244 (310)
T ss_dssp GGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH
T ss_pred HHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH
Confidence 9999999999999999998765443333344567889999999998889999999999999999999999996543 33
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 218 (226)
.....+............++.++.+++.+||+.||.+|||+.++++.|+++......+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp HHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred HHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 333333322222223467899999999999999999999999999999998776555544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=274.85 Aligned_cols=207 Identities=26% Similarity=0.379 Sum_probs=165.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+|+||+.+++|.+++.... ...+++..+..++.||+.||.|||++| ++||||||+
T Consensus 81 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~ 157 (389)
T 3gni_B 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKAS 157 (389)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 56899999999999999999999999999999999997643 234999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-------cccCCCCCCCCccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||+++.++.++|+|||.+....... .......++..|+|||++.+ ..++.++|+|||||++++|++|..||
T Consensus 158 NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp GEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999875432211 11223456788999999987 56889999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCC--------------------------------------------ccCCCCCCCCHHHHHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKG--------------------------------------------KRLEIPRNVNPHVASIIEAC 188 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~li~~~ 188 (226)
...+..+......... .....+..+++++.+||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp TTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 7655433332211000 01123456789999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 189 WANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 189 l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
|+.||.+|||+.++++ +.+++..
T Consensus 318 L~~dP~~Rpta~ell~--hp~f~~~ 340 (389)
T 3gni_B 318 LQRNPDARPSASTLLN--HSFFKQI 340 (389)
T ss_dssp TCSCTTTSCCHHHHTT--SGGGGGC
T ss_pred hhcCcccCCCHHHHhc--CHHHHHH
Confidence 9999999999999998 5666543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=270.87 Aligned_cols=203 Identities=30% Similarity=0.491 Sum_probs=159.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..++.++.|++.||.|||++| ++||||||+
T Consensus 71 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~ 145 (361)
T 3uc3_A 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLE 145 (361)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGG
T ss_pred HhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence 46799999999999999999999999999999999997643 3999999999999999999999999 999999999
Q ss_pred cEEEcCCCc--EEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCH-
Q 027225 82 NLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDIYSFGVILWELATLQQPWGNLNP- 157 (226)
Q Consensus 82 nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~- 157 (226)
||+++.++. ++|+|||++...... .......+++.|+|||++.+..+..+ +|+||+|+++|+|++|+.||...+.
T Consensus 146 Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 146 NTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp GEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred HEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 999987765 999999988643322 22334567899999999988777655 8999999999999999999976432
Q ss_pred ---HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 ---AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
......+............+++++.++|.+||+.||.+|||+.++++ +.++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~ 280 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT--HSWFLK 280 (361)
T ss_dssp CCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHT
T ss_pred HHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh--Ccchhc
Confidence 33333333233333334468999999999999999999999999998 666643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=287.93 Aligned_cols=199 Identities=24% Similarity=0.460 Sum_probs=177.6
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++.+.+..|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||+
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NIL 474 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM 474 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEE
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEE
Confidence 79999999999999999999999999999999998743 4999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 164 (226)
++.++.+||+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 475 l~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i 554 (674)
T 3pfq_A 475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554 (674)
T ss_dssp ECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999876444434455677899999999999999999999999999999999999999998888877777
Q ss_pred hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH-----HHHHHHHHHhhcC
Q 027225 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----STIMELLRPLIKS 212 (226)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~~l~~~~~~ 212 (226)
. .....++..+++++.+||.+||+.||.+||++ ++|++ +.+++.
T Consensus 555 ~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~--h~ff~~ 603 (674)
T 3pfq_A 555 M--EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--HAFFRY 603 (674)
T ss_dssp H--SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS--SGGGSS
T ss_pred H--hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc--CccccC
Confidence 4 34556788899999999999999999999998 77776 455543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=260.35 Aligned_cols=205 Identities=27% Similarity=0.425 Sum_probs=175.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+.+++|.+.+.... .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~ 134 (284)
T 3kk8_A 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPE 134 (284)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHH
Confidence 46799999999999999999999999999999999887643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCc---EEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++.++. ++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..
T Consensus 135 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 213 (284)
T 3kk8_A 135 NLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213 (284)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECCSSCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCcEEEeeceeeEEcccCcc-ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence 999976655 99999999876544322 23456788999999999988999999999999999999999999988887
Q ss_pred HHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
+....+........ ....+++++.++|.+||+.||.+|||+.++++ .++++...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~~ 269 (284)
T 3kk8_A 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICNRE 269 (284)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHSCC
T ss_pred HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccCCh
Confidence 77766654433322 23578999999999999999999999999999 66665543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=263.94 Aligned_cols=205 Identities=36% Similarity=0.662 Sum_probs=170.0
Q ss_pred CCCCCCcCcceeeeEEecC-CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++++||||+++++++.+. +..++|+||+.+++|.+++...+ ...+++..++.++.|++.||.+||++| ++|+||+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk 144 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLA 144 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Confidence 4678999999999997554 57999999999999999997643 223789999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
|+||+++.++.++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..
T Consensus 145 p~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 221 (278)
T 1byg_A 145 ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221 (278)
T ss_dssp GGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred cceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999988654432 123345678999999988888999999999999999998 99999887776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+. .......+..+++++.++|.+||+.||.+|||+.++++.|+++...
T Consensus 222 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 222 DVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp GHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHh-cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 6665554 3344566788999999999999999999999999999999988653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=264.11 Aligned_cols=206 Identities=33% Similarity=0.560 Sum_probs=175.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.. .++|+|++.+++|.+++.... ..+++..+..++.|++.||.+||++| ++|+||+|+
T Consensus 76 ~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~ 150 (291)
T 1u46_A 76 HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAAR 150 (291)
T ss_dssp HHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred HhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchh
Confidence 4678999999999998765 899999999999999997632 34899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.
T Consensus 151 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 151 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp GEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 99999999999999999876433211 1223445668999999988888899999999999999999 9999999888
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+.........+..++.++.++|.+||+.||.+|||+.++++.|+++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 231 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 8877777656666667788999999999999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=263.72 Aligned_cols=212 Identities=28% Similarity=0.464 Sum_probs=172.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+++++|.+++........+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 74 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ 151 (295)
T 2clq_A 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGD 151 (295)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChh
Confidence 568999999999999999999999999999999999986543445789999999999999999999999 999999999
Q ss_pred cEEEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++. ++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||||+++++|++|..||......
T Consensus 152 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (295)
T 2clq_A 152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231 (295)
T ss_dssp GEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred hEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence 999987 88999999999876554333344556788999999987643 788999999999999999999999764332
Q ss_pred -HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 159 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
...............+..+++++.++|.+||+.||.+|||+.++++ +++++......
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~~~ 289 (295)
T 2clq_A 232 QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV--DEFLKVSSKKK 289 (295)
T ss_dssp HHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGCC-----
T ss_pred hHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--ChhhhhccccC
Confidence 2222222233445667889999999999999999999999999998 78887655433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=265.20 Aligned_cols=204 Identities=25% Similarity=0.425 Sum_probs=174.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..++.++.|++.||.|||+.| ++|+||+|+
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~ 144 (321)
T 2a2a_A 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPE 144 (321)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChH
Confidence 46789999999999999999999999999999999998743 4899999999999999999999999 999999999
Q ss_pred cEEEcCCC----cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 82 NLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
||+++.++ .++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.
T Consensus 145 NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp GEEESCTTSSSCCEEECCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred HEEEecCCCCcCCEEEccCccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999887 79999999987654432 22345678899999999988899999999999999999999999998887
Q ss_pred HHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.+....+....... ..+..++..+.++|.+||+.||.+|||+.++++ ..+++..
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~--hp~~~~~ 279 (321)
T 2a2a_A 224 QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR--HPWITPV 279 (321)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH--STTTSCS
T ss_pred HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc--CccccCC
Confidence 77666554322211 123578999999999999999999999999998 6666543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=265.91 Aligned_cols=206 Identities=21% Similarity=0.380 Sum_probs=166.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..+..++.|++.||.|||++| ++|+||+|+
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~ 131 (311)
T 4agu_A 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPE 131 (311)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChh
Confidence 46799999999999999999999999999999999987643 3999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+..+.
T Consensus 132 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 211 (311)
T 4agu_A 132 NILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ 211 (311)
T ss_dssp GEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998765544444445567889999999876 5578999999999999999999999988776655
Q ss_pred HHHHhhCCc-------------------cCCC----------CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 161 VAAVGFKGK-------------------RLEI----------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 161 ~~~~~~~~~-------------------~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
...+..... .... ...+++++.++|.+||+.||.+|||++++++ +.+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~ 289 (311)
T 4agu_A 212 LYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH--HPYFE 289 (311)
T ss_dssp HHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT--SGGGT
T ss_pred HHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc--ChHHH
Confidence 443321100 0000 1357889999999999999999999999998 77777
Q ss_pred CCC
Q 027225 212 SPT 214 (226)
Q Consensus 212 ~~~ 214 (226)
+..
T Consensus 290 ~~~ 292 (311)
T 4agu_A 290 NIR 292 (311)
T ss_dssp TCC
T ss_pred hcc
Confidence 654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=263.12 Aligned_cols=196 Identities=31% Similarity=0.561 Sum_probs=173.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+.+++|.+++... .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 75 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ 148 (303)
T 3a7i_A 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAA 148 (303)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChh
Confidence 4679999999999999999999999999999999999753 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+..
T Consensus 149 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 228 (303)
T 3a7i_A 149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228 (303)
T ss_dssp GEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred eEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence 99999999999999999876554433344566788999999999888899999999999999999999999988777666
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+. .......+..++.++.++|.+||+.||.+|||+.++++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 229 FLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHH-HSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhh-cCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 5554 23344567789999999999999999999999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=263.36 Aligned_cols=204 Identities=29% Similarity=0.505 Sum_probs=170.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.++ ..++|+|++.+++|.+++.+.+ ..+++..+..++.|++.||.+||++| ++|+||+|+
T Consensus 68 ~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~ 142 (281)
T 3cc6_A 68 KNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVR 142 (281)
T ss_dssp HHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGG
T ss_pred HhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccc
Confidence 457899999999998754 5789999999999999997643 23899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+
T Consensus 143 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~ 222 (281)
T 3cc6_A 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222 (281)
T ss_dssp GEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred eEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence 99999999999999999875443221 1223445678999999988888999999999999999998 999998776666
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
...... .......+..+++.+.++|.+||..||.+|||+.++++.|++++.
T Consensus 223 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 223 VIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHh-cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 555544 234455677899999999999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=268.32 Aligned_cols=207 Identities=27% Similarity=0.427 Sum_probs=165.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||||+
T Consensus 103 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 177 (349)
T 2w4o_A 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPE 177 (349)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred HhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcc
Confidence 46799999999999999999999999999999999998743 4899999999999999999999999 999999999
Q ss_pred cEEEcC---CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++. ++.++|+|||++...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 178 NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 178 NLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp GEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred cEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 999975 889999999998754432 1223456788999999999988999999999999999999999999765544
Q ss_pred H-HHHHHhhCCcc--CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 159 Q-VVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 159 ~-~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
+ ....+...... ......++.++.++|.+||+.||++|||+.++++ ..++......
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~~~~ 315 (349)
T 2w4o_A 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVTGKAAN 315 (349)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTTSTTCC
T ss_pred HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccCCCccc
Confidence 3 33333222221 1233578999999999999999999999999999 7888765543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=273.26 Aligned_cols=209 Identities=31% Similarity=0.521 Sum_probs=174.0
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-----------CCcCCHHHHHHHHHHHHHHHHHHhcC
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----------REMLDERRRLNMAYDVAKGMNYLHRR 69 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~ 69 (226)
+++ +||||+++++++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.
T Consensus 104 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 183 (333)
T 2i1m_A 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK 183 (333)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 345 899999999999999999999999999999999875321 23479999999999999999999999
Q ss_pred CCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 70 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
| ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 184 ~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 184 N--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp T--EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred C--cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHc
Confidence 9 99999999999999999999999999875433211 1223334568999999988889999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 148 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
|..||.....................+...++++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 262 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 262 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 89999876654444333334444555677899999999999999999999999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=261.89 Aligned_cols=202 Identities=24% Similarity=0.376 Sum_probs=172.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+++++|.+++...+ .+++..+..++.|++.||.+||++| ++|+||+|+
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~ 135 (277)
T 3f3z_A 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPE 135 (277)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHH
Confidence 57899999999999999999999999999999999987643 3899999999999999999999999 999999999
Q ss_pred cEEE---cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||++ +.++.++|+|||.+....... ......+++.|+|||.+.+. ++.++|+||||+++++|++|..||...+..
T Consensus 136 Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (277)
T 3f3z_A 136 NFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213 (277)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCcEEEEecccceeccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence 9999 788899999999987654332 23445678899999998766 889999999999999999999999988877
Q ss_pred HHHHHHhhCCccCCC--CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+......... ...+++++.++|.+||+.||.+|||+.++++ +++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~ 267 (277)
T 3f3z_A 214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFEK 267 (277)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHH
T ss_pred HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 776666433322211 1368999999999999999999999999998 555443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=268.07 Aligned_cols=209 Identities=27% Similarity=0.369 Sum_probs=170.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-------------------------------------CC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------------------------------VR 44 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------------------------------~~ 44 (226)
++++||||+++++++.+.+..++||||+++++|.+++.... ..
T Consensus 83 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (345)
T 3hko_A 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD 162 (345)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred HhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 46789999999999999999999999999999999986210 01
Q ss_pred CcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCC--cEEEccCCCccccccccc----ccCCCCCCCCc
Q 027225 45 EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFL----SSKSAAGTPEW 118 (226)
Q Consensus 45 ~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~----~~~~~~~~~~~ 118 (226)
..+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++ .++|+|||.+........ ......+++.|
T Consensus 163 ~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 163 FVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence 12467888899999999999999999 99999999999998776 899999999875432211 22345678899
Q ss_pred cCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCC--CCCCHHHHHHHHHHcccCCC
Q 027225 119 MAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPW 194 (226)
Q Consensus 119 ~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~ 194 (226)
+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+.........+ ..+++++.++|.+||+.||.
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 99999875 567899999999999999999999999888777666654443333222 35899999999999999999
Q ss_pred CCCCHHHHHHHHHHhhcCCC
Q 027225 195 KRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 195 ~Rps~~~~l~~l~~~~~~~~ 214 (226)
+|||+.++++ ..+++...
T Consensus 321 ~Rps~~~~l~--hp~~~~~~ 338 (345)
T 3hko_A 321 ERFDAMRALQ--HPWISQFS 338 (345)
T ss_dssp TSCCHHHHHH--SHHHHTTS
T ss_pred HCCCHHHHhc--ChhhccCh
Confidence 9999999999 77776643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=272.00 Aligned_cols=205 Identities=26% Similarity=0.410 Sum_probs=161.6
Q ss_pred CCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 3 RLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
..+||||+++++++.. .+..|+||||+.||+|.+++...+ ...+++..+..++.|++.||.|||+.| |+||||
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDl 187 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 187 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCc
Confidence 3589999999999875 567999999999999999998754 335999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+||+++. ++.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 188 kp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp CGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CcceEEEecCCCCccEEEEecccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987 7889999999987544322 223456788999999999888999999999999999999999999764
Q ss_pred CHHH----HHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 NPAQ----VVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+... ....+....... .....++.++.++|.+||+.||.+|||+.++++ +.++...
T Consensus 267 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~~ 328 (400)
T 1nxk_A 267 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQS 328 (400)
T ss_dssp TTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHTT
T ss_pred ccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccCC
Confidence 4221 222222222211 223578999999999999999999999999999 6666543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=266.84 Aligned_cols=206 Identities=22% Similarity=0.296 Sum_probs=164.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++| ++|+||||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp 160 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKP 160 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCH
Confidence 4678999999999999999999999999975 9999998744 3999999999999999999999999 99999999
Q ss_pred CcEEEc-----CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVD-----KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||+++ .++.++|+|||.+..............++..|+|||++.+.. ++.++||||||+++++|++|..||..
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 999994 455699999999876554433444556688999999998754 79999999999999999999999988
Q ss_pred CCHHHHHHHHhhCCccCC----------------------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKRLE----------------------------IPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
.+..+....+........ .+..+++++.++|.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-- 318 (329)
T 3gbz_A 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE-- 318 (329)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--
T ss_pred CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC--
Confidence 777665544422111000 01126789999999999999999999999999
Q ss_pred HHhhcCCC
Q 027225 207 RPLIKSPT 214 (226)
Q Consensus 207 ~~~~~~~~ 214 (226)
+.+++...
T Consensus 319 hp~f~~~~ 326 (329)
T 3gbz_A 319 HPYFSHND 326 (329)
T ss_dssp SGGGSSSC
T ss_pred CcccCCCC
Confidence 88887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=282.61 Aligned_cols=206 Identities=29% Similarity=0.428 Sum_probs=176.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..++.++.|++.||.|||++| ++||||||
T Consensus 80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp 154 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKP 154 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCH
Confidence 468899999999999999999999999999999999997643 4999999999999999999999999 99999999
Q ss_pred CcEEE---cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||++ +.++.++|+|||++....... ......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.
T Consensus 155 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 155 ENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp GGEEESSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEEecCCCCCcEEEEeeeeeEEccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999 567899999999887544332 1223457889999999977 488999999999999999999999999888
Q ss_pred HHHHHHHhhCCccCCC--CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 158 AQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
.+....+......... +..+++++.++|.+||+.||.+|||+.++++ +++++....
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~~~~ 290 (484)
T 3nyv_A 233 YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHHHTC
T ss_pred HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhccccc
Confidence 8877776554433332 3578999999999999999999999999998 666655443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=262.97 Aligned_cols=206 Identities=25% Similarity=0.503 Sum_probs=176.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++... ...+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 79 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~ 154 (314)
T 3com_A 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAG 154 (314)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHH
Confidence 5789999999999999999999999999999999998732 224899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||...+.....
T Consensus 155 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 234 (314)
T 3com_A 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234 (314)
T ss_dssp GEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred HEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999876555444444556788999999999888899999999999999999999999887766555
Q ss_pred HHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 162 AAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 162 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
....... .....+..++..+.++|.+||..||.+|||+.++++ ..+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~~ 285 (314)
T 3com_A 235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRSA 285 (314)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHTC
T ss_pred HHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhcC
Confidence 4443222 223345668999999999999999999999999998 5666543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=279.51 Aligned_cols=205 Identities=26% Similarity=0.409 Sum_probs=174.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++||||+++++++.+.+..|+||||++||+|.+++.+.+. ...+++..++.++.||+.||.|||++| |+||||||
T Consensus 240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP 317 (543)
T 3c4z_A 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKP 317 (543)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCCh
Confidence 467999999999999999999999999999999999876432 345999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN---- 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---- 156 (226)
+||+++.+|.++|+|||++..............+++.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 318 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~ 397 (543)
T 3c4z_A 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397 (543)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC
T ss_pred HHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh
Confidence 9999999999999999999765544333445578999999999999889999999999999999999999997642
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCH-----HHHHHHHHHhhcC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----STIMELLRPLIKS 212 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~~l~~~~~~ 212 (226)
..+....+. ......+..+++++.++|.+||+.||.+||++ +++++ +.+++.
T Consensus 398 ~~~~~~~i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~--Hpff~~ 454 (543)
T 3c4z_A 398 NKELKQRVL--EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT--HPLFRD 454 (543)
T ss_dssp HHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT--SGGGTT
T ss_pred HHHHHHHHh--hcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc--CccccC
Confidence 334444332 33456678899999999999999999999965 67776 555544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=269.02 Aligned_cols=209 Identities=29% Similarity=0.498 Sum_probs=172.4
Q ss_pred CCCCCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++++||||+++++++.+. ...++||||+++++|.+++.+.. +++..++.++.|++.||.+||+.| ++|+||+
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dik 161 (318)
T 3lxp_A 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLA 161 (318)
T ss_dssp HHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred HhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCc
Confidence 467999999999999874 56899999999999999998754 899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 162 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 162 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp GGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred hheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 999999999999999999987654322 12233456677999999998888899999999999999999999986532
Q ss_pred HHH--------------HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 157 PAQ--------------VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 157 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
... ..............+..++.++.++|.+||+.||.+|||+.++++.|+.+......+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 242 TKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred hhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 211 111111233455667789999999999999999999999999999999987655433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=268.04 Aligned_cols=201 Identities=28% Similarity=0.468 Sum_probs=170.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||++| ++|+||||+
T Consensus 109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~ 183 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG 183 (348)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGG
T ss_pred HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHH
Confidence 46899999999999999999999999997 58888875432 34899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++.++.++|+|||++...... ....+++.|+|||++. +..++.++||||||+++++|++|..||...+..
T Consensus 184 NIll~~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 259 (348)
T 1u5q_A 184 NILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259 (348)
T ss_dssp GEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HEEECCCCCEEEeeccCceecCCC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999998654432 3456788999999984 456788999999999999999999999888776
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.....+.........+..+++.+.++|.+||+.||.+|||+.++++ ..++...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--h~~~~~~ 312 (348)
T 1u5q_A 260 SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRE 312 (348)
T ss_dssp HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHSC
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh--Chhhhcc
Confidence 6655554444444445678999999999999999999999999998 5555443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=260.55 Aligned_cols=206 Identities=28% Similarity=0.456 Sum_probs=168.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+.+..++|+||+.+++|.+++.... ....+++..+..++.|++.||.|||+.| ++|+||+
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dik 151 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLK 151 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCS
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCC
Confidence 357899999999999999999999999999999999886421 1245999999999999999999999999 9999999
Q ss_pred CCcEEE---cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 80 SPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 80 p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|+||++ +.++.++|+|||.+...... .......+++.|+|||.+.+ .++.++|+||||+++++|++|..||...+
T Consensus 152 p~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 152 PENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp GGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 999999 45678999999998754432 22334567889999999864 47899999999999999999999999888
Q ss_pred HHHHHHHHhhCCccCCC-CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 157 PAQVVAAVGFKGKRLEI-PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..+.............. ...+++++.++|.+||+.||.+|||+.++++ .++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~f~~ 284 (285)
T 3is5_A 230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH--HEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGGC
T ss_pred HHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHhhc
Confidence 87776666544433322 2457899999999999999999999999998 677654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=268.49 Aligned_cols=212 Identities=33% Similarity=0.511 Sum_probs=170.6
Q ss_pred CCCCCCcCcceeeeEEe--cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++. +.+..++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Di 153 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDL 153 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCC
Confidence 35789999999999886 4566999999999999999997632 23999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus 154 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 154 AARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp SGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999987643322 1223345667799999998888899999999999999999999998543
Q ss_pred CHH--------------HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 156 NPA--------------QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 156 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
... ...............+..+++++.++|.+||+.||.+|||+.++++.|+.+.......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 234 SAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 321 1112222234455667789999999999999999999999999999999987755433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=258.24 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=171.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+++++|.+++.... .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ 134 (276)
T 2yex_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPE 134 (276)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChH
Confidence 56899999999999999999999999999999999997643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++.++.++|+|||.+...... ........++..|+|||.+.+..+ +.++|+||||+++++|++|..||...+..
T Consensus 135 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp GEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred HEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 999999999999999998754322 122334567889999999987664 67899999999999999999999765543
Q ss_pred -HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 159 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
..................+++.+.++|.+||+.||.+|||+.++++ +.+++.....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~~ 271 (276)
T 2yex_A 215 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNKPLKK 271 (276)
T ss_dssp SHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTCCCC-
T ss_pred HHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc--CccccChhhc
Confidence 2222222222233334578999999999999999999999999998 6777655433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=263.04 Aligned_cols=204 Identities=24% Similarity=0.314 Sum_probs=167.3
Q ss_pred CCCcCcceeeeEEecCC-----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 4 LRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
++||||+++++++.... ..++|+|++. ++|.+++.... ...+++..+..++.|++.||+|||++| ++|+||
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dl 146 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDL 146 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCC
Confidence 46999999999998765 4899999996 59999998754 334899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+||+++.++.++|+|||.+....... ......+++.|+|||++.+..++.++|+||||+++++|++|..||...+..
T Consensus 147 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 147 KPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp CTTTEEECTTSCEEECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred CHHHEEEcCCCCEEEeeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999987544322 223456788999999999888999999999999999999999999888776
Q ss_pred HHHHHHhhCCccC-------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRL-------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+....+....... .....+++++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--h~~~~~~ 303 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ--HSYLHKD 303 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTC---
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc--CccccCC
Confidence 6555442211100 012367899999999999999999999999999 7777664
Q ss_pred C
Q 027225 214 T 214 (226)
Q Consensus 214 ~ 214 (226)
.
T Consensus 304 ~ 304 (308)
T 3g33_A 304 E 304 (308)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=262.86 Aligned_cols=206 Identities=33% Similarity=0.556 Sum_probs=166.5
Q ss_pred CCCCcCcceeeeEEecC----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC--------C
Q 027225 3 RLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR--------N 70 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~ 70 (226)
.++||||+++++++.+. ...++||||+.+++|.+++.... +++..++.++.|++.||.|||+. |
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 162 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC
Confidence 45999999999999877 67999999999999999997643 89999999999999999999998 8
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc----cCCCCCCCCccCcccccCCCCCCc------hhHHHHHH
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPEVLRDEPSNEK------SDIYSFGV 140 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~------~Dv~slG~ 140 (226)
++|+||||+||+++.++.++|+|||.+......... .....++..|+|||++.+...... +||||||+
T Consensus 163 --ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 163 --IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp --EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred --EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence 999999999999999999999999998654332221 124567889999999987766554 99999999
Q ss_pred HHHHHHhC----------CCCCCCC-----CHHHHHHHHhhCCccCCCCC-----CCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 141 ILWELATL----------QQPWGNL-----NPAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 141 ~l~~l~~g----------~~p~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
++|+|++| ..||... ..................+. .++.++.+++.+||+.||.+|||+.
T Consensus 241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 99999999 6777542 22233333332333333332 4567799999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 027225 201 TIMELLRPLIKSPT 214 (226)
Q Consensus 201 ~~l~~l~~~~~~~~ 214 (226)
++++.|+.+..+..
T Consensus 321 ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 321 RVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHhhcc
Confidence 99999999988754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=259.30 Aligned_cols=204 Identities=32% Similarity=0.554 Sum_probs=169.2
Q ss_pred CCCCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|++++||||+++++++.. +...++|+||+++++|.+++.+.+ .+++..++.++.|++.||.|||+.|.+++|+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~ 155 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEEC
Confidence 467899999999999865 355899999999999999998643 4899999999999999999999987569999
Q ss_pred CCCCCcEEEc-CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 77 DLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 77 di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+|+||+++ .++.++|+|||.+...... ......+++.|+|||.+.+. ++.++|+||||+++++|++|..||...
T Consensus 156 dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 156 DLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCHHHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999997 7889999999998654332 22334578899999988754 889999999999999999999999874
Q ss_pred CH-HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 156 NP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 156 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.. ................+...++++.++|.+||+.||.+|||+.++++ +.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~f~~ 288 (290)
T 1t4h_A 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQE 288 (290)
T ss_dssp SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC-
T ss_pred CcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--Cccccc
Confidence 44 44444443333344456678899999999999999999999999998 677654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=258.72 Aligned_cols=207 Identities=24% Similarity=0.431 Sum_probs=170.2
Q ss_pred CCCCCCcCcceeeeEE--ecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAV--TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++ .+.+..++|+||+.++ |.+++.... ...+++..+..++.|++.||.|||++| ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl 135 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDI 135 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCC
Confidence 4678999999999998 4456799999999875 777776533 345999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCC--CCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+|+||+++.++.++|+|||.+...... ........++..|+|||++.+... +.++|+||||+++++|++|..||..
T Consensus 136 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 136 KPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998754322 122234567889999999986543 6799999999999999999999998
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
.+..+....+.. .....+..+++++.++|.+||+.||.+|||+.++++ ..+++...+
T Consensus 216 ~~~~~~~~~i~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~ 272 (305)
T 2wtk_C 216 DNIYKLFENIGK--GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKKHP 272 (305)
T ss_dssp SSHHHHHHHHHH--CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSCCC
T ss_pred chHHHHHHHHhc--CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccCCC
Confidence 887776665543 344567789999999999999999999999999998 566655433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=268.55 Aligned_cols=210 Identities=29% Similarity=0.494 Sum_probs=177.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
++++||||+++++++.+.+..++|+||+++++|.+++..... ...+++..++.++.|++.||.|||+.| ++|+|
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~d 165 (327)
T 2yfx_A 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRD 165 (327)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred hhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCc
Confidence 467999999999999999999999999999999999986432 135899999999999999999999999 99999
Q ss_pred CCCCcEEEcC---CCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 027225 78 LKSPNLLVDK---KYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP 151 (226)
Q Consensus 78 i~p~nil~~~---~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p 151 (226)
|+|+||+++. +..++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++++|++ |..|
T Consensus 166 lkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 245 (327)
T 2yfx_A 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245 (327)
T ss_dssp CCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999984 4469999999886533221 11223345678999999988888999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
|...+..+....+. .......+..++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 246 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 246 YPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp STTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCCcCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 99888777666554 344556677899999999999999999999999999999998876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=264.27 Aligned_cols=196 Identities=23% Similarity=0.432 Sum_probs=168.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccC-CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+.+..++|+|++.+| +|.+++...+ .+++..+..++.|++.||.|||++| ++|+|||
T Consensus 83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlk 157 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIK 157 (335)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccC
Confidence 46789999999999999999999999998766 9999998754 4999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
|+||+++.++.++|+|||.+....... ......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.....
T Consensus 158 p~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~- 235 (335)
T 3dls_A 158 DENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE- 235 (335)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-
T ss_pred HHHEEEcCCCcEEEeecccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-
Confidence 999999999999999999987654332 2234467889999999988776 7889999999999999999999976322
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
........+..+++++.++|.+||+.||.+|||+.++++ ..+++.
T Consensus 236 -------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--hp~~~~ 280 (335)
T 3dls_A 236 -------TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT--DPWVTQ 280 (335)
T ss_dssp -------GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH--CTTTTC
T ss_pred -------HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc--CccccC
Confidence 122334456678999999999999999999999999999 666654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=286.65 Aligned_cols=204 Identities=28% Similarity=0.517 Sum_probs=174.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.. +..++||||+.+|+|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+
T Consensus 425 ~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~ 498 (635)
T 4fl3_A 425 QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 498 (635)
T ss_dssp HHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred HhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChH
Confidence 46899999999999975 45899999999999999997643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
||+++.++.+||+|||++....... .......++..|+|||++.+..++.++||||||+++++|++ |+.||...+.
T Consensus 499 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 499 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp GEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999987543321 11222334567999999998889999999999999999998 9999999888
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+. .......+..+++++.++|.+||+.||.+|||+.++++.|++++.+
T Consensus 579 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 579 SEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 87777665 4456677888999999999999999999999999999999988753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=267.88 Aligned_cols=207 Identities=32% Similarity=0.587 Sum_probs=172.9
Q ss_pred CCcCcceeeeEEecCC-ceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHhcCC
Q 027225 5 RHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHRRN 70 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~~~ 70 (226)
+||||+++++++.+.+ ..++|+||+.+++|.+++..... ...+++..++.++.|++.||.|||+.|
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6899999999997754 49999999999999999987542 123889999999999999999999999
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT- 147 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 147 (226)
++|+||||+||+++.++.++|+|||.+........ ......++..|+|||++.+..++.++|+||||+++++|++
T Consensus 169 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 169 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875432211 1223345678999999998889999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
|..||...+..+..............+..+++++.+++.+||+.||.+|||+.++++.|+.++...
T Consensus 247 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 999998766444333333344455667789999999999999999999999999999999987653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=259.30 Aligned_cols=202 Identities=29% Similarity=0.518 Sum_probs=167.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++...+ .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ 140 (276)
T 2h6d_A 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPE 140 (276)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGG
T ss_pred hcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChh
Confidence 56899999999999999999999999999999999998643 3899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.++|+|||.+....... ......+++.|+|||.+.+... +.++|+||||+++++|++|..||...+..+.
T Consensus 141 Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 219 (276)
T 2h6d_A 141 NVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219 (276)
T ss_dssp GEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hEEECCCCCEEEeecccccccCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 9999999999999999887654321 2234456789999999987765 5799999999999999999999998877776
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
...+.. .....+..++.++.++|.+||+.||.+|||+.++++ ..+++..
T Consensus 220 ~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~~ 268 (276)
T 2h6d_A 220 FKKIRG--GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQD 268 (276)
T ss_dssp HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHTT
T ss_pred HHHhhc--CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh--ChhhccC
Confidence 665543 334556778999999999999999999999999999 6776653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=265.49 Aligned_cols=204 Identities=28% Similarity=0.491 Sum_probs=165.5
Q ss_pred CCcCcceeeeEEec------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 5 RHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 5 ~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+||||+++++++.. .+..++|+||+.+++|.+++.... ...+++..++.++.|++.||.|||+.| ++|+||
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dl 155 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDI 155 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCC
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Confidence 79999999999976 467999999999999999998643 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
+|+||+++.++.++|+|||.+..............++..|+|||.+. +..++.++|+||||+++++|++|..||.
T Consensus 156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 156 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp SGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred cHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999876544333334456788999999987 4557889999999999999999999998
Q ss_pred CCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+.......+.........+..++..+.++|.+||..||.+|||+.++++ ..+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~~~ 293 (326)
T 2x7f_A 236 DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIRDQ 293 (326)
T ss_dssp TSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHHCC
T ss_pred CCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHhhC
Confidence 887766665554444333445678999999999999999999999999998 6666654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=275.56 Aligned_cols=197 Identities=32% Similarity=0.467 Sum_probs=170.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..|+||||+.+|+|.+.+.... .+++..+..++.||+.||.|||++| ++||||||
T Consensus 90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp 164 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKP 164 (494)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCh
Confidence 467899999999999999999999999999999999887643 3999999999999999999999999 99999999
Q ss_pred CcEEEcCC---CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.. +.++|+|||++....... ......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.
T Consensus 165 ~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 165 ENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECBTTB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhEEEeCCCCCCcEEEEECCCCeECCCCc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999764 459999999987654432 2344568899999999875 488999999999999999999999999888
Q ss_pred HHHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+....+........ ....+++++.++|.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 887777654443332 23578999999999999999999999999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=261.51 Aligned_cols=201 Identities=32% Similarity=0.553 Sum_probs=161.5
Q ss_pred CCCCcCcceeeeEEecC----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh--------cCC
Q 027225 3 RLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH--------RRN 70 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------~~~ 70 (226)
+++||||+++++++.+. ...++|+||+++|+|.++++.. .+++..++.++.|++.||.||| +.|
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 133 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC
Confidence 47999999999987543 4589999999999999999654 3999999999999999999999 899
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccc----cCCCCCCCCccCcccccCC------CCCCchhHHHHHH
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGV 140 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~------~~~~~~Dv~slG~ 140 (226)
++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+. .++.++||||+|+
T Consensus 134 --ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 134 --IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp --EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred --eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence 999999999999999999999999998654332211 2334678899999999876 3346899999999
Q ss_pred HHHHHHhC----------CCCCCCC-----CHHHHHHHHhhCCccCCCCC-----CCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 141 ILWELATL----------QQPWGNL-----NPAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 141 ~l~~l~~g----------~~p~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
++|+|++| ..||... ..................+. ..++++.+++.+||+.||.+|||+.
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 291 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence 99999999 8888542 22233333322333333332 3457899999999999999999999
Q ss_pred HHHHHHHHh
Q 027225 201 TIMELLRPL 209 (226)
Q Consensus 201 ~~l~~l~~~ 209 (226)
++++.|+++
T Consensus 292 ~i~~~L~~i 300 (301)
T 3q4u_A 292 RIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhcc
Confidence 999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=280.15 Aligned_cols=203 Identities=26% Similarity=0.389 Sum_probs=173.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..|+||||+.||+|.+++...+ ...+++..++.++.||+.||+|||++| |+||||||+
T Consensus 239 ~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPe 315 (576)
T 2acx_A 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPE 315 (576)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchh
Confidence 46799999999999999999999999999999999998654 334999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----H
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN----P 157 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~ 157 (226)
||+++.+|.++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+ .
T Consensus 316 NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~ 394 (576)
T 2acx_A 316 NILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394 (576)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred eEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence 9999999999999999987654322 1234578999999999999889999999999999999999999997653 3
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
.+....+. .....++..+++++.++|.+||+.||.+|| +++++++ +.+++.
T Consensus 395 ~~i~~~i~--~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~~ 450 (576)
T 2acx_A 395 EEVERLVK--EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFKK 450 (576)
T ss_dssp HHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGTT
T ss_pred HHHHHHhh--cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhcc
Confidence 33443332 234456788999999999999999999999 7899987 566654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=265.28 Aligned_cols=206 Identities=19% Similarity=0.290 Sum_probs=169.1
Q ss_pred CCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++ +||||+++++++.+++..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.| ++||||||
T Consensus 59 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp 133 (330)
T 2izr_A 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKP 133 (330)
T ss_dssp HHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence 345 8999999999999999999999999 899999998642 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCc-----EEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q 027225 81 PNLLVDKKYT-----VKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 81 ~nil~~~~~~-----~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 148 (226)
+||+++.++. ++|+|||++........ ......+++.|+|||++.+..++.++|+||||+++++|++|
T Consensus 134 ~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 213 (330)
T 2izr_A 134 ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213 (330)
T ss_dssp GGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcC
Confidence 9999998887 99999999976443322 12355688999999999999899999999999999999999
Q ss_pred CCCCCCCCH---HHHHHHHhhCCccC---CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 149 QQPWGNLNP---AQVVAAVGFKGKRL---EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 149 ~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..||...+. .+....+....... .....++ ++.+++.+||+.||.+||++.++.+.|++++...
T Consensus 214 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 214 SLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp SCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 999987433 22222221111111 1122344 9999999999999999999999999999887543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=264.96 Aligned_cols=207 Identities=31% Similarity=0.472 Sum_probs=168.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++........+++..++.++.|++.||.|||+.| ++|+||+|+
T Consensus 85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~ 162 (307)
T 2nru_A 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSA 162 (307)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHH
Confidence 467999999999999999999999999999999999986443456999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||.+........ ......+++.|+|||.+.+. ++.++|+||||+++++|++|..||......+
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999875443211 22345678899999998764 7889999999999999999999997643322
Q ss_pred ----HHHHHhhC---------CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 ----VVAAVGFK---------GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ----~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
........ ......+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111111 11112233455789999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=261.02 Aligned_cols=205 Identities=26% Similarity=0.428 Sum_probs=174.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||+|+
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~ 135 (304)
T 2jam_A 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPE 135 (304)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGG
T ss_pred HhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence 46799999999999999999999999999999999987643 4899999999999999999999999 999999999
Q ss_pred cEEE---cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||++ +.++.++|+|||.+...... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..
T Consensus 136 NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 213 (304)
T 2jam_A 136 NLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213 (304)
T ss_dssp GCEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HEEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999 77889999999988654322 112234678899999999988999999999999999999999999988877
Q ss_pred HHHHHHhhCCcc--CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 159 QVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 159 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+....+...... ...+..+++++.++|.+||+.||.+|||+.++++ ..++++...
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~~~ 270 (304)
T 2jam_A 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDGNTA 270 (304)
T ss_dssp HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHSSCS
T ss_pred HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccCCCc
Confidence 766665443322 2334678999999999999999999999999998 667765443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=265.00 Aligned_cols=184 Identities=23% Similarity=0.361 Sum_probs=147.3
Q ss_pred eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 22 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
.++||||+++++|.+++.+.......++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||.+..
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 213 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccc
Confidence 8999999999999999998766666788889999999999999999999 99999999999999999999999999876
Q ss_pred ccccc------------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCc
Q 027225 102 KANTF------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169 (226)
Q Consensus 102 ~~~~~------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 169 (226)
..... .......+++.|+|||.+.+..++.++|+||||+++++|++|..|+.. ......... ...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~-~~~ 290 (332)
T 3qd2_B 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR-NLK 290 (332)
T ss_dssp CSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH-TTC
T ss_pred cccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh-ccC
Confidence 54431 122334678899999999998899999999999999999998766422 111111111 112
Q ss_pred cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 170 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 170 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
........++++.++|.+||+.||.+|||+.++++ +.++++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--~~~f~~ 331 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE--NAIFEN 331 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH--STTCCC
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh--chhhhc
Confidence 22222456788999999999999999999999998 666553
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=276.66 Aligned_cols=205 Identities=29% Similarity=0.484 Sum_probs=175.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..|+|+||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.| ++||||||
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp 174 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN--IVHRDIKP 174 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcH
Confidence 357899999999999999999999999999999999987643 3999999999999999999999999 99999999
Q ss_pred CcEEEcCCC---cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++ .++|+|||++...... .......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.
T Consensus 175 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 175 ENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp GGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999998776 6999999998765433 22345568899999999875 488999999999999999999999999888
Q ss_pred HHHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 158 AQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.+....+........ ....+++++.++|.+||+.||.+|||+.++++ +++++...
T Consensus 253 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~ 309 (504)
T 3q5i_A 253 QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKYA 309 (504)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHTC
T ss_pred HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhch
Confidence 887777754433222 22578999999999999999999999999998 66665443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=275.64 Aligned_cols=203 Identities=31% Similarity=0.479 Sum_probs=172.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..|+|+||+.+++|.+.+...+ .+++..+..++.||+.||.|||++| |+||||||+
T Consensus 76 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~ 150 (486)
T 3mwu_A 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE 150 (486)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred HhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchH
Confidence 56899999999999999999999999999999999887643 4999999999999999999999999 999999999
Q ss_pred cEEEc---CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++ .++.++|+|||++...... .......+++.|+|||++.+. ++.++|+||+|+++|+|++|..||...+..
T Consensus 151 Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 151 NILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp GEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99995 4567999999998754433 223345678999999999875 889999999999999999999999998888
Q ss_pred HHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+....+........ ....+++++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~ 283 (486)
T 3mwu_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKY 283 (486)
T ss_dssp HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHT
T ss_pred HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccC
Confidence 77776654443332 23578999999999999999999999999999 6666543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=262.23 Aligned_cols=207 Identities=28% Similarity=0.427 Sum_probs=166.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcC---CCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRR---NPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~i~h~ 76 (226)
|++++||||+++++++.+.+..++|+||+.+++|.+++..... ...+++..+..++.|++.||.|||+. | ++|+
T Consensus 81 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~ 158 (326)
T 3uim_A 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHR 158 (326)
T ss_dssp GGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECC
T ss_pred HHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeC
Confidence 4678999999999999999999999999999999999986542 34599999999999999999999999 9 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...
T Consensus 159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred CCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccc
Confidence 999999999999999999999987654322 2233445788999999998888899999999999999999999999521
Q ss_pred -----CHHHHHHHHhhCCcc------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 156 -----NPAQVVAAVGFKGKR------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 156 -----~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
............... ...+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 111111111100000 011122347899999999999999999999999999853
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=264.90 Aligned_cols=210 Identities=28% Similarity=0.376 Sum_probs=162.1
Q ss_pred CCCCCcCcceeeeEEec-----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-------
Q 027225 2 KRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR------- 69 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~------- 69 (226)
+.++||||+++++.+.. ...+++||||+++|+|.+++.... .++..+..++.|++.||.|||+.
T Consensus 62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~ 137 (336)
T 3g2f_A 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHY 137 (336)
T ss_dssp TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGC
T ss_pred HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 46899999999986532 235789999999999999997654 68899999999999999999999
Q ss_pred --CCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccc--------ccccCCCCCCCCccCcccccCC-------CCCCc
Q 027225 70 --NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------FLSSKSAAGTPEWMAPEVLRDE-------PSNEK 132 (226)
Q Consensus 70 --~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~--------~~~~~~~~~~~~~~~PE~~~~~-------~~~~~ 132 (226)
| ++|+||||+||+++.++.++|+|||++...... ........++..|+|||++.+. .++.+
T Consensus 138 ~~~--ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 215 (336)
T 3g2f_A 138 KPA--ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215 (336)
T ss_dssp BCC--EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred ccc--eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence 9 999999999999999999999999998754322 1112244578899999999873 34568
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHhhCCccCCCCCC------CCHHHHHHHHHH
Q 027225 133 SDIYSFGVILWELATLQQPWGNL------------------NPAQVVAAVGFKGKRLEIPRN------VNPHVASIIEAC 188 (226)
Q Consensus 133 ~Dv~slG~~l~~l~~g~~p~~~~------------------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~ 188 (226)
+||||||+++|+|++|..||... ...+.............++.. .++++.++|.+|
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHH
Confidence 99999999999999997765221 112222222223333344443 335899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 189 WANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 189 l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
|+.||++|||+.++++.|++++..-..-.
T Consensus 296 l~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 296 WDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp SCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 99999999999999999999886654443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=265.54 Aligned_cols=197 Identities=28% Similarity=0.453 Sum_probs=165.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~ 79 (226)
|++++||||+++++++.+++..++||||+++++|.+++.+.+ .+++..+..++.|++.||.|||+. | ++|+|||
T Consensus 85 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlk 159 (360)
T 3eqc_A 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVK 159 (360)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCS
T ss_pred HHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCcc
Confidence 467899999999999999999999999999999999998743 389999999999999999999995 9 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.++.++|+|||.+...... ......+++.|+|||++.+..++.++|+||||+++++|++|..||...+..+
T Consensus 160 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 160 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp GGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred HHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999998654332 2234567889999999999889999999999999999999999998776654
Q ss_pred HHHHHh------------------------------------------hCCccCCCCCCCCHHHHHHHHHHcccCCCCCC
Q 027225 160 VVAAVG------------------------------------------FKGKRLEIPRNVNPHVASIIEACWANEPWKRP 197 (226)
Q Consensus 160 ~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 197 (226)
...... ...........++.++.++|.+||+.||.+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 317 (360)
T 3eqc_A 238 LELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317 (360)
T ss_dssp HHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC
Confidence 432221 11111122345789999999999999999999
Q ss_pred CHHHHHH
Q 027225 198 SFSTIME 204 (226)
Q Consensus 198 s~~~~l~ 204 (226)
|+.++++
T Consensus 318 t~~ell~ 324 (360)
T 3eqc_A 318 DLKQLMV 324 (360)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=263.19 Aligned_cols=204 Identities=24% Similarity=0.389 Sum_probs=171.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHH------hcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL------LHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPI 73 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~------~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i 73 (226)
|++++||||+++++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .| +
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i 173 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN--I 173 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC--E
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC--E
Confidence 4678999999999999999999999999999999998 55422 3459999999999999999999999 99 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCC-chhHHHHHHHHHHHHhCCCC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNE-KSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~-~~Dv~slG~~l~~l~~g~~p 151 (226)
+|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||+|+++++|++|..|
T Consensus 174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred eecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765433 23445678899999999877 4555 89999999999999999999
Q ss_pred CCCCCH-HHHHHHHhhCCccCCCC-------------------CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 152 WGNLNP-AQVVAAVGFKGKRLEIP-------------------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 152 ~~~~~~-~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
|...+. .+....+.. .....+ ..++.++.++|.+||+.||.+|||+.++++ +.+++
T Consensus 252 f~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~--hp~f~ 327 (348)
T 2pml_X 252 FSLKISLVELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK--HEWLA 327 (348)
T ss_dssp SCCSSCSHHHHHHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGT
T ss_pred CCCCCcHHHHHHHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc--Ccccc
Confidence 987665 555554432 222333 568999999999999999999999999998 67776
Q ss_pred CC
Q 027225 212 SP 213 (226)
Q Consensus 212 ~~ 213 (226)
..
T Consensus 328 ~~ 329 (348)
T 2pml_X 328 DT 329 (348)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=259.53 Aligned_cols=203 Identities=24% Similarity=0.433 Sum_probs=171.0
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.||||+++++++.+.+..++|+||+.+++|.+++.... ...+++..++.++.|++.||+|||++| ++|+||+|+||+
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl 163 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNIL 163 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEE
Confidence 57999999999999999999999999999999986543 345999999999999999999999999 999999999999
Q ss_pred EcC---CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 85 VDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 85 ~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
++. ++.++|+|||.+........ .....+++.|+|||++.+..++.++|+||||+++++|++|..||...+..+..
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCcEEEeeCccccccCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 987 78999999999876543322 23456788999999999988999999999999999999999999988877766
Q ss_pred HHHhhCCcc--CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 162 AAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 162 ~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+...... ......+++.+.++|.+||+.||.+|||++++++ ..+++..
T Consensus 243 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~~ 294 (327)
T 3lm5_A 243 LNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQW 294 (327)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCCC
T ss_pred HHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhccc
Confidence 555433322 2334578999999999999999999999999998 7777654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=262.79 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=168.0
Q ss_pred CCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++...+ .+|+|+||+ +++|.+++... .+++..+..++.|++.||.|||+.| ++|
T Consensus 79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~--ivH 151 (367)
T 1cm8_A 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG--IIH 151 (367)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred HhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 5679999999999997653 469999999 77999999763 3899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
|||||+||+++.++.+||+|||+++..... .....++..|+|||++.+ ..++.++|+||+||++++|++|+.||.+
T Consensus 152 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 152 RDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcCHHHEEEcCCCCEEEEeeecccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765432 334567889999999887 5689999999999999999999999988
Q ss_pred CCHHHHHHHHhhCCc-----------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 155 LNPAQVVAAVGFKGK-----------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+..+....+..... ........++++.++|.+||..||.+|||+.++++
T Consensus 229 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~- 307 (367)
T 1cm8_A 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA- 307 (367)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH-
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc-
Confidence 776554433321100 11223567899999999999999999999999999
Q ss_pred HHHhhcCCC
Q 027225 206 LRPLIKSPT 214 (226)
Q Consensus 206 l~~~~~~~~ 214 (226)
+.+++...
T Consensus 308 -hp~f~~~~ 315 (367)
T 1cm8_A 308 -HPYFESLH 315 (367)
T ss_dssp -SGGGTTTC
T ss_pred -ChHHHhhc
Confidence 78877654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=256.67 Aligned_cols=197 Identities=25% Similarity=0.443 Sum_probs=167.0
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.+++.+.. .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ 137 (283)
T 3bhy_A 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPE 137 (283)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChH
Confidence 46789999999999999999999999999999999997633 4899999999999999999999999 999999999
Q ss_pred cEEEcCCC----cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 82 NLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 82 nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
||+++.++ .++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.
T Consensus 138 Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HEEEecCCCCCCceEEEecccceeccCCCc-ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 99998877 899999999876543322 2344578899999999988899999999999999999999999998887
Q ss_pred HHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+....+....... .....++..+.+++.+||..||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 77666554332221 123578899999999999999999999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=261.08 Aligned_cols=207 Identities=30% Similarity=0.528 Sum_probs=170.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||+|+
T Consensus 71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~ 146 (302)
T 2j7t_A 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAG 146 (302)
T ss_dssp HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGG
T ss_pred hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHH
Confidence 46799999999999999999999999999999999987532 23899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccc-----cCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+++.++.++|+|||.+..............++..|+|||.+ .+..++.++|+||||+++++|++|..||...+
T Consensus 147 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp GEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999999999999999875443332333445678899999998 35667899999999999999999999999887
Q ss_pred HHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 157 PAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
............ .....+..++.++.++|.+||+.||.+|||+.++++ +.+++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~~ 283 (302)
T 2j7t_A 227 PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE--HPFVSSIT 283 (302)
T ss_dssp HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT--STTTTTCC
T ss_pred HHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc--ChHHhhhc
Confidence 766555443332 223345678999999999999999999999999998 66666543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=263.92 Aligned_cols=199 Identities=23% Similarity=0.342 Sum_probs=164.4
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
.+.||||+++++++...+..++|||++ +++|.+++.+.. ...+++..+..++.||+.||.|||+.| ++|+||||+|
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~N 167 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPEN 167 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCccc
Confidence 346999999999999999999999999 889999998654 234899999999999999999999999 9999999999
Q ss_pred EEEcC-------------------------CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHH
Q 027225 83 LLVDK-------------------------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYS 137 (226)
Q Consensus 83 il~~~-------------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 137 (226)
|+++. ++.++|+|||.+...... .....+++.|+|||++.+..++.++||||
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHH
Confidence 99975 789999999998754432 23456788999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCC------------------------CC-------------------
Q 027225 138 FGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE------------------------IP------------------- 174 (226)
Q Consensus 138 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~------------------- 174 (226)
|||++++|++|+.||...+..+....+........ .+
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 99999999999999988776655443322111100 00
Q ss_pred -CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 175 -RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 175 -~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
...++.+.++|.+||+.||.+|||+.++++ +.++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~--hp~f 359 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLK--HKFL 359 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGG
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhc--Cccc
Confidence 112477889999999999999999999987 5544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=261.74 Aligned_cols=207 Identities=24% Similarity=0.364 Sum_probs=165.3
Q ss_pred CCCCCcCcceeeeEEecCC--ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++++||||+++++++.+.. ..++||||+.+++|.+++........+++..++.++.|++.||.|||+.| ++|+|||
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlk 139 (319)
T 4euu_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIK 139 (319)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred HhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCC
Confidence 4679999999999998765 78999999999999999987554445999999999999999999999999 9999999
Q ss_pred CCcEEE----cCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc--------CCCCCCchhHHHHHHHHHHHHh
Q 027225 80 SPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR--------DEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 80 p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
|+||++ +.++.++|+|||.+........ .....++..|+|||++. +..++.++|+||||+++++|++
T Consensus 140 p~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~ 218 (319)
T 4euu_A 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (319)
T ss_dssp GGGEEEEECTTSCEEEEECCCTTCEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH
T ss_pred HHHEEEeccCCCCceEEEccCCCceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh
Confidence 999999 7777899999999876544322 23456788999999986 4567899999999999999999
Q ss_pred CCCCCCCCC----HHHHHHHHhhCCcc-----------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 148 LQQPWGNLN----PAQVVAAVGFKGKR-----------------------LEIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 148 g~~p~~~~~----~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
|..||.... ..+....+...... ...+..++..+.++|.+||+.||.+|||++
T Consensus 219 g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (319)
T 4euu_A 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (319)
T ss_dssp SSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHH
Confidence 999996422 12222222211110 011223456899999999999999999999
Q ss_pred HHHHHHHHhhc
Q 027225 201 TIMELLRPLIK 211 (226)
Q Consensus 201 ~~l~~l~~~~~ 211 (226)
|+++...+-..
T Consensus 299 ell~h~~d~~~ 309 (319)
T 4euu_A 299 QFFAETSDILH 309 (319)
T ss_dssp HHHHHHHHHTC
T ss_pred HhhhccHHHhh
Confidence 99998876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=265.13 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=163.4
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+||+.+++|.++....+ .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~ 153 (331)
T 4aaa_A 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPE 153 (331)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChh
Confidence 46899999999999999999999999999999998876543 3999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++++|++|..||...+..+.
T Consensus 154 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (331)
T 4aaa_A 154 NILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233 (331)
T ss_dssp GEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999987655444444456678899999999875 578999999999999999999999988776554
Q ss_pred HHHHhhCCcc-----------------C------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 161 VAAVGFKGKR-----------------L------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 161 ~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
...+...... . .....+++++.++|.+||+.||.+|||+.++++ +.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~ 311 (331)
T 4aaa_A 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQ 311 (331)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHH
T ss_pred HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc--Cchhc
Confidence 4332211000 0 011357899999999999999999999999997 55554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=256.85 Aligned_cols=205 Identities=26% Similarity=0.420 Sum_probs=167.8
Q ss_pred CCCCCcCcceeeeEEec----------------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHH
Q 027225 2 KRLRHPNIVLFMGAVTQ----------------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 65 (226)
++++||||+++++++.. ....++|+||+++++|.+++.... ...+++..++.++.|++.||.|
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~ 137 (284)
T 2a19_B 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDY 137 (284)
T ss_dssp HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHH
Confidence 46799999999998864 345899999999999999997542 2358999999999999999999
Q ss_pred HhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 66 lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
||+.| ++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++++|
T Consensus 138 lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 214 (284)
T 2a19_B 138 IHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214 (284)
T ss_dssp HHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHH
T ss_pred HHhCC--eeeccCCHHHEEEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHH
Confidence 99999 9999999999999999999999999987654432 23344678899999999988899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 146 ATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 146 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
++|..|+... ....... .....+..++.++.++|.+||+.||.+|||+.++++.|+.+.+.....
T Consensus 215 ~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 215 LHVCDTAFET--SKFFTDL----RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HSCCSSHHHH--HHHHHHH----HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HhcCCcchhH--HHHHHHh----hcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 9998887431 1111111 122345678999999999999999999999999999999988765543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=257.55 Aligned_cols=197 Identities=21% Similarity=0.269 Sum_probs=161.8
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.+||||+++++++.+++..++||||+ +++|.+++...+ ..+++..++.++.|++.||.|||+.| ++|+||||+||
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NI 188 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANI 188 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHE
Confidence 38999999999999999999999999 669999887643 24999999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 163 (226)
+++.++.+||+|||.+....... ......+++.|+|||++.+ .++.++||||+|+++++|++|..++..... ...
T Consensus 189 ll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~ 263 (311)
T 3p1a_A 189 FLGPRGRCKLGDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQ 263 (311)
T ss_dssp EECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHH
T ss_pred EECCCCCEEEccceeeeecccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHH
Confidence 99999999999999987654332 2334567889999999887 588999999999999999999776644222 222
Q ss_pred HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..........+..+++++.++|.+||+.||++|||+.++++ ..+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 310 (311)
T 3p1a_A 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA--LPVLRQ 310 (311)
T ss_dssp HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGSC
T ss_pred HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh--CccccC
Confidence 22222223345678999999999999999999999999999 777764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=266.63 Aligned_cols=208 Identities=20% Similarity=0.255 Sum_probs=164.2
Q ss_pred CCCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||+++++++...+ ..++||||+.++.+............+++..+..++.|++.||.|||++| ++
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--iv 163 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--IC 163 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 35789999999999995443 38899999987544443322112345999999999999999999999999 99
Q ss_pred EeCCCCCcEEEc-CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 75 HRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 75 h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||||||+||+++ .++.+||+|||+++...... ......+++.|+|||++.+. .++.++|+||+||++|+|++|+.||
T Consensus 164 HrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999 78999999999987653332 23345678899999998765 4899999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCcc---------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKR---------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+.+..+....+...... ..++..+++++.++|.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~- 321 (394)
T 4e7w_A 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC- 321 (394)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT-
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc-
Confidence 887765544333211000 0123458899999999999999999999999998
Q ss_pred HHHhhcCC
Q 027225 206 LRPLIKSP 213 (226)
Q Consensus 206 l~~~~~~~ 213 (226)
+.++++.
T Consensus 322 -hp~f~~~ 328 (394)
T 4e7w_A 322 -HPFFDEL 328 (394)
T ss_dssp -SGGGSTT
T ss_pred -Chhhhhh
Confidence 7777654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=263.49 Aligned_cols=199 Identities=23% Similarity=0.418 Sum_probs=169.3
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++...+..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||+
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl 232 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENIL 232 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence 7999999999999999999999999999999999863 34999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD------EPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
++.++.++|+|||++...... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999988765432 22334567889999999863 34678999999999999999999999887776
Q ss_pred HHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
.....+........ ....++.++.++|.+||+.||.+|||+.++++ ..+++
T Consensus 312 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~ 364 (365)
T 2y7j_A 312 LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ--HPFFE 364 (365)
T ss_dssp HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGC
T ss_pred HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CcccC
Confidence 66665543332222 12568899999999999999999999999998 66654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=260.13 Aligned_cols=203 Identities=25% Similarity=0.420 Sum_probs=160.7
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.+||||+++++++.+++..++||||+.+++|.+++...+ .+++..+..++.|++.||+|||++| ++|+||||+||
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Ni 142 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENI 142 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGE
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHE
Confidence 479999999999999999999999999999999998643 4899999999999999999999999 99999999999
Q ss_pred EEcCCCc---EEEccCCCcccccccc-------cccCCCCCCCCccCcccccC-----CCCCCchhHHHHHHHHHHHHhC
Q 027225 84 LVDKKYT---VKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 84 l~~~~~~---~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g 148 (226)
+++.++. ++|+|||++....... .......++..|+|||++.+ ..++.++|+||||+++++|++|
T Consensus 143 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g 222 (316)
T 2ac3_A 143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222 (316)
T ss_dssp EESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHS
T ss_pred EEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHC
Confidence 9988776 9999999886533211 11223457889999999875 4468899999999999999999
Q ss_pred CCCCCCCCH---------------HHHHHHHhhCCccCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 149 QQPWGNLNP---------------AQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 149 ~~p~~~~~~---------------~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
..||..... ......+... ....+ ..+++++.++|.+||+.||.+|||+.++++ +.+
T Consensus 223 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~ 298 (316)
T 2ac3_A 223 YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ--HPW 298 (316)
T ss_dssp SCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--STT
T ss_pred CCCCcccccccccccccccchhHHHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc--Chh
Confidence 999976532 2222333222 22222 468899999999999999999999999999 788
Q ss_pred hcCCCC
Q 027225 210 IKSPTP 215 (226)
Q Consensus 210 ~~~~~~ 215 (226)
+++..+
T Consensus 299 ~~~~~~ 304 (316)
T 2ac3_A 299 VQGCAP 304 (316)
T ss_dssp CC----
T ss_pred hcCCCC
Confidence 876544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=265.79 Aligned_cols=201 Identities=23% Similarity=0.348 Sum_probs=162.7
Q ss_pred CCC-CcCcceeeeEEecCC--ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 3 RLR-HPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 3 ~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++. ||||+++++++..++ ..|+||||+.+ +|.+++... .+++..+..++.|++.||.|||+.| ++|||||
T Consensus 64 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlk 136 (388)
T 3oz6_A 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMK 136 (388)
T ss_dssp HTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred hccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCC
Confidence 455 999999999997544 68999999975 899998763 3899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCccccccc---------------------ccccCCCCCCCCccCcccccC-CCCCCchhHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANT---------------------FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYS 137 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~---------------------~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~s 137 (226)
|+||+++.++.++|+|||+++..... ........+++.|+|||++.+ ..++.++|+||
T Consensus 137 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 216 (388)
T 3oz6_A 137 PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216 (388)
T ss_dssp GGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred HHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence 99999999999999999998754321 111223467889999999986 56899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccC---------------------------------------------C
Q 027225 138 FGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---------------------------------------------E 172 (226)
Q Consensus 138 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------------~ 172 (226)
+||++++|++|..||.+.+..+....+......+ .
T Consensus 217 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (388)
T 3oz6_A 217 LGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296 (388)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccc
Confidence 9999999999999998877666554432111100 1
Q ss_pred CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 173 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+..+++++.+||.+||+.||.+|||++++++ +.+++.
T Consensus 297 ~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~--Hp~~~~ 334 (388)
T 3oz6_A 297 PKADCNEEALDLLDKLLQFNPNKRISANDALK--HPFVSI 334 (388)
T ss_dssp TTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--STTTTT
T ss_pred ccccCCHHHHHHHHHhhccCcccCCCHHHHhC--CHHHHH
Confidence 12367899999999999999999999999999 677654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=256.98 Aligned_cols=210 Identities=30% Similarity=0.506 Sum_probs=166.5
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcC-----CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|++++||||+++++++..++..++|+||+.+++|.+++.. ......+++..++.++.|++.||.|||+.| ++|
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H 144 (303)
T 2vwi_A 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIH 144 (303)
T ss_dssp CCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCC
Confidence 5678999999999999999999999999999999999863 111345899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccc-----cccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-----LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~ 149 (226)
+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+ ..++.++|+||||+++++|++|.
T Consensus 145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 224 (303)
T 2vwi_A 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224 (303)
T ss_dssp CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999876543221 11233457889999999875 45789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhhCCcc--------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 150 QPWGNLNPAQVVAAVGFKGKR--------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.||...+.............. ......++.++.++|.+||+.||.+|||+.++++ +.+++...
T Consensus 225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~~ 295 (303)
T 2vwi_A 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR--HKFFQKAK 295 (303)
T ss_dssp CTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT--STTC----
T ss_pred CCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh--ChhhhcCC
Confidence 999887665544333222111 1223568899999999999999999999999998 67766543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.96 Aligned_cols=205 Identities=30% Similarity=0.586 Sum_probs=173.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+ +..++||||+.+|+|.+++...+ ..+++..++.++.|++.||.|||++| ++||||||+
T Consensus 446 ~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~ 520 (656)
T 2j0j_A 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 520 (656)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred HhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchH
Confidence 46799999999999854 56899999999999999998643 23899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~ 159 (226)
||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+
T Consensus 521 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 600 (656)
T 2j0j_A 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600 (656)
T ss_dssp GEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred hEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999999876543321 1223345678999999988889999999999999999997 999999888877
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+. .......+..+++.+.++|.+||..||.+|||+.++++.|++++..
T Consensus 601 ~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 601 VIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 766664 3344567788999999999999999999999999999999988753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=260.59 Aligned_cols=204 Identities=33% Similarity=0.534 Sum_probs=167.8
Q ss_pred CCCCCcCcceeeeEEe--cCCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCC---CCeEE
Q 027225 2 KRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRN---PPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~i~h 75 (226)
++++||||+++++++. .++..++|+||+++++|.+++.... ....+++..++.++.|++.||.+||+.| .+++|
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH 139 (279)
T 2w5a_A 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139 (279)
T ss_dssp HHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred HhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence 4679999999999884 4567999999999999999997532 1334899999999999999999999976 23999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus 140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 99999999999999999999998865443322222335678899999999888899999999999999999999999988
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 206 (226)
+..+....+.. ......+..++.++.++|.+||+.||.+|||+.++++.+
T Consensus 220 ~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 220 SQKELAGKIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp SHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CHHHHHHHHhh-cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 87776665543 333456778999999999999999999999999999843
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=259.53 Aligned_cols=209 Identities=20% Similarity=0.261 Sum_probs=167.6
Q ss_pred CCCCCcCcceeeeEEec--------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 2 KRLRHPNIVLFMGAVTQ--------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
++++||||+++++++.. .+..++||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||++| +
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i 145 (351)
T 3mi9_A 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK--I 145 (351)
T ss_dssp HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred HhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 46789999999999976 3468999999976 7777776543 23999999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCccccccc----ccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 148 (226)
+|+||||+||+++.++.++|+|||.+...... ........+++.|+|||++.+. .++.++|+||||+++++|++|
T Consensus 146 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred eCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999998754322 1222345568899999998764 478999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhhCCccCC--CCCC----------------------------CCHHHHHHHHHHcccCCCCCCC
Q 027225 149 QQPWGNLNPAQVVAAVGFKGKRLE--IPRN----------------------------VNPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~----------------------------~~~~~~~li~~~l~~~p~~Rps 198 (226)
..||...+..+....+........ .... .++++.++|.+||+.||.+|||
T Consensus 226 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 305 (351)
T 3mi9_A 226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305 (351)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence 999998877665554432211111 1000 2678999999999999999999
Q ss_pred HHHHHHHHHHhhcCCCCCC
Q 027225 199 FSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 199 ~~~~l~~l~~~~~~~~~~~ 217 (226)
+.++++ +.++...+.+.
T Consensus 306 ~~e~l~--hp~f~~~~~~~ 322 (351)
T 3mi9_A 306 SDDALN--HDFFWSDPMPS 322 (351)
T ss_dssp HHHHHT--SGGGGSSSCCC
T ss_pred HHHHhC--CCCcCCCCCcc
Confidence 999999 88888755443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=265.05 Aligned_cols=211 Identities=21% Similarity=0.274 Sum_probs=167.5
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
...|+||+++++++...+..++|+|++. ++|.+++.... ...+++..++.++.||+.||+|||+.| |+||||||+|
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~N 230 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPEN 230 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGG
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence 3478999999999999999999999996 59999987654 234899999999999999999999999 9999999999
Q ss_pred EEEcCCCc--EEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 83 LLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 83 il~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
|+++.++. ++|+|||+++..... .....+++.|+|||++.+..++.++|||||||++++|++|..||...+..+.
T Consensus 231 ILl~~~~~~~vkL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 231 ILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp EEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eEEccCCCcceEEeecccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999887 999999998654432 3345678899999999998899999999999999999999999988776655
Q ss_pred HHHHhhCCccC---------------------------------------------------------CCCCCCCHHHHH
Q 027225 161 VAAVGFKGKRL---------------------------------------------------------EIPRNVNPHVAS 183 (226)
Q Consensus 161 ~~~~~~~~~~~---------------------------------------------------------~~~~~~~~~~~~ 183 (226)
...+....... .++...++++.+
T Consensus 308 l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~d 387 (429)
T 3kvw_A 308 LACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387 (429)
T ss_dssp HHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHH
T ss_pred HHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHH
Confidence 43332110000 011234788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCCC
Q 027225 184 IIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222 (226)
Q Consensus 184 li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~ 222 (226)
||.+||+.||.+|||+.|+++ +.+++...+.+.....
T Consensus 388 li~~~L~~dP~~Rpta~e~L~--Hpw~~~~~~~~~~~~~ 424 (429)
T 3kvw_A 388 FLKQCLEWDPAVRMTPGQALR--HPWLRRRLPKPPTGEK 424 (429)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT--STTTC-----------
T ss_pred HHHHHCCCChhhCCCHHHHhC--ChhhccCCCCCCcccc
Confidence 999999999999999999999 8898887766655443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=261.65 Aligned_cols=213 Identities=19% Similarity=0.343 Sum_probs=166.6
Q ss_pred CCCCCcCcceeeeEEe----cCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++. .....++|+||+.+++|.+++.+. .....+++..++.++.|++.||.|||+.| ++|+
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~ 158 (317)
T 2buj_A 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHR 158 (317)
T ss_dssp HTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred hhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 5689999999999996 334689999999999999998752 11345999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccc---------cCCCCCCCCccCcccccCCC---CCCchhHHHHHHHHHH
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS---------SKSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWE 144 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~~ 144 (226)
||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+.. ++.++|+||||+++++
T Consensus 159 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 238 (317)
T 2buj_A 159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238 (317)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999987653321110 11223577899999987654 5889999999999999
Q ss_pred HHhCCCCCCCCCH--HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 145 LATLQQPWGNLNP--AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 145 l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
|++|..||..... ........ .......+..++.++.++|.+||+.||.+|||+.++++.|+.+....+.+.
T Consensus 239 l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 239 MMFGEGPYDMVFQKGDSVALAVQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp HHHSSCTTHHHHHTTSCHHHHHH-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred HHhCCCChhhhhcccchhhHHhh-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 9999999953111 11111111 222334456789999999999999999999999999999998876555443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=254.71 Aligned_cols=203 Identities=23% Similarity=0.391 Sum_probs=172.1
Q ss_pred CC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++ .||||+++++++.+++..++|+||+.+++|.+++.... .+++..+..++.|++.||.+||+.| ++|+||+|+
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ 153 (298)
T 1phk_A 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPE 153 (298)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcc
Confidence 44 49999999999999999999999999999999998643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc------CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR------DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++.++|+|||.+...... .......++..|+|||.+. ...++.++|+||||+++++|++|..||...
T Consensus 154 Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 154 NILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp GEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 999999999999999998764432 2233456788999999985 445788999999999999999999999888
Q ss_pred CHHHHHHHHhhCCccCCC--CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 NPAQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+..+....+......... ...++.++.++|.+||+.||.+|||+.++++ ..+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~ 290 (298)
T 1phk_A 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQQY 290 (298)
T ss_dssp SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGCTT
T ss_pred cHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhhhc
Confidence 777666655443333222 2468999999999999999999999999998 7777654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=256.33 Aligned_cols=197 Identities=20% Similarity=0.370 Sum_probs=162.0
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
+||||+++++++.+++..++|+||+++++|.+++..... ...+++..++.++.|++.||.|||++| ++|+||||+||
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NI 146 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNI 146 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHE
Confidence 899999999999999999999999999999999976321 134899999999999999999999999 99999999999
Q ss_pred EEcCC-------------------CcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHH
Q 027225 84 LVDKK-------------------YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILW 143 (226)
Q Consensus 84 l~~~~-------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~ 143 (226)
+++.+ ..++|+|||.+...... ....++..|+|||.+.+. .++.++|+||||++++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 222 (289)
T 1x8b_A 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 222 (289)
T ss_dssp EEC--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHH
T ss_pred EEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHH
Confidence 99844 47999999988765443 234578899999999876 4567999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 144 ELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 144 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+|++|..++...+.... + ........+..+++++.++|.+||+.||.+|||+.++++ +.++.+.
T Consensus 223 ~l~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~ 286 (289)
T 1x8b_A 223 CAAGAEPLPRNGDQWHE---I-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK--HSVLLSA 286 (289)
T ss_dssp HHTTCCCCCSSSHHHHH---H-HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--CTTC---
T ss_pred HHhcCCCCCcchhHHHH---H-HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh--ChHhhhh
Confidence 99999887655432221 2 133445667789999999999999999999999999998 6666653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=255.09 Aligned_cols=208 Identities=20% Similarity=0.278 Sum_probs=166.8
Q ss_pred CCCCcCcceeeeEE-ecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RLRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+++|++++..+..+ .+.+..++|+||+ +++|.+++.... ..+++..+..++.|++.||.|||++| ++|+||||+
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~ 134 (296)
T 4hgt_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD 134 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence 46777766665554 6677899999999 889999998532 23999999999999999999999999 999999999
Q ss_pred cEEE---cCCCcEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCC
Q 027225 82 NLLV---DKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 82 nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
||++ +.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||+|+++++|++|+.|
T Consensus 135 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 214 (296)
T 4hgt_A 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214 (296)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 9999 7889999999999876443321 22345678899999999998899999999999999999999999
Q ss_pred CCCCCHH---HHHHHH---hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 152 WGNLNPA---QVVAAV---GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 152 ~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
|...+.. +..... ............+++++.++|.+||+.||.+|||+.++++.|++++.....
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 215 WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred CcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 9754321 111111 111111122367899999999999999999999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=263.89 Aligned_cols=210 Identities=19% Similarity=0.238 Sum_probs=168.9
Q ss_pred CCCCcCcce---------------eeeEEec-CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHH
Q 027225 3 RLRHPNIVL---------------FMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66 (226)
Q Consensus 3 ~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 66 (226)
+++||||++ +++++.. ++..++||||+ +++|.+++.... ...+++..++.++.|++.||.||
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~L 175 (352)
T 2jii_A 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFL 175 (352)
T ss_dssp HHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHH
T ss_pred HhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 456777766 7777776 67899999999 899999998642 24599999999999999999999
Q ss_pred hcCCCCeEEeCCCCCcEEEcCCC--cEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHH
Q 027225 67 HRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYS 137 (226)
Q Consensus 67 H~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 137 (226)
|++| ++|+||||+||+++.++ .++|+|||++........ ......+++.|+|||.+.+..++.++|+||
T Consensus 176 H~~~--ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 253 (352)
T 2jii_A 176 HENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQS 253 (352)
T ss_dssp HHTT--CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred HhCC--ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHH
Confidence 9999 99999999999999998 899999999875443221 113346788999999999988999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC--HHHHHHHHhh-CCccCCC------CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 027225 138 FGVILWELATLQQPWGNLN--PAQVVAAVGF-KGKRLEI------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 208 (226)
Q Consensus 138 lG~~l~~l~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 208 (226)
||+++++|++|..||.... .......... ....... ...+++++.++|.+||+.||.+|||+.++++.|++
T Consensus 254 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp HHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 9999999999999997653 3322222211 1111111 12578999999999999999999999999999999
Q ss_pred hhcCCCCC
Q 027225 209 LIKSPTPQ 216 (226)
Q Consensus 209 ~~~~~~~~ 216 (226)
++......
T Consensus 334 ~~~~~~~~ 341 (352)
T 2jii_A 334 LLQDLRVS 341 (352)
T ss_dssp HHHHTTCC
T ss_pred HHHhcCCC
Confidence 98776544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=259.67 Aligned_cols=206 Identities=31% Similarity=0.529 Sum_probs=168.5
Q ss_pred CCCCCCcCcceeeeEEecCC--ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
|++++||||+++++++...+ ..++|+||+++++|.+++.... ..+++..++.++.|++.||.+||+.| ++|+||
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~di 171 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDL 171 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCC
Confidence 35789999999999987654 7899999999999999998643 24899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|..|+...
T Consensus 172 kp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 172 ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred CcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999876543321 122334566799999998888889999999999999999999887542
Q ss_pred CHH----------------HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 156 NPA----------------QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 156 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
... ...... ........+..++.++.++|.+||+.||.+|||+.++++.|+++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 252 PAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhccccchhhhHHHHHHHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 110 111111 1233455677899999999999999999999999999999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=258.08 Aligned_cols=205 Identities=32% Similarity=0.498 Sum_probs=166.9
Q ss_pred CCCCcCcceeeeEEecCC----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh--------cCC
Q 027225 3 RLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH--------RRN 70 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------~~~ 70 (226)
+++||||+++++++.... ..++|+||+.+++|.+++.+.. +++..++.++.|++.||.||| +.|
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 167 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC
Confidence 479999999999998876 7999999999999999997643 899999999999999999999 889
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccCCCC------CCchhHHHHHH
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPS------NEKSDIYSFGV 140 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~------~~~~Dv~slG~ 140 (226)
++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+... +.++|+||||+
T Consensus 168 --ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 168 --IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245 (342)
T ss_dssp --EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred --eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence 99999999999999999999999999876443321 2344567889999999987632 36899999999
Q ss_pred HHHHHHhC----------CCCCCCCC-----HHHHHHHHhhCCccCCCCC-----CCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 141 ILWELATL----------QQPWGNLN-----PAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 141 ~l~~l~~g----------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
++|+|++| ..||.... .................+. ..+..+.+++.+||+.||.+|||+.
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 325 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence 99999999 77886542 2333333322223333332 2346899999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 027225 201 TIMELLRPLIKSP 213 (226)
Q Consensus 201 ~~l~~l~~~~~~~ 213 (226)
++++.|+++....
T Consensus 326 ~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 326 RIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHh
Confidence 9999999997764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=253.69 Aligned_cols=210 Identities=20% Similarity=0.276 Sum_probs=167.6
Q ss_pred CCCCCcCcceeeeEE-ecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++|++++..+.++ .+.+..++|+||+ +++|.+++.... ..+++..+..++.|++.||+|||++| ++|+||||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp 133 (296)
T 3uzp_A 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKP 133 (296)
T ss_dssp HHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred HHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCH
Confidence 356777766655554 6677789999999 889999997432 24999999999999999999999999 99999999
Q ss_pred CcEEE---cCCCcEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC
Q 027225 81 PNLLV---DKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 81 ~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+||++ +.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|+.
T Consensus 134 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 3uzp_A 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999 4888999999999876544322 1234567889999999999889999999999999999999999
Q ss_pred CCCCCCH---HHHHHHH---hhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 151 PWGNLNP---AQVVAAV---GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 151 p~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
||...+. .+....+ ............+++++.+++.+||+.||.+|||+.++++.|++++......
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 214 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp TTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 9976332 1111111 1111112234678999999999999999999999999999999998776543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=259.83 Aligned_cols=201 Identities=22% Similarity=0.393 Sum_probs=161.2
Q ss_pred CCCC--cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 3 RLRH--PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 3 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++| |||+++++++.+++..++|||+ .+++|.+++.+.+ .+++.++..++.|++.||.|||+.| ++||||||
T Consensus 63 ~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp 136 (343)
T 3dbq_A 63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 136 (343)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred hhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCc
Confidence 4555 9999999999999999999995 5779999998743 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccC-----------CCCCCchhHHHHHHHHHHHHh
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRD-----------EPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Dv~slG~~l~~l~~ 147 (226)
+||+++ ++.++|+|||++........ ......+++.|+|||++.+ ..++.++||||||+++++|++
T Consensus 137 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 215 (343)
T 3dbq_A 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215 (343)
T ss_dssp GGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred ceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 999997 56899999999876543221 2234568899999999864 557889999999999999999
Q ss_pred CCCCCCCCCH-HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 148 LQQPWGNLNP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 148 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
|..||..... ................+...+.++.++|.+||+.||.+|||+.++++ +.+++.
T Consensus 216 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 279 (343)
T 3dbq_A 216 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 279 (343)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHS
T ss_pred CCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh--Cccccc
Confidence 9999976433 23333333334455667778899999999999999999999999998 555543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=253.50 Aligned_cols=206 Identities=23% Similarity=0.351 Sum_probs=170.4
Q ss_pred CCCCcCcceeeeEEe-----cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 3 RLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
+++||||+++++++. .....++|+|++. ++|.+++.... ...+++..++.++.|++.||.|||+.| ++|+|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~d 145 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 145 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecc
Confidence 358999999999987 5567999999997 59999997644 234899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
|+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++++|++|..||...+.
T Consensus 146 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 146 LKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CCGGGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCHHHeEEcCCCCEEEecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999999999987654322 23345678899999999988899999999999999999999999988776
Q ss_pred HHHHHHHhhCCc-------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGK-------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+..... .......++..+.++|.+||+.||.+|||+.++++ +.+++.
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~ 302 (326)
T 1blx_A 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQD 302 (326)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTT
T ss_pred HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc--Cccccc
Confidence 655444321100 01233568899999999999999999999999998 677665
Q ss_pred CCC
Q 027225 213 PTP 215 (226)
Q Consensus 213 ~~~ 215 (226)
...
T Consensus 303 ~~~ 305 (326)
T 1blx_A 303 LER 305 (326)
T ss_dssp CCC
T ss_pred cch
Confidence 443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=254.65 Aligned_cols=204 Identities=25% Similarity=0.449 Sum_probs=157.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~ 79 (226)
++++||||+++++++.+++..++|+||+++ +|.+++... .....+++..++.++.|++.||.|||++ | ++|+|||
T Consensus 61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlk 137 (290)
T 3fme_A 61 RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVK 137 (290)
T ss_dssp TTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCS
T ss_pred HhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCC
Confidence 568999999999999999999999999975 887776531 1133599999999999999999999998 9 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccc----cCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL----RDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|+||+++.++.++|+|||.+........ .....+++.|+|||.+ .+..++.++|+||+|+++++|++|..||...
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 138 PSNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp GGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred HHHEEECCCCCEEEeecCCccccccccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 9999999999999999999876543322 2334678899999996 4556788999999999999999999999863
Q ss_pred -CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 156 -NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
..................+..+++++.++|.+||+.||.+|||+.++++ +.+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--hp~f~ 271 (290)
T 3fme_A 217 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ--HPFFT 271 (290)
T ss_dssp SCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHH
T ss_pred CchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh--Ccccc
Confidence 3333333333233333344578999999999999999999999999998 45543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=261.59 Aligned_cols=198 Identities=22% Similarity=0.378 Sum_probs=160.7
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEE
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~ 85 (226)
||||+++++++..++..|+||| +.+++|.+++.+.. .+++.++..++.||+.||.|||+.| |+||||||+||++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll 188 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI 188 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEE
T ss_pred CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE
Confidence 6999999999999999999999 56789999998744 4899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccC-----------CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 86 DKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRD-----------EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 86 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
+ ++.+||+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 189 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf 267 (390)
T 2zmd_A 189 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267 (390)
T ss_dssp S-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred E-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcc
Confidence 6 57999999999876543221 2234568899999999865 35788999999999999999999999
Q ss_pred CCCCH-HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 153 GNLNP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 153 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..... ......+.........+...+.++.++|.+||+.||.+|||+.++++ ..+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~~~~ 326 (390)
T 2zmd_A 268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 326 (390)
T ss_dssp TTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHS
T ss_pred hhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh--CcCccc
Confidence 76533 33333333333444566777899999999999999999999999998 555543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=265.75 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=157.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++..+ ..++||||+.+++|.+++...+ .+++..+..++.|++.||.|||++| ++|+||||+
T Consensus 195 ~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~ 268 (419)
T 3i6u_A 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPE 268 (419)
T ss_dssp HHCCCTTBCCCCEEEESS-EEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred HhCCCCCEeeEEEEEecC-ceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChH
Confidence 568999999999998654 5899999999999999988643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCC---cEEEccCCCcccccccccccCCCCCCCCccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++ .++|+|||++...... .......+++.|+|||++.+ ..++.++|+||||+++++|++|..||...
T Consensus 269 NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 269 NVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp GEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred hEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99997544 5999999998765433 22334567889999999864 45678999999999999999999999764
Q ss_pred CHH-HHHHHHhhCCc--cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 156 NPA-QVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 156 ~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
... .....+..... .......+++.+.++|.+||+.||.+|||+.++++ +.+++.
T Consensus 348 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~~ 405 (419)
T 3i6u_A 348 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR--HPWLQD 405 (419)
T ss_dssp SSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGCC
T ss_pred cchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC--CcccCC
Confidence 332 22222221111 11223568999999999999999999999999998 666654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=259.90 Aligned_cols=210 Identities=29% Similarity=0.466 Sum_probs=151.2
Q ss_pred CC-CCcCcceeeeEEe--------cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 3 RL-RHPNIVLFMGAVT--------QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~--------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
++ +||||+++++++. ....+++|+||+. |+|.+++........+++..++.++.|++.||.|||+.|.++
T Consensus 81 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~i 159 (337)
T 3ll6_A 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI 159 (337)
T ss_dssp HHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Confidence 45 4999999999994 3344899999996 599998875332345999999999999999999999987669
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCcccccccccc------------cCCCCCCCCccCcccc---cCCCCCCchhHHHH
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS------------SKSAAGTPEWMAPEVL---RDEPSNEKSDIYSF 138 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------~~~~~~~~~~~~PE~~---~~~~~~~~~Dv~sl 138 (226)
+|+||||+||+++.++.++|+|||.+......... .....+++.|+|||++ .+..++.++|||||
T Consensus 160 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239 (337)
T ss_dssp BCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHH
T ss_pred EEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHH
Confidence 99999999999999999999999998764432111 1134477889999998 45567889999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 139 GVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 139 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
|+++++|++|..||.......... .......+...+..+.++|.+||+.||.+|||+.++++.|+.+.......+
T Consensus 240 G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 240 GCILYLLCFRQHPFEDGAKLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp HHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred HHHHHHHHhCCCCCcchhHHHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 999999999999997655433322 222233456677889999999999999999999999999999877544433
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=258.44 Aligned_cols=204 Identities=23% Similarity=0.317 Sum_probs=163.2
Q ss_pred CCCCCCcCcceeeeEEec--------------------------------------CCceEEEEeecccCCHHHHhcCC-
Q 027225 1 MKRLRHPNIVLFMGAVTQ--------------------------------------PPNLSIVTEYLSRGSLYRLLHKP- 41 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~sL~~~~~~~- 41 (226)
|++++||||+++++++.. +...++||||+++ +|.+.+...
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~ 132 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI 132 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH
Confidence 467899999999999843 3348899999985 877766531
Q ss_pred CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEc-CCCcEEEccCCCcccccccccccCCCCCCCCccC
Q 027225 42 GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120 (226)
Q Consensus 42 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 120 (226)
.....+++..+..++.||+.||.|||+.| ++||||||+||+++ .++.++|+|||.+....... ......++..|+|
T Consensus 133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~a 209 (383)
T 3eb0_A 133 RSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRA 209 (383)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccC
Confidence 11335999999999999999999999999 99999999999997 68899999999987654332 2334566889999
Q ss_pred cccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCc---------------------------cCC
Q 027225 121 PEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK---------------------------RLE 172 (226)
Q Consensus 121 PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~ 172 (226)
||.+.+.. ++.++|+||+||++++|++|+.||.+.+..+....+..... ...
T Consensus 210 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (383)
T 3eb0_A 210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI 289 (383)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH
T ss_pred HHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh
Confidence 99988754 89999999999999999999999988776655444321100 001
Q ss_pred CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 173 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 173 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
.+..+++++.++|.+||+.||.+|||+.++++ +.++
T Consensus 290 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f 325 (383)
T 3eb0_A 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMA--HPFF 325 (383)
T ss_dssp SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGG
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--CHHH
Confidence 34568899999999999999999999999996 4444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=265.27 Aligned_cols=208 Identities=24% Similarity=0.369 Sum_probs=167.1
Q ss_pred CCCCCcCcceeeeEEecCC--ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
++++||||+++++++.+.+ ..++||||+.+++|.+++........+++..++.++.|++.||.|||+.| ++|||||
T Consensus 62 ~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 139 (396)
T 4eut_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIK 139 (396)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred HhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcC
Confidence 4679999999999998765 68999999999999999987554445999999999999999999999999 9999999
Q ss_pred CCcEEE----cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC--------CCCCCchhHHHHHHHHHHHHh
Q 027225 80 SPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 80 p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~ 147 (226)
|+||++ +.++.++|+|||.+....... ......++..|+|||++.+ ..++.++|+||||+++|+|++
T Consensus 140 p~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t 218 (396)
T 4eut_A 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (396)
T ss_dssp GGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH
Confidence 999999 777789999999987654432 2334567889999999865 345678999999999999999
Q ss_pred CCCCCCCC----CHHHHHHHHhhCCcc-------------------C----CCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 148 LQQPWGNL----NPAQVVAAVGFKGKR-------------------L----EIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 148 g~~p~~~~----~~~~~~~~~~~~~~~-------------------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
|..||... ...+....+...... . ..+..++..+.+++.+||+.||++||++.
T Consensus 219 g~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (396)
T 4eut_A 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (396)
T ss_dssp SSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence 99999532 223333333222111 0 11123456889999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 027225 201 TIMELLRPLIKS 212 (226)
Q Consensus 201 ~~l~~l~~~~~~ 212 (226)
++++.+++++..
T Consensus 299 e~l~~l~~il~~ 310 (396)
T 4eut_A 299 QFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHHTC
T ss_pred HHHHHHHHHhhc
Confidence 999999998765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=268.83 Aligned_cols=191 Identities=14% Similarity=0.151 Sum_probs=153.3
Q ss_pred CCCCCCcCcceee-------eEEecCCc-----------------eEEEEeecccCCHHHHhcCCCC----CCcCCHHHH
Q 027225 1 MKRLRHPNIVLFM-------GAVTQPPN-----------------LSIVTEYLSRGSLYRLLHKPGV----REMLDERRR 52 (226)
Q Consensus 1 l~~l~h~~i~~~~-------~~~~~~~~-----------------~~lv~e~~~~~sL~~~~~~~~~----~~~~~~~~~ 52 (226)
|++++||||++++ +++.+.+. .|+||||+ +|+|.+++...+. ...+++..+
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~ 208 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR 208 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence 4677999999998 77766543 89999999 5799999986321 112335888
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-----
Q 027225 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE----- 127 (226)
Q Consensus 53 ~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----- 127 (226)
+.++.|++.||+|||++| ++||||||+||+++.++.+||+|||++...... .....+ +.|+|||++.+.
T Consensus 209 ~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~ 282 (377)
T 3byv_A 209 LQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISY 282 (377)
T ss_dssp HHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHH
T ss_pred HHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccc
Confidence 889999999999999999 999999999999999999999999998764432 223455 899999999877
Q ss_pred ------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHH
Q 027225 128 ------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 201 (226)
Q Consensus 128 ------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 201 (226)
.++.++||||||+++|+|++|..||...+..+... ........+++++.++|.+||+.||.+|||+.+
T Consensus 283 ~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 283 HRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred cccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 78999999999999999999999997654332211 112334678999999999999999999999999
Q ss_pred HHH
Q 027225 202 IME 204 (226)
Q Consensus 202 ~l~ 204 (226)
+++
T Consensus 357 ~l~ 359 (377)
T 3byv_A 357 AME 359 (377)
T ss_dssp HHT
T ss_pred Hhh
Confidence 987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.24 Aligned_cols=203 Identities=24% Similarity=0.412 Sum_probs=166.0
Q ss_pred CCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++... ...++|+|++.+ +|.+++.... +++..+..++.|++.||.|||++| ++|+
T Consensus 80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 152 (364)
T 3qyz_A 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN--VLHR 152 (364)
T ss_dssp HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred HhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence 468999999999999654 468999999975 9999987643 899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||||+||+++.++.++|+|||.+........ ......+++.|+|||++.+ ..++.++|+||+|+++++|++|..||
T Consensus 153 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 232 (364)
T 3qyz_A 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232 (364)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999876543322 1234567889999998654 44789999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCcc-----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
...+..+....+...... ......+++++.++|.+||+.||.+|||+.+++
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp CCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 877655544333211000 011246789999999999999999999999999
Q ss_pred HHHHHhhcCC
Q 027225 204 ELLRPLIKSP 213 (226)
Q Consensus 204 ~~l~~~~~~~ 213 (226)
+ +.+++..
T Consensus 313 ~--hp~~~~~ 320 (364)
T 3qyz_A 313 A--HPYLEQY 320 (364)
T ss_dssp T--SGGGTTT
T ss_pred c--Ccchhhc
Confidence 9 7887764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=259.80 Aligned_cols=205 Identities=27% Similarity=0.405 Sum_probs=157.9
Q ss_pred CCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++... +..|+|+|++.+ +|.+++.... .+++..+..++.||+.||.|||+.| ++||
T Consensus 80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g--ivHr 153 (432)
T 3n9x_A 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG--IIHR 153 (432)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCCC
Confidence 568999999999999766 569999999965 9999998743 4999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCccccccccc----------------------ccCCCCCCCCccCcccc-cCCCCCCch
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----------------------SSKSAAGTPEWMAPEVL-RDEPSNEKS 133 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~----------------------~~~~~~~~~~~~~PE~~-~~~~~~~~~ 133 (226)
||||+||+++.++.+||+|||+++....... ......++..|+|||++ .+..++.++
T Consensus 154 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~ 233 (432)
T 3n9x_A 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233 (432)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHH
T ss_pred CCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccc
Confidence 9999999999999999999999976443211 12455678999999986 455689999
Q ss_pred hHHHHHHHHHHHHhCCCC-----------CCCCCH------------------HH-----------------------HH
Q 027225 134 DIYSFGVILWELATLQQP-----------WGNLNP------------------AQ-----------------------VV 161 (226)
Q Consensus 134 Dv~slG~~l~~l~~g~~p-----------~~~~~~------------------~~-----------------------~~ 161 (226)
|+||+||++++|++|..| |.+.+. .+ ..
T Consensus 234 DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~ 313 (432)
T 3n9x_A 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI 313 (432)
T ss_dssp HHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred ccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHH
Confidence 999999999999985433 333220 00 11
Q ss_pred HHHhhCCccCC-----CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 162 AAVGFKGKRLE-----IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 162 ~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
..+........ ....+++++.+||.+||+.||.+|||++++++ +.+++...
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~ 369 (432)
T 3n9x_A 314 KYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVR 369 (432)
T ss_dssp HHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTTC
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc--Chhhhhcc
Confidence 11111111111 11458999999999999999999999999999 78877653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=256.04 Aligned_cols=198 Identities=24% Similarity=0.383 Sum_probs=164.8
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
+||||+++++++..++..++||||+.+++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||||+||+
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 191 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENIL 191 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEE
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 69999999999999999999999999999999998643 4999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEccCCCccccccc-ccccCCCCCCCCccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC----H
Q 027225 85 VDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNLN----P 157 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~ 157 (226)
++.++.++|+|||++...... ........+++.|+|||++.+. .++.++|+||||+++|+|++|..||.... .
T Consensus 192 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 271 (355)
T 1vzo_A 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271 (355)
T ss_dssp ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred ECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH
Confidence 999999999999998754322 2223345678899999999863 46889999999999999999999996432 2
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhc
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIK 211 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~ 211 (226)
......+ .......+..++..+.++|.+||..||.+|| +++++++ ..++.
T Consensus 272 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~--h~~f~ 326 (355)
T 1vzo_A 272 AEISRRI--LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFFQ 326 (355)
T ss_dssp HHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGGT
T ss_pred HHHHHHH--hccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc--Ccchh
Confidence 2333222 2334556778999999999999999999999 9999998 44444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=269.15 Aligned_cols=199 Identities=25% Similarity=0.379 Sum_probs=157.1
Q ss_pred CCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++...+ ..|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+.| |+|
T Consensus 116 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiH 187 (464)
T 3ttj_A 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIH 187 (464)
T ss_dssp HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 4679999999999996553 47999999976 56666643 2899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
|||||+||+++.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||+||++++|++|+.||.+.
T Consensus 188 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp CCCCGGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCChHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765432 2233456788999999999999999999999999999999999999988
Q ss_pred CHHHHHHHHhhCCccC--------------------C---------CCCC-----------CCHHHHHHHHHHcccCCCC
Q 027225 156 NPAQVVAAVGFKGKRL--------------------E---------IPRN-----------VNPHVASIIEACWANEPWK 195 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~--------------------~---------~~~~-----------~~~~~~~li~~~l~~~p~~ 195 (226)
+..+....+....... . ++.. .++++.+||.+||..||.+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 7655544332111100 0 0000 1567999999999999999
Q ss_pred CCCHHHHHHHHHHhhc
Q 027225 196 RPSFSTIMELLRPLIK 211 (226)
Q Consensus 196 Rps~~~~l~~l~~~~~ 211 (226)
|||++|+++ +.+++
T Consensus 347 R~ta~e~L~--Hp~~~ 360 (464)
T 3ttj_A 347 RISVDDALQ--HPYIN 360 (464)
T ss_dssp SCCHHHHHT--STTTG
T ss_pred CCCHHHHhc--Chhhh
Confidence 999999999 77765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=250.51 Aligned_cols=201 Identities=31% Similarity=0.494 Sum_probs=168.3
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+.+..++|+|++.+++|.+++...+ .+++..++.++.|++.||.+||+.| ++|+||+|+
T Consensus 76 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~ 150 (287)
T 2wei_A 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE 150 (287)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred HhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChh
Confidence 57899999999999999999999999999999999887633 4899999999999999999999999 999999999
Q ss_pred cEEEcCC---CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 82 NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 82 nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
||+++.+ +.++|+|||.+....... ......++..|+|||.+.+. ++.++|+||||+++++|++|..||...+..
T Consensus 151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 151 NILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp GEEESCSSTTCCEEECSTTGGGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hEEEecCCCcccEEEeccCcceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9999654 469999999886543321 11223356789999998765 889999999999999999999999988877
Q ss_pred HHHHHHhhCCccCCC--CCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+....+......... ...++.++.++|.+||+.||.+|||+.++++ ..+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~ 281 (287)
T 2wei_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQ 281 (287)
T ss_dssp HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHH
T ss_pred HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHh
Confidence 766665443332222 2578999999999999999999999999998 45544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=259.96 Aligned_cols=200 Identities=23% Similarity=0.367 Sum_probs=153.0
Q ss_pred CCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++... ...|+|+|++ +++|.+++... .+++..+..++.||+.||.|||+.| ++|
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH 155 (367)
T 2fst_X 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIH 155 (367)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eee
Confidence 467999999999999654 5689999999 67999988753 3999999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
|||||+||+++.++.++|+|||+++..... .....++..|+|||++.+ ..++.++|+||+||++++|++|+.||.+
T Consensus 156 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 156 RDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp CCCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCHhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998764432 234567889999999887 5688999999999999999999999988
Q ss_pred CCHHHHHHHHhhCCcc------------------------C-----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKR------------------------L-----EIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~------------------------~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+..+....+...... . ......++++.+||.+||..||.+|||+.++++
T Consensus 233 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~- 311 (367)
T 2fst_X 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA- 311 (367)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT-
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc-
Confidence 7765544433211000 0 011356889999999999999999999999999
Q ss_pred HHHhhcCC
Q 027225 206 LRPLIKSP 213 (226)
Q Consensus 206 l~~~~~~~ 213 (226)
+.+++..
T Consensus 312 -hp~~~~~ 318 (367)
T 2fst_X 312 -HAYFAQY 318 (367)
T ss_dssp -SGGGTTT
T ss_pred -Chhhhhc
Confidence 7777754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=258.38 Aligned_cols=204 Identities=24% Similarity=0.414 Sum_probs=145.0
Q ss_pred CCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 3 RLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
.+.||||+++++++.. +...++||||+.+++|.+++.+.+ ...+++..++.++.|++.||.|||++| ++|+||
T Consensus 78 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dl 154 (336)
T 3fhr_A 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDV 154 (336)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred hcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence 4689999999999976 445899999999999999998754 345999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+|+||+++. ++.++|+|||.+...... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus 155 kp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CHHHEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 999999976 445999999998754432 223445688999999998888889999999999999999999999765
Q ss_pred CHHHHHHH----HhhCC--ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 156 NPAQVVAA----VGFKG--KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 156 ~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
........ +.... ........+++++.++|.+||+.||.+|||+.++++ ..+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 294 (336)
T 3fhr_A 233 TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQS 294 (336)
T ss_dssp ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHTG
T ss_pred cchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Ccccccc
Confidence 54332111 11111 111223578999999999999999999999999999 6676654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=257.23 Aligned_cols=199 Identities=24% Similarity=0.376 Sum_probs=162.6
Q ss_pred CCCCCcCcceeeeEEecCCce------EEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQPPNL------SIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++...+.. ++|+||+. ++|.+++.. .+++..+..++.|++.||.|||++| ++|
T Consensus 96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH 167 (371)
T 4exu_A 96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVH 167 (371)
T ss_dssp HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcC
Confidence 467999999999999877654 99999997 589888753 2899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||||+||+++.++.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||..
T Consensus 168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 168 RDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp SCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998754432 234566889999999887 5689999999999999999999999988
Q ss_pred CCHHHHHHHHhhCCcc-----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+..+....+...... ......+++++.++|.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~- 323 (371)
T 4exu_A 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT- 323 (371)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT-
T ss_pred CChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc-
Confidence 7765554433211100 0112467899999999999999999999999999
Q ss_pred HHHhhcCC
Q 027225 206 LRPLIKSP 213 (226)
Q Consensus 206 l~~~~~~~ 213 (226)
+.+++..
T Consensus 324 -hp~f~~~ 330 (371)
T 4exu_A 324 -HPFFEPF 330 (371)
T ss_dssp -SGGGTTT
T ss_pred -CcccccC
Confidence 7887754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=262.52 Aligned_cols=205 Identities=26% Similarity=0.370 Sum_probs=156.4
Q ss_pred CCCCCcCcceeeeEEec-----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++.. ....|+|+|++. ++|.+++.... .+++..+..++.||+.||.|||+.| |+||
T Consensus 107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--iiHr 180 (458)
T 3rp9_A 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG--ILHR 180 (458)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCC
T ss_pred HhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC--cCCC
Confidence 46799999999999943 356999999985 69999998743 4999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCccccccccc---------------------------ccCCCCCCCCccCcccc-cCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---------------------------SSKSAAGTPEWMAPEVL-RDEP 128 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~---------------------------~~~~~~~~~~~~~PE~~-~~~~ 128 (226)
||||+||+++.++.+||+|||+++....... ......+++.|+|||++ .+..
T Consensus 181 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 260 (458)
T 3rp9_A 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260 (458)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCC
T ss_pred CCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCC
Confidence 9999999999999999999999976432211 12234568899999986 4566
Q ss_pred CCCchhHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHH-hh----------
Q 027225 129 SNEKSDIYSFGVILWELAT-----------LQQPWGNLNP--------------------AQVVAAV-GF---------- 166 (226)
Q Consensus 129 ~~~~~Dv~slG~~l~~l~~-----------g~~p~~~~~~--------------------~~~~~~~-~~---------- 166 (226)
++.++|||||||++|+|++ |..+|.+.+. .+....+ ..
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~ 340 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHh
Confidence 8999999999999999998 5666644321 0100000 00
Q ss_pred -------------CCc-----cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 167 -------------KGK-----RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 167 -------------~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
... ........++++.+||.+||..||.+|||++|+++ +.++++..
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~~~ 404 (458)
T 3rp9_A 341 ALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKEVR 404 (458)
T ss_dssp TSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC
T ss_pred hcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhhcC
Confidence 000 01112456899999999999999999999999999 88887653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=261.47 Aligned_cols=207 Identities=21% Similarity=0.281 Sum_probs=161.1
Q ss_pred CCCCCCcCcceeeeEEecC------CceEEEEeecccCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
|++++||||+++++++... ...++|+||+.+ +|.+.+... .....+++..+..++.||+.||.|||+.| |
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--i 177 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--I 177 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--E
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 3578999999999988432 237799999976 666655421 11334999999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCC-CcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCC
Q 027225 74 VHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 74 ~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
+||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+. .++.++||||+||++|+|++|+.|
T Consensus 178 vHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCChhhEEEeCCCCeEEeccchhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 999999999999965 578999999997644322 23345678899999998765 689999999999999999999999
Q ss_pred CCCCCHHHHHHHHhhCC---------------ccCC------------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 152 WGNLNPAQVVAAVGFKG---------------KRLE------------IPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 152 ~~~~~~~~~~~~~~~~~---------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
|.+.+..+....+.... .... ++..+++++.+||.+||..||.+|||+.++++
T Consensus 257 f~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 98877554433221110 0001 23457899999999999999999999999998
Q ss_pred HHHHhhcCC
Q 027225 205 LLRPLIKSP 213 (226)
Q Consensus 205 ~l~~~~~~~ 213 (226)
+.++...
T Consensus 337 --hp~f~~~ 343 (420)
T 1j1b_A 337 --HSFFDEL 343 (420)
T ss_dssp --SGGGGGG
T ss_pred --CHhhccc
Confidence 6666543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=254.90 Aligned_cols=206 Identities=24% Similarity=0.370 Sum_probs=165.4
Q ss_pred CCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++... ...++|+|++. ++|.+++... .+++..+..++.|++.||.|||++| ++|+
T Consensus 64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~ 136 (353)
T 2b9h_A 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN--VIHR 136 (353)
T ss_dssp HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred HhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence 467999999999988654 67999999997 4999998763 3899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccc----------cCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHH
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----------SKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l 145 (226)
||||+||+++.++.++|+|||.+......... .....++..|+|||++.+ ..++.++|+||||+++++|
T Consensus 137 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 216 (353)
T 2b9h_A 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216 (353)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHH
Confidence 99999999999999999999998764432111 122456889999998764 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhhCCcc------------------------------CCCCCCCCHHHHHHHHHHcccCCCC
Q 027225 146 ATLQQPWGNLNPAQVVAAVGFKGKR------------------------------LEIPRNVNPHVASIIEACWANEPWK 195 (226)
Q Consensus 146 ~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 195 (226)
++|..||...+..+....+...... ......+++++.++|.+||+.||.+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 296 (353)
T 2b9h_A 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296 (353)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGG
T ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCccc
Confidence 9999999887765543322111000 0012468899999999999999999
Q ss_pred CCCHHHHHHHHHHhhcCCCCC
Q 027225 196 RPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 196 Rps~~~~l~~l~~~~~~~~~~ 216 (226)
|||+.++++ +.+++.....
T Consensus 297 Rpt~~ell~--hp~~~~~~~~ 315 (353)
T 2b9h_A 297 RITAKEALE--HPYLQTYHDP 315 (353)
T ss_dssp SCCHHHHHT--SGGGTTTCCT
T ss_pred CCCHHHHhc--CccccccCCc
Confidence 999999999 7888765443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=254.37 Aligned_cols=196 Identities=26% Similarity=0.392 Sum_probs=157.7
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++..++ .++|+||+.+++|.+++.... .+++..++.++.|++.||.|||++| ++|+||+|+
T Consensus 70 ~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~ 143 (322)
T 2ycf_A 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPE 143 (322)
T ss_dssp HHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred HhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 4679999999999997665 899999999999999997643 4999999999999999999999999 999999999
Q ss_pred cEEEcCCCc---EEEccCCCcccccccccccCCCCCCCCccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++. ++|+|||.+........ .....++..|+|||++. ...++.++|+||||+++++|++|..||...
T Consensus 144 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 144 NVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp GEEESSSSSSCCEEECCCTTCEECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred HEEEecCCCCCeEEEccCccceecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999987654 99999999876443211 12234678999999974 455789999999999999999999999764
Q ss_pred CHH-HHHHHHhhCCc--cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 156 NPA-QVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 156 ~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
... .....+..... ....+..++.++.++|.+||+.||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 332 22222211111 11223568999999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=256.03 Aligned_cols=207 Identities=21% Similarity=0.241 Sum_probs=162.3
Q ss_pred CCCCCcCcceeeeEEecCCc-------eEEEEeecccCCHHHHhcC-CCCCCcCCHHHHHHHHHHHHHHHHHHh--cCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPN-------LSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDVAKGMNYLH--RRNP 71 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~ 71 (226)
++++||||+++++++...+. .++||||+.+ +|.+.+.. ......+++..+..++.|++.||.||| +.|
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~- 151 (360)
T 3e3p_A 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN- 151 (360)
T ss_dssp HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-
T ss_pred HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-
Confidence 35689999999999965433 8899999986 55443331 112345899999999999999999999 899
Q ss_pred CeEEeCCCCCcEEEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCC
Q 027225 72 PIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 72 ~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~ 149 (226)
++|+||||+||+++. ++.++|+|||.+....... ......+++.|+|||++.+.. ++.++||||||+++++|++|.
T Consensus 152 -ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 152 -VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp -CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred -eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999996 8899999999987654432 233456788999999987654 799999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhhCCcc------------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCH
Q 027225 150 QPWGNLNPAQVVAAVGFKGKR------------------------------LEIPRNVNPHVASIIEACWANEPWKRPSF 199 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 199 (226)
.||...+..+....+...... .......++++.++|.+||+.||.+|||+
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 309 (360)
T 3e3p_A 230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309 (360)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH
Confidence 999887776655444211000 11122367899999999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 027225 200 STIMELLRPLIKSPT 214 (226)
Q Consensus 200 ~~~l~~l~~~~~~~~ 214 (226)
.++++ +.++++..
T Consensus 310 ~e~l~--hp~f~~~~ 322 (360)
T 3e3p_A 310 YEALC--HPYFDELH 322 (360)
T ss_dssp HHHTT--SGGGGGGG
T ss_pred HHHhc--CccccccC
Confidence 99999 77766543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=259.61 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=155.3
Q ss_pred CCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++...+ ..|+||||+.+ +|.+++.. .+++..+..++.|++.||.|||++| ++|
T Consensus 79 ~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH 150 (371)
T 2xrw_A 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIH 150 (371)
T ss_dssp HHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence 4679999999999997664 68999999975 78888853 2899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||||+||+++.++.++|+|||.+....... ......++..|+|||++.+..++.++|+||||+++++|++|..||.+.
T Consensus 151 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp SCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCHHHEEEcCCCCEEEEEeeccccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999987654321 223456788999999999988999999999999999999999999887
Q ss_pred CHHHHHHHHhhCCccC--------------------C--------------CCC------CCCHHHHHHHHHHcccCCCC
Q 027225 156 NPAQVVAAVGFKGKRL--------------------E--------------IPR------NVNPHVASIIEACWANEPWK 195 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~--------------------~--------------~~~------~~~~~~~~li~~~l~~~p~~ 195 (226)
+..+....+....... . .+. ..+.++.+||.+||+.||.+
T Consensus 230 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 7665544432211100 0 000 11568999999999999999
Q ss_pred CCCHHHHHHHHHHhhcC
Q 027225 196 RPSFSTIMELLRPLIKS 212 (226)
Q Consensus 196 Rps~~~~l~~l~~~~~~ 212 (226)
|||++++++ +.+++.
T Consensus 310 R~t~~e~l~--hp~~~~ 324 (371)
T 2xrw_A 310 RISVDEALQ--HPYINV 324 (371)
T ss_dssp SCCHHHHHH--SHHHHT
T ss_pred CCCHHHHhC--Ccchhh
Confidence 999999998 666553
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=253.41 Aligned_cols=200 Identities=23% Similarity=0.371 Sum_probs=162.1
Q ss_pred CCCCCcCcceeeeEEecCCc------eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++...+. .++|+||+. ++|.+++.. .+++..+..++.|++.||.|||++| ++|
T Consensus 78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH 149 (353)
T 3coi_A 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVH 149 (353)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 46799999999999987654 499999997 488888753 2899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||..
T Consensus 150 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 150 RDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp SSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998754432 234466889999999887 5678999999999999999999999988
Q ss_pred CCHHHHHHHHhhC-----------------------------CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 155 LNPAQVVAAVGFK-----------------------------GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 155 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+..+....+... .........+++++.++|.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~- 305 (353)
T 3coi_A 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT- 305 (353)
T ss_dssp SCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT-
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc-
Confidence 7765543332110 0011223467899999999999999999999999998
Q ss_pred HHHhhcCCC
Q 027225 206 LRPLIKSPT 214 (226)
Q Consensus 206 l~~~~~~~~ 214 (226)
+.+++...
T Consensus 306 -hp~f~~~~ 313 (353)
T 3coi_A 306 -HPFFEPFR 313 (353)
T ss_dssp -SGGGTTTC
T ss_pred -Ccchhhcc
Confidence 77776543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=251.66 Aligned_cols=207 Identities=21% Similarity=0.341 Sum_probs=164.3
Q ss_pred CCCCCcCcceeeeEEe--------------cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 2 KRLRHPNIVLFMGAVT--------------QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
++++||||+++++++. +.+..++|+||+. ++|.+++.+. .+++..++.++.|++.||+|||
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH 137 (320)
T 2i6l_A 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH 137 (320)
T ss_dssp HTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH
Confidence 5789999999999884 3467899999997 5999999753 3899999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEc-CCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHH
Q 027225 68 RRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVIL 142 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l 142 (226)
++| ++|+||||+||+++ +++.++|+|||.+....... .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 138 ~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 215 (320)
T 2i6l_A 138 SAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215 (320)
T ss_dssp HTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHH
T ss_pred hCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHH
Confidence 999 99999999999997 56799999999987643221 11223345778999998865 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHhhCCcc----------------------------CCCCCCCCHHHHHHHHHHcccCCC
Q 027225 143 WELATLQQPWGNLNPAQVVAAVGFKGKR----------------------------LEIPRNVNPHVASIIEACWANEPW 194 (226)
Q Consensus 143 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~ 194 (226)
++|++|..||...+..+....+...... ......++.++.++|.+||+.||.
T Consensus 216 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 295 (320)
T 2i6l_A 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295 (320)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcc
Confidence 9999999999887765554433211110 012346899999999999999999
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCC
Q 027225 195 KRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 195 ~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
+|||+.++++ +.+++....+.
T Consensus 296 ~Rpt~~ell~--hp~~~~~~~p~ 316 (320)
T 2i6l_A 296 DRLTAEEALS--HPYMSIYSFPM 316 (320)
T ss_dssp GSCCHHHHHT--SHHHHTTCC--
T ss_pred ccCCHHHHhC--CcccccccCcc
Confidence 9999999999 78887654443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=250.11 Aligned_cols=201 Identities=20% Similarity=0.326 Sum_probs=162.0
Q ss_pred CCC-CcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 3 RLR-HPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 3 ~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
+++ ||||+++++++.+ ....++|+||+.+++|.+++.. +++..+..++.|++.||.|||++| ++|+|||
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dik 157 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVK 157 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCC
Confidence 455 9999999999987 6679999999999999999864 899999999999999999999999 9999999
Q ss_pred CCcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC-C
Q 027225 80 SPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNL-N 156 (226)
Q Consensus 80 p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~ 156 (226)
|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||... +
T Consensus 158 p~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 158 PHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred HHHEEEcCCCCEEEEEeCCCceEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 9999999776 89999999987544332 2334567888999999987 56889999999999999999999998443 2
Q ss_pred HHHHHHHHhh-------------CC----------------------ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHH
Q 027225 157 PAQVVAAVGF-------------KG----------------------KRLEIPRNVNPHVASIIEACWANEPWKRPSFST 201 (226)
Q Consensus 157 ~~~~~~~~~~-------------~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 201 (226)
..+....+.. .. .....+..+++++.++|.+||+.||.+|||+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 2221111100 00 000112237899999999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 027225 202 IMELLRPLIKSPT 214 (226)
Q Consensus 202 ~l~~l~~~~~~~~ 214 (226)
+++ +.+++...
T Consensus 317 ~l~--hp~f~~~~ 327 (330)
T 3nsz_A 317 AME--HPYFYTVV 327 (330)
T ss_dssp HHT--SGGGTTCC
T ss_pred Hhc--CccHhhhc
Confidence 999 78877643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=256.43 Aligned_cols=204 Identities=20% Similarity=0.323 Sum_probs=159.5
Q ss_pred CCCCCcCcceeeeEEec-----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 2 KRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
++++||||+++++++.. ....|+|+||+.+ +|.+++.... ..+++..+..++.|++.||.|||++| ++|+
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~ 158 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG--VVHR 158 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc--CEec
Confidence 46799999999999843 3458999999974 8888887543 34999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||||+||+++.++.++|+|||.+....... ......+++.|+|||++.+ ..++.++|+||+|+++++|++|..||...
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCChHHEEEcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986543322 2334566788999999877 56899999999999999999999999887
Q ss_pred CHHHHHHHHhhCCcc------------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 156 NPAQVVAAVGFKGKR------------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
+..+....+...... .......++.+.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~- 316 (362)
T 3pg1_A 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR- 316 (362)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT-
T ss_pred CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc-
Confidence 766554433211100 0112456889999999999999999999999999
Q ss_pred HHHhhcCC
Q 027225 206 LRPLIKSP 213 (226)
Q Consensus 206 l~~~~~~~ 213 (226)
+.+++..
T Consensus 317 -hp~f~~~ 323 (362)
T 3pg1_A 317 -HPYFESL 323 (362)
T ss_dssp -SGGGTTT
T ss_pred -Cchhhhc
Confidence 7887765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=254.01 Aligned_cols=203 Identities=14% Similarity=0.112 Sum_probs=165.6
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC--CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
...|+||+++++++...+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.| |+||||||
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp 200 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKP 200 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSG
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCH
Confidence 3459999999999999999999999999999999997421 1345999999999999999999999999 99999999
Q ss_pred CcEEEcC-----------CCcEEEccCCCcccccc--cccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 81 PNLLVDK-----------KYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 81 ~nil~~~-----------~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
+||+++. ++.++|+|||++..... .........++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 201 ~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp GGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred HHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 9999988 89999999999965331 1223345568999999999999989999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCC-CCHHHHHHHHHHhhcCC
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR-PSFSTIMELLRPLIKSP 213 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R-ps~~~~l~~l~~~~~~~ 213 (226)
|+.||........ ...........++.+.+++..|++.+|.+| |++.++.+.|++++...
T Consensus 281 g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 281 GTYMKVKNEGGEC------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp SSCCCEEEETTEE------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCccccCCCCce------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 9999854322100 000000111346789999999999999999 78899999998887653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=260.52 Aligned_cols=211 Identities=21% Similarity=0.336 Sum_probs=156.3
Q ss_pred CCCCCCcCcceeeeEEe--cCCceEEEEeecccCCHHHHhcCC------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKP------GVREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++||||+++++++. .....++|+||+.+ +|.+++... .....+++..++.++.||+.||.|||++|
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-- 148 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 35689999999999995 46779999999975 888877531 11224899999999999999999999999
Q ss_pred eEEeCCCCCcEEE----cCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHH
Q 027225 73 IVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWE 144 (226)
Q Consensus 73 i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 144 (226)
|+||||||+||++ +.++.++|+|||+++...... .......+++.|+|||++.+. .++.++|||||||++|+
T Consensus 149 ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 228 (405)
T 3rgf_A 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228 (405)
T ss_dssp CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHH
T ss_pred EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHH
Confidence 9999999999999 677899999999987654321 223345678899999999874 48899999999999999
Q ss_pred HHhCCCCCCCCCHH----------HHHHHHhhCCccC-----------------------------------CCCCCCCH
Q 027225 145 LATLQQPWGNLNPA----------QVVAAVGFKGKRL-----------------------------------EIPRNVNP 179 (226)
Q Consensus 145 l~~g~~p~~~~~~~----------~~~~~~~~~~~~~-----------------------------------~~~~~~~~ 179 (226)
|++|..||...+.. ............. ......++
T Consensus 229 ll~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (405)
T 3rgf_A 229 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308 (405)
T ss_dssp HHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTS
T ss_pred HHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCH
Confidence 99999999755431 1111111000000 00112377
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 180 ~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
.+.+||.+||+.||.+|||++++++ +.++.+.+.+
T Consensus 309 ~~~~Ll~~~L~~dP~~R~ta~e~L~--hp~f~~~~~~ 343 (405)
T 3rgf_A 309 KAFHLLQKLLTMDPIKRITSEQAMQ--DPYFLEDPLP 343 (405)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTSSSCC
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc--ChhhccCCCC
Confidence 8999999999999999999999999 8998875543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=260.54 Aligned_cols=205 Identities=21% Similarity=0.282 Sum_probs=166.2
Q ss_pred CCCC-cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
.++| ++|..+..++.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+|+||||+
T Consensus 58 ~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~ 132 (483)
T 3sv0_A 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPD 132 (483)
T ss_dssp HTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcc
Confidence 4555 56666777777888899999999 889999998532 23999999999999999999999999 999999999
Q ss_pred cEEE---cCCCcEEEccCCCccccccccc-------ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCC
Q 027225 82 NLLV---DKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP 151 (226)
Q Consensus 82 nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 151 (226)
||++ +.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P 212 (483)
T 3sv0_A 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (483)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999 6888999999999876543322 12255678899999999999999999999999999999999999
Q ss_pred CCCCCH---HHHHHHHhhC---CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 152 WGNLNP---AQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 152 ~~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
|..... .+....+... .........++.++.+++.+||+.+|.+||++.+|++.|++++..
T Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 213 WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp TSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 976443 2222222111 111123367899999999999999999999999999999988653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=249.27 Aligned_cols=199 Identities=22% Similarity=0.290 Sum_probs=163.5
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.|++|+++++++.+.+..++||||+ +++|.+++...+ ...+++..+..++.|++.||+|||++| ++|+||||+||+
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 150 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENIL 150 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEE
Confidence 4567999999999999999999999 889999998654 234899999999999999999999999 999999999999
Q ss_pred EcC-------------------CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHH
Q 027225 85 VDK-------------------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145 (226)
Q Consensus 85 ~~~-------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 145 (226)
++. ++.++|+|||.+...... .....++..|+|||++.+..++.++|+||||+++++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp ESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred EeccccccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence 987 668999999998754332 2345678899999999998899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhhCCcc------------------------------------------CCCCCCCCHHHHH
Q 027225 146 ATLQQPWGNLNPAQVVAAVGFKGKR------------------------------------------LEIPRNVNPHVAS 183 (226)
Q Consensus 146 ~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~ 183 (226)
++|..||...+..+........... .......++++.+
T Consensus 228 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp HHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 9999999887766544332211100 0111223578999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 184 IIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 184 li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+|.+||+.||.+|||+.++++ +++++.
T Consensus 308 li~~~L~~dP~~Rpt~~ell~--hp~f~~ 334 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALK--HPFFDL 334 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTT--SGGGGG
T ss_pred HHHHHhCcCcccccCHHHHhc--CHHHHH
Confidence 999999999999999999998 666654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=248.16 Aligned_cols=202 Identities=22% Similarity=0.375 Sum_probs=160.0
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEE
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~ 85 (226)
||||+++++++.+++..++|+| +.+++|.+++...+ .+++..++.++.|++.||.|||+.| ++|+||+|+||++
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~ 160 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI 160 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE
Confidence 6999999999999999999999 55789999998743 4899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccC-----------CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 86 DKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRD-----------EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 86 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
++ +.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||
T Consensus 161 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (313)
T 3cek_A 161 VD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239 (313)
T ss_dssp ET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence 75 7999999999875433221 1234457889999999876 35778999999999999999999999
Q ss_pred CCCCH-HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 027225 153 GNLNP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216 (226)
Q Consensus 153 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 216 (226)
..... ................+...+.++.++|.+||+.||.+|||+.++++ ..+++....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~~~ 302 (313)
T 3cek_A 240 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHP 302 (313)
T ss_dssp TTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHCC---
T ss_pred hhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc--CccccCCCCc
Confidence 76543 33333333333445566778899999999999999999999999999 6676654433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=248.03 Aligned_cols=203 Identities=27% Similarity=0.440 Sum_probs=156.4
Q ss_pred CCCCCCcCcceeeeEEec-------------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh
Q 027225 1 MKRLRHPNIVLFMGAVTQ-------------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH 67 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 67 (226)
|++++||||+++++++.+ .+..++|+||+++++|.+++...+ ..+++..++.++.|++.||.|||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH 133 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH 133 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH
Confidence 467899999999998865 356899999999999999998543 24888999999999999999999
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--------------cccCCCCCCCCccCcccccCC-CCCCc
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--------------LSSKSAAGTPEWMAPEVLRDE-PSNEK 132 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--------------~~~~~~~~~~~~~~PE~~~~~-~~~~~ 132 (226)
++| ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.+
T Consensus 134 ~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 211 (303)
T 1zy4_A 134 SQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211 (303)
T ss_dssp HTT--CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTH
T ss_pred hCC--eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcch
Confidence 999 9999999999999999999999999987543221 112334577889999999865 57899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhCC--ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 133 SDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKG--KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 133 ~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
+|+||||+++++|++ ||... +..+......... .....+...+..+.++|.+||+.||.+|||+.++++ +.+
T Consensus 212 ~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~ 286 (303)
T 1zy4_A 212 IDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN--SGW 286 (303)
T ss_dssp HHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH--SSC
T ss_pred hhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC--CCC
Confidence 999999999999998 45432 2222333322111 122344567788999999999999999999999998 566
Q ss_pred hcC
Q 027225 210 IKS 212 (226)
Q Consensus 210 ~~~ 212 (226)
++.
T Consensus 287 ~~~ 289 (303)
T 1zy4_A 287 LPV 289 (303)
T ss_dssp SCC
T ss_pred cCC
Confidence 543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=249.97 Aligned_cols=199 Identities=27% Similarity=0.482 Sum_probs=142.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcC--CCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDL 78 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di 78 (226)
+.++||||+++++++.+++..++|+||+.+ +|.+++.. ......+++..+..++.|++.||.+||+. | ++|+||
T Consensus 76 ~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dl 152 (327)
T 3aln_A 76 RSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDI 152 (327)
T ss_dssp SSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCC
T ss_pred HcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCC
Confidence 567999999999999999999999999986 88877753 11133489999999999999999999998 9 999999
Q ss_pred CCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccc----cCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL----RDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 79 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+|+||+++.++.++|+|||.+........ .....++..|+|||.+ .+..++.++|+||||+++++|++|..||..
T Consensus 153 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 153 KPSNILLDRSGNIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp CGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred CHHHEEEcCCCCEEEccCCCceecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999876543322 2233578899999998 455678999999999999999999999976
Q ss_pred CCHHHHHHHHhhCCccCCC----CCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKRLEI----PRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+................. ...+++++.++|.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 232 WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 5432111111111111112 2468999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=247.61 Aligned_cols=197 Identities=27% Similarity=0.448 Sum_probs=151.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~p 80 (226)
+.++||||+++++++.+++..++||||+ ++.+..+.... ...+++..+..++.|++.||.|||+. | ++|+||+|
T Consensus 79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp 153 (318)
T 2dyl_A 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKP 153 (318)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCG
T ss_pred HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCH
Confidence 4579999999999999999999999999 55666666532 22489999999999999999999995 9 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.++|+|||.+....... ......+++.|+|||.+. +..++.++|+||+|+++++|++|..||...
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 154 SNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp GGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred HHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999886544322 123445788999999985 445788999999999999999999999874
Q ss_pred -CHHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 156 -NPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 156 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+..+......... ........+++++.++|.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 233 KTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3333333332221 222223468999999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=261.28 Aligned_cols=192 Identities=14% Similarity=0.086 Sum_probs=142.0
Q ss_pred CCcCcceee-------eEEecC-----------------CceEEEEeecccCCHHHHhcCCCCCCcCCHHHH------HH
Q 027225 5 RHPNIVLFM-------GAVTQP-----------------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR------LN 54 (226)
Q Consensus 5 ~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~------~~ 54 (226)
+||||++++ +++... ...|+||||+. ++|.+++...+. .+....+ ..
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~ 198 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHI 198 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHH
Confidence 699988755 555433 23899999998 799999986421 2444455 67
Q ss_pred HHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC--CCCCCc
Q 027225 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSNEK 132 (226)
Q Consensus 55 ~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~ 132 (226)
++.||+.||+|||++| ++||||||+||+++.++.+||+|||++........ ...+++.|+|||++.+ ..++.+
T Consensus 199 i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~ 273 (371)
T 3q60_A 199 LTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFTHA 273 (371)
T ss_dssp HHHHHHHHHHHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECCHH
T ss_pred HHHHHHHHHHHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCcCcc
Confidence 7799999999999999 99999999999999999999999999876544321 2334589999999987 668999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hhC--CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 133 SDIYSFGVILWELATLQQPWGNLNPAQVVAAV-----GFK--GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 133 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+|+||||+++|+|++|+.||............ ... .........+++.+.++|.+||+.||++|||+.++++
T Consensus 274 ~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999999766432111000 000 1111223578999999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=245.65 Aligned_cols=192 Identities=24% Similarity=0.474 Sum_probs=158.8
Q ss_pred CCcCcceeeeEEecCCceEEEEee-cccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEY-LSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~-~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
+||||+++++++.+.+..++|+|+ +.+++|.+++.+.+ .+++..++.++.|++.||.|||+.| ++|+||+|+||
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni 170 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENI 170 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhE
Confidence 899999999999999999999999 78999999998743 3999999999999999999999999 99999999999
Q ss_pred EEc-CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 84 LVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 84 l~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
+++ .++.++|+|||.+...... ......++..|+|||.+.+..+ +.++|+||||+++++|++|+.||.... +.
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~- 245 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EI- 245 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH-
T ss_pred EEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HH-
Confidence 999 8899999999998765443 2234557889999999876655 458999999999999999999997532 11
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.......+..++.++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 246 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--~~~~~~~ 290 (312)
T 2iwi_A 246 -----LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL--DPWMQTP 290 (312)
T ss_dssp -----HHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--STTTCC-
T ss_pred -----hhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc--ChhhcCc
Confidence 11234566789999999999999999999999999998 6666543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=249.15 Aligned_cols=201 Identities=18% Similarity=0.273 Sum_probs=161.8
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEE
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV 85 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~ 85 (226)
+.+++.+++++...+..++|||++ +++|.+++.... ...+++..++.++.||+.||.|||++| ++|+||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll 156 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILF 156 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence 344999999999999999999999 567777776543 234899999999999999999999999 9999999999999
Q ss_pred -------------------cCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 86 -------------------DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 86 -------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
+.++.++|+|||.+...... .....++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence 66789999999998754332 23456788999999999988999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhhCCccC------------------------------------------CCCCCCCHHHHHH
Q 027225 147 TLQQPWGNLNPAQVVAAVGFKGKRL------------------------------------------EIPRNVNPHVASI 184 (226)
Q Consensus 147 ~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~l 184 (226)
+|..||...+..+....+....... ......+.++.++
T Consensus 234 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 313 (355)
T 2eu9_A 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313 (355)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence 9999998877655433322111000 0011224589999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 185 IEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 185 i~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
|.+||+.||.+|||+.++++ +.++++..+
T Consensus 314 i~~~L~~dP~~Rpt~~e~l~--hp~f~~~~~ 342 (355)
T 2eu9_A 314 MRRMLEFDPAQRITLAEALL--HPFFAGLTP 342 (355)
T ss_dssp HHHHTCSSTTTSCCHHHHTT--SGGGGGCCH
T ss_pred HHHHhcCChhhCcCHHHHhc--ChhhcCCCh
Confidence 99999999999999999998 777776543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=256.24 Aligned_cols=197 Identities=25% Similarity=0.384 Sum_probs=151.0
Q ss_pred CC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++ +||||+++++++.+.+..|+|+|++.+ +|.+++..... ...+..+..++.|++.||.|||+.| |+||||||+
T Consensus 73 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~ 147 (432)
T 3p23_A 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPH 147 (432)
T ss_dssp HSCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTT
T ss_pred hccCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHH
Confidence 45 799999999999999999999999965 99999986542 2445566789999999999999999 999999999
Q ss_pred cEEEcC---C--CcEEEccCCCcccccccc---cccCCCCCCCCccCcccccC---CCCCCchhHHHHHHHHHHHHh-CC
Q 027225 82 NLLVDK---K--YTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELAT-LQ 149 (226)
Q Consensus 82 nil~~~---~--~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~-g~ 149 (226)
||+++. + ..++|+|||++....... .......+++.|+|||++.+ ..++.++|||||||++++|++ |.
T Consensus 148 NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp SEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred HEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 999953 2 357899999987644321 22334568899999999974 456779999999999999999 89
Q ss_pred CCCCCCCHHHHHHHHhhCCcc-CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 150 QPWGNLNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 150 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.||.................. ...+...+..+.++|.+||+.||.+|||+.++++
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp BTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 999766554444333211111 1112334567899999999999999999999995
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=246.35 Aligned_cols=192 Identities=21% Similarity=0.423 Sum_probs=162.6
Q ss_pred CCcCcceeeeEEecCCceEEEEeeccc-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.||||+++++++.+.+..++|+|++.+ ++|.+++...+ .+++..++.++.|++.||.|||+.| ++|+||+|+||
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NI 180 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENI 180 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHE
Confidence 469999999999999999999999975 89999998643 4899999999999999999999999 99999999999
Q ss_pred EEc-CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 84 LVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 84 l~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
+++ +++.++|+|||.+...... ......++..|+|||.+.+... +.++|+||||+++++|++|..||...+ +.
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~- 255 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI- 255 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH-
T ss_pred EEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hh-
Confidence 999 7889999999998765433 2234467889999999876654 678999999999999999999997532 11
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.......+..+++++.++|.+||+.||.+|||+.++++ ..+++..
T Consensus 256 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--hp~~~~~ 300 (320)
T 3a99_A 256 -----IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDV 300 (320)
T ss_dssp -----HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSSC
T ss_pred -----hcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc--CHhhcCc
Confidence 11233456789999999999999999999999999998 5666554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.38 Aligned_cols=200 Identities=22% Similarity=0.235 Sum_probs=161.5
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc--CCCCeEEeCCCCCc
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR--RNPPIVHRDLKSPN 82 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~i~h~di~p~n 82 (226)
.|++|+++++++...+..++|||++. ++|.+++.... ...+++..+..++.|++.||.|||+ .| |+||||||+|
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~N 189 (382)
T 2vx3_A 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPEN 189 (382)
T ss_dssp GGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGG
T ss_pred cceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCccc
Confidence 34569999999999999999999996 49999998654 2348999999999999999999994 67 9999999999
Q ss_pred EEEc--CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 83 LLVD--KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 83 il~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
|+++ .++.++|+|||+++..... .....+++.|+|||++.+..++.++|||||||++++|++|..||...+..+.
T Consensus 190 Ill~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 190 ILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp EEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9995 4778999999998765432 3345678899999999998899999999999999999999999998877665
Q ss_pred HHHHhhCCccCC----------------CC------------------CC----------------------------CC
Q 027225 161 VAAVGFKGKRLE----------------IP------------------RN----------------------------VN 178 (226)
Q Consensus 161 ~~~~~~~~~~~~----------------~~------------------~~----------------------------~~ 178 (226)
...+........ .+ .. .+
T Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (382)
T 2vx3_A 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADY 346 (382)
T ss_dssp HHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHH
T ss_pred HHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhh
Confidence 544322110000 00 00 01
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 179 ~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+++.+||.+||+.||.+|||+.++++ +++++..
T Consensus 347 ~~~~dli~~mL~~dP~~Rpta~e~L~--hp~f~~~ 379 (382)
T 2vx3_A 347 LKFKDLILRMLDYDPKTRIQPYYALQ--HSFFKKT 379 (382)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGCC-
T ss_pred HHHHHHHHHhcCCChhhCCCHHHHhc--CcccccC
Confidence 37899999999999999999999999 7887764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=252.98 Aligned_cols=198 Identities=21% Similarity=0.301 Sum_probs=155.2
Q ss_pred CCcCcceeeeEEe----cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCC
Q 027225 5 RHPNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK 79 (226)
Q Consensus 5 ~h~~i~~~~~~~~----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~ 79 (226)
.|+||+++++++. +....++|||++ +++|.+.+.+.. ...+++..++.++.||+.||.|||++ | ++|||||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDik 174 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIK 174 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCS
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 4899999999997 556799999999 556666665432 23499999999999999999999998 9 9999999
Q ss_pred CCcEEEcCCC-------------------------------------------------cEEEccCCCcccccccccccC
Q 027225 80 SPNLLVDKKY-------------------------------------------------TVKVCDFGLSRLKANTFLSSK 110 (226)
Q Consensus 80 p~nil~~~~~-------------------------------------------------~~~l~df~~~~~~~~~~~~~~ 110 (226)
|+||+++.++ .++|+|||.+...... ..
T Consensus 175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~ 251 (397)
T 1wak_A 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FT 251 (397)
T ss_dssp GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SC
T ss_pred HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---Cc
Confidence 9999998775 7999999998765432 33
Q ss_pred CCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-hhCCc--------------
Q 027225 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP------AQVVAAV-GFKGK-------------- 169 (226)
Q Consensus 111 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~~~~-------------- 169 (226)
...++..|+|||++.+..++.++|||||||++|+|++|..||...+. ......+ .....
T Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 331 (397)
T 1wak_A 252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331 (397)
T ss_dssp SCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGG
T ss_pred cCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccc
Confidence 45678899999999998899999999999999999999999975432 1111111 00000
Q ss_pred -------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 170 -------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 170 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
....+...++++.+||.+||+.||.+|||+.++++ +.+++
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 396 (397)
T 1wak_A 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR--HPWLN 396 (397)
T ss_dssp TBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT--SGGGG
T ss_pred ccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh--Ccccc
Confidence 00112233567899999999999999999999998 66654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=252.08 Aligned_cols=197 Identities=24% Similarity=0.407 Sum_probs=147.9
Q ss_pred CCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCC----cCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE----MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
.+||||+++++++.+++..|+|+||+. |+|.+++....... ..++..++.++.|++.||+|||++| ++|||||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLk 142 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLK 142 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCC
Confidence 389999999999999999999999996 59999998754211 1133356789999999999999999 9999999
Q ss_pred CCcEEEcCC-------------CcEEEccCCCccccccccc----ccCCCCCCCCccCcccccC-------CCCCCchhH
Q 027225 80 SPNLLVDKK-------------YTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRD-------EPSNEKSDI 135 (226)
Q Consensus 80 p~nil~~~~-------------~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv 135 (226)
|+||+++.+ +.++|+|||++........ ......+++.|+|||++.+ ..++.++||
T Consensus 143 p~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp GGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred hHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 999999754 4899999999876543321 1224567889999999975 557899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCC----CCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 136 YSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEI----PRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 136 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
|||||++++|++ |..||......+..... ........ ...+++++.++|.+||+.||.+|||+.++++
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHHHHHHH-TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhHHHHhc-CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 999999999999 89999765544322211 11111111 1234578999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=249.51 Aligned_cols=201 Identities=20% Similarity=0.350 Sum_probs=157.9
Q ss_pred CCcCcceeeeEEecCC----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEeCCC
Q 027225 5 RHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK 79 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i~h~di~ 79 (226)
.||||+++++++...+ ..++|+|++ +++|.+++.... ...+++..+..++.||+.||.|||++ | ++|+|||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dik 159 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIK 159 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCS
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCC
Confidence 4899999999997654 699999999 889999997643 23489999999999999999999998 9 9999999
Q ss_pred CCcEEEc------CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 80 SPNLLVD------KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 80 p~nil~~------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
|+||+++ ..+.++|+|||.+...... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999995 3447999999998765432 234467889999999999889999999999999999999999997
Q ss_pred CCCHH------H-HHHHHhhCC---------------------------------------ccCCCCCCCCHHHHHHHHH
Q 027225 154 NLNPA------Q-VVAAVGFKG---------------------------------------KRLEIPRNVNPHVASIIEA 187 (226)
Q Consensus 154 ~~~~~------~-~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~li~~ 187 (226)
..+.. + ......... .....+..++.++.+||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 54311 1 111110000 0112233456789999999
Q ss_pred HcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 188 CWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 188 ~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
||+.||.+|||+.++++ +.+++...
T Consensus 317 ~L~~dP~~Rpt~~ell~--hp~f~~~~ 341 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVN--HPWLKDTL 341 (373)
T ss_dssp GGCSSTTTCBCHHHHHT--CGGGTTCT
T ss_pred HhccCccccCCHHHHhh--Chhhhccc
Confidence 99999999999999999 77877653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=238.09 Aligned_cols=186 Identities=26% Similarity=0.439 Sum_probs=148.2
Q ss_pred CCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 3 RLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
..+||||+++++++.. ....++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.| ++|+||
T Consensus 67 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl 143 (299)
T 3m2w_A 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 143 (299)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred hccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence 4589999999999976 677999999999999999998754 235999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 79 KSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 79 ~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+||+++. ++.++|+|||.+.... +..++.++|+||+|+++++|++|..||...
T Consensus 144 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 144 KPENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp SGGGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred CHHHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999999998 7889999999874322 233678899999999999999999999765
Q ss_pred CHHHHHHHHhhC--CccCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 156 NPAQVVAAVGFK--GKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 156 ~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+........... ......+ ..+++++.++|.+||+.||.+|||+.++++ +.++.....
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~~~~ 265 (299)
T 3m2w_A 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTK 265 (299)
T ss_dssp ------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHTGGG
T ss_pred cchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhccccc
Confidence 543322111111 1111222 568999999999999999999999999998 666665443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=257.30 Aligned_cols=209 Identities=20% Similarity=0.253 Sum_probs=163.0
Q ss_pred CCCCCcCcceeeeEEec------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 2 KRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
++++||||+++++++.. ++..++|+||+++++|.+++........+++..++.++.|++.||.|||+.| ++|
T Consensus 67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVH 144 (676)
T 3qa8_A 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIH 144 (676)
T ss_dssp HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCC
T ss_pred HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 46799999999999865 6778999999999999999987654456999999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCc---EEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 76 RDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 76 ~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
+||+|+||+++.++. ++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHeEeecCCCceeEEEccccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 999999999997664 8999999987654332 234456788999999999888999999999999999999999999
Q ss_pred CCCCHHHHH---------HHHhhC---Cc------c----CCCCCCCCHHHHHHHHHHcccCCCCCCCHHH-----HHHH
Q 027225 153 GNLNPAQVV---------AAVGFK---GK------R----LEIPRNVNPHVASIIEACWANEPWKRPSFST-----IMEL 205 (226)
Q Consensus 153 ~~~~~~~~~---------~~~~~~---~~------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-----~l~~ 205 (226)
......... ...... .. . ......+++.+.++|.+||..||.+|||+.+ ..+.
T Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 224 LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred CcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 654322110 000000 00 0 0122346789999999999999999999988 4566
Q ss_pred HHHhhcCC
Q 027225 206 LRPLIKSP 213 (226)
Q Consensus 206 l~~~~~~~ 213 (226)
++.++...
T Consensus 304 l~~iL~~k 311 (676)
T 3qa8_A 304 LDSILSLK 311 (676)
T ss_dssp HHHHHCCC
T ss_pred HHHHHhcc
Confidence 66666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=232.80 Aligned_cols=178 Identities=17% Similarity=0.197 Sum_probs=144.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..|+||||++|++|.+++.+. ....++..++.|++.||.|||++| ++|+||||+
T Consensus 86 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~ 158 (286)
T 3uqc_A 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPS 158 (286)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGG
T ss_pred hcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcc
Confidence 5789999999999999999999999999999999999642 456678889999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
||+++.+|.++|++++. ++ .++.++|+||||+++|+|++|+.||...+..+..
T Consensus 159 NIll~~~g~~kl~~~~~--------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 159 RVRVSIDGDVVLAYPAT--------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp GEEEETTSCEEECSCCC--------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred cEEEcCCCCEEEEeccc--------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 99999999999985432 22 2678999999999999999999999875542211
Q ss_pred H-HHhhCCccC----CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 162 A-AVGFKGKRL----EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 162 ~-~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
. ......... .....+++++.++|.+||+.||.+| |+.++++.|+++.....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0 000000111 1235789999999999999999999 99999999999876544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=259.19 Aligned_cols=189 Identities=21% Similarity=0.286 Sum_probs=150.8
Q ss_pred CCCCCCcCcceeeeEEecCCc-----eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|++++||||+++++++.+.+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||++| |+|
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiH 205 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVY 205 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--Cee
Confidence 467899999999999987665 7999999999999988754 3899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||||+||+++.+ .+||+|||.+...... ....+++.|+|||++.+. .+.++||||||+++++|++|..|+...
T Consensus 206 rDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 206 NDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred cccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 9999999999986 8999999998765433 345678999999998776 488999999999999999998887642
Q ss_pred CHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHhh
Q 027225 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-SFSTIMELLRPLI 210 (226)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~ 210 (226)
.... ..........++.+.++|.+||+.||.+|| +++++...|..++
T Consensus 280 ~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 280 YVDG--------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ECSS--------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccc--------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 1100 000000112457899999999999999998 4666666666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=230.95 Aligned_cols=170 Identities=15% Similarity=0.155 Sum_probs=137.1
Q ss_pred ceEEEEeecccCCHHHHhcC----CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccC
Q 027225 21 NLSIVTEYLSRGSLYRLLHK----PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDF 96 (226)
Q Consensus 21 ~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df 96 (226)
.++++++.+ +++|.+++.. ......+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~~~~kL~DF 255 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGF 255 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecCCeEEEEec
Confidence 467788866 5699998851 112345888899999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCccCcccc----------cCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Q 027225 97 GLSRLKANTFLSSKSAAGTPEWMAPEVL----------RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 166 (226)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~----------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 166 (226)
|+++..... .....+ +.|+|||++ .+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 256 G~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~--- 328 (413)
T 3dzo_A 256 EHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW--- 328 (413)
T ss_dssp GGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG---
T ss_pred cceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH---
Confidence 998765443 234455 899999999 555578899999999999999999999987654332221
Q ss_pred CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 167 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 167 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
.......+++++.++|.+||+.||.+||++.+++
T Consensus 329 ---~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 329 ---IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp ---GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ---HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1222346889999999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=224.42 Aligned_cols=173 Identities=15% Similarity=0.147 Sum_probs=133.0
Q ss_pred CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCcEEEcCCC--------
Q 027225 19 PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNLLVDKKY-------- 89 (226)
Q Consensus 19 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~i~h~di~p~nil~~~~~-------- 89 (226)
.+..|+||||+.+|++.+.+.+ ..+++..++.++.||+.||.||| +.| |+||||||+||+++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~ 207 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTL 207 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeec
Confidence 6789999999999977666644 23899999999999999999999 899 99999999999999887
Q ss_pred ------------cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCC
Q 027225 90 ------------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI-LWELATLQQPWGNLN 156 (226)
Q Consensus 90 ------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~-l~~l~~g~~p~~~~~ 156 (226)
.+||+|||+++..... ...+++.|+|||++.+.. +.++||||+|++ .+++++|..||....
T Consensus 208 ~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~ 281 (336)
T 2vuw_A 208 NGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL 281 (336)
T ss_dssp TTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH
T ss_pred cCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh
Confidence 8999999999765432 336788999999998876 889999998777 667888988885321
Q ss_pred H-HHHHHHHh-hCCccCC----CCCCCCHHHHHHHHHHcccCCCCCCCHHHHH-HHHHHhh
Q 027225 157 P-AQVVAAVG-FKGKRLE----IPRNVNPHVASIIEACWANEPWKRPSFSTIM-ELLRPLI 210 (226)
Q Consensus 157 ~-~~~~~~~~-~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l-~~l~~~~ 210 (226)
. ........ ....... .+..+++++.+||.+||+.| |+.+++ + ++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~--Hp~f 335 (336)
T 2vuw_A 282 WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQ--HSLF 335 (336)
T ss_dssp HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHH--CGGG
T ss_pred hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhc--CCCc
Confidence 1 11111111 0111111 12357889999999999976 999998 6 4443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=225.40 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=103.4
Q ss_pred CCCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|+++ .|+||+++++++++++..|+||||++|++|.+++.+.+ .++.. +++.||+.||+|+|++| |+|||||
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIK 366 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG--FWHDDVR 366 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT--CEESCCC
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC--ceeccCc
Confidence 3456 79999999999999999999999999999999998754 36654 47889999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL 148 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 148 (226)
|+|||++.+|++||+|||+++.............+++.|+|||++.+. ...++|+|++|++++.+.++
T Consensus 367 PeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 367 PWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp GGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred hHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 999999999999999999987655444444445678899999999876 56789999999987776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-24 Score=180.02 Aligned_cols=136 Identities=18% Similarity=0.244 Sum_probs=111.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++..++...+..|+||||+++++|.+++.. +..++.|++.+|.|||++| |+||||||+
T Consensus 394 ~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~ 460 (540)
T 3en9_A 394 ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTS 460 (540)
T ss_dssp HHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTT
T ss_pred HhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHH
Confidence 567999999665555567778999999999999999875 4478999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccc-------cCCCCCCCCccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLS-------SKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||+++. .+||+|||+++........ .....+++.|+|||++.. ..++..+|+|+..+-..+-+.++.+|
T Consensus 461 NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 461 NFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp SEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999999 9999999999865543211 124457889999999986 45677889999888777777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.7e-18 Score=131.08 Aligned_cols=77 Identities=21% Similarity=0.248 Sum_probs=64.4
Q ss_pred ceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCC
Q 027225 10 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY 89 (226)
Q Consensus 10 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~ 89 (226)
+++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.+||+.| ++|+||||+||+++ ++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TT
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CC
Confidence 555555543 55799999999999998 432 123468999999999999999 99999999999999 99
Q ss_pred cEEEccCCCcc
Q 027225 90 TVKVCDFGLSR 100 (226)
Q Consensus 90 ~~~l~df~~~~ 100 (226)
.++|+|||+++
T Consensus 230 ~vkl~DFG~a~ 240 (282)
T 1zar_A 230 GIWIIDFPQSV 240 (282)
T ss_dssp EEEECCCTTCE
T ss_pred cEEEEECCCCe
Confidence 99999999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=7.6e-15 Score=110.57 Aligned_cols=71 Identities=23% Similarity=0.299 Sum_probs=59.5
Q ss_pred ceEEEEeeccc-C----CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCcEEEcCCCcEEEc
Q 027225 21 NLSIVTEYLSR-G----SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNLLVDKKYTVKVC 94 (226)
Q Consensus 21 ~~~lv~e~~~~-~----sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~i~h~di~p~nil~~~~~~~~l~ 94 (226)
..++||||+.+ | +|.++... .++..+..++.|++.+|.+|| +.| ++||||||+||+++. .++|+
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~--~~~li 211 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID--KVYFI 211 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS--SEEEC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC--cEEEE
Confidence 57999999942 3 77776543 234566789999999999999 999 999999999999998 89999
Q ss_pred cCCCccc
Q 027225 95 DFGLSRL 101 (226)
Q Consensus 95 df~~~~~ 101 (226)
|||++..
T Consensus 212 DFG~a~~ 218 (258)
T 1zth_A 212 DMGQAVT 218 (258)
T ss_dssp CCTTCEE
T ss_pred ECccccc
Confidence 9999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.25 E-value=6.2e-13 Score=104.72 Aligned_cols=69 Identities=14% Similarity=0.166 Sum_probs=57.0
Q ss_pred eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEEEcCCC----------cE
Q 027225 22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----------TV 91 (226)
Q Consensus 22 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil~~~~~----------~~ 91 (226)
.++||||++|++|..+... +....++.|++.+|.+||+.| ++||||||.|||+++++ .+
T Consensus 186 ~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~d~~~~~~~~ 254 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAEDPSSITLTP 254 (397)
T ss_dssp TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSSCTTSEEEEE
T ss_pred ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcccccccccce
Confidence 4799999999888665432 123467889999999999999 99999999999998776 38
Q ss_pred EEccCCCccc
Q 027225 92 KVCDFGLSRL 101 (226)
Q Consensus 92 ~l~df~~~~~ 101 (226)
.++||+.+..
T Consensus 255 ~iID~~Q~V~ 264 (397)
T 4gyi_A 255 IIIXFPQMVS 264 (397)
T ss_dssp EECCCTTCEE
T ss_pred EEEEeCCccc
Confidence 9999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=1.7e-09 Score=81.35 Aligned_cols=85 Identities=13% Similarity=0.055 Sum_probs=68.0
Q ss_pred CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-----------------
Q 027225 6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR----------------- 68 (226)
Q Consensus 6 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~----------------- 68 (226)
+..+.++++++.+.+..|+|||+++|.+|.+.+.. ......++.++..+|..||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 56788899999888899999999999999887421 11223577888999999998
Q ss_pred ------------------------------------------CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 69 ------------------------------------------RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 69 ------------------------------------------~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
.. ++|||++|.||++++++.+.++||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~--l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV--FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEE--EECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCce--EECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 34 8999999999999876556799998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.74 E-value=2.9e-08 Score=78.00 Aligned_cols=91 Identities=18% Similarity=0.224 Sum_probs=71.4
Q ss_pred CcCcceeeeEEecC---CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-------------
Q 027225 6 HPNIVLFMGAVTQP---PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR------------- 69 (226)
Q Consensus 6 h~~i~~~~~~~~~~---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~------------- 69 (226)
+..+.+++.++.+. +..|+|||+++|.++.+... ..++..+...++.++..+|..||+.
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~ 171 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKP 171 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCC
Confidence 44578888888776 45899999999977754211 1267888888999999999999972
Q ss_pred -------------------------------------------CCCeEEeCCCCCcEEEcCCCc--EEEccCCCccc
Q 027225 70 -------------------------------------------NPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL 101 (226)
Q Consensus 70 -------------------------------------------~~~i~h~di~p~nil~~~~~~--~~l~df~~~~~ 101 (226)
...++|||+++.||+++.++. +.++||+.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 172 GNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 123999999999999987653 68999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.61 E-value=9.4e-08 Score=71.43 Aligned_cols=81 Identities=19% Similarity=0.167 Sum_probs=60.1
Q ss_pred cceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC------------------
Q 027225 9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN------------------ 70 (226)
Q Consensus 9 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~------------------ 70 (226)
+.+++++...++..++|||+++|.+|. ... .+. ..++.++..+|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~ 145 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERAR 145 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH
Confidence 567888888888899999999998884 221 122 135566777777777642
Q ss_pred --------------------------------------CCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 71 --------------------------------------PPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 71 --------------------------------------~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
..++|||++|.||++++++.+.++||+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 146 TRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877556799999753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.53 E-value=1.9e-06 Score=61.91 Aligned_cols=142 Identities=18% Similarity=0.227 Sum_probs=96.7
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccC
Q 027225 32 GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 110 (226)
Q Consensus 32 ~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 110 (226)
.||.+++...+ .+++++++|.++.|.+.+|..+-. .. -...-+.|..|++..+|.+.+.+-. +.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~~~-s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAPAA-DD---------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECCC--------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccccc-cc----------
Confidence 47999998653 359999999999999999888722 22 1233467899999999999887411 10
Q ss_pred CCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcc
Q 027225 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA 190 (226)
Q Consensus 111 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 190 (226)
.....+.+||... ...+.+.-|||||+++|..+--.. ...-+..+|+.+..||..|..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL-------------------~e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL-------------------KENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC-------------------CTTEEECCCHHHHHHHHHHTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC-------------------CcccchhhCHHHHHHHHHHHh
Confidence 1122466887764 345788999999999998875221 123356799999999999986
Q ss_pred c-------------------------CCCCCCCHHHHHHHHHHhh
Q 027225 191 N-------------------------EPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 191 ~-------------------------~p~~Rps~~~~l~~l~~~~ 210 (226)
. .+..|.++++|++.=..=+
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 6 2468899999987654433
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.50 E-value=9.6e-08 Score=73.34 Aligned_cols=138 Identities=20% Similarity=0.171 Sum_probs=84.6
Q ss_pred cceeeeEEecCC---ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC---------------
Q 027225 9 IVLFMGAVTQPP---NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN--------------- 70 (226)
Q Consensus 9 i~~~~~~~~~~~---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--------------- 70 (226)
+.+++......+ ..|+||++++|.++.+.... .++.++...++.++...+..||+..
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~ 149 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREK 149 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHH
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHH
Confidence 334554443333 35899999999888653321 1677777778888888888887511
Q ss_pred -----------------------------------------CCeEEeCCCCCcEEEcC--CCcEEEccCCCccccccccc
Q 027225 71 -----------------------------------------PPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFL 107 (226)
Q Consensus 71 -----------------------------------------~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~ 107 (226)
..++|||++|.||+++. ++.+.++||+.+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 150 INEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH
Confidence 13799999999999998 45678999998765322111
Q ss_pred ccCCCCCCCCccCccccc------CCC--------CCCchhHHHHHHHHHHHHhCCCCC
Q 027225 108 SSKSAAGTPEWMAPEVLR------DEP--------SNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 108 ~~~~~~~~~~~~~PE~~~------~~~--------~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
........ .-.+|+... +.. .....+.|+++.+++.+.+|..+|
T Consensus 230 l~~~~~~~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDD-EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTT-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhc-cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11110000 001222111 000 011268899999999999997655
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.6e-06 Score=64.06 Aligned_cols=85 Identities=16% Similarity=0.216 Sum_probs=63.0
Q ss_pred cceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC------------------
Q 027225 9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN------------------ 70 (226)
Q Consensus 9 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~------------------ 70 (226)
+.+++.++.+.+..++|||+++|.++.+..... ......+..++...|..||+..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~ 154 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQ 154 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHH
Confidence 567888898889999999999998887765431 1122335556666666666531
Q ss_pred --------------------------------------CCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 71 --------------------------------------PPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 71 --------------------------------------~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
..++|||+++.||+++.++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 155 SRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 138999999999999987767799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-05 Score=59.21 Aligned_cols=88 Identities=19% Similarity=0.193 Sum_probs=56.7
Q ss_pred cceeeeEEe-cCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----------------
Q 027225 9 IVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN----------------- 70 (226)
Q Consensus 9 i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----------------- 70 (226)
+.+++.++. ..+..++|||+++|.++.+..-. .++..+...+..++...|..||+..
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~ 148 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNK 148 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHH
Confidence 556666664 45668999999999888763211 0333444444444444444444321
Q ss_pred -----------------------------------------CCeEEeCCCCCcEEEcC---CCcE-EEccCCCccc
Q 027225 71 -----------------------------------------PPIVHRDLKSPNLLVDK---KYTV-KVCDFGLSRL 101 (226)
Q Consensus 71 -----------------------------------------~~i~h~di~p~nil~~~---~~~~-~l~df~~~~~ 101 (226)
..++|+|+++.||+++. ++.+ .++||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 149 ILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 12799999999999987 4554 8999997654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=9.5e-05 Score=57.80 Aligned_cols=29 Identities=24% Similarity=0.321 Sum_probs=24.6
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+++.||++++++.+.++||+.+..
T Consensus 224 l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 224 LLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp EECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred EEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 99999999999999654578999987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.003 Score=48.76 Aligned_cols=30 Identities=23% Similarity=0.342 Sum_probs=26.7
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
.+ ++|||+++.||+++.++.+.++||+.+.
T Consensus 222 ~~--l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PN--LCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CC--EECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred Cc--eecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 45 9999999999999877889999999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.018 Score=43.69 Aligned_cols=28 Identities=25% Similarity=0.313 Sum_probs=24.3
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5666889999987754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.032 Score=40.04 Aligned_cols=115 Identities=10% Similarity=0.083 Sum_probs=76.4
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcEE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL 84 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~nil 84 (226)
.||+.+.. .+-++++.+.+.++.-+.+.=+..+.. .+....++++.+|+....++++ -+|--++|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~------~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS------FTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG------SCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh------cCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEE
Confidence 57777766 566666666666665432222222333 7888999999999888744433 458899999999
Q ss_pred EcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 85 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
++.++.+++...|... -++|. ..+...=.-..=|++..+++++..|
T Consensus 112 f~~~~~p~i~~RGik~-----------------~l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQN-----------------VVDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECTTSCEEESCCEETT-----------------TBSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EcCCCCEEEEEccCcc-----------------CCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999998776521 12221 1233334457788888999987766
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0077 Score=48.13 Aligned_cols=33 Identities=21% Similarity=0.346 Sum_probs=28.1
Q ss_pred hcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccc
Q 027225 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 102 (226)
Q Consensus 67 H~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~ 102 (226)
+... ++|||+++.||+++.++ +.++||+.+...
T Consensus 230 ~~~~--liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQA--LIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCE--EECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCe--EEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 4566 99999999999999876 999999987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.018 Score=44.18 Aligned_cols=26 Identities=27% Similarity=0.417 Sum_probs=23.0
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEccCC
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCDFG 97 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~df~ 97 (226)
+.++|+|+.+.|++++.++ ..+.|++
T Consensus 207 ~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 207 PSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred ceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 4599999999999999887 8899974
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.039 Score=39.74 Aligned_cols=114 Identities=11% Similarity=0.095 Sum_probs=74.4
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHH-HHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN-YLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~-~lH~~~~~i~h~di~p~ni 83 (226)
.||+. --.+-.+++.+.+.++.-+++.=+..++. .+....++++.+|+.... +++ . -+|--++|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceE
Confidence 56666 33444666777777776543333334443 788899988888888665 443 3 55889999999
Q ss_pred EEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 84 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
+++.++.+++...|.- ..++|.. .+...=.-+.=|++..++.++..|
T Consensus 116 ~f~~~~~p~i~hRGi~-----------------~~lpP~e-----~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 116 MFNRALEPFFLHVGVK-----------------ESLPPDE-----WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp EECTTCCEEESCCEET-----------------TTBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEeCCCcEEEEEcCCc-----------------ccCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999877752 1223321 222233346777888888876544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.78 E-value=0.017 Score=44.16 Aligned_cols=29 Identities=21% Similarity=0.229 Sum_probs=25.0
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+++.||+++.++.+.++||+.+..
T Consensus 189 liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 189 VIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCCCCCccCEEEeCCceEEEecchhccC
Confidence 99999999999999875568999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.026 Score=43.40 Aligned_cols=30 Identities=40% Similarity=0.498 Sum_probs=26.2
Q ss_pred eEEeCCCCCcEEEcCC----CcEEEccCCCcccc
Q 027225 73 IVHRDLKSPNLLVDKK----YTVKVCDFGLSRLK 102 (226)
Q Consensus 73 i~h~di~p~nil~~~~----~~~~l~df~~~~~~ 102 (226)
++|||+++.||+++.+ +.+.++||+.+...
T Consensus 185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 9999999999999874 67999999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.42 E-value=0.037 Score=42.87 Aligned_cols=29 Identities=24% Similarity=0.477 Sum_probs=26.3
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||+++.++.+.++||+.+..
T Consensus 208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 208 LCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 99999999999999878899999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.28 E-value=0.045 Score=41.87 Aligned_cols=27 Identities=22% Similarity=0.215 Sum_probs=23.9
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|||+++.||+++ + .+.++||+.+..
T Consensus 197 l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 197 RLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp ECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 89999999999999 4 899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.65 E-value=0.082 Score=42.77 Aligned_cols=15 Identities=33% Similarity=0.472 Sum_probs=14.0
Q ss_pred CeEEeCCCCCcEEEc
Q 027225 72 PIVHRDLKSPNLLVD 86 (226)
Q Consensus 72 ~i~h~di~p~nil~~ 86 (226)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 399999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.55 E-value=0.098 Score=40.83 Aligned_cols=28 Identities=29% Similarity=0.558 Sum_probs=23.9
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+++.||++++++ +.++||+.+..
T Consensus 214 l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 214 FCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 99999999999998664 89999987753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=93.09 E-value=0.13 Score=40.64 Aligned_cols=31 Identities=19% Similarity=0.366 Sum_probs=25.8
Q ss_pred cCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 68 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
... ++|||+.+.||+++.+ .+.++||..+..
T Consensus 226 ~~~--L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AET--LIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCE--EECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCc--eeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 345 9999999999999876 489999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=92.70 E-value=0.048 Score=43.73 Aligned_cols=29 Identities=28% Similarity=0.460 Sum_probs=24.1
Q ss_pred eEEeCCCCCcEEEcCC----------------------------CcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKK----------------------------YTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~----------------------------~~~~l~df~~~~~ 101 (226)
++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 251 ~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 251 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 9999999999999875 6789999987754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=92.33 E-value=0.076 Score=41.82 Aligned_cols=30 Identities=23% Similarity=0.408 Sum_probs=26.4
Q ss_pred CeEEeCCCCCcEEEcCC----CcEEEccCCCccc
Q 027225 72 PIVHRDLKSPNLLVDKK----YTVKVCDFGLSRL 101 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~----~~~~l~df~~~~~ 101 (226)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 39999999999999876 7899999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.41 E-value=0.11 Score=41.22 Aligned_cols=29 Identities=28% Similarity=0.464 Sum_probs=25.0
Q ss_pred eEEeCCCCCcEEE------cCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLV------DKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~------~~~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||++ ++++.+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4466899999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=88.95 E-value=0.39 Score=35.95 Aligned_cols=24 Identities=33% Similarity=0.403 Sum_probs=20.0
Q ss_pred CCeEEeCCCCCcEEEcCCCcEEEcc
Q 027225 71 PPIVHRDLKSPNLLVDKKYTVKVCD 95 (226)
Q Consensus 71 ~~i~h~di~p~nil~~~~~~~~l~d 95 (226)
++++|||+.+.||+++.++. .+.|
T Consensus 188 p~LvHGDlw~gNvl~~~~g~-~~iD 211 (288)
T 3f7w_A 188 PARIHGDLWNGNVLWQDDGA-VVID 211 (288)
T ss_dssp CEEECSCCSGGGEEEETTEE-EECS
T ss_pred CeeeecCCCCCcEEEcCCCe-EEEe
Confidence 45999999999999999874 4555
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=88.53 E-value=0.23 Score=39.75 Aligned_cols=28 Identities=29% Similarity=0.596 Sum_probs=25.4
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||+ +.++.+.++||..+..
T Consensus 264 ~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 264 FAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred EECCCCCcccee-cCCCcEEEEecccCCc
Confidence 999999999999 7788999999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 226 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 3e-66
Identities = 72/221 (32%), Positives = 125/221 (56%), Gaps = 14/221 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+++ RH NI+LFMG T P L+IVT++ SLY LH + + + +++A A
Sbjct: 58 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTA 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
+GM+YLH ++ I+HRDLKS N+ + + TVK+ DFGL+ + + + + +G+ W
Sbjct: 115 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---- 171
MAPEV+R + P + +SD+Y+FG++L+EL T Q P+ N+N + + +G
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
++ N + ++ C + +RP F I+ + L +S
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-62
Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 7/210 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAY 57
++ L+HPNIV + + N L IV EY G L ++ K R+ LDE L +
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116
Query: 58 DVAKGMNYLHRRN---PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ + HRR+ ++HRDLK N+ +D K VK+ DFGL+R+ + +K+ G
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
TP +M+PE + NEKSDI+S G +L+EL L P+ + ++ + +GK IP
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIP 235
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ + II + + RPS I+E
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-61
Identities = 74/209 (35%), Positives = 114/209 (54%), Gaps = 9/209 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
M +LRH N+V +G + + L IVTEY+++GSL L G R +L L + DV
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 112
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ M YL N VHRDL + N+LV + KV DFGL++ ++T + +W
Sbjct: 113 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWT 167
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG +++ P
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 226
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLR 207
P V +++ CW + RPSF + E L
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-60
Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L +P IV +G V Q L +V E G L++ L RE + + + V+
Sbjct: 63 MHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVS 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
GM YL +N VHRDL + N+L+ ++ K+ DFGLS+ + + + + +
Sbjct: 120 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + +SD++S+GV +WE + Q+P+ + +V+A + +GKR+E P
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
P + +++ CW + RP F T+ + +R S
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 8e-60
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 12/223 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ HPNIV + A NL I+ E+ + G++ ++ + L E + +
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTL 120
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+NYLH I+HRDLK+ N+L +K+ DFG+S T S GTP WMA
Sbjct: 121 DALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
Query: 121 PEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRLEIP 174
PEV+ +D P + K+D++S G+ L E+A ++ P LNP +V+ + + L P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217
+ + ++ C R + S +++ P + + +P
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVTVDSNKP 279
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-59
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 12/210 (5%)
Query: 1 MKRLRHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+K L+HPNIV F + V + +VTE ++ G+L L + V + + +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWC 118
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPN-LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
+ KG+ +LH R PPI+HRDLK N + +VK+ D GL+ LK +F +K+ GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGT 176
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIP 174
PE+MAPE+ E +E D+Y+FG+ + E+AT + P+ N AQ+ V K
Sbjct: 177 PEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ P V IIE C +R S ++
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-59
Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 11/220 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++L +P IV +G + + + +V E G L + L + + ++ + + + V+
Sbjct: 62 MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVS 117
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
GM YL N VHRDL + N+L+ ++ K+ DFGLS+ N + + +
Sbjct: 118 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + + KSD++SFGV++WE + Q+P+ + ++V A + KG+R+ P
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 234
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
+ ++ CW + RP F+ + LR +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-58
Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 5/213 (2%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+L+H +V VTQ P + I+TEY+ GSL L P L + L+MA +A
Sbjct: 62 MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIA 119
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
+GM ++ RN +HRDL++ N+LV + K+ DFGL+R ++ N + + + A +W
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
APE + KSD++SFG++L E+ T + V +G R+ P N
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+ ++ CW P RP+F + +L +
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-58
Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 7/214 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L HP +V G + + +V E++ G L L R + L M DV
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
+GM YL ++HRDL + N LV + +KV DFG++R + + + SS +W
Sbjct: 112 EGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
+PEV + KSD++SFGV++WE+ + + P+ N + ++VV + G RL PR +
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 228
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
HV I+ CW P RP+FS ++ L + +S
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-58
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 9/204 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
LRHPNI+ G + ++ EY G++YR L K DE+R ++A
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELA 116
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
++Y H + ++HRD+K NLL+ +K+ DFG S ++ + GT +++
Sbjct: 117 NALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLP 172
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE++ +EK D++S GV+ +E + P+ + + P V
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEG 230
Query: 181 VASIIEACWANEPWKRPSFSTIME 204
+I + P +RP ++E
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (464), Expect = 8e-58
Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 11/219 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + HPN++ G VT+ + I+TE++ GSL L + + + + M +A
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIA 138
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKSAAGT 115
GM YL N VHRDL + N+LV+ KV DFGLSR + T+ S+
Sbjct: 139 AGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
W APE ++ SD++S+G+++WE+ + ++P+ ++ V+ A+ + RL P
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
+ + ++ CW + RP F I+ L +I++P
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-57
Identities = 76/223 (34%), Positives = 118/223 (52%), Gaps = 7/223 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK+LRH +V V++ P + IVTEY+S+GSL L + + + ++MA +A
Sbjct: 66 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIA 123
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWM 119
GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + N + + + A +W
Sbjct: 124 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE KSD++SFG++L EL T + P+ + +V+ V +G R+ P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 240
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221
+ ++ CW EP +RP+F + L S PQ P +
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-57
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 9/223 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M+ ++PNIV ++ + L +V EYL+ GSL ++ + + DE + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ + +LH ++HRD+KS N+L+ +VK+ DFG + GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
PEV+ + K DI+S G++ E+ + P+ N NP + + + G L+ P ++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 222
+ C + KR S +++ +K P S T +
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTPL 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-57
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR--------------- 44
M +L H NIV +GA T + ++ EY G L L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 45 -----EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
+L L AY VAKGM +L ++ VHRDL + N+LV VK+CDFGL+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 100 RL--KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
R + ++ +A +WMAPE L + KSD++S+G++LWE+ +L P+ +
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 206
+ G +++ P + I+++CWA + KRPSF + L
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-57
Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 19/238 (7%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM------------- 46
+ +L HPNI+ +GA L + EY G+L L K V E
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
L ++ L+ A DVA+GM+YL +HRDL + N+LV + Y K+ DFGLSR + +
Sbjct: 124 LSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVY 180
Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVG 165
+ WMA E L SD++S+GV+LWE+ +L P+ + A++ +
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 166 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
+G RLE P N + V ++ CW +P++RPSF+ I+ L +++ + T
Sbjct: 241 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-56
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 7/209 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M L H +V G T+ + I+TEY++ G L L + R ++ L M DV
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVC 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
+ M YL + +HRDL + N LV+ + VKV DFGLSR + + + SS + W
Sbjct: 111 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
PEVL + KSDI++FGV++WE+ +L + P+ ++ + +G RL P +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 227
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLR 207
V +I+ +CW + +RP+F ++ +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 2e-56
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 14/226 (6%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+++LRHPN + + G + +V EY + L ++ L E + +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGAL 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + + A S GTP WMA
Sbjct: 126 QGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMA 179
Query: 121 PEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
PEV+ + + K D++S G+ ELA + P N+N + + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239
Query: 178 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
+ + + +++C P RP+ +++ + P D+
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERPPTVIMDLI 283
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 4e-56
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 9/217 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + H NI+ G +++ + I+TEY+ G+L + L + + + M +A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIA 120
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS---AAGTPE 117
GM YL N VHRDL + N+LV+ KV DFGLSR+ + ++ +
Sbjct: 121 AGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIPRN 176
W APE + SD++SFG+++WE+ T + L+ +V+ A+ G RL P +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 237
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
+ ++ CW E +RP F+ I+ +L LI++P
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-56
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 9/211 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M L H N++ G V PP + +VTE GSL L K A VA
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVA 121
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
+GM YL + +HRDL + NLL+ + VK+ DFGL R + ++ +
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
W APE L+ + SD + FGV LWE+ T Q+PW LN +Q++ + +G+RL P +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLR 207
+ +++ CWA++P RP+F + + L
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (444), Expect = 6e-55
Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 4/215 (1%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
MK ++HPN+V +G T+ P I+TE+++ G+L L + R+ + L MA ++
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 125
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
M YL ++N +HRDL + N LV + + VKV DFGLSR + +T+ + A +W
Sbjct: 126 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
APE L + KSD+++FGV+LWE+AT V + K R+E P
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243
Query: 180 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214
V ++ ACW P RPSF+ I + + + +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 5e-54
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 27/235 (11%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------- 46
M +PNIV +G + ++ EY++ G L L +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 47 -------LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
L +L +A VA GM YL R VHRDL + N LV + VK+ DFGLS
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 100 RL--KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLN 156
R A+ + + + A WM PE + +SD++++GV+LWE+ + P+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
+V+ V G L P N + +++ CW+ P RPSF +I +L+ + +
Sbjct: 248 HEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-53
Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 8/213 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M++ HP+IV +G +T+ + I+ E + G L L LD + AY ++
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLS 118
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
+ YL + VHRD+ + N+LV VK+ DFGLSR ++ +T+ + +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
APE + SD++ FGV +WE+ +P+ + V+ + G+RL +P N
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 235
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
P + S++ CWA +P +RP F+ + L +++
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-53
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 11/218 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
MK HPN++ +G + +V Y+ G L + + + V
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQV 139
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGT 115
AKGM +L + VHRDL + N ++D+K+TVKV DFGL+R + ++ + A
Sbjct: 140 AKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIP 174
+WMA E L+ + KSD++SFGV+LWEL T P+ ++N + + +G+RL P
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQP 256
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+ ++ CW + RPSFS ++ + + +
Sbjct: 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-53
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 7/215 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M + +P++ +G + + ++T+ + G L + + ++ + + LN +A
Sbjct: 65 MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 121
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
KGMNYL R +VHRDL + N+LV VK+ DFGL++L ++ +W
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
MA E + +SD++S+GV +WEL T + PA ++++ KG+RL P
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 179 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213
V I+ CW + RP F ++ + + P
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-53
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 9/223 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ P IV F GA +SI E++ GSL ++L K G + E+ ++ V
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVI 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KG+ YL ++ I+HRD+K N+LV+ + +K+CDFG+S ++ + S GT +M+
Sbjct: 115 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMS 171
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE L+ + +SDI+S G+ L E+A + P + ++ F + P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPR 229
Query: 181 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
+ + RP + I ELL ++ P P+
Sbjct: 230 PRTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFS 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 5e-53
Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 21/233 (9%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM------------- 46
+ L H NIV +GA T ++TEY G L L + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 --LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--K 102
LD L+ +Y VAKGM +L +N +HRDL + N+L+ K+CDFGL+R
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 103 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVV 161
+ ++ +A +WMAPE + + +SD++S+G+ LWEL +L +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214
+ +G R+ P + + I++ CW +P KRP+F I++L+ I T
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-51
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 11/220 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
K L H N+V F G + + EY S G L+ + + E + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLM 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
G+ YLH I HRD+K NLL+D++ +K+ DFGL+ + N GT +
Sbjct: 114 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIPRN 176
+APE+L+ E D++S G++L + + PW + Q + K L +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 216
++ +++ P R + I + P +
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKK--DRWYNKPLKK 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-50
Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 13/228 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------VREMLDERRRL 53
MK ++V +G V+Q ++ E ++RG L L V + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 54 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKS 111
MA ++A GM YL+ VHRDL + N +V + +TVK+ DFG++R + + +
Sbjct: 137 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
WM+PE L+D SD++SFGV+LWE+ATL +QP+ L+ QV+ V +G
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGL 253
Query: 171 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 218
L+ P N + ++ CW P RPSF I+ ++ ++ + S
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-50
Identities = 68/252 (26%), Positives = 108/252 (42%), Gaps = 44/252 (17%)
Query: 1 MKRLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
LRH NI+ F+ A + L +V++Y GSL+ L++ + + +A
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLA 106
Query: 57 YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN----TF 106
A G+ +LH + P I HRDLKS N+LV K T + D GL+ +
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166
Query: 107 LSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELAT----------LQQ 150
++ GT +MAPEVL D S +++DIY+ G++ WE+A Q
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
Query: 151 PWGNLNPA-----QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWANEPWKRPSFS 200
P+ +L P+ ++ V + R IP +A I+ CW R +
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286
Query: 201 TIMELLRPLIKS 212
I + L L +
Sbjct: 287 RIKKTLSQLSQQ 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-49
Identities = 70/226 (30%), Positives = 115/226 (50%), Gaps = 18/226 (7%)
Query: 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREM 46
MK + +H NI+ +GA TQ L ++ EY S+G+L L E
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 104
L + ++ AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 105 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
+ + + +WMAPE L D +SD++SFGV+LWE+ TL P + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210
+G R++ P N + ++ CW P +RP+F ++E L ++
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-49
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 19/229 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPG-------------VREM 46
+ H N+V +GA T+P L ++ E+ G+L L ++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 104
L + ++ VAKGM +L R +HRDL + N+L+ +K VK+CDFGL+R K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 105 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAA 163
++ A +WMAPE + D +SD++SFGV+LWE+ +L P+ + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+G R+ P P + + CW EP +RP+FS ++E L L+++
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-49
Identities = 43/230 (18%), Positives = 99/230 (43%), Gaps = 13/230 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ RH NI+ + L ++ E++S ++ ++ L+ER ++ + V
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVC 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+ + +LH N I H D++ N++ + T+K+ +FG +R + + PE+
Sbjct: 113 EALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEY 169
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK---RLEIPR 175
APEV + + + +D++S G +++ L + P+ Q++ + + E +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-MNAEYTFDEEAFK 228
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 225
++ ++ E R + S ++ P +K + S + L
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQKIERVSTKVIRTL 276
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (406), Expect = 1e-48
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 11/227 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M LRHP +V A + ++ E++S G L+ + + + E + V
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVC 134
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
KG+ ++H N VH DLK N++ K +K+ DFGL+ + S K GT E+
Sbjct: 135 KGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEF 191
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRN 176
APEV +P +D++S GV+ + L + P+G N + + V +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223
++ I +P R + +E P + + +P
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPGNAPGRDSQIP 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 2e-48
Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M +L HP ++ A + ++ E+LS G L+ + + + E +N
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQAC 137
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
+G+ ++H + IVH D+K N++ + K +VK+ DFGL+ + + T E+
Sbjct: 138 EGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEF 194
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRN 176
APE++ EP +D+++ GV+ + L + P+ + + + V + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIME 204
V+P I+ EP KR + +E
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-48
Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 9/205 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
M RL HP V L Y G L + + K G DE ++
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIV 118
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEW 118
+ YLH I+HRDLK N+L+++ +++ DFG +++ + + + S GT ++
Sbjct: 119 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
++PE+L ++ + + SD+++ G I+++L P+ N + + + P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFF 234
Query: 179 PHVASIIEACWANEPWKRPSFSTIM 203
P ++E + KR +
Sbjct: 235 PKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-47
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
HP + NL V EYL+ G L + D R A ++
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEII 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ +LH + IV+RDLK N+L+DK +K+ DFG+ + + + GTP+++A
Sbjct: 114 LGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE+L + N D +SFGV+L+E+ Q P+ + ++ ++ + PR +
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKE 229
Query: 181 VASIIEACWANEPWKRPS 198
++ + EP KR
Sbjct: 230 AKDLLVKLFVREPEKRLG 247
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 2e-46
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 13/230 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ +++HPNIV +L ++ + +S G L+ + + G ER + + V
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 117
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
+ YLH IVHRDLK NLL D+ + + DFGLS+++ + S +A GTP
Sbjct: 118 DAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPG 174
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR-- 175
++APEVL +P ++ D +S GVI + L P+ + N A++ + + P
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 176 NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 225
+++ I +P KR + ++ P I T +
Sbjct: 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIAGDTALDKNIHQSVS 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 1e-45
Identities = 46/213 (21%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
++++ HPNI+ +V + + +G L+ L + L E+ + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
+ + LH+ N IVHRDLK N+L+D +K+ DFG S + + + GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTPSYL 176
Query: 120 APEVLRDEPS------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
APE++ + ++ D++S GVI++ L P+ + ++ + +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 174 PR--NVNPHVASIIEACWANEPWKRPSFSTIME 204
P + + V ++ +P KR + +
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 145 bits (366), Expect = 2e-43
Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 16/220 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
L HP IV IV EY+ +L ++H G + +R + +
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVI 117
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAA 113
D + +N+ H+ I+HRD+K N+++ VKV DFG++R N+ + +
Sbjct: 118 ADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--L 171
GT ++++PE R + + +SD+YS G +L+E+ T + P+ +P V +
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
Query: 172 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211
++ + +++ A P R T E+ L++
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPENRY--QTAAEMRADLVR 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-42
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 10/215 (4%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ RHP + A L V EY + G L+ L + + E R ++
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIV 115
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH R+ +V+RD+K NL++DK +K+ DFGL + + + K+ GTPE++A
Sbjct: 116 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEVL D D + GV+++E+ + P+ N + ++ + + + PR ++P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPE 231
Query: 181 VASIIEACWANEPWKRPS--FSTIMELLR-PLIKS 212
S++ +P +R S E++ S
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 1e-42
Identities = 50/217 (23%), Positives = 96/217 (44%), Gaps = 12/217 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ P IV A P LS + + ++ G L+ L + + E A ++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEII 117
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ ++H R +V+RDLK N+L+D+ V++ D GL+ + ++ GT +MA
Sbjct: 118 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMA 173
Query: 121 PEVL-RDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIPRNVN 178
PEVL + + +D +S G +L++L P+ + + +E+P + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 179 PHVASIIEACWANEPWKRPS--FSTIMELLR-PLIKS 212
P + S++E + +R E+ P +S
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-42
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 19/230 (8%)
Query: 1 MKRLRHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+ + P+IV ++ L IV E L G L+ + G + ER +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIM 117
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAA 113
+ + + YLH N I HRD+K NLL K +K+ DFG ++ + + S +
Sbjct: 118 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPC 174
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--GFKGKRL 171
TP ++APEVL E ++ D++S GVI++ L P+ + + + + + +
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
Query: 172 EIPR----NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217
E P V+ V +I EP +R + + M P I T P
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVP 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (357), Expect = 1e-41
Identities = 49/209 (23%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+ + HP I+ G + ++ +Y+ G L+ LL K + A +V
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVC 114
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ YLH ++ I++RDLK N+L+DK +K+ DFG ++ + + GTP+++A
Sbjct: 115 LALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIA 169
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PEV+ +P N+ D +SFG++++E+ P+ + N + + L P N
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNED 227
Query: 181 VASIIEACWANEPWKRPSF--STIMELLR 207
V ++ + +R + ++
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 6e-41
Identities = 41/242 (16%), Positives = 84/242 (34%), Gaps = 21/242 (8%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
K ++ + + + +++ L SL L + + + L +A +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMI 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRL-------KANTFLSSK 110
+ Y+H +N +HRD+K N L+ K V + DFGL++ + + +K
Sbjct: 114 SRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV------ 164
+ GT + + + + D+ S G +L PW L A
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDMP 223
+ + A+ + C + +P +S + +L R + D
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291
Query: 224 LL 225
+L
Sbjct: 292 ML 293
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 137 bits (345), Expect = 4e-40
Identities = 34/230 (14%), Positives = 72/230 (31%), Gaps = 22/230 (9%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
K L + + Q +++ L SL LL G + A +
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQML 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFLSS------ 109
+ +H ++ +V+RD+K N L+ + + + V DFG+ + +
Sbjct: 112 ARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 110 -KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV------VA 162
K+ +GT +M+ + + D+ + G + PW L A +
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 163 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
E+ + P + + L +++
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-40
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K ++HPN++ ++ ++ E ++ G L+ L + +E L E +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 123
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDK----KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
G+ YLH I H DLK N+++ K +K+ DFGL+ K + K+ GTP
Sbjct: 124 NGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 180
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIP 174
E++APE++ EP ++D++S GVI + L + P+ + +A V E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIME 204
N + I +P KR + ++
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-39
Identities = 41/228 (17%), Positives = 88/228 (38%), Gaps = 20/228 (8%)
Query: 1 MKRLR--HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
+K++ ++ + +P + ++ E R L E + +
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQ 118
Query: 59 VAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
V + + + H ++HRD+K N+L+D + +K+ DFG L +T + GT
Sbjct: 119 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGTRV 174
Query: 118 WMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
+ PE +R + ++S G++L+++ P+ + ++ +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQVFFRQR 226
Query: 177 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 224
V+ +I C A P RP+F I P ++ ++ L
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETAEIHL 272
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 7e-36
Identities = 46/209 (22%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ + P +V + NL +V EY++ G ++ L + G E A +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
YLH + +++RDLK NLL+D++ ++V DFG ++ + GTPE +A
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALA 206
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
PE++ + N+ D ++ GV+++E+A P+ P Q+ + ++ P + +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSD 264
Query: 181 VASIIEACWANEPWKRPS--FSTIMELLR 207
+ ++ + KR + + ++
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-34
Identities = 46/234 (19%), Positives = 88/234 (37%), Gaps = 35/234 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
++ HPN+V T L++V E++ + L P + +M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 121
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
+ + +G+++LH +VHRDLK N+LV +K+ DFGL+R+ + ++ S T
Sbjct: 122 MFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVT 178
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV----------- 164
+ APEVL D++S G I E+ + + + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 165 --------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ +++ ++ C P KR S + +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-34
Identities = 50/251 (19%), Positives = 90/251 (35%), Gaps = 38/251 (15%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
++ L HPNI+ + A N+S+V +++ + +L
Sbjct: 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ YLH+ I+HRDLK NLL+D+ +K+ DFGL++ + + T + A
Sbjct: 111 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 168
Query: 121 PEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--------------- 164
PE+L D+++ G IL EL + + +
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 165 ----------GFKGKRL-EIPRNVNPHVASIIEACWANEPWKRPSFSTIM------ELLR 207
F G L I + +I+ + P R + + +
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
Query: 208 PLIKSPTPQPS 218
P P+P+
Sbjct: 289 PTPGCQLPRPN 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (302), Expect = 8e-34
Identities = 46/232 (19%), Positives = 85/232 (36%), Gaps = 33/232 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + L +V E+L + L G L+ + +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLL 110
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
G+ Y H R ++HRDLK NLL++++ +K+ DFGL+R T + A
Sbjct: 111 NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 121 PEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--------------- 164
P+VL + + DI+S G I E+ + ++ A + +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 165 ------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ ++ ++ +P +R + +E
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-32
Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 1 MKRLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
++ +R P +V A L ++ +Y++ G L+ L + RE E ++
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEI 138
Query: 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEW 118
+ +LH+ I++RD+K N+L+D V + DFGLS A+ + GT E+
Sbjct: 139 VLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 119 MAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--GFKGKRLEIP 174
MAP+++R D ++ D +S GV+++EL T P+ A + P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 175 RNVNPHVASIIEACWANEPWKRPSFS--TIMELLR 207
+ ++ +I+ +P KR E+
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-32
Identities = 48/247 (19%), Positives = 91/247 (36%), Gaps = 37/247 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L HPNIV + + L +V E+L + + L + + +
Sbjct: 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLL 112
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+G+ + H ++HRDLK NLL++ + +K+ DFGL+R + T + A
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 121 PEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--------------- 164
PE+L + + DI+S G I E+ T + + + + +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 165 ------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212
+ ++ ++ S++ +P KR S + P +
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQD 288
Query: 213 ---PTPQ 216
P P
Sbjct: 289 VTKPVPH 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-32
Identities = 42/260 (16%), Positives = 74/260 (28%), Gaps = 42/260 (16%)
Query: 1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
M++L H NIV L++V +Y+ H ++ L
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLK-SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
Y + + + Y+H I HRD+K LL +K+CDFG ++ +
Sbjct: 127 YMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--------- 164
+ D++S G +L EL Q + + + +
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 165 ------------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM--- 203
P ++ P R +
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 204 ---ELLRPLIKSPTPQPSPT 220
EL P +K P + +P
Sbjct: 305 FFDELRDPNVKLPNGRDTPA 324
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-30
Identities = 53/267 (19%), Positives = 93/267 (34%), Gaps = 49/267 (18%)
Query: 1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
+ R RH NI+ + P + +L LY+LL L
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFL 115
Query: 57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAA 113
Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R+ +
Sbjct: 116 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 114 GTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-------- 164
T + APE++ + + DI+S G IL E+ + + + + + +
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 165 ---------------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203
K + N + +++ P KR +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 204 ------ELLRPLIKSPTPQPSPTDMPL 224
+ P + P DM L
Sbjct: 294 AHPYLEQYYDPSDEPIAEAPFKFDMEL 320
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-29
Identities = 46/265 (17%), Positives = 96/265 (36%), Gaps = 53/265 (20%)
Query: 1 MKRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRR 52
++ L+H N+V + ++ +V ++ L + + + +R
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR- 121
Query: 53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLS 108
+ + G+ Y+HR I+HRD+K+ N+L+ + +K+ DFGL+R K +
Sbjct: 122 --VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 109 SKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--- 164
+ T + PE+L E D++ G I+ E+ T +A +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 165 ----------------------GFKGKRLEIPRNVNPHVAS-----IIEACWANEPWKRP 197
KG++ ++ + +V +I+ +P +R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 198 SFSTIMELLRPLIKSPTPQPSPTDM 222
+ S P P+D+
Sbjct: 298 DSDDALN--HDFFWS---DPMPSDL 317
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 8e-29
Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 34/233 (14%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+K L+H NIV + L++V E+ + G LD + + +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLL 111
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
KG+ + H RN ++HRDLK NLL+++ +K+ +FGL+R + T +
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 121 PEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG----------- 168
P+VL + D++S G I ELA +P N F+
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 169 -----------------KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ + +N +++ P +R S ++
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-27
Identities = 49/240 (20%), Positives = 88/240 (36%), Gaps = 46/240 (19%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
+K +RH N++ + T L +V ++ + H+ L E R
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQF 125
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + KG+ Y+H HRDLK NL V++ +K+ DFGL+R +
Sbjct: 126 LVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVV 180
Query: 115 TPEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-------- 165
T + APEV L + DI+S G I+ E+ T + + + + +
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 166 --------------------FKGKRL-EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204
+ K I N +P +++E + +R + +
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 3e-24
Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 17/233 (7%)
Query: 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
MK + H NI+ + T ++ +V E + + + D R
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSY 123
Query: 55 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
+ Y + G+ +LH +HRDLK N++V T+K+ DFGL+R +F+ +
Sbjct: 124 LLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-V 180
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
T + APEV+ E DI+S G I+ E+ + + + V + P
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCP 239
Query: 175 RNVNPHVASIIEACWANEPWKRPSFSTIM-ELLRPLIKSPTPQPSPTDMPLLT 226
+ ++ + +F + + L P + LL+
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.4 bits (231), Expect = 3e-23
Identities = 45/245 (18%), Positives = 89/245 (36%), Gaps = 50/245 (20%)
Query: 1 MKRLR-HPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
++ LR PNI+ V P + ++V E+++ +L L + Y
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMY 136
Query: 58 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTP 116
++ K ++Y H I+HRD+K N+++D + +++ D+GL+ +
Sbjct: 137 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASR 193
Query: 117 EWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKGK---- 169
+ PE+L D + D++S G +L + ++P+ G+ N Q+V G
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 170 ------------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSF 199
E V+P ++ + R +
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 200 STIME 204
ME
Sbjct: 314 REAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 5e-20
Identities = 47/239 (19%), Positives = 92/239 (38%), Gaps = 44/239 (18%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLS-----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
+K ++H N++ + T +L + +L L ++ L + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFL 126
Query: 56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
Y + +G+ Y+H + I+HRDLK NL V++ +K+ DFGL+R + T
Sbjct: 127 IYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVAT 181
Query: 116 PEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV---------- 164
+ APE+ L N+ DI+S G I+ EL T + + + + +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 165 -----------GFKGKRLEIPR--------NVNPHVASIIEACWANEPWKRPSFSTIME 204
+ ++P+ NP ++E + KR + + +
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.1 bits (178), Expect = 7e-16
Identities = 35/171 (20%), Positives = 67/171 (39%), Gaps = 23/171 (13%)
Query: 1 MKRLRHPNIV-------------LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML 47
++R+ + L P + +V + G L K +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 48 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD------KKYTVKVCDFGLSRL 101
++ + G++Y+HRR I+H D+K N+L++ +K+ D G +
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181
Query: 102 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
+ +S T E+ +PEVL P +DI+S +++EL T +
Sbjct: 182 YDEHYTNSI---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.7 bits (136), Expect = 1e-10
Identities = 19/148 (12%), Positives = 40/148 (27%), Gaps = 33/148 (22%)
Query: 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
+++L+ + ++ L + + +
Sbjct: 68 LQKLQGLAVPKVYAW--------------EGNAVLMELIDAKELYRVRVENPDEVLDMIL 113
Query: 61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
+ + + R IVH DL N+LV + + + DF S E
Sbjct: 114 EEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVGEEGW 157
Query: 121 PEVLRDEPSNEKSDI---YSFGVILWEL 145
E+L + N + Y +
Sbjct: 158 REILERDVRNIITYFSRTYRTEKDINSA 185
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 226 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.01 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.63 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 89.36 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=321.68 Aligned_cols=209 Identities=27% Similarity=0.479 Sum_probs=183.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||++||+|.+++.+.. +++.+++.++.||+.||+|||++| |+||||||
T Consensus 71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp 144 (293)
T d1yhwa1 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKS 144 (293)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcH
Confidence 357899999999999999999999999999999999987643 999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.+|.+||+|||+++.............|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+.
T Consensus 145 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 224 (293)
T d1yhwa1 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (293)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH
Confidence 99999999999999999998765544445566789999999999998899999999999999999999999988877665
Q ss_pred HHHHhh-CCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 027225 161 VAAVGF-KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 217 (226)
Q Consensus 161 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 217 (226)
...+.. .......+..++++++++|.+||+.||.+|||+.|+++ +++++...+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~~~~~~~ 280 (293)
T d1yhwa1 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLS 280 (293)
T ss_dssp HHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGGGCCCGG
T ss_pred HHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhCCCCCCC
Confidence 544432 33345566789999999999999999999999999998 78887655443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=316.70 Aligned_cols=201 Identities=26% Similarity=0.515 Sum_probs=178.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||
T Consensus 60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp 134 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKP 134 (263)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeecc
Confidence 357899999999999999999999999999999999998643 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.++.+||+|||++...... ......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+.
T Consensus 135 ~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 212 (263)
T d2j4za1 135 ENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212 (263)
T ss_dssp GGEEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999998755433 22345688999999999999899999999999999999999999998888777
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
...+. ......+..+++++.++|.+||+.||.+|||++|+++ ++++++
T Consensus 213 ~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~--hp~~~~ 260 (263)
T d2j4za1 213 YKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITA 260 (263)
T ss_dssp HHHHH--TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--CHHHHH
T ss_pred HHHHH--cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc--CcCcCC
Confidence 76664 3445677889999999999999999999999999998 566543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-51 Score=315.02 Aligned_cols=207 Identities=30% Similarity=0.584 Sum_probs=174.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+++|+|.+++.... +.+++.++..++.|++.||+|||++| ++||||||
T Consensus 81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp 156 (299)
T d1jpaa_ 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAA 156 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCcccc
Confidence 478999999999999999999999999999999999887643 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-----ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-----SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~ 154 (226)
+||+++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|+|+| |..||.+
T Consensus 157 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp GGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 999999999999999999875433211 1122345778999999999889999999999999999998 8999999
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+..+....+. ...+...+..+++++.+++.+||+.||++|||+.+|++.|+++++.
T Consensus 237 ~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 237 MTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 88888777665 4455667888999999999999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=315.85 Aligned_cols=206 Identities=30% Similarity=0.505 Sum_probs=177.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+++|+|.+++.+.+ ..+++.++..++.||+.||.|||++| |+||||||
T Consensus 63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp 138 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKA 138 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecCh
Confidence 357899999999999999999999999999999999976532 24999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.+||+|||++..............|++.|+|||++. +..++.++||||+||++|+|++|+.||.+.
T Consensus 139 ~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 139 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp GGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999876554444445667899999999984 445788999999999999999999999988
Q ss_pred CHHHHHHHHhhCC-ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 156 NPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 156 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+..+....+.... .....+..+++++.+||.+||+.||.+|||+.|+++ +++++.
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~--hp~~~~ 274 (288)
T d2jfla1 219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVTV 274 (288)
T ss_dssp CGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGCC
T ss_pred CHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 8777666554332 334556789999999999999999999999999998 677764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=310.87 Aligned_cols=205 Identities=24% Similarity=0.358 Sum_probs=173.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++| |+||||||
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp 131 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKP 131 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccH
Confidence 467899999999999999999999999999999999998643 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||++++++.+||+|||+++..... ........|++.|+|||++.+..+ +.++||||+||++|+|++|+.||.....
T Consensus 132 ~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred HHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999999764322 222345678999999999988775 5789999999999999999999976543
Q ss_pred H-HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 A-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
. ..................+++++.+||.+||+.||++|||++|+++ +++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~~ 265 (271)
T d1nvra_ 212 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNK 265 (271)
T ss_dssp TSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTC
T ss_pred HHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhCc
Confidence 2 3333333333344445678999999999999999999999999998 677764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=308.11 Aligned_cols=209 Identities=35% Similarity=0.606 Sum_probs=171.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+ +..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++| |+||||||
T Consensus 58 l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp 132 (276)
T d1uwha_ 58 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKS 132 (276)
T ss_dssp HTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCH
Confidence 478999999999998764 56899999999999999997543 24999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCC---CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
+||+++.++.+||+|||+++..... ........+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.
T Consensus 133 ~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 133 NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp GGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred HHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 9999999999999999998764432 1223455788999999998643 3688999999999999999999999876
Q ss_pred CHHHHHH-HHhhCC---ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 156 NPAQVVA-AVGFKG---KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 156 ~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
+...... ...... .....+..+++++.+++.+||+.||.+|||+.++++.|+.+.++.|
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 6544333 332221 1224567789999999999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=312.66 Aligned_cols=197 Identities=23% Similarity=0.437 Sum_probs=172.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++| |+||||||
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp 136 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKP 136 (288)
T ss_dssp HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCc
Confidence 357899999999999999999999999999999999988744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc--ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||++++++.++|+|||+++..... ........|++.|+|||++.+..++.++||||+||++|+|++|..||...+..
T Consensus 137 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 216 (288)
T d1uu3a_ 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216 (288)
T ss_dssp GGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH
Confidence 9999999999999999999765432 22233457899999999999999999999999999999999999999998888
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
+....+. .....++..+++++++||.+||+.||++|||++|+++
T Consensus 217 ~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 217 LIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHHH--TTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHHH--cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 7776664 3345677889999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=308.77 Aligned_cols=203 Identities=33% Similarity=0.552 Sum_probs=163.7
Q ss_pred CCCCCCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHhcCCC---CeE
Q 027225 1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNP---PIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---~i~ 74 (226)
|++++||||+++++++.+ ++..|+|||||++|+|.+++.+.. ....+++..++.++.|++.||.|||+.|. .|+
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii 136 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence 578999999999999965 456899999999999999986421 13459999999999999999999998531 299
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
||||||+||+++.++.+||+|||++..............+++.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 99999999999999999999999998765544444566789999999999998899999999999999999999999999
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
.+..+....+.. ......+..+++++.++|.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~~~i~~-~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 217 FSQKELAGKIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 888877766643 3344667889999999999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=306.87 Aligned_cols=204 Identities=28% Similarity=0.538 Sum_probs=177.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.. +..++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++| ++||||||
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp 135 (277)
T d1xbba_ 62 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAA 135 (277)
T ss_dssp HHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcc
Confidence 467899999999999965 45899999999999999998743 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc---ccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.++++|||+++..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+
T Consensus 136 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred hhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 9999999999999999998754322 122334567889999999998889999999999999999998 899999988
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
..+....+. ...+...+..+++++.++|.+||+.||.+|||+.+|.+.|+.++.
T Consensus 216 ~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 216 GSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 887776665 456677788999999999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-51 Score=309.62 Aligned_cols=209 Identities=35% Similarity=0.621 Sum_probs=179.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++||||+++|+|.+++.+.. ...+++..+..++.|++.||+|||++| |+||||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp 143 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAA 143 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCcccc
Confidence 357899999999999999999999999999999999987543 345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP-WGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p-~~~~~~~ 158 (226)
+||+++.++.+||+|||+++...... .......++..|+|||++.+..++.++||||+|+++|+|++|..| +...+..
T Consensus 144 ~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~ 223 (287)
T d1opja_ 144 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223 (287)
T ss_dssp GGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence 99999999999999999997654332 222233467789999999988899999999999999999997665 5555666
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+....+. .......+..+++++.+||.+||+.||++|||+.++++.|+.++...
T Consensus 224 ~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 224 QVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HHHHHHh-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 5555443 45566778899999999999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=305.10 Aligned_cols=205 Identities=32% Similarity=0.616 Sum_probs=170.2
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+++..++||||+++|+|.+++.... ..++++.+..++.|++.||.|||+++ ++||||||+
T Consensus 55 ~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~ 130 (263)
T d1sm2a_ 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAAR 130 (263)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGG
T ss_pred HhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchh
Confidence 57899999999999999999999999999999999987643 34899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~ 159 (226)
||++++++.+||+|||+++....... ......++..|+|||++.+..++.++||||+|+++|+|+++ ..|+...+..+
T Consensus 131 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 131 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp GEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred heeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence 99999999999999999876543322 22335678899999999999999999999999999999995 66677777777
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
....+. .......|...++++.+++.+||+.||++|||++++++.|+++..
T Consensus 211 ~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 211 VVEDIS-TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH-hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 766664 345556678889999999999999999999999999999998864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=304.29 Aligned_cols=202 Identities=32% Similarity=0.559 Sum_probs=170.0
Q ss_pred CCCCCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|++++||||+++++++.+ +...|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++.+|+||
T Consensus 62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHr 138 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCCCCEEeC
Confidence 478999999999999864 345899999999999999998743 4999999999999999999999987669999
Q ss_pred CCCCCcEEEc-CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 77 DLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 77 di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||||+||+++ .++.+||+|||+++..... ......|++.|+|||++.+. ++.++||||+||++|+|++|+.||...
T Consensus 139 DiKp~NILl~~~~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~~~~-~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 139 DLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcChhhceeeCCCCCEEEeecCcceeccCC--ccCCcccCccccCHHHhCCC-CCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 9999999996 5789999999999754332 23345789999999998765 899999999999999999999999765
Q ss_pred C-HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 156 N-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 156 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
. ..+....+.........+...++++.++|.+||+.||++|||++|+++ ++++
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~--Hp~f 269 (270)
T d1t4ha_ 216 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFF 269 (270)
T ss_dssp SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGG
T ss_pred ccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC--Cccc
Confidence 4 444445554333444556778999999999999999999999999998 5554
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-50 Score=308.80 Aligned_cols=205 Identities=27% Similarity=0.456 Sum_probs=168.1
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+|||||+||+|.+++.+.+ .+++.++..++.||+.||+|||++| ++||||||
T Consensus 61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp 135 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKP 135 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecc
Confidence 367899999999999999999999999999999999998743 4999999999999999999999999 99999999
Q ss_pred CcEEEc---CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||++. +++.+||+|||+++..... .......|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+.
T Consensus 136 ~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 136 ENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp GGEEESSSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cceeecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 999994 5789999999998754432 223456789999999999999999999999999999999999999998888
Q ss_pred HHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
.+....+....... ..+..+|+++.++|.+||+.||.+|||+.|+++ ++++++.
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~~ 270 (307)
T d1a06a_ 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIAGD 270 (307)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTTSS
T ss_pred HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhCCC
Confidence 77776665443332 334678999999999999999999999999998 6777653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=307.63 Aligned_cols=206 Identities=30% Similarity=0.530 Sum_probs=179.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+ +..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++| ++||||||
T Consensus 63 l~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp 137 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAA 137 (285)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCch
Confidence 357899999999999975 46899999999999999986532 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||+||++|+|+| |..||...+
T Consensus 138 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp GGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred hheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999997654321 22334457789999999998889999999999999999998 899999888
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..+....+. ...++..|..+++++.++|.+||+.||++|||+.+|.+.|+.++.+
T Consensus 218 ~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 GPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp THHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 777766664 4556778889999999999999999999999999999999877654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=311.88 Aligned_cols=202 Identities=27% Similarity=0.498 Sum_probs=180.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||
T Consensus 59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP 133 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKL 133 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCG
T ss_pred HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCH
Confidence 467899999999999999999999999999999999998744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.+|.+||+|||+++.............|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..+.
T Consensus 134 ~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence 99999999999999999998765544445567789999999999999999999999999999999999999999988887
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhc
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIK 211 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~ 211 (226)
...+.. ....+|..+|+++.+||.+||+.||.+|++ ++++++ +++++
T Consensus 214 ~~~i~~--~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~--Hp~f~ 265 (337)
T d1o6la_ 214 FELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--HRFFL 265 (337)
T ss_dssp HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred HHHHhc--CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc--Ccccc
Confidence 776643 446778899999999999999999999994 888887 45543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-50 Score=308.73 Aligned_cols=201 Identities=26% Similarity=0.440 Sum_probs=174.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+|||||.+|+|..++... +.+++..++.++.||+.||.|||++| |+||||||
T Consensus 69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp 143 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKA 143 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSG
T ss_pred HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCc
Confidence 47899999999999999999999999999999998776653 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.+||+|||++..... .....|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.
T Consensus 144 ~NILl~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 144 GNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp GGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ceEEECCCCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999999876443 234578999999999864 3478899999999999999999999998887
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+.........+..+++++.+||.+||+.||.+|||+.++++ ++++..
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~ 272 (309)
T d1u5ra_ 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (309)
T ss_dssp HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence 77666665444444456678999999999999999999999999988 555544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-50 Score=312.23 Aligned_cols=216 Identities=25% Similarity=0.409 Sum_probs=182.3
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||++||+|.+++.+.. ..+++..++.++.||+.||.|||++| ++||||||
T Consensus 77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp 152 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKP 152 (350)
T ss_dssp HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--Ceeeeech
Confidence 357899999999999999999999999999999999986532 24999999999999999999999999 99999999
Q ss_pred CcEEEc--CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVD--KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++ .++.+||+|||+++...... ......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..
T Consensus 153 ~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 153 ENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp GGEEESSTTSCCEEECCCTTCEECCTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hHeeeccCCCCeEEEeecchheeccccc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 999995 46789999999987654332 233457789999999999998999999999999999999999999988888
Q ss_pred HHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCCCC
Q 027225 159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 223 (226)
Q Consensus 159 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~ 223 (226)
+....+....... .....+++++++||.+||+.||++|||+.|+++ +.+++.......+..+|
T Consensus 232 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSCTTCCSCCCCBC
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCCCCCCCchhhCC
Confidence 8777665443332 223568999999999999999999999999999 78887655444444443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=312.65 Aligned_cols=203 Identities=33% Similarity=0.544 Sum_probs=175.1
Q ss_pred CC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC--------------------CCcCCHHHHHHHHHHHHH
Q 027225 3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------------------REMLDERRRLNMAYDVAK 61 (226)
Q Consensus 3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------------------~~~~~~~~~~~~~~~l~~ 61 (226)
++ +||||+++++++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.
T Consensus 96 ~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 175 (325)
T d1rjba_ 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175 (325)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred HhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence 45 899999999999999999999999999999999976431 235899999999999999
Q ss_pred HHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHH
Q 027225 62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139 (226)
Q Consensus 62 ~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 139 (226)
||+|||++| |+||||||+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||+|
T Consensus 176 gl~yLH~~~--IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~G 253 (325)
T d1rjba_ 176 GMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253 (325)
T ss_dssp HHHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHhCC--eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchh
Confidence 999999999 99999999999999999999999999876443322 22234568899999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 027225 140 VILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 207 (226)
Q Consensus 140 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 207 (226)
|++|+|++ |..||.+.+..+....+.....+...+..+++++.+||.+||+.||++|||+++|++.|.
T Consensus 254 vil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99999997 899998876655555554456667778899999999999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=304.61 Aligned_cols=208 Identities=32% Similarity=0.608 Sum_probs=177.9
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+ +..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp 137 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRA 137 (272)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccch
Confidence 357899999999998865 56799999999999999886543 234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~ 158 (226)
+||++++++.+||+|||+++...... .......+++.|+|||++.+..++.++||||+|+++|+|+|| ..|+...+..
T Consensus 138 ~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~ 217 (272)
T d1qpca_ 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (272)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997654332 223345678899999999988899999999999999999996 5556666666
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
+....+. ...+...+..+++++.+++.+||+.||++|||+.+|++.|+++++++
T Consensus 218 ~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 218 EVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHH-hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 6666654 45566678889999999999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=304.24 Aligned_cols=215 Identities=34% Similarity=0.591 Sum_probs=178.8
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.+ +..++||||+.+|+|..++.... .+.+++.+++.++.|++.||+|||++| ++||||||+
T Consensus 67 ~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~ 142 (285)
T d1fmka3 67 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA 142 (285)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred HhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccce
Confidence 57899999999999965 56899999999999999987532 234999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQ 159 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~ 159 (226)
||++++++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||+|+++|+|++|.. |+......+
T Consensus 143 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~ 222 (285)
T d1fmka3 143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222 (285)
T ss_dssp GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987643322 22334567889999999999989999999999999999999655 456666666
Q ss_pred HHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCCCCCCCC
Q 027225 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 221 (226)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 221 (226)
....+. .......+..+++++.++|.+||+.||++|||+++|+++|+++++..+|+..|.+
T Consensus 223 ~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 223 VLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp HHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred HHHHHH-hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 666554 4455667889999999999999999999999999999999999999988777754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=309.33 Aligned_cols=203 Identities=28% Similarity=0.441 Sum_probs=167.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~ 79 (226)
|++++||||++++++|.++++.|+||||+.||+|.+++.+.+ .+++..++.++.|++.||.|||+ +| |+|||||
T Consensus 58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiK 132 (322)
T d1s9ja_ 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVK 132 (322)
T ss_dssp GGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCS
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccC
Confidence 578999999999999999999999999999999999998643 49999999999999999999997 59 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
|+||+++.+|.+||+|||++...... ......|++.|+|||++.+..++.++||||+||++|+|++|+.||...+..+
T Consensus 133 P~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 133 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp GGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred HHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999999998765432 2335678999999999999999999999999999999999999997654332
Q ss_pred HHHH------------------------------------------HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC
Q 027225 160 VVAA------------------------------------------VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 197 (226)
Q Consensus 160 ~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 197 (226)
.... .............++.++.++|.+||+.||.+||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 290 (322)
T d1s9ja_ 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290 (322)
T ss_dssp HHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc
Confidence 2110 0000001111234688999999999999999999
Q ss_pred CHHHHHHHHHHhhcC
Q 027225 198 SFSTIMELLRPLIKS 212 (226)
Q Consensus 198 s~~~~l~~l~~~~~~ 212 (226)
|++|+++ +++++.
T Consensus 291 ta~e~L~--Hpf~~~ 303 (322)
T d1s9ja_ 291 DLKQLMV--HAFIKR 303 (322)
T ss_dssp CHHHHHT--SHHHHH
T ss_pred CHHHHhh--CHhhCc
Confidence 9999998 555543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=296.93 Aligned_cols=204 Identities=31% Similarity=0.564 Sum_probs=179.6
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
+++++||||+++++++.+++..++||||+.+|+|.+++.... ..+++..++.++.|+++||.|||+.| ++||||||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~ 128 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAA 128 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSG
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccc
Confidence 357899999999999999999999999999999999976542 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc-ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||+|+++|+|+| |+.||...+..
T Consensus 129 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp GGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred eeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 999999999999999999875443322 2234567888999999998889999999999999999998 79999999988
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
++...+. ...+...|...++++.++|.+||+.||++|||++++++.|.++
T Consensus 209 ~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 209 ETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHH-hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 8877775 4556677889999999999999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.6e-49 Score=307.75 Aligned_cols=205 Identities=25% Similarity=0.427 Sum_probs=177.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||++++++|.+++..|+|||||+||+|.+++...+ ..+++.+++.++.||+.||.|||++| |+||||||
T Consensus 80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp 155 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKP 155 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 478999999999999999999999999999999999887643 23999999999999999999999999 99999999
Q ss_pred CcEEEc--CCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVD--KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++ .++.+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 156 ~NILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 156 ENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp GGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ccccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999997 6789999999998765432 2233456788999999999999999999999999999999999999998888
Q ss_pred HHHHHHhhCCcc--CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+...... ......+++++.+||.+||+.||.+|||+.|+++ +.++++
T Consensus 235 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--Hp~~~~ 288 (352)
T d1koba_ 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLKG 288 (352)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTSS
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhCC
Confidence 877766544332 2344679999999999999999999999999998 566654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=302.65 Aligned_cols=207 Identities=26% Similarity=0.433 Sum_probs=177.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+|||||++|+|.+++.+.+ .+++..++.++.|++.||+|||+.| ++||||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp 141 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKP 141 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc--eeeccccc
Confidence 356899999999999999999999999999999999998743 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCC----cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 81 PNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
+||+++.++ .+|++|||++....... ......+++.|+|||++.+..++.++||||+||++|+|++|..||.+.+
T Consensus 142 ~Nill~~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceEEEecCCCcccceEecchhhhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 999998776 59999999987654332 2344567889999999999889999999999999999999999999988
Q ss_pred HHHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 157 PAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
..+....+....... ..+..+|+++.+||.+||+.||.+|||++++++ +++++....
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~~~~ 279 (293)
T d1jksa_ 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIKPKDT 279 (293)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTCC---
T ss_pred HHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCCCCh
Confidence 888776665433322 233678999999999999999999999999998 788875433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-49 Score=302.11 Aligned_cols=200 Identities=26% Similarity=0.494 Sum_probs=177.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..|+||||+.||+|..++.... .+++..++.++.||+.||+|||++| |+||||||
T Consensus 58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp 132 (316)
T d1fota_ 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKP 132 (316)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCG
T ss_pred HHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc--EEccccCc
Confidence 357899999999999999999999999999999999998744 3899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.+|.+||+|||+++..... .....|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..+.
T Consensus 133 ~NILl~~~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 209 (316)
T d1fota_ 133 ENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209 (316)
T ss_dssp GGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred hheeEcCCCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence 9999999999999999999765543 3356789999999999999899999999999999999999999999888877
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
...+.. .....+..+++++.++|.+||..||.+|+ |++++++ ++++++
T Consensus 210 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~--Hp~f~~ 262 (316)
T d1fota_ 210 YEKILN--AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFKE 262 (316)
T ss_dssp HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGSS
T ss_pred HHHHHc--CCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc--Cccccc
Confidence 776643 34466788999999999999999999996 8999987 555543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=298.62 Aligned_cols=208 Identities=32% Similarity=0.610 Sum_probs=173.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+||+.++++.+++.... +.+++.++..++.|++.||+|||+.+ |+||||||
T Consensus 63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp 138 (283)
T d1mqba_ 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAA 138 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc--cccCcccc
Confidence 357899999999999999999999999999999999887543 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~ 156 (226)
+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||+|+++|+|+++.. |+...+
T Consensus 139 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~ 218 (283)
T d1mqba_ 139 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218 (283)
T ss_dssp GGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC
Confidence 999999999999999999976433221 1223456788999999999999999999999999999999655 556666
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
..+....+. ...+...+..++.++.++|.+||+.||++|||+.+|++.|+++++..
T Consensus 219 ~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 219 NHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHh-ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 666665554 45566778889999999999999999999999999999999998763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=300.89 Aligned_cols=215 Identities=21% Similarity=0.270 Sum_probs=178.6
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
++++||||+++++++.++++.|+||||+.++++..+.... ..+++..+..++.||+.||+|||++| ++||||||+
T Consensus 55 ~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~ 129 (299)
T d1ua2a_ 55 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPN 129 (299)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred HhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcc
Confidence 5689999999999999999999999999998877776653 34899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.++.+||+|||.+..............+++.|+|||++.+. .++.++||||+||++|+|++|..||...+..+.
T Consensus 130 NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp GEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence 9999999999999999997766555555566789999999998755 468999999999999999999999988877666
Q ss_pred HHHHhhCCccC--------------------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 161 VAAVGFKGKRL--------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 161 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
...+....... .....+++++.+||.+||+.||++|||++|+++ ++++++.+
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~~~p 287 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNRP 287 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSSS
T ss_pred HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CHhhCCCC
Confidence 55442210000 001356889999999999999999999999999 88998766
Q ss_pred CCCCCCCCC
Q 027225 215 PQPSPTDMP 223 (226)
Q Consensus 215 ~~~~~~~~~ 223 (226)
.+..+..+|
T Consensus 288 ~p~~~~~~p 296 (299)
T d1ua2a_ 288 GPTPGCQLP 296 (299)
T ss_dssp CCCCSSSSC
T ss_pred CCCCCCCCC
Confidence 544444444
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=298.37 Aligned_cols=206 Identities=30% Similarity=0.589 Sum_probs=169.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++. ++..|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++| ++||||||
T Consensus 62 l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp 136 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAA 136 (273)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred HHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccch
Confidence 36789999999999996 467999999999999999876532 24899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccc-cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||+|+++|+|++ |..||...+..
T Consensus 137 ~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 137 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp GGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred hheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999987644322 22334556789999999998889999999999999999998 89999988888
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+. .....+.+..+++++.++|.+||+.||.+|||+.+|++.|++++..
T Consensus 217 ~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 217 DVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp GHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 7777665 4555677889999999999999999999999999999999988653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=302.91 Aligned_cols=195 Identities=28% Similarity=0.458 Sum_probs=176.8
Q ss_pred CCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 027225 3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~n 82 (226)
+++||||+++++++.+++..|+||||+++|+|.+++...+ .+++.+++.++.||+.||+|||++| ++||||||+|
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~N 133 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDN 133 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGG
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccc
Confidence 5799999999999999999999999999999999998743 3899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 027225 83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 162 (226)
Q Consensus 83 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 162 (226)
|++++++.+||+|||.++.............|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..+...
T Consensus 134 iL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp EEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999866555455556678999999999999999999999999999999999999999988888777
Q ss_pred HHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH-HHHH
Q 027225 163 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIME 204 (226)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~ 204 (226)
.+.. .....+..+++++.+||.+||+.||.+||++. ++++
T Consensus 214 ~i~~--~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 214 SIRM--DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHc--CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 7753 34567788999999999999999999999996 7765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-48 Score=303.52 Aligned_cols=202 Identities=25% Similarity=0.399 Sum_probs=173.1
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+.++||||+++++++.+++..|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++| ++||||||+
T Consensus 62 ~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~ 136 (364)
T d1omwa3 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 136 (364)
T ss_dssp SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred hcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccc
Confidence 56789999999999999999999999999999999998743 4899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
||+++.+|.+||+|||+++..... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+.
T Consensus 137 NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 214 (364)
T d1omwa3 137 NILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214 (364)
T ss_dssp GEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred eeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999765443 2345578999999999874 5689999999999999999999999976544332
Q ss_pred HHH-HhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCC-----HHHHHHHHHHhhcC
Q 027225 161 VAA-VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKS 212 (226)
Q Consensus 161 ~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~~ 212 (226)
... ..........+..+++++.+||.+||+.||.+||| ++++++ ++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--Hp~f~~ 270 (364)
T d1omwa3 215 HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFRS 270 (364)
T ss_dssp HHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--SGGGTT
T ss_pred HHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--CccccC
Confidence 222 22244555667889999999999999999999999 799988 566654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-48 Score=302.58 Aligned_cols=199 Identities=24% Similarity=0.416 Sum_probs=177.4
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+.+..++|+||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||
T Consensus 95 l~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP 169 (350)
T d1rdqe_ 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKP 169 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHHcCCCcEeecccccccccccccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCH
Confidence 478899999999999999999999999999999999998744 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 160 (226)
+||+++.+|.+||+|||+++..... .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.
T Consensus 170 ~NILl~~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 170 ENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHcccCCCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 9999999999999999999765433 2345688999999999999999999999999999999999999998888777
Q ss_pred HHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhc
Q 027225 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIK 211 (226)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~ 211 (226)
...+.. .....+..+++++.++|++||+.||.+|+ |++++++ +++++
T Consensus 247 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~--Hp~f~ 298 (350)
T d1rdqe_ 247 YEKIVS--GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp HHHHHH--CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred HHHHhc--CCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc--Ccccc
Confidence 776643 34566788999999999999999999994 8999987 55544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=294.77 Aligned_cols=204 Identities=36% Similarity=0.665 Sum_probs=172.2
Q ss_pred CCCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+ .+.+++||||+++|+|.+++...+ ...+++..++.++.|++.||.|||+.+ ++||||+
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlk 130 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLA 130 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc--eeccccc
Confidence 478999999999999865 466899999999999999997532 234899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA 158 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 158 (226)
|+||+++.++.++++|||.++..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 131 p~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 131 ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp GGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred hHhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 99999999999999999998764433 223456778999999998889999999999999999998 78889888887
Q ss_pred HHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+....+. ...+.+.+..+++++.++|.+||..||.+|||+.++++.|+++.+
T Consensus 208 ~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 208 DVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp GHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHH-cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 7777764 456677888999999999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-48 Score=293.78 Aligned_cols=203 Identities=23% Similarity=0.393 Sum_probs=174.6
Q ss_pred CCCC-CcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++ ||||+++++++.++++.|+||||+++|+|.+++..++ .+++.+++.++.||+.||+|||++| ++||||||
T Consensus 64 ~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp 138 (277)
T d1phka_ 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN--IVHRDLKP 138 (277)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred HHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--Cccccccc
Confidence 3455 9999999999999999999999999999999998644 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccC------CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD------EPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
+||+++.++.+||+|||+++...... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||..
T Consensus 139 ~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 139 ENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 99999999999999999997655432 2345678899999999853 3457899999999999999999999999
Q ss_pred CCHHHHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 155 LNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+..+....+........ ....+|+++++++.+||+.||++|||++|+++ +++++.
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~--h~~~~~ 275 (277)
T d1phka_ 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQQ 275 (277)
T ss_dssp SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGCT
T ss_pred CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHHHH
Confidence 888777766654433322 33479999999999999999999999999988 666653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=296.09 Aligned_cols=211 Identities=34% Similarity=0.643 Sum_probs=182.3
Q ss_pred CCCC-CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-------------CCCCcCCHHHHHHHHHHHHHHHHHH
Q 027225 1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-------------GVREMLDERRRLNMAYDVAKGMNYL 66 (226)
Q Consensus 1 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~l 66 (226)
|+++ +||||+++++++.+++..++||||+++|+|.+++.+. .....+++..+..++.|++.||.|+
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 3566 7999999999999999999999999999999999753 2234599999999999999999999
Q ss_pred hcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHH
Q 027225 67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146 (226)
Q Consensus 67 H~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 146 (226)
|+.+ ++||||||+||+++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 144 H~~~--iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell 220 (309)
T d1fvra_ 144 SQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220 (309)
T ss_dssp HHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred hcCC--ccccccccceEEEcCCCceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHH
Confidence 9999 99999999999999999999999999875443322 23445788999999999988999999999999999999
Q ss_pred hCC-CCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 147 TLQ-QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 147 ~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
+|. .||...+..+....+. ...++..+..+++++.+||.+||+.||++|||+++|++.|++++.....
T Consensus 221 ~~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 221 SLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp TTSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred hcCCCCCCCCCHHHHHHHHH-hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 975 5788888888777664 4456777888999999999999999999999999999999999876543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=293.81 Aligned_cols=204 Identities=33% Similarity=0.560 Sum_probs=177.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+ +..++|+||+++|++.+++..+. +.+++..+..++.|++.||.|||++| ++||||||
T Consensus 65 l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp 139 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAA 139 (273)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred HHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecH
Confidence 357899999999999976 46899999999999998877542 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN 156 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 156 (226)
+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 140 ~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred HHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 999999999999999999876433322 2233445678999999999989999999999999999998 899999999
Q ss_pred HHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHh
Q 027225 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 209 (226)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 209 (226)
..+....+.....+.+.+..+++++.++|.+||..||++|||+.+|.+.|++.
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99888888767777777889999999999999999999999999999988764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=291.77 Aligned_cols=205 Identities=33% Similarity=0.609 Sum_probs=181.6
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHRRNP 71 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 71 (226)
+||||++++++|.+++..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+.+
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~- 155 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 155 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence 799999999999999999999999999999999975431 245899999999999999999999999
Q ss_pred CeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-C
Q 027225 72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L 148 (226)
Q Consensus 72 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 148 (226)
++||||||+||+++.++.+||+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 156 -ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g 234 (299)
T d1fgka_ 156 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234 (299)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence 99999999999999999999999999876544322 2344567789999999999899999999999999999998 6
Q ss_pred CCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 149 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..||.+.+..+....+. ....+..+..+++++.++|.+||+.||.+|||+.+|++.|++++..
T Consensus 235 ~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 235 GSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp CCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 88999888887776665 4566778889999999999999999999999999999999998653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=299.53 Aligned_cols=205 Identities=20% Similarity=0.351 Sum_probs=175.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++.+|+|||||+||+|.+++.+.+ ..+++.+++.++.||+.||+|||++| |+||||||
T Consensus 55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp 130 (321)
T d1tkia_ 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRP 130 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccc
Confidence 357899999999999999999999999999999999997643 23899999999999999999999999 99999999
Q ss_pred CcEEEcCC--CcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 027225 81 PNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158 (226)
Q Consensus 81 ~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 158 (226)
+||+++.+ +.++++|||++....... ......+++.|+|||...+..++.++|+||+||++|+|++|..||...+..
T Consensus 131 ~NIll~~~~~~~ikl~DFG~~~~~~~~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 131 ENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp GGEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred cceeecCCCceEEEEcccchhhccccCC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 99999854 489999999987654332 223445688999999999998999999999999999999999999998888
Q ss_pred HHHHHHhhCCccCC--CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
+....+........ ....+++++++||.+||..||.+|||++|+++ +++++.
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~~ 263 (321)
T d1tkia_ 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred HHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhcc
Confidence 87776654332221 22468999999999999999999999999998 566544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-47 Score=290.41 Aligned_cols=206 Identities=24% Similarity=0.421 Sum_probs=169.9
Q ss_pred CCCCCCcCcceeeeEEecCCc----eEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|++++||||+++++++..++. .|+||||++|++|.+++...+ .+++.+++.++.||+.||+|||++| ++||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--iiHr 135 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG--IIHR 135 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCc
Confidence 357899999999999976543 899999999999999987744 4999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCcccccccc---cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||||+||+++.++..+++|||.+....... .......|++.|+|||++.+..++.++||||+||++|+|++|+.||.
T Consensus 136 DiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp CCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 999999999999999999999876433221 23344568899999999999889999999999999999999999999
Q ss_pred CCCHHHHHHHHhhCCccC--CCCCCCCHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHhhc
Q 027225 154 NLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRP-SFSTIMELLRPLIK 211 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~~ 211 (226)
..+..+............ .....+|+++.++|.+||+.||.+|| |++++++.|.++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 888877665554333322 34567999999999999999999998 89999999988754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=295.77 Aligned_cols=203 Identities=28% Similarity=0.446 Sum_probs=165.4
Q ss_pred CCCcCcceeeeEEec----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 4 LRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 4 l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
.+||||++++++|.+ +..+|+|||||+||+|.+++.+.+ ...+++.+++.++.||+.||+|||++| |+|||||
T Consensus 62 ~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiK 138 (335)
T d2ozaa1 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVK 138 (335)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred cCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccc
Confidence 589999999999875 466999999999999999998754 345999999999999999999999999 9999999
Q ss_pred CCcEEEcC---CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 80 SPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 80 p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
|+||+++. .+.+||+|||+++..... .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+
T Consensus 139 p~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 139 PENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred ccccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 99999975 457999999998765443 23345678999999999999889999999999999999999999997655
Q ss_pred HHHHHHHHhh--CCccCCCC----CCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 157 PAQVVAAVGF--KGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 157 ~~~~~~~~~~--~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
..+....... ......++ ..+++++.+||.+||+.||.+|||+.++++ ++++..
T Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 277 (335)
T d2ozaa1 218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 277 (335)
T ss_dssp CC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhhC
Confidence 4443322211 12222223 257899999999999999999999999998 565544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-47 Score=291.52 Aligned_cols=207 Identities=32% Similarity=0.562 Sum_probs=178.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCC---------------------CCcCCHHHHHHHHHHH
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYDV 59 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---------------------~~~~~~~~~~~~~~~l 59 (226)
|++++||||+++++++.+.+..++|+|++.+|+|.+++..... ...+++..++.++.|+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999864211 2248899999999999
Q ss_pred HHHHHHHhcCCCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHH
Q 027225 60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYS 137 (226)
Q Consensus 60 ~~~l~~lH~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 137 (226)
+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||
T Consensus 150 ~~gl~ylH~~~--ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS 227 (301)
T d1lufa_ 150 AAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227 (301)
T ss_dssp HHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHhhhcccCC--eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhcc
Confidence 99999999999 9999999999999999999999999987543322 2233455678999999999999999999999
Q ss_pred HHHHHHHHHhCC-CCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhh
Q 027225 138 FGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 210 (226)
Q Consensus 138 lG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 210 (226)
||+++|+|++|. .||...+..+....+. .......+..+++++.++|.+||+.+|++|||+.+|++.|+++.
T Consensus 228 ~Gvvl~ell~~~~~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 999999999985 6788888888877765 44566778899999999999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=291.58 Aligned_cols=207 Identities=33% Similarity=0.606 Sum_probs=168.6
Q ss_pred CCCcCcceeeeEEecC-CceEEEEeecccCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHhcC
Q 027225 4 LRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLHRR 69 (226)
Q Consensus 4 l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lH~~ 69 (226)
.+|+||+.+++++.+. +..++||||+++|+|.+++.... ....+++.++..++.|++.||+|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3789999999988654 56899999999999999986432 123489999999999999999999999
Q ss_pred CCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 70 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
| |+||||||+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||+||++|+|++
T Consensus 154 ~--ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 154 K--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp T--CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 9 9999999999999999999999999987543332 22334567889999999999989999999999999999998
Q ss_pred C-CCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 148 L-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 148 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
| ..||...+..+..............+..+++++.++|.+||+.||++|||+.+++++|++++++
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 7 5578776554444433345566777888999999999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=294.48 Aligned_cols=206 Identities=28% Similarity=0.531 Sum_probs=174.7
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.++ ..++++|++.+++|.+++.... ..+++..++.++.|++.||+|||++| |+||||||
T Consensus 65 l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp 139 (317)
T d1xkka_ 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 139 (317)
T ss_dssp HHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchh
Confidence 3578999999999999875 5778889999999999887643 34999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~ 157 (226)
+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||+|+++|+|+| |..||...+.
T Consensus 140 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 140 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp GGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred hcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 999999999999999999876443221 2233457889999999999889999999999999999998 7899988887
Q ss_pred HHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+. ...+...+..+++++.+++.+||+.||.+|||+.++++.|..+.+.
T Consensus 220 ~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 220 SEISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp GGHHHHHH-HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHH-cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 77666554 4455677888999999999999999999999999999999877543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=288.53 Aligned_cols=210 Identities=30% Similarity=0.519 Sum_probs=174.3
Q ss_pred CCCCCCcCcceeeeEEec-CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~ 79 (226)
|++++||||+++++++.+ ++..++||||+++++|.+++..... ..++..+..++.|++.||.|+|+.+ ++|||||
T Consensus 82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK 157 (311)
T d1r0pa_ 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLA 157 (311)
T ss_dssp HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC--cccCCcc
Confidence 467899999999999865 5679999999999999999886543 3778899999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEccCCCcccccccc----cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC-
Q 027225 80 SPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN- 154 (226)
Q Consensus 80 p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~- 154 (226)
|+||++++++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 158 ~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 158 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp GGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred HHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 999999999999999999987643321 122234567899999999988899999999999999999998777654
Q ss_pred CCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
.+..+....+. ...+...+..+++++.++|.+||+.||++|||+.||++.|+++++....
T Consensus 238 ~~~~~~~~~i~-~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 238 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -----CHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCHHHHHHHHH-cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 33333444333 4556677788999999999999999999999999999999999876444
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=284.88 Aligned_cols=209 Identities=22% Similarity=0.300 Sum_probs=171.8
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.++++.|+||||+.++.+....... ...+++..++.++.|++.||+|||++| |+||||||
T Consensus 55 l~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKp 130 (298)
T d1gz8a_ 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKP 130 (298)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCc
Confidence 47899999999999999999999999999764444433332 234999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.+||+|||.+..............+++.|+|||++.... .+.++|+||+|+++|+|++|+.||...+..+
T Consensus 131 eNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp GGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred hheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence 999999999999999999977665555555667889999999887665 5789999999999999999999998877666
Q ss_pred HHHHHhhCCcc----------------CC-----------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 160 VVAAVGFKGKR----------------LE-----------IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 160 ~~~~~~~~~~~----------------~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
....+...... .. ....+++++.+||.+||+.||++|||++|+++ ++++++
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~--H~ff~~ 288 (298)
T d1gz8a_ 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQD 288 (298)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTT
T ss_pred HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--CHhhcc
Confidence 54433211000 00 01356789999999999999999999999999 788876
Q ss_pred CCC
Q 027225 213 PTP 215 (226)
Q Consensus 213 ~~~ 215 (226)
...
T Consensus 289 ~~~ 291 (298)
T d1gz8a_ 289 VTK 291 (298)
T ss_dssp CCC
T ss_pred CCC
Confidence 533
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=287.47 Aligned_cols=207 Identities=32% Similarity=0.564 Sum_probs=176.6
Q ss_pred CCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCC---------------CCCcCCHHHHHHHHHHHHHHHHHHhcC
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG---------------VREMLDERRRLNMAYDVAKGMNYLHRR 69 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~~l~~lH~~ 69 (226)
+||||+++++++.+++..++||||+++|+|.+++.+.. ....+++..+..++.||+.|++|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 69999999999999999999999999999999987532 123589999999999999999999999
Q ss_pred CCCeEEeCCCCCcEEEcCCCcEEEccCCCcccccccc--cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHh
Q 027225 70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 70 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 147 (226)
| ++||||||+||+++.++.++++|||.++...... .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 165 ~--ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 165 N--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp T--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence 9 9999999999999999999999999987644322 22334567889999999998889999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCC
Q 027225 148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 213 (226)
Q Consensus 148 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 213 (226)
|..|+...+..+....+.....+...+...++++.+||.+||+.||++|||+.+|+++|++++.++
T Consensus 243 ~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp TTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 566676666555544444455666677889999999999999999999999999999999887664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-45 Score=279.75 Aligned_cols=204 Identities=23% Similarity=0.304 Sum_probs=167.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+++..++++|++.++.+..+....+ .+++..+..++.||+.||+|||+.| |+||||||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp 128 (286)
T d1ob3a_ 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKP 128 (286)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc--EEecCCCC
Confidence 578999999999999999999999999998877777776543 4999999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 159 (226)
+||+++.++.+|++|||.+..............+++.|+|||.+.+. .++.++|+||+||++++|++|+.||.+.+..+
T Consensus 129 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~ 208 (286)
T d1ob3a_ 129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (286)
T ss_dssp GGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999999987766554445556678899999998765 46899999999999999999999998877666
Q ss_pred HHHHHhhCCcc---------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 160 VVAAVGFKGKR---------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 160 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
....+...... ......+++++.+||++||+.||++|||++|+++ +++++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~--Hp~f~ 285 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFK 285 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGG
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 54433211000 1123467899999999999999999999999998 66665
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=281.35 Aligned_cols=208 Identities=34% Similarity=0.571 Sum_probs=181.0
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCC-------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-------GVREMLDERRRLNMAYDVAKGMNYLHRRNPPI 73 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 73 (226)
+++++||||+++++++..++..++|+||+.+|+|.+++... .....+++..+..++.|++.||.|||+++ +
T Consensus 77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--i 154 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--F 154 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--e
Confidence 46889999999999999999999999999999999987642 12234789999999999999999999999 9
Q ss_pred EEeCCCCCcEEEcCCCcEEEccCCCccccccccc--ccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhC-CC
Q 027225 74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQ 150 (226)
Q Consensus 74 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~ 150 (226)
+||||||+||++++++.+||+|||+++....... ......+++.|+|||.+.+..++.++|+||+|+++++|++| ..
T Consensus 155 vHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~ 234 (308)
T d1p4oa_ 155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234 (308)
T ss_dssp BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred eeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875443322 23344568899999999999899999999999999999998 57
Q ss_pred CCCCCCHHHHHHHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 151 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
||.+.+..+....+. .......+..+++.+.++|.+||+.+|.+|||+++|++.|++.+.
T Consensus 235 p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 235 PYQGLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCHHHHHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 888888888877665 455667788999999999999999999999999999999987755
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=280.68 Aligned_cols=205 Identities=23% Similarity=0.344 Sum_probs=169.4
Q ss_pred CCCCcCcceeeeEEec-----CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 027225 3 RLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD 77 (226)
Q Consensus 3 ~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~d 77 (226)
.++||||++++++|.. ....++++|++.++++....... ...+++..++.++.|++.||+|||++| |+|||
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrD 141 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 141 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCC
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecC
Confidence 3589999999999853 34689999999887766554433 234899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 78 i~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
|||+||+++.++.++++|||.+...... .......+++.|+|||++.+..++.++||||+||++|+|++|+.||...+.
T Consensus 142 iKp~NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 142 LKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCccEEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999999998654433 234566789999999999999999999999999999999999999998887
Q ss_pred HHHHHHHhhCCc-------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVGFKGK-------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
.+....+..... .......+++++.+||.+||+.||++|||+.|+++ ++++++
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~--Hpff~~ 298 (305)
T d1blxa_ 221 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQD 298 (305)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTT
T ss_pred HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhcC
Confidence 665554321100 11234567899999999999999999999999999 788876
Q ss_pred CC
Q 027225 213 PT 214 (226)
Q Consensus 213 ~~ 214 (226)
..
T Consensus 299 i~ 300 (305)
T d1blxa_ 299 LE 300 (305)
T ss_dssp CC
T ss_pred ch
Confidence 53
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=281.45 Aligned_cols=193 Identities=21% Similarity=0.414 Sum_probs=164.0
Q ss_pred CCcCcceeeeEEecCCceEEEEeeccc-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCcE
Q 027225 5 RHPNIVLFMGAVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ni 83 (226)
.||||+++++++.+++..++|||++.+ +++.+++.+.+ .+++++++.++.||+.||+|||++| ++||||||+||
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NI 141 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENI 141 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccce
Confidence 489999999999999999999999975 68888887643 4999999999999999999999999 99999999999
Q ss_pred EEcC-CCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 027225 84 LVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161 (226)
Q Consensus 84 l~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 161 (226)
+++. ++.+||+|||.++..... ......|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+ ++
T Consensus 142 ll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i- 216 (273)
T d1xwsa_ 142 LIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI- 216 (273)
T ss_dssp EEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH-
T ss_pred EEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HH-
Confidence 9985 479999999998765433 2345678999999999987654 567899999999999999999997532 11
Q ss_pred HHHhhCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 162 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.......+..+|+++.++|.+||+.||++|||++|+++ .+++++..
T Consensus 217 -----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~~~~ 262 (273)
T d1xwsa_ 217 -----IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVL 262 (273)
T ss_dssp -----HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSSCC
T ss_pred -----hhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhCCCC
Confidence 12334567789999999999999999999999999998 77877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=275.70 Aligned_cols=206 Identities=31% Similarity=0.451 Sum_probs=162.5
Q ss_pred CCCCCCcCcceeeeEEecCC----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc--------
Q 027225 1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-------- 68 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-------- 68 (226)
+++++||||+++++++.+++ ..|+||||+++|+|.+++++.+ +++..++.++.+++.||+|+|+
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~ 126 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 46789999999999997654 4899999999999999998653 8999999999999999999997
Q ss_pred CCCCeEEeCCCCCcEEEcCCCcEEEccCCCccccccccc----ccCCCCCCCCccCcccccCCC------CCCchhHHHH
Q 027225 69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSF 138 (226)
Q Consensus 69 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~------~~~~~Dv~sl 138 (226)
+| |+||||||+||+++.++.+||+|||++........ ......+++.|+|||++.+.. ++.++|||||
T Consensus 127 ~~--IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 127 PA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CE--EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred CC--eeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 47 99999999999999999999999999876543321 233456889999999987653 4568999999
Q ss_pred HHHHHHHHhCCCCCCC---------------CCHHHHHHHHhhCCccCCCCCCC-----CHHHHHHHHHHcccCCCCCCC
Q 027225 139 GVILWELATLQQPWGN---------------LNPAQVVAAVGFKGKRLEIPRNV-----NPHVASIIEACWANEPWKRPS 198 (226)
Q Consensus 139 G~~l~~l~~g~~p~~~---------------~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps 198 (226)
||++|+|++|..|+.. ...............++..+... ...+.+++.+||+.||++|||
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 284 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC
Confidence 9999999999877632 12222333332222233333322 246899999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 027225 199 FSTIMELLRPLIKS 212 (226)
Q Consensus 199 ~~~~l~~l~~~~~~ 212 (226)
+.||++.|+++...
T Consensus 285 ~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 285 ALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999988654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=273.99 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=167.2
Q ss_pred CCCCCCcCcceeeeEEecCC------ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||++++++|...+ .+|+||||+ +.+|..+..... +++..++.++.||+.||.|||++| |+
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~--Ii 143 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAG--II 143 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHHhCC--Cc
Confidence 35789999999999997654 479999999 668888876533 999999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWG 153 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~ 153 (226)
||||||+||+++.++.++++|||.+...... .....+++.|+|||++.+. .++.++|+||+||++++|++|..||.
T Consensus 144 HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 144 HRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCcchhhcccccccccccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 9999999999999999999999999765443 3355678899999998764 46899999999999999999999998
Q ss_pred CCCHHHHHHHHhhCCc-----------------------------cCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHH
Q 027225 154 NLNPAQVVAAVGFKGK-----------------------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 204 (226)
Q Consensus 154 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 204 (226)
..+..+.......... ........++++.+||.+||..||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 8776554332211100 11123567899999999999999999999999999
Q ss_pred HHHHhhcCCC
Q 027225 205 LLRPLIKSPT 214 (226)
Q Consensus 205 ~l~~~~~~~~ 214 (226)
+++++...
T Consensus 301 --Hp~f~~~~ 308 (346)
T d1cm8a_ 301 --HPYFESLH 308 (346)
T ss_dssp --SGGGTTTC
T ss_pred --ChhhCcCC
Confidence 77776643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=275.22 Aligned_cols=207 Identities=20% Similarity=0.249 Sum_probs=161.1
Q ss_pred CCCCCCcCcceeeeEEec------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||++++++|.. ..+.|+||||++++.+..+.........+++.+++.++.||+.||+|||++| |+
T Consensus 67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--Ii 144 (350)
T d1q5ka_ 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--IC 144 (350)
T ss_dssp HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EE
T ss_pred HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--Cc
Confidence 357899999999999853 2347899999987644444332112335999999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 75 HRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 75 h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||||||+||+++.++ .+||+|||++...... .......++..|+|||.+.+ ..++.++||||+||++|+|++|..||
T Consensus 145 HrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf 223 (350)
T d1q5ka_ 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223 (350)
T ss_dssp CCCCCGGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred ccCCCcceEEEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC
Confidence 999999999999775 8999999998765433 22344577889999998765 45899999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCC---------------ccC------------CCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 153 GNLNPAQVVAAVGFKG---------------KRL------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~---------------~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
...+..+....+.... ... ......++++.+||.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~- 302 (350)
T d1q5ka_ 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA- 302 (350)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT-
T ss_pred CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc-
Confidence 8877655443331100 000 112357899999999999999999999999998
Q ss_pred HHHhhcC
Q 027225 206 LRPLIKS 212 (226)
Q Consensus 206 l~~~~~~ 212 (226)
+.++++
T Consensus 303 -Hp~f~~ 308 (350)
T d1q5ka_ 303 -HSFFDE 308 (350)
T ss_dssp -SGGGGG
T ss_pred -CHhhcc
Confidence 555543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=266.76 Aligned_cols=208 Identities=23% Similarity=0.334 Sum_probs=173.2
Q ss_pred CCCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
|++++||||+++++++.+....++|++++.+++|..++...+ .+++..++.++.|++.||+|||++| |+||||||
T Consensus 55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP 129 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKP 129 (292)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred HHhcCcCCEEeeccccccccceeEEeeecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccC
Confidence 468999999999999999999999999999999998887644 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCC-CCCCHH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPW-GNLNPA 158 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~-~~~~~~ 158 (226)
+||+++.++.++++|||.+..............++..|.|||.+.+.. ++.++|+||+||++++|++|+.|| ...+..
T Consensus 130 ~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 209 (292)
T d1unla_ 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred cccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH
Confidence 999999999999999999987665544455556678899999987665 689999999999999999999986 444444
Q ss_pred HHHHHHhhCC---------------------------ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhc
Q 027225 159 QVVAAVGFKG---------------------------KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 211 (226)
Q Consensus 159 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 211 (226)
+....+.... ........+++++.+||++||+.||++|||++|+++ +.+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~--Hp~f~ 287 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFS 287 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGS
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--Chhhc
Confidence 4433322110 111123467889999999999999999999999999 78887
Q ss_pred CCCC
Q 027225 212 SPTP 215 (226)
Q Consensus 212 ~~~~ 215 (226)
+..|
T Consensus 288 ~~~~ 291 (292)
T d1unla_ 288 DFCP 291 (292)
T ss_dssp SCSC
T ss_pred CCCC
Confidence 6544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=271.86 Aligned_cols=205 Identities=23% Similarity=0.384 Sum_probs=163.2
Q ss_pred CCCCCCcCcceeeeEEecCC----ceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 027225 1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~ 76 (226)
|++++||||+++++++.... ..+++++++.+|+|.+++.... +++..++.++.|++.||+|||++| |+||
T Consensus 60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~----l~~~~i~~i~~qil~al~yLH~~~--iiHR 133 (345)
T d1pmea_ 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN--VLHR 133 (345)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred HHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--CcCC
Confidence 45789999999999997543 2344455566889999997643 999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEccCCCccccccccc---ccCCCCCCCCccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 027225 77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW 152 (226)
Q Consensus 77 di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~ 152 (226)
||||+||++++++.+||+|||++........ ......+++.|+|||++.. ..++.++|+||+||++++|++|+.||
T Consensus 134 DIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 134 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence 9999999999999999999999875433322 2344567889999999854 45688999999999999999999999
Q ss_pred CCCCHHHHHHHHhhCCcc-----------------------------CCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHH
Q 027225 153 GNLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 203 (226)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 203 (226)
...+..+........... ......+++++.+|+.+||+.||.+|||+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 887765444332211000 011246788999999999999999999999999
Q ss_pred HHHHHhhcCC
Q 027225 204 ELLRPLIKSP 213 (226)
Q Consensus 204 ~~l~~~~~~~ 213 (226)
+ +++++..
T Consensus 294 ~--hpf~~~~ 301 (345)
T d1pmea_ 294 A--HPYLEQY 301 (345)
T ss_dssp T--SGGGTTT
T ss_pred c--CHhhccC
Confidence 8 6776644
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=266.39 Aligned_cols=206 Identities=19% Similarity=0.240 Sum_probs=164.7
Q ss_pred CCCCCCcCcceeeeEEec--------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 027225 1 MKRLRHPNIVLFMGAVTQ--------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP 72 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 72 (226)
|++++||||+++++++.. +++.|+|||++.++.+....... ..+++..++.++.|++.||.|||++|
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~-- 137 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK-- 137 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccCC--
Confidence 357899999999999855 35689999999887776665543 34999999999999999999999999
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcccccccc----cccCCCCCCCCccCcccccCC-CCCCchhHHHHHHHHHHHHh
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELAT 147 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~ 147 (226)
|+||||||+||+++.++.++++|||++....... .......+++.|+|||++.+. .++.++|+||+||++++|++
T Consensus 138 ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~ 217 (318)
T d3blha1 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217 (318)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh
Confidence 9999999999999999999999999986543221 222334678999999998765 57899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhCCccCC--CC----------------------------CCCCHHHHHHHHHHcccCCCCCC
Q 027225 148 LQQPWGNLNPAQVVAAVGFKGKRLE--IP----------------------------RNVNPHVASIIEACWANEPWKRP 197 (226)
Q Consensus 148 g~~p~~~~~~~~~~~~~~~~~~~~~--~~----------------------------~~~~~~~~~li~~~l~~~p~~Rp 197 (226)
|+.||.+.+..+....+........ .. ...++++.+||.+||+.||++||
T Consensus 218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 297 (318)
T d3blha1 218 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297 (318)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc
Confidence 9999988777665544432211110 00 01367889999999999999999
Q ss_pred CHHHHHHHHHHhhcCC
Q 027225 198 SFSTIMELLRPLIKSP 213 (226)
Q Consensus 198 s~~~~l~~l~~~~~~~ 213 (226)
|++|+++ +++++..
T Consensus 298 sa~elL~--Hpff~~~ 311 (318)
T d3blha1 298 DSDDALN--HDFFWSD 311 (318)
T ss_dssp CHHHHHH--SGGGSSS
T ss_pred CHHHHHc--ChhhccC
Confidence 9999999 9999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=271.54 Aligned_cols=204 Identities=24% Similarity=0.381 Sum_probs=167.1
Q ss_pred CCCCC-cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++| |||+++++++.+....++++||+.+|+|.+++...+ .+++..+..++.||+.||+|+|+.| ++||||||
T Consensus 83 ~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp 157 (322)
T d1vzoa_ 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKL 157 (322)
T ss_dssp HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred HhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCc
Confidence 45666 899999999999999999999999999999998744 3789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEccCCCccccccc-ccccCCCCCCCCccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 027225 81 PNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNLNP 157 (226)
Q Consensus 81 ~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 157 (226)
+||+++.++.++|+|||.+...... ........+++.|++||.+.+. .++.++||||+||++|+|++|..||...+.
T Consensus 158 ~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 158 ENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp GGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred cceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999998754332 2334456678899999999754 367899999999999999999999966543
Q ss_pred HHHHHHHh--hCCccCCCCCCCCHHHHHHHHHHcccCCCCCC-----CHHHHHHHHHHhhcC
Q 027225 158 AQVVAAVG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFSTIMELLRPLIKS 212 (226)
Q Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~~ 212 (226)
.+....+. ........+..+++++.++|.+||+.||.+|| |++|+++ +++++.
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~--Hpff~~ 297 (322)
T d1vzoa_ 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFFQK 297 (322)
T ss_dssp CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGGTT
T ss_pred HHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc--CHhhcC
Confidence 22222111 12344566778999999999999999999999 5889887 555543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-41 Score=258.27 Aligned_cols=207 Identities=17% Similarity=0.232 Sum_probs=169.0
Q ss_pred CCCC-cCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 3 RLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 3 ~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
+++| +|++.+++++.++...++|||++ +++|.+++...+ ..++...+..++.|++.||+|||++| ++||||||+
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~ 130 (293)
T d1csna_ 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPD 130 (293)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGG
T ss_pred HhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCcc
Confidence 4544 89999999999999999999999 679999987643 24999999999999999999999999 999999999
Q ss_pred cEEEcC-----CCcEEEccCCCcccccccc-------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCC
Q 027225 82 NLLVDK-----KYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 149 (226)
Q Consensus 82 nil~~~-----~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 149 (226)
||+++. ++.++|+|||+++...... .......|++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 131 Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~ 210 (293)
T d1csna_ 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210 (293)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCC
Confidence 999974 5689999999997644321 1223456899999999999999999999999999999999999
Q ss_pred CCCCCCCH---HHHHHHHhhC---CccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcCCC
Q 027225 150 QPWGNLNP---AQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 214 (226)
Q Consensus 150 ~p~~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 214 (226)
.||..... .+....+... .........+++++.+++..|+..+|.+||+++.+.+.|+++++...
T Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 211 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 99975432 2222222111 11222346789999999999999999999999999999998876543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=265.90 Aligned_cols=202 Identities=22% Similarity=0.331 Sum_probs=161.6
Q ss_pred CCCCCCcCcceeeeEEecC-----CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 027225 1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH 75 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h 75 (226)
|++++||||+++++++... ...+++++++.+|+|.+++..+ .+++..++.++.||+.||+|||++| |+|
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g--iiH 144 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIH 144 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC--Ccc
Confidence 3578999999999999633 3456667778899999999754 3999999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 76 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
|||||+||+++.++.++++|||.+...... .....++..|+|||+..+.. ++.++|+||+||++|+|++|+.||.+
T Consensus 145 rDiKp~NILi~~~~~~kl~dfg~a~~~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 145 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp CCCCGGGEEECTTCCEEECCC----CCTGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCccccccccccccccccchhcccCcc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 999999999999999999999998654433 33456678899999877654 58899999999999999999999988
Q ss_pred CCHHHHHHHHhhCCccC---------------------C--------CCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 027225 155 LNPAQVVAAVGFKGKRL---------------------E--------IPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 205 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 205 (226)
.+.......+....... . ....+++++.+||.+||..||.+|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~- 300 (348)
T d2gfsa1 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA- 300 (348)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT-
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc-
Confidence 77655544332111110 0 12357899999999999999999999999999
Q ss_pred HHHhhcCC
Q 027225 206 LRPLIKSP 213 (226)
Q Consensus 206 l~~~~~~~ 213 (226)
+.+++..
T Consensus 301 -Hp~f~~~ 307 (348)
T d2gfsa1 301 -HAYFAQY 307 (348)
T ss_dssp -SGGGTTT
T ss_pred -CHhhCCC
Confidence 7888754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.5e-41 Score=261.05 Aligned_cols=200 Identities=20% Similarity=0.318 Sum_probs=158.9
Q ss_pred CCC-CCcCcceeeeEEec--CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 027225 2 KRL-RHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78 (226)
Q Consensus 2 ~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di 78 (226)
+++ .||||++++++|.. ....++||||+.+++|..+.+. +++..++.++.||+.||.|||++| |+||||
T Consensus 84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~------l~e~~i~~i~~qil~aL~~LH~~g--IvHrDi 155 (328)
T d3bqca1 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IMHRDV 155 (328)
T ss_dssp HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTS------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcC------CCHHHHHHHHHHHHHHHHHHhhcc--cccccc
Confidence 345 49999999999974 4569999999999999877533 999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-cEEEccCCCcccccccccccCCCCCCCCccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 027225 79 KSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLN 156 (226)
Q Consensus 79 ~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 156 (226)
||+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+.. ++.++|+||+||+++++++|+.||....
T Consensus 156 Kp~NILi~~~~~~vkl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp SGGGEEEETTTTEEEECCGGGCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccceEEcCCCCeeeecccccceeccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 99999998655 68999999987654332 234556788999999987654 6899999999999999999999996543
Q ss_pred H-HHHHHHHhh-------------CC----------------------ccCCCCCCCCHHHHHHHHHHcccCCCCCCCHH
Q 027225 157 P-AQVVAAVGF-------------KG----------------------KRLEIPRNVNPHVASIIEACWANEPWKRPSFS 200 (226)
Q Consensus 157 ~-~~~~~~~~~-------------~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 200 (226)
. .+....+.. .. ........+++++.+||++||..||++|||++
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 2 221111100 00 00011234789999999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 027225 201 TIMELLRPLIKS 212 (226)
Q Consensus 201 ~~l~~l~~~~~~ 212 (226)
|+++ +++++.
T Consensus 315 e~L~--Hp~F~~ 324 (328)
T d3bqca1 315 EAME--HPYFYT 324 (328)
T ss_dssp HHHT--SGGGTT
T ss_pred HHhc--CcccCC
Confidence 9998 777765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-40 Score=252.88 Aligned_cols=206 Identities=20% Similarity=0.270 Sum_probs=160.4
Q ss_pred CCCCCcCc-ceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 027225 2 KRLRHPNI-VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80 (226)
Q Consensus 2 ~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p 80 (226)
++++|+|+ +.+.+++.+++..++||||+. +++.+.+.... ..+++..+..++.|++.||+|||++| |+||||||
T Consensus 57 ~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp 131 (299)
T d1ckia_ 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKP 131 (299)
T ss_dssp HHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred HHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCH
Confidence 45666665 455666678888999999994 57766665432 34999999999999999999999999 99999999
Q ss_pred CcEEEc---CCCcEEEccCCCcccccccc-------cccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCC
Q 027225 81 PNLLVD---KKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ 150 (226)
Q Consensus 81 ~nil~~---~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 150 (226)
+||+++ .+..++++|||.++...... .......+++.|+|||.+.+..++.++|||||||++++|++|..
T Consensus 132 ~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred hhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCC
Confidence 999985 35579999999998654332 12334568999999999999989999999999999999999999
Q ss_pred CCCCCCHHHHHHHHh------hCCccCCCCCCCCHHHHHHHHHHcccCCCCCCCHHHHHHHHHHhhcC
Q 027225 151 PWGNLNPAQVVAAVG------FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 151 p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 212 (226)
||............. ...........+++++.+++.+||+.+|.+||++.++.+.|++++..
T Consensus 212 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 212 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 997655433222111 11122233467899999999999999999999999999999987653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=266.13 Aligned_cols=201 Identities=24% Similarity=0.336 Sum_probs=154.3
Q ss_pred CCCCCCcCcceeeeEEec------CCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 027225 1 MKRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74 (226)
Q Consensus 1 l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~ 74 (226)
|++++||||++++++|.. ..+.|+||||+.++.+..+ .. .+++..++.++.|++.||+|||++| |+
T Consensus 70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~-~~-----~~~~~~i~~~~~qil~gl~~LH~~g--ii 141 (355)
T d2b1pa1 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QM-----ELDHERMSYLLYQMLCGIKHLHSAG--II 141 (355)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHH-TS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhh-hc-----CCCHHHHHHHHHHHHHHHHHhhhcc--cc
Confidence 357899999999999964 3678999999977555444 32 2899999999999999999999999 99
Q ss_pred EeCCCCCcEEEcCCCcEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 027225 75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154 (226)
Q Consensus 75 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 154 (226)
||||||+||+++.++.++++|||.++..... .......+++.|+|||++.+..++.++|+||+||++++|++|+.||.+
T Consensus 142 HrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCccccccccccceeeechhhhhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 9999999999999999999999987654443 223345678899999999999999999999999999999999999987
Q ss_pred CCHHHHHHHHhhCCcc--------------------CC--------------C------CCCCCHHHHHHHHHHcccCCC
Q 027225 155 LNPAQVVAAVGFKGKR--------------------LE--------------I------PRNVNPHVASIIEACWANEPW 194 (226)
Q Consensus 155 ~~~~~~~~~~~~~~~~--------------------~~--------------~------~~~~~~~~~~li~~~l~~~p~ 194 (226)
.+.......+...... .. . ....++++.+||++||..||+
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 7665543332110000 00 0 012357899999999999999
Q ss_pred CCCCHHHHHHHHHHhhcC
Q 027225 195 KRPSFSTIMELLRPLIKS 212 (226)
Q Consensus 195 ~Rps~~~~l~~l~~~~~~ 212 (226)
+|||++|+++ +++++.
T Consensus 301 ~R~ta~elL~--Hpw~~~ 316 (355)
T d2b1pa1 301 KRISVDDALQ--HPYINV 316 (355)
T ss_dssp TSCCHHHHHT--STTTGG
T ss_pred HCcCHHHHhc--CcccCC
Confidence 9999999998 777765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-35 Score=230.99 Aligned_cols=204 Identities=18% Similarity=0.297 Sum_probs=149.9
Q ss_pred CCcCcceeeeEEecC--CceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEeCCCCC
Q 027225 5 RHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSP 81 (226)
Q Consensus 5 ~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i~h~di~p~ 81 (226)
.|+||+++++++... ...+++++++..+..............+++..+..++.|++.||.|||+ .| |+||||||+
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~ 155 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPE 155 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGG
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChh
Confidence 579999999998653 4566666665544333332222224558999999999999999999998 89 999999999
Q ss_pred cEEEcCCC------cEEEccCCCcccccccccccCCCCCCCCccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 027225 82 NLLVDKKY------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155 (226)
Q Consensus 82 nil~~~~~------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 155 (226)
||+++.++ .++++|||.+...... .....+++.|+|||++.+..++.++|+||+||++++|++|+.||...
T Consensus 156 NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 156 NVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred HeeeeccCcccccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 99998655 3899999998654432 34566888999999999988999999999999999999999998643
Q ss_pred CHH-------HHHHHHhhCC---------------------------------------ccCCCCCCCCHHHHHHHHHHc
Q 027225 156 NPA-------QVVAAVGFKG---------------------------------------KRLEIPRNVNPHVASIIEACW 189 (226)
Q Consensus 156 ~~~-------~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~li~~~l 189 (226)
... .......... .....+...++++.+||.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 211 0111000000 000112234678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhcCCCC
Q 027225 190 ANEPWKRPSFSTIMELLRPLIKSPTP 215 (226)
Q Consensus 190 ~~~p~~Rps~~~~l~~l~~~~~~~~~ 215 (226)
..||.+|||++|+++ ++++++...
T Consensus 313 ~~dP~~Rpta~e~L~--Hp~f~~~~~ 336 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVN--HPWLKDTLG 336 (362)
T ss_dssp CSSTTTCBCHHHHHT--CGGGTTCTT
T ss_pred CCChhHCcCHHHHhc--CcccCCCCC
Confidence 999999999999998 888885543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.60 E-value=3.5e-16 Score=110.91 Aligned_cols=85 Identities=20% Similarity=0.244 Sum_probs=67.9
Q ss_pred CCCCCcCcceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 027225 2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81 (226)
Q Consensus 2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i~h~di~p~ 81 (226)
.++.|.+++..+++. ..+++||++++..+.+ ++...+..++.|++.++.+||+.| ++||||||+
T Consensus 69 ~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~ 132 (191)
T d1zara2 69 QKLQGLAVPKVYAWE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQY 132 (191)
T ss_dssp HHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTT
T ss_pred HHccCCCcceEEEec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChh
Confidence 356788888877653 2489999998765433 334445678999999999999999 999999999
Q ss_pred cEEEcCCCcEEEccCCCccccc
Q 027225 82 NLLVDKKYTVKVCDFGLSRLKA 103 (226)
Q Consensus 82 nil~~~~~~~~l~df~~~~~~~ 103 (226)
||+++++ .++|+|||.+....
T Consensus 133 NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 133 NVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp SEEEETT-EEEECCCTTCEETT
T ss_pred heeeeCC-CEEEEECCCcccCC
Confidence 9999976 58999999886543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.01 E-value=5.5e-06 Score=60.14 Aligned_cols=84 Identities=12% Similarity=0.055 Sum_probs=58.3
Q ss_pred cceeeeEEecCCceEEEEeecccCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC------------------
Q 027225 9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN------------------ 70 (226)
Q Consensus 9 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~------------------ 70 (226)
+.+++.+..+++..++||++++|.++.+..... .... .+..++...+..||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~---~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~ 143 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QSPE---KIIELYAECIRLFHSIDISDCPYTNSLDSRLAELD 143 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SCHH---HHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEeccccccccccccc-----ccHH---HHHHHHHHHHHHHhccCccccccCcchhhhhhhHH
Confidence 467788888888899999999998886654321 1111 23344445555555321
Q ss_pred ---------------------------------------CCeEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 71 ---------------------------------------PPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 71 ---------------------------------------~~i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
..++|+|+.|.||++++++..-++||+.+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 144 YLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137999999999999987666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.53 E-value=4.9e-05 Score=54.63 Aligned_cols=28 Identities=25% Similarity=0.330 Sum_probs=24.4
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCcc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 100 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~ 100 (226)
++|+|+.|.||+++.++.+.++||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987667899998653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.10 E-value=0.0057 Score=46.59 Aligned_cols=28 Identities=21% Similarity=0.401 Sum_probs=24.7
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|||+++.|||++++ .++++|+..+..
T Consensus 225 LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 225 LIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred eeccCCcCCceeEcCC-ceEEechhhccc
Confidence 9999999999999877 589999987653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.63 E-value=0.0019 Score=47.65 Aligned_cols=29 Identities=21% Similarity=0.229 Sum_probs=26.0
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.++||+++++...-+.||+.++.
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcchhhhhcccccceeEeccccccc
Confidence 99999999999999987778999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.53 E-value=0.13 Score=37.58 Aligned_cols=27 Identities=22% Similarity=0.215 Sum_probs=22.5
Q ss_pred eEEeCCCCCcEEEcCCCcEEEccCCCccc
Q 027225 73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 101 (226)
Q Consensus 73 i~h~di~p~nil~~~~~~~~l~df~~~~~ 101 (226)
++|+|+.+.||+++++ ..++||+-++.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899997754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=89.36 E-value=0.072 Score=40.23 Aligned_cols=15 Identities=40% Similarity=0.689 Sum_probs=13.2
Q ss_pred eEEeCCCCCcEEEcC
Q 027225 73 IVHRDLKSPNLLVDK 87 (226)
Q Consensus 73 i~h~di~p~nil~~~ 87 (226)
++|+|+.+.||++..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 689999999999853
|